Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'Okihiro (syndrome de)'
(id=16837048 ; fe=Okihiro (syndrome de) ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=2146 creation date=2021-07-24 touchdate=2025-11-02 05:09:28.000)
≈ 6349 relations sortantes

  1. Okihiro (syndrome de) -- r_associated #0: 60 / 1 -> syndrome
    n1=Okihiro (syndrome de) | n2=syndrome | rel=r_associated | relid=0 | w=60
  2. Okihiro (syndrome de) -- r_associated #0: 55 / 0.917 -> Okihiro
    n1=Okihiro (syndrome de) | n2=Okihiro | rel=r_associated | relid=0 | w=55
  3. Okihiro (syndrome de) -- r_associated #0: 33 / 0.55 -> oléome
    n1=Okihiro (syndrome de) | n2=oléome | rel=r_associated | relid=0 | w=33
  4. Okihiro (syndrome de) -- r_associated #0: 29 / 0.483 -> Duane (syndrome de)
    n1=Okihiro (syndrome de) | n2=Duane (syndrome de) | rel=r_associated | relid=0 | w=29
  5. Okihiro (syndrome de) -- r_associated #0: 29 / 0.483 -> olézapine
    n1=Okihiro (syndrome de) | n2=olézapine | rel=r_associated | relid=0 | w=29
  6. Okihiro (syndrome de) -- r_associated #0: 28 / 0.467 -> olécranectomie
    n1=Okihiro (syndrome de) | n2=olécranectomie | rel=r_associated | relid=0 | w=28
  7. Okihiro (syndrome de) -- r_associated #0: 28 / 0.467 -> oléome pulmonaire
    n1=Okihiro (syndrome de) | n2=oléome pulmonaire | rel=r_associated | relid=0 | w=28
  8. Okihiro (syndrome de) -- r_associated #0: 27 / 0.45 -> en:Okihiro's syndrome
    n1=Okihiro (syndrome de) | n2=en:Okihiro's syndrome | rel=r_associated | relid=0 | w=27
  9. Okihiro (syndrome de) -- r_associated #0: 27 / 0.45 -> neuroleptiques
    n1=Okihiro (syndrome de) | n2=neuroleptiques | rel=r_associated | relid=0 | w=27
  10. Okihiro (syndrome de) -- r_associated #0: 27 / 0.45 -> OKT3
    n1=Okihiro (syndrome de) | n2=OKT3 | rel=r_associated | relid=0 | w=27
  11. Okihiro (syndrome de) -- r_associated #0: 27 / 0.45 -> olanzapine
    n1=Okihiro (syndrome de) | n2=olanzapine | rel=r_associated | relid=0 | w=27
  12. Okihiro (syndrome de) -- r_associated #0: 26 / 0.433 -> olécrâne
    n1=Okihiro (syndrome de) | n2=olécrâne | rel=r_associated | relid=0 | w=26
  13. Okihiro (syndrome de) -- r_associated #0: 26 / 0.433 -> syndrome de Duane
    n1=Okihiro (syndrome de) | n2=syndrome de Duane | rel=r_associated | relid=0 | w=26
  14. Okihiro (syndrome de) -- r_associated #0: 26 / 0.433 -> syndrome de Okihiro
    n1=Okihiro (syndrome de) | n2=syndrome de Okihiro | rel=r_associated | relid=0 | w=26
  15. Okihiro (syndrome de) -- r_associated #0: 25 / 0.417 -> chimie
    n1=Okihiro (syndrome de) | n2=chimie | rel=r_associated | relid=0 | w=25
  16. Okihiro (syndrome de) -- r_associated #0: 25 / 0.417 -> médecine
    n1=Okihiro (syndrome de) | n2=médecine | rel=r_associated | relid=0 | w=25
  17. Okihiro (syndrome de) -- r_associated #0: 24 / 0.4 -> oléine
    n1=Okihiro (syndrome de) | n2=oléine | rel=r_associated | relid=0 | w=24
  18. Okihiro (syndrome de) -- r_associated #0: 21 / 0.35 -> (syndrome de)
    n1=Okihiro (syndrome de) | n2=(syndrome de) | rel=r_associated | relid=0 | w=21
  19. Okihiro (syndrome de) -- r_associated #0: 20 / 0.333 -> en:duane syndrome
    n1=Okihiro (syndrome de) | n2=en:duane syndrome | rel=r_associated | relid=0 | w=20
  20. Okihiro (syndrome de) -- r_associated #0: 20 / 0.333 -> syndrome de duane
    n1=Okihiro (syndrome de) | n2=syndrome de duane | rel=r_associated | relid=0 | w=20
  21. Okihiro (syndrome de) -- r_associated #0: 20 / 0.333 -> syndrome de Türk-Stilling-Duane
    n1=Okihiro (syndrome de) | n2=syndrome de Türk-Stilling-Duane | rel=r_associated | relid=0 | w=20
  22. Okihiro (syndrome de) -- r_associated #0: 15 / 0.25 -> pharmacie
    n1=Okihiro (syndrome de) | n2=pharmacie | rel=r_associated | relid=0 | w=15
  23. Okihiro (syndrome de) -- r_associated #0: 11 / 0.183 -> processus pathologique
    n1=Okihiro (syndrome de) | n2=processus pathologique | rel=r_associated | relid=0 | w=11
  24. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> acide 9-octadécénoïque
    n1=Okihiro (syndrome de) | n2=acide 9-octadécénoïque | rel=r_associated | relid=0 | w=10
  25. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> acide oléique
    n1=Okihiro (syndrome de) | n2=acide oléique | rel=r_associated | relid=0 | w=10
  26. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> aérosol
    n1=Okihiro (syndrome de) | n2=aérosol | rel=r_associated | relid=0 | w=10
  27. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> air médical
    n1=Okihiro (syndrome de) | n2=air médical | rel=r_associated | relid=0 | w=10
  28. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> anatomie
    n1=Okihiro (syndrome de) | n2=anatomie | rel=r_associated | relid=0 | w=10
  29. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> anatomie
    (ensemble des organes)
    n1=Okihiro (syndrome de) | n2=anatomie
    (ensemble des organes)
    | rel=r_associated | relid=0 | w=10
  30. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> anatomie
    (science)
    n1=Okihiro (syndrome de) | n2=anatomie
    (science)
    | rel=r_associated | relid=0 | w=10
  31. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> anticorps OKT
    n1=Okihiro (syndrome de) | n2=anticorps OKT | rel=r_associated | relid=0 | w=10
  32. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> antipsychotique
    n1=Okihiro (syndrome de) | n2=antipsychotique | rel=r_associated | relid=0 | w=10
  33. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> apophyse
    n1=Okihiro (syndrome de) | n2=apophyse | rel=r_associated | relid=0 | w=10
  34. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> articulation
    n1=Okihiro (syndrome de) | n2=articulation | rel=r_associated | relid=0 | w=10
  35. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> CD3
    n1=Okihiro (syndrome de) | n2=CD3 | rel=r_associated | relid=0 | w=10
  36. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> Chimie
    n1=Okihiro (syndrome de) | n2=Chimie | rel=r_associated | relid=0 | w=10
  37. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> corps
    n1=Okihiro (syndrome de) | n2=corps | rel=r_associated | relid=0 | w=10
  38. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> corps
    (anatomie)
    n1=Okihiro (syndrome de) | n2=corps
    (anatomie)
    | rel=r_associated | relid=0 | w=10
  39. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> coude
    n1=Okihiro (syndrome de) | n2=coude | rel=r_associated | relid=0 | w=10
  40. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> coude droit
    n1=Okihiro (syndrome de) | n2=coude droit | rel=r_associated | relid=0 | w=10
  41. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> coude gauche
    n1=Okihiro (syndrome de) | n2=coude gauche | rel=r_associated | relid=0 | w=10
  42. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> coude
    (bras)
    n1=Okihiro (syndrome de) | n2=coude
    (bras)
    | rel=r_associated | relid=0 | w=10
  43. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> cubitus
    n1=Okihiro (syndrome de) | n2=cubitus | rel=r_associated | relid=0 | w=10
  44. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> élaïne
    n1=Okihiro (syndrome de) | n2=élaïne | rel=r_associated | relid=0 | w=10
  45. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:(61)cu-atsm
    n1=Okihiro (syndrome de) | n2=en:(61)cu-atsm | rel=r_associated | relid=0 | w=10
  46. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:[18f]-labeled substance p antagonist receptor quantifier
    n1=Okihiro (syndrome de) | n2=en:[18f]-labeled substance p antagonist receptor quantifier | rel=r_associated | relid=0 | w=10
  47. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:[18f]l-fac
    n1=Okihiro (syndrome de) | n2=en:[18f]l-fac | rel=r_associated | relid=0 | w=10
  48. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:[18f]l-fmac
    n1=Okihiro (syndrome de) | n2=en:[18f]l-fmac | rel=r_associated | relid=0 | w=10
  49. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:1,2-carbon c 13-labeled glucose
    n1=Okihiro (syndrome de) | n2=en:1,2-carbon c 13-labeled glucose | rel=r_associated | relid=0 | w=10
  50. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:11c topotecan
    n1=Okihiro (syndrome de) | n2=en:11c topotecan | rel=r_associated | relid=0 | w=10
  51. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:13-deoxydoxorubicin
    n1=Okihiro (syndrome de) | n2=en:13-deoxydoxorubicin | rel=r_associated | relid=0 | w=10
  52. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:14c bms-275183
    n1=Okihiro (syndrome de) | n2=en:14c bms-275183 | rel=r_associated | relid=0 | w=10
  53. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:16,16-dimethyl prostaglandin e2
    n1=Okihiro (syndrome de) | n2=en:16,16-dimethyl prostaglandin e2 | rel=r_associated | relid=0 | w=10
  54. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:18-f-fluoroacetate
    n1=Okihiro (syndrome de) | n2=en:18-f-fluoroacetate | rel=r_associated | relid=0 | w=10
  55. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:18f-fhbg
    n1=Okihiro (syndrome de) | n2=en:18f-fhbg | rel=r_associated | relid=0 | w=10
  56. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:18f-fluoroazomycin arabinoside
    n1=Okihiro (syndrome de) | n2=en:18f-fluoroazomycin arabinoside | rel=r_associated | relid=0 | w=10
  57. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:18f-fluoromisonidazole
    n1=Okihiro (syndrome de) | n2=en:18f-fluoromisonidazole | rel=r_associated | relid=0 | w=10
  58. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:18f-labeled mini-peg spacered rgd dimer
    n1=Okihiro (syndrome de) | n2=en:18f-labeled mini-peg spacered rgd dimer | rel=r_associated | relid=0 | w=10
  59. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:1st generation/typical
    n1=Okihiro (syndrome de) | n2=en:1st generation/typical | rel=r_associated | relid=0 | w=10
  60. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:2-0, 3-0 desulfated heparin
    n1=Okihiro (syndrome de) | n2=en:2-0, 3-0 desulfated heparin | rel=r_associated | relid=0 | w=10
  61. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:2-deoxy-d-glucose
    n1=Okihiro (syndrome de) | n2=en:2-deoxy-d-glucose | rel=r_associated | relid=0 | w=10
  62. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:2-fluoropropionyl-labeled pegylated dimeric rgd peptide
    n1=Okihiro (syndrome de) | n2=en:2-fluoropropionyl-labeled pegylated dimeric rgd peptide | rel=r_associated | relid=0 | w=10
  63. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:2-hydroxyflutamide depot
    n1=Okihiro (syndrome de) | n2=en:2-hydroxyflutamide depot | rel=r_associated | relid=0 | w=10
  64. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:2-hydroxyoleic acid
    n1=Okihiro (syndrome de) | n2=en:2-hydroxyoleic acid | rel=r_associated | relid=0 | w=10
  65. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:2-methoxyestradiol
    n1=Okihiro (syndrome de) | n2=en:2-methoxyestradiol | rel=r_associated | relid=0 | w=10
  66. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:2-methoxyestradiol nanocrystal colloidal dispersion
    n1=Okihiro (syndrome de) | n2=en:2-methoxyestradiol nanocrystal colloidal dispersion | rel=r_associated | relid=0 | w=10
  67. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:2-octyl cyanocrylate
    n1=Okihiro (syndrome de) | n2=en:2-octyl cyanocrylate | rel=r_associated | relid=0 | w=10
  68. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:2'-f-ara-deoxyuridine
    n1=Okihiro (syndrome de) | n2=en:2'-f-ara-deoxyuridine | rel=r_associated | relid=0 | w=10
  69. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:2g-1 tcr retroviral vector-transduced lymphocytes
    n1=Okihiro (syndrome de) | n2=en:2g-1 tcr retroviral vector-transduced lymphocytes | rel=r_associated | relid=0 | w=10
  70. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:3-deazauridine
    n1=Okihiro (syndrome de) | n2=en:3-deazauridine | rel=r_associated | relid=0 | w=10
  71. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:3,4-methylenedioxymethamphetamine
    n1=Okihiro (syndrome de) | n2=en:3,4-methylenedioxymethamphetamine | rel=r_associated | relid=0 | w=10
  72. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:3'-aminomethyl nicotine-p. aeruginosa r-exoprotein a conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:3'-aminomethyl nicotine-p. aeruginosa r-exoprotein a conjugate vaccine | rel=r_associated | relid=0 | w=10
  73. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:3'-c-ethynylcytidine
    n1=Okihiro (syndrome de) | n2=en:3'-c-ethynylcytidine | rel=r_associated | relid=0 | w=10
  74. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:4-(n-(s-glutathionylacetyl)amino)phenylarsenoxide
    n1=Okihiro (syndrome de) | n2=en:4-(n-(s-glutathionylacetyl)amino)phenylarsenoxide | rel=r_associated | relid=0 | w=10
  75. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:4-1bb agonist monoclonal antibody pf-05082566
    n1=Okihiro (syndrome de) | n2=en:4-1bb agonist monoclonal antibody pf-05082566 | rel=r_associated | relid=0 | w=10
  76. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:4-nitroestrone 3-methyl ether
    n1=Okihiro (syndrome de) | n2=en:4-nitroestrone 3-methyl ether | rel=r_associated | relid=0 | w=10
  77. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:4-peptide melanoma vaccine
    n1=Okihiro (syndrome de) | n2=en:4-peptide melanoma vaccine | rel=r_associated | relid=0 | w=10
  78. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:4-thio-2-deoxycytidine
    n1=Okihiro (syndrome de) | n2=en:4-thio-2-deoxycytidine | rel=r_associated | relid=0 | w=10
  79. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:4'-iodo-4'-deoxydoxorubicin
    n1=Okihiro (syndrome de) | n2=en:4'-iodo-4'-deoxydoxorubicin | rel=r_associated | relid=0 | w=10
  80. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:5-[18f]fluorouracil
    n1=Okihiro (syndrome de) | n2=en:5-[18f]fluorouracil | rel=r_associated | relid=0 | w=10
  81. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:5-fitc-labeled colon-heptapeptide
    n1=Okihiro (syndrome de) | n2=en:5-fitc-labeled colon-heptapeptide | rel=r_associated | relid=0 | w=10
  82. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:5-fitc-labeled gi-heptapeptide
    n1=Okihiro (syndrome de) | n2=en:5-fitc-labeled gi-heptapeptide | rel=r_associated | relid=0 | w=10
  83. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:5-fluoro-2-deoxycytidine
    n1=Okihiro (syndrome de) | n2=en:5-fluoro-2-deoxycytidine | rel=r_associated | relid=0 | w=10
  84. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:5-fluoropyrimidinone
    n1=Okihiro (syndrome de) | n2=en:5-fluoropyrimidinone | rel=r_associated | relid=0 | w=10
  85. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:5-fluorouracil/salicylic acid topical solution
    n1=Okihiro (syndrome de) | n2=en:5-fluorouracil/salicylic acid topical solution | rel=r_associated | relid=0 | w=10
  86. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:5-ht3 receptor antagonist
    n1=Okihiro (syndrome de) | n2=en:5-ht3 receptor antagonist | rel=r_associated | relid=0 | w=10
  87. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:50% oxygen/50% nitrous oxide premix
    n1=Okihiro (syndrome de) | n2=en:50% oxygen/50% nitrous oxide premix | rel=r_associated | relid=0 | w=10
  88. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:6-azauridine
    n1=Okihiro (syndrome de) | n2=en:6-azauridine | rel=r_associated | relid=0 | w=10
  89. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases isoform 3 inhibitor act-pfk-158
    n1=Okihiro (syndrome de) | n2=en:6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases isoform 3 inhibitor act-pfk-158 | rel=r_associated | relid=0 | w=10
  90. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:6,8-bis(benzylthio)octanoic acid
    n1=Okihiro (syndrome de) | n2=en:6,8-bis(benzylthio)octanoic acid | rel=r_associated | relid=0 | w=10
  91. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:7-aminoflunitrazepam
    n1=Okihiro (syndrome de) | n2=en:7-aminoflunitrazepam | rel=r_associated | relid=0 | w=10
  92. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:7-cyanoquinocarcinol
    n1=Okihiro (syndrome de) | n2=en:7-cyanoquinocarcinol | rel=r_associated | relid=0 | w=10
  93. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:7-hydroxystaurosporine
    n1=Okihiro (syndrome de) | n2=en:7-hydroxystaurosporine | rel=r_associated | relid=0 | w=10
  94. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:714-x
    n1=Okihiro (syndrome de) | n2=en:714-x | rel=r_associated | relid=0 | w=10
  95. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:8-hydroxyloxapine
    n1=Okihiro (syndrome de) | n2=en:8-hydroxyloxapine | rel=r_associated | relid=0 | w=10
  96. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:8-hydroxyquinoline sulfate ointment
    n1=Okihiro (syndrome de) | n2=en:8-hydroxyquinoline sulfate ointment | rel=r_associated | relid=0 | w=10
  97. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:851b gel
    n1=Okihiro (syndrome de) | n2=en:851b gel | rel=r_associated | relid=0 | w=10
  98. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abacavir or derivative
    n1=Okihiro (syndrome de) | n2=en:abacavir or derivative | rel=r_associated | relid=0 | w=10
  99. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abacavir sulfate
    n1=Okihiro (syndrome de) | n2=en:abacavir sulfate | rel=r_associated | relid=0 | w=10
  100. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abagovomab
    n1=Okihiro (syndrome de) | n2=en:abagovomab | rel=r_associated | relid=0 | w=10
  101. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abaperidone
    n1=Okihiro (syndrome de) | n2=en:abaperidone | rel=r_associated | relid=0 | w=10
  102. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abarelix
    n1=Okihiro (syndrome de) | n2=en:abarelix | rel=r_associated | relid=0 | w=10
  103. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abatacept
    n1=Okihiro (syndrome de) | n2=en:abatacept | rel=r_associated | relid=0 | w=10
  104. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abbv-221
    n1=Okihiro (syndrome de) | n2=en:abbv-221 | rel=r_associated | relid=0 | w=10
  105. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abemaciclib
    n1=Okihiro (syndrome de) | n2=en:abemaciclib | rel=r_associated | relid=0 | w=10
  106. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abexinostat
    n1=Okihiro (syndrome de) | n2=en:abexinostat | rel=r_associated | relid=0 | w=10
  107. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abiraterone acetate
    n1=Okihiro (syndrome de) | n2=en:abiraterone acetate | rel=r_associated | relid=0 | w=10
  108. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abortifacient agents
    n1=Okihiro (syndrome de) | n2=en:abortifacient agents | rel=r_associated | relid=0 | w=10
  109. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abp 215
    n1=Okihiro (syndrome de) | n2=en:abp 215 | rel=r_associated | relid=0 | w=10
  110. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abr-217620
    n1=Okihiro (syndrome de) | n2=en:abr-217620 | rel=r_associated | relid=0 | w=10
  111. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:absorbable adhesion barrier gel
    n1=Okihiro (syndrome de) | n2=en:absorbable adhesion barrier gel | rel=r_associated | relid=0 | w=10
  112. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:absorbable fibrin sealant patch
    n1=Okihiro (syndrome de) | n2=en:absorbable fibrin sealant patch | rel=r_associated | relid=0 | w=10
  113. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:absorbable gelatin sponge
    n1=Okihiro (syndrome de) | n2=en:absorbable gelatin sponge | rel=r_associated | relid=0 | w=10
  114. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:absorbable modified polymer hemostatic powder
    n1=Okihiro (syndrome de) | n2=en:absorbable modified polymer hemostatic powder | rel=r_associated | relid=0 | w=10
  115. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abt-510
    n1=Okihiro (syndrome de) | n2=en:abt-510 | rel=r_associated | relid=0 | w=10
  116. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abt-751
    n1=Okihiro (syndrome de) | n2=en:abt-751 | rel=r_associated | relid=0 | w=10
  117. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abvd regimen
    n1=Okihiro (syndrome de) | n2=en:abvd regimen | rel=r_associated | relid=0 | w=10
  118. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:abve regimen
    n1=Okihiro (syndrome de) | n2=en:abve regimen | rel=r_associated | relid=0 | w=10
  119. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ac regimen
    n1=Okihiro (syndrome de) | n2=en:ac regimen | rel=r_associated | relid=0 | w=10
  120. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ac-t regimen
    n1=Okihiro (syndrome de) | n2=en:ac-t regimen | rel=r_associated | relid=0 | w=10
  121. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acadesine
    n1=Okihiro (syndrome de) | n2=en:acadesine | rel=r_associated | relid=0 | w=10
  122. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acai berry juice
    n1=Okihiro (syndrome de) | n2=en:acai berry juice | rel=r_associated | relid=0 | w=10
  123. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acalabrutinib
    n1=Okihiro (syndrome de) | n2=en:acalabrutinib | rel=r_associated | relid=0 | w=10
  124. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acaprazine
    n1=Okihiro (syndrome de) | n2=en:acaprazine | rel=r_associated | relid=0 | w=10
  125. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acarbose
    n1=Okihiro (syndrome de) | n2=en:acarbose | rel=r_associated | relid=0 | w=10
  126. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acaricides
    n1=Okihiro (syndrome de) | n2=en:acaricides | rel=r_associated | relid=0 | w=10
  127. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ace inhibitor
    n1=Okihiro (syndrome de) | n2=en:ace inhibitor | rel=r_associated | relid=0 | w=10
  128. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acellular cadaveric dermal matrix
    n1=Okihiro (syndrome de) | n2=en:acellular cadaveric dermal matrix | rel=r_associated | relid=0 | w=10
  129. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acenocoumarol
    n1=Okihiro (syndrome de) | n2=en:acenocoumarol | rel=r_associated | relid=0 | w=10
  130. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acetaminophen
    n1=Okihiro (syndrome de) | n2=en:acetaminophen | rel=r_associated | relid=0 | w=10
  131. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acetazolamide sodium
    n1=Okihiro (syndrome de) | n2=en:acetazolamide sodium | rel=r_associated | relid=0 | w=10
  132. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acetic acid
    n1=Okihiro (syndrome de) | n2=en:acetic acid | rel=r_associated | relid=0 | w=10
  133. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acetic acid or derivative
    n1=Okihiro (syndrome de) | n2=en:acetic acid or derivative | rel=r_associated | relid=0 | w=10
  134. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acetohexamide
    n1=Okihiro (syndrome de) | n2=en:acetohexamide | rel=r_associated | relid=0 | w=10
  135. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acetophenazine
    n1=Okihiro (syndrome de) | n2=en:acetophenazine | rel=r_associated | relid=0 | w=10
  136. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acetophenazine maleate
    n1=Okihiro (syndrome de) | n2=en:acetophenazine maleate | rel=r_associated | relid=0 | w=10
  137. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acetyl-l-carnitine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:acetyl-l-carnitine hydrochloride | rel=r_associated | relid=0 | w=10
  138. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acetylcholine chloride
    n1=Okihiro (syndrome de) | n2=en:acetylcholine chloride | rel=r_associated | relid=0 | w=10
  139. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acetylcysteine
    n1=Okihiro (syndrome de) | n2=en:acetylcysteine | rel=r_associated | relid=0 | w=10
  140. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acitretin
    n1=Okihiro (syndrome de) | n2=en:acitretin | rel=r_associated | relid=0 | w=10
  141. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acivicin
    n1=Okihiro (syndrome de) | n2=en:acivicin | rel=r_associated | relid=0 | w=10
  142. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aclarubicin
    n1=Okihiro (syndrome de) | n2=en:aclarubicin | rel=r_associated | relid=0 | w=10
  143. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acodazole
    n1=Okihiro (syndrome de) | n2=en:acodazole | rel=r_associated | relid=0 | w=10
  144. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acolbifene hydrochloride
    n1=Okihiro (syndrome de) | n2=en:acolbifene hydrochloride | rel=r_associated | relid=0 | w=10
  145. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acoustic coupling fluid
    n1=Okihiro (syndrome de) | n2=en:acoustic coupling fluid | rel=r_associated | relid=0 | w=10
  146. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acridine carboxamide
    n1=Okihiro (syndrome de) | n2=en:acridine carboxamide | rel=r_associated | relid=0 | w=10
  147. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acromion
    n1=Okihiro (syndrome de) | n2=en:acromion | rel=r_associated | relid=0 | w=10
  148. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:actinium ac 225 lintuzumab
    n1=Okihiro (syndrome de) | n2=en:actinium ac 225 lintuzumab | rel=r_associated | relid=0 | w=10
  149. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:activated marrow infiltrating lymphocytes
    n1=Okihiro (syndrome de) | n2=en:activated marrow infiltrating lymphocytes | rel=r_associated | relid=0 | w=10
  150. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:activin type 2b receptor fc fusion protein stm 434
    n1=Okihiro (syndrome de) | n2=en:activin type 2b receptor fc fusion protein stm 434 | rel=r_associated | relid=0 | w=10
  151. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acyclovir
    n1=Okihiro (syndrome de) | n2=en:acyclovir | rel=r_associated | relid=0 | w=10
  152. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:acyclovir sodium
    n1=Okihiro (syndrome de) | n2=en:acyclovir sodium | rel=r_associated | relid=0 | w=10
  153. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ad-hcmv-flt3l
    n1=Okihiro (syndrome de) | n2=en:ad-hcmv-flt3l | rel=r_associated | relid=0 | w=10
  154. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ad-hcmv-tk
    n1=Okihiro (syndrome de) | n2=en:ad-hcmv-tk | rel=r_associated | relid=0 | w=10
  155. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ad-isf35
    n1=Okihiro (syndrome de) | n2=en:ad-isf35 | rel=r_associated | relid=0 | w=10
  156. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ad-reic/dkk3 vaccine
    n1=Okihiro (syndrome de) | n2=en:ad-reic/dkk3 vaccine | rel=r_associated | relid=0 | w=10
  157. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ad-sig-hmuc-1/ecdcd40l vaccine
    n1=Okihiro (syndrome de) | n2=en:ad-sig-hmuc-1/ecdcd40l vaccine | rel=r_associated | relid=0 | w=10
  158. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ad5-cmv-nis
    n1=Okihiro (syndrome de) | n2=en:ad5-cmv-nis | rel=r_associated | relid=0 | w=10
  159. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ad5-ycd/muttk(sr39)rep-adp
    n1=Okihiro (syndrome de) | n2=en:ad5-ycd/muttk(sr39)rep-adp | rel=r_associated | relid=0 | w=10
  160. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ad5-ycd/muttksr39rep-hil12
    n1=Okihiro (syndrome de) | n2=en:ad5-ycd/muttksr39rep-hil12 | rel=r_associated | relid=0 | w=10
  161. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ad5.sstr/tk.rgd
    n1=Okihiro (syndrome de) | n2=en:ad5.sstr/tk.rgd | rel=r_associated | relid=0 | w=10
  162. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ad5cmv-p53 gene
    n1=Okihiro (syndrome de) | n2=en:ad5cmv-p53 gene | rel=r_associated | relid=0 | w=10
  163. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ad5f35-lmp1/lmp2-transduced autologous dendritic cells
    n1=Okihiro (syndrome de) | n2=en:ad5f35-lmp1/lmp2-transduced autologous dendritic cells | rel=r_associated | relid=0 | w=10
  164. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ade regimen
    n1=Okihiro (syndrome de) | n2=en:ade regimen | rel=r_associated | relid=0 | w=10
  165. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adecatumumab
    n1=Okihiro (syndrome de) | n2=en:adecatumumab | rel=r_associated | relid=0 | w=10
  166. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adefovir dipivoxil
    n1=Okihiro (syndrome de) | n2=en:adefovir dipivoxil | rel=r_associated | relid=0 | w=10
  167. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenosine
    n1=Okihiro (syndrome de) | n2=en:adenosine | rel=r_associated | relid=0 | w=10
  168. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenosine a2 receptor agonists
    n1=Okihiro (syndrome de) | n2=en:adenosine a2 receptor agonists | rel=r_associated | relid=0 | w=10
  169. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenosine a2a receptor antagonist pbf-509
    n1=Okihiro (syndrome de) | n2=en:adenosine a2a receptor antagonist pbf-509 | rel=r_associated | relid=0 | w=10
  170. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenosine a3 receptor agonist cf102
    n1=Okihiro (syndrome de) | n2=en:adenosine a3 receptor agonist cf102 | rel=r_associated | relid=0 | w=10
  171. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenosine triphosphate
    n1=Okihiro (syndrome de) | n2=en:adenosine triphosphate | rel=r_associated | relid=0 | w=10
  172. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenosine-a2a receptor antagonist cpi-444
    n1=Okihiro (syndrome de) | n2=en:adenosine-a2a receptor antagonist cpi-444 | rel=r_associated | relid=0 | w=10
  173. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovector encoding mda7
    n1=Okihiro (syndrome de) | n2=en:adenovector encoding mda7 | rel=r_associated | relid=0 | w=10
  174. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201
    n1=Okihiro (syndrome de) | n2=en:adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201 | rel=r_associated | relid=0 | w=10
  175. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenoviral transduced hil-12-expressing autologous dendritic cells inxn-3001 plus activator ligand inxn-1001
    n1=Okihiro (syndrome de) | n2=en:adenoviral transduced hil-12-expressing autologous dendritic cells inxn-3001 plus activator ligand inxn-1001 | rel=r_associated | relid=0 | w=10
  176. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenoviral vector ad5-cea(6d) vaccine
    n1=Okihiro (syndrome de) | n2=en:adenoviral vector ad5-cea(6d) vaccine | rel=r_associated | relid=0 | w=10
  177. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus 5-cd40 ligand
    n1=Okihiro (syndrome de) | n2=en:adenovirus 5-cd40 ligand | rel=r_associated | relid=0 | w=10
  178. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus 5-human guanylyl cyclase c-padre vaccine
    n1=Okihiro (syndrome de) | n2=en:adenovirus 5-human guanylyl cyclase c-padre vaccine | rel=r_associated | relid=0 | w=10
  179. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus b7-1
    n1=Okihiro (syndrome de) | n2=en:adenovirus b7-1 | rel=r_associated | relid=0 | w=10
  180. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus encoding human aquaporin-1
    n1=Okihiro (syndrome de) | n2=en:adenovirus encoding human aquaporin-1 | rel=r_associated | relid=0 | w=10
  181. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus encoding rat her-2/neu
    n1=Okihiro (syndrome de) | n2=en:adenovirus encoding rat her-2/neu | rel=r_associated | relid=0 | w=10
  182. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus encoding recombinant human endostatin
    n1=Okihiro (syndrome de) | n2=en:adenovirus encoding recombinant human endostatin | rel=r_associated | relid=0 | w=10
  183. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus encoding tyrosinase/mart-1/magea6-transduced autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:adenovirus encoding tyrosinase/mart-1/magea6-transduced autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  184. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus her2-transduced autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:adenovirus her2-transduced autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  185. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus rsv-tk
    n1=Okihiro (syndrome de) | n2=en:adenovirus rsv-tk | rel=r_associated | relid=0 | w=10
  186. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus vector
    n1=Okihiro (syndrome de) | n2=en:adenovirus vector | rel=r_associated | relid=0 | w=10
  187. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus-encoding e.coli pnp
    n1=Okihiro (syndrome de) | n2=en:adenovirus-encoding e.coli pnp | rel=r_associated | relid=0 | w=10
  188. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus-mediated human interleukin-12
    n1=Okihiro (syndrome de) | n2=en:adenovirus-mediated human interleukin-12 | rel=r_associated | relid=0 | w=10
  189. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus-mediated human interleukin-12 inxn-2001 plus activator ligand inxn-1001
    n1=Okihiro (syndrome de) | n2=en:adenovirus-mediated human interleukin-12 inxn-2001 plus activator ligand inxn-1001 | rel=r_associated | relid=0 | w=10
  190. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus-p53 transduced dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:adenovirus-p53 transduced dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  191. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus-psa prostate cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:adenovirus-psa prostate cancer vaccine | rel=r_associated | relid=0 | w=10
  192. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adenovirus/cytomegalovirus/epstein-barr virus-specific allogeneic cytotoxic t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:adenovirus/cytomegalovirus/epstein-barr virus-specific allogeneic cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  193. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adgmcaix-transduced autologous dendritic cells
    n1=Okihiro (syndrome de) | n2=en:adgmcaix-transduced autologous dendritic cells | rel=r_associated | relid=0 | w=10
  194. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adh-1
    n1=Okihiro (syndrome de) | n2=en:adh-1 | rel=r_associated | relid=0 | w=10
  195. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adinazolam
    n1=Okihiro (syndrome de) | n2=en:adinazolam | rel=r_associated | relid=0 | w=10
  196. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adinazolam mesylate
    n1=Okihiro (syndrome de) | n2=en:adinazolam mesylate | rel=r_associated | relid=0 | w=10
  197. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adipose-derived regenerative cells
    n1=Okihiro (syndrome de) | n2=en:adipose-derived regenerative cells | rel=r_associated | relid=0 | w=10
  198. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adipose-derived stromal vascular fraction cells
    n1=Okihiro (syndrome de) | n2=en:adipose-derived stromal vascular fraction cells | rel=r_associated | relid=0 | w=10
  199. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adozelesin
    n1=Okihiro (syndrome de) | n2=en:adozelesin | rel=r_associated | relid=0 | w=10
  200. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adrenal hormone preparation
    n1=Okihiro (syndrome de) | n2=en:adrenal hormone preparation | rel=r_associated | relid=0 | w=10
  201. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adrenergic alpha-antagonists [moa]
    n1=Okihiro (syndrome de) | n2=en:adrenergic alpha-antagonists [moa] | rel=r_associated | relid=0 | w=10
  202. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adrenergic beta-antagonists [moa]
    n1=Okihiro (syndrome de) | n2=en:adrenergic beta-antagonists [moa] | rel=r_associated | relid=0 | w=10
  203. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:adrtvp-1-transduced prostate cancer cell-based vaccine
    n1=Okihiro (syndrome de) | n2=en:adrtvp-1-transduced prostate cancer cell-based vaccine | rel=r_associated | relid=0 | w=10
  204. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ae37 peptide/gm-csf vaccine
    n1=Okihiro (syndrome de) | n2=en:ae37 peptide/gm-csf vaccine | rel=r_associated | relid=0 | w=10
  205. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aee788
    n1=Okihiro (syndrome de) | n2=en:aee788 | rel=r_associated | relid=0 | w=10
  206. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aeg35156
    n1=Okihiro (syndrome de) | n2=en:aeg35156 | rel=r_associated | relid=0 | w=10
  207. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aerosol sargramostim
    n1=Okihiro (syndrome de) | n2=en:aerosol sargramostim | rel=r_associated | relid=0 | w=10
  208. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aerosolized aldesleukin
    n1=Okihiro (syndrome de) | n2=en:aerosolized aldesleukin | rel=r_associated | relid=0 | w=10
  209. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aerosolized liposomal rubitecan
    n1=Okihiro (syndrome de) | n2=en:aerosolized liposomal rubitecan | rel=r_associated | relid=0 | w=10
  210. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:afamelanotide
    n1=Okihiro (syndrome de) | n2=en:afamelanotide | rel=r_associated | relid=0 | w=10
  211. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:afatinib dimaleate
    n1=Okihiro (syndrome de) | n2=en:afatinib dimaleate | rel=r_associated | relid=0 | w=10
  212. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:afimoxifene
    n1=Okihiro (syndrome de) | n2=en:afimoxifene | rel=r_associated | relid=0 | w=10
  213. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:afp gene hepatocellular carcinoma vaccine
    n1=Okihiro (syndrome de) | n2=en:afp gene hepatocellular carcinoma vaccine | rel=r_associated | relid=0 | w=10
  214. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:afp464
    n1=Okihiro (syndrome de) | n2=en:afp464 | rel=r_associated | relid=0 | w=10
  215. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:afuresertib
    n1=Okihiro (syndrome de) | n2=en:afuresertib | rel=r_associated | relid=0 | w=10
  216. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ag-024322
    n1=Okihiro (syndrome de) | n2=en:ag-024322 | rel=r_associated | relid=0 | w=10
  217. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:agaricus blazei murill extract
    n1=Okihiro (syndrome de) | n2=en:agaricus blazei murill extract | rel=r_associated | relid=0 | w=10
  218. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:agatolimod sodium
    n1=Okihiro (syndrome de) | n2=en:agatolimod sodium | rel=r_associated | relid=0 | w=10
  219. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:agent affecting cardiovascular system
    n1=Okihiro (syndrome de) | n2=en:agent affecting cardiovascular system | rel=r_associated | relid=0 | w=10
  220. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aglatimagene besadenovec
    n1=Okihiro (syndrome de) | n2=en:aglatimagene besadenovec | rel=r_associated | relid=0 | w=10
  221. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:agonistic anti-cd40 monoclonal antibody adc-1013
    n1=Okihiro (syndrome de) | n2=en:agonistic anti-cd40 monoclonal antibody adc-1013 | rel=r_associated | relid=0 | w=10
  222. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:agonistic anti-ox40 monoclonal antibody medi6383
    n1=Okihiro (syndrome de) | n2=en:agonistic anti-ox40 monoclonal antibody medi6383 | rel=r_associated | relid=0 | w=10
  223. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:agonistic anti-ox40 monoclonal antibody medi6469
    n1=Okihiro (syndrome de) | n2=en:agonistic anti-ox40 monoclonal antibody medi6469 | rel=r_associated | relid=0 | w=10
  224. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aim2(-1)/ht001(-1)/taf1b(-1) frameshift peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:aim2(-1)/ht001(-1)/taf1b(-1) frameshift peptide vaccine | rel=r_associated | relid=0 | w=10
  225. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ak 3012
    n1=Okihiro (syndrome de) | n2=en:ak 3012 | rel=r_associated | relid=0 | w=10
  226. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:akt 1/2 inhibitor bay1125976
    n1=Okihiro (syndrome de) | n2=en:akt 1/2 inhibitor bay1125976 | rel=r_associated | relid=0 | w=10
  227. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:akt inhibitor arq 092
    n1=Okihiro (syndrome de) | n2=en:akt inhibitor arq 092 | rel=r_associated | relid=0 | w=10
  228. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:akt inhibitor azd5363
    n1=Okihiro (syndrome de) | n2=en:akt inhibitor azd5363 | rel=r_associated | relid=0 | w=10
  229. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:akt inhibitor gsk2141795
    n1=Okihiro (syndrome de) | n2=en:akt inhibitor gsk2141795 | rel=r_associated | relid=0 | w=10
  230. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:akt inhibitor ly2780301
    n1=Okihiro (syndrome de) | n2=en:akt inhibitor ly2780301 | rel=r_associated | relid=0 | w=10
  231. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:akt inhibitor mk2206
    n1=Okihiro (syndrome de) | n2=en:akt inhibitor mk2206 | rel=r_associated | relid=0 | w=10
  232. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:akt inhibitor sr13668
    n1=Okihiro (syndrome de) | n2=en:akt inhibitor sr13668 | rel=r_associated | relid=0 | w=10
  233. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:akt-1/2 inhibitor-treated tumor infiltrating lymphocytes
    n1=Okihiro (syndrome de) | n2=en:akt-1/2 inhibitor-treated tumor infiltrating lymphocytes | rel=r_associated | relid=0 | w=10
  234. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:akt/erk inhibitor onc201
    n1=Okihiro (syndrome de) | n2=en:akt/erk inhibitor onc201 | rel=r_associated | relid=0 | w=10
  235. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:al721
    n1=Okihiro (syndrome de) | n2=en:al721 | rel=r_associated | relid=0 | w=10
  236. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alanosine
    n1=Okihiro (syndrome de) | n2=en:alanosine | rel=r_associated | relid=0 | w=10
  237. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:albumin
    n1=Okihiro (syndrome de) | n2=en:albumin | rel=r_associated | relid=0 | w=10
  238. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:albuterol sulfate
    n1=Okihiro (syndrome de) | n2=en:albuterol sulfate | rel=r_associated | relid=0 | w=10
  239. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alcohol
    n1=Okihiro (syndrome de) | n2=en:alcohol | rel=r_associated | relid=0 | w=10
  240. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alcohol [chemical class]
    n1=Okihiro (syndrome de) | n2=en:alcohol [chemical class] | rel=r_associated | relid=0 | w=10
  241. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alcohol deterrents
    n1=Okihiro (syndrome de) | n2=en:alcohol deterrents | rel=r_associated | relid=0 | w=10
  242. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alcohol products
    n1=Okihiro (syndrome de) | n2=en:alcohol products | rel=r_associated | relid=0 | w=10
  243. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aldesleukin
    n1=Okihiro (syndrome de) | n2=en:aldesleukin | rel=r_associated | relid=0 | w=10
  244. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aldoxorubicin
    n1=Okihiro (syndrome de) | n2=en:aldoxorubicin | rel=r_associated | relid=0 | w=10
  245. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alectinib
    n1=Okihiro (syndrome de) | n2=en:alectinib | rel=r_associated | relid=0 | w=10
  246. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alefacept
    n1=Okihiro (syndrome de) | n2=en:alefacept | rel=r_associated | relid=0 | w=10
  247. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alemtuzumab
    n1=Okihiro (syndrome de) | n2=en:alemtuzumab | rel=r_associated | relid=0 | w=10
  248. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alendronate sodium
    n1=Okihiro (syndrome de) | n2=en:alendronate sodium | rel=r_associated | relid=0 | w=10
  249. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alfentanil
    n1=Okihiro (syndrome de) | n2=en:alfentanil | rel=r_associated | relid=0 | w=10
  250. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alfentanil hydrochloride
    n1=Okihiro (syndrome de) | n2=en:alfentanil hydrochloride | rel=r_associated | relid=0 | w=10
  251. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alfuzosin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:alfuzosin hydrochloride | rel=r_associated | relid=0 | w=10
  252. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:algenpantucel-l
    n1=Okihiro (syndrome de) | n2=en:algenpantucel-l | rel=r_associated | relid=0 | w=10
  253. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alginic acid
    n1=Okihiro (syndrome de) | n2=en:alginic acid | rel=r_associated | relid=0 | w=10
  254. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alisertib
    n1=Okihiro (syndrome de) | n2=en:alisertib | rel=r_associated | relid=0 | w=10
  255. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alitretinoin
    n1=Okihiro (syndrome de) | n2=en:alitretinoin | rel=r_associated | relid=0 | w=10
  256. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alizapride
    n1=Okihiro (syndrome de) | n2=en:alizapride | rel=r_associated | relid=0 | w=10
  257. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alk inhibitor asp3026
    n1=Okihiro (syndrome de) | n2=en:alk inhibitor asp3026 | rel=r_associated | relid=0 | w=10
  258. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alk inhibitor ro5424802
    n1=Okihiro (syndrome de) | n2=en:alk inhibitor ro5424802 | rel=r_associated | relid=0 | w=10
  259. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alk inhibitor x-396
    n1=Okihiro (syndrome de) | n2=en:alk inhibitor x-396 | rel=r_associated | relid=0 | w=10
  260. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alk-fak inhibitor cep-37440
    n1=Okihiro (syndrome de) | n2=en:alk-fak inhibitor cep-37440 | rel=r_associated | relid=0 | w=10
  261. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alk/fak/pyk2 inhibitor ct-707
    n1=Okihiro (syndrome de) | n2=en:alk/fak/pyk2 inhibitor ct-707 | rel=r_associated | relid=0 | w=10
  262. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alk/ros1 inhibitor pf-06463922
    n1=Okihiro (syndrome de) | n2=en:alk/ros1 inhibitor pf-06463922 | rel=r_associated | relid=0 | w=10
  263. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alk/trk inhibitor tsr-011
    n1=Okihiro (syndrome de) | n2=en:alk/trk inhibitor tsr-011 | rel=r_associated | relid=0 | w=10
  264. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alk5 inhibitor tew-7197
    n1=Okihiro (syndrome de) | n2=en:alk5 inhibitor tew-7197 | rel=r_associated | relid=0 | w=10
  265. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alkaline water
    n1=Okihiro (syndrome de) | n2=en:alkaline water | rel=r_associated | relid=0 | w=10
  266. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alkalinizing agent (substance)
    n1=Okihiro (syndrome de) | n2=en:alkalinizing agent (substance) | rel=r_associated | relid=0 | w=10
  267. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alkyl sulfonate antineoplastic
    n1=Okihiro (syndrome de) | n2=en:alkyl sulfonate antineoplastic | rel=r_associated | relid=0 | w=10
  268. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allergen product
    n1=Okihiro (syndrome de) | n2=en:allergen product | rel=r_associated | relid=0 | w=10
  269. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allergenic extract
    n1=Okihiro (syndrome de) | n2=en:allergenic extract | rel=r_associated | relid=0 | w=10
  270. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allodepleted haploidentical t cells-expressing inducible caspase 9
    n1=Okihiro (syndrome de) | n2=en:allodepleted haploidentical t cells-expressing inducible caspase 9 | rel=r_associated | relid=0 | w=10
  271. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allodepleted t cell immunotherapeutic atir101
    n1=Okihiro (syndrome de) | n2=en:allodepleted t cell immunotherapeutic atir101 | rel=r_associated | relid=0 | w=10
  272. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic adenovirus-specific cytotoxic t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:allogeneic adenovirus-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  273. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic aml antigen-expressing dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:allogeneic aml antigen-expressing dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  274. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic b7.1/hla-a1 transfected tumor cell vaccine
    n1=Okihiro (syndrome de) | n2=en:allogeneic b7.1/hla-a1 transfected tumor cell vaccine | rel=r_associated | relid=0 | w=10
  275. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic cd19-specific car-modified cd8 plus central memory-derived virus-specific t cells
    n1=Okihiro (syndrome de) | n2=en:allogeneic cd19-specific car-modified cd8 plus central memory-derived virus-specific t cells | rel=r_associated | relid=0 | w=10
  276. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic cd4+ memory th1-like t cells/microparticle-bound anti-cd3/anti-cd28
    n1=Okihiro (syndrome de) | n2=en:allogeneic cd4+ memory th1-like t cells/microparticle-bound anti-cd3/anti-cd28 | rel=r_associated | relid=0 | w=10
  277. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic cd56-positive cd3-negative natural killer cells
    n1=Okihiro (syndrome de) | n2=en:allogeneic cd56-positive cd3-negative natural killer cells | rel=r_associated | relid=0 | w=10
  278. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic cmv/adv-specific cytotoxic t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:allogeneic cmv/adv-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  279. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic cytomegalovirus-specific cytotoxic t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:allogeneic cytomegalovirus-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  280. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic dendritic cell vaccine combig-dc
    n1=Okihiro (syndrome de) | n2=en:allogeneic dendritic cell vaccine combig-dc | rel=r_associated | relid=0 | w=10
  281. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic dendritic cell-myeloma idiotype vaccine
    n1=Okihiro (syndrome de) | n2=en:allogeneic dendritic cell-myeloma idiotype vaccine | rel=r_associated | relid=0 | w=10
  282. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic epstein-barr virus-specific cytotoxic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:allogeneic epstein-barr virus-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  283. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic glioblastoma stem-like cell line lysate-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:allogeneic glioblastoma stem-like cell line lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  284. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic gm-csf-based myeloma cell vaccine
    n1=Okihiro (syndrome de) | n2=en:allogeneic gm-csf-based myeloma cell vaccine | rel=r_associated | relid=0 | w=10
  285. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic gm-csf-secreting breast cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:allogeneic gm-csf-secreting breast cancer vaccine | rel=r_associated | relid=0 | w=10
  286. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic gm-csf-secreting lethally irradiated whole melanoma cell vaccine
    n1=Okihiro (syndrome de) | n2=en:allogeneic gm-csf-secreting lethally irradiated whole melanoma cell vaccine | rel=r_associated | relid=0 | w=10
  287. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic gm-csf-secreting tumor vaccine panc 10.05 pcdna-1/gm-neo
    n1=Okihiro (syndrome de) | n2=en:allogeneic gm-csf-secreting tumor vaccine panc 10.05 pcdna-1/gm-neo | rel=r_associated | relid=0 | w=10
  288. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic gm-csf-secreting tumor vaccine panc 6.03 pcdna-1/gm-neo
    n1=Okihiro (syndrome de) | n2=en:allogeneic gm-csf-secreting tumor vaccine panc 6.03 pcdna-1/gm-neo | rel=r_associated | relid=0 | w=10
  289. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic hla-a2/4-1bb ligand-expressing melanoma vaccine
    n1=Okihiro (syndrome de) | n2=en:allogeneic hla-a2/4-1bb ligand-expressing melanoma vaccine | rel=r_associated | relid=0 | w=10
  290. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic il13-zetakine/hytk-expressing-glucocorticoid resistant cytotoxic t lymphocytes grm13z40-2
    n1=Okihiro (syndrome de) | n2=en:allogeneic il13-zetakine/hytk-expressing-glucocorticoid resistant cytotoxic t lymphocytes grm13z40-2 | rel=r_associated | relid=0 | w=10
  291. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic irradiated melanoma cell vaccine csf470
    n1=Okihiro (syndrome de) | n2=en:allogeneic irradiated melanoma cell vaccine csf470 | rel=r_associated | relid=0 | w=10
  292. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic large multivalent immunogen breast cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:allogeneic large multivalent immunogen breast cancer vaccine | rel=r_associated | relid=0 | w=10
  293. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic large multivalent immunogen melanoma vaccine lp2307
    n1=Okihiro (syndrome de) | n2=en:allogeneic large multivalent immunogen melanoma vaccine lp2307 | rel=r_associated | relid=0 | w=10
  294. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic lmp1/lmp2-specific cytotoxic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:allogeneic lmp1/lmp2-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  295. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic melanoma vaccine agi-101h
    n1=Okihiro (syndrome de) | n2=en:allogeneic melanoma vaccine agi-101h | rel=r_associated | relid=0 | w=10
  296. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:allogeneic mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  297. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic multipotent adult progenitor cells
    n1=Okihiro (syndrome de) | n2=en:allogeneic multipotent adult progenitor cells | rel=r_associated | relid=0 | w=10
  298. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic multivirus-specific cytotoxic t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:allogeneic multivirus-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  299. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic natural killer cell line mg4101
    n1=Okihiro (syndrome de) | n2=en:allogeneic natural killer cell line mg4101 | rel=r_associated | relid=0 | w=10
  300. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic natural killer cell line nk-92
    n1=Okihiro (syndrome de) | n2=en:allogeneic natural killer cell line nk-92 | rel=r_associated | relid=0 | w=10
  301. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic renal cell carcinoma vaccine mgn1601
    n1=Okihiro (syndrome de) | n2=en:allogeneic renal cell carcinoma vaccine mgn1601 | rel=r_associated | relid=0 | w=10
  302. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic t-lymphocytes bpx-501
    n1=Okihiro (syndrome de) | n2=en:allogeneic t-lymphocytes bpx-501 | rel=r_associated | relid=0 | w=10
  303. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allogeneic tumor cell vaccine
    n1=Okihiro (syndrome de) | n2=en:allogeneic tumor cell vaccine | rel=r_associated | relid=0 | w=10
  304. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allopurinol
    n1=Okihiro (syndrome de) | n2=en:allopurinol | rel=r_associated | relid=0 | w=10
  305. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allopurinol and purine inhibitors
    n1=Okihiro (syndrome de) | n2=en:allopurinol and purine inhibitors | rel=r_associated | relid=0 | w=10
  306. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allosteric bcr-abl tyrosine kinase inhibitor abl001
    n1=Okihiro (syndrome de) | n2=en:allosteric bcr-abl tyrosine kinase inhibitor abl001 | rel=r_associated | relid=0 | w=10
  307. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:allovectin-7
    n1=Okihiro (syndrome de) | n2=en:allovectin-7 | rel=r_associated | relid=0 | w=10
  308. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:almurtide
    n1=Okihiro (syndrome de) | n2=en:almurtide | rel=r_associated | relid=0 | w=10
  309. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aloe vera gel
    n1=Okihiro (syndrome de) | n2=en:aloe vera gel | rel=r_associated | relid=0 | w=10
  310. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aloe/anise/ascorbic acid/clove/peppermint/spearmint/thyme-based mouthwash
    n1=Okihiro (syndrome de) | n2=en:aloe/anise/ascorbic acid/clove/peppermint/spearmint/thyme-based mouthwash | rel=r_associated | relid=0 | w=10
  311. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alogliptin
    n1=Okihiro (syndrome de) | n2=en:alogliptin | rel=r_associated | relid=0 | w=10
  312. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alopecia preparation
    n1=Okihiro (syndrome de) | n2=en:alopecia preparation | rel=r_associated | relid=0 | w=10
  313. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpelisib
    n1=Okihiro (syndrome de) | n2=en:alpelisib | rel=r_associated | relid=0 | w=10
  314. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpertine
    n1=Okihiro (syndrome de) | n2=en:alpertine | rel=r_associated | relid=0 | w=10
  315. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpha fetoprotein adenoviral vector vaccine
    n1=Okihiro (syndrome de) | n2=en:alpha fetoprotein adenoviral vector vaccine | rel=r_associated | relid=0 | w=10
  316. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpha fetoprotein plasmid dna vaccine
    n1=Okihiro (syndrome de) | n2=en:alpha fetoprotein plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  317. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpha galactosylceramide
    n1=Okihiro (syndrome de) | n2=en:alpha galactosylceramide | rel=r_associated | relid=0 | w=10
  318. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpha-1-proteinase inhibitor human
    n1=Okihiro (syndrome de) | n2=en:alpha-1-proteinase inhibitor human | rel=r_associated | relid=0 | w=10
  319. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma vaccine
    n1=Okihiro (syndrome de) | n2=en:alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma vaccine | rel=r_associated | relid=0 | w=10
  320. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpha-fetoprotein peptide-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:alpha-fetoprotein peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  321. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpha-folate receptor-targeting thymidylate synthase inhibitor onx-0801
    n1=Okihiro (syndrome de) | n2=en:alpha-folate receptor-targeting thymidylate synthase inhibitor onx-0801 | rel=r_associated | relid=0 | w=10
  322. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpha-gal glycosphingolipids
    n1=Okihiro (syndrome de) | n2=en:alpha-gal glycosphingolipids | rel=r_associated | relid=0 | w=10
  323. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpha-galactosylceramide-pulsed autologous dendritic cells
    n1=Okihiro (syndrome de) | n2=en:alpha-galactosylceramide-pulsed autologous dendritic cells | rel=r_associated | relid=0 | w=10
  324. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpha-lipoic acid
    n1=Okihiro (syndrome de) | n2=en:alpha-lipoic acid | rel=r_associated | relid=0 | w=10
  325. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpha-lipoic acid-palladium/vitamin/mineral supplement
    n1=Okihiro (syndrome de) | n2=en:alpha-lipoic acid-palladium/vitamin/mineral supplement | rel=r_associated | relid=0 | w=10
  326. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpha-tocopheryloxyacetic acid
    n1=Okihiro (syndrome de) | n2=en:alpha-tocopheryloxyacetic acid | rel=r_associated | relid=0 | w=10
  327. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alpha-type-1 polarized dendritic cells
    n1=Okihiro (syndrome de) | n2=en:alpha-type-1 polarized dendritic cells | rel=r_associated | relid=0 | w=10
  328. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alphaprodine
    n1=Okihiro (syndrome de) | n2=en:alphaprodine | rel=r_associated | relid=0 | w=10
  329. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alprazolam
    n1=Okihiro (syndrome de) | n2=en:alprazolam | rel=r_associated | relid=0 | w=10
  330. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alprostadil
    n1=Okihiro (syndrome de) | n2=en:alprostadil | rel=r_associated | relid=0 | w=10
  331. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alteplase
    n1=Okihiro (syndrome de) | n2=en:alteplase | rel=r_associated | relid=0 | w=10
  332. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:altiratinib
    n1=Okihiro (syndrome de) | n2=en:altiratinib | rel=r_associated | relid=0 | w=10
  333. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:altretamine
    n1=Okihiro (syndrome de) | n2=en:altretamine | rel=r_associated | relid=0 | w=10
  334. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aluminum and/or aluminum compound
    n1=Okihiro (syndrome de) | n2=en:aluminum and/or aluminum compound | rel=r_associated | relid=0 | w=10
  335. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aluminum hydroxide/magnesium hydroxide
    n1=Okihiro (syndrome de) | n2=en:aluminum hydroxide/magnesium hydroxide | rel=r_associated | relid=0 | w=10
  336. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aluminum sulfate
    n1=Okihiro (syndrome de) | n2=en:aluminum sulfate | rel=r_associated | relid=0 | w=10
  337. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alvac-cea b7.1 vaccine
    n1=Okihiro (syndrome de) | n2=en:alvac-cea b7.1 vaccine | rel=r_associated | relid=0 | w=10
  338. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alvac-cea vaccine
    n1=Okihiro (syndrome de) | n2=en:alvac-cea vaccine | rel=r_associated | relid=0 | w=10
  339. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alvac-eso-1 vaccine
    n1=Okihiro (syndrome de) | n2=en:alvac-eso-1 vaccine | rel=r_associated | relid=0 | w=10
  340. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alvac-hb7.1
    n1=Okihiro (syndrome de) | n2=en:alvac-hb7.1 | rel=r_associated | relid=0 | w=10
  341. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alvac-mart-1 vaccine
    n1=Okihiro (syndrome de) | n2=en:alvac-mart-1 vaccine | rel=r_associated | relid=0 | w=10
  342. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alvac(2) melanoma multi-antigen therapeutic vaccine
    n1=Okihiro (syndrome de) | n2=en:alvac(2) melanoma multi-antigen therapeutic vaccine | rel=r_associated | relid=0 | w=10
  343. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alvac(2)-ny-eso-1 (m)/tricom vaccine
    n1=Okihiro (syndrome de) | n2=en:alvac(2)-ny-eso-1 (m)/tricom vaccine | rel=r_associated | relid=0 | w=10
  344. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alvelestat
    n1=Okihiro (syndrome de) | n2=en:alvelestat | rel=r_associated | relid=0 | w=10
  345. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alvespimycin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:alvespimycin hydrochloride | rel=r_associated | relid=0 | w=10
  346. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alvimopan
    n1=Okihiro (syndrome de) | n2=en:alvimopan | rel=r_associated | relid=0 | w=10
  347. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:alvocidib hydrochloride
    n1=Okihiro (syndrome de) | n2=en:alvocidib hydrochloride | rel=r_associated | relid=0 | w=10
  348. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amantadine and derivatives
    n1=Okihiro (syndrome de) | n2=en:amantadine and derivatives | rel=r_associated | relid=0 | w=10
  349. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amantadine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:amantadine hydrochloride | rel=r_associated | relid=0 | w=10
  350. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amatuximab
    n1=Okihiro (syndrome de) | n2=en:amatuximab | rel=r_associated | relid=0 | w=10
  351. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:american ginseng
    n1=Okihiro (syndrome de) | n2=en:american ginseng | rel=r_associated | relid=0 | w=10
  352. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ametantrone
    n1=Okihiro (syndrome de) | n2=en:ametantrone | rel=r_associated | relid=0 | w=10
  353. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amg 224
    n1=Okihiro (syndrome de) | n2=en:amg 224 | rel=r_associated | relid=0 | w=10
  354. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amicarbalide
    n1=Okihiro (syndrome de) | n2=en:amicarbalide | rel=r_associated | relid=0 | w=10
  355. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amifampridine
    n1=Okihiro (syndrome de) | n2=en:amifampridine | rel=r_associated | relid=0 | w=10
  356. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amifostine
    n1=Okihiro (syndrome de) | n2=en:amifostine | rel=r_associated | relid=0 | w=10
  357. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amikacin sulfate
    n1=Okihiro (syndrome de) | n2=en:amikacin sulfate | rel=r_associated | relid=0 | w=10
  358. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amilomer
    n1=Okihiro (syndrome de) | n2=en:amilomer | rel=r_associated | relid=0 | w=10
  359. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amino acid injection
    n1=Okihiro (syndrome de) | n2=en:amino acid injection | rel=r_associated | relid=0 | w=10
  360. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aminobenzoate potassium
    n1=Okihiro (syndrome de) | n2=en:aminobenzoate potassium | rel=r_associated | relid=0 | w=10
  361. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aminocamptothecin
    n1=Okihiro (syndrome de) | n2=en:aminocamptothecin | rel=r_associated | relid=0 | w=10
  362. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aminocamptothecin colloidal dispersion
    n1=Okihiro (syndrome de) | n2=en:aminocamptothecin colloidal dispersion | rel=r_associated | relid=0 | w=10
  363. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aminocaproic acid
    n1=Okihiro (syndrome de) | n2=en:aminocaproic acid | rel=r_associated | relid=0 | w=10
  364. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aminoglutethimide
    n1=Okihiro (syndrome de) | n2=en:aminoglutethimide | rel=r_associated | relid=0 | w=10
  365. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aminoketone phenylethylamine derivative
    n1=Okihiro (syndrome de) | n2=en:aminoketone phenylethylamine derivative | rel=r_associated | relid=0 | w=10
  366. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aminolevulinic acid hydrochloride
    n1=Okihiro (syndrome de) | n2=en:aminolevulinic acid hydrochloride | rel=r_associated | relid=0 | w=10
  367. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aminophylline
    n1=Okihiro (syndrome de) | n2=en:aminophylline | rel=r_associated | relid=0 | w=10
  368. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aminopterin
    n1=Okihiro (syndrome de) | n2=en:aminopterin | rel=r_associated | relid=0 | w=10
  369. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aminosyn
    n1=Okihiro (syndrome de) | n2=en:aminosyn | rel=r_associated | relid=0 | w=10
  370. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aminothiadiazole
    n1=Okihiro (syndrome de) | n2=en:aminothiadiazole | rel=r_associated | relid=0 | w=10
  371. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amiodarone and derivatives
    n1=Okihiro (syndrome de) | n2=en:amiodarone and derivatives | rel=r_associated | relid=0 | w=10
  372. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amiodarone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:amiodarone hydrochloride | rel=r_associated | relid=0 | w=10
  373. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amiperone
    n1=Okihiro (syndrome de) | n2=en:amiperone | rel=r_associated | relid=0 | w=10
  374. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amitriptyline hydrochloride
    n1=Okihiro (syndrome de) | n2=en:amitriptyline hydrochloride | rel=r_associated | relid=0 | w=10
  375. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aml mrna positive lysate loaded autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:aml mrna positive lysate loaded autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  376. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ammonia n-13
    n1=Okihiro (syndrome de) | n2=en:ammonia n-13 | rel=r_associated | relid=0 | w=10
  377. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ammonium bicarbonate
    n1=Okihiro (syndrome de) | n2=en:ammonium bicarbonate | rel=r_associated | relid=0 | w=10
  378. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ammonium bromide
    n1=Okihiro (syndrome de) | n2=en:ammonium bromide | rel=r_associated | relid=0 | w=10
  379. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ammonium chloride
    n1=Okihiro (syndrome de) | n2=en:ammonium chloride | rel=r_associated | relid=0 | w=10
  380. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ammonium glycyrrhizate
    n1=Okihiro (syndrome de) | n2=en:ammonium glycyrrhizate | rel=r_associated | relid=0 | w=10
  381. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ammonium phosphate
    n1=Okihiro (syndrome de) | n2=en:ammonium phosphate | rel=r_associated | relid=0 | w=10
  382. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ammonium sulfate
    n1=Okihiro (syndrome de) | n2=en:ammonium sulfate | rel=r_associated | relid=0 | w=10
  383. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amnion-derived cellular cytokine solution
    n1=Okihiro (syndrome de) | n2=en:amnion-derived cellular cytokine solution | rel=r_associated | relid=0 | w=10
  384. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amolimogene bepiplasmid
    n1=Okihiro (syndrome de) | n2=en:amolimogene bepiplasmid | rel=r_associated | relid=0 | w=10
  385. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amonafide dihydrochloride
    n1=Okihiro (syndrome de) | n2=en:amonafide dihydrochloride | rel=r_associated | relid=0 | w=10
  386. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amonafide l-malate
    n1=Okihiro (syndrome de) | n2=en:amonafide l-malate | rel=r_associated | relid=0 | w=10
  387. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amoxicillin
    n1=Okihiro (syndrome de) | n2=en:amoxicillin | rel=r_associated | relid=0 | w=10
  388. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amoxicillin-clavulanate potassium
    n1=Okihiro (syndrome de) | n2=en:amoxicillin-clavulanate potassium | rel=r_associated | relid=0 | w=10
  389. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amphetamine and derivatives
    n1=Okihiro (syndrome de) | n2=en:amphetamine and derivatives | rel=r_associated | relid=0 | w=10
  390. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amphotericin b deoxycholate
    n1=Okihiro (syndrome de) | n2=en:amphotericin b deoxycholate | rel=r_associated | relid=0 | w=10
  391. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amphotericin product
    n1=Okihiro (syndrome de) | n2=en:amphotericin product | rel=r_associated | relid=0 | w=10
  392. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ampicillin sodium/sulbactam sodium
    n1=Okihiro (syndrome de) | n2=en:ampicillin sodium/sulbactam sodium | rel=r_associated | relid=0 | w=10
  393. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amrubicin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:amrubicin hydrochloride | rel=r_associated | relid=0 | w=10
  394. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amsacrine
    n1=Okihiro (syndrome de) | n2=en:amsacrine | rel=r_associated | relid=0 | w=10
  395. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amsilarotene
    n1=Okihiro (syndrome de) | n2=en:amsilarotene | rel=r_associated | relid=0 | w=10
  396. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amt2003
    n1=Okihiro (syndrome de) | n2=en:amt2003 | rel=r_associated | relid=0 | w=10
  397. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amuvatinib
    n1=Okihiro (syndrome de) | n2=en:amuvatinib | rel=r_associated | relid=0 | w=10
  398. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amylase
    n1=Okihiro (syndrome de) | n2=en:amylase | rel=r_associated | relid=0 | w=10
  399. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:amylin analog
    n1=Okihiro (syndrome de) | n2=en:amylin analog | rel=r_associated | relid=0 | w=10
  400. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anagrelide hydrochloride
    n1=Okihiro (syndrome de) | n2=en:anagrelide hydrochloride | rel=r_associated | relid=0 | w=10
  401. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anagrelide prolonged-release formulation
    n1=Okihiro (syndrome de) | n2=en:anagrelide prolonged-release formulation | rel=r_associated | relid=0 | w=10
  402. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anakinra
    n1=Okihiro (syndrome de) | n2=en:anakinra | rel=r_associated | relid=0 | w=10
  403. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:analgesic agent
    n1=Okihiro (syndrome de) | n2=en:analgesic agent | rel=r_associated | relid=0 | w=10
  404. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anamorelin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:anamorelin hydrochloride | rel=r_associated | relid=0 | w=10
  405. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anastrozole
    n1=Okihiro (syndrome de) | n2=en:anastrozole | rel=r_associated | relid=0 | w=10
  406. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anaxirone
    n1=Okihiro (syndrome de) | n2=en:anaxirone | rel=r_associated | relid=0 | w=10
  407. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ancestim
    n1=Okihiro (syndrome de) | n2=en:ancestim | rel=r_associated | relid=0 | w=10
  408. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ancitabine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:ancitabine hydrochloride | rel=r_associated | relid=0 | w=10
  409. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anconeal process of ulna
    n1=Okihiro (syndrome de) | n2=en:anconeal process of ulna | rel=r_associated | relid=0 | w=10
  410. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:androgen antagonist apc-100
    n1=Okihiro (syndrome de) | n2=en:androgen antagonist apc-100 | rel=r_associated | relid=0 | w=10
  411. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:androgen receptor antagonist arn-509
    n1=Okihiro (syndrome de) | n2=en:androgen receptor antagonist arn-509 | rel=r_associated | relid=0 | w=10
  412. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:androgen receptor antagonist shr3680
    n1=Okihiro (syndrome de) | n2=en:androgen receptor antagonist shr3680 | rel=r_associated | relid=0 | w=10
  413. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:androgen receptor antisense oligonucleotide azd5312
    n1=Okihiro (syndrome de) | n2=en:androgen receptor antisense oligonucleotide azd5312 | rel=r_associated | relid=0 | w=10
  414. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:androgen receptor antisense oligonucleotide ezn-4176
    n1=Okihiro (syndrome de) | n2=en:androgen receptor antisense oligonucleotide ezn-4176 | rel=r_associated | relid=0 | w=10
  415. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:androgen receptor inhibitor epi-506
    n1=Okihiro (syndrome de) | n2=en:androgen receptor inhibitor epi-506 | rel=r_associated | relid=0 | w=10
  416. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:androgen receptor ligand-binding domain-encoding plasmid dna vaccine mvi-118
    n1=Okihiro (syndrome de) | n2=en:androgen receptor ligand-binding domain-encoding plasmid dna vaccine mvi-118 | rel=r_associated | relid=0 | w=10
  417. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:androgenic steroid
    n1=Okihiro (syndrome de) | n2=en:androgenic steroid | rel=r_associated | relid=0 | w=10
  418. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:andrographolide
    n1=Okihiro (syndrome de) | n2=en:andrographolide | rel=r_associated | relid=0 | w=10
  419. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:androstane steroid he3235
    n1=Okihiro (syndrome de) | n2=en:androstane steroid he3235 | rel=r_associated | relid=0 | w=10
  420. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anesthetic agent
    n1=Okihiro (syndrome de) | n2=en:anesthetic agent | rel=r_associated | relid=0 | w=10
  421. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anetholtrithion
    n1=Okihiro (syndrome de) | n2=en:anetholtrithion | rel=r_associated | relid=0 | w=10
  422. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anetumab ravtansine
    n1=Okihiro (syndrome de) | n2=en:anetumab ravtansine | rel=r_associated | relid=0 | w=10
  423. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ang2/vegf-binding peptides-antibody fusion protein cvx-241
    n1=Okihiro (syndrome de) | n2=en:ang2/vegf-binding peptides-antibody fusion protein cvx-241 | rel=r_associated | relid=0 | w=10
  424. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:angelica sinensis root extract
    n1=Okihiro (syndrome de) | n2=en:angelica sinensis root extract | rel=r_associated | relid=0 | w=10
  425. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:angiogenesis inhibitor
    n1=Okihiro (syndrome de) | n2=en:angiogenesis inhibitor | rel=r_associated | relid=0 | w=10
  426. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:angiogenesis inhibitor gt-111
    n1=Okihiro (syndrome de) | n2=en:angiogenesis inhibitor gt-111 | rel=r_associated | relid=0 | w=10
  427. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:angiogenesis inhibitor ji-101
    n1=Okihiro (syndrome de) | n2=en:angiogenesis inhibitor ji-101 | rel=r_associated | relid=0 | w=10
  428. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:angiogenesis/heparanase inhibitor pg545
    n1=Okihiro (syndrome de) | n2=en:angiogenesis/heparanase inhibitor pg545 | rel=r_associated | relid=0 | w=10
  429. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:angiopoietin-2-specific fusion protein pf-04856884
    n1=Okihiro (syndrome de) | n2=en:angiopoietin-2-specific fusion protein pf-04856884 | rel=r_associated | relid=0 | w=10
  430. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:angiostatin
    n1=Okihiro (syndrome de) | n2=en:angiostatin | rel=r_associated | relid=0 | w=10
  431. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anguidine
    n1=Okihiro (syndrome de) | n2=en:anguidine | rel=r_associated | relid=0 | w=10
  432. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anhydrovinblastine
    n1=Okihiro (syndrome de) | n2=en:anhydrovinblastine | rel=r_associated | relid=0 | w=10
  433. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anidulafungin
    n1=Okihiro (syndrome de) | n2=en:anidulafungin | rel=r_associated | relid=0 | w=10
  434. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aniline mustard
    n1=Okihiro (syndrome de) | n2=en:aniline mustard | rel=r_associated | relid=0 | w=10
  435. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anion exchange resins
    n1=Okihiro (syndrome de) | n2=en:anion exchange resins | rel=r_associated | relid=0 | w=10
  436. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anisopirol
    n1=Okihiro (syndrome de) | n2=en:anisopirol | rel=r_associated | relid=0 | w=10
  437. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ankle mortise
    n1=Okihiro (syndrome de) | n2=en:ankle mortise | rel=r_associated | relid=0 | w=10
  438. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anlotinib hydrochloride
    n1=Okihiro (syndrome de) | n2=en:anlotinib hydrochloride | rel=r_associated | relid=0 | w=10
  439. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:annamycin liposomal
    n1=Okihiro (syndrome de) | n2=en:annamycin liposomal | rel=r_associated | relid=0 | w=10
  440. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:annonaceous acetogenins
    n1=Okihiro (syndrome de) | n2=en:annonaceous acetogenins | rel=r_associated | relid=0 | w=10
  441. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anterior foramen magnum
    n1=Okihiro (syndrome de) | n2=en:anterior foramen magnum | rel=r_associated | relid=0 | w=10
  442. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anthocyanin-rich corn extract
    n1=Okihiro (syndrome de) | n2=en:anthocyanin-rich corn extract | rel=r_associated | relid=0 | w=10
  443. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anthracycline analogue gpx-150
    n1=Okihiro (syndrome de) | n2=en:anthracycline analogue gpx-150 | rel=r_associated | relid=0 | w=10
  444. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anthralin
    n1=Okihiro (syndrome de) | n2=en:anthralin | rel=r_associated | relid=0 | w=10
  445. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti c-kit antibody-drug conjugate lop628
    n1=Okihiro (syndrome de) | n2=en:anti c-kit antibody-drug conjugate lop628 | rel=r_associated | relid=0 | w=10
  446. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti glaucoma preparation
    n1=Okihiro (syndrome de) | n2=en:anti glaucoma preparation | rel=r_associated | relid=0 | w=10
  447. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-5t4 antibody-drug conjugate pf-06263507
    n1=Okihiro (syndrome de) | n2=en:anti-5t4 antibody-drug conjugate pf-06263507 | rel=r_associated | relid=0 | w=10
  448. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-a33 monoclonal antibody krn330
    n1=Okihiro (syndrome de) | n2=en:anti-a33 monoclonal antibody krn330 | rel=r_associated | relid=0 | w=10
  449. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-a5b1 integrin monoclonal antibody pf-04605412
    n1=Okihiro (syndrome de) | n2=en:anti-a5b1 integrin monoclonal antibody pf-04605412 | rel=r_associated | relid=0 | w=10
  450. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ags-16 monoclonal antibody ags-16m18
    n1=Okihiro (syndrome de) | n2=en:anti-ags-16 monoclonal antibody ags-16m18 | rel=r_associated | relid=0 | w=10
  451. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ags-5 antibody-drug conjugate asg-5me
    n1=Okihiro (syndrome de) | n2=en:anti-ags-5 antibody-drug conjugate asg-5me | rel=r_associated | relid=0 | w=10
  452. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ags-8 monoclonal antibody ags-8m4
    n1=Okihiro (syndrome de) | n2=en:anti-ags-8 monoclonal antibody ags-8m4 | rel=r_associated | relid=0 | w=10
  453. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-alk-1 monoclonal antibody pf-03446962
    n1=Okihiro (syndrome de) | n2=en:anti-alk-1 monoclonal antibody pf-03446962 | rel=r_associated | relid=0 | w=10
  454. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-allergic agents
    n1=Okihiro (syndrome de) | n2=en:anti-allergic agents | rel=r_associated | relid=0 | w=10
  455. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-alpha5beta1 integrin antibody mint1526a
    n1=Okihiro (syndrome de) | n2=en:anti-alpha5beta1 integrin antibody mint1526a | rel=r_associated | relid=0 | w=10
  456. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-alphavbeta3 monoclonal antibody emd 525797
    n1=Okihiro (syndrome de) | n2=en:anti-alphavbeta3 monoclonal antibody emd 525797 | rel=r_associated | relid=0 | w=10
  457. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-amyloid monoclonal antibody neod001
    n1=Okihiro (syndrome de) | n2=en:anti-amyloid monoclonal antibody neod001 | rel=r_associated | relid=0 | w=10
  458. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ang2 monoclonal antibody medi-3617
    n1=Okihiro (syndrome de) | n2=en:anti-ang2 monoclonal antibody medi-3617 | rel=r_associated | relid=0 | w=10
  459. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-angiopoietin monoclonal antibody amg 780
    n1=Okihiro (syndrome de) | n2=en:anti-angiopoietin monoclonal antibody amg 780 | rel=r_associated | relid=0 | w=10
  460. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-b4 blocked ricin immunotoxin
    n1=Okihiro (syndrome de) | n2=en:anti-b4 blocked ricin immunotoxin | rel=r_associated | relid=0 | w=10
  461. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-b7-h3 antibody ds-5573a
    n1=Okihiro (syndrome de) | n2=en:anti-b7-h3 antibody ds-5573a | rel=r_associated | relid=0 | w=10
  462. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-bcma antibody-drug conjugate gsk2857916
    n1=Okihiro (syndrome de) | n2=en:anti-bcma antibody-drug conjugate gsk2857916 | rel=r_associated | relid=0 | w=10
  463. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-c-fms monoclonal antibody amg 820
    n1=Okihiro (syndrome de) | n2=en:anti-c-fms monoclonal antibody amg 820 | rel=r_associated | relid=0 | w=10
  464. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-c-kit monoclonal antibody ktn0158
    n1=Okihiro (syndrome de) | n2=en:anti-c-kit monoclonal antibody ktn0158 | rel=r_associated | relid=0 | w=10
  465. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-c-met monoclonal antibody abt-700
    n1=Okihiro (syndrome de) | n2=en:anti-c-met monoclonal antibody abt-700 | rel=r_associated | relid=0 | w=10
  466. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-c-met monoclonal antibody argx-111
    n1=Okihiro (syndrome de) | n2=en:anti-c-met monoclonal antibody argx-111 | rel=r_associated | relid=0 | w=10
  467. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-c-met monoclonal antibody ly2875358
    n1=Okihiro (syndrome de) | n2=en:anti-c-met monoclonal antibody ly2875358 | rel=r_associated | relid=0 | w=10
  468. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-c-met monoclonal antibody sait301
    n1=Okihiro (syndrome de) | n2=en:anti-c-met monoclonal antibody sait301 | rel=r_associated | relid=0 | w=10
  469. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-c4.4a antibody-drug conjugate bay1129980
    n1=Okihiro (syndrome de) | n2=en:anti-c4.4a antibody-drug conjugate bay1129980 | rel=r_associated | relid=0 | w=10
  470. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ca19-9 monoclonal antibody 5b1
    n1=Okihiro (syndrome de) | n2=en:anti-ca19-9 monoclonal antibody 5b1 | rel=r_associated | relid=0 | w=10
  471. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ca6-dm4 immunoconjugate sar566658
    n1=Okihiro (syndrome de) | n2=en:anti-ca6-dm4 immunoconjugate sar566658 | rel=r_associated | relid=0 | w=10
  472. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd123 monoclonal antibody csl360
    n1=Okihiro (syndrome de) | n2=en:anti-cd123 monoclonal antibody csl360 | rel=r_associated | relid=0 | w=10
  473. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd123 monoclonal antibody csl362
    n1=Okihiro (syndrome de) | n2=en:anti-cd123 monoclonal antibody csl362 | rel=r_associated | relid=0 | w=10
  474. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd123 monoclonal antibody khk2823
    n1=Okihiro (syndrome de) | n2=en:anti-cd123 monoclonal antibody khk2823 | rel=r_associated | relid=0 | w=10
  475. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd123 x anti-cd3 bispecific antibody xmab1404
    n1=Okihiro (syndrome de) | n2=en:anti-cd123 x anti-cd3 bispecific antibody xmab1404 | rel=r_associated | relid=0 | w=10
  476. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd123/cd3 bispecific antibody jnj-63709178
    n1=Okihiro (syndrome de) | n2=en:anti-cd123/cd3 bispecific antibody jnj-63709178 | rel=r_associated | relid=0 | w=10
  477. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd123/cd3 monoclonal antibody mgd006
    n1=Okihiro (syndrome de) | n2=en:anti-cd123/cd3 monoclonal antibody mgd006 | rel=r_associated | relid=0 | w=10
  478. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd133-car vector-transduced allogeneic t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-cd133-car vector-transduced allogeneic t lymphocytes | rel=r_associated | relid=0 | w=10
  479. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd157 monoclonal antibody men1112
    n1=Okihiro (syndrome de) | n2=en:anti-cd157 monoclonal antibody men1112 | rel=r_associated | relid=0 | w=10
  480. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd19 antibody-drug conjugate sgn-cd19b
    n1=Okihiro (syndrome de) | n2=en:anti-cd19 antibody-drug conjugate sgn-cd19b | rel=r_associated | relid=0 | w=10
  481. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd19 monoclonal antibody di-b4
    n1=Okihiro (syndrome de) | n2=en:anti-cd19 monoclonal antibody di-b4 | rel=r_associated | relid=0 | w=10
  482. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd19 monoclonal antibody mdx-1342
    n1=Okihiro (syndrome de) | n2=en:anti-cd19 monoclonal antibody mdx-1342 | rel=r_associated | relid=0 | w=10
  483. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd19 monoclonal antibody medi-551
    n1=Okihiro (syndrome de) | n2=en:anti-cd19 monoclonal antibody medi-551 | rel=r_associated | relid=0 | w=10
  484. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd19 monoclonal antibody xmab5574
    n1=Okihiro (syndrome de) | n2=en:anti-cd19 monoclonal antibody xmab5574 | rel=r_associated | relid=0 | w=10
  485. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd19-car fmc63-28z retroviral vector-transduced allogeneic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-cd19-car fmc63-28z retroviral vector-transduced allogeneic t-lymphocytes | rel=r_associated | relid=0 | w=10
  486. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd19-car retroviral vector-transduced autologous t cells
    n1=Okihiro (syndrome de) | n2=en:anti-cd19-car retroviral vector-transduced autologous t cells | rel=r_associated | relid=0 | w=10
  487. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd19-car-cd3zeta-4-1bb-expressing allogenic natural killer cells
    n1=Okihiro (syndrome de) | n2=en:anti-cd19-car-cd3zeta-4-1bb-expressing allogenic natural killer cells | rel=r_associated | relid=0 | w=10
  488. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd19-dm4 immunoconjugate sar3419
    n1=Okihiro (syndrome de) | n2=en:anti-cd19-dm4 immunoconjugate sar3419 | rel=r_associated | relid=0 | w=10
  489. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd19/anti-cd22 bispecific immunotoxin dt2219arl
    n1=Okihiro (syndrome de) | n2=en:anti-cd19/anti-cd22 bispecific immunotoxin dt2219arl | rel=r_associated | relid=0 | w=10
  490. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd19/cd28/cd3zeta car gammaretroviral vector-transduced autologous t lymphocytes kte-c19
    n1=Okihiro (syndrome de) | n2=en:anti-cd19/cd28/cd3zeta car gammaretroviral vector-transduced autologous t lymphocytes kte-c19 | rel=r_associated | relid=0 | w=10
  491. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd19/cd3 tetravalent antibody afm11
    n1=Okihiro (syndrome de) | n2=en:anti-cd19/cd3 tetravalent antibody afm11 | rel=r_associated | relid=0 | w=10
  492. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd20 b9e9 scfv-streptavidin fusion protein
    n1=Okihiro (syndrome de) | n2=en:anti-cd20 b9e9 scfv-streptavidin fusion protein | rel=r_associated | relid=0 | w=10
  493. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd20 monoclonal antibody pro131921
    n1=Okihiro (syndrome de) | n2=en:anti-cd20 monoclonal antibody pro131921 | rel=r_associated | relid=0 | w=10
  494. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd20 monoclonal antibody sct400
    n1=Okihiro (syndrome de) | n2=en:anti-cd20 monoclonal antibody sct400 | rel=r_associated | relid=0 | w=10
  495. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd20 monoclonal antibody tl011
    n1=Okihiro (syndrome de) | n2=en:anti-cd20 monoclonal antibody tl011 | rel=r_associated | relid=0 | w=10
  496. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002
    n1=Okihiro (syndrome de) | n2=en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002 | rel=r_associated | relid=0 | w=10
  497. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd20-car-cd3zeta-4-1bb-expressing autologous t-lymphocyte cells
    n1=Okihiro (syndrome de) | n2=en:anti-cd20-car-cd3zeta-4-1bb-expressing autologous t-lymphocyte cells | rel=r_associated | relid=0 | w=10
  498. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd20-engineered toxin body mt-3724
    n1=Okihiro (syndrome de) | n2=en:anti-cd20-engineered toxin body mt-3724 | rel=r_associated | relid=0 | w=10
  499. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd20/cd3 monoclonal antibody regn1979
    n1=Okihiro (syndrome de) | n2=en:anti-cd20/cd3 monoclonal antibody regn1979 | rel=r_associated | relid=0 | w=10
  500. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd200 monoclonal antibody alxn6000
    n1=Okihiro (syndrome de) | n2=en:anti-cd200 monoclonal antibody alxn6000 | rel=r_associated | relid=0 | w=10
  501. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd22 car-expressing t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-cd22 car-expressing t lymphocytes | rel=r_associated | relid=0 | w=10
  502. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd22 monoclonal antibody-mmae conjugate dcdt2980s
    n1=Okihiro (syndrome de) | n2=en:anti-cd22 monoclonal antibody-mmae conjugate dcdt2980s | rel=r_associated | relid=0 | w=10
  503. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd22 scfv tcrz:41bb-car lentiviral vector-transduced autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-cd22 scfv tcrz:41bb-car lentiviral vector-transduced autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  504. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd22-car m971-bbz lentiviral vector-transduced autologous t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-cd22-car m971-bbz lentiviral vector-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  505. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd25-pbd antibody-drug conjugate adct-301
    n1=Okihiro (syndrome de) | n2=en:anti-cd25-pbd antibody-drug conjugate adct-301 | rel=r_associated | relid=0 | w=10
  506. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd27l antibody-drug conjugate amg 172
    n1=Okihiro (syndrome de) | n2=en:anti-cd27l antibody-drug conjugate amg 172 | rel=r_associated | relid=0 | w=10
  507. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1)
    n1=Okihiro (syndrome de) | n2=en:anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1) | rel=r_associated | relid=0 | w=10
  508. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd3 okt3/humanized anti-gd2 3f8 bispecific antibody-activated t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-cd3 okt3/humanized anti-gd2 3f8 bispecific antibody-activated t lymphocytes | rel=r_associated | relid=0 | w=10
  509. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd3 x anti-cd20 bispecific antibody-armed activated t cells
    n1=Okihiro (syndrome de) | n2=en:anti-cd3 x anti-cd20 bispecific antibody-armed activated t cells | rel=r_associated | relid=0 | w=10
  510. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd3/anti-cd20 trifunctional bispecific monoclonal antibody fbta05
    n1=Okihiro (syndrome de) | n2=en:anti-cd3/anti-cd20 trifunctional bispecific monoclonal antibody fbta05 | rel=r_associated | relid=0 | w=10
  511. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd3/anti-egfr-bispecific monoclonal antibody-armed activated autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-cd3/anti-egfr-bispecific monoclonal antibody-armed activated autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  512. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd30 monoclonal antibody mdx-1401
    n1=Okihiro (syndrome de) | n2=en:anti-cd30 monoclonal antibody mdx-1401 | rel=r_associated | relid=0 | w=10
  513. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd30 monoclonal antibody xmab2513
    n1=Okihiro (syndrome de) | n2=en:anti-cd30 monoclonal antibody xmab2513 | rel=r_associated | relid=0 | w=10
  514. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd30/cd16a monoclonal antibody afm13
    n1=Okihiro (syndrome de) | n2=en:anti-cd30/cd16a monoclonal antibody afm13 | rel=r_associated | relid=0 | w=10
  515. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd33 antibody-drug conjugate imgn779
    n1=Okihiro (syndrome de) | n2=en:anti-cd33 antibody-drug conjugate imgn779 | rel=r_associated | relid=0 | w=10
  516. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd33 monoclonal antibody bi 836858
    n1=Okihiro (syndrome de) | n2=en:anti-cd33 monoclonal antibody bi 836858 | rel=r_associated | relid=0 | w=10
  517. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd33 monoclonal antibody-dm4 conjugate ave9633
    n1=Okihiro (syndrome de) | n2=en:anti-cd33 monoclonal antibody-dm4 conjugate ave9633 | rel=r_associated | relid=0 | w=10
  518. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd33/cd3 bite antibody amg 330
    n1=Okihiro (syndrome de) | n2=en:anti-cd33/cd3 bite antibody amg 330 | rel=r_associated | relid=0 | w=10
  519. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd37 antibody-drug conjugate imgn529
    n1=Okihiro (syndrome de) | n2=en:anti-cd37 antibody-drug conjugate imgn529 | rel=r_associated | relid=0 | w=10
  520. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd37 mmae antibody-drug conjugate ags67e
    n1=Okihiro (syndrome de) | n2=en:anti-cd37 mmae antibody-drug conjugate ags67e | rel=r_associated | relid=0 | w=10
  521. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd37 monoclonal antibody bi 836826
    n1=Okihiro (syndrome de) | n2=en:anti-cd37 monoclonal antibody bi 836826 | rel=r_associated | relid=0 | w=10
  522. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd38 monoclonal antibody mor03087
    n1=Okihiro (syndrome de) | n2=en:anti-cd38 monoclonal antibody mor03087 | rel=r_associated | relid=0 | w=10
  523. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd38 monoclonal antibody sar650984
    n1=Okihiro (syndrome de) | n2=en:anti-cd38 monoclonal antibody sar650984 | rel=r_associated | relid=0 | w=10
  524. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd40 monoclonal antibody chi lob 7/4
    n1=Okihiro (syndrome de) | n2=en:anti-cd40 monoclonal antibody chi lob 7/4 | rel=r_associated | relid=0 | w=10
  525. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd40 monoclonal antibody sea-cd40
    n1=Okihiro (syndrome de) | n2=en:anti-cd40 monoclonal antibody sea-cd40 | rel=r_associated | relid=0 | w=10
  526. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd40l fc-fusion protein bms-986004
    n1=Okihiro (syndrome de) | n2=en:anti-cd40l fc-fusion protein bms-986004 | rel=r_associated | relid=0 | w=10
  527. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd44 monoclonal antibody ro5429083
    n1=Okihiro (syndrome de) | n2=en:anti-cd44 monoclonal antibody ro5429083 | rel=r_associated | relid=0 | w=10
  528. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd45 bc8 monoclonal antibody-streptavidin conjugate
    n1=Okihiro (syndrome de) | n2=en:anti-cd45 bc8 monoclonal antibody-streptavidin conjugate | rel=r_associated | relid=0 | w=10
  529. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd45 monoclonal antibody
    n1=Okihiro (syndrome de) | n2=en:anti-cd45 monoclonal antibody | rel=r_associated | relid=0 | w=10
  530. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd45 monoclonal antibody ahn-12
    n1=Okihiro (syndrome de) | n2=en:anti-cd45 monoclonal antibody ahn-12 | rel=r_associated | relid=0 | w=10
  531. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd45 monoclonal antibody bc8
    n1=Okihiro (syndrome de) | n2=en:anti-cd45 monoclonal antibody bc8 | rel=r_associated | relid=0 | w=10
  532. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd47 monoclonal antibody cc-90002
    n1=Okihiro (syndrome de) | n2=en:anti-cd47 monoclonal antibody cc-90002 | rel=r_associated | relid=0 | w=10
  533. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd47 monoclonal antibody hu5f9-g4
    n1=Okihiro (syndrome de) | n2=en:anti-cd47 monoclonal antibody hu5f9-g4 | rel=r_associated | relid=0 | w=10
  534. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd7 immunotoxin
    n1=Okihiro (syndrome de) | n2=en:anti-cd7 immunotoxin | rel=r_associated | relid=0 | w=10
  535. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd70 antibody-drug conjugate mdx-1203
    n1=Okihiro (syndrome de) | n2=en:anti-cd70 antibody-drug conjugate mdx-1203 | rel=r_associated | relid=0 | w=10
  536. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd70 antibody-drug conjugate sgn-cd70a
    n1=Okihiro (syndrome de) | n2=en:anti-cd70 antibody-drug conjugate sgn-cd70a | rel=r_associated | relid=0 | w=10
  537. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd70 monoclonal antibody argx-110
    n1=Okihiro (syndrome de) | n2=en:anti-cd70 monoclonal antibody argx-110 | rel=r_associated | relid=0 | w=10
  538. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd70 monoclonal antibody mdx-1411
    n1=Okihiro (syndrome de) | n2=en:anti-cd70 monoclonal antibody mdx-1411 | rel=r_associated | relid=0 | w=10
  539. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd73 monoclonal antibody medi9447
    n1=Okihiro (syndrome de) | n2=en:anti-cd73 monoclonal antibody medi9447 | rel=r_associated | relid=0 | w=10
  540. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd98 monoclonal antibody ign523
    n1=Okihiro (syndrome de) | n2=en:anti-cd98 monoclonal antibody ign523 | rel=r_associated | relid=0 | w=10
  541. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cd98 monoclonal antibody khk2898
    n1=Okihiro (syndrome de) | n2=en:anti-cd98 monoclonal antibody khk2898 | rel=r_associated | relid=0 | w=10
  542. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cea bite monoclonal antibody amg211
    n1=Okihiro (syndrome de) | n2=en:anti-cea bite monoclonal antibody amg211 | rel=r_associated | relid=0 | w=10
  543. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cea igcd28tcr-transduced autologous t cells
    n1=Okihiro (syndrome de) | n2=en:anti-cea igcd28tcr-transduced autologous t cells | rel=r_associated | relid=0 | w=10
  544. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cea tcr retroviral vector-transduced autologous peripheral blood lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-cea tcr retroviral vector-transduced autologous peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  545. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cea-car autologous t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-cea-car autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  546. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cea/anti-dtpa-in (f6-734) bispecific antibody
    n1=Okihiro (syndrome de) | n2=en:anti-cea/anti-dtpa-in (f6-734) bispecific antibody | rel=r_associated | relid=0 | w=10
  547. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cea/anti-hsg bispecific monoclonal antibody tf2
    n1=Okihiro (syndrome de) | n2=en:anti-cea/anti-hsg bispecific monoclonal antibody tf2 | rel=r_associated | relid=0 | w=10
  548. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cea/cd3 bispecific antibody ro6958688
    n1=Okihiro (syndrome de) | n2=en:anti-cea/cd3 bispecific antibody ro6958688 | rel=r_associated | relid=0 | w=10
  549. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ceacam1 monoclonal antibody cm-24
    n1=Okihiro (syndrome de) | n2=en:anti-ceacam1 monoclonal antibody cm-24 | rel=r_associated | relid=0 | w=10
  550. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ceacam5 antibody-drug conjugate sar408701
    n1=Okihiro (syndrome de) | n2=en:anti-ceacam5 antibody-drug conjugate sar408701 | rel=r_associated | relid=0 | w=10
  551. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ceacam6 afaikl2 antibody fragment/jack bean urease immunoconjugate l-dos47
    n1=Okihiro (syndrome de) | n2=en:anti-ceacam6 afaikl2 antibody fragment/jack bean urease immunoconjugate l-dos47 | rel=r_associated | relid=0 | w=10
  552. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-cldn6 monoclonal antibody imab027
    n1=Okihiro (syndrome de) | n2=en:anti-cldn6 monoclonal antibody imab027 | rel=r_associated | relid=0 | w=10
  553. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-csf1r monoclonal antibody fpa008
    n1=Okihiro (syndrome de) | n2=en:anti-csf1r monoclonal antibody fpa008 | rel=r_associated | relid=0 | w=10
  554. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-csf1r monoclonal antibody imc-cs4
    n1=Okihiro (syndrome de) | n2=en:anti-csf1r monoclonal antibody imc-cs4 | rel=r_associated | relid=0 | w=10
  555. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ctgf monoclonal antibody fg-3019
    n1=Okihiro (syndrome de) | n2=en:anti-ctgf monoclonal antibody fg-3019 | rel=r_associated | relid=0 | w=10
  556. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ctla-4 mab rna-transfected autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:anti-ctla-4 mab rna-transfected autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  557. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ctla-4 monoclonal antibody agen1884
    n1=Okihiro (syndrome de) | n2=en:anti-ctla-4 monoclonal antibody agen1884 | rel=r_associated | relid=0 | w=10
  558. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ctla4 moab rna/gitrl rna-transfected autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:anti-ctla4 moab rna/gitrl rna-transfected autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  559. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-denatured collagen monoclonal antibody trc093
    n1=Okihiro (syndrome de) | n2=en:anti-denatured collagen monoclonal antibody trc093 | rel=r_associated | relid=0 | w=10
  560. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-diabetic agent
    n1=Okihiro (syndrome de) | n2=en:anti-diabetic agent | rel=r_associated | relid=0 | w=10
  561. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-dkk-1 monoclonal antibody ly2812176
    n1=Okihiro (syndrome de) | n2=en:anti-dkk-1 monoclonal antibody ly2812176 | rel=r_associated | relid=0 | w=10
  562. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-dkk1 monoclonal antibody bhq880
    n1=Okihiro (syndrome de) | n2=en:anti-dkk1 monoclonal antibody bhq880 | rel=r_associated | relid=0 | w=10
  563. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-dll4 monoclonal antibody medi0639
    n1=Okihiro (syndrome de) | n2=en:anti-dll4 monoclonal antibody medi0639 | rel=r_associated | relid=0 | w=10
  564. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-dll4 monoclonal antibody regn421
    n1=Okihiro (syndrome de) | n2=en:anti-dll4 monoclonal antibody regn421 | rel=r_associated | relid=0 | w=10
  565. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-dll4/vegf bispecific monoclonal antibody omp-305b83
    n1=Okihiro (syndrome de) | n2=en:anti-dll4/vegf bispecific monoclonal antibody omp-305b83 | rel=r_associated | relid=0 | w=10
  566. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-dr5 agonist monoclonal antibody tra-8
    n1=Okihiro (syndrome de) | n2=en:anti-dr5 agonist monoclonal antibody tra-8 | rel=r_associated | relid=0 | w=10
  567. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-dr5 agonistic antibody ds-8273a
    n1=Okihiro (syndrome de) | n2=en:anti-dr5 agonistic antibody ds-8273a | rel=r_associated | relid=0 | w=10
  568. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-egfr monoclonal antibody gc1118
    n1=Okihiro (syndrome de) | n2=en:anti-egfr monoclonal antibody gc1118 | rel=r_associated | relid=0 | w=10
  569. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-egfr monoclonal antibody gt-mab 5.2-gex
    n1=Okihiro (syndrome de) | n2=en:anti-egfr monoclonal antibody gt-mab 5.2-gex | rel=r_associated | relid=0 | w=10
  570. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-egfr monoclonal antibody mixture mm-151
    n1=Okihiro (syndrome de) | n2=en:anti-egfr monoclonal antibody mixture mm-151 | rel=r_associated | relid=0 | w=10
  571. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-egfr monoclonal antibody mixture sym004
    n1=Okihiro (syndrome de) | n2=en:anti-egfr monoclonal antibody mixture sym004 | rel=r_associated | relid=0 | w=10
  572. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-egfr monoclonal antibody ro5083945
    n1=Okihiro (syndrome de) | n2=en:anti-egfr monoclonal antibody ro5083945 | rel=r_associated | relid=0 | w=10
  573. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-egfr monoclonal antibody sct200
    n1=Okihiro (syndrome de) | n2=en:anti-egfr monoclonal antibody sct200 | rel=r_associated | relid=0 | w=10
  574. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-egfr monoclonal antibody syn004
    n1=Okihiro (syndrome de) | n2=en:anti-egfr monoclonal antibody syn004 | rel=r_associated | relid=0 | w=10
  575. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-egfr tap antibody-drug conjugate imgn289
    n1=Okihiro (syndrome de) | n2=en:anti-egfr tap antibody-drug conjugate imgn289 | rel=r_associated | relid=0 | w=10
  576. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-egfr/c-met bispecific antibody jnj-61186372
    n1=Okihiro (syndrome de) | n2=en:anti-egfr/c-met bispecific antibody jnj-61186372 | rel=r_associated | relid=0 | w=10
  577. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-egfrviii antibody drug conjugate amg 595
    n1=Okihiro (syndrome de) | n2=en:anti-egfrviii antibody drug conjugate amg 595 | rel=r_associated | relid=0 | w=10
  578. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-egfrviii car-transduced allogeneic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-egfrviii car-transduced allogeneic t-lymphocytes | rel=r_associated | relid=0 | w=10
  579. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-egfrviii immunotoxin mr1-1
    n1=Okihiro (syndrome de) | n2=en:anti-egfrviii immunotoxin mr1-1 | rel=r_associated | relid=0 | w=10
  580. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-egp-2 immunotoxin moc31-pe
    n1=Okihiro (syndrome de) | n2=en:anti-egp-2 immunotoxin moc31-pe | rel=r_associated | relid=0 | w=10
  581. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-endoglin chimeric monoclonal antibody trc105
    n1=Okihiro (syndrome de) | n2=en:anti-endoglin chimeric monoclonal antibody trc105 | rel=r_associated | relid=0 | w=10
  582. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-endosialin monoclonal antibody morab-004
    n1=Okihiro (syndrome de) | n2=en:anti-endosialin monoclonal antibody morab-004 | rel=r_associated | relid=0 | w=10
  583. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-enpp3 antibody-drug conjugate ags-16c3f
    n1=Okihiro (syndrome de) | n2=en:anti-enpp3 antibody-drug conjugate ags-16c3f | rel=r_associated | relid=0 | w=10
  584. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-enpp3/mmaf antibody-drug conjugate ags-16m8f
    n1=Okihiro (syndrome de) | n2=en:anti-enpp3/mmaf antibody-drug conjugate ags-16m8f | rel=r_associated | relid=0 | w=10
  585. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-epcam antibody fragment-pseudomonas-exotoxin fusion protein
    n1=Okihiro (syndrome de) | n2=en:anti-epcam antibody fragment-pseudomonas-exotoxin fusion protein | rel=r_associated | relid=0 | w=10
  586. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-epha2 monoclonal antibody ds-8895a
    n1=Okihiro (syndrome de) | n2=en:anti-epha2 monoclonal antibody ds-8895a | rel=r_associated | relid=0 | w=10
  587. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-epha2 monoclonal antibody-mmaf immunoconjugate medi-547
    n1=Okihiro (syndrome de) | n2=en:anti-epha2 monoclonal antibody-mmaf immunoconjugate medi-547 | rel=r_associated | relid=0 | w=10
  588. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-epha3 monoclonal antibody kb004
    n1=Okihiro (syndrome de) | n2=en:anti-epha3 monoclonal antibody kb004 | rel=r_associated | relid=0 | w=10
  589. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes | rel=r_associated | relid=0 | w=10
  590. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-erbb2/anti-erbb3 bispecific monoclonal antibody mm-111
    n1=Okihiro (syndrome de) | n2=en:anti-erbb2/anti-erbb3 bispecific monoclonal antibody mm-111 | rel=r_associated | relid=0 | w=10
  591. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-erbb3 monoclonal antibody av-203
    n1=Okihiro (syndrome de) | n2=en:anti-erbb3 monoclonal antibody av-203 | rel=r_associated | relid=0 | w=10
  592. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-erbb3 monoclonal antibody ktn3379
    n1=Okihiro (syndrome de) | n2=en:anti-erbb3 monoclonal antibody ktn3379 | rel=r_associated | relid=0 | w=10
  593. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-erbb3 monoclonal antibody regn1400
    n1=Okihiro (syndrome de) | n2=en:anti-erbb3 monoclonal antibody regn1400 | rel=r_associated | relid=0 | w=10
  594. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-erbb3/anti-igf-1r bispecific monoclonal antibody mm-141
    n1=Okihiro (syndrome de) | n2=en:anti-erbb3/anti-igf-1r bispecific monoclonal antibody mm-141 | rel=r_associated | relid=0 | w=10
  595. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-etbr/mmae antibody-drug conjugate dedn6526a
    n1=Okihiro (syndrome de) | n2=en:anti-etbr/mmae antibody-drug conjugate dedn6526a | rel=r_associated | relid=0 | w=10
  596. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-fgf23 igg1 monoclonal antibody krn23
    n1=Okihiro (syndrome de) | n2=en:anti-fgf23 igg1 monoclonal antibody krn23 | rel=r_associated | relid=0 | w=10
  597. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-fgfr2 antibody bay1179470
    n1=Okihiro (syndrome de) | n2=en:anti-fgfr2 antibody bay1179470 | rel=r_associated | relid=0 | w=10
  598. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-fgfr2 antibody-drug conjugate bay1187982
    n1=Okihiro (syndrome de) | n2=en:anti-fgfr2 antibody-drug conjugate bay1187982 | rel=r_associated | relid=0 | w=10
  599. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-fgfr2 monoclonal antibody fpa144
    n1=Okihiro (syndrome de) | n2=en:anti-fgfr2 monoclonal antibody fpa144 | rel=r_associated | relid=0 | w=10
  600. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-fgfr3 antibody-drug conjugate ly3076226
    n1=Okihiro (syndrome de) | n2=en:anti-fgfr3 antibody-drug conjugate ly3076226 | rel=r_associated | relid=0 | w=10
  601. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-fgfr3 monoclonal antibody b-701
    n1=Okihiro (syndrome de) | n2=en:anti-fgfr3 monoclonal antibody b-701 | rel=r_associated | relid=0 | w=10
  602. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-fgfr3 monoclonal antibody mfgr1877s
    n1=Okihiro (syndrome de) | n2=en:anti-fgfr3 monoclonal antibody mfgr1877s | rel=r_associated | relid=0 | w=10
  603. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-fgfr4 monoclonal antibody u3-1784
    n1=Okihiro (syndrome de) | n2=en:anti-fgfr4 monoclonal antibody u3-1784 | rel=r_associated | relid=0 | w=10
  604. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-flt3 monoclonal antibody imc-eb10
    n1=Okihiro (syndrome de) | n2=en:anti-flt3 monoclonal antibody imc-eb10 | rel=r_associated | relid=0 | w=10
  605. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-fucosyl-gm1 monoclonal antibody bms-986012
    n1=Okihiro (syndrome de) | n2=en:anti-fucosyl-gm1 monoclonal antibody bms-986012 | rel=r_associated | relid=0 | w=10
  606. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ganglioside gm2 monoclonal antibody biw-8962
    n1=Okihiro (syndrome de) | n2=en:anti-ganglioside gm2 monoclonal antibody biw-8962 | rel=r_associated | relid=0 | w=10
  607. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-gcc antibody-drug conjugate mln0264
    n1=Okihiro (syndrome de) | n2=en:anti-gcc antibody-drug conjugate mln0264 | rel=r_associated | relid=0 | w=10
  608. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-gd2 monoclonal antibody hu14.18k322a
    n1=Okihiro (syndrome de) | n2=en:anti-gd2 monoclonal antibody hu14.18k322a | rel=r_associated | relid=0 | w=10
  609. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-gd2 monoclonal antibody morab-028
    n1=Okihiro (syndrome de) | n2=en:anti-gd2 monoclonal antibody morab-028 | rel=r_associated | relid=0 | w=10
  610. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-gitr agonistic monoclonal antibody incagn01876
    n1=Okihiro (syndrome de) | n2=en:anti-gitr agonistic monoclonal antibody incagn01876 | rel=r_associated | relid=0 | w=10
  611. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-gitr monoclonal antibody gwn 323
    n1=Okihiro (syndrome de) | n2=en:anti-gitr monoclonal antibody gwn 323 | rel=r_associated | relid=0 | w=10
  612. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-gitr monoclonal antibody mk-4166
    n1=Okihiro (syndrome de) | n2=en:anti-gitr monoclonal antibody mk-4166 | rel=r_associated | relid=0 | w=10
  613. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-gnrh vaccine pep223
    n1=Okihiro (syndrome de) | n2=en:anti-gnrh vaccine pep223 | rel=r_associated | relid=0 | w=10
  614. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-gpa33/cd3 monoclonal antibody mgd007
    n1=Okihiro (syndrome de) | n2=en:anti-gpa33/cd3 monoclonal antibody mgd007 | rel=r_associated | relid=0 | w=10
  615. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-gpc3 monoclonal antibody gc33
    n1=Okihiro (syndrome de) | n2=en:anti-gpc3 monoclonal antibody gc33 | rel=r_associated | relid=0 | w=10
  616. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-gpc3-car autologous t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-gpc3-car autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  617. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-grp78 monoclonal antibody pat-sm6
    n1=Okihiro (syndrome de) | n2=en:anti-grp78 monoclonal antibody pat-sm6 | rel=r_associated | relid=0 | w=10
  618. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-hb-egf monoclonal antibody khk2866
    n1=Okihiro (syndrome de) | n2=en:anti-hb-egf monoclonal antibody khk2866 | rel=r_associated | relid=0 | w=10
  619. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-hbegf monoclonal antibody u3-1565
    n1=Okihiro (syndrome de) | n2=en:anti-hbegf monoclonal antibody u3-1565 | rel=r_associated | relid=0 | w=10
  620. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-hcv e2 monoclonal antibody mbl-hcv1
    n1=Okihiro (syndrome de) | n2=en:anti-hcv e2 monoclonal antibody mbl-hcv1 | rel=r_associated | relid=0 | w=10
  621. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-hepcidin monoclonal antibody ly2787106
    n1=Okihiro (syndrome de) | n2=en:anti-hepcidin monoclonal antibody ly2787106 | rel=r_associated | relid=0 | w=10
  622. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-her-2-car retroviral vector-transduced autologous peripheral blood lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-her-2-car retroviral vector-transduced autologous peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  623. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-her2 antibody-drug conjugate arx788
    n1=Okihiro (syndrome de) | n2=en:anti-her2 antibody-drug conjugate arx788 | rel=r_associated | relid=0 | w=10
  624. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-her2 antibody-drug conjugate medi4276
    n1=Okihiro (syndrome de) | n2=en:anti-her2 antibody-drug conjugate medi4276 | rel=r_associated | relid=0 | w=10
  625. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-her2 monoclonal antibody ct-p6
    n1=Okihiro (syndrome de) | n2=en:anti-her2 monoclonal antibody ct-p6 | rel=r_associated | relid=0 | w=10
  626. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-her2-car autologous cmv-specific cytotoxic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-her2-car autologous cmv-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  627. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-her3 monoclonal antibody gsk2849330
    n1=Okihiro (syndrome de) | n2=en:anti-her3 monoclonal antibody gsk2849330 | rel=r_associated | relid=0 | w=10
  628. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-her3 monoclonal antibody ljm716
    n1=Okihiro (syndrome de) | n2=en:anti-her3 monoclonal antibody ljm716 | rel=r_associated | relid=0 | w=10
  629. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-hgf monoclonal antibody tak-701
    n1=Okihiro (syndrome de) | n2=en:anti-hgf monoclonal antibody tak-701 | rel=r_associated | relid=0 | w=10
  630. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-hif-1alpha lna antisense oligonucleotide ezn-2968
    n1=Okihiro (syndrome de) | n2=en:anti-hif-1alpha lna antisense oligonucleotide ezn-2968 | rel=r_associated | relid=0 | w=10
  631. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-hla-a2/ny-eso-1 tcr-transduced autologous t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-hla-a2/ny-eso-1 tcr-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  632. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-hla-dr monoclonal antibody immu-114
    n1=Okihiro (syndrome de) | n2=en:anti-hla-dr monoclonal antibody immu-114 | rel=r_associated | relid=0 | w=10
  633. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-human chorionic gonadotropin vaccine
    n1=Okihiro (syndrome de) | n2=en:anti-human chorionic gonadotropin vaccine | rel=r_associated | relid=0 | w=10
  634. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-human gitr monoclonal antibody trx518
    n1=Okihiro (syndrome de) | n2=en:anti-human gitr monoclonal antibody trx518 | rel=r_associated | relid=0 | w=10
  635. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-icam-1 monoclonal antibody bi-505
    n1=Okihiro (syndrome de) | n2=en:anti-icam-1 monoclonal antibody bi-505 | rel=r_associated | relid=0 | w=10
  636. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-icos agonist antibody gsk3359609
    n1=Okihiro (syndrome de) | n2=en:anti-icos agonist antibody gsk3359609 | rel=r_associated | relid=0 | w=10
  637. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-icos monoclonal antibody medi-570
    n1=Okihiro (syndrome de) | n2=en:anti-icos monoclonal antibody medi-570 | rel=r_associated | relid=0 | w=10
  638. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-idiotypic monoclonal antibody bec2
    n1=Okihiro (syndrome de) | n2=en:anti-idiotypic monoclonal antibody bec2 | rel=r_associated | relid=0 | w=10
  639. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-igf-1r monoclonal antibody ave1642
    n1=Okihiro (syndrome de) | n2=en:anti-igf-1r monoclonal antibody ave1642 | rel=r_associated | relid=0 | w=10
  640. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-igf-1r recombinant monoclonal antibody biib022
    n1=Okihiro (syndrome de) | n2=en:anti-igf-1r recombinant monoclonal antibody biib022 | rel=r_associated | relid=0 | w=10
  641. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-igf1/2 monoclonal antibody medi-573
    n1=Okihiro (syndrome de) | n2=en:anti-igf1/2 monoclonal antibody medi-573 | rel=r_associated | relid=0 | w=10
  642. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-il-1 alpha monoclonal antibody ca-18c3
    n1=Okihiro (syndrome de) | n2=en:anti-il-1 alpha monoclonal antibody ca-18c3 | rel=r_associated | relid=0 | w=10
  643. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-il-1 alpha monoclonal antibody mabp1
    n1=Okihiro (syndrome de) | n2=en:anti-il-1 alpha monoclonal antibody mabp1 | rel=r_associated | relid=0 | w=10
  644. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-il-13 humanized monoclonal antibody tnx-650
    n1=Okihiro (syndrome de) | n2=en:anti-il-13 humanized monoclonal antibody tnx-650 | rel=r_associated | relid=0 | w=10
  645. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-il-15 monoclonal antibody amg 714
    n1=Okihiro (syndrome de) | n2=en:anti-il-15 monoclonal antibody amg 714 | rel=r_associated | relid=0 | w=10
  646. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-il-4/il-13 combination agent qbx258
    n1=Okihiro (syndrome de) | n2=en:anti-il-4/il-13 combination agent qbx258 | rel=r_associated | relid=0 | w=10
  647. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-il-8 monoclonal antibody humax-il8
    n1=Okihiro (syndrome de) | n2=en:anti-il-8 monoclonal antibody humax-il8 | rel=r_associated | relid=0 | w=10
  648. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-infective agent
    n1=Okihiro (syndrome de) | n2=en:anti-infective agent | rel=r_associated | relid=0 | w=10
  649. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-inflammatory agents
    n1=Okihiro (syndrome de) | n2=en:anti-inflammatory agents | rel=r_associated | relid=0 | w=10
  650. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-inflammatory antibody alxn1007
    n1=Okihiro (syndrome de) | n2=en:anti-inflammatory antibody alxn1007 | rel=r_associated | relid=0 | w=10
  651. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-inhibitor coagulant complex
    n1=Okihiro (syndrome de) | n2=en:anti-inhibitor coagulant complex | rel=r_associated | relid=0 | w=10
  652. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-inhibitor coagulant complex feiba nf
    n1=Okihiro (syndrome de) | n2=en:anti-inhibitor coagulant complex feiba nf | rel=r_associated | relid=0 | w=10
  653. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-integrin monoclonal antibody-dm4 immunoconjugate imgn388
    n1=Okihiro (syndrome de) | n2=en:anti-integrin monoclonal antibody-dm4 immunoconjugate imgn388 | rel=r_associated | relid=0 | w=10
  654. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-interferon gamma monoclonal antibody ni-0501
    n1=Okihiro (syndrome de) | n2=en:anti-interferon gamma monoclonal antibody ni-0501 | rel=r_associated | relid=0 | w=10
  655. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-interleukin 6 monoclonal antibody ald518
    n1=Okihiro (syndrome de) | n2=en:anti-interleukin 6 monoclonal antibody ald518 | rel=r_associated | relid=0 | w=10
  656. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-kir monoclonal antibody iph 2101
    n1=Okihiro (syndrome de) | n2=en:anti-kir monoclonal antibody iph 2101 | rel=r_associated | relid=0 | w=10
  657. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-kir3dl2 monoclonal antibody iph4102
    n1=Okihiro (syndrome de) | n2=en:anti-kir3dl2 monoclonal antibody iph4102 | rel=r_associated | relid=0 | w=10
  658. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ksp/anti-vegf sirnas aln-vsp02
    n1=Okihiro (syndrome de) | n2=en:anti-ksp/anti-vegf sirnas aln-vsp02 | rel=r_associated | relid=0 | w=10
  659. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-lag-3 monoclonal antibody bms-986016
    n1=Okihiro (syndrome de) | n2=en:anti-lag-3 monoclonal antibody bms-986016 | rel=r_associated | relid=0 | w=10
  660. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-lag-3 monoclonal antibody lag525
    n1=Okihiro (syndrome de) | n2=en:anti-lag-3 monoclonal antibody lag525 | rel=r_associated | relid=0 | w=10
  661. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-lamp1 antibody-drug conjugate sar428926
    n1=Okihiro (syndrome de) | n2=en:anti-lamp1 antibody-drug conjugate sar428926 | rel=r_associated | relid=0 | w=10
  662. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-lgr5 monoclonal antibody bnc101
    n1=Okihiro (syndrome de) | n2=en:anti-lgr5 monoclonal antibody bnc101 | rel=r_associated | relid=0 | w=10
  663. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-liv-1 monoclonal antibody-mmae conjugate sgn-liv1a
    n1=Okihiro (syndrome de) | n2=en:anti-liv-1 monoclonal antibody-mmae conjugate sgn-liv1a | rel=r_associated | relid=0 | w=10
  664. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ly6e antibody-drug conjugate dlye5953a
    n1=Okihiro (syndrome de) | n2=en:anti-ly6e antibody-drug conjugate dlye5953a | rel=r_associated | relid=0 | w=10
  665. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-m-csf monoclonal antibody mcs110
    n1=Okihiro (syndrome de) | n2=en:anti-m-csf monoclonal antibody mcs110 | rel=r_associated | relid=0 | w=10
  666. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-masp-2 monoclonal antibody oms721
    n1=Okihiro (syndrome de) | n2=en:anti-masp-2 monoclonal antibody oms721 | rel=r_associated | relid=0 | w=10
  667. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-melanin monoclonal antibody pti-6d2
    n1=Okihiro (syndrome de) | n2=en:anti-melanin monoclonal antibody pti-6d2 | rel=r_associated | relid=0 | w=10
  668. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-mesothelin antibody-drug conjugate bms-986148
    n1=Okihiro (syndrome de) | n2=en:anti-mesothelin antibody-drug conjugate bms-986148 | rel=r_associated | relid=0 | w=10
  669. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-mesothelin car vector-transduced autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-mesothelin car vector-transduced autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  670. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-mesothelin cir mrna-electroporated autologous t cells
    n1=Okihiro (syndrome de) | n2=en:anti-mesothelin cir mrna-electroporated autologous t cells | rel=r_associated | relid=0 | w=10
  671. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-mesothelin icasp9m28z car-transduced autologous t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-mesothelin icasp9m28z car-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  672. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-mesothelin-pseudomonas exotoxin 24 cytolytic fusion protein lmb-100
    n1=Okihiro (syndrome de) | n2=en:anti-mesothelin-pseudomonas exotoxin 24 cytolytic fusion protein lmb-100 | rel=r_associated | relid=0 | w=10
  673. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-mesothelin/mmae antibody-drug conjugate dmot4039a
    n1=Okihiro (syndrome de) | n2=en:anti-mesothelin/mmae antibody-drug conjugate dmot4039a | rel=r_associated | relid=0 | w=10
  674. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-met monoclonal antibody mixture sym015
    n1=Okihiro (syndrome de) | n2=en:anti-met monoclonal antibody mixture sym015 | rel=r_associated | relid=0 | w=10
  675. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-met/egfr monoclonal antibody ly3164530
    n1=Okihiro (syndrome de) | n2=en:anti-met/egfr monoclonal antibody ly3164530 | rel=r_associated | relid=0 | w=10
  676. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-mmp-9 monoclonal antibody gs-5745
    n1=Okihiro (syndrome de) | n2=en:anti-mmp-9 monoclonal antibody gs-5745 | rel=r_associated | relid=0 | w=10
  677. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-muc1 car-transduced autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-muc1 car-transduced autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  678. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-muc1 monoclonal antibody bth1704
    n1=Okihiro (syndrome de) | n2=en:anti-muc1 monoclonal antibody bth1704 | rel=r_associated | relid=0 | w=10
  679. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-myeloma monoclonal antibody-dm4 immunoconjugate bt-062
    n1=Okihiro (syndrome de) | n2=en:anti-myeloma monoclonal antibody-dm4 immunoconjugate bt-062 | rel=r_associated | relid=0 | w=10
  680. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-myostatin monoclonal antibody ly2495655
    n1=Okihiro (syndrome de) | n2=en:anti-myostatin monoclonal antibody ly2495655 | rel=r_associated | relid=0 | w=10
  681. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-napi2b/mmae antibody-drug conjugate dnib0600a
    n1=Okihiro (syndrome de) | n2=en:anti-napi2b/mmae antibody-drug conjugate dnib0600a | rel=r_associated | relid=0 | w=10
  682. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-nectin 4 antibody-drug conjugate asg-22ce
    n1=Okihiro (syndrome de) | n2=en:anti-nectin 4 antibody-drug conjugate asg-22ce | rel=r_associated | relid=0 | w=10
  683. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-nectin-4 monoclonal antibody-drug conjugate ags-22m6e
    n1=Okihiro (syndrome de) | n2=en:anti-nectin-4 monoclonal antibody-drug conjugate ags-22m6e | rel=r_associated | relid=0 | w=10
  684. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-neuropilin-1 monoclonal antibody mnrp1685a
    n1=Okihiro (syndrome de) | n2=en:anti-neuropilin-1 monoclonal antibody mnrp1685a | rel=r_associated | relid=0 | w=10
  685. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-nf-p2x7 antibody ointment bil-010t
    n1=Okihiro (syndrome de) | n2=en:anti-nf-p2x7 antibody ointment bil-010t | rel=r_associated | relid=0 | w=10
  686. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-nucleolin aptamer as1411
    n1=Okihiro (syndrome de) | n2=en:anti-nucleolin aptamer as1411 | rel=r_associated | relid=0 | w=10
  687. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ny-eso-1 immunotherapeutic gsk-2241658a
    n1=Okihiro (syndrome de) | n2=en:anti-ny-eso-1 immunotherapeutic gsk-2241658a | rel=r_associated | relid=0 | w=10
  688. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ny-eso1 tcr-transduced autologous cd62l+-derived t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-ny-eso1 tcr-transduced autologous cd62l+-derived t-lymphocytes | rel=r_associated | relid=0 | w=10
  689. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ofa immunotherapeutic bb-mpi-03
    n1=Okihiro (syndrome de) | n2=en:anti-ofa immunotherapeutic bb-mpi-03 | rel=r_associated | relid=0 | w=10
  690. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ox40 antibody bms 986178
    n1=Okihiro (syndrome de) | n2=en:anti-ox40 antibody bms 986178 | rel=r_associated | relid=0 | w=10
  691. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ox40 antibody pf-04518600
    n1=Okihiro (syndrome de) | n2=en:anti-ox40 antibody pf-04518600 | rel=r_associated | relid=0 | w=10
  692. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ox40 monoclonal antibody
    n1=Okihiro (syndrome de) | n2=en:anti-ox40 monoclonal antibody | rel=r_associated | relid=0 | w=10
  693. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ox40 monoclonal antibody gsk3174998
    n1=Okihiro (syndrome de) | n2=en:anti-ox40 monoclonal antibody gsk3174998 | rel=r_associated | relid=0 | w=10
  694. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ox40 monoclonal antibody medi0562
    n1=Okihiro (syndrome de) | n2=en:anti-ox40 monoclonal antibody medi0562 | rel=r_associated | relid=0 | w=10
  695. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ox40 monoclonal antibody moxr0916
    n1=Okihiro (syndrome de) | n2=en:anti-ox40 monoclonal antibody moxr0916 | rel=r_associated | relid=0 | w=10
  696. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-p53 t-cell receptor-transduced peripheral blood lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-p53 t-cell receptor-transduced peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  697. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pd-1 checkpoint inhibitor pf-06801591
    n1=Okihiro (syndrome de) | n2=en:anti-pd-1 checkpoint inhibitor pf-06801591 | rel=r_associated | relid=0 | w=10
  698. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pd-1 fusion protein amp-224
    n1=Okihiro (syndrome de) | n2=en:anti-pd-1 fusion protein amp-224 | rel=r_associated | relid=0 | w=10
  699. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pd-1 monoclonal antibody bgb-a317
    n1=Okihiro (syndrome de) | n2=en:anti-pd-1 monoclonal antibody bgb-a317 | rel=r_associated | relid=0 | w=10
  700. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pd-1 monoclonal antibody medi0680
    n1=Okihiro (syndrome de) | n2=en:anti-pd-1 monoclonal antibody medi0680 | rel=r_associated | relid=0 | w=10
  701. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pd-1 monoclonal antibody pdr001
    n1=Okihiro (syndrome de) | n2=en:anti-pd-1 monoclonal antibody pdr001 | rel=r_associated | relid=0 | w=10
  702. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pd-1 monoclonal antibody regn2810
    n1=Okihiro (syndrome de) | n2=en:anti-pd-1 monoclonal antibody regn2810 | rel=r_associated | relid=0 | w=10
  703. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pd-1 monoclonal antibody shr-1210
    n1=Okihiro (syndrome de) | n2=en:anti-pd-1 monoclonal antibody shr-1210 | rel=r_associated | relid=0 | w=10
  704. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pd-1 monoclonal antibody tsr-042
    n1=Okihiro (syndrome de) | n2=en:anti-pd-1 monoclonal antibody tsr-042 | rel=r_associated | relid=0 | w=10
  705. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pd-l1 monoclonal antibody ly3300054
    n1=Okihiro (syndrome de) | n2=en:anti-pd-l1 monoclonal antibody ly3300054 | rel=r_associated | relid=0 | w=10
  706. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pd-l1 monoclonal antibody mdx-1105
    n1=Okihiro (syndrome de) | n2=en:anti-pd-l1 monoclonal antibody mdx-1105 | rel=r_associated | relid=0 | w=10
  707. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pd-l1/tgfbetarii fusion protein msb0011359c
    n1=Okihiro (syndrome de) | n2=en:anti-pd-l1/tgfbetarii fusion protein msb0011359c | rel=r_associated | relid=0 | w=10
  708. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pdgfr alpha monoclonal antibody medi-575
    n1=Okihiro (syndrome de) | n2=en:anti-pdgfr alpha monoclonal antibody medi-575 | rel=r_associated | relid=0 | w=10
  709. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pgf monoclonal antibody ro5323441
    n1=Okihiro (syndrome de) | n2=en:anti-pgf monoclonal antibody ro5323441 | rel=r_associated | relid=0 | w=10
  710. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pkn3 sirna atu027
    n1=Okihiro (syndrome de) | n2=en:anti-pkn3 sirna atu027 | rel=r_associated | relid=0 | w=10
  711. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-plgf monoclonal antibody tb-403
    n1=Okihiro (syndrome de) | n2=en:anti-plgf monoclonal antibody tb-403 | rel=r_associated | relid=0 | w=10
  712. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-pr1/hla-a2 monoclonal antibody hu8f4
    n1=Okihiro (syndrome de) | n2=en:anti-pr1/hla-a2 monoclonal antibody hu8f4 | rel=r_associated | relid=0 | w=10
  713. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-prame immunotherapeutic gsk2302032a
    n1=Okihiro (syndrome de) | n2=en:anti-prame immunotherapeutic gsk2302032a | rel=r_associated | relid=0 | w=10
  714. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes | rel=r_associated | relid=0 | w=10
  715. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-prolactin receptor antibody lfa102
    n1=Okihiro (syndrome de) | n2=en:anti-prolactin receptor antibody lfa102 | rel=r_associated | relid=0 | w=10
  716. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-psca fully human monoclonal antibody ags-1c4d4
    n1=Okihiro (syndrome de) | n2=en:anti-psca fully human monoclonal antibody ags-1c4d4 | rel=r_associated | relid=0 | w=10
  717. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-psma monoclonal antibody mdx1201-a488
    n1=Okihiro (syndrome de) | n2=en:anti-psma monoclonal antibody mdx1201-a488 | rel=r_associated | relid=0 | w=10
  718. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-psma monoclonal antibody-mmae conjugate
    n1=Okihiro (syndrome de) | n2=en:anti-psma monoclonal antibody-mmae conjugate | rel=r_associated | relid=0 | w=10
  719. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-psma/cd3 bite monoclonal antibody mt112
    n1=Okihiro (syndrome de) | n2=en:anti-psma/cd3 bite monoclonal antibody mt112 | rel=r_associated | relid=0 | w=10
  720. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-psma/cd3 monoclonal antibody mor209/es414
    n1=Okihiro (syndrome de) | n2=en:anti-psma/cd3 monoclonal antibody mor209/es414 | rel=r_associated | relid=0 | w=10
  721. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-rspo3 monoclonal antibody omp-131r10
    n1=Okihiro (syndrome de) | n2=en:anti-rspo3 monoclonal antibody omp-131r10 | rel=r_associated | relid=0 | w=10
  722. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-sclu monoclonal antibody ab-16b5
    n1=Okihiro (syndrome de) | n2=en:anti-sclu monoclonal antibody ab-16b5 | rel=r_associated | relid=0 | w=10
  723. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-sema4d monoclonal antibody vx15/2503
    n1=Okihiro (syndrome de) | n2=en:anti-sema4d monoclonal antibody vx15/2503 | rel=r_associated | relid=0 | w=10
  724. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-slitrk6 monoclonal antibody-mmae conjugate ags15e
    n1=Okihiro (syndrome de) | n2=en:anti-slitrk6 monoclonal antibody-mmae conjugate ags15e | rel=r_associated | relid=0 | w=10
  725. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-ta-muc1 monoclonal antibody pankomab
    n1=Okihiro (syndrome de) | n2=en:anti-ta-muc1 monoclonal antibody pankomab | rel=r_associated | relid=0 | w=10
  726. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-tf monoclonal antibody alt-836
    n1=Okihiro (syndrome de) | n2=en:anti-tf monoclonal antibody alt-836 | rel=r_associated | relid=0 | w=10
  727. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-tf monoclonal antibody-mmae conjugate
    n1=Okihiro (syndrome de) | n2=en:anti-tf monoclonal antibody-mmae conjugate | rel=r_associated | relid=0 | w=10
  728. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-tgf-beta rii monoclonal antibody imc-tr1
    n1=Okihiro (syndrome de) | n2=en:anti-tgf-beta rii monoclonal antibody imc-tr1 | rel=r_associated | relid=0 | w=10
  729. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-thymocyte globulin
    n1=Okihiro (syndrome de) | n2=en:anti-thymocyte globulin | rel=r_associated | relid=0 | w=10
  730. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-thyroglobulin mtcr-transduced autologous peripheral blood lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-thyroglobulin mtcr-transduced autologous peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  731. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-tim-3 monoclonal antibody mbg453
    n1=Okihiro (syndrome de) | n2=en:anti-tim-3 monoclonal antibody mbg453 | rel=r_associated | relid=0 | w=10
  732. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-tissue factor monoclonal antibody morab-066
    n1=Okihiro (syndrome de) | n2=en:anti-tissue factor monoclonal antibody morab-066 | rel=r_associated | relid=0 | w=10
  733. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-tlr2 monoclonal antibody opn-305
    n1=Okihiro (syndrome de) | n2=en:anti-tlr2 monoclonal antibody opn-305 | rel=r_associated | relid=0 | w=10
  734. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-transthyretin sirna aln-ttr02
    n1=Okihiro (syndrome de) | n2=en:anti-transthyretin sirna aln-ttr02 | rel=r_associated | relid=0 | w=10
  735. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-tumor necrosis factor alpha drug
    n1=Okihiro (syndrome de) | n2=en:anti-tumor necrosis factor alpha drug | rel=r_associated | relid=0 | w=10
  736. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-tweak monoclonal antibody ro5458640
    n1=Okihiro (syndrome de) | n2=en:anti-tweak monoclonal antibody ro5458640 | rel=r_associated | relid=0 | w=10
  737. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-vegf anticalin prs-050-peg40
    n1=Okihiro (syndrome de) | n2=en:anti-vegf anticalin prs-050-peg40 | rel=r_associated | relid=0 | w=10
  738. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-vegf/ang2 nanobody bi 836880
    n1=Okihiro (syndrome de) | n2=en:anti-vegf/ang2 nanobody bi 836880 | rel=r_associated | relid=0 | w=10
  739. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-vegfc monoclonal antibody vgx-100
    n1=Okihiro (syndrome de) | n2=en:anti-vegfc monoclonal antibody vgx-100 | rel=r_associated | relid=0 | w=10
  740. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-vegfr2-car retroviral vector-transduced autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:anti-vegfr2-car retroviral vector-transduced autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  741. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-vegfr3 monoclonal antibody imc-3c5
    n1=Okihiro (syndrome de) | n2=en:anti-vegfr3 monoclonal antibody imc-3c5 | rel=r_associated | relid=0 | w=10
  742. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-vista monoclonal antibody jnj 61610588
    n1=Okihiro (syndrome de) | n2=en:anti-vista monoclonal antibody jnj 61610588 | rel=r_associated | relid=0 | w=10
  743. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anti-von willebrand factor nanobody
    n1=Okihiro (syndrome de) | n2=en:anti-von willebrand factor nanobody | rel=r_associated | relid=0 | w=10
  744. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antiangiogenic drug combination tl-118
    n1=Okihiro (syndrome de) | n2=en:antiangiogenic drug combination tl-118 | rel=r_associated | relid=0 | w=10
  745. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antiarrhythmic agent
    n1=Okihiro (syndrome de) | n2=en:antiarrhythmic agent | rel=r_associated | relid=0 | w=10
  746. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antiarthritic agent
    n1=Okihiro (syndrome de) | n2=en:antiarthritic agent | rel=r_associated | relid=0 | w=10
  747. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antibiotic
    n1=Okihiro (syndrome de) | n2=en:antibiotic | rel=r_associated | relid=0 | w=10
  748. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antibiotic sq109
    n1=Okihiro (syndrome de) | n2=en:antibiotic sq109 | rel=r_associated | relid=0 | w=10
  749. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antibody-drug conjugate abbv-085
    n1=Okihiro (syndrome de) | n2=en:antibody-drug conjugate abbv-085 | rel=r_associated | relid=0 | w=10
  750. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antibody-drug conjugate abbv-399
    n1=Okihiro (syndrome de) | n2=en:antibody-drug conjugate abbv-399 | rel=r_associated | relid=0 | w=10
  751. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antibody-drug conjugate abbv-838
    n1=Okihiro (syndrome de) | n2=en:antibody-drug conjugate abbv-838 | rel=r_associated | relid=0 | w=10
  752. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antibody-drug conjugate adct-402
    n1=Okihiro (syndrome de) | n2=en:antibody-drug conjugate adct-402 | rel=r_associated | relid=0 | w=10
  753. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antibody-drug conjugate bay79-4620
    n1=Okihiro (syndrome de) | n2=en:antibody-drug conjugate bay79-4620 | rel=r_associated | relid=0 | w=10
  754. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antibody-drug conjugate dfrf4539a
    n1=Okihiro (syndrome de) | n2=en:antibody-drug conjugate dfrf4539a | rel=r_associated | relid=0 | w=10
  755. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antibody-drug conjugate pf-06647020
    n1=Okihiro (syndrome de) | n2=en:antibody-drug conjugate pf-06647020 | rel=r_associated | relid=0 | w=10
  756. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antibody-drug conjugate pf-06647263
    n1=Okihiro (syndrome de) | n2=en:antibody-drug conjugate pf-06647263 | rel=r_associated | relid=0 | w=10
  757. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antibody-drug conjugate pf-06664178
    n1=Okihiro (syndrome de) | n2=en:antibody-drug conjugate pf-06664178 | rel=r_associated | relid=0 | w=10
  758. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antibody-drug conjugate sc-002
    n1=Okihiro (syndrome de) | n2=en:antibody-drug conjugate sc-002 | rel=r_associated | relid=0 | w=10
  759. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antibody-drug conjugate sc-003
    n1=Okihiro (syndrome de) | n2=en:antibody-drug conjugate sc-003 | rel=r_associated | relid=0 | w=10
  760. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antibody-drug conjugate sc16ld6.5
    n1=Okihiro (syndrome de) | n2=en:antibody-drug conjugate sc16ld6.5 | rel=r_associated | relid=0 | w=10
  761. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anticachexia agent mt-102
    n1=Okihiro (syndrome de) | n2=en:anticachexia agent mt-102 | rel=r_associated | relid=0 | w=10
  762. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:anticholinergic agent
    n1=Okihiro (syndrome de) | n2=en:anticholinergic agent | rel=r_associated | relid=0 | w=10
  763. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antidiuretic
    n1=Okihiro (syndrome de) | n2=en:antidiuretic | rel=r_associated | relid=0 | w=10
  764. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antidote
    n1=Okihiro (syndrome de) | n2=en:antidote | rel=r_associated | relid=0 | w=10
  765. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antifungal agent f901318
    n1=Okihiro (syndrome de) | n2=en:antifungal agent f901318 | rel=r_associated | relid=0 | w=10
  766. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antigen-targeted personalized breast cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:antigen-targeted personalized breast cancer vaccine | rel=r_associated | relid=0 | w=10
  767. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antihemophilic factor agent
    n1=Okihiro (syndrome de) | n2=en:antihemophilic factor agent | rel=r_associated | relid=0 | w=10
  768. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antihemophilic factor, human recombinant
    n1=Okihiro (syndrome de) | n2=en:antihemophilic factor, human recombinant | rel=r_associated | relid=0 | w=10
  769. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antihistamines
    n1=Okihiro (syndrome de) | n2=en:antihistamines | rel=r_associated | relid=0 | w=10
  770. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antihypertensive agent
    n1=Okihiro (syndrome de) | n2=en:antihypertensive agent | rel=r_associated | relid=0 | w=10
  771. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antilipemic agent
    n1=Okihiro (syndrome de) | n2=en:antilipemic agent | rel=r_associated | relid=0 | w=10
  772. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antimetabolite
    n1=Okihiro (syndrome de) | n2=en:antimetabolite | rel=r_associated | relid=0 | w=10
  773. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antimetabolite ff-10502
    n1=Okihiro (syndrome de) | n2=en:antimetabolite ff-10502 | rel=r_associated | relid=0 | w=10
  774. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antimoniotungstate
    n1=Okihiro (syndrome de) | n2=en:antimoniotungstate | rel=r_associated | relid=0 | w=10
  775. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antimony
    n1=Okihiro (syndrome de) | n2=en:antimony | rel=r_associated | relid=0 | w=10
  776. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antineoplastic agent
    n1=Okihiro (syndrome de) | n2=en:antineoplastic agent | rel=r_associated | relid=0 | w=10
  777. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antineoplastic agent combination sm-88
    n1=Okihiro (syndrome de) | n2=en:antineoplastic agent combination sm-88 | rel=r_associated | relid=0 | w=10
  778. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antineoplastic agent trx-818
    n1=Okihiro (syndrome de) | n2=en:antineoplastic agent trx-818 | rel=r_associated | relid=0 | w=10
  779. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antineoplaston a10
    n1=Okihiro (syndrome de) | n2=en:antineoplaston a10 | rel=r_associated | relid=0 | w=10
  780. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antineoplaston as2-1
    n1=Okihiro (syndrome de) | n2=en:antineoplaston as2-1 | rel=r_associated | relid=0 | w=10
  781. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antiperspirant cream f511
    n1=Okihiro (syndrome de) | n2=en:antiperspirant cream f511 | rel=r_associated | relid=0 | w=10
  782. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antiplatelet agent
    n1=Okihiro (syndrome de) | n2=en:antiplatelet agent | rel=r_associated | relid=0 | w=10
  783. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antipsychotic agent
    n1=Okihiro (syndrome de) | n2=en:antipsychotic agent | rel=r_associated | relid=0 | w=10
  784. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antipsychotics,other
    n1=Okihiro (syndrome de) | n2=en:antipsychotics,other | rel=r_associated | relid=0 | w=10
  785. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antipyrine
    n1=Okihiro (syndrome de) | n2=en:antipyrine | rel=r_associated | relid=0 | w=10
  786. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antirheumatic agents
    n1=Okihiro (syndrome de) | n2=en:antirheumatic agents | rel=r_associated | relid=0 | w=10
  787. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antispasmodic agent
    n1=Okihiro (syndrome de) | n2=en:antispasmodic agent | rel=r_associated | relid=0 | w=10
  788. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antithrombin iii, human
    n1=Okihiro (syndrome de) | n2=en:antithrombin iii, human | rel=r_associated | relid=0 | w=10
  789. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antitumor b
    n1=Okihiro (syndrome de) | n2=en:antitumor b | rel=r_associated | relid=0 | w=10
  790. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antivaricose agent
    n1=Okihiro (syndrome de) | n2=en:antivaricose agent | rel=r_associated | relid=0 | w=10
  791. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antiviral agent csj148
    n1=Okihiro (syndrome de) | n2=en:antiviral agent csj148 | rel=r_associated | relid=0 | w=10
  792. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antrodia cinnamomea supplement
    n1=Okihiro (syndrome de) | n2=en:antrodia cinnamomea supplement | rel=r_associated | relid=0 | w=10
  793. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:antroquinonol capsule
    n1=Okihiro (syndrome de) | n2=en:antroquinonol capsule | rel=r_associated | relid=0 | w=10
  794. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apatinib
    n1=Okihiro (syndrome de) | n2=en:apatinib | rel=r_associated | relid=0 | w=10
  795. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apatorsen
    n1=Okihiro (syndrome de) | n2=en:apatorsen | rel=r_associated | relid=0 | w=10
  796. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apaziquone
    n1=Okihiro (syndrome de) | n2=en:apaziquone | rel=r_associated | relid=0 | w=10
  797. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apc8015f
    n1=Okihiro (syndrome de) | n2=en:apc8015f | rel=r_associated | relid=0 | w=10
  798. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apf530
    n1=Okihiro (syndrome de) | n2=en:apf530 | rel=r_associated | relid=0 | w=10
  799. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:api 31510 topical cream
    n1=Okihiro (syndrome de) | n2=en:api 31510 topical cream | rel=r_associated | relid=0 | w=10
  800. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apilimod dimesylate capsule
    n1=Okihiro (syndrome de) | n2=en:apilimod dimesylate capsule | rel=r_associated | relid=0 | w=10
  801. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apixaban
    n1=Okihiro (syndrome de) | n2=en:apixaban | rel=r_associated | relid=0 | w=10
  802. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apolizumab
    n1=Okihiro (syndrome de) | n2=en:apolizumab | rel=r_associated | relid=0 | w=10
  803. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apomab
    n1=Okihiro (syndrome de) | n2=en:apomab | rel=r_associated | relid=0 | w=10
  804. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apomine
    n1=Okihiro (syndrome de) | n2=en:apomine | rel=r_associated | relid=0 | w=10
  805. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apoptosis inducer bzl101
    n1=Okihiro (syndrome de) | n2=en:apoptosis inducer bzl101 | rel=r_associated | relid=0 | w=10
  806. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apoptosis inducer gcs-100
    n1=Okihiro (syndrome de) | n2=en:apoptosis inducer gcs-100 | rel=r_associated | relid=0 | w=10
  807. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apoptosis inducer mpc-2130
    n1=Okihiro (syndrome de) | n2=en:apoptosis inducer mpc-2130 | rel=r_associated | relid=0 | w=10
  808. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells
    n1=Okihiro (syndrome de) | n2=en:apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells | rel=r_associated | relid=0 | w=10
  809. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:appendicular skeleton
    n1=Okihiro (syndrome de) | n2=en:appendicular skeleton | rel=r_associated | relid=0 | w=10
  810. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aprepitant
    n1=Okihiro (syndrome de) | n2=en:aprepitant | rel=r_associated | relid=0 | w=10
  811. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:apricoxib
    n1=Okihiro (syndrome de) | n2=en:apricoxib | rel=r_associated | relid=0 | w=10
  812. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aprotinin
    n1=Okihiro (syndrome de) | n2=en:aprotinin | rel=r_associated | relid=0 | w=10
  813. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ar antagonist bms-641988
    n1=Okihiro (syndrome de) | n2=en:ar antagonist bms-641988 | rel=r_associated | relid=0 | w=10
  814. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ar antagonist odm-201
    n1=Okihiro (syndrome de) | n2=en:ar antagonist odm-201 | rel=r_associated | relid=0 | w=10
  815. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ar ligand binding domain-targeting agent azd3514
    n1=Okihiro (syndrome de) | n2=en:ar ligand binding domain-targeting agent azd3514 | rel=r_associated | relid=0 | w=10
  816. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:arbutamine
    n1=Okihiro (syndrome de) | n2=en:arbutamine | rel=r_associated | relid=0 | w=10
  817. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:arch of the vertebra
    n1=Okihiro (syndrome de) | n2=en:arch of the vertebra | rel=r_associated | relid=0 | w=10
  818. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:archexin
    n1=Okihiro (syndrome de) | n2=en:archexin | rel=r_associated | relid=0 | w=10
  819. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:arcitumomab
    n1=Okihiro (syndrome de) | n2=en:arcitumomab | rel=r_associated | relid=0 | w=10
  820. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:argatroban
    n1=Okihiro (syndrome de) | n2=en:argatroban | rel=r_associated | relid=0 | w=10
  821. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:arginine butyrate
    n1=Okihiro (syndrome de) | n2=en:arginine butyrate | rel=r_associated | relid=0 | w=10
  822. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:arginine/omega-3 fatty acids/nucleotides oral supplement
    n1=Okihiro (syndrome de) | n2=en:arginine/omega-3 fatty acids/nucleotides oral supplement | rel=r_associated | relid=0 | w=10
  823. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:argipressin
    n1=Okihiro (syndrome de) | n2=en:argipressin | rel=r_associated | relid=0 | w=10
  824. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aripiprazole
    n1=Okihiro (syndrome de) | n2=en:aripiprazole | rel=r_associated | relid=0 | w=10
  825. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:armodafinil
    n1=Okihiro (syndrome de) | n2=en:armodafinil | rel=r_associated | relid=0 | w=10
  826. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:arnebia indigo jade pearl topical cream
    n1=Okihiro (syndrome de) | n2=en:arnebia indigo jade pearl topical cream | rel=r_associated | relid=0 | w=10
  827. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:arsanilic acid
    n1=Okihiro (syndrome de) | n2=en:arsanilic acid | rel=r_associated | relid=0 | w=10
  828. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:arsenic and/or arsenic compound
    n1=Okihiro (syndrome de) | n2=en:arsenic and/or arsenic compound | rel=r_associated | relid=0 | w=10
  829. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:arsenic trioxide
    n1=Okihiro (syndrome de) | n2=en:arsenic trioxide | rel=r_associated | relid=0 | w=10
  830. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:artemether sublingual spray
    n1=Okihiro (syndrome de) | n2=en:artemether sublingual spray | rel=r_associated | relid=0 | w=10
  831. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:artemisia vulgaris
    n1=Okihiro (syndrome de) | n2=en:artemisia vulgaris | rel=r_associated | relid=0 | w=10
  832. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:artesunate
    n1=Okihiro (syndrome de) | n2=en:artesunate | rel=r_associated | relid=0 | w=10
  833. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:artichoke whole phytocomplex concentrate
    n1=Okihiro (syndrome de) | n2=en:artichoke whole phytocomplex concentrate | rel=r_associated | relid=0 | w=10
  834. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:articular cartilage of proximal epiphysis of ulna
    n1=Okihiro (syndrome de) | n2=en:articular cartilage of proximal epiphysis of ulna | rel=r_associated | relid=0 | w=10
  835. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:arzoxifene hydrochloride
    n1=Okihiro (syndrome de) | n2=en:arzoxifene hydrochloride | rel=r_associated | relid=0 | w=10
  836. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:as03-adjuvanted h1n1 pandemic influenza vaccine
    n1=Okihiro (syndrome de) | n2=en:as03-adjuvanted h1n1 pandemic influenza vaccine | rel=r_associated | relid=0 | w=10
  837. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:asaley
    n1=Okihiro (syndrome de) | n2=en:asaley | rel=r_associated | relid=0 | w=10
  838. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ascorbic acid
    n1=Okihiro (syndrome de) | n2=en:ascorbic acid | rel=r_associated | relid=0 | w=10
  839. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:asenapine
    n1=Okihiro (syndrome de) | n2=en:asenapine | rel=r_associated | relid=0 | w=10
  840. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:asenapine maleate
    n1=Okihiro (syndrome de) | n2=en:asenapine maleate | rel=r_associated | relid=0 | w=10
  841. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:asfotase alfa
    n1=Okihiro (syndrome de) | n2=en:asfotase alfa | rel=r_associated | relid=0 | w=10
  842. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ashwagandha root powder extract
    n1=Okihiro (syndrome de) | n2=en:ashwagandha root powder extract | rel=r_associated | relid=0 | w=10
  843. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:asian ginseng
    n1=Okihiro (syndrome de) | n2=en:asian ginseng | rel=r_associated | relid=0 | w=10
  844. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ask1 inhibitor gs-4997
    n1=Okihiro (syndrome de) | n2=en:ask1 inhibitor gs-4997 | rel=r_associated | relid=0 | w=10
  845. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:asp4132
    n1=Okihiro (syndrome de) | n2=en:asp4132 | rel=r_associated | relid=0 | w=10
  846. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:asp9521
    n1=Okihiro (syndrome de) | n2=en:asp9521 | rel=r_associated | relid=0 | w=10
  847. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:asp9853
    n1=Okihiro (syndrome de) | n2=en:asp9853 | rel=r_associated | relid=0 | w=10
  848. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:asparaginase
    n1=Okihiro (syndrome de) | n2=en:asparaginase | rel=r_associated | relid=0 | w=10
  849. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:asparaginase erwinia chrysanthemi
    n1=Okihiro (syndrome de) | n2=en:asparaginase erwinia chrysanthemi | rel=r_associated | relid=0 | w=10
  850. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aspirin
    n1=Okihiro (syndrome de) | n2=en:aspirin | rel=r_associated | relid=0 | w=10
  851. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aspirin/simvastatin/atenolol/ramipril/thiazide capsule
    n1=Okihiro (syndrome de) | n2=en:aspirin/simvastatin/atenolol/ramipril/thiazide capsule | rel=r_associated | relid=0 | w=10
  852. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:astragalus-based formulation qing shu yi qi tang
    n1=Okihiro (syndrome de) | n2=en:astragalus-based formulation qing shu yi qi tang | rel=r_associated | relid=0 | w=10
  853. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:astringent
    n1=Okihiro (syndrome de) | n2=en:astringent | rel=r_associated | relid=0 | w=10
  854. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:astuprotimut-r
    n1=Okihiro (syndrome de) | n2=en:astuprotimut-r | rel=r_associated | relid=0 | w=10
  855. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:asulacrine isethionate
    n1=Okihiro (syndrome de) | n2=en:asulacrine isethionate | rel=r_associated | relid=0 | w=10
  856. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:asunaprevir
    n1=Okihiro (syndrome de) | n2=en:asunaprevir | rel=r_associated | relid=0 | w=10
  857. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:at 211 monoclonal antibody 81c6
    n1=Okihiro (syndrome de) | n2=en:at 211 monoclonal antibody 81c6 | rel=r_associated | relid=0 | w=10
  858. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atamestane
    n1=Okihiro (syndrome de) | n2=en:atamestane | rel=r_associated | relid=0 | w=10
  859. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atazanavir
    n1=Okihiro (syndrome de) | n2=en:atazanavir | rel=r_associated | relid=0 | w=10
  860. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atenolol
    n1=Okihiro (syndrome de) | n2=en:atenolol | rel=r_associated | relid=0 | w=10
  861. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atezolizumab
    n1=Okihiro (syndrome de) | n2=en:atezolizumab | rel=r_associated | relid=0 | w=10
  862. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atiprimod
    n1=Okihiro (syndrome de) | n2=en:atiprimod | rel=r_associated | relid=0 | w=10
  863. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atm kinase inhibitor azd0156
    n1=Okihiro (syndrome de) | n2=en:atm kinase inhibitor azd0156 | rel=r_associated | relid=0 | w=10
  864. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atn-161
    n1=Okihiro (syndrome de) | n2=en:atn-161 | rel=r_associated | relid=0 | w=10
  865. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atomoxetine
    n1=Okihiro (syndrome de) | n2=en:atomoxetine | rel=r_associated | relid=0 | w=10
  866. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atomoxetine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:atomoxetine hydrochloride | rel=r_associated | relid=0 | w=10
  867. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atorvastatin calcium
    n1=Okihiro (syndrome de) | n2=en:atorvastatin calcium | rel=r_associated | relid=0 | w=10
  868. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atr kinase inhibitor azd6738
    n1=Okihiro (syndrome de) | n2=en:atr kinase inhibitor azd6738 | rel=r_associated | relid=0 | w=10
  869. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atr kinase inhibitor vx-970
    n1=Okihiro (syndrome de) | n2=en:atr kinase inhibitor vx-970 | rel=r_associated | relid=0 | w=10
  870. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atr-101
    n1=Okihiro (syndrome de) | n2=en:atr-101 | rel=r_associated | relid=0 | w=10
  871. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atrasentan hydrochloride
    n1=Okihiro (syndrome de) | n2=en:atrasentan hydrochloride | rel=r_associated | relid=0 | w=10
  872. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atropine sulfate
    n1=Okihiro (syndrome de) | n2=en:atropine sulfate | rel=r_associated | relid=0 | w=10
  873. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:attenuated chimpanzee adenovirus 5t4 vaccine
    n1=Okihiro (syndrome de) | n2=en:attenuated chimpanzee adenovirus 5t4 vaccine | rel=r_associated | relid=0 | w=10
  874. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:attenuated corynebacterium parvum
    n1=Okihiro (syndrome de) | n2=en:attenuated corynebacterium parvum | rel=r_associated | relid=0 | w=10
  875. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:attenuated listeria monocytogenes crs-100
    n1=Okihiro (syndrome de) | n2=en:attenuated listeria monocytogenes crs-100 | rel=r_associated | relid=0 | w=10
  876. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001
    n1=Okihiro (syndrome de) | n2=en:attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001 | rel=r_associated | relid=0 | w=10
  877. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:atypical antipsychotic
    n1=Okihiro (syndrome de) | n2=en:atypical antipsychotic | rel=r_associated | relid=0 | w=10
  878. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:auranofin
    n1=Okihiro (syndrome de) | n2=en:auranofin | rel=r_associated | relid=0 | w=10
  879. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aurora a kinase inhibitor mk5108
    n1=Okihiro (syndrome de) | n2=en:aurora a kinase inhibitor mk5108 | rel=r_associated | relid=0 | w=10
  880. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aurora a kinase inhibitor tas-119
    n1=Okihiro (syndrome de) | n2=en:aurora a kinase inhibitor tas-119 | rel=r_associated | relid=0 | w=10
  881. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aurora a kinase/tyrosine kinase inhibitor enmd-2076
    n1=Okihiro (syndrome de) | n2=en:aurora a kinase/tyrosine kinase inhibitor enmd-2076 | rel=r_associated | relid=0 | w=10
  882. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aurora b serine/threonine kinase inhibitor tak-901
    n1=Okihiro (syndrome de) | n2=en:aurora b serine/threonine kinase inhibitor tak-901 | rel=r_associated | relid=0 | w=10
  883. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aurora b/c kinase inhibitor gsk1070916a
    n1=Okihiro (syndrome de) | n2=en:aurora b/c kinase inhibitor gsk1070916a | rel=r_associated | relid=0 | w=10
  884. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aurora kinase inhibitor amg 900
    n1=Okihiro (syndrome de) | n2=en:aurora kinase inhibitor amg 900 | rel=r_associated | relid=0 | w=10
  885. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aurora kinase inhibitor bi 811283
    n1=Okihiro (syndrome de) | n2=en:aurora kinase inhibitor bi 811283 | rel=r_associated | relid=0 | w=10
  886. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aurora kinase inhibitor mln8054
    n1=Okihiro (syndrome de) | n2=en:aurora kinase inhibitor mln8054 | rel=r_associated | relid=0 | w=10
  887. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aurora kinase inhibitor pf-03814735
    n1=Okihiro (syndrome de) | n2=en:aurora kinase inhibitor pf-03814735 | rel=r_associated | relid=0 | w=10
  888. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aurora kinase inhibitor sns-314
    n1=Okihiro (syndrome de) | n2=en:aurora kinase inhibitor sns-314 | rel=r_associated | relid=0 | w=10
  889. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aurora kinase inhibitor ttp607
    n1=Okihiro (syndrome de) | n2=en:aurora kinase inhibitor ttp607 | rel=r_associated | relid=0 | w=10
  890. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aurora kinase/vegfr2 inhibitor cyc116
    n1=Okihiro (syndrome de) | n2=en:aurora kinase/vegfr2 inhibitor cyc116 | rel=r_associated | relid=0 | w=10
  891. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous ad-cd154-transduced cll b cells
    n1=Okihiro (syndrome de) | n2=en:autologous ad-cd154-transduced cll b cells | rel=r_associated | relid=0 | w=10
  892. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous anti-cd123 car tcr/4-1bb-expressing t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous anti-cd123 car tcr/4-1bb-expressing t-lymphocytes | rel=r_associated | relid=0 | w=10
  893. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous anti-cd19 car-expressing t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous anti-cd19 car-expressing t lymphocytes | rel=r_associated | relid=0 | w=10
  894. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014
    n1=Okihiro (syndrome de) | n2=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014 | rel=r_associated | relid=0 | w=10
  895. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes jcar017
    n1=Okihiro (syndrome de) | n2=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes jcar017 | rel=r_associated | relid=0 | w=10
  896. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes | rel=r_associated | relid=0 | w=10
  897. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous anti-gp100:154-162 t-cell receptor gene-engineered peripheral blood lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous anti-gp100:154-162 t-cell receptor gene-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  898. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  899. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous anti-psma gene-modified t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous anti-psma gene-modified t-lymphocytes | rel=r_associated | relid=0 | w=10
  900. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous beta-a(t87q)-globin gene-transduced cd34-positive cells
    n1=Okihiro (syndrome de) | n2=en:autologous beta-a(t87q)-globin gene-transduced cd34-positive cells | rel=r_associated | relid=0 | w=10
  901. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous bone marrow-derived cd34/cxcr4-positive stem cells amr-001
    n1=Okihiro (syndrome de) | n2=en:autologous bone marrow-derived cd34/cxcr4-positive stem cells amr-001 | rel=r_associated | relid=0 | w=10
  902. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes | rel=r_associated | relid=0 | w=10
  903. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous cd133-positive btsc mrna-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous cd133-positive btsc mrna-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  904. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous cd171-specific car-cd28 zeta-4-1-bb-egfrt-expressing t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous cd171-specific car-cd28 zeta-4-1-bb-egfrt-expressing t lymphocytes | rel=r_associated | relid=0 | w=10
  905. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous cd19-28z chimeric antigen receptor-expressing t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous cd19-28z chimeric antigen receptor-expressing t-lymphocytes | rel=r_associated | relid=0 | w=10
  906. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells
    n1=Okihiro (syndrome de) | n2=en:autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells | rel=r_associated | relid=0 | w=10
  907. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous cd34-positive hematopoietic progenitor cells
    n1=Okihiro (syndrome de) | n2=en:autologous cd34-positive hematopoietic progenitor cells | rel=r_associated | relid=0 | w=10
  908. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous cd8 positive pbl sensitized to drosophila cell-presented melanoma peptides
    n1=Okihiro (syndrome de) | n2=en:autologous cd8 positive pbl sensitized to drosophila cell-presented melanoma peptides | rel=r_associated | relid=0 | w=10
  909. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous cd8+ melanoma specific t cells
    n1=Okihiro (syndrome de) | n2=en:autologous cd8+ melanoma specific t cells | rel=r_associated | relid=0 | w=10
  910. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous cea-specific cytotoxic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous cea-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  911. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous colon cancer cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous colon cancer cell vaccine | rel=r_associated | relid=0 | w=10
  912. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous colorectal tumor antigen-pulsed dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous colorectal tumor antigen-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  913. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous ct7/mage-a3/wt1 mrna-electroporated langerhans-type dendritic cells
    n1=Okihiro (syndrome de) | n2=en:autologous ct7/mage-a3/wt1 mrna-electroporated langerhans-type dendritic cells | rel=r_associated | relid=0 | w=10
  914. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous cultured acute myeloid leukemia-specific cytotoxic t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous cultured acute myeloid leukemia-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  915. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous cytomegalovirus-specific cytotoxic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous cytomegalovirus-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  916. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous cytotoxic t-lymphocytes induced with muc1 gene-transfected dendritic cells
    n1=Okihiro (syndrome de) | n2=en:autologous cytotoxic t-lymphocytes induced with muc1 gene-transfected dendritic cells | rel=r_associated | relid=0 | w=10
  917. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous cytotoxic t-lymphocytes induced with muc1 peptide-pulsed dendritic cells
    n1=Okihiro (syndrome de) | n2=en:autologous cytotoxic t-lymphocytes induced with muc1 peptide-pulsed dendritic cells | rel=r_associated | relid=0 | w=10
  918. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous dendritic cell vaccine act2001
    n1=Okihiro (syndrome de) | n2=en:autologous dendritic cell vaccine act2001 | rel=r_associated | relid=0 | w=10
  919. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous dendritic cell-adenovirus ccl21 vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous dendritic cell-adenovirus ccl21 vaccine | rel=r_associated | relid=0 | w=10
  920. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous dendritic cell-adenovirus p53 vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous dendritic cell-adenovirus p53 vaccine | rel=r_associated | relid=0 | w=10
  921. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine | rel=r_associated | relid=0 | w=10
  922. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous dendritic cell-autologous tumor mrna-human cd40l vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous dendritic cell-autologous tumor mrna-human cd40l vaccine | rel=r_associated | relid=0 | w=10
  923. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous dendritic cell-based immunotherapeutic av0113
    n1=Okihiro (syndrome de) | n2=en:autologous dendritic cell-based immunotherapeutic av0113 | rel=r_associated | relid=0 | w=10
  924. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous dendritic cell-tumor fusion vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous dendritic cell-tumor fusion vaccine | rel=r_associated | relid=0 | w=10
  925. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous dendritic cells/cmv pp65 peptide
    n1=Okihiro (syndrome de) | n2=en:autologous dendritic cells/cmv pp65 peptide | rel=r_associated | relid=0 | w=10
  926. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous dinitrophenyl-modified ovarian cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous dinitrophenyl-modified ovarian cancer vaccine | rel=r_associated | relid=0 | w=10
  927. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous ebv-ctl cd19car zeta
    n1=Okihiro (syndrome de) | n2=en:autologous ebv-ctl cd19car zeta | rel=r_associated | relid=0 | w=10
  928. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine | rel=r_associated | relid=0 | w=10
  929. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous epstein-barr virus-transformed b-lymphoblastoid cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous epstein-barr virus-transformed b-lymphoblastoid cell vaccine | rel=r_associated | relid=0 | w=10
  930. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous expanded mesenchymal stem cells oti-010
    n1=Okihiro (syndrome de) | n2=en:autologous expanded mesenchymal stem cells oti-010 | rel=r_associated | relid=0 | w=10
  931. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous glioma cell lysate
    n1=Okihiro (syndrome de) | n2=en:autologous glioma cell lysate | rel=r_associated | relid=0 | w=10
  932. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous gm-csf-secreting breast cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous gm-csf-secreting breast cancer vaccine | rel=r_associated | relid=0 | w=10
  933. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous gm-csf-secreting lethally irradiated colorectal cancer cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous gm-csf-secreting lethally irradiated colorectal cancer cell vaccine | rel=r_associated | relid=0 | w=10
  934. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous gm-csf-secreting lethally irradiated leukemia cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous gm-csf-secreting lethally irradiated leukemia cell vaccine | rel=r_associated | relid=0 | w=10
  935. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous gm-csf-secreting melanoma vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous gm-csf-secreting melanoma vaccine | rel=r_associated | relid=0 | w=10
  936. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous hbv-specific tcr-redirected t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous hbv-specific tcr-redirected t-lymphocytes | rel=r_associated | relid=0 | w=10
  937. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous heat-shock protein 70 peptide vaccine ag-858
    n1=Okihiro (syndrome de) | n2=en:autologous heat-shock protein 70 peptide vaccine ag-858 | rel=r_associated | relid=0 | w=10
  938. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous her2 chimeric receptor/tgfbeta dominant negative receptor-expressing ebv-specific cytotoxic t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous her2 chimeric receptor/tgfbeta dominant negative receptor-expressing ebv-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  939. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous hnscc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous hnscc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine | rel=r_associated | relid=0 | w=10
  940. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous hpv-16/18 e6/e7-specific tgf-beta-resistant t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous hpv-16/18 e6/e7-specific tgf-beta-resistant t lymphocytes | rel=r_associated | relid=0 | w=10
  941. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous ic9-gd2-car-expressing vzv-specific t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous ic9-gd2-car-expressing vzv-specific t lymphocytes | rel=r_associated | relid=0 | w=10
  942. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous il-21-modulated cd8+ mart1-specific t cells
    n1=Okihiro (syndrome de) | n2=en:autologous il-21-modulated cd8+ mart1-specific t cells | rel=r_associated | relid=0 | w=10
  943. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous immunoglobulin idiotype-klh conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous immunoglobulin idiotype-klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  944. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous interferon-producing killer dendritic cells
    n1=Okihiro (syndrome de) | n2=en:autologous interferon-producing killer dendritic cells | rel=r_associated | relid=0 | w=10
  945. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous lmp1-/lmp2- specific cytotoxic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous lmp1-/lmp2- specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  946. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous lymphoid effector cells specific against tumor cells
    n1=Okihiro (syndrome de) | n2=en:autologous lymphoid effector cells specific against tumor cells | rel=r_associated | relid=0 | w=10
  947. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  948. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine | rel=r_associated | relid=0 | w=10
  949. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine | rel=r_associated | relid=0 | w=10
  950. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine | rel=r_associated | relid=0 | w=10
  951. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous mage-a3-specific hla-a*01-restricted t cell receptor gene engineered lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous mage-a3-specific hla-a*01-restricted t cell receptor gene engineered lymphocytes | rel=r_associated | relid=0 | w=10
  952. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous melanoma lysate-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous melanoma lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  953. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  954. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous melanoma lysate/ny-eso-1-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous melanoma lysate/ny-eso-1-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  955. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous mesenchymal stem cells apceth_101
    n1=Okihiro (syndrome de) | n2=en:autologous mesenchymal stem cells apceth_101 | rel=r_associated | relid=0 | w=10
  956. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous muc1-mannan fusion protein pulsed dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous muc1-mannan fusion protein pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  957. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous neuroblastoma lysate/klh-pulsed dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous neuroblastoma lysate/klh-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  958. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous nsclc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous nsclc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine | rel=r_associated | relid=0 | w=10
  959. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous nsclc peptide-specific dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous nsclc peptide-specific dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  960. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes | rel=r_associated | relid=0 | w=10
  961. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous ofa-ilrp rna-transfected dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous ofa-ilrp rna-transfected dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  962. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  963. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous oxidized ovarian tumor cell lysate vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous oxidized ovarian tumor cell lysate vaccine | rel=r_associated | relid=0 | w=10
  964. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il-12 and anti-ny-eso-1 tcr
    n1=Okihiro (syndrome de) | n2=en:autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il-12 and anti-ny-eso-1 tcr | rel=r_associated | relid=0 | w=10
  965. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous pluripotent aldhbr stem cells ald-451
    n1=Okihiro (syndrome de) | n2=en:autologous pluripotent aldhbr stem cells ald-451 | rel=r_associated | relid=0 | w=10
  966. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous prostate cancer antigen-expressing dendritic cell vaccine bpx-101
    n1=Okihiro (syndrome de) | n2=en:autologous prostate cancer antigen-expressing dendritic cell vaccine bpx-101 | rel=r_associated | relid=0 | w=10
  967. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous prostate stem cell antigen-specific car t cells bpx-601
    n1=Okihiro (syndrome de) | n2=en:autologous prostate stem cell antigen-specific car t cells bpx-601 | rel=r_associated | relid=0 | w=10
  968. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  969. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous sarcoma cell lysate
    n1=Okihiro (syndrome de) | n2=en:autologous sarcoma cell lysate | rel=r_associated | relid=0 | w=10
  970. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous sarcoma lysate-pulsed dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous sarcoma lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  971. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous t-lymphocytes-expressing ny-eso-1-c259-specific enhanced t-cell receptors
    n1=Okihiro (syndrome de) | n2=en:autologous t-lymphocytes-expressing ny-eso-1-c259-specific enhanced t-cell receptors | rel=r_associated | relid=0 | w=10
  972. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous tarp peptide-pulsed dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous tarp peptide-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  973. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous tns9.3.55-transduced cd34-positive cells
    n1=Okihiro (syndrome de) | n2=en:autologous tns9.3.55-transduced cd34-positive cells | rel=r_associated | relid=0 | w=10
  974. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous trimix-dc melanoma vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous trimix-dc melanoma vaccine | rel=r_associated | relid=0 | w=10
  975. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine | rel=r_associated | relid=0 | w=10
  976. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous tumor cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous tumor cell vaccine | rel=r_associated | relid=0 | w=10
  977. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous tumor infiltrating lymphocytes ln-144
    n1=Okihiro (syndrome de) | n2=en:autologous tumor infiltrating lymphocytes ln-144 | rel=r_associated | relid=0 | w=10
  978. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  979. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes
    n1=Okihiro (syndrome de) | n2=en:autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes | rel=r_associated | relid=0 | w=10
  980. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:autonomic agents
    n1=Okihiro (syndrome de) | n2=en:autonomic agents | rel=r_associated | relid=0 | w=10
  981. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:av2-dm antiviral spray
    n1=Okihiro (syndrome de) | n2=en:av2-dm antiviral spray | rel=r_associated | relid=0 | w=10
  982. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:avanafil
    n1=Okihiro (syndrome de) | n2=en:avanafil | rel=r_associated | relid=0 | w=10
  983. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:avelumab
    n1=Okihiro (syndrome de) | n2=en:avelumab | rel=r_associated | relid=0 | w=10
  984. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:avitinib maleate
    n1=Okihiro (syndrome de) | n2=en:avitinib maleate | rel=r_associated | relid=0 | w=10
  985. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:avitriptan
    n1=Okihiro (syndrome de) | n2=en:avitriptan | rel=r_associated | relid=0 | w=10
  986. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:avitriptan fumarate
    n1=Okihiro (syndrome de) | n2=en:avitriptan fumarate | rel=r_associated | relid=0 | w=10
  987. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:avn944
    n1=Okihiro (syndrome de) | n2=en:avn944 | rel=r_associated | relid=0 | w=10
  988. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:axamozide
    n1=Okihiro (syndrome de) | n2=en:axamozide | rel=r_associated | relid=0 | w=10
  989. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:axial skeleton
    n1=Okihiro (syndrome de) | n2=en:axial skeleton | rel=r_associated | relid=0 | w=10
  990. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:axitinib
    n1=Okihiro (syndrome de) | n2=en:axitinib | rel=r_associated | relid=0 | w=10
  991. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:axl inhibitor bgb324
    n1=Okihiro (syndrome de) | n2=en:axl inhibitor bgb324 | rel=r_associated | relid=0 | w=10
  992. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:axl inhibitor tp-0903
    n1=Okihiro (syndrome de) | n2=en:axl inhibitor tp-0903 | rel=r_associated | relid=0 | w=10
  993. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azabuperone
    n1=Okihiro (syndrome de) | n2=en:azabuperone | rel=r_associated | relid=0 | w=10
  994. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azacitidine
    n1=Okihiro (syndrome de) | n2=en:azacitidine | rel=r_associated | relid=0 | w=10
  995. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azacyclonol
    n1=Okihiro (syndrome de) | n2=en:azacyclonol | rel=r_associated | relid=0 | w=10
  996. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azadirachta indica
    n1=Okihiro (syndrome de) | n2=en:azadirachta indica | rel=r_associated | relid=0 | w=10
  997. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azaperone
    n1=Okihiro (syndrome de) | n2=en:azaperone | rel=r_associated | relid=0 | w=10
  998. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azapicyl
    n1=Okihiro (syndrome de) | n2=en:azapicyl | rel=r_associated | relid=0 | w=10
  999. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azaquinzole
    n1=Okihiro (syndrome de) | n2=en:azaquinzole | rel=r_associated | relid=0 | w=10
  1000. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azaribine
    n1=Okihiro (syndrome de) | n2=en:azaribine | rel=r_associated | relid=0 | w=10
  1001. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azaserine
    n1=Okihiro (syndrome de) | n2=en:azaserine | rel=r_associated | relid=0 | w=10
  1002. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azasteroids
    n1=Okihiro (syndrome de) | n2=en:azasteroids | rel=r_associated | relid=0 | w=10
  1003. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azathioprine sodium
    n1=Okihiro (syndrome de) | n2=en:azathioprine sodium | rel=r_associated | relid=0 | w=10
  1004. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azd5438
    n1=Okihiro (syndrome de) | n2=en:azd5438 | rel=r_associated | relid=0 | w=10
  1005. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azelaic acid
    n1=Okihiro (syndrome de) | n2=en:azelaic acid | rel=r_associated | relid=0 | w=10
  1006. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azimexon
    n1=Okihiro (syndrome de) | n2=en:azimexon | rel=r_associated | relid=0 | w=10
  1007. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:aziridinylbenzoquinone rh1
    n1=Okihiro (syndrome de) | n2=en:aziridinylbenzoquinone rh1 | rel=r_associated | relid=0 | w=10
  1008. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azithromycin
    n1=Okihiro (syndrome de) | n2=en:azithromycin | rel=r_associated | relid=0 | w=10
  1009. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azlocillin
    n1=Okihiro (syndrome de) | n2=en:azlocillin | rel=r_associated | relid=0 | w=10
  1010. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azp
    n1=Okihiro (syndrome de) | n2=en:azp | rel=r_associated | relid=0 | w=10
  1011. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:azurin:50-77 cell penetrating peptide p28
    n1=Okihiro (syndrome de) | n2=en:azurin:50-77 cell penetrating peptide p28 | rel=r_associated | relid=0 | w=10
  1012. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:b-raf/vegfr-2 inhibitor raf265
    n1=Okihiro (syndrome de) | n2=en:b-raf/vegfr-2 inhibitor raf265 | rel=r_associated | relid=0 | w=10
  1013. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:b16alphagal melanoma vaccine
    n1=Okihiro (syndrome de) | n2=en:b16alphagal melanoma vaccine | rel=r_associated | relid=0 | w=10
  1014. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:b43-genistein immunoconjugate
    n1=Okihiro (syndrome de) | n2=en:b43-genistein immunoconjugate | rel=r_associated | relid=0 | w=10
  1015. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:b43-pap immunotoxin
    n1=Okihiro (syndrome de) | n2=en:b43-pap immunotoxin | rel=r_associated | relid=0 | w=10
  1016. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:b7-dc crosslinking antibody rhigm12b7
    n1=Okihiro (syndrome de) | n2=en:b7-dc crosslinking antibody rhigm12b7 | rel=r_associated | relid=0 | w=10
  1017. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bacitracin
    n1=Okihiro (syndrome de) | n2=en:bacitracin | rel=r_associated | relid=0 | w=10
  1018. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:baclofen
    n1=Okihiro (syndrome de) | n2=en:baclofen | rel=r_associated | relid=0 | w=10
  1019. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:baclofen/amitriptyline/ketamine gel
    n1=Okihiro (syndrome de) | n2=en:baclofen/amitriptyline/ketamine gel | rel=r_associated | relid=0 | w=10
  1020. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bacteriophage phi x 174
    n1=Okihiro (syndrome de) | n2=en:bacteriophage phi x 174 | rel=r_associated | relid=0 | w=10
  1021. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bafetinib
    n1=Okihiro (syndrome de) | n2=en:bafetinib | rel=r_associated | relid=0 | w=10
  1022. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:balanced crystalloid solution
    n1=Okihiro (syndrome de) | n2=en:balanced crystalloid solution | rel=r_associated | relid=0 | w=10
  1023. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:balsalazide
    n1=Okihiro (syndrome de) | n2=en:balsalazide | rel=r_associated | relid=0 | w=10
  1024. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:banoxantrone
    n1=Okihiro (syndrome de) | n2=en:banoxantrone | rel=r_associated | relid=0 | w=10
  1025. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:barasertib
    n1=Okihiro (syndrome de) | n2=en:barasertib | rel=r_associated | relid=0 | w=10
  1026. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bardoxolone
    n1=Okihiro (syndrome de) | n2=en:bardoxolone | rel=r_associated | relid=0 | w=10
  1027. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bardoxolone methyl
    n1=Okihiro (syndrome de) | n2=en:bardoxolone methyl | rel=r_associated | relid=0 | w=10
  1028. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:baricitinib
    n1=Okihiro (syndrome de) | n2=en:baricitinib | rel=r_associated | relid=0 | w=10
  1029. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:barium sulfate
    n1=Okihiro (syndrome de) | n2=en:barium sulfate | rel=r_associated | relid=0 | w=10
  1030. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:barley malt extract
    n1=Okihiro (syndrome de) | n2=en:barley malt extract | rel=r_associated | relid=0 | w=10
  1031. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:base of the skull
    n1=Okihiro (syndrome de) | n2=en:base of the skull | rel=r_associated | relid=0 | w=10
  1032. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:basiliximab
    n1=Okihiro (syndrome de) | n2=en:basiliximab | rel=r_associated | relid=0 | w=10
  1033. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:batabulin sodium
    n1=Okihiro (syndrome de) | n2=en:batabulin sodium | rel=r_associated | relid=0 | w=10
  1034. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:batanopride
    n1=Okihiro (syndrome de) | n2=en:batanopride | rel=r_associated | relid=0 | w=10
  1035. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:batelapine
    n1=Okihiro (syndrome de) | n2=en:batelapine | rel=r_associated | relid=0 | w=10
  1036. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:batelapine maleate
    n1=Okihiro (syndrome de) | n2=en:batelapine maleate | rel=r_associated | relid=0 | w=10
  1037. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:batoprazine
    n1=Okihiro (syndrome de) | n2=en:batoprazine | rel=r_associated | relid=0 | w=10
  1038. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bavituximab
    n1=Okihiro (syndrome de) | n2=en:bavituximab | rel=r_associated | relid=0 | w=10
  1039. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bay 56-3722
    n1=Okihiro (syndrome de) | n2=en:bay 56-3722 | rel=r_associated | relid=0 | w=10
  1040. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bay 86-4367
    n1=Okihiro (syndrome de) | n2=en:bay 86-4367 | rel=r_associated | relid=0 | w=10
  1041. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bay 87-2243
    n1=Okihiro (syndrome de) | n2=en:bay 87-2243 | rel=r_associated | relid=0 | w=10
  1042. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bazedoxifene
    n1=Okihiro (syndrome de) | n2=en:bazedoxifene | rel=r_associated | relid=0 | w=10
  1043. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bbr 3464
    n1=Okihiro (syndrome de) | n2=en:bbr 3464 | rel=r_associated | relid=0 | w=10
  1044. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bc-819 plasmid/polyethylenimine complex
    n1=Okihiro (syndrome de) | n2=en:bc-819 plasmid/polyethylenimine complex | rel=r_associated | relid=0 | w=10
  1045. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bcg solution
    n1=Okihiro (syndrome de) | n2=en:bcg solution | rel=r_associated | relid=0 | w=10
  1046. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bcg vaccine
    n1=Okihiro (syndrome de) | n2=en:bcg vaccine | rel=r_associated | relid=0 | w=10
  1047. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bcl-2 inhibitor bcl201
    n1=Okihiro (syndrome de) | n2=en:bcl-2 inhibitor bcl201 | rel=r_associated | relid=0 | w=10
  1048. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bcma-specific car-expressing t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:bcma-specific car-expressing t lymphocytes | rel=r_associated | relid=0 | w=10
  1049. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bcr-abl (b2a2)-derived peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:bcr-abl (b2a2)-derived peptide vaccine | rel=r_associated | relid=0 | w=10
  1050. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bcr-abl (b3a2)-derived peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:bcr-abl (b3a2)-derived peptide vaccine | rel=r_associated | relid=0 | w=10
  1051. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bcr-abl p210-b3a2 breakpoint-derived pentapeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:bcr-abl p210-b3a2 breakpoint-derived pentapeptide vaccine | rel=r_associated | relid=0 | w=10
  1052. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bcr-abl peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:bcr-abl peptide vaccine | rel=r_associated | relid=0 | w=10
  1053. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beacopp regimen
    n1=Okihiro (syndrome de) | n2=en:beacopp regimen | rel=r_associated | relid=0 | w=10
  1054. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:becatecarin
    n1=Okihiro (syndrome de) | n2=en:becatecarin | rel=r_associated | relid=0 | w=10
  1055. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beclomethasone dipropionate
    n1=Okihiro (syndrome de) | n2=en:beclomethasone dipropionate | rel=r_associated | relid=0 | w=10
  1056. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bee pollen
    n1=Okihiro (syndrome de) | n2=en:bee pollen | rel=r_associated | relid=0 | w=10
  1057. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beetroot juice
    n1=Okihiro (syndrome de) | n2=en:beetroot juice | rel=r_associated | relid=0 | w=10
  1058. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:begelomab
    n1=Okihiro (syndrome de) | n2=en:begelomab | rel=r_associated | relid=0 | w=10
  1059. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:belagenpumatucel-l
    n1=Okihiro (syndrome de) | n2=en:belagenpumatucel-l | rel=r_associated | relid=0 | w=10
  1060. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:belaperidone
    n1=Okihiro (syndrome de) | n2=en:belaperidone | rel=r_associated | relid=0 | w=10
  1061. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:belimumab
    n1=Okihiro (syndrome de) | n2=en:belimumab | rel=r_associated | relid=0 | w=10
  1062. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:belinostat
    n1=Okihiro (syndrome de) | n2=en:belinostat | rel=r_associated | relid=0 | w=10
  1063. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beloranib
    n1=Okihiro (syndrome de) | n2=en:beloranib | rel=r_associated | relid=0 | w=10
  1064. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:belotecan hydrochloride
    n1=Okihiro (syndrome de) | n2=en:belotecan hydrochloride | rel=r_associated | relid=0 | w=10
  1065. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bemiparin sodium
    n1=Okihiro (syndrome de) | n2=en:bemiparin sodium | rel=r_associated | relid=0 | w=10
  1066. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benactyzine
    n1=Okihiro (syndrome de) | n2=en:benactyzine | rel=r_associated | relid=0 | w=10
  1067. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benazepril hydrochloride
    n1=Okihiro (syndrome de) | n2=en:benazepril hydrochloride | rel=r_associated | relid=0 | w=10
  1068. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bendamustine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:bendamustine hydrochloride | rel=r_associated | relid=0 | w=10
  1069. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bendamustine-containing nanoparticle-based formulation rxdx-107
    n1=Okihiro (syndrome de) | n2=en:bendamustine-containing nanoparticle-based formulation rxdx-107 | rel=r_associated | relid=0 | w=10
  1070. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bendamustine-vorinostat fusion molecule edo-s101
    n1=Okihiro (syndrome de) | n2=en:bendamustine-vorinostat fusion molecule edo-s101 | rel=r_associated | relid=0 | w=10
  1071. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benegrastim
    n1=Okihiro (syndrome de) | n2=en:benegrastim | rel=r_associated | relid=0 | w=10
  1072. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benoxinate
    n1=Okihiro (syndrome de) | n2=en:benoxinate | rel=r_associated | relid=0 | w=10
  1073. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bentazepam
    n1=Okihiro (syndrome de) | n2=en:bentazepam | rel=r_associated | relid=0 | w=10
  1074. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzaldehyde dimethane sulfonate
    n1=Okihiro (syndrome de) | n2=en:benzaldehyde dimethane sulfonate | rel=r_associated | relid=0 | w=10
  1075. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzamide derivative antipsychotic agent
    n1=Okihiro (syndrome de) | n2=en:benzamide derivative antipsychotic agent | rel=r_associated | relid=0 | w=10
  1076. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzimidazolinone derivative antipsychotic agent
    n1=Okihiro (syndrome de) | n2=en:benzimidazolinone derivative antipsychotic agent | rel=r_associated | relid=0 | w=10
  1077. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzimidazolinone derivative antipsychotic preparation
    n1=Okihiro (syndrome de) | n2=en:benzimidazolinone derivative antipsychotic preparation | rel=r_associated | relid=0 | w=10
  1078. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzindopyrine
    n1=Okihiro (syndrome de) | n2=en:benzindopyrine | rel=r_associated | relid=0 | w=10
  1079. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzindopyrine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:benzindopyrine hydrochloride | rel=r_associated | relid=0 | w=10
  1080. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzisoxazole derivative antipsychotic agent
    n1=Okihiro (syndrome de) | n2=en:benzisoxazole derivative antipsychotic agent | rel=r_associated | relid=0 | w=10
  1081. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benznidazole
    n1=Okihiro (syndrome de) | n2=en:benznidazole | rel=r_associated | relid=0 | w=10
  1082. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzodiazepine
    n1=Okihiro (syndrome de) | n2=en:benzodiazepine | rel=r_associated | relid=0 | w=10
  1083. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzodiazepine nucleus
    n1=Okihiro (syndrome de) | n2=en:benzodiazepine nucleus | rel=r_associated | relid=0 | w=10
  1084. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzodiazepine sedative
    n1=Okihiro (syndrome de) | n2=en:benzodiazepine sedative | rel=r_associated | relid=0 | w=10
  1085. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzodiazepinones
    n1=Okihiro (syndrome de) | n2=en:benzodiazepinones | rel=r_associated | relid=0 | w=10
  1086. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzothiazepine
    n1=Okihiro (syndrome de) | n2=en:benzothiazepine | rel=r_associated | relid=0 | w=10
  1087. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzoyl peroxide
    n1=Okihiro (syndrome de) | n2=en:benzoyl peroxide | rel=r_associated | relid=0 | w=10
  1088. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzoylphenylurea
    n1=Okihiro (syndrome de) | n2=en:benzoylphenylurea | rel=r_associated | relid=0 | w=10
  1089. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzquinamide
    n1=Okihiro (syndrome de) | n2=en:benzquinamide | rel=r_associated | relid=0 | w=10
  1090. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzydamine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:benzydamine hydrochloride | rel=r_associated | relid=0 | w=10
  1091. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:benzyl alcohol and derivatives
    n1=Okihiro (syndrome de) | n2=en:benzyl alcohol and derivatives | rel=r_associated | relid=0 | w=10
  1092. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bep regimen
    n1=Okihiro (syndrome de) | n2=en:bep regimen | rel=r_associated | relid=0 | w=10
  1093. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:berberine chloride
    n1=Okihiro (syndrome de) | n2=en:berberine chloride | rel=r_associated | relid=0 | w=10
  1094. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:berubicin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:berubicin hydrochloride | rel=r_associated | relid=0 | w=10
  1095. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bet bromodomain inhibitor zen-3694
    n1=Okihiro (syndrome de) | n2=en:bet bromodomain inhibitor zen-3694 | rel=r_associated | relid=0 | w=10
  1096. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bet bromodomains 2/3/4 inhibitor mk-8628
    n1=Okihiro (syndrome de) | n2=en:bet bromodomains 2/3/4 inhibitor mk-8628 | rel=r_associated | relid=0 | w=10
  1097. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bet inhibitor bay1238097
    n1=Okihiro (syndrome de) | n2=en:bet inhibitor bay1238097 | rel=r_associated | relid=0 | w=10
  1098. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bet inhibitor bms-986158
    n1=Okihiro (syndrome de) | n2=en:bet inhibitor bms-986158 | rel=r_associated | relid=0 | w=10
  1099. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bet inhibitor cpi-0610
    n1=Okihiro (syndrome de) | n2=en:bet inhibitor cpi-0610 | rel=r_associated | relid=0 | w=10
  1100. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bet inhibitor ft-1101
    n1=Okihiro (syndrome de) | n2=en:bet inhibitor ft-1101 | rel=r_associated | relid=0 | w=10
  1101. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bet inhibitor gs-5829
    n1=Okihiro (syndrome de) | n2=en:bet inhibitor gs-5829 | rel=r_associated | relid=0 | w=10
  1102. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bet inhibitor gsk2820151
    n1=Okihiro (syndrome de) | n2=en:bet inhibitor gsk2820151 | rel=r_associated | relid=0 | w=10
  1103. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bet inhibitor gsk525762
    n1=Okihiro (syndrome de) | n2=en:bet inhibitor gsk525762 | rel=r_associated | relid=0 | w=10
  1104. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bet inhibitor incb054329
    n1=Okihiro (syndrome de) | n2=en:bet inhibitor incb054329 | rel=r_associated | relid=0 | w=10
  1105. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bet inhibitor incb057643
    n1=Okihiro (syndrome de) | n2=en:bet inhibitor incb057643 | rel=r_associated | relid=0 | w=10
  1106. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bet inhibitor ten-010
    n1=Okihiro (syndrome de) | n2=en:bet inhibitor ten-010 | rel=r_associated | relid=0 | w=10
  1107. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beta alethine
    n1=Okihiro (syndrome de) | n2=en:beta alethine | rel=r_associated | relid=0 | w=10
  1108. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beta endophorin
    n1=Okihiro (syndrome de) | n2=en:beta endophorin | rel=r_associated | relid=0 | w=10
  1109. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beta-adrenergic antagonist
    n1=Okihiro (syndrome de) | n2=en:beta-adrenergic antagonist | rel=r_associated | relid=0 | w=10
  1110. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beta-carotene
    n1=Okihiro (syndrome de) | n2=en:beta-carotene | rel=r_associated | relid=0 | w=10
  1111. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beta-elemene
    n1=Okihiro (syndrome de) | n2=en:beta-elemene | rel=r_associated | relid=0 | w=10
  1112. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beta-glucan
    n1=Okihiro (syndrome de) | n2=en:beta-glucan | rel=r_associated | relid=0 | w=10
  1113. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beta-glucan mm-10-001
    n1=Okihiro (syndrome de) | n2=en:beta-glucan mm-10-001 | rel=r_associated | relid=0 | w=10
  1114. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beta-glucan/alginate/hyaluronic acid/squalene/avocado oil-containing emulsion
    n1=Okihiro (syndrome de) | n2=en:beta-glucan/alginate/hyaluronic acid/squalene/avocado oil-containing emulsion | rel=r_associated | relid=0 | w=10
  1115. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beta-glucan/lactobacillus casei/bifidobacterium lactis-based supplement
    n1=Okihiro (syndrome de) | n2=en:beta-glucan/lactobacillus casei/bifidobacterium lactis-based supplement | rel=r_associated | relid=0 | w=10
  1116. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beta-hydroxy-beta-methylbutyrate supplement
    n1=Okihiro (syndrome de) | n2=en:beta-hydroxy-beta-methylbutyrate supplement | rel=r_associated | relid=0 | w=10
  1117. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beta-lapachone prodrug arq 761
    n1=Okihiro (syndrome de) | n2=en:beta-lapachone prodrug arq 761 | rel=r_associated | relid=0 | w=10
  1118. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:beta-thioguanine deoxyriboside
    n1=Okihiro (syndrome de) | n2=en:beta-thioguanine deoxyriboside | rel=r_associated | relid=0 | w=10
  1119. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:betahistine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:betahistine hydrochloride | rel=r_associated | relid=0 | w=10
  1120. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:betamethasone
    n1=Okihiro (syndrome de) | n2=en:betamethasone | rel=r_associated | relid=0 | w=10
  1121. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:betulinic acid
    n1=Okihiro (syndrome de) | n2=en:betulinic acid | rel=r_associated | relid=0 | w=10
  1122. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bevacizumab
    n1=Okihiro (syndrome de) | n2=en:bevacizumab | rel=r_associated | relid=0 | w=10
  1123. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bevacizumab-irdye 800cw
    n1=Okihiro (syndrome de) | n2=en:bevacizumab-irdye 800cw | rel=r_associated | relid=0 | w=10
  1124. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bexarotene
    n1=Okihiro (syndrome de) | n2=en:bexarotene | rel=r_associated | relid=0 | w=10
  1125. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bh3 mimetic abt-737
    n1=Okihiro (syndrome de) | n2=en:bh3 mimetic abt-737 | rel=r_associated | relid=0 | w=10
  1126. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bi 2536
    n1=Okihiro (syndrome de) | n2=en:bi 2536 | rel=r_associated | relid=0 | w=10
  1127. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bi 831266
    n1=Okihiro (syndrome de) | n2=en:bi 831266 | rel=r_associated | relid=0 | w=10
  1128. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bi 894999
    n1=Okihiro (syndrome de) | n2=en:bi 894999 | rel=r_associated | relid=0 | w=10
  1129. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bi-functional alkylating agent val-083
    n1=Okihiro (syndrome de) | n2=en:bi-functional alkylating agent val-083 | rel=r_associated | relid=0 | w=10
  1130. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bi-shrna-furin/gm-csf-expressing autologous tumor cell vaccine
    n1=Okihiro (syndrome de) | n2=en:bi-shrna-furin/gm-csf-expressing autologous tumor cell vaccine | rel=r_associated | relid=0 | w=10
  1131. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:biafine cream
    n1=Okihiro (syndrome de) | n2=en:biafine cream | rel=r_associated | relid=0 | w=10
  1132. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bibx 1382
    n1=Okihiro (syndrome de) | n2=en:bibx 1382 | rel=r_associated | relid=0 | w=10
  1133. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bicalutamide
    n1=Okihiro (syndrome de) | n2=en:bicalutamide | rel=r_associated | relid=0 | w=10
  1134. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bifeprunox
    n1=Okihiro (syndrome de) | n2=en:bifeprunox | rel=r_associated | relid=0 | w=10
  1135. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bifidobacterium lactis/lactobacillus acidophilus/l. plantarum/l. salivarius probiotic supplement
    n1=Okihiro (syndrome de) | n2=en:bifidobacterium lactis/lactobacillus acidophilus/l. plantarum/l. salivarius probiotic supplement | rel=r_associated | relid=0 | w=10
  1136. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bifunctional expression vector plasmid dna-bi-shrna ews/fli1 type 1 lipoplex
    n1=Okihiro (syndrome de) | n2=en:bifunctional expression vector plasmid dna-bi-shrna ews/fli1 type 1 lipoplex | rel=r_associated | relid=0 | w=10
  1137. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:biguanides
    n1=Okihiro (syndrome de) | n2=en:biguanides | rel=r_associated | relid=0 | w=10
  1138. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bilberries
    n1=Okihiro (syndrome de) | n2=en:bilberries | rel=r_associated | relid=0 | w=10
  1139. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bile acids
    n1=Okihiro (syndrome de) | n2=en:bile acids | rel=r_associated | relid=0 | w=10
  1140. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bimagrumab
    n1=Okihiro (syndrome de) | n2=en:bimagrumab | rel=r_associated | relid=0 | w=10
  1141. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bimatoprost
    n1=Okihiro (syndrome de) | n2=en:bimatoprost | rel=r_associated | relid=0 | w=10
  1142. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:binetrakin
    n1=Okihiro (syndrome de) | n2=en:binetrakin | rel=r_associated | relid=0 | w=10
  1143. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:binimetinib
    n1=Okihiro (syndrome de) | n2=en:binimetinib | rel=r_associated | relid=0 | w=10
  1144. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bioflavonoid
    n1=Okihiro (syndrome de) | n2=en:bioflavonoid | rel=r_associated | relid=0 | w=10
  1145. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:biological agent
    n1=Okihiro (syndrome de) | n2=en:biological agent | rel=r_associated | relid=0 | w=10
  1146. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:biological factors
    n1=Okihiro (syndrome de) | n2=en:biological factors | rel=r_associated | relid=0 | w=10
  1147. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:biomed 101
    n1=Okihiro (syndrome de) | n2=en:biomed 101 | rel=r_associated | relid=0 | w=10
  1148. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:biphosphonate
    n1=Okihiro (syndrome de) | n2=en:biphosphonate | rel=r_associated | relid=0 | w=10
  1149. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bipolar agents, other
    n1=Okihiro (syndrome de) | n2=en:bipolar agents, other | rel=r_associated | relid=0 | w=10
  1150. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bipyridine inotropic
    n1=Okihiro (syndrome de) | n2=en:bipyridine inotropic | rel=r_associated | relid=0 | w=10
  1151. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:biricodar dicitrate
    n1=Okihiro (syndrome de) | n2=en:biricodar dicitrate | rel=r_associated | relid=0 | w=10
  1152. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:birinapant
    n1=Okihiro (syndrome de) | n2=en:birinapant | rel=r_associated | relid=0 | w=10
  1153. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bis(choline)tetrathiomolybdate
    n1=Okihiro (syndrome de) | n2=en:bis(choline)tetrathiomolybdate | rel=r_associated | relid=0 | w=10
  1154. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bisacodyl
    n1=Okihiro (syndrome de) | n2=en:bisacodyl | rel=r_associated | relid=0 | w=10
  1155. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bisantrene hydrochloride
    n1=Okihiro (syndrome de) | n2=en:bisantrene hydrochloride | rel=r_associated | relid=0 | w=10
  1156. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bismuth and/or bismuth compound
    n1=Okihiro (syndrome de) | n2=en:bismuth and/or bismuth compound | rel=r_associated | relid=0 | w=10
  1157. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bismuth bi213 monoclonal antibody m195
    n1=Okihiro (syndrome de) | n2=en:bismuth bi213 monoclonal antibody m195 | rel=r_associated | relid=0 | w=10
  1158. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bismuth compound
    n1=Okihiro (syndrome de) | n2=en:bismuth compound | rel=r_associated | relid=0 | w=10
  1159. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bismuth subcitrate
    n1=Okihiro (syndrome de) | n2=en:bismuth subcitrate | rel=r_associated | relid=0 | w=10
  1160. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bismuth subsalicylate
    n1=Okihiro (syndrome de) | n2=en:bismuth subsalicylate | rel=r_associated | relid=0 | w=10
  1161. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bisoprolol fumarate
    n1=Okihiro (syndrome de) | n2=en:bisoprolol fumarate | rel=r_associated | relid=0 | w=10
  1162. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bisorcic
    n1=Okihiro (syndrome de) | n2=en:bisorcic | rel=r_associated | relid=0 | w=10
  1163. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bispecific antibody 2b1
    n1=Okihiro (syndrome de) | n2=en:bispecific antibody 2b1 | rel=r_associated | relid=0 | w=10
  1164. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bispecific antibody 4g7xh22
    n1=Okihiro (syndrome de) | n2=en:bispecific antibody 4g7xh22 | rel=r_associated | relid=0 | w=10
  1165. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bispecific antibody mdx-h210
    n1=Okihiro (syndrome de) | n2=en:bispecific antibody mdx-h210 | rel=r_associated | relid=0 | w=10
  1166. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bispecific antibody mdx447
    n1=Okihiro (syndrome de) | n2=en:bispecific antibody mdx447 | rel=r_associated | relid=0 | w=10
  1167. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bispecific human anti-ang-2/anti-vegf-a antibody ro5520985
    n1=Okihiro (syndrome de) | n2=en:bispecific human anti-ang-2/anti-vegf-a antibody ro5520985 | rel=r_associated | relid=0 | w=10
  1168. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bivalent hpv16/18 therapeutic cervical cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:bivalent hpv16/18 therapeutic cervical cancer vaccine | rel=r_associated | relid=0 | w=10
  1169. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bizelesin
    n1=Okihiro (syndrome de) | n2=en:bizelesin | rel=r_associated | relid=0 | w=10
  1170. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bl22 immunotoxin
    n1=Okihiro (syndrome de) | n2=en:bl22 immunotoxin | rel=r_associated | relid=0 | w=10
  1171. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:black cohosh
    n1=Okihiro (syndrome de) | n2=en:black cohosh | rel=r_associated | relid=0 | w=10
  1172. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:black raspberry nectar
    n1=Okihiro (syndrome de) | n2=en:black raspberry nectar | rel=r_associated | relid=0 | w=10
  1173. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:black seed oil
    n1=Okihiro (syndrome de) | n2=en:black seed oil | rel=r_associated | relid=0 | w=10
  1174. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:black tea
    n1=Okihiro (syndrome de) | n2=en:black tea | rel=r_associated | relid=0 | w=10
  1175. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:blackberry allergenic extract
    n1=Okihiro (syndrome de) | n2=en:blackberry allergenic extract | rel=r_associated | relid=0 | w=10
  1176. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bleomycin
    n1=Okihiro (syndrome de) | n2=en:bleomycin | rel=r_associated | relid=0 | w=10
  1177. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bleomycin sulfate
    n1=Okihiro (syndrome de) | n2=en:bleomycin sulfate | rel=r_associated | relid=0 | w=10
  1178. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:blex 404
    n1=Okihiro (syndrome de) | n2=en:blex 404 | rel=r_associated | relid=0 | w=10
  1179. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:blinatumomab
    n1=Okihiro (syndrome de) | n2=en:blinatumomab | rel=r_associated | relid=0 | w=10
  1180. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:blue citrus-based herbal capsule
    n1=Okihiro (syndrome de) | n2=en:blue citrus-based herbal capsule | rel=r_associated | relid=0 | w=10
  1181. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:blueberry powder supplement
    n1=Okihiro (syndrome de) | n2=en:blueberry powder supplement | rel=r_associated | relid=0 | w=10
  1182. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bmi1 inhibitor ptc596
    n1=Okihiro (syndrome de) | n2=en:bmi1 inhibitor ptc596 | rel=r_associated | relid=0 | w=10
  1183. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bms-184476
    n1=Okihiro (syndrome de) | n2=en:bms-184476 | rel=r_associated | relid=0 | w=10
  1184. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bms-188797
    n1=Okihiro (syndrome de) | n2=en:bms-188797 | rel=r_associated | relid=0 | w=10
  1185. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bms-214662
    n1=Okihiro (syndrome de) | n2=en:bms-214662 | rel=r_associated | relid=0 | w=10
  1186. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bms-275183
    n1=Okihiro (syndrome de) | n2=en:bms-275183 | rel=r_associated | relid=0 | w=10
  1187. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bms-817378
    n1=Okihiro (syndrome de) | n2=en:bms-817378 | rel=r_associated | relid=0 | w=10
  1188. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bms-986156
    n1=Okihiro (syndrome de) | n2=en:bms-986156 | rel=r_associated | relid=0 | w=10
  1189. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bms-986205
    n1=Okihiro (syndrome de) | n2=en:bms-986205 | rel=r_associated | relid=0 | w=10
  1190. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:boanmycin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:boanmycin hydrochloride | rel=r_associated | relid=0 | w=10
  1191. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:boceprevir
    n1=Okihiro (syndrome de) | n2=en:boceprevir | rel=r_associated | relid=0 | w=10
  1192. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bone
    n1=Okihiro (syndrome de) | n2=en:bone | rel=r_associated | relid=0 | w=10
  1193. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bone cements
    n1=Okihiro (syndrome de) | n2=en:bone cements | rel=r_associated | relid=0 | w=10
  1194. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bone graft - material
    n1=Okihiro (syndrome de) | n2=en:bone graft - material | rel=r_associated | relid=0 | w=10
  1195. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bone meal
    n1=Okihiro (syndrome de) | n2=en:bone meal | rel=r_associated | relid=0 | w=10
  1196. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bone metastasis targeting peptide-11
    n1=Okihiro (syndrome de) | n2=en:bone metastasis targeting peptide-11 | rel=r_associated | relid=0 | w=10
  1197. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bone of proximal epiphysis of ulna
    n1=Okihiro (syndrome de) | n2=en:bone of proximal epiphysis of ulna | rel=r_associated | relid=0 | w=10
  1198. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bone resorption inhibitor
    n1=Okihiro (syndrome de) | n2=en:bone resorption inhibitor | rel=r_associated | relid=0 | w=10
  1199. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bony part of proximal epiphysis of ulna
    n1=Okihiro (syndrome de) | n2=en:bony part of proximal epiphysis of ulna | rel=r_associated | relid=0 | w=10
  1200. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:boron phenylalanine
    n1=Okihiro (syndrome de) | n2=en:boron phenylalanine | rel=r_associated | relid=0 | w=10
  1201. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:boronophenylalanine-fructose complex
    n1=Okihiro (syndrome de) | n2=en:boronophenylalanine-fructose complex | rel=r_associated | relid=0 | w=10
  1202. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bortezomib
    n1=Okihiro (syndrome de) | n2=en:bortezomib | rel=r_associated | relid=0 | w=10
  1203. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bosutinib
    n1=Okihiro (syndrome de) | n2=en:bosutinib | rel=r_associated | relid=0 | w=10
  1204. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:boswellia serrata extract
    n1=Okihiro (syndrome de) | n2=en:boswellia serrata extract | rel=r_associated | relid=0 | w=10
  1205. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:botanical extracts rinse izn-6n4
    n1=Okihiro (syndrome de) | n2=en:botanical extracts rinse izn-6n4 | rel=r_associated | relid=0 | w=10
  1206. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:botanical lotion cg428
    n1=Okihiro (syndrome de) | n2=en:botanical lotion cg428 | rel=r_associated | relid=0 | w=10
  1207. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:botulinum toxin type a
    n1=Okihiro (syndrome de) | n2=en:botulinum toxin type a | rel=r_associated | relid=0 | w=10
  1208. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bovine cartilage
    n1=Okihiro (syndrome de) | n2=en:bovine cartilage | rel=r_associated | relid=0 | w=10
  1209. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bovine derived substance
    n1=Okihiro (syndrome de) | n2=en:bovine derived substance | rel=r_associated | relid=0 | w=10
  1210. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bovine lactoferrin supplement
    n1=Okihiro (syndrome de) | n2=en:bovine lactoferrin supplement | rel=r_associated | relid=0 | w=10
  1211. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bowman-birk inhibitor concentrate
    n1=Okihiro (syndrome de) | n2=en:bowman-birk inhibitor concentrate | rel=r_associated | relid=0 | w=10
  1212. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bp-cx1-platinum complex bp-c1
    n1=Okihiro (syndrome de) | n2=en:bp-cx1-platinum complex bp-c1 | rel=r_associated | relid=0 | w=10
  1213. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:br96-doxorubicin immunoconjugate
    n1=Okihiro (syndrome de) | n2=en:br96-doxorubicin immunoconjugate | rel=r_associated | relid=0 | w=10
  1214. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brachyury-expressing modified vaccinia ankara-tricom vaccine
    n1=Okihiro (syndrome de) | n2=en:brachyury-expressing modified vaccinia ankara-tricom vaccine | rel=r_associated | relid=0 | w=10
  1215. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brachyury-expressing yeast vaccine gi-6301
    n1=Okihiro (syndrome de) | n2=en:brachyury-expressing yeast vaccine gi-6301 | rel=r_associated | relid=0 | w=10
  1216. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:braf inhibitor arq 736
    n1=Okihiro (syndrome de) | n2=en:braf inhibitor arq 736 | rel=r_associated | relid=0 | w=10
  1217. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:braf inhibitor plx8394
    n1=Okihiro (syndrome de) | n2=en:braf inhibitor plx8394 | rel=r_associated | relid=0 | w=10
  1218. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:braf(v600e) inhibitor cep-32496
    n1=Okihiro (syndrome de) | n2=en:braf(v600e) inhibitor cep-32496 | rel=r_associated | relid=0 | w=10
  1219. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:braf(v600e) kinase inhibitor ro5212054
    n1=Okihiro (syndrome de) | n2=en:braf(v600e) kinase inhibitor ro5212054 | rel=r_associated | relid=0 | w=10
  1220. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:braf/egfr inhibitor bgb-283
    n1=Okihiro (syndrome de) | n2=en:braf/egfr inhibitor bgb-283 | rel=r_associated | relid=0 | w=10
  1221. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brain tumor initiating cell vaccine
    n1=Okihiro (syndrome de) | n2=en:brain tumor initiating cell vaccine | rel=r_associated | relid=0 | w=10
  1222. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bran
    n1=Okihiro (syndrome de) | n2=en:bran | rel=r_associated | relid=0 | w=10
  1223. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:branched-chain amino acid supplement
    n1=Okihiro (syndrome de) | n2=en:branched-chain amino acid supplement | rel=r_associated | relid=0 | w=10
  1224. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brassica vegetable
    n1=Okihiro (syndrome de) | n2=en:brassica vegetable | rel=r_associated | relid=0 | w=10
  1225. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brazergoline
    n1=Okihiro (syndrome de) | n2=en:brazergoline | rel=r_associated | relid=0 | w=10
  1226. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brd4 inhibitor plx51107
    n1=Okihiro (syndrome de) | n2=en:brd4 inhibitor plx51107 | rel=r_associated | relid=0 | w=10
  1227. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brentuximab vedotin
    n1=Okihiro (syndrome de) | n2=en:brentuximab vedotin | rel=r_associated | relid=0 | w=10
  1228. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brequinar
    n1=Okihiro (syndrome de) | n2=en:brequinar | rel=r_associated | relid=0 | w=10
  1229. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brexpiprazole
    n1=Okihiro (syndrome de) | n2=en:brexpiprazole | rel=r_associated | relid=0 | w=10
  1230. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:briciclib sodium
    n1=Okihiro (syndrome de) | n2=en:briciclib sodium | rel=r_associated | relid=0 | w=10
  1231. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brigatinib
    n1=Okihiro (syndrome de) | n2=en:brigatinib | rel=r_associated | relid=0 | w=10
  1232. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brilacidin oral rinse
    n1=Okihiro (syndrome de) | n2=en:brilacidin oral rinse | rel=r_associated | relid=0 | w=10
  1233. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brincidofovir
    n1=Okihiro (syndrome de) | n2=en:brincidofovir | rel=r_associated | relid=0 | w=10
  1234. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brivanib
    n1=Okihiro (syndrome de) | n2=en:brivanib | rel=r_associated | relid=0 | w=10
  1235. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brivanib alaninate
    n1=Okihiro (syndrome de) | n2=en:brivanib alaninate | rel=r_associated | relid=0 | w=10
  1236. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brivudine
    n1=Okihiro (syndrome de) | n2=en:brivudine | rel=r_associated | relid=0 | w=10
  1237. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brivudine phosphoramidate
    n1=Okihiro (syndrome de) | n2=en:brivudine phosphoramidate | rel=r_associated | relid=0 | w=10
  1238. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brn01
    n1=Okihiro (syndrome de) | n2=en:brn01 | rel=r_associated | relid=0 | w=10
  1239. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:broad-spectrum human papillomavirus vaccine v505
    n1=Okihiro (syndrome de) | n2=en:broad-spectrum human papillomavirus vaccine v505 | rel=r_associated | relid=0 | w=10
  1240. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:broccoli sprout extract
    n1=Okihiro (syndrome de) | n2=en:broccoli sprout extract | rel=r_associated | relid=0 | w=10
  1241. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:broccoli sprout/broccoli seed extract supplement
    n1=Okihiro (syndrome de) | n2=en:broccoli sprout/broccoli seed extract supplement | rel=r_associated | relid=0 | w=10
  1242. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:broclepride
    n1=Okihiro (syndrome de) | n2=en:broclepride | rel=r_associated | relid=0 | w=10
  1243. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bromazepam
    n1=Okihiro (syndrome de) | n2=en:bromazepam | rel=r_associated | relid=0 | w=10
  1244. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bromelains
    n1=Okihiro (syndrome de) | n2=en:bromelains | rel=r_associated | relid=0 | w=10
  1245. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bromhexine
    n1=Okihiro (syndrome de) | n2=en:bromhexine | rel=r_associated | relid=0 | w=10
  1246. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bromides
    n1=Okihiro (syndrome de) | n2=en:bromides | rel=r_associated | relid=0 | w=10
  1247. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bromine compound agent
    n1=Okihiro (syndrome de) | n2=en:bromine compound agent | rel=r_associated | relid=0 | w=10
  1248. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bromocriptine mesylate
    n1=Okihiro (syndrome de) | n2=en:bromocriptine mesylate | rel=r_associated | relid=0 | w=10
  1249. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bromodomain inhibitor abbv-075
    n1=Okihiro (syndrome de) | n2=en:bromodomain inhibitor abbv-075 | rel=r_associated | relid=0 | w=10
  1250. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bromperidol
    n1=Okihiro (syndrome de) | n2=en:bromperidol | rel=r_associated | relid=0 | w=10
  1251. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brontictuzumab
    n1=Okihiro (syndrome de) | n2=en:brontictuzumab | rel=r_associated | relid=0 | w=10
  1252. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bropirimine
    n1=Okihiro (syndrome de) | n2=en:bropirimine | rel=r_associated | relid=0 | w=10
  1253. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brostallicin
    n1=Okihiro (syndrome de) | n2=en:brostallicin | rel=r_associated | relid=0 | w=10
  1254. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:brotizolam
    n1=Okihiro (syndrome de) | n2=en:brotizolam | rel=r_associated | relid=0 | w=10
  1255. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:broxuridine
    n1=Okihiro (syndrome de) | n2=en:broxuridine | rel=r_associated | relid=0 | w=10
  1256. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bruceantin
    n1=Okihiro (syndrome de) | n2=en:bruceantin | rel=r_associated | relid=0 | w=10
  1257. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bryostatin 1
    n1=Okihiro (syndrome de) | n2=en:bryostatin 1 | rel=r_associated | relid=0 | w=10
  1258. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:btct4465a
    n1=Okihiro (syndrome de) | n2=en:btct4465a | rel=r_associated | relid=0 | w=10
  1259. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:btk inhibitor bgb-3111
    n1=Okihiro (syndrome de) | n2=en:btk inhibitor bgb-3111 | rel=r_associated | relid=0 | w=10
  1260. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:btk inhibitor gdc-0853
    n1=Okihiro (syndrome de) | n2=en:btk inhibitor gdc-0853 | rel=r_associated | relid=0 | w=10
  1261. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:btk inhibitor ono-4059
    n1=Okihiro (syndrome de) | n2=en:btk inhibitor ono-4059 | rel=r_associated | relid=0 | w=10
  1262. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:budesonide
    n1=Okihiro (syndrome de) | n2=en:budesonide | rel=r_associated | relid=0 | w=10
  1263. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:budesonide/formoterol fumarate dihydrate inhalation aerosol
    n1=Okihiro (syndrome de) | n2=en:budesonide/formoterol fumarate dihydrate inhalation aerosol | rel=r_associated | relid=0 | w=10
  1264. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:buformin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:buformin hydrochloride | rel=r_associated | relid=0 | w=10
  1265. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:buparlisib
    n1=Okihiro (syndrome de) | n2=en:buparlisib | rel=r_associated | relid=0 | w=10
  1266. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bupivacaine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:bupivacaine hydrochloride | rel=r_associated | relid=0 | w=10
  1267. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:buprenorphine
    n1=Okihiro (syndrome de) | n2=en:buprenorphine | rel=r_associated | relid=0 | w=10
  1268. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:buprenorphine transdermal matrix patch
    n1=Okihiro (syndrome de) | n2=en:buprenorphine transdermal matrix patch | rel=r_associated | relid=0 | w=10
  1269. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bupropion + naltrexone
    n1=Okihiro (syndrome de) | n2=en:bupropion + naltrexone | rel=r_associated | relid=0 | w=10
  1270. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bupropion hydrochloride
    n1=Okihiro (syndrome de) | n2=en:bupropion hydrochloride | rel=r_associated | relid=0 | w=10
  1271. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:burixafor
    n1=Okihiro (syndrome de) | n2=en:burixafor | rel=r_associated | relid=0 | w=10
  1272. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:buserelin
    n1=Okihiro (syndrome de) | n2=en:buserelin | rel=r_associated | relid=0 | w=10
  1273. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:buspirone
    n1=Okihiro (syndrome de) | n2=en:buspirone | rel=r_associated | relid=0 | w=10
  1274. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:buspirone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:buspirone hydrochloride | rel=r_associated | relid=0 | w=10
  1275. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:busulfan
    n1=Okihiro (syndrome de) | n2=en:busulfan | rel=r_associated | relid=0 | w=10
  1276. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:busulfan/melphalan regimen
    n1=Okihiro (syndrome de) | n2=en:busulfan/melphalan regimen | rel=r_associated | relid=0 | w=10
  1277. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:butamben
    n1=Okihiro (syndrome de) | n2=en:butamben | rel=r_associated | relid=0 | w=10
  1278. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:butaperazine
    n1=Okihiro (syndrome de) | n2=en:butaperazine | rel=r_associated | relid=0 | w=10
  1279. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:butaperazine maleate
    n1=Okihiro (syndrome de) | n2=en:butaperazine maleate | rel=r_associated | relid=0 | w=10
  1280. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:buthionine sulfoximine
    n1=Okihiro (syndrome de) | n2=en:buthionine sulfoximine | rel=r_associated | relid=0 | w=10
  1281. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:butirosin
    n1=Okihiro (syndrome de) | n2=en:butirosin | rel=r_associated | relid=0 | w=10
  1282. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:butocin
    n1=Okihiro (syndrome de) | n2=en:butocin | rel=r_associated | relid=0 | w=10
  1283. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:butylscopolamine bromide
    n1=Okihiro (syndrome de) | n2=en:butylscopolamine bromide | rel=r_associated | relid=0 | w=10
  1284. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:butyrophenone derivative antipsychotic agent
    n1=Okihiro (syndrome de) | n2=en:butyrophenone derivative antipsychotic agent | rel=r_associated | relid=0 | w=10
  1285. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:butyrophenone tranquilizers
    n1=Okihiro (syndrome de) | n2=en:butyrophenone tranquilizers | rel=r_associated | relid=0 | w=10
  1286. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:bw a773u
    n1=Okihiro (syndrome de) | n2=en:bw a773u | rel=r_associated | relid=0 | w=10
  1287. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:c-kit inhibitor plx9486
    n1=Okihiro (syndrome de) | n2=en:c-kit inhibitor plx9486 | rel=r_associated | relid=0 | w=10
  1288. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:c-met inhibitor amg 208
    n1=Okihiro (syndrome de) | n2=en:c-met inhibitor amg 208 | rel=r_associated | relid=0 | w=10
  1289. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:c-met inhibitor amg 337
    n1=Okihiro (syndrome de) | n2=en:c-met inhibitor amg 337 | rel=r_associated | relid=0 | w=10
  1290. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:c-met inhibitor jnj-38877605
    n1=Okihiro (syndrome de) | n2=en:c-met inhibitor jnj-38877605 | rel=r_associated | relid=0 | w=10
  1291. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:c-met inhibitor mk2461
    n1=Okihiro (syndrome de) | n2=en:c-met inhibitor mk2461 | rel=r_associated | relid=0 | w=10
  1292. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:c-met inhibitor mk8033
    n1=Okihiro (syndrome de) | n2=en:c-met inhibitor mk8033 | rel=r_associated | relid=0 | w=10
  1293. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:c-met inhibitor msc2156119j
    n1=Okihiro (syndrome de) | n2=en:c-met inhibitor msc2156119j | rel=r_associated | relid=0 | w=10
  1294. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:c-myb antisense oligonucleotide g4460
    n1=Okihiro (syndrome de) | n2=en:c-myb antisense oligonucleotide g4460 | rel=r_associated | relid=0 | w=10
  1295. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:c-visa bikdd:liposome
    n1=Okihiro (syndrome de) | n2=en:c-visa bikdd:liposome | rel=r_associated | relid=0 | w=10
  1296. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:c3-targeted complement inhibitor apl-2
    n1=Okihiro (syndrome de) | n2=en:c3-targeted complement inhibitor apl-2 | rel=r_associated | relid=0 | w=10
  1297. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cabazitaxel
    n1=Okihiro (syndrome de) | n2=en:cabazitaxel | rel=r_associated | relid=0 | w=10
  1298. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cabergoline
    n1=Okihiro (syndrome de) | n2=en:cabergoline | rel=r_associated | relid=0 | w=10
  1299. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cabozantinib s-malate
    n1=Okihiro (syndrome de) | n2=en:cabozantinib s-malate | rel=r_associated | relid=0 | w=10
  1300. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cadazolid
    n1=Okihiro (syndrome de) | n2=en:cadazolid | rel=r_associated | relid=0 | w=10
  1301. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cadexomer iodine
    n1=Okihiro (syndrome de) | n2=en:cadexomer iodine | rel=r_associated | relid=0 | w=10
  1302. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:caf regimen
    n1=Okihiro (syndrome de) | n2=en:caf regimen | rel=r_associated | relid=0 | w=10
  1303. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:caffeine
    n1=Okihiro (syndrome de) | n2=en:caffeine | rel=r_associated | relid=0 | w=10
  1304. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cafusertib hydrochloride
    n1=Okihiro (syndrome de) | n2=en:cafusertib hydrochloride | rel=r_associated | relid=0 | w=10
  1305. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:caix inhibitor dtp348
    n1=Okihiro (syndrome de) | n2=en:caix inhibitor dtp348 | rel=r_associated | relid=0 | w=10
  1306. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:caix inhibitor slc-0111
    n1=Okihiro (syndrome de) | n2=en:caix inhibitor slc-0111 | rel=r_associated | relid=0 | w=10
  1307. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calamine
    n1=Okihiro (syndrome de) | n2=en:calamine | rel=r_associated | relid=0 | w=10
  1308. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calaspargase pegol
    n1=Okihiro (syndrome de) | n2=en:calaspargase pegol | rel=r_associated | relid=0 | w=10
  1309. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcipotriene
    n1=Okihiro (syndrome de) | n2=en:calcipotriene | rel=r_associated | relid=0 | w=10
  1310. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcitonin
    n1=Okihiro (syndrome de) | n2=en:calcitonin | rel=r_associated | relid=0 | w=10
  1311. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcitonin salmon
    n1=Okihiro (syndrome de) | n2=en:calcitonin salmon | rel=r_associated | relid=0 | w=10
  1312. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcitriol
    n1=Okihiro (syndrome de) | n2=en:calcitriol | rel=r_associated | relid=0 | w=10
  1313. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcium aluminosilicate anti-diarrheal
    n1=Okihiro (syndrome de) | n2=en:calcium aluminosilicate anti-diarrheal | rel=r_associated | relid=0 | w=10
  1314. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcium carbonate
    n1=Okihiro (syndrome de) | n2=en:calcium carbonate | rel=r_associated | relid=0 | w=10
  1315. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcium channel blocker
    n1=Okihiro (syndrome de) | n2=en:calcium channel blocker | rel=r_associated | relid=0 | w=10
  1316. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcium chloride
    n1=Okihiro (syndrome de) | n2=en:calcium chloride | rel=r_associated | relid=0 | w=10
  1317. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcium citrate
    n1=Okihiro (syndrome de) | n2=en:calcium citrate | rel=r_associated | relid=0 | w=10
  1318. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcium gluconate
    n1=Okihiro (syndrome de) | n2=en:calcium gluconate | rel=r_associated | relid=0 | w=10
  1319. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcium iodide
    n1=Okihiro (syndrome de) | n2=en:calcium iodide | rel=r_associated | relid=0 | w=10
  1320. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcium polycarbophil
    n1=Okihiro (syndrome de) | n2=en:calcium polycarbophil | rel=r_associated | relid=0 | w=10
  1321. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcium regulating agent
    n1=Okihiro (syndrome de) | n2=en:calcium regulating agent | rel=r_associated | relid=0 | w=10
  1322. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcium saccharate
    n1=Okihiro (syndrome de) | n2=en:calcium saccharate | rel=r_associated | relid=0 | w=10
  1323. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcium-41 chloride aqueous solution
    n1=Okihiro (syndrome de) | n2=en:calcium-41 chloride aqueous solution | rel=r_associated | relid=0 | w=10
  1324. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calcium-46 chloride aqueous solution
    n1=Okihiro (syndrome de) | n2=en:calcium-46 chloride aqueous solution | rel=r_associated | relid=0 | w=10
  1325. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calculus bovis/moschus/olibanum/myrrha capsule
    n1=Okihiro (syndrome de) | n2=en:calculus bovis/moschus/olibanum/myrrha capsule | rel=r_associated | relid=0 | w=10
  1326. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calendula officinalis/plantago major/cochlearia armoracia/hamamelis virginiana herbal toothpaste
    n1=Okihiro (syndrome de) | n2=en:calendula officinalis/plantago major/cochlearia armoracia/hamamelis virginiana herbal toothpaste | rel=r_associated | relid=0 | w=10
  1327. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calendula ointment
    n1=Okihiro (syndrome de) | n2=en:calendula ointment | rel=r_associated | relid=0 | w=10
  1328. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calfactant
    n1=Okihiro (syndrome de) | n2=en:calfactant | rel=r_associated | relid=0 | w=10
  1329. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:calusterone
    n1=Okihiro (syndrome de) | n2=en:calusterone | rel=r_associated | relid=0 | w=10
  1330. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:camazepam
    n1=Okihiro (syndrome de) | n2=en:camazepam | rel=r_associated | relid=0 | w=10
  1331. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:camphor
    n1=Okihiro (syndrome de) | n2=en:camphor | rel=r_associated | relid=0 | w=10
  1332. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:camptothecin
    n1=Okihiro (syndrome de) | n2=en:camptothecin | rel=r_associated | relid=0 | w=10
  1333. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:camptothecin analogue tlc388
    n1=Okihiro (syndrome de) | n2=en:camptothecin analogue tlc388 | rel=r_associated | relid=0 | w=10
  1334. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:camptothecin-20(s)-o-propionate hydrate
    n1=Okihiro (syndrome de) | n2=en:camptothecin-20(s)-o-propionate hydrate | rel=r_associated | relid=0 | w=10
  1335. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:campy cva agar
    n1=Okihiro (syndrome de) | n2=en:campy cva agar | rel=r_associated | relid=0 | w=10
  1336. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:canada balsam
    n1=Okihiro (syndrome de) | n2=en:canada balsam | rel=r_associated | relid=0 | w=10
  1337. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:canarypox-hil-12 melanoma vaccine
    n1=Okihiro (syndrome de) | n2=en:canarypox-hil-12 melanoma vaccine | rel=r_associated | relid=0 | w=10
  1338. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cancell
    n1=Okihiro (syndrome de) | n2=en:cancell | rel=r_associated | relid=0 | w=10
  1339. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cancer peptide vaccine s-588410
    n1=Okihiro (syndrome de) | n2=en:cancer peptide vaccine s-588410 | rel=r_associated | relid=0 | w=10
  1340. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cancer stemness kinase inhibitor bbi503
    n1=Okihiro (syndrome de) | n2=en:cancer stemness kinase inhibitor bbi503 | rel=r_associated | relid=0 | w=10
  1341. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:candesartan cilexetil
    n1=Okihiro (syndrome de) | n2=en:candesartan cilexetil | rel=r_associated | relid=0 | w=10
  1342. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:candida albicans skin test reagent
    n1=Okihiro (syndrome de) | n2=en:candida albicans skin test reagent | rel=r_associated | relid=0 | w=10
  1343. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:canertinib dihydrochloride
    n1=Okihiro (syndrome de) | n2=en:canertinib dihydrochloride | rel=r_associated | relid=0 | w=10
  1344. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:canfosfamide hydrochloride
    n1=Okihiro (syndrome de) | n2=en:canfosfamide hydrochloride | rel=r_associated | relid=0 | w=10
  1345. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cannabidiol
    n1=Okihiro (syndrome de) | n2=en:cannabidiol | rel=r_associated | relid=0 | w=10
  1346. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cannabinol
    n1=Okihiro (syndrome de) | n2=en:cannabinol | rel=r_associated | relid=0 | w=10
  1347. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cannabis extract oil sr capsule
    n1=Okihiro (syndrome de) | n2=en:cannabis extract oil sr capsule | rel=r_associated | relid=0 | w=10
  1348. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cantuzumab ravtansine
    n1=Okihiro (syndrome de) | n2=en:cantuzumab ravtansine | rel=r_associated | relid=0 | w=10
  1349. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:capecitabine
    n1=Okihiro (syndrome de) | n2=en:capecitabine | rel=r_associated | relid=0 | w=10
  1350. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:capecitabine rapidly disintegrating tablet
    n1=Okihiro (syndrome de) | n2=en:capecitabine rapidly disintegrating tablet | rel=r_associated | relid=0 | w=10
  1351. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:capmatinib
    n1=Okihiro (syndrome de) | n2=en:capmatinib | rel=r_associated | relid=0 | w=10
  1352. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:capox regimen
    n1=Okihiro (syndrome de) | n2=en:capox regimen | rel=r_associated | relid=0 | w=10
  1353. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:capreomycin
    n1=Okihiro (syndrome de) | n2=en:capreomycin | rel=r_associated | relid=0 | w=10
  1354. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:capromab pendetide
    n1=Okihiro (syndrome de) | n2=en:capromab pendetide | rel=r_associated | relid=0 | w=10
  1355. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:capsaicin
    n1=Okihiro (syndrome de) | n2=en:capsaicin | rel=r_associated | relid=0 | w=10
  1356. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:capsicum extract
    n1=Okihiro (syndrome de) | n2=en:capsicum extract | rel=r_associated | relid=0 | w=10
  1357. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:captopril
    n1=Okihiro (syndrome de) | n2=en:captopril | rel=r_associated | relid=0 | w=10
  1358. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:car.cd30-expressing autologous epstein-barr virus-specific cytotoxic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:car.cd30-expressing autologous epstein-barr virus-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  1359. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:caracemide
    n1=Okihiro (syndrome de) | n2=en:caracemide | rel=r_associated | relid=0 | w=10
  1360. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:caramiphen
    n1=Okihiro (syndrome de) | n2=en:caramiphen | rel=r_associated | relid=0 | w=10
  1361. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbamazepin
    n1=Okihiro (syndrome de) | n2=en:carbamazepin | rel=r_associated | relid=0 | w=10
  1362. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbamazepine
    n1=Okihiro (syndrome de) | n2=en:carbamazepine | rel=r_associated | relid=0 | w=10
  1363. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbamide peroxide
    n1=Okihiro (syndrome de) | n2=en:carbamide peroxide | rel=r_associated | relid=0 | w=10
  1364. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbendazim
    n1=Okihiro (syndrome de) | n2=en:carbendazim | rel=r_associated | relid=0 | w=10
  1365. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbenicillin
    n1=Okihiro (syndrome de) | n2=en:carbenicillin | rel=r_associated | relid=0 | w=10
  1366. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbetimer
    n1=Okihiro (syndrome de) | n2=en:carbetimer | rel=r_associated | relid=0 | w=10
  1367. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbidopa
    n1=Okihiro (syndrome de) | n2=en:carbidopa | rel=r_associated | relid=0 | w=10
  1368. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbogen
    n1=Okihiro (syndrome de) | n2=en:carbogen | rel=r_associated | relid=0 | w=10
  1369. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbohydrate supplement drink
    n1=Okihiro (syndrome de) | n2=en:carbohydrate supplement drink | rel=r_associated | relid=0 | w=10
  1370. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 11 alpha-methyltryptophan
    n1=Okihiro (syndrome de) | n2=en:carbon c 11 alpha-methyltryptophan | rel=r_associated | relid=0 | w=10
  1371. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 11 choline
    n1=Okihiro (syndrome de) | n2=en:carbon c 11 choline | rel=r_associated | relid=0 | w=10
  1372. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 11 erlotinib hydrochloride
    n1=Okihiro (syndrome de) | n2=en:carbon c 11 erlotinib hydrochloride | rel=r_associated | relid=0 | w=10
  1373. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 11 methylaminoisobutyrate
    n1=Okihiro (syndrome de) | n2=en:carbon c 11 methylaminoisobutyrate | rel=r_associated | relid=0 | w=10
  1374. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 11 n-desmethyl-loperamide
    n1=Okihiro (syndrome de) | n2=en:carbon c 11 n-desmethyl-loperamide | rel=r_associated | relid=0 | w=10
  1375. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 11 pbr-28
    n1=Okihiro (syndrome de) | n2=en:carbon c 11 pbr-28 | rel=r_associated | relid=0 | w=10
  1376. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 11 sarcosine
    n1=Okihiro (syndrome de) | n2=en:carbon c 11 sarcosine | rel=r_associated | relid=0 | w=10
  1377. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 11 sepantronium bromide
    n1=Okihiro (syndrome de) | n2=en:carbon c 11 sepantronium bromide | rel=r_associated | relid=0 | w=10
  1378. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 13 acetate
    n1=Okihiro (syndrome de) | n2=en:carbon c 13 acetate | rel=r_associated | relid=0 | w=10
  1379. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 13 lycopene
    n1=Okihiro (syndrome de) | n2=en:carbon c 13 lycopene | rel=r_associated | relid=0 | w=10
  1380. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 13 octanoate
    n1=Okihiro (syndrome de) | n2=en:carbon c 13 octanoate | rel=r_associated | relid=0 | w=10
  1381. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 13 phytoene
    n1=Okihiro (syndrome de) | n2=en:carbon c 13 phytoene | rel=r_associated | relid=0 | w=10
  1382. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 13 phytofluene
    n1=Okihiro (syndrome de) | n2=en:carbon c 13 phytofluene | rel=r_associated | relid=0 | w=10
  1383. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 13/nitrogen n 15-labeled valine
    n1=Okihiro (syndrome de) | n2=en:carbon c 13/nitrogen n 15-labeled valine | rel=r_associated | relid=0 | w=10
  1384. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 14 anlotinib hydrochloride
    n1=Okihiro (syndrome de) | n2=en:carbon c 14 anlotinib hydrochloride | rel=r_associated | relid=0 | w=10
  1385. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 14 eribulin acetate
    n1=Okihiro (syndrome de) | n2=en:carbon c 14 eribulin acetate | rel=r_associated | relid=0 | w=10
  1386. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 14 gilteritinib
    n1=Okihiro (syndrome de) | n2=en:carbon c 14 gilteritinib | rel=r_associated | relid=0 | w=10
  1387. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 14 ibrutinib
    n1=Okihiro (syndrome de) | n2=en:carbon c 14 ibrutinib | rel=r_associated | relid=0 | w=10
  1388. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 14 lenvatinib mesylate
    n1=Okihiro (syndrome de) | n2=en:carbon c 14 lenvatinib mesylate | rel=r_associated | relid=0 | w=10
  1389. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 14 ombrabulin
    n1=Okihiro (syndrome de) | n2=en:carbon c 14 ombrabulin | rel=r_associated | relid=0 | w=10
  1390. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 14 oxaliplatin
    n1=Okihiro (syndrome de) | n2=en:carbon c 14 oxaliplatin | rel=r_associated | relid=0 | w=10
  1391. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 14 roniciclib
    n1=Okihiro (syndrome de) | n2=en:carbon c 14 roniciclib | rel=r_associated | relid=0 | w=10
  1392. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 14 selumetinib
    n1=Okihiro (syndrome de) | n2=en:carbon c 14 selumetinib | rel=r_associated | relid=0 | w=10
  1393. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 14 telotristat etiprate
    n1=Okihiro (syndrome de) | n2=en:carbon c 14 telotristat etiprate | rel=r_associated | relid=0 | w=10
  1394. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 14 vemurafenib
    n1=Okihiro (syndrome de) | n2=en:carbon c 14 vemurafenib | rel=r_associated | relid=0 | w=10
  1395. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c 14-labeled ixazomib
    n1=Okihiro (syndrome de) | n2=en:carbon c 14-labeled ixazomib | rel=r_associated | relid=0 | w=10
  1396. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c-13 dextromethorphan
    n1=Okihiro (syndrome de) | n2=en:carbon c-13 dextromethorphan | rel=r_associated | relid=0 | w=10
  1397. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c-14 dacomitinib
    n1=Okihiro (syndrome de) | n2=en:carbon c-14 dacomitinib | rel=r_associated | relid=0 | w=10
  1398. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon c11 temozolomide
    n1=Okihiro (syndrome de) | n2=en:carbon c11 temozolomide | rel=r_associated | relid=0 | w=10
  1399. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon nanoparticle-based formulation
    n1=Okihiro (syndrome de) | n2=en:carbon nanoparticle-based formulation | rel=r_associated | relid=0 | w=10
  1400. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbon-11 acetate
    n1=Okihiro (syndrome de) | n2=en:carbon-11 acetate | rel=r_associated | relid=0 | w=10
  1401. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbonic anhydrase inhibitor
    n1=Okihiro (syndrome de) | n2=en:carbonic anhydrase inhibitor | rel=r_associated | relid=0 | w=10
  1402. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carboplatin
    n1=Okihiro (syndrome de) | n2=en:carboplatin | rel=r_associated | relid=0 | w=10
  1403. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carboplatin-taxol regimen
    n1=Okihiro (syndrome de) | n2=en:carboplatin-taxol regimen | rel=r_associated | relid=0 | w=10
  1404. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carboplatin-taxol-bevacizumab regimen
    n1=Okihiro (syndrome de) | n2=en:carboplatin-taxol-bevacizumab regimen | rel=r_associated | relid=0 | w=10
  1405. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carboplatin/etoposide/melphalan regimen
    n1=Okihiro (syndrome de) | n2=en:carboplatin/etoposide/melphalan regimen | rel=r_associated | relid=0 | w=10
  1406. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carboxyamidotriazole
    n1=Okihiro (syndrome de) | n2=en:carboxyamidotriazole | rel=r_associated | relid=0 | w=10
  1407. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carboxyamidotriazole orotate
    n1=Okihiro (syndrome de) | n2=en:carboxyamidotriazole orotate | rel=r_associated | relid=0 | w=10
  1408. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carboxylesterase-expressing allogeneic neural stem cells
    n1=Okihiro (syndrome de) | n2=en:carboxylesterase-expressing allogeneic neural stem cells | rel=r_associated | relid=0 | w=10
  1409. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carboxymethylcellulose
    n1=Okihiro (syndrome de) | n2=en:carboxymethylcellulose | rel=r_associated | relid=0 | w=10
  1410. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carboxymethylcellulose sodium
    n1=Okihiro (syndrome de) | n2=en:carboxymethylcellulose sodium | rel=r_associated | relid=0 | w=10
  1411. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carboxyphenyl retinamide
    n1=Okihiro (syndrome de) | n2=en:carboxyphenyl retinamide | rel=r_associated | relid=0 | w=10
  1412. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carburazepam
    n1=Okihiro (syndrome de) | n2=en:carburazepam | rel=r_associated | relid=0 | w=10
  1413. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carbutamide
    n1=Okihiro (syndrome de) | n2=en:carbutamide | rel=r_associated | relid=0 | w=10
  1414. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carcinoembryonic antigen peptide 1
    n1=Okihiro (syndrome de) | n2=en:carcinoembryonic antigen peptide 1 | rel=r_associated | relid=0 | w=10
  1415. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carcinoembryonic antigen peptide 1-6d
    n1=Okihiro (syndrome de) | n2=en:carcinoembryonic antigen peptide 1-6d | rel=r_associated | relid=0 | w=10
  1416. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carcinoembryonic antigen peptide 1-6d virus-like replicon particles vaccine
    n1=Okihiro (syndrome de) | n2=en:carcinoembryonic antigen peptide 1-6d virus-like replicon particles vaccine | rel=r_associated | relid=0 | w=10
  1417. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carcinoembryonic antigen peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:carcinoembryonic antigen peptide vaccine | rel=r_associated | relid=0 | w=10
  1418. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carcinoembryonic antigen rna-pulsed dc cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:carcinoembryonic antigen rna-pulsed dc cancer vaccine | rel=r_associated | relid=0 | w=10
  1419. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carcinoembryonic antigen-expressing measles virus
    n1=Okihiro (syndrome de) | n2=en:carcinoembryonic antigen-expressing measles virus | rel=r_associated | relid=0 | w=10
  1420. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carcinogen
    n1=Okihiro (syndrome de) | n2=en:carcinogen | rel=r_associated | relid=0 | w=10
  1421. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carfilzomib
    n1=Okihiro (syndrome de) | n2=en:carfilzomib | rel=r_associated | relid=0 | w=10
  1422. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:caricotamide/tretazicar
    n1=Okihiro (syndrome de) | n2=en:caricotamide/tretazicar | rel=r_associated | relid=0 | w=10
  1423. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carlumab
    n1=Okihiro (syndrome de) | n2=en:carlumab | rel=r_associated | relid=0 | w=10
  1424. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carmustine
    n1=Okihiro (syndrome de) | n2=en:carmustine | rel=r_associated | relid=0 | w=10
  1425. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carmustine in ethanol
    n1=Okihiro (syndrome de) | n2=en:carmustine in ethanol | rel=r_associated | relid=0 | w=10
  1426. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carmustine sustained-release implant wafer
    n1=Okihiro (syndrome de) | n2=en:carmustine sustained-release implant wafer | rel=r_associated | relid=0 | w=10
  1427. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carphenazine
    n1=Okihiro (syndrome de) | n2=en:carphenazine | rel=r_associated | relid=0 | w=10
  1428. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carphenazine maleate
    n1=Okihiro (syndrome de) | n2=en:carphenazine maleate | rel=r_associated | relid=0 | w=10
  1429. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carpipramine dihydrochloride
    n1=Okihiro (syndrome de) | n2=en:carpipramine dihydrochloride | rel=r_associated | relid=0 | w=10
  1430. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carrageenan-containing gel
    n1=Okihiro (syndrome de) | n2=en:carrageenan-containing gel | rel=r_associated | relid=0 | w=10
  1431. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carrot juice
    n1=Okihiro (syndrome de) | n2=en:carrot juice | rel=r_associated | relid=0 | w=10
  1432. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carrot/jilin ginseng/licorice root/tangerine peel/soy beverage
    n1=Okihiro (syndrome de) | n2=en:carrot/jilin ginseng/licorice root/tangerine peel/soy beverage | rel=r_associated | relid=0 | w=10
  1433. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cartilage
    n1=Okihiro (syndrome de) | n2=en:cartilage | rel=r_associated | relid=0 | w=10
  1434. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carubicin
    n1=Okihiro (syndrome de) | n2=en:carubicin | rel=r_associated | relid=0 | w=10
  1435. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carvedilol
    n1=Okihiro (syndrome de) | n2=en:carvedilol | rel=r_associated | relid=0 | w=10
  1436. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carvedilol phosphate extended-release capsule
    n1=Okihiro (syndrome de) | n2=en:carvedilol phosphate extended-release capsule | rel=r_associated | relid=0 | w=10
  1437. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carvotroline
    n1=Okihiro (syndrome de) | n2=en:carvotroline | rel=r_associated | relid=0 | w=10
  1438. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:carzelesin
    n1=Okihiro (syndrome de) | n2=en:carzelesin | rel=r_associated | relid=0 | w=10
  1439. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:casein/whey protein/soy protein/pea protein/fat mix/epa/dha-based nutritional supplement
    n1=Okihiro (syndrome de) | n2=en:casein/whey protein/soy protein/pea protein/fat mix/epa/dha-based nutritional supplement | rel=r_associated | relid=0 | w=10
  1440. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:caseinate protein isolate
    n1=Okihiro (syndrome de) | n2=en:caseinate protein isolate | rel=r_associated | relid=0 | w=10
  1441. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:casopitant mesylate
    n1=Okihiro (syndrome de) | n2=en:casopitant mesylate | rel=r_associated | relid=0 | w=10
  1442. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:caspofungin acetate
    n1=Okihiro (syndrome de) | n2=en:caspofungin acetate | rel=r_associated | relid=0 | w=10
  1443. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:castor oil
    n1=Okihiro (syndrome de) | n2=en:castor oil | rel=r_associated | relid=0 | w=10
  1444. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:catechol-o-methyltransferase inhibitor
    n1=Okihiro (syndrome de) | n2=en:catechol-o-methyltransferase inhibitor | rel=r_associated | relid=0 | w=10
  1445. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cathelicidin ll-37
    n1=Okihiro (syndrome de) | n2=en:cathelicidin ll-37 | rel=r_associated | relid=0 | w=10
  1446. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cathepsin-activatable cy5 fluorescent imaging probe lum015
    n1=Okihiro (syndrome de) | n2=en:cathepsin-activatable cy5 fluorescent imaging probe lum015 | rel=r_associated | relid=0 | w=10
  1447. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cationic liposome-encapsulated paclitaxel
    n1=Okihiro (syndrome de) | n2=en:cationic liposome-encapsulated paclitaxel | rel=r_associated | relid=0 | w=10
  1448. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:catumaxomab
    n1=Okihiro (syndrome de) | n2=en:catumaxomab | rel=r_associated | relid=0 | w=10
  1449. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cayenne extract
    n1=Okihiro (syndrome de) | n2=en:cayenne extract | rel=r_associated | relid=0 | w=10
  1450. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cb10-277
    n1=Okihiro (syndrome de) | n2=en:cb10-277 | rel=r_associated | relid=0 | w=10
  1451. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cbp-501
    n1=Okihiro (syndrome de) | n2=en:cbp-501 | rel=r_associated | relid=0 | w=10
  1452. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cbp/beta-catenin antagonist pri-724
    n1=Okihiro (syndrome de) | n2=en:cbp/beta-catenin antagonist pri-724 | rel=r_associated | relid=0 | w=10
  1453. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cc-1088
    n1=Okihiro (syndrome de) | n2=en:cc-1088 | rel=r_associated | relid=0 | w=10
  1454. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cc-401
    n1=Okihiro (syndrome de) | n2=en:cc-401 | rel=r_associated | relid=0 | w=10
  1455. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cc-8490
    n1=Okihiro (syndrome de) | n2=en:cc-8490 | rel=r_associated | relid=0 | w=10
  1456. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ccl21-expressing h1944 cell vaccine
    n1=Okihiro (syndrome de) | n2=en:ccl21-expressing h1944 cell vaccine | rel=r_associated | relid=0 | w=10
  1457. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ccr2 antagonist ccx872-b
    n1=Okihiro (syndrome de) | n2=en:ccr2 antagonist ccx872-b | rel=r_associated | relid=0 | w=10
  1458. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ccr2 antagonist pf-04136309
    n1=Okihiro (syndrome de) | n2=en:ccr2 antagonist pf-04136309 | rel=r_associated | relid=0 | w=10
  1459. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd-expressing bifidobacterium aps001f
    n1=Okihiro (syndrome de) | n2=en:cd-expressing bifidobacterium aps001f | rel=r_associated | relid=0 | w=10
  1460. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine
    n1=Okihiro (syndrome de) | n2=en:cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  1461. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd133 antigen peptide-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:cd133 antigen peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  1462. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd138car-cd137/tcrzeta-expressing t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:cd138car-cd137/tcrzeta-expressing t lymphocytes | rel=r_associated | relid=0 | w=10
  1463. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd19/cd3 dual-affinity retargeting protein jnj-64052781
    n1=Okihiro (syndrome de) | n2=en:cd19/cd3 dual-affinity retargeting protein jnj-64052781 | rel=r_associated | relid=0 | w=10
  1464. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd19car-cd28zeta-4-1bb-expressing allogeneic t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:cd19car-cd28zeta-4-1bb-expressing allogeneic t lymphocytes | rel=r_associated | relid=0 | w=10
  1465. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd19car-cd3zeta-4-1bb-cd28-expressing autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:cd19car-cd3zeta-4-1bb-cd28-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  1466. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd19car-cd3zeta-4-1bb-expressing allogeneic t-lymphocyte cells
    n1=Okihiro (syndrome de) | n2=en:cd19car-cd3zeta-4-1bb-expressing allogeneic t-lymphocyte cells | rel=r_associated | relid=0 | w=10
  1467. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  1468. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd19car-cd3zeta-expressing autologous t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:cd19car-cd3zeta-expressing autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  1469. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd20-targeted polypeptide tru-015
    n1=Okihiro (syndrome de) | n2=en:cd20-targeted polypeptide tru-015 | rel=r_associated | relid=0 | w=10
  1470. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc
    n1=Okihiro (syndrome de) | n2=en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc | rel=r_associated | relid=0 | w=10
  1471. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd28car/cd137car-expressing t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:cd28car/cd137car-expressing t-lymphocytes | rel=r_associated | relid=0 | w=10
  1472. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd3/cd28 costimulated autologous t-cells
    n1=Okihiro (syndrome de) | n2=en:cd3/cd28 costimulated autologous t-cells | rel=r_associated | relid=0 | w=10
  1473. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd30 car-expressing autologous t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:cd30 car-expressing autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  1474. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd33car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:cd33car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  1475. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd34/tk75-transduced donor lymphocytes
    n1=Okihiro (syndrome de) | n2=en:cd34/tk75-transduced donor lymphocytes | rel=r_associated | relid=0 | w=10
  1476. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd4+ cd25+ regulatory t cells
    n1=Okihiro (syndrome de) | n2=en:cd4+ cd25+ regulatory t cells | rel=r_associated | relid=0 | w=10
  1477. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd40 agonist monoclonal antibody cp-870,893
    n1=Okihiro (syndrome de) | n2=en:cd40 agonist monoclonal antibody cp-870,893 | rel=r_associated | relid=0 | w=10
  1478. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd40 agonist monoclonal antibody ro7009789
    n1=Okihiro (syndrome de) | n2=en:cd40 agonist monoclonal antibody ro7009789 | rel=r_associated | relid=0 | w=10
  1479. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd40 agonistic monoclonal antibody apx005m
    n1=Okihiro (syndrome de) | n2=en:cd40 agonistic monoclonal antibody apx005m | rel=r_associated | relid=0 | w=10
  1480. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd5789 cream
    n1=Okihiro (syndrome de) | n2=en:cd5789 cream | rel=r_associated | relid=0 | w=10
  1481. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd80 breast cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:cd80 breast cancer vaccine | rel=r_associated | relid=0 | w=10
  1482. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cd95 ecd/igg-fc fusion protein apg101
    n1=Okihiro (syndrome de) | n2=en:cd95 ecd/igg-fc fusion protein apg101 | rel=r_associated | relid=0 | w=10
  1483. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cda inhibitor e7727/decitabine combination agent astx727
    n1=Okihiro (syndrome de) | n2=en:cda inhibitor e7727/decitabine combination agent astx727 | rel=r_associated | relid=0 | w=10
  1484. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdc7 inhibitor tak-931
    n1=Okihiro (syndrome de) | n2=en:cdc7 inhibitor tak-931 | rel=r_associated | relid=0 | w=10
  1485. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdc7 kinase inhibitor bms-863233
    n1=Okihiro (syndrome de) | n2=en:cdc7 kinase inhibitor bms-863233 | rel=r_associated | relid=0 | w=10
  1486. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdc7 kinase inhibitor nms-1116354
    n1=Okihiro (syndrome de) | n2=en:cdc7 kinase inhibitor nms-1116354 | rel=r_associated | relid=0 | w=10
  1487. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdisc sdtm anatomical location terminology
    n1=Okihiro (syndrome de) | n2=en:cdisc sdtm anatomical location terminology | rel=r_associated | relid=0 | w=10
  1488. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdisc sdtm terminology
    n1=Okihiro (syndrome de) | n2=en:cdisc sdtm terminology | rel=r_associated | relid=0 | w=10
  1489. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdisc send terminology
    n1=Okihiro (syndrome de) | n2=en:cdisc send terminology | rel=r_associated | relid=0 | w=10
  1490. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdk inhibitor p276-00
    n1=Okihiro (syndrome de) | n2=en:cdk inhibitor p276-00 | rel=r_associated | relid=0 | w=10
  1491. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdk inhibitor sns-032
    n1=Okihiro (syndrome de) | n2=en:cdk inhibitor sns-032 | rel=r_associated | relid=0 | w=10
  1492. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdk/jak2/flt3 inhibitor tg02 citrate
    n1=Okihiro (syndrome de) | n2=en:cdk/jak2/flt3 inhibitor tg02 citrate | rel=r_associated | relid=0 | w=10
  1493. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdk2/5/9 inhibitor cyc065
    n1=Okihiro (syndrome de) | n2=en:cdk2/5/9 inhibitor cyc065 | rel=r_associated | relid=0 | w=10
  1494. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdk2/trka inhibitor pha-848125 ac
    n1=Okihiro (syndrome de) | n2=en:cdk2/trka inhibitor pha-848125 ac | rel=r_associated | relid=0 | w=10
  1495. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdk4 inhibitor p1446a-05
    n1=Okihiro (syndrome de) | n2=en:cdk4 inhibitor p1446a-05 | rel=r_associated | relid=0 | w=10
  1496. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdk4/6 inhibitor g1t28
    n1=Okihiro (syndrome de) | n2=en:cdk4/6 inhibitor g1t28 | rel=r_associated | relid=0 | w=10
  1497. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdk4/6 inhibitor shr6390
    n1=Okihiro (syndrome de) | n2=en:cdk4/6 inhibitor shr6390 | rel=r_associated | relid=0 | w=10
  1498. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdki at7519
    n1=Okihiro (syndrome de) | n2=en:cdki at7519 | rel=r_associated | relid=0 | w=10
  1499. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cdki r547
    n1=Okihiro (syndrome de) | n2=en:cdki r547 | rel=r_associated | relid=0 | w=10
  1500. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cea/tetanus toxoid t helper epitope fusion protein-expressing dna plasmid vaccine
    n1=Okihiro (syndrome de) | n2=en:cea/tetanus toxoid t helper epitope fusion protein-expressing dna plasmid vaccine | rel=r_associated | relid=0 | w=10
  1501. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cebpa-targeting sarna mtl-cebpa liposome
    n1=Okihiro (syndrome de) | n2=en:cebpa-targeting sarna mtl-cebpa liposome | rel=r_associated | relid=0 | w=10
  1502. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cebranopadol
    n1=Okihiro (syndrome de) | n2=en:cebranopadol | rel=r_associated | relid=0 | w=10
  1503. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cediranib maleate
    n1=Okihiro (syndrome de) | n2=en:cediranib maleate | rel=r_associated | relid=0 | w=10
  1504. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cef regimen
    n1=Okihiro (syndrome de) | n2=en:cef regimen | rel=r_associated | relid=0 | w=10
  1505. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cefamandole
    n1=Okihiro (syndrome de) | n2=en:cefamandole | rel=r_associated | relid=0 | w=10
  1506. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cefazolin sodium
    n1=Okihiro (syndrome de) | n2=en:cefazolin sodium | rel=r_associated | relid=0 | w=10
  1507. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cefepime hydrochloride
    n1=Okihiro (syndrome de) | n2=en:cefepime hydrochloride | rel=r_associated | relid=0 | w=10
  1508. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cefixime
    n1=Okihiro (syndrome de) | n2=en:cefixime | rel=r_associated | relid=0 | w=10
  1509. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cefmetazole sodium
    n1=Okihiro (syndrome de) | n2=en:cefmetazole sodium | rel=r_associated | relid=0 | w=10
  1510. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cefotaxime
    n1=Okihiro (syndrome de) | n2=en:cefotaxime | rel=r_associated | relid=0 | w=10
  1511. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cefpodoxime proxetil
    n1=Okihiro (syndrome de) | n2=en:cefpodoxime proxetil | rel=r_associated | relid=0 | w=10
  1512. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ceftazidime sodium
    n1=Okihiro (syndrome de) | n2=en:ceftazidime sodium | rel=r_associated | relid=0 | w=10
  1513. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ceftazidime/avibactam sodium
    n1=Okihiro (syndrome de) | n2=en:ceftazidime/avibactam sodium | rel=r_associated | relid=0 | w=10
  1514. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ceftobiprole medocaril
    n1=Okihiro (syndrome de) | n2=en:ceftobiprole medocaril | rel=r_associated | relid=0 | w=10
  1515. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ceftriaxone sodium
    n1=Okihiro (syndrome de) | n2=en:ceftriaxone sodium | rel=r_associated | relid=0 | w=10
  1516. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:celecoxib
    n1=Okihiro (syndrome de) | n2=en:celecoxib | rel=r_associated | relid=0 | w=10
  1517. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cell cycle checkpoint/dna repair antagonist ic83
    n1=Okihiro (syndrome de) | n2=en:cell cycle checkpoint/dna repair antagonist ic83 | rel=r_associated | relid=0 | w=10
  1518. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cellulose, oxidized
    n1=Okihiro (syndrome de) | n2=en:cellulose, oxidized | rel=r_associated | relid=0 | w=10
  1519. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cemadotin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:cemadotin hydrochloride | rel=r_associated | relid=0 | w=10
  1520. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cenersen
    n1=Okihiro (syndrome de) | n2=en:cenersen | rel=r_associated | relid=0 | w=10
  1521. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cenisertib
    n1=Okihiro (syndrome de) | n2=en:cenisertib | rel=r_associated | relid=0 | w=10
  1522. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cenp-e inhibitor gsk-923295
    n1=Okihiro (syndrome de) | n2=en:cenp-e inhibitor gsk-923295 | rel=r_associated | relid=0 | w=10
  1523. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:central nervous system agents
    n1=Okihiro (syndrome de) | n2=en:central nervous system agents | rel=r_associated | relid=0 | w=10
  1524. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cep-2563 dihydrochloride
    n1=Okihiro (syndrome de) | n2=en:cep-2563 dihydrochloride | rel=r_associated | relid=0 | w=10
  1525. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cephalexin
    n1=Okihiro (syndrome de) | n2=en:cephalexin | rel=r_associated | relid=0 | w=10
  1526. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cephalothin sodium
    n1=Okihiro (syndrome de) | n2=en:cephalothin sodium | rel=r_associated | relid=0 | w=10
  1527. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ceramide
    n1=Okihiro (syndrome de) | n2=en:ceramide | rel=r_associated | relid=0 | w=10
  1528. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ceritinib
    n1=Okihiro (syndrome de) | n2=en:ceritinib | rel=r_associated | relid=0 | w=10
  1529. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:certolizumab
    n1=Okihiro (syndrome de) | n2=en:certolizumab | rel=r_associated | relid=0 | w=10
  1530. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ceruminolytic agent
    n1=Okihiro (syndrome de) | n2=en:ceruminolytic agent | rel=r_associated | relid=0 | w=10
  1531. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cervical curve
    n1=Okihiro (syndrome de) | n2=en:cervical curve | rel=r_associated | relid=0 | w=10
  1532. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cervical spine
    n1=Okihiro (syndrome de) | n2=en:cervical spine | rel=r_associated | relid=0 | w=10
  1533. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cesium cs 137
    n1=Okihiro (syndrome de) | n2=en:cesium cs 137 | rel=r_associated | relid=0 | w=10
  1534. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cesium cs-131
    n1=Okihiro (syndrome de) | n2=en:cesium cs-131 | rel=r_associated | relid=0 | w=10
  1535. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ceteth-20
    n1=Okihiro (syndrome de) | n2=en:ceteth-20 | rel=r_associated | relid=0 | w=10
  1536. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cetirizine
    n1=Okihiro (syndrome de) | n2=en:cetirizine | rel=r_associated | relid=0 | w=10
  1537. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cetraria islandica subsp. islandica extract
    n1=Okihiro (syndrome de) | n2=en:cetraria islandica subsp. islandica extract | rel=r_associated | relid=0 | w=10
  1538. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cetrorelix
    n1=Okihiro (syndrome de) | n2=en:cetrorelix | rel=r_associated | relid=0 | w=10
  1539. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cetrorelix acetate
    n1=Okihiro (syndrome de) | n2=en:cetrorelix acetate | rel=r_associated | relid=0 | w=10
  1540. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cetuximab
    n1=Okihiro (syndrome de) | n2=en:cetuximab | rel=r_associated | relid=0 | w=10
  1541. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cetuximab-ir700 conjugate rm-1929
    n1=Okihiro (syndrome de) | n2=en:cetuximab-ir700 conjugate rm-1929 | rel=r_associated | relid=0 | w=10
  1542. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cetuximab-irdye 800cw
    n1=Okihiro (syndrome de) | n2=en:cetuximab-irdye 800cw | rel=r_associated | relid=0 | w=10
  1543. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cevimeline hydrochloride
    n1=Okihiro (syndrome de) | n2=en:cevimeline hydrochloride | rel=r_associated | relid=0 | w=10
  1544. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cfms tyrosine kinase inhibitor arry-382
    n1=Okihiro (syndrome de) | n2=en:cfms tyrosine kinase inhibitor arry-382 | rel=r_associated | relid=0 | w=10
  1545. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cg7870
    n1=Okihiro (syndrome de) | n2=en:cg7870 | rel=r_associated | relid=0 | w=10
  1546. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cgp-6809
    n1=Okihiro (syndrome de) | n2=en:cgp-6809 | rel=r_associated | relid=0 | w=10
  1547. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chamomile
    n1=Okihiro (syndrome de) | n2=en:chamomile | rel=r_associated | relid=0 | w=10
  1548. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:changchun marina
    n1=Okihiro (syndrome de) | n2=en:changchun marina | rel=r_associated | relid=0 | w=10
  1549. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:checkpoint kinase inhibitor azd7762
    n1=Okihiro (syndrome de) | n2=en:checkpoint kinase inhibitor azd7762 | rel=r_associated | relid=0 | w=10
  1550. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:checkpoint kinase inhibitor xl844
    n1=Okihiro (syndrome de) | n2=en:checkpoint kinase inhibitor xl844 | rel=r_associated | relid=0 | w=10
  1551. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chelating agent
    n1=Okihiro (syndrome de) | n2=en:chelating agent | rel=r_associated | relid=0 | w=10
  1552. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chelating agents and antidotes
    n1=Okihiro (syndrome de) | n2=en:chelating agents and antidotes | rel=r_associated | relid=0 | w=10
  1553. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cherry
    n1=Okihiro (syndrome de) | n2=en:cherry | rel=r_associated | relid=0 | w=10
  1554. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chewing gum dosage form
    n1=Okihiro (syndrome de) | n2=en:chewing gum dosage form | rel=r_associated | relid=0 | w=10
  1555. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chiauranib
    n1=Okihiro (syndrome de) | n2=en:chiauranib | rel=r_associated | relid=0 | w=10
  1556. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chidamide
    n1=Okihiro (syndrome de) | n2=en:chidamide | rel=r_associated | relid=0 | w=10
  1557. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chimeric fibril-reactive monoclonal antibody 111f4
    n1=Okihiro (syndrome de) | n2=en:chimeric fibril-reactive monoclonal antibody 111f4 | rel=r_associated | relid=0 | w=10
  1558. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chimeric humanized anti-cd47 antibody
    n1=Okihiro (syndrome de) | n2=en:chimeric humanized anti-cd47 antibody | rel=r_associated | relid=0 | w=10
  1559. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chinese herbal formulation changtai keli
    n1=Okihiro (syndrome de) | n2=en:chinese herbal formulation changtai keli | rel=r_associated | relid=0 | w=10
  1560. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chinese herbal formulation phy906
    n1=Okihiro (syndrome de) | n2=en:chinese herbal formulation phy906 | rel=r_associated | relid=0 | w=10
  1561. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chinese herbal medicine compound tpe-1
    n1=Okihiro (syndrome de) | n2=en:chinese herbal medicine compound tpe-1 | rel=r_associated | relid=0 | w=10
  1562. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chinese herbs
    n1=Okihiro (syndrome de) | n2=en:chinese herbs | rel=r_associated | relid=0 | w=10
  1563. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chining decoction
    n1=Okihiro (syndrome de) | n2=en:chining decoction | rel=r_associated | relid=0 | w=10
  1564. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chk1 inhibitor gdc-0425
    n1=Okihiro (syndrome de) | n2=en:chk1 inhibitor gdc-0425 | rel=r_associated | relid=0 | w=10
  1565. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chk1 inhibitor gdc-0575
    n1=Okihiro (syndrome de) | n2=en:chk1 inhibitor gdc-0575 | rel=r_associated | relid=0 | w=10
  1566. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chk1 inhibitor mk-8776
    n1=Okihiro (syndrome de) | n2=en:chk1 inhibitor mk-8776 | rel=r_associated | relid=0 | w=10
  1567. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chk1 inhibitor pf-477736
    n1=Okihiro (syndrome de) | n2=en:chk1 inhibitor pf-477736 | rel=r_associated | relid=0 | w=10
  1568. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chloral derivative
    n1=Okihiro (syndrome de) | n2=en:chloral derivative | rel=r_associated | relid=0 | w=10
  1569. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlorambucil
    n1=Okihiro (syndrome de) | n2=en:chlorambucil | rel=r_associated | relid=0 | w=10
  1570. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlorambucil-prednisone regimen
    n1=Okihiro (syndrome de) | n2=en:chlorambucil-prednisone regimen | rel=r_associated | relid=0 | w=10
  1571. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chloramphenicol
    n1=Okihiro (syndrome de) | n2=en:chloramphenicol | rel=r_associated | relid=0 | w=10
  1572. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlordiazepoxide
    n1=Okihiro (syndrome de) | n2=en:chlordiazepoxide | rel=r_associated | relid=0 | w=10
  1573. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlordiazepoxide hydrochloride
    n1=Okihiro (syndrome de) | n2=en:chlordiazepoxide hydrochloride | rel=r_associated | relid=0 | w=10
  1574. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlorhexidine
    n1=Okihiro (syndrome de) | n2=en:chlorhexidine | rel=r_associated | relid=0 | w=10
  1575. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlorhexidine gluconate
    n1=Okihiro (syndrome de) | n2=en:chlorhexidine gluconate | rel=r_associated | relid=0 | w=10
  1576. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlorhexidine/ethyl alcohol mouthwash
    n1=Okihiro (syndrome de) | n2=en:chlorhexidine/ethyl alcohol mouthwash | rel=r_associated | relid=0 | w=10
  1577. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlormezanone
    n1=Okihiro (syndrome de) | n2=en:chlormezanone | rel=r_associated | relid=0 | w=10
  1578. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlorogenic acid
    n1=Okihiro (syndrome de) | n2=en:chlorogenic acid | rel=r_associated | relid=0 | w=10
  1579. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlorophyllin
    n1=Okihiro (syndrome de) | n2=en:chlorophyllin | rel=r_associated | relid=0 | w=10
  1580. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chloroquine
    n1=Okihiro (syndrome de) | n2=en:chloroquine | rel=r_associated | relid=0 | w=10
  1581. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chloroquinoxaline sulfonamide
    n1=Okihiro (syndrome de) | n2=en:chloroquinoxaline sulfonamide | rel=r_associated | relid=0 | w=10
  1582. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlorotoxin-indocyanine green imaging agent blz-100
    n1=Okihiro (syndrome de) | n2=en:chlorotoxin-indocyanine green imaging agent blz-100 | rel=r_associated | relid=0 | w=10
  1583. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlorozotocin
    n1=Okihiro (syndrome de) | n2=en:chlorozotocin | rel=r_associated | relid=0 | w=10
  1584. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlorpromazine
    n1=Okihiro (syndrome de) | n2=en:chlorpromazine | rel=r_associated | relid=0 | w=10
  1585. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlorpromazine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:chlorpromazine hydrochloride | rel=r_associated | relid=0 | w=10
  1586. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlorpropamide
    n1=Okihiro (syndrome de) | n2=en:chlorpropamide | rel=r_associated | relid=0 | w=10
  1587. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlorprothixene
    n1=Okihiro (syndrome de) | n2=en:chlorprothixene | rel=r_associated | relid=0 | w=10
  1588. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chlorzoxazone
    n1=Okihiro (syndrome de) | n2=en:chlorzoxazone | rel=r_associated | relid=0 | w=10
  1589. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cholecalciferol
    n1=Okihiro (syndrome de) | n2=en:cholecalciferol | rel=r_associated | relid=0 | w=10
  1590. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cholecalciferol/whey protein isolate/epa/dha-based nutritional supplement
    n1=Okihiro (syndrome de) | n2=en:cholecalciferol/whey protein isolate/epa/dha-based nutritional supplement | rel=r_associated | relid=0 | w=10
  1591. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cholelitholytic and/or choleretic agent
    n1=Okihiro (syndrome de) | n2=en:cholelitholytic and/or choleretic agent | rel=r_associated | relid=0 | w=10
  1592. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:choleretic agent
    n1=Okihiro (syndrome de) | n2=en:choleretic agent | rel=r_associated | relid=0 | w=10
  1593. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:choline kinase alpha inhibitor tcd-717
    n1=Okihiro (syndrome de) | n2=en:choline kinase alpha inhibitor tcd-717 | rel=r_associated | relid=0 | w=10
  1594. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:choline magnesium trisalicylate
    n1=Okihiro (syndrome de) | n2=en:choline magnesium trisalicylate | rel=r_associated | relid=0 | w=10
  1595. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:choline salicylate
    n1=Okihiro (syndrome de) | n2=en:choline salicylate | rel=r_associated | relid=0 | w=10
  1596. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cholinergic muscarinic antagonists [moa]
    n1=Okihiro (syndrome de) | n2=en:cholinergic muscarinic antagonists [moa] | rel=r_associated | relid=0 | w=10
  1597. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chondroitin sulfate
    n1=Okihiro (syndrome de) | n2=en:chondroitin sulfate | rel=r_associated | relid=0 | w=10
  1598. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chop regimen
    n1=Okihiro (syndrome de) | n2=en:chop regimen | rel=r_associated | relid=0 | w=10
  1599. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chp-her-2 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:chp-her-2 peptide vaccine | rel=r_associated | relid=0 | w=10
  1600. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chp-ny-eso-1 peptide vaccine imf-001
    n1=Okihiro (syndrome de) | n2=en:chp-ny-eso-1 peptide vaccine imf-001 | rel=r_associated | relid=0 | w=10
  1601. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chromium cr-51 edetate
    n1=Okihiro (syndrome de) | n2=en:chromium cr-51 edetate | rel=r_associated | relid=0 | w=10
  1602. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:chromomycin a3
    n1=Okihiro (syndrome de) | n2=en:chromomycin a3 | rel=r_associated | relid=0 | w=10
  1603. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ciclopirox
    n1=Okihiro (syndrome de) | n2=en:ciclopirox | rel=r_associated | relid=0 | w=10
  1604. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ciclopirox olamine lotion
    n1=Okihiro (syndrome de) | n2=en:ciclopirox olamine lotion | rel=r_associated | relid=0 | w=10
  1605. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ciclopirox olamine oral
    n1=Okihiro (syndrome de) | n2=en:ciclopirox olamine oral | rel=r_associated | relid=0 | w=10
  1606. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ciclotizolam
    n1=Okihiro (syndrome de) | n2=en:ciclotizolam | rel=r_associated | relid=0 | w=10
  1607. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cidan herbal capsule
    n1=Okihiro (syndrome de) | n2=en:cidan herbal capsule | rel=r_associated | relid=0 | w=10
  1608. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cidofovir
    n1=Okihiro (syndrome de) | n2=en:cidofovir | rel=r_associated | relid=0 | w=10
  1609. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cidofovir and derivatives
    n1=Okihiro (syndrome de) | n2=en:cidofovir and derivatives | rel=r_associated | relid=0 | w=10
  1610. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cilastatin
    n1=Okihiro (syndrome de) | n2=en:cilastatin | rel=r_associated | relid=0 | w=10
  1611. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cilengitide
    n1=Okihiro (syndrome de) | n2=en:cilengitide | rel=r_associated | relid=0 | w=10
  1612. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cimetidine
    n1=Okihiro (syndrome de) | n2=en:cimetidine | rel=r_associated | relid=0 | w=10
  1613. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cinacalcet hydrochloride
    n1=Okihiro (syndrome de) | n2=en:cinacalcet hydrochloride | rel=r_associated | relid=0 | w=10
  1614. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cinchona alkaloids
    n1=Okihiro (syndrome de) | n2=en:cinchona alkaloids | rel=r_associated | relid=0 | w=10
  1615. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cinobufagin
    n1=Okihiro (syndrome de) | n2=en:cinobufagin | rel=r_associated | relid=0 | w=10
  1616. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cinolazepam
    n1=Okihiro (syndrome de) | n2=en:cinolazepam | rel=r_associated | relid=0 | w=10
  1617. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cintredekin besudotox
    n1=Okihiro (syndrome de) | n2=en:cintredekin besudotox | rel=r_associated | relid=0 | w=10
  1618. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cinuperone
    n1=Okihiro (syndrome de) | n2=en:cinuperone | rel=r_associated | relid=0 | w=10
  1619. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cipatinib
    n1=Okihiro (syndrome de) | n2=en:cipatinib | rel=r_associated | relid=0 | w=10
  1620. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ciprofloxacin
    n1=Okihiro (syndrome de) | n2=en:ciprofloxacin | rel=r_associated | relid=0 | w=10
  1621. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cirmtuzumab
    n1=Okihiro (syndrome de) | n2=en:cirmtuzumab | rel=r_associated | relid=0 | w=10
  1622. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cis-urocanic acid
    n1=Okihiro (syndrome de) | n2=en:cis-urocanic acid | rel=r_associated | relid=0 | w=10
  1623. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cisapride
    n1=Okihiro (syndrome de) | n2=en:cisapride | rel=r_associated | relid=0 | w=10
  1624. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cisatracurium besylate
    n1=Okihiro (syndrome de) | n2=en:cisatracurium besylate | rel=r_associated | relid=0 | w=10
  1625. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cisplatin
    n1=Okihiro (syndrome de) | n2=en:cisplatin | rel=r_associated | relid=0 | w=10
  1626. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cisplatin liposomal
    n1=Okihiro (syndrome de) | n2=en:cisplatin liposomal | rel=r_associated | relid=0 | w=10
  1627. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cisplatin-e therapeutic implant
    n1=Okihiro (syndrome de) | n2=en:cisplatin-e therapeutic implant | rel=r_associated | relid=0 | w=10
  1628. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:citalopram
    n1=Okihiro (syndrome de) | n2=en:citalopram | rel=r_associated | relid=0 | w=10
  1629. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:citalopram hydrobromide
    n1=Okihiro (syndrome de) | n2=en:citalopram hydrobromide | rel=r_associated | relid=0 | w=10
  1630. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:citatuzumab bogatox
    n1=Okihiro (syndrome de) | n2=en:citatuzumab bogatox | rel=r_associated | relid=0 | w=10
  1631. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:citicoline
    n1=Okihiro (syndrome de) | n2=en:citicoline | rel=r_associated | relid=0 | w=10
  1632. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:citric acid + magnesium oxide + sodium picosulfate
    n1=Okihiro (syndrome de) | n2=en:citric acid + magnesium oxide + sodium picosulfate | rel=r_associated | relid=0 | w=10
  1633. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:citrulline
    n1=Okihiro (syndrome de) | n2=en:citrulline | rel=r_associated | relid=0 | w=10
  1634. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:citrullus vulgaris extract
    n1=Okihiro (syndrome de) | n2=en:citrullus vulgaris extract | rel=r_associated | relid=0 | w=10
  1635. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cixutumumab
    n1=Okihiro (syndrome de) | n2=en:cixutumumab | rel=r_associated | relid=0 | w=10
  1636. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ck2-targeting synthetic peptide cigb-300
    n1=Okihiro (syndrome de) | n2=en:ck2-targeting synthetic peptide cigb-300 | rel=r_associated | relid=0 | w=10
  1637. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cl 246738
    n1=Okihiro (syndrome de) | n2=en:cl 246738 | rel=r_associated | relid=0 | w=10
  1638. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cladribine
    n1=Okihiro (syndrome de) | n2=en:cladribine | rel=r_associated | relid=0 | w=10
  1639. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clarithromycin
    n1=Okihiro (syndrome de) | n2=en:clarithromycin | rel=r_associated | relid=0 | w=10
  1640. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:claudiximab
    n1=Okihiro (syndrome de) | n2=en:claudiximab | rel=r_associated | relid=0 | w=10
  1641. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clevidipine
    n1=Okihiro (syndrome de) | n2=en:clevidipine | rel=r_associated | relid=0 | w=10
  1642. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clevudine
    n1=Okihiro (syndrome de) | n2=en:clevudine | rel=r_associated | relid=0 | w=10
  1643. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:climazolam
    n1=Okihiro (syndrome de) | n2=en:climazolam | rel=r_associated | relid=0 | w=10
  1644. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clindamycin
    n1=Okihiro (syndrome de) | n2=en:clindamycin | rel=r_associated | relid=0 | w=10
  1645. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clindamycin phosphate
    n1=Okihiro (syndrome de) | n2=en:clindamycin phosphate | rel=r_associated | relid=0 | w=10
  1646. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clindamycin/hydrocortisone lotion
    n1=Okihiro (syndrome de) | n2=en:clindamycin/hydrocortisone lotion | rel=r_associated | relid=0 | w=10
  1647. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clinical data interchange standards consortium terminology
    n1=Okihiro (syndrome de) | n2=en:clinical data interchange standards consortium terminology | rel=r_associated | relid=0 | w=10
  1648. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clino-san vaginal lubricant
    n1=Okihiro (syndrome de) | n2=en:clino-san vaginal lubricant | rel=r_associated | relid=0 | w=10
  1649. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clioquinol
    n1=Okihiro (syndrome de) | n2=en:clioquinol | rel=r_associated | relid=0 | w=10
  1650. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clivus
    n1=Okihiro (syndrome de) | n2=en:clivus | rel=r_associated | relid=0 | w=10
  1651. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clobazam
    n1=Okihiro (syndrome de) | n2=en:clobazam | rel=r_associated | relid=0 | w=10
  1652. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clobetasol propionate
    n1=Okihiro (syndrome de) | n2=en:clobetasol propionate | rel=r_associated | relid=0 | w=10
  1653. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clodronate disodium
    n1=Okihiro (syndrome de) | n2=en:clodronate disodium | rel=r_associated | relid=0 | w=10
  1654. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clofarabine
    n1=Okihiro (syndrome de) | n2=en:clofarabine | rel=r_associated | relid=0 | w=10
  1655. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clofibrate
    n1=Okihiro (syndrome de) | n2=en:clofibrate | rel=r_associated | relid=0 | w=10
  1656. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clomiphene
    n1=Okihiro (syndrome de) | n2=en:clomiphene | rel=r_associated | relid=0 | w=10
  1657. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clomiphene citrate
    n1=Okihiro (syndrome de) | n2=en:clomiphene citrate | rel=r_associated | relid=0 | w=10
  1658. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clonazepam
    n1=Okihiro (syndrome de) | n2=en:clonazepam | rel=r_associated | relid=0 | w=10
  1659. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clonidine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:clonidine hydrochloride | rel=r_associated | relid=0 | w=10
  1660. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clonidine-containing mucoadhesive buccal tablet
    n1=Okihiro (syndrome de) | n2=en:clonidine-containing mucoadhesive buccal tablet | rel=r_associated | relid=0 | w=10
  1661. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clopidogrel
    n1=Okihiro (syndrome de) | n2=en:clopidogrel | rel=r_associated | relid=0 | w=10
  1662. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clopidogrel bisulfate
    n1=Okihiro (syndrome de) | n2=en:clopidogrel bisulfate | rel=r_associated | relid=0 | w=10
  1663. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clopipazan
    n1=Okihiro (syndrome de) | n2=en:clopipazan | rel=r_associated | relid=0 | w=10
  1664. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clopipazan mesylate
    n1=Okihiro (syndrome de) | n2=en:clopipazan mesylate | rel=r_associated | relid=0 | w=10
  1665. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clorazepate
    n1=Okihiro (syndrome de) | n2=en:clorazepate | rel=r_associated | relid=0 | w=10
  1666. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clorazepate dipotassium
    n1=Okihiro (syndrome de) | n2=en:clorazepate dipotassium | rel=r_associated | relid=0 | w=10
  1667. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clorazepate monopotassium
    n1=Okihiro (syndrome de) | n2=en:clorazepate monopotassium | rel=r_associated | relid=0 | w=10
  1668. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clorazepic acid
    n1=Okihiro (syndrome de) | n2=en:clorazepic acid | rel=r_associated | relid=0 | w=10
  1669. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clostridium butyricum-containing probiotic
    n1=Okihiro (syndrome de) | n2=en:clostridium butyricum-containing probiotic | rel=r_associated | relid=0 | w=10
  1670. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clostridium novyi-nt spores
    n1=Okihiro (syndrome de) | n2=en:clostridium novyi-nt spores | rel=r_associated | relid=0 | w=10
  1671. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clothiapine
    n1=Okihiro (syndrome de) | n2=en:clothiapine | rel=r_associated | relid=0 | w=10
  1672. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clothixamide
    n1=Okihiro (syndrome de) | n2=en:clothixamide | rel=r_associated | relid=0 | w=10
  1673. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clothixamide maleate
    n1=Okihiro (syndrome de) | n2=en:clothixamide maleate | rel=r_associated | relid=0 | w=10
  1674. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clotiazepam
    n1=Okihiro (syndrome de) | n2=en:clotiazepam | rel=r_associated | relid=0 | w=10
  1675. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clotrimazole
    n1=Okihiro (syndrome de) | n2=en:clotrimazole | rel=r_associated | relid=0 | w=10
  1676. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cloxypendyl
    n1=Okihiro (syndrome de) | n2=en:cloxypendyl | rel=r_associated | relid=0 | w=10
  1677. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:clozapine
    n1=Okihiro (syndrome de) | n2=en:clozapine | rel=r_associated | relid=0 | w=10
  1678. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cmet car-mrna electroporated autologous t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:cmet car-mrna electroporated autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  1679. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cmf regimen
    n1=Okihiro (syndrome de) | n2=en:cmf regimen | rel=r_associated | relid=0 | w=10
  1680. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cmv n495 peptide
    n1=Okihiro (syndrome de) | n2=en:cmv n495 peptide | rel=r_associated | relid=0 | w=10
  1681. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cmv pp65 peptide-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:cmv pp65 peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  1682. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cmvpp65-a*0201 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:cmvpp65-a*0201 peptide vaccine | rel=r_associated | relid=0 | w=10
  1683. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cmvpp65/gb plasmid vaccine asp0113
    n1=Okihiro (syndrome de) | n2=en:cmvpp65/gb plasmid vaccine asp0113 | rel=r_associated | relid=0 | w=10
  1684. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cndo-109-activated allogeneic natural killer cells
    n1=Okihiro (syndrome de) | n2=en:cndo-109-activated allogeneic natural killer cells | rel=r_associated | relid=0 | w=10
  1685. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cngrc peptide-tnf alpha conjugate
    n1=Okihiro (syndrome de) | n2=en:cngrc peptide-tnf alpha conjugate | rel=r_associated | relid=0 | w=10
  1686. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:coagulation factor ix
    n1=Okihiro (syndrome de) | n2=en:coagulation factor ix | rel=r_associated | relid=0 | w=10
  1687. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:coagulation factor vii
    n1=Okihiro (syndrome de) | n2=en:coagulation factor vii | rel=r_associated | relid=0 | w=10
  1688. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:coal tar
    n1=Okihiro (syndrome de) | n2=en:coal tar | rel=r_associated | relid=0 | w=10
  1689. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cobalamin
    n1=Okihiro (syndrome de) | n2=en:cobalamin | rel=r_associated | relid=0 | w=10
  1690. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cobimetinib
    n1=Okihiro (syndrome de) | n2=en:cobimetinib | rel=r_associated | relid=0 | w=10
  1691. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cobiprostone
    n1=Okihiro (syndrome de) | n2=en:cobiprostone | rel=r_associated | relid=0 | w=10
  1692. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:coccidioidin
    n1=Okihiro (syndrome de) | n2=en:coccidioidin | rel=r_associated | relid=0 | w=10
  1693. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cocculus/nux vomica/tabacum/petroleum extract
    n1=Okihiro (syndrome de) | n2=en:cocculus/nux vomica/tabacum/petroleum extract | rel=r_associated | relid=0 | w=10
  1694. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cocillana extract
    n1=Okihiro (syndrome de) | n2=en:cocillana extract | rel=r_associated | relid=0 | w=10
  1695. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cocoa extract
    n1=Okihiro (syndrome de) | n2=en:cocoa extract | rel=r_associated | relid=0 | w=10
  1696. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:coconut oil
    n1=Okihiro (syndrome de) | n2=en:coconut oil | rel=r_associated | relid=0 | w=10
  1697. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cod liver oil
    n1=Okihiro (syndrome de) | n2=en:cod liver oil | rel=r_associated | relid=0 | w=10
  1698. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:codeine phosphate
    n1=Okihiro (syndrome de) | n2=en:codeine phosphate | rel=r_associated | relid=0 | w=10
  1699. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:coenzyme q10
    n1=Okihiro (syndrome de) | n2=en:coenzyme q10 | rel=r_associated | relid=0 | w=10
  1700. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:coffee dietary supplement
    n1=Okihiro (syndrome de) | n2=en:coffee dietary supplement | rel=r_associated | relid=0 | w=10
  1701. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:colchicine
    n1=Okihiro (syndrome de) | n2=en:colchicine | rel=r_associated | relid=0 | w=10
  1702. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cold contaminant-free iobenguane i-131
    n1=Okihiro (syndrome de) | n2=en:cold contaminant-free iobenguane i-131 | rel=r_associated | relid=0 | w=10
  1703. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:colesevelam hydrochloride
    n1=Okihiro (syndrome de) | n2=en:colesevelam hydrochloride | rel=r_associated | relid=0 | w=10
  1704. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:colistimethate sodium
    n1=Okihiro (syndrome de) | n2=en:colistimethate sodium | rel=r_associated | relid=0 | w=10
  1705. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:colistin
    n1=Okihiro (syndrome de) | n2=en:colistin | rel=r_associated | relid=0 | w=10
  1706. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:colistin sulfate
    n1=Okihiro (syndrome de) | n2=en:colistin sulfate | rel=r_associated | relid=0 | w=10
  1707. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:collagen
    n1=Okihiro (syndrome de) | n2=en:collagen | rel=r_associated | relid=0 | w=10
  1708. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:collagen/aloe vera/vitamin e/lidocaine topical hydrogel
    n1=Okihiro (syndrome de) | n2=en:collagen/aloe vera/vitamin e/lidocaine topical hydrogel | rel=r_associated | relid=0 | w=10
  1709. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:collagenase
    n1=Okihiro (syndrome de) | n2=en:collagenase | rel=r_associated | relid=0 | w=10
  1710. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:collodion
    n1=Okihiro (syndrome de) | n2=en:collodion | rel=r_associated | relid=0 | w=10
  1711. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:colloidal gold-bound tumor necrosis factor
    n1=Okihiro (syndrome de) | n2=en:colloidal gold-bound tumor necrosis factor | rel=r_associated | relid=0 | w=10
  1712. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:colloidal oatmeal cream
    n1=Okihiro (syndrome de) | n2=en:colloidal oatmeal cream | rel=r_associated | relid=0 | w=10
  1713. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:colony stimulating factor
    n1=Okihiro (syndrome de) | n2=en:colony stimulating factor | rel=r_associated | relid=0 | w=10
  1714. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:colorectal tumor-associated peptides vaccine ima910
    n1=Okihiro (syndrome de) | n2=en:colorectal tumor-associated peptides vaccine ima910 | rel=r_associated | relid=0 | w=10
  1715. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:combretastatin a1 diphosphate
    n1=Okihiro (syndrome de) | n2=en:combretastatin a1 diphosphate | rel=r_associated | relid=0 | w=10
  1716. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:complement c5 inhibitor alxn1210
    n1=Okihiro (syndrome de) | n2=en:complement c5 inhibitor alxn1210 | rel=r_associated | relid=0 | w=10
  1717. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:compound kushen injection
    n1=Okihiro (syndrome de) | n2=en:compound kushen injection | rel=r_associated | relid=0 | w=10
  1718. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:compound sodium lactate solution
    n1=Okihiro (syndrome de) | n2=en:compound sodium lactate solution | rel=r_associated | relid=0 | w=10
  1719. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:conatumumab
    n1=Okihiro (syndrome de) | n2=en:conatumumab | rel=r_associated | relid=0 | w=10
  1720. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:concentrated beet crystals
    n1=Okihiro (syndrome de) | n2=en:concentrated beet crystals | rel=r_associated | relid=0 | w=10
  1721. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:concentrated fortified collagen protein hydrolysate liquid supplement
    n1=Okihiro (syndrome de) | n2=en:concentrated fortified collagen protein hydrolysate liquid supplement | rel=r_associated | relid=0 | w=10
  1722. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:conditionally replicative adenovirus 5/3-delta24
    n1=Okihiro (syndrome de) | n2=en:conditionally replicative adenovirus 5/3-delta24 | rel=r_associated | relid=0 | w=10
  1723. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:condyle
    n1=Okihiro (syndrome de) | n2=en:condyle | rel=r_associated | relid=0 | w=10
  1724. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:conjugated estrogens/bazedoxifene
    n1=Okihiro (syndrome de) | n2=en:conjugated estrogens/bazedoxifene | rel=r_associated | relid=0 | w=10
  1725. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:conjugated linoleic acid
    n1=Okihiro (syndrome de) | n2=en:conjugated linoleic acid | rel=r_associated | relid=0 | w=10
  1726. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:contrast agent cs-1000
    n1=Okihiro (syndrome de) | n2=en:contrast agent cs-1000 | rel=r_associated | relid=0 | w=10
  1727. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:controlled substance
    n1=Okihiro (syndrome de) | n2=en:controlled substance | rel=r_associated | relid=0 | w=10
  1728. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copanlisib
    n1=Okihiro (syndrome de) | n2=en:copanlisib | rel=r_associated | relid=0 | w=10
  1729. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copdac regimen
    n1=Okihiro (syndrome de) | n2=en:copdac regimen | rel=r_associated | relid=0 | w=10
  1730. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copovithane
    n1=Okihiro (syndrome de) | n2=en:copovithane | rel=r_associated | relid=0 | w=10
  1731. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copp regimen
    n1=Okihiro (syndrome de) | n2=en:copp regimen | rel=r_associated | relid=0 | w=10
  1732. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copp-abv regimen
    n1=Okihiro (syndrome de) | n2=en:copp-abv regimen | rel=r_associated | relid=0 | w=10
  1733. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper chloride
    n1=Okihiro (syndrome de) | n2=en:copper chloride | rel=r_associated | relid=0 | w=10
  1734. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper cu 62 ethylglyoxal bis(thiosemicarbazone)
    n1=Okihiro (syndrome de) | n2=en:copper cu 62 ethylglyoxal bis(thiosemicarbazone) | rel=r_associated | relid=0 | w=10
  1735. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper cu 62-atsm
    n1=Okihiro (syndrome de) | n2=en:copper cu 62-atsm | rel=r_associated | relid=0 | w=10
  1736. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper cu 62-ptsm
    n1=Okihiro (syndrome de) | n2=en:copper cu 62-ptsm | rel=r_associated | relid=0 | w=10
  1737. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper cu 64 anti-cea monoclonal antibody m5a
    n1=Okihiro (syndrome de) | n2=en:copper cu 64 anti-cea monoclonal antibody m5a | rel=r_associated | relid=0 | w=10
  1738. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper cu 64 plerixafor
    n1=Okihiro (syndrome de) | n2=en:copper cu 64 plerixafor | rel=r_associated | relid=0 | w=10
  1739. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper cu 64 tp3805
    n1=Okihiro (syndrome de) | n2=en:copper cu 64 tp3805 | rel=r_associated | relid=0 | w=10
  1740. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper cu 64 trastuzumab
    n1=Okihiro (syndrome de) | n2=en:copper cu 64 trastuzumab | rel=r_associated | relid=0 | w=10
  1741. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper cu 64-atsm
    n1=Okihiro (syndrome de) | n2=en:copper cu 64-atsm | rel=r_associated | relid=0 | w=10
  1742. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper cu 64-dota b-fab
    n1=Okihiro (syndrome de) | n2=en:copper cu 64-dota b-fab | rel=r_associated | relid=0 | w=10
  1743. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper cu 64-dota-ae105
    n1=Okihiro (syndrome de) | n2=en:copper cu 64-dota-ae105 | rel=r_associated | relid=0 | w=10
  1744. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper cu 64-dota-anti-her3 monoclonal antibody u3-1287
    n1=Okihiro (syndrome de) | n2=en:copper cu 64-dota-anti-her3 monoclonal antibody u3-1287 | rel=r_associated | relid=0 | w=10
  1745. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper cu 64-dota-rituximab
    n1=Okihiro (syndrome de) | n2=en:copper cu 64-dota-rituximab | rel=r_associated | relid=0 | w=10
  1746. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper cu 64-dota-trastuzumab
    n1=Okihiro (syndrome de) | n2=en:copper cu 64-dota-trastuzumab | rel=r_associated | relid=0 | w=10
  1747. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper gluconate
    n1=Okihiro (syndrome de) | n2=en:copper gluconate | rel=r_associated | relid=0 | w=10
  1748. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:copper supplement
    n1=Okihiro (syndrome de) | n2=en:copper supplement | rel=r_associated | relid=0 | w=10
  1749. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cord blood-derived expanded natural killer cell infusion pnk-007
    n1=Okihiro (syndrome de) | n2=en:cord blood-derived expanded natural killer cell infusion pnk-007 | rel=r_associated | relid=0 | w=10
  1750. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cordycepin
    n1=Okihiro (syndrome de) | n2=en:cordycepin | rel=r_associated | relid=0 | w=10
  1751. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:corifollitropin alfa
    n1=Okihiro (syndrome de) | n2=en:corifollitropin alfa | rel=r_associated | relid=0 | w=10
  1752. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:coriolus versicolor extract
    n1=Okihiro (syndrome de) | n2=en:coriolus versicolor extract | rel=r_associated | relid=0 | w=10
  1753. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:corn
    n1=Okihiro (syndrome de) | n2=en:corn | rel=r_associated | relid=0 | w=10
  1754. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:corticorelin acetate
    n1=Okihiro (syndrome de) | n2=en:corticorelin acetate | rel=r_associated | relid=0 | w=10
  1755. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:corticosteroids and derivatives
    n1=Okihiro (syndrome de) | n2=en:corticosteroids and derivatives | rel=r_associated | relid=0 | w=10
  1756. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:corticotropin
    n1=Okihiro (syndrome de) | n2=en:corticotropin | rel=r_associated | relid=0 | w=10
  1757. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:corticotropin releasing hormone
    n1=Okihiro (syndrome de) | n2=en:corticotropin releasing hormone | rel=r_associated | relid=0 | w=10
  1758. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
    n1=Okihiro (syndrome de) | n2=en:corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) | rel=r_associated | relid=0 | w=10
  1759. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:corynebacterium granulosum p40
    n1=Okihiro (syndrome de) | n2=en:corynebacterium granulosum p40 | rel=r_associated | relid=0 | w=10
  1760. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cositecan
    n1=Okihiro (syndrome de) | n2=en:cositecan | rel=r_associated | relid=0 | w=10
  1761. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cosmeceuticals
    n1=Okihiro (syndrome de) | n2=en:cosmeceuticals | rel=r_associated | relid=0 | w=10
  1762. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:costal arch
    n1=Okihiro (syndrome de) | n2=en:costal arch | rel=r_associated | relid=0 | w=10
  1763. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:coumarin
    n1=Okihiro (syndrome de) | n2=en:coumarin | rel=r_associated | relid=0 | w=10
  1764. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:counterfeit drugs
    n1=Okihiro (syndrome de) | n2=en:counterfeit drugs | rel=r_associated | relid=0 | w=10
  1765. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:coxsackievirus a21
    n1=Okihiro (syndrome de) | n2=en:coxsackievirus a21 | rel=r_associated | relid=0 | w=10
  1766. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cp 461
    n1=Okihiro (syndrome de) | n2=en:cp 461 | rel=r_associated | relid=0 | w=10
  1767. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cp-547632
    n1=Okihiro (syndrome de) | n2=en:cp-547632 | rel=r_associated | relid=0 | w=10
  1768. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cp-609,754
    n1=Okihiro (syndrome de) | n2=en:cp-609,754 | rel=r_associated | relid=0 | w=10
  1769. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cp-724,714
    n1=Okihiro (syndrome de) | n2=en:cp-724,714 | rel=r_associated | relid=0 | w=10
  1770. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cpg oligodeoxynucleotide gnkg168
    n1=Okihiro (syndrome de) | n2=en:cpg oligodeoxynucleotide gnkg168 | rel=r_associated | relid=0 | w=10
  1771. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cpg-28 oligodeoxynucleotide
    n1=Okihiro (syndrome de) | n2=en:cpg-28 oligodeoxynucleotide | rel=r_associated | relid=0 | w=10
  1772. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cr2-fh fusion protein tt30
    n1=Okihiro (syndrome de) | n2=en:cr2-fh fusion protein tt30 | rel=r_associated | relid=0 | w=10
  1773. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:creatine monohydrate
    n1=Okihiro (syndrome de) | n2=en:creatine monohydrate | rel=r_associated | relid=0 | w=10
  1774. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:crenolanib
    n1=Okihiro (syndrome de) | n2=en:crenolanib | rel=r_associated | relid=0 | w=10
  1775. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:crenolanib besylate
    n1=Okihiro (syndrome de) | n2=en:crenolanib besylate | rel=r_associated | relid=0 | w=10
  1776. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cridanimod sodium
    n1=Okihiro (syndrome de) | n2=en:cridanimod sodium | rel=r_associated | relid=0 | w=10
  1777. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:crisnatol mesylate
    n1=Okihiro (syndrome de) | n2=en:crisnatol mesylate | rel=r_associated | relid=0 | w=10
  1778. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:crizotinib
    n1=Okihiro (syndrome de) | n2=en:crizotinib | rel=r_associated | relid=0 | w=10
  1779. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:crl 1005
    n1=Okihiro (syndrome de) | n2=en:crl 1005 | rel=r_associated | relid=0 | w=10
  1780. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:crolibulin
    n1=Okihiro (syndrome de) | n2=en:crolibulin | rel=r_associated | relid=0 | w=10
  1781. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cromolyn sodium inhalant pa101
    n1=Okihiro (syndrome de) | n2=en:cromolyn sodium inhalant pa101 | rel=r_associated | relid=0 | w=10
  1782. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:crotamiton
    n1=Okihiro (syndrome de) | n2=en:crotamiton | rel=r_associated | relid=0 | w=10
  1783. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:crotoxin
    n1=Okihiro (syndrome de) | n2=en:crotoxin | rel=r_associated | relid=0 | w=10
  1784. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cryoprotective agent
    n1=Okihiro (syndrome de) | n2=en:cryoprotective agent | rel=r_associated | relid=0 | w=10
  1785. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:crystalline genistein formulation axp107-11
    n1=Okihiro (syndrome de) | n2=en:crystalline genistein formulation axp107-11 | rel=r_associated | relid=0 | w=10
  1786. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ct2584 hms
    n1=Okihiro (syndrome de) | n2=en:ct2584 hms | rel=r_associated | relid=0 | w=10
  1787. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ctp-37-dt vaccine
    n1=Okihiro (syndrome de) | n2=en:ctp-37-dt vaccine | rel=r_associated | relid=0 | w=10
  1788. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ctrp agent terminology
    n1=Okihiro (syndrome de) | n2=en:ctrp agent terminology | rel=r_associated | relid=0 | w=10
  1789. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ctrp terminology
    n1=Okihiro (syndrome de) | n2=en:ctrp terminology | rel=r_associated | relid=0 | w=10
  1790. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cupric sulfate
    n1=Okihiro (syndrome de) | n2=en:cupric sulfate | rel=r_associated | relid=0 | w=10
  1791. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:curcumin
    n1=Okihiro (syndrome de) | n2=en:curcumin | rel=r_associated | relid=0 | w=10
  1792. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:curcumin-based gel
    n1=Okihiro (syndrome de) | n2=en:curcumin-based gel | rel=r_associated | relid=0 | w=10
  1793. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:curcumin/green tea extract/polygonum cuspidatum extract/soybean extract capsule
    n1=Okihiro (syndrome de) | n2=en:curcumin/green tea extract/polygonum cuspidatum extract/soybean extract capsule | rel=r_associated | relid=0 | w=10
  1794. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:custirsen sodium
    n1=Okihiro (syndrome de) | n2=en:custirsen sodium | rel=r_associated | relid=0 | w=10
  1795. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cvp regimen
    n1=Okihiro (syndrome de) | n2=en:cvp regimen | rel=r_associated | relid=0 | w=10
  1796. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cxc chemokine receptor 2 antagonist azd5069
    n1=Okihiro (syndrome de) | n2=en:cxc chemokine receptor 2 antagonist azd5069 | rel=r_associated | relid=0 | w=10
  1797. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cxcr4 antagonist bl-8040
    n1=Okihiro (syndrome de) | n2=en:cxcr4 antagonist bl-8040 | rel=r_associated | relid=0 | w=10
  1798. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cxcr4 inhibitor msx-122
    n1=Okihiro (syndrome de) | n2=en:cxcr4 inhibitor msx-122 | rel=r_associated | relid=0 | w=10
  1799. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cxcr4 inhibitor pol6326
    n1=Okihiro (syndrome de) | n2=en:cxcr4 inhibitor pol6326 | rel=r_associated | relid=0 | w=10
  1800. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cxcr4 inhibitor x4p-001
    n1=Okihiro (syndrome de) | n2=en:cxcr4 inhibitor x4p-001 | rel=r_associated | relid=0 | w=10
  1801. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cxcr4 peptide antagonist ly2510924
    n1=Okihiro (syndrome de) | n2=en:cxcr4 peptide antagonist ly2510924 | rel=r_associated | relid=0 | w=10
  1802. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyanocobalamin
    n1=Okihiro (syndrome de) | n2=en:cyanocobalamin | rel=r_associated | relid=0 | w=10
  1803. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyanocobalamin/dexamethasone/gentamicin/procaine formulation
    n1=Okihiro (syndrome de) | n2=en:cyanocobalamin/dexamethasone/gentamicin/procaine formulation | rel=r_associated | relid=0 | w=10
  1804. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyclandelate
    n1=Okihiro (syndrome de) | n2=en:cyclandelate | rel=r_associated | relid=0 | w=10
  1805. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyclin b1 peptide-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:cyclin b1 peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  1806. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyclobenzaprine
    n1=Okihiro (syndrome de) | n2=en:cyclobenzaprine | rel=r_associated | relid=0 | w=10
  1807. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyclobenzaprine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:cyclobenzaprine hydrochloride | rel=r_associated | relid=0 | w=10
  1808. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyclodextrin-based polymer-camptothecin crlx101
    n1=Okihiro (syndrome de) | n2=en:cyclodextrin-based polymer-camptothecin crlx101 | rel=r_associated | relid=0 | w=10
  1809. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cycloleucine
    n1=Okihiro (syndrome de) | n2=en:cycloleucine | rel=r_associated | relid=0 | w=10
  1810. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyclopentenyl cytosine
    n1=Okihiro (syndrome de) | n2=en:cyclopentenyl cytosine | rel=r_associated | relid=0 | w=10
  1811. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyclophenazine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:cyclophenazine hydrochloride | rel=r_associated | relid=0 | w=10
  1812. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyclophosphamide
    n1=Okihiro (syndrome de) | n2=en:cyclophosphamide | rel=r_associated | relid=0 | w=10
  1813. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyclophosphamide/dactinomycin/vincristine
    n1=Okihiro (syndrome de) | n2=en:cyclophosphamide/dactinomycin/vincristine | rel=r_associated | relid=0 | w=10
  1814. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyclophosphamide/epirubicin/vincristine/prednisone
    n1=Okihiro (syndrome de) | n2=en:cyclophosphamide/epirubicin/vincristine/prednisone | rel=r_associated | relid=0 | w=10
  1815. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cycloserine
    n1=Okihiro (syndrome de) | n2=en:cycloserine | rel=r_associated | relid=0 | w=10
  1816. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyclosporine
    n1=Okihiro (syndrome de) | n2=en:cyclosporine | rel=r_associated | relid=0 | w=10
  1817. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyclosporine and derivatives
    n1=Okihiro (syndrome de) | n2=en:cyclosporine and derivatives | rel=r_associated | relid=0 | w=10
  1818. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyclosporine ophthalmic emulsion
    n1=Okihiro (syndrome de) | n2=en:cyclosporine ophthalmic emulsion | rel=r_associated | relid=0 | w=10
  1819. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyl-02 plasmid dna
    n1=Okihiro (syndrome de) | n2=en:cyl-02 plasmid dna | rel=r_associated | relid=0 | w=10
  1820. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyp17 inhibitor cfg920
    n1=Okihiro (syndrome de) | n2=en:cyp17 inhibitor cfg920 | rel=r_associated | relid=0 | w=10
  1821. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyp17 inhibitor vt-464
    n1=Okihiro (syndrome de) | n2=en:cyp17 inhibitor vt-464 | rel=r_associated | relid=0 | w=10
  1822. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyp17 lyase inhibitor asn001
    n1=Okihiro (syndrome de) | n2=en:cyp17 lyase inhibitor asn001 | rel=r_associated | relid=0 | w=10
  1823. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyp17/androgen receptor inhibitor odm 204
    n1=Okihiro (syndrome de) | n2=en:cyp17/androgen receptor inhibitor odm 204 | rel=r_associated | relid=0 | w=10
  1824. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyprazepam
    n1=Okihiro (syndrome de) | n2=en:cyprazepam | rel=r_associated | relid=0 | w=10
  1825. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyproheptadine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:cyproheptadine hydrochloride | rel=r_associated | relid=0 | w=10
  1826. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cyproterone acetate
    n1=Okihiro (syndrome de) | n2=en:cyproterone acetate | rel=r_associated | relid=0 | w=10
  1827. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cysteamine
    n1=Okihiro (syndrome de) | n2=en:cysteamine | rel=r_associated | relid=0 | w=10
  1828. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cysteine-rich non-denatured whey protein isolate imn1207
    n1=Okihiro (syndrome de) | n2=en:cysteine-rich non-denatured whey protein isolate imn1207 | rel=r_associated | relid=0 | w=10
  1829. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cystemustine
    n1=Okihiro (syndrome de) | n2=en:cystemustine | rel=r_associated | relid=0 | w=10
  1830. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cytarabine
    n1=Okihiro (syndrome de) | n2=en:cytarabine | rel=r_associated | relid=0 | w=10
  1831. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cytarabine monophosphate prodrug mb07133
    n1=Okihiro (syndrome de) | n2=en:cytarabine monophosphate prodrug mb07133 | rel=r_associated | relid=0 | w=10
  1832. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cytembena
    n1=Okihiro (syndrome de) | n2=en:cytembena | rel=r_associated | relid=0 | w=10
  1833. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cytidine analog rx-3117
    n1=Okihiro (syndrome de) | n2=en:cytidine analog rx-3117 | rel=r_associated | relid=0 | w=10
  1834. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cytochlor
    n1=Okihiro (syndrome de) | n2=en:cytochlor | rel=r_associated | relid=0 | w=10
  1835. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cytokine-induced killer cells
    n1=Okihiro (syndrome de) | n2=en:cytokine-induced killer cells | rel=r_associated | relid=0 | w=10
  1836. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cytomegalovirus ie-1-specific cytotoxic t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:cytomegalovirus ie-1-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  1837. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:cytomegalovirus pp65-specific cytotoxic t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:cytomegalovirus pp65-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  1838. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:d vitamin
    n1=Okihiro (syndrome de) | n2=en:d vitamin | rel=r_associated | relid=0 | w=10
  1839. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:d-methionine formulation mrx-1024
    n1=Okihiro (syndrome de) | n2=en:d-methionine formulation mrx-1024 | rel=r_associated | relid=0 | w=10
  1840. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:d1/3-mage-3-his fusion protein
    n1=Okihiro (syndrome de) | n2=en:d1/3-mage-3-his fusion protein | rel=r_associated | relid=0 | w=10
  1841. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:d4064a
    n1=Okihiro (syndrome de) | n2=en:d4064a | rel=r_associated | relid=0 | w=10
  1842. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dab389 epidermal growth factor
    n1=Okihiro (syndrome de) | n2=en:dab389 epidermal growth factor | rel=r_associated | relid=0 | w=10
  1843. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dabigatran etexilate mesylate
    n1=Okihiro (syndrome de) | n2=en:dabigatran etexilate mesylate | rel=r_associated | relid=0 | w=10
  1844. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dabrafenib
    n1=Okihiro (syndrome de) | n2=en:dabrafenib | rel=r_associated | relid=0 | w=10
  1845. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dacarbazine
    n1=Okihiro (syndrome de) | n2=en:dacarbazine | rel=r_associated | relid=0 | w=10
  1846. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dacetuzumab
    n1=Okihiro (syndrome de) | n2=en:dacetuzumab | rel=r_associated | relid=0 | w=10
  1847. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dach polymer platinate ap5346
    n1=Okihiro (syndrome de) | n2=en:dach polymer platinate ap5346 | rel=r_associated | relid=0 | w=10
  1848. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dach-platin micelle nc-4016
    n1=Okihiro (syndrome de) | n2=en:dach-platin micelle nc-4016 | rel=r_associated | relid=0 | w=10
  1849. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:daclatasvir
    n1=Okihiro (syndrome de) | n2=en:daclatasvir | rel=r_associated | relid=0 | w=10
  1850. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:daclizumab
    n1=Okihiro (syndrome de) | n2=en:daclizumab | rel=r_associated | relid=0 | w=10
  1851. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dacomitinib
    n1=Okihiro (syndrome de) | n2=en:dacomitinib | rel=r_associated | relid=0 | w=10
  1852. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dactinomycin
    n1=Okihiro (syndrome de) | n2=en:dactinomycin | rel=r_associated | relid=0 | w=10
  1853. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:daflon 500
    n1=Okihiro (syndrome de) | n2=en:daflon 500 | rel=r_associated | relid=0 | w=10
  1854. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dakins solution
    n1=Okihiro (syndrome de) | n2=en:dakins solution | rel=r_associated | relid=0 | w=10
  1855. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dalantercept
    n1=Okihiro (syndrome de) | n2=en:dalantercept | rel=r_associated | relid=0 | w=10
  1856. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dalbavancin
    n1=Okihiro (syndrome de) | n2=en:dalbavancin | rel=r_associated | relid=0 | w=10
  1857. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dalfopristin
    n1=Okihiro (syndrome de) | n2=en:dalfopristin | rel=r_associated | relid=0 | w=10
  1858. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dalotuzumab
    n1=Okihiro (syndrome de) | n2=en:dalotuzumab | rel=r_associated | relid=0 | w=10
  1859. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dalteparin
    n1=Okihiro (syndrome de) | n2=en:dalteparin | rel=r_associated | relid=0 | w=10
  1860. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:danazol
    n1=Okihiro (syndrome de) | n2=en:danazol | rel=r_associated | relid=0 | w=10
  1861. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dandelion extract
    n1=Okihiro (syndrome de) | n2=en:dandelion extract | rel=r_associated | relid=0 | w=10
  1862. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:daniquidone
    n1=Okihiro (syndrome de) | n2=en:daniquidone | rel=r_associated | relid=0 | w=10
  1863. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dantrolene
    n1=Okihiro (syndrome de) | n2=en:dantrolene | rel=r_associated | relid=0 | w=10
  1864. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:danusertib
    n1=Okihiro (syndrome de) | n2=en:danusertib | rel=r_associated | relid=0 | w=10
  1865. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:daporinad
    n1=Okihiro (syndrome de) | n2=en:daporinad | rel=r_associated | relid=0 | w=10
  1866. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dapsone
    n1=Okihiro (syndrome de) | n2=en:dapsone | rel=r_associated | relid=0 | w=10
  1867. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dapsone gel
    n1=Okihiro (syndrome de) | n2=en:dapsone gel | rel=r_associated | relid=0 | w=10
  1868. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:daptomycin
    n1=Okihiro (syndrome de) | n2=en:daptomycin | rel=r_associated | relid=0 | w=10
  1869. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:daratumumab
    n1=Okihiro (syndrome de) | n2=en:daratumumab | rel=r_associated | relid=0 | w=10
  1870. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:darbepoetin alfa
    n1=Okihiro (syndrome de) | n2=en:darbepoetin alfa | rel=r_associated | relid=0 | w=10
  1871. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:darinaparsin
    n1=Okihiro (syndrome de) | n2=en:darinaparsin | rel=r_associated | relid=0 | w=10
  1872. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dasabuvir
    n1=Okihiro (syndrome de) | n2=en:dasabuvir | rel=r_associated | relid=0 | w=10
  1873. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dasatinib
    n1=Okihiro (syndrome de) | n2=en:dasatinib | rel=r_associated | relid=0 | w=10
  1874. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:daunorubicin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:daunorubicin hydrochloride | rel=r_associated | relid=0 | w=10
  1875. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:daunorubicin-dna complex
    n1=Okihiro (syndrome de) | n2=en:daunorubicin-dna complex | rel=r_associated | relid=0 | w=10
  1876. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dbve-pc regimen
    n1=Okihiro (syndrome de) | n2=en:dbve-pc regimen | rel=r_associated | relid=0 | w=10
  1877. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dc-cholesterol liposome
    n1=Okihiro (syndrome de) | n2=en:dc-cholesterol liposome | rel=r_associated | relid=0 | w=10
  1878. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dc-ova vaccine
    n1=Okihiro (syndrome de) | n2=en:dc-ova vaccine | rel=r_associated | relid=0 | w=10
  1879. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dcb-bo1202
    n1=Okihiro (syndrome de) | n2=en:dcb-bo1202 | rel=r_associated | relid=0 | w=10
  1880. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dcds0780a
    n1=Okihiro (syndrome de) | n2=en:dcds0780a | rel=r_associated | relid=0 | w=10
  1881. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dcr ligand-bearing liposome-encapsulated melanoma antigens vaccine
    n1=Okihiro (syndrome de) | n2=en:dcr ligand-bearing liposome-encapsulated melanoma antigens vaccine | rel=r_associated | relid=0 | w=10
  1882. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:deanol
    n1=Okihiro (syndrome de) | n2=en:deanol | rel=r_associated | relid=0 | w=10
  1883. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dec-205/ny-eso-1 fusion protein cdx-1401
    n1=Okihiro (syndrome de) | n2=en:dec-205/ny-eso-1 fusion protein cdx-1401 | rel=r_associated | relid=0 | w=10
  1884. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:decitabine
    n1=Okihiro (syndrome de) | n2=en:decitabine | rel=r_associated | relid=0 | w=10
  1885. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:declopramide
    n1=Okihiro (syndrome de) | n2=en:declopramide | rel=r_associated | relid=0 | w=10
  1886. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:defactinib
    n1=Okihiro (syndrome de) | n2=en:defactinib | rel=r_associated | relid=0 | w=10
  1887. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:deferasirox
    n1=Okihiro (syndrome de) | n2=en:deferasirox | rel=r_associated | relid=0 | w=10
  1888. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:deferiprone
    n1=Okihiro (syndrome de) | n2=en:deferiprone | rel=r_associated | relid=0 | w=10
  1889. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:deferoxamine mesylate
    n1=Okihiro (syndrome de) | n2=en:deferoxamine mesylate | rel=r_associated | relid=0 | w=10
  1890. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:defibrotide sodium
    n1=Okihiro (syndrome de) | n2=en:defibrotide sodium | rel=r_associated | relid=0 | w=10
  1891. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:defined green tea catechin extract
    n1=Okihiro (syndrome de) | n2=en:defined green tea catechin extract | rel=r_associated | relid=0 | w=10
  1892. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:degarelix
    n1=Okihiro (syndrome de) | n2=en:degarelix | rel=r_associated | relid=0 | w=10
  1893. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins
    n1=Okihiro (syndrome de) | n2=en:deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins | rel=r_associated | relid=0 | w=10
  1894. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dehydrated human amnion/chorion membrane
    n1=Okihiro (syndrome de) | n2=en:dehydrated human amnion/chorion membrane | rel=r_associated | relid=0 | w=10
  1895. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dehydroemetine
    n1=Okihiro (syndrome de) | n2=en:dehydroemetine | rel=r_associated | relid=0 | w=10
  1896. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:delanzomib
    n1=Okihiro (syndrome de) | n2=en:delanzomib | rel=r_associated | relid=0 | w=10
  1897. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:delavirdine
    n1=Okihiro (syndrome de) | n2=en:delavirdine | rel=r_associated | relid=0 | w=10
  1898. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:delorazepam
    n1=Okihiro (syndrome de) | n2=en:delorazepam | rel=r_associated | relid=0 | w=10
  1899. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:delta-8-tetrahydrocannabinol
    n1=Okihiro (syndrome de) | n2=en:delta-8-tetrahydrocannabinol | rel=r_associated | relid=0 | w=10
  1900. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:delta-tocopherol
    n1=Okihiro (syndrome de) | n2=en:delta-tocopherol | rel=r_associated | relid=0 | w=10
  1901. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:delta-tocotrienol
    n1=Okihiro (syndrome de) | n2=en:delta-tocotrienol | rel=r_associated | relid=0 | w=10
  1902. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:demcizumab
    n1=Okihiro (syndrome de) | n2=en:demcizumab | rel=r_associated | relid=0 | w=10
  1903. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:demeclocycline hydrochloride
    n1=Okihiro (syndrome de) | n2=en:demeclocycline hydrochloride | rel=r_associated | relid=0 | w=10
  1904. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:demineralized bone matrix
    n1=Okihiro (syndrome de) | n2=en:demineralized bone matrix | rel=r_associated | relid=0 | w=10
  1905. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:demoxepam
    n1=Okihiro (syndrome de) | n2=en:demoxepam | rel=r_associated | relid=0 | w=10
  1906. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dendritic cell-autologous lung tumor vaccine
    n1=Okihiro (syndrome de) | n2=en:dendritic cell-autologous lung tumor vaccine | rel=r_associated | relid=0 | w=10
  1907. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dendritic cell-cea peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:dendritic cell-cea peptide vaccine | rel=r_associated | relid=0 | w=10
  1908. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dendritic cell-gp100-mart-1 antigen vaccine
    n1=Okihiro (syndrome de) | n2=en:dendritic cell-gp100-mart-1 antigen vaccine | rel=r_associated | relid=0 | w=10
  1909. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dendritic cell-idiotype-keyhole limpet hemocyanin vaccine
    n1=Okihiro (syndrome de) | n2=en:dendritic cell-idiotype-keyhole limpet hemocyanin vaccine | rel=r_associated | relid=0 | w=10
  1910. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dendritic cell-mart-1 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:dendritic cell-mart-1 peptide vaccine | rel=r_associated | relid=0 | w=10
  1911. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dendritic cell-precision multiple antigen t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:dendritic cell-precision multiple antigen t-lymphocytes | rel=r_associated | relid=0 | w=10
  1912. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dendritic cell-recombinant prostate-specific membrane antigen vaccine
    n1=Okihiro (syndrome de) | n2=en:dendritic cell-recombinant prostate-specific membrane antigen vaccine | rel=r_associated | relid=0 | w=10
  1913. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dendritic cell-targeting lentiviral vector id-lv305
    n1=Okihiro (syndrome de) | n2=en:dendritic cell-targeting lentiviral vector id-lv305 | rel=r_associated | relid=0 | w=10
  1914. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:denenicokin
    n1=Okihiro (syndrome de) | n2=en:denenicokin | rel=r_associated | relid=0 | w=10
  1915. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:denibulin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:denibulin hydrochloride | rel=r_associated | relid=0 | w=10
  1916. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:denileukin diftitox
    n1=Okihiro (syndrome de) | n2=en:denileukin diftitox | rel=r_associated | relid=0 | w=10
  1917. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:denintuzumab mafodotin
    n1=Okihiro (syndrome de) | n2=en:denintuzumab mafodotin | rel=r_associated | relid=0 | w=10
  1918. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:denosumab
    n1=Okihiro (syndrome de) | n2=en:denosumab | rel=r_associated | relid=0 | w=10
  1919. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dental agent
    n1=Okihiro (syndrome de) | n2=en:dental agent | rel=r_associated | relid=0 | w=10
  1920. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dental disclosing preparation
    n1=Okihiro (syndrome de) | n2=en:dental disclosing preparation | rel=r_associated | relid=0 | w=10
  1921. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:deoxycytidine
    n1=Okihiro (syndrome de) | n2=en:deoxycytidine | rel=r_associated | relid=0 | w=10
  1922. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:deoxycytidine analogue tas-109
    n1=Okihiro (syndrome de) | n2=en:deoxycytidine analogue tas-109 | rel=r_associated | relid=0 | w=10
  1923. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:depatuxizumab
    n1=Okihiro (syndrome de) | n2=en:depatuxizumab | rel=r_associated | relid=0 | w=10
  1924. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:depdc1/mphosh1 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:depdc1/mphosh1 peptide vaccine | rel=r_associated | relid=0 | w=10
  1925. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:derma-membrane-structure topical cream
    n1=Okihiro (syndrome de) | n2=en:derma-membrane-structure topical cream | rel=r_associated | relid=0 | w=10
  1926. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dermatologic agents
    n1=Okihiro (syndrome de) | n2=en:dermatologic agents | rel=r_associated | relid=0 | w=10
  1927. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:desflurane
    n1=Okihiro (syndrome de) | n2=en:desflurane | rel=r_associated | relid=0 | w=10
  1928. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:designer drugs
    n1=Okihiro (syndrome de) | n2=en:designer drugs | rel=r_associated | relid=0 | w=10
  1929. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:desipramine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:desipramine hydrochloride | rel=r_associated | relid=0 | w=10
  1930. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:deslorelin
    n1=Okihiro (syndrome de) | n2=en:deslorelin | rel=r_associated | relid=0 | w=10
  1931. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:desmethylclobazam
    n1=Okihiro (syndrome de) | n2=en:desmethylclobazam | rel=r_associated | relid=0 | w=10
  1932. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:desmethylmisonidazole
    n1=Okihiro (syndrome de) | n2=en:desmethylmisonidazole | rel=r_associated | relid=0 | w=10
  1933. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:desmopressin acetate
    n1=Okihiro (syndrome de) | n2=en:desmopressin acetate | rel=r_associated | relid=0 | w=10
  1934. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:desogestrel
    n1=Okihiro (syndrome de) | n2=en:desogestrel | rel=r_associated | relid=0 | w=10
  1935. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:desvenlafaxine succinate
    n1=Okihiro (syndrome de) | n2=en:desvenlafaxine succinate | rel=r_associated | relid=0 | w=10
  1936. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:detorubicin
    n1=Okihiro (syndrome de) | n2=en:detorubicin | rel=r_associated | relid=0 | w=10
  1937. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:detox-b adjuvant
    n1=Okihiro (syndrome de) | n2=en:detox-b adjuvant | rel=r_associated | relid=0 | w=10
  1938. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:detoxpc
    n1=Okihiro (syndrome de) | n2=en:detoxpc | rel=r_associated | relid=0 | w=10
  1939. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:deuterated 3-methylhistidine
    n1=Okihiro (syndrome de) | n2=en:deuterated 3-methylhistidine | rel=r_associated | relid=0 | w=10
  1940. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:deuterated phenanthrene
    n1=Okihiro (syndrome de) | n2=en:deuterated phenanthrene | rel=r_associated | relid=0 | w=10
  1941. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:deuterium oxide
    n1=Okihiro (syndrome de) | n2=en:deuterium oxide | rel=r_associated | relid=0 | w=10
  1942. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dexamethasone
    n1=Okihiro (syndrome de) | n2=en:dexamethasone | rel=r_associated | relid=0 | w=10
  1943. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dexamethasone intravitreal implant
    n1=Okihiro (syndrome de) | n2=en:dexamethasone intravitreal implant | rel=r_associated | relid=0 | w=10
  1944. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dexanabinol
    n1=Okihiro (syndrome de) | n2=en:dexanabinol | rel=r_associated | relid=0 | w=10
  1945. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dexmedetomidine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:dexmedetomidine hydrochloride | rel=r_associated | relid=0 | w=10
  1946. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dexmethylphenidate
    n1=Okihiro (syndrome de) | n2=en:dexmethylphenidate | rel=r_associated | relid=0 | w=10
  1947. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dexniguldipine
    n1=Okihiro (syndrome de) | n2=en:dexniguldipine | rel=r_associated | relid=0 | w=10
  1948. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dexpanthenol
    n1=Okihiro (syndrome de) | n2=en:dexpanthenol | rel=r_associated | relid=0 | w=10
  1949. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dexpanthenol mouthwash
    n1=Okihiro (syndrome de) | n2=en:dexpanthenol mouthwash | rel=r_associated | relid=0 | w=10
  1950. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dexrazoxane hydrochloride
    n1=Okihiro (syndrome de) | n2=en:dexrazoxane hydrochloride | rel=r_associated | relid=0 | w=10
  1951. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dextran
    n1=Okihiro (syndrome de) | n2=en:dextran | rel=r_associated | relid=0 | w=10
  1952. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dextran sulfate sodium
    n1=Okihiro (syndrome de) | n2=en:dextran sulfate sodium | rel=r_associated | relid=0 | w=10
  1953. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dextroamphetamine sulfate
    n1=Okihiro (syndrome de) | n2=en:dextroamphetamine sulfate | rel=r_associated | relid=0 | w=10
  1954. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dextroamphetamine-amphetamine
    n1=Okihiro (syndrome de) | n2=en:dextroamphetamine-amphetamine | rel=r_associated | relid=0 | w=10
  1955. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dextromethorphan
    n1=Okihiro (syndrome de) | n2=en:dextromethorphan | rel=r_associated | relid=0 | w=10
  1956. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dextromethorphan hydrobromide
    n1=Okihiro (syndrome de) | n2=en:dextromethorphan hydrobromide | rel=r_associated | relid=0 | w=10
  1957. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dextropropoxyphene hydrochloride
    n1=Okihiro (syndrome de) | n2=en:dextropropoxyphene hydrochloride | rel=r_associated | relid=0 | w=10
  1958. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dexverapamil
    n1=Okihiro (syndrome de) | n2=en:dexverapamil | rel=r_associated | relid=0 | w=10
  1959. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dezaguanine
    n1=Okihiro (syndrome de) | n2=en:dezaguanine | rel=r_associated | relid=0 | w=10
  1960. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dha-paclitaxel
    n1=Okihiro (syndrome de) | n2=en:dha-paclitaxel | rel=r_associated | relid=0 | w=10
  1961. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dhap regimen
    n1=Okihiro (syndrome de) | n2=en:dhap regimen | rel=r_associated | relid=0 | w=10
  1962. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dhea mustard
    n1=Okihiro (syndrome de) | n2=en:dhea mustard | rel=r_associated | relid=0 | w=10
  1963. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dher2 vaccine+as15 adjuvant
    n1=Okihiro (syndrome de) | n2=en:dher2 vaccine+as15 adjuvant | rel=r_associated | relid=0 | w=10
  1964. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:di-dga-rfb4 immunotoxin
    n1=Okihiro (syndrome de) | n2=en:di-dga-rfb4 immunotoxin | rel=r_associated | relid=0 | w=10
  1965. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:di-leu16-il2 immunocytokine
    n1=Okihiro (syndrome de) | n2=en:di-leu16-il2 immunocytokine | rel=r_associated | relid=0 | w=10
  1966. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diacetylmorphine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:diacetylmorphine hydrochloride | rel=r_associated | relid=0 | w=10
  1967. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diagnostic agents
    n1=Okihiro (syndrome de) | n2=en:diagnostic agents | rel=r_associated | relid=0 | w=10
  1968. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diammonium glycyrrhizinate
    n1=Okihiro (syndrome de) | n2=en:diammonium glycyrrhizinate | rel=r_associated | relid=0 | w=10
  1969. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dianhydrogalactitol
    n1=Okihiro (syndrome de) | n2=en:dianhydrogalactitol | rel=r_associated | relid=0 | w=10
  1970. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dianicline
    n1=Okihiro (syndrome de) | n2=en:dianicline | rel=r_associated | relid=0 | w=10
  1971. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diaphysis of the bone
    n1=Okihiro (syndrome de) | n2=en:diaphysis of the bone | rel=r_associated | relid=0 | w=10
  1972. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diarylaminopropylamine
    n1=Okihiro (syndrome de) | n2=en:diarylaminopropylamine | rel=r_associated | relid=0 | w=10
  1973. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diazepam
    n1=Okihiro (syndrome de) | n2=en:diazepam | rel=r_associated | relid=0 | w=10
  1974. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diazepam hydrochloride
    n1=Okihiro (syndrome de) | n2=en:diazepam hydrochloride | rel=r_associated | relid=0 | w=10
  1975. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diazepinomicin
    n1=Okihiro (syndrome de) | n2=en:diazepinomicin | rel=r_associated | relid=0 | w=10
  1976. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diaziquone
    n1=Okihiro (syndrome de) | n2=en:diaziquone | rel=r_associated | relid=0 | w=10
  1977. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diazooxonorleucine
    n1=Okihiro (syndrome de) | n2=en:diazooxonorleucine | rel=r_associated | relid=0 | w=10
  1978. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diazoxide
    n1=Okihiro (syndrome de) | n2=en:diazoxide | rel=r_associated | relid=0 | w=10
  1979. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dibenzoxazepine derivative antipsychotic agent
    n1=Okihiro (syndrome de) | n2=en:dibenzoxazepine derivative antipsychotic agent | rel=r_associated | relid=0 | w=10
  1980. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dichloromethotrexate
    n1=Okihiro (syndrome de) | n2=en:dichloromethotrexate | rel=r_associated | relid=0 | w=10
  1981. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diclofenac epolamine patch
    n1=Okihiro (syndrome de) | n2=en:diclofenac epolamine patch | rel=r_associated | relid=0 | w=10
  1982. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diclofenac sodium gel
    n1=Okihiro (syndrome de) | n2=en:diclofenac sodium gel | rel=r_associated | relid=0 | w=10
  1983. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diclometide
    n1=Okihiro (syndrome de) | n2=en:diclometide | rel=r_associated | relid=0 | w=10
  1984. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dicumarol
    n1=Okihiro (syndrome de) | n2=en:dicumarol | rel=r_associated | relid=0 | w=10
  1985. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:didanosine
    n1=Okihiro (syndrome de) | n2=en:didanosine | rel=r_associated | relid=0 | w=10
  1986. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:didemnin b
    n1=Okihiro (syndrome de) | n2=en:didemnin b | rel=r_associated | relid=0 | w=10
  1987. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dideoxyadenosine
    n1=Okihiro (syndrome de) | n2=en:dideoxyadenosine | rel=r_associated | relid=0 | w=10
  1988. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:didesethylflurazepam
    n1=Okihiro (syndrome de) | n2=en:didesethylflurazepam | rel=r_associated | relid=0 | w=10
  1989. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:didox
    n1=Okihiro (syndrome de) | n2=en:didox | rel=r_associated | relid=0 | w=10
  1990. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dienogest
    n1=Okihiro (syndrome de) | n2=en:dienogest | rel=r_associated | relid=0 | w=10
  1991. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dietary gum
    n1=Okihiro (syndrome de) | n2=en:dietary gum | rel=r_associated | relid=0 | w=10
  1992. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dietary product
    n1=Okihiro (syndrome de) | n2=en:dietary product | rel=r_associated | relid=0 | w=10
  1993. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diethylene glycol monoethyl ether
    n1=Okihiro (syndrome de) | n2=en:diethylene glycol monoethyl ether | rel=r_associated | relid=0 | w=10
  1994. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diethylhomospermine
    n1=Okihiro (syndrome de) | n2=en:diethylhomospermine | rel=r_associated | relid=0 | w=10
  1995. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diethylnorspermine
    n1=Okihiro (syndrome de) | n2=en:diethylnorspermine | rel=r_associated | relid=0 | w=10
  1996. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diethylstilbestrol
    n1=Okihiro (syndrome de) | n2=en:diethylstilbestrol | rel=r_associated | relid=0 | w=10
  1997. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diflomotecan
    n1=Okihiro (syndrome de) | n2=en:diflomotecan | rel=r_associated | relid=0 | w=10
  1998. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diflunisal
    n1=Okihiro (syndrome de) | n2=en:diflunisal | rel=r_associated | relid=0 | w=10
  1999. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:digitoxin
    n1=Okihiro (syndrome de) | n2=en:digitoxin | rel=r_associated | relid=0 | w=10
  2000. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:digoxin
    n1=Okihiro (syndrome de) | n2=en:digoxin | rel=r_associated | relid=0 | w=10
  2001. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dihydro-5-azacytidine
    n1=Okihiro (syndrome de) | n2=en:dihydro-5-azacytidine | rel=r_associated | relid=0 | w=10
  2002. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dihydrocarbostyril derivative antipsychotic agent
    n1=Okihiro (syndrome de) | n2=en:dihydrocarbostyril derivative antipsychotic agent | rel=r_associated | relid=0 | w=10
  2003. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dihydrocodeine
    n1=Okihiro (syndrome de) | n2=en:dihydrocodeine | rel=r_associated | relid=0 | w=10
  2004. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dihydroindolone derivative antipsychotic agent
    n1=Okihiro (syndrome de) | n2=en:dihydroindolone derivative antipsychotic agent | rel=r_associated | relid=0 | w=10
  2005. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dihydrolenperone
    n1=Okihiro (syndrome de) | n2=en:dihydrolenperone | rel=r_associated | relid=0 | w=10
  2006. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dihydropyridine calcium channel blocker [epc]
    n1=Okihiro (syndrome de) | n2=en:dihydropyridine calcium channel blocker [epc] | rel=r_associated | relid=0 | w=10
  2007. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diindolylmethane
    n1=Okihiro (syndrome de) | n2=en:diindolylmethane | rel=r_associated | relid=0 | w=10
  2008. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diltiazem hydrochloride
    n1=Okihiro (syndrome de) | n2=en:diltiazem hydrochloride | rel=r_associated | relid=0 | w=10
  2009. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dimeprozan
    n1=Okihiro (syndrome de) | n2=en:dimeprozan | rel=r_associated | relid=0 | w=10
  2010. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dimesna
    n1=Okihiro (syndrome de) | n2=en:dimesna | rel=r_associated | relid=0 | w=10
  2011. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dimethicone-containing botanicals-based lotion
    n1=Okihiro (syndrome de) | n2=en:dimethicone-containing botanicals-based lotion | rel=r_associated | relid=0 | w=10
  2012. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dimethicone/polymer barrier cream
    n1=Okihiro (syndrome de) | n2=en:dimethicone/polymer barrier cream | rel=r_associated | relid=0 | w=10
  2013. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dimethyl fumarate
    n1=Okihiro (syndrome de) | n2=en:dimethyl fumarate | rel=r_associated | relid=0 | w=10
  2014. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dimethyl sulfone
    n1=Okihiro (syndrome de) | n2=en:dimethyl sulfone | rel=r_associated | relid=0 | w=10
  2015. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dimethyl sulfoxide
    n1=Okihiro (syndrome de) | n2=en:dimethyl sulfoxide | rel=r_associated | relid=0 | w=10
  2016. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dimethylmyleran
    n1=Okihiro (syndrome de) | n2=en:dimethylmyleran | rel=r_associated | relid=0 | w=10
  2017. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dimoxyline
    n1=Okihiro (syndrome de) | n2=en:dimoxyline | rel=r_associated | relid=0 | w=10
  2018. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dimozide
    n1=Okihiro (syndrome de) | n2=en:dimozide | rel=r_associated | relid=0 | w=10
  2019. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dinaciclib
    n1=Okihiro (syndrome de) | n2=en:dinaciclib | rel=r_associated | relid=0 | w=10
  2020. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dinitrochlorobenzene
    n1=Okihiro (syndrome de) | n2=en:dinitrochlorobenzene | rel=r_associated | relid=0 | w=10
  2021. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dinitrofluorobenzene
    n1=Okihiro (syndrome de) | n2=en:dinitrofluorobenzene | rel=r_associated | relid=0 | w=10
  2022. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dinitrophenyl
    n1=Okihiro (syndrome de) | n2=en:dinitrophenyl | rel=r_associated | relid=0 | w=10
  2023. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine
    n1=Okihiro (syndrome de) | n2=en:dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine | rel=r_associated | relid=0 | w=10
  2024. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dinoprost tromethamine
    n1=Okihiro (syndrome de) | n2=en:dinoprost tromethamine | rel=r_associated | relid=0 | w=10
  2025. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dinutuximab
    n1=Okihiro (syndrome de) | n2=en:dinutuximab | rel=r_associated | relid=0 | w=10
  2026. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dioscorea nipponica makino extract dne3
    n1=Okihiro (syndrome de) | n2=en:dioscorea nipponica makino extract dne3 | rel=r_associated | relid=0 | w=10
  2027. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diphencyprone
    n1=Okihiro (syndrome de) | n2=en:diphencyprone | rel=r_associated | relid=0 | w=10
  2028. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diphenhydramine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:diphenhydramine hydrochloride | rel=r_associated | relid=0 | w=10
  2029. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diphenhydramine hydrochloride/dexamethasone/nystatin magic mouthwash
    n1=Okihiro (syndrome de) | n2=en:diphenhydramine hydrochloride/dexamethasone/nystatin magic mouthwash | rel=r_associated | relid=0 | w=10
  2030. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diphenhydramine/lidocaine/antacid mouthwash
    n1=Okihiro (syndrome de) | n2=en:diphenhydramine/lidocaine/antacid mouthwash | rel=r_associated | relid=0 | w=10
  2031. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diphenylbutylpiperidine derivative antipsychotic agent
    n1=Okihiro (syndrome de) | n2=en:diphenylbutylpiperidine derivative antipsychotic agent | rel=r_associated | relid=0 | w=10
  2032. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diphtheria toxin fragment-interleukin-2 fusion protein e7777
    n1=Okihiro (syndrome de) | n2=en:diphtheria toxin fragment-interleukin-2 fusion protein e7777 | rel=r_associated | relid=0 | w=10
  2033. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diphtheria toxoid/tetanus toxoid vaccine adsorbed
    n1=Okihiro (syndrome de) | n2=en:diphtheria toxoid/tetanus toxoid vaccine adsorbed | rel=r_associated | relid=0 | w=10
  2034. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diphtheria toxoid/tetanus toxoid/acellular pertussis adsorbed, recombinant hepatitis b/inactivated poliovirus vaccine combined
    n1=Okihiro (syndrome de) | n2=en:diphtheria toxoid/tetanus toxoid/acellular pertussis adsorbed, recombinant hepatitis b/inactivated poliovirus vaccine combined | rel=r_associated | relid=0 | w=10
  2035. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed
    n1=Okihiro (syndrome de) | n2=en:diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed | rel=r_associated | relid=0 | w=10
  2036. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis-haemophilus influenzae type b vaccine
    n1=Okihiro (syndrome de) | n2=en:diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis-haemophilus influenzae type b vaccine | rel=r_associated | relid=0 | w=10
  2037. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dipyridamole
    n1=Okihiro (syndrome de) | n2=en:dipyridamole | rel=r_associated | relid=0 | w=10
  2038. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:directly observed therapy
    n1=Okihiro (syndrome de) | n2=en:directly observed therapy | rel=r_associated | relid=0 | w=10
  2039. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:disaccharide tripeptide glycerol dipalmitoyl
    n1=Okihiro (syndrome de) | n2=en:disaccharide tripeptide glycerol dipalmitoyl | rel=r_associated | relid=0 | w=10
  2040. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:disopyramide
    n1=Okihiro (syndrome de) | n2=en:disopyramide | rel=r_associated | relid=0 | w=10
  2041. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:distilled water
    n1=Okihiro (syndrome de) | n2=en:distilled water | rel=r_associated | relid=0 | w=10
  2042. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:disulfiram
    n1=Okihiro (syndrome de) | n2=en:disulfiram | rel=r_associated | relid=0 | w=10
  2043. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ditiocarb
    n1=Okihiro (syndrome de) | n2=en:ditiocarb | rel=r_associated | relid=0 | w=10
  2044. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:diuretic
    n1=Okihiro (syndrome de) | n2=en:diuretic | rel=r_associated | relid=0 | w=10
  2045. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:divalproex sodium
    n1=Okihiro (syndrome de) | n2=en:divalproex sodium | rel=r_associated | relid=0 | w=10
  2046. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:divaplon
    n1=Okihiro (syndrome de) | n2=en:divaplon | rel=r_associated | relid=0 | w=10
  2047. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dkk1-neutralizing monoclonal antibody dkn-01
    n1=Okihiro (syndrome de) | n2=en:dkk1-neutralizing monoclonal antibody dkn-01 | rel=r_associated | relid=0 | w=10
  2048. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dl-selenomethionine
    n1=Okihiro (syndrome de) | n2=en:dl-selenomethionine | rel=r_associated | relid=0 | w=10
  2049. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dlk1/epha2/hbb/nrp1/rgs5/tem1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:dlk1/epha2/hbb/nrp1/rgs5/tem1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  2050. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dm-choc-pen
    n1=Okihiro (syndrome de) | n2=en:dm-choc-pen | rel=r_associated | relid=0 | w=10
  2051. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dm4-conjugated anti-cripto monoclonal antibody biib015
    n1=Okihiro (syndrome de) | n2=en:dm4-conjugated anti-cripto monoclonal antibody biib015 | rel=r_associated | relid=0 | w=10
  2052. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dmuc4064a
    n1=Okihiro (syndrome de) | n2=en:dmuc4064a | rel=r_associated | relid=0 | w=10
  2053. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dn-101
    n1=Okihiro (syndrome de) | n2=en:dn-101 | rel=r_associated | relid=0 | w=10
  2054. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dna interference oligonucleotide pnt2258
    n1=Okihiro (syndrome de) | n2=en:dna interference oligonucleotide pnt2258 | rel=r_associated | relid=0 | w=10
  2055. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dna minor groove binding agent pm060184
    n1=Okihiro (syndrome de) | n2=en:dna minor groove binding agent pm060184 | rel=r_associated | relid=0 | w=10
  2056. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dna minor groove binding agent sg2000
    n1=Okihiro (syndrome de) | n2=en:dna minor groove binding agent sg2000 | rel=r_associated | relid=0 | w=10
  2057. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dna plasmid encoding interleukin-12 ino-9012
    n1=Okihiro (syndrome de) | n2=en:dna plasmid encoding interleukin-12 ino-9012 | rel=r_associated | relid=0 | w=10
  2058. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dna plasmid-encoding interleukin-12/hpv dna plasmids therapeutic vaccine ino-3112
    n1=Okihiro (syndrome de) | n2=en:dna plasmid-encoding interleukin-12/hpv dna plasmids therapeutic vaccine ino-3112 | rel=r_associated | relid=0 | w=10
  2059. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dna vaccine vb10.16
    n1=Okihiro (syndrome de) | n2=en:dna vaccine vb10.16 | rel=r_associated | relid=0 | w=10
  2060. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dna vector ppra-psm vaccine
    n1=Okihiro (syndrome de) | n2=en:dna vector ppra-psm vaccine | rel=r_associated | relid=0 | w=10
  2061. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dna-dependent protein kinase-targeting sidna dt01
    n1=Okihiro (syndrome de) | n2=en:dna-dependent protein kinase-targeting sidna dt01 | rel=r_associated | relid=0 | w=10
  2062. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dna-pk inhibitor msc2490484a
    n1=Okihiro (syndrome de) | n2=en:dna-pk inhibitor msc2490484a | rel=r_associated | relid=0 | w=10
  2063. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dna-pk/tor kinase inhibitor cc-115
    n1=Okihiro (syndrome de) | n2=en:dna-pk/tor kinase inhibitor cc-115 | rel=r_associated | relid=0 | w=10
  2064. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dnr-expressing nasopharyngeal carcinoma-specific cytotoxic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:dnr-expressing nasopharyngeal carcinoma-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  2065. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dobupride
    n1=Okihiro (syndrome de) | n2=en:dobupride | rel=r_associated | relid=0 | w=10
  2066. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dobutamine
    n1=Okihiro (syndrome de) | n2=en:dobutamine | rel=r_associated | relid=0 | w=10
  2067. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:docetaxel
    n1=Okihiro (syndrome de) | n2=en:docetaxel | rel=r_associated | relid=0 | w=10
  2068. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:docetaxel emulsion anx-514
    n1=Okihiro (syndrome de) | n2=en:docetaxel emulsion anx-514 | rel=r_associated | relid=0 | w=10
  2069. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:docetaxel formulation ckd-810
    n1=Okihiro (syndrome de) | n2=en:docetaxel formulation ckd-810 | rel=r_associated | relid=0 | w=10
  2070. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:docetaxel lipid microspheres
    n1=Okihiro (syndrome de) | n2=en:docetaxel lipid microspheres | rel=r_associated | relid=0 | w=10
  2071. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:docetaxel-loaded nanopharmaceutical crlx301
    n1=Okihiro (syndrome de) | n2=en:docetaxel-loaded nanopharmaceutical crlx301 | rel=r_associated | relid=0 | w=10
  2072. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:docetaxel-pnp
    n1=Okihiro (syndrome de) | n2=en:docetaxel-pnp | rel=r_associated | relid=0 | w=10
  2073. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doconexent
    n1=Okihiro (syndrome de) | n2=en:doconexent | rel=r_associated | relid=0 | w=10
  2074. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:docosahexaenoic acid
    n1=Okihiro (syndrome de) | n2=en:docosahexaenoic acid | rel=r_associated | relid=0 | w=10
  2075. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:docusate
    n1=Okihiro (syndrome de) | n2=en:docusate | rel=r_associated | relid=0 | w=10
  2076. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dofequidar fumarate
    n1=Okihiro (syndrome de) | n2=en:dofequidar fumarate | rel=r_associated | relid=0 | w=10
  2077. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dofetilide
    n1=Okihiro (syndrome de) | n2=en:dofetilide | rel=r_associated | relid=0 | w=10
  2078. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dolasetron mesylate
    n1=Okihiro (syndrome de) | n2=en:dolasetron mesylate | rel=r_associated | relid=0 | w=10
  2079. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dolastatin 10
    n1=Okihiro (syndrome de) | n2=en:dolastatin 10 | rel=r_associated | relid=0 | w=10
  2080. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dolutegravir
    n1=Okihiro (syndrome de) | n2=en:dolutegravir | rel=r_associated | relid=0 | w=10
  2081. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:domperidone
    n1=Okihiro (syndrome de) | n2=en:domperidone | rel=r_associated | relid=0 | w=10
  2082. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:donafenib
    n1=Okihiro (syndrome de) | n2=en:donafenib | rel=r_associated | relid=0 | w=10
  2083. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:donepezil
    n1=Okihiro (syndrome de) | n2=en:donepezil | rel=r_associated | relid=0 | w=10
  2084. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:donepezil + memantine
    n1=Okihiro (syndrome de) | n2=en:donepezil + memantine | rel=r_associated | relid=0 | w=10
  2085. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:donepezil hydrochloride
    n1=Okihiro (syndrome de) | n2=en:donepezil hydrochloride | rel=r_associated | relid=0 | w=10
  2086. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:donor lymphocytes
    n1=Okihiro (syndrome de) | n2=en:donor lymphocytes | rel=r_associated | relid=0 | w=10
  2087. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:donor regulatory t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:donor regulatory t-lymphocytes | rel=r_associated | relid=0 | w=10
  2088. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:donor-derived wt1/prame/ny-eso-1/survivin-specific t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:donor-derived wt1/prame/ny-eso-1/survivin-specific t-lymphocytes | rel=r_associated | relid=0 | w=10
  2089. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dopamine agonist
    n1=Okihiro (syndrome de) | n2=en:dopamine agonist | rel=r_associated | relid=0 | w=10
  2090. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dopamine antagonists [moa]
    n1=Okihiro (syndrome de) | n2=en:dopamine antagonists [moa] | rel=r_associated | relid=0 | w=10
  2091. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dopamine-somatostatin chimeric molecule bim-23a760
    n1=Okihiro (syndrome de) | n2=en:dopamine-somatostatin chimeric molecule bim-23a760 | rel=r_associated | relid=0 | w=10
  2092. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dornase alfa
    n1=Okihiro (syndrome de) | n2=en:dornase alfa | rel=r_associated | relid=0 | w=10
  2093. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dornase alfa inhalation solution
    n1=Okihiro (syndrome de) | n2=en:dornase alfa inhalation solution | rel=r_associated | relid=0 | w=10
  2094. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dorsal curve
    n1=Okihiro (syndrome de) | n2=en:dorsal curve | rel=r_associated | relid=0 | w=10
  2095. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dorsum
    n1=Okihiro (syndrome de) | n2=en:dorsum | rel=r_associated | relid=0 | w=10
  2096. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dot1l inhibitor epz-5676
    n1=Okihiro (syndrome de) | n2=en:dot1l inhibitor epz-5676 | rel=r_associated | relid=0 | w=10
  2097. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dotap:cholesterol-fus1 liposome complex
    n1=Okihiro (syndrome de) | n2=en:dotap:cholesterol-fus1 liposome complex | rel=r_associated | relid=0 | w=10
  2098. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dovitinib lactate
    n1=Okihiro (syndrome de) | n2=en:dovitinib lactate | rel=r_associated | relid=0 | w=10
  2099. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxazosin mesylate
    n1=Okihiro (syndrome de) | n2=en:doxazosin mesylate | rel=r_associated | relid=0 | w=10
  2100. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxefazepam
    n1=Okihiro (syndrome de) | n2=en:doxefazepam | rel=r_associated | relid=0 | w=10
  2101. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxepin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:doxepin hydrochloride | rel=r_associated | relid=0 | w=10
  2102. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxercalciferol
    n1=Okihiro (syndrome de) | n2=en:doxercalciferol | rel=r_associated | relid=0 | w=10
  2103. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxifluridine
    n1=Okihiro (syndrome de) | n2=en:doxifluridine | rel=r_associated | relid=0 | w=10
  2104. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxorubicin hcl inhalation solution
    n1=Okihiro (syndrome de) | n2=en:doxorubicin hcl inhalation solution | rel=r_associated | relid=0 | w=10
  2105. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxorubicin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:doxorubicin hydrochloride | rel=r_associated | relid=0 | w=10
  2106. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxorubicin-dna complex
    n1=Okihiro (syndrome de) | n2=en:doxorubicin-dna complex | rel=r_associated | relid=0 | w=10
  2107. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxorubicin-eluting beads
    n1=Okihiro (syndrome de) | n2=en:doxorubicin-eluting beads | rel=r_associated | relid=0 | w=10
  2108. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxorubicin-hpma conjugate
    n1=Okihiro (syndrome de) | n2=en:doxorubicin-hpma conjugate | rel=r_associated | relid=0 | w=10
  2109. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxorubicin-magnetic targeted carrier complex
    n1=Okihiro (syndrome de) | n2=en:doxorubicin-magnetic targeted carrier complex | rel=r_associated | relid=0 | w=10
  2110. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxycycline
    n1=Okihiro (syndrome de) | n2=en:doxycycline | rel=r_associated | relid=0 | w=10
  2111. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxycycline hyclate
    n1=Okihiro (syndrome de) | n2=en:doxycycline hyclate | rel=r_associated | relid=0 | w=10
  2112. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxycycline hyclate foam
    n1=Okihiro (syndrome de) | n2=en:doxycycline hyclate foam | rel=r_associated | relid=0 | w=10
  2113. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:doxycycline hyclate injection
    n1=Okihiro (syndrome de) | n2=en:doxycycline hyclate injection | rel=r_associated | relid=0 | w=10
  2114. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dpt/bcg/measles/serratia/pneumococcus vaccine
    n1=Okihiro (syndrome de) | n2=en:dpt/bcg/measles/serratia/pneumococcus vaccine | rel=r_associated | relid=0 | w=10
  2115. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dpt/typhoid/staphylococcus aureus/paratyphoid a/paratyphoid b vaccine
    n1=Okihiro (syndrome de) | n2=en:dpt/typhoid/staphylococcus aureus/paratyphoid a/paratyphoid b vaccine | rel=r_associated | relid=0 | w=10
  2116. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dr5-targeting tetrameric nanobody agonist tas266
    n1=Okihiro (syndrome de) | n2=en:dr5-targeting tetrameric nanobody agonist tas266 | rel=r_associated | relid=0 | w=10
  2117. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dromostanolone propionate
    n1=Okihiro (syndrome de) | n2=en:dromostanolone propionate | rel=r_associated | relid=0 | w=10
  2118. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dronabinol
    n1=Okihiro (syndrome de) | n2=en:dronabinol | rel=r_associated | relid=0 | w=10
  2119. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:droperidol
    n1=Okihiro (syndrome de) | n2=en:droperidol | rel=r_associated | relid=0 | w=10
  2120. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:drotrecogin alfa (activated)
    n1=Okihiro (syndrome de) | n2=en:drotrecogin alfa (activated) | rel=r_associated | relid=0 | w=10
  2121. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:drug allergen by structure
    n1=Okihiro (syndrome de) | n2=en:drug allergen by structure | rel=r_associated | relid=0 | w=10
  2122. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:drug combinations
    n1=Okihiro (syndrome de) | n2=en:drug combinations | rel=r_associated | relid=0 | w=10
  2123. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:drug groups primarily affecting the musculoskeletal system
    n1=Okihiro (syndrome de) | n2=en:drug groups primarily affecting the musculoskeletal system | rel=r_associated | relid=0 | w=10
  2124. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:drug products by fda established pharmacologic class
    n1=Okihiro (syndrome de) | n2=en:drug products by fda established pharmacologic class | rel=r_associated | relid=0 | w=10
  2125. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:drug products by generic ingredient combinations
    n1=Okihiro (syndrome de) | n2=en:drug products by generic ingredient combinations | rel=r_associated | relid=0 | w=10
  2126. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:drug products by va class
    n1=Okihiro (syndrome de) | n2=en:drug products by va class | rel=r_associated | relid=0 | w=10
  2127. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:drug values
    n1=Okihiro (syndrome de) | n2=en:drug values | rel=r_associated | relid=0 | w=10
  2128. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:drug-device combination product
    n1=Okihiro (syndrome de) | n2=en:drug-device combination product | rel=r_associated | relid=0 | w=10
  2129. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:drugs treating radiation contamination
    n1=Okihiro (syndrome de) | n2=en:drugs treating radiation contamination | rel=r_associated | relid=0 | w=10
  2130. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:drugs used in metabolic disorders
    n1=Okihiro (syndrome de) | n2=en:drugs used in metabolic disorders | rel=r_associated | relid=0 | w=10
  2131. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:drugs used to treat addiction
    n1=Okihiro (syndrome de) | n2=en:drugs used to treat addiction | rel=r_associated | relid=0 | w=10
  2132. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:drugs, chinese herbal
    n1=Okihiro (syndrome de) | n2=en:drugs, chinese herbal | rel=r_associated | relid=0 | w=10
  2133. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:drugs, essential
    n1=Okihiro (syndrome de) | n2=en:drugs, essential | rel=r_associated | relid=0 | w=10
  2134. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dt(388)il3 fusion protein sl-401
    n1=Okihiro (syndrome de) | n2=en:dt(388)il3 fusion protein sl-401 | rel=r_associated | relid=0 | w=10
  2135. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dta-h19 plasmid
    n1=Okihiro (syndrome de) | n2=en:dta-h19 plasmid | rel=r_associated | relid=0 | w=10
  2136. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dtgm fusion protein
    n1=Okihiro (syndrome de) | n2=en:dtgm fusion protein | rel=r_associated | relid=0 | w=10
  2137. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dual igf-1r/insr inhibitor bms-754807
    n1=Okihiro (syndrome de) | n2=en:dual igf-1r/insr inhibitor bms-754807 | rel=r_associated | relid=0 | w=10
  2138. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dual pi3 kinase/mtor inhibitor gdc-0980
    n1=Okihiro (syndrome de) | n2=en:dual pi3 kinase/mtor inhibitor gdc-0980 | rel=r_associated | relid=0 | w=10
  2139. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dual variable domain immunoglobulin abt-165
    n1=Okihiro (syndrome de) | n2=en:dual variable domain immunoglobulin abt-165 | rel=r_associated | relid=0 | w=10
  2140. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:duborimycin
    n1=Okihiro (syndrome de) | n2=en:duborimycin | rel=r_associated | relid=0 | w=10
  2141. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dulanermin
    n1=Okihiro (syndrome de) | n2=en:dulanermin | rel=r_associated | relid=0 | w=10
  2142. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:duligotuzumab
    n1=Okihiro (syndrome de) | n2=en:duligotuzumab | rel=r_associated | relid=0 | w=10
  2143. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:duloxetine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:duloxetine hydrochloride | rel=r_associated | relid=0 | w=10
  2144. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:duoperone
    n1=Okihiro (syndrome de) | n2=en:duoperone | rel=r_associated | relid=0 | w=10
  2145. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:duoperone fumarate
    n1=Okihiro (syndrome de) | n2=en:duoperone fumarate | rel=r_associated | relid=0 | w=10
  2146. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:durvalumab
    n1=Okihiro (syndrome de) | n2=en:durvalumab | rel=r_associated | relid=0 | w=10
  2147. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dutasteride
    n1=Okihiro (syndrome de) | n2=en:dutasteride | rel=r_associated | relid=0 | w=10
  2148. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dutpase/dpd inhibitor tas-114
    n1=Okihiro (syndrome de) | n2=en:dutpase/dpd inhibitor tas-114 | rel=r_associated | relid=0 | w=10
  2149. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:dwj1319
    n1=Okihiro (syndrome de) | n2=en:dwj1319 | rel=r_associated | relid=0 | w=10
  2150. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:e-101 solution
    n1=Okihiro (syndrome de) | n2=en:e-101 solution | rel=r_associated | relid=0 | w=10
  2151. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:e-selectin antagonist gmi-1271
    n1=Okihiro (syndrome de) | n2=en:e-selectin antagonist gmi-1271 | rel=r_associated | relid=0 | w=10
  2152. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:e. coli cd-expressing genetically modified neural stem cells
    n1=Okihiro (syndrome de) | n2=en:e. coli cd-expressing genetically modified neural stem cells | rel=r_associated | relid=0 | w=10
  2153. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:e1a lipid complex
    n1=Okihiro (syndrome de) | n2=en:e1a lipid complex | rel=r_associated | relid=0 | w=10
  2154. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:e1m184v peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:e1m184v peptide vaccine | rel=r_associated | relid=0 | w=10
  2155. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:e2f1 pathway activator arq 171
    n1=Okihiro (syndrome de) | n2=en:e2f1 pathway activator arq 171 | rel=r_associated | relid=0 | w=10
  2156. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:e7046
    n1=Okihiro (syndrome de) | n2=en:e7046 | rel=r_associated | relid=0 | w=10
  2157. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:e7820
    n1=Okihiro (syndrome de) | n2=en:e7820 | rel=r_associated | relid=0 | w=10
  2158. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:east indian sandalwood oil mouth rinse
    n1=Okihiro (syndrome de) | n2=en:east indian sandalwood oil mouth rinse | rel=r_associated | relid=0 | w=10
  2159. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ebselen-containing oral capsule spi-1005
    n1=Okihiro (syndrome de) | n2=en:ebselen-containing oral capsule spi-1005 | rel=r_associated | relid=0 | w=10
  2160. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ebv-specific cytotoxic t-lymphocyte
    n1=Okihiro (syndrome de) | n2=en:ebv-specific cytotoxic t-lymphocyte | rel=r_associated | relid=0 | w=10
  2161. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:echinacea extract
    n1=Okihiro (syndrome de) | n2=en:echinacea extract | rel=r_associated | relid=0 | w=10
  2162. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:echinomycin
    n1=Okihiro (syndrome de) | n2=en:echinomycin | rel=r_associated | relid=0 | w=10
  2163. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ecromeximab
    n1=Okihiro (syndrome de) | n2=en:ecromeximab | rel=r_associated | relid=0 | w=10
  2164. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eculizumab
    n1=Okihiro (syndrome de) | n2=en:eculizumab | rel=r_associated | relid=0 | w=10
  2165. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:edatrexate
    n1=Okihiro (syndrome de) | n2=en:edatrexate | rel=r_associated | relid=0 | w=10
  2166. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:edelfosine
    n1=Okihiro (syndrome de) | n2=en:edelfosine | rel=r_associated | relid=0 | w=10
  2167. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:edetate calcium disodium
    n1=Okihiro (syndrome de) | n2=en:edetate calcium disodium | rel=r_associated | relid=0 | w=10
  2168. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:edotecarin
    n1=Okihiro (syndrome de) | n2=en:edotecarin | rel=r_associated | relid=0 | w=10
  2169. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:edoxaban tosylate
    n1=Okihiro (syndrome de) | n2=en:edoxaban tosylate | rel=r_associated | relid=0 | w=10
  2170. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:edrecolomab
    n1=Okihiro (syndrome de) | n2=en:edrecolomab | rel=r_associated | relid=0 | w=10
  2171. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ef5
    n1=Okihiro (syndrome de) | n2=en:ef5 | rel=r_associated | relid=0 | w=10
  2172. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:efalizumab
    n1=Okihiro (syndrome de) | n2=en:efalizumab | rel=r_associated | relid=0 | w=10
  2173. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:efaproxiral
    n1=Okihiro (syndrome de) | n2=en:efaproxiral | rel=r_associated | relid=0 | w=10
  2174. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:efatutazone dihydrochloride
    n1=Okihiro (syndrome de) | n2=en:efatutazone dihydrochloride | rel=r_associated | relid=0 | w=10
  2175. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:efavirenz
    n1=Okihiro (syndrome de) | n2=en:efavirenz | rel=r_associated | relid=0 | w=10
  2176. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:efavirenz and derivatives
    n1=Okihiro (syndrome de) | n2=en:efavirenz and derivatives | rel=r_associated | relid=0 | w=10
  2177. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eflornithine
    n1=Okihiro (syndrome de) | n2=en:eflornithine | rel=r_associated | relid=0 | w=10
  2178. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eflornithine hydrochloride ointment
    n1=Okihiro (syndrome de) | n2=en:eflornithine hydrochloride ointment | rel=r_associated | relid=0 | w=10
  2179. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:efs-ada lentiviral vector-transduced cd34-positive autologous lymphocytes
    n1=Okihiro (syndrome de) | n2=en:efs-ada lentiviral vector-transduced cd34-positive autologous lymphocytes | rel=r_associated | relid=0 | w=10
  2180. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:efungumab
    n1=Okihiro (syndrome de) | n2=en:efungumab | rel=r_associated | relid=0 | w=10
  2181. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eg5 kinesin-related motor protein inhibitor 4sc-205
    n1=Okihiro (syndrome de) | n2=en:eg5 kinesin-related motor protein inhibitor 4sc-205 | rel=r_associated | relid=0 | w=10
  2182. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eg5 kinesin-related motor protein inhibitor arq 621
    n1=Okihiro (syndrome de) | n2=en:eg5 kinesin-related motor protein inhibitor arq 621 | rel=r_associated | relid=0 | w=10
  2183. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egb761
    n1=Okihiro (syndrome de) | n2=en:egb761 | rel=r_associated | relid=0 | w=10
  2184. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfr antagonist hemay022
    n1=Okihiro (syndrome de) | n2=en:egfr antagonist hemay022 | rel=r_associated | relid=0 | w=10
  2185. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfr antisense dna
    n1=Okihiro (syndrome de) | n2=en:egfr antisense dna | rel=r_associated | relid=0 | w=10
  2186. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfr car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:egfr car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  2187. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfr inhibitor abt-414
    n1=Okihiro (syndrome de) | n2=en:egfr inhibitor abt-414 | rel=r_associated | relid=0 | w=10
  2188. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfr inhibitor asp8273
    n1=Okihiro (syndrome de) | n2=en:egfr inhibitor asp8273 | rel=r_associated | relid=0 | w=10
  2189. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfr inhibitor azd3759
    n1=Okihiro (syndrome de) | n2=en:egfr inhibitor azd3759 | rel=r_associated | relid=0 | w=10
  2190. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfr inhibitor co-1686
    n1=Okihiro (syndrome de) | n2=en:egfr inhibitor co-1686 | rel=r_associated | relid=0 | w=10
  2191. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfr inhibitor egf816
    n1=Okihiro (syndrome de) | n2=en:egfr inhibitor egf816 | rel=r_associated | relid=0 | w=10
  2192. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfr inhibitor hm61713
    n1=Okihiro (syndrome de) | n2=en:egfr inhibitor hm61713 | rel=r_associated | relid=0 | w=10
  2193. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfr mutation-selective inhibitor ac0010ma
    n1=Okihiro (syndrome de) | n2=en:egfr mutation-selective inhibitor ac0010ma | rel=r_associated | relid=0 | w=10
  2194. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfr t790m inhibitor pf-06747775
    n1=Okihiro (syndrome de) | n2=en:egfr t790m inhibitor pf-06747775 | rel=r_associated | relid=0 | w=10
  2195. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfr/her2 inhibitor ap32788
    n1=Okihiro (syndrome de) | n2=en:egfr/her2 inhibitor ap32788 | rel=r_associated | relid=0 | w=10
  2196. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfr/her2 inhibitor av-412
    n1=Okihiro (syndrome de) | n2=en:egfr/her2 inhibitor av-412 | rel=r_associated | relid=0 | w=10
  2197. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfr/her2 kinase inhibitor tak-285
    n1=Okihiro (syndrome de) | n2=en:egfr/her2 kinase inhibitor tak-285 | rel=r_associated | relid=0 | w=10
  2198. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfrbi-armed autologous t cells
    n1=Okihiro (syndrome de) | n2=en:egfrbi-armed autologous t cells | rel=r_associated | relid=0 | w=10
  2199. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:egfrviii-specific car-transduced autologous t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:egfrviii-specific car-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  2200. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eicosapentaenoic acid
    n1=Okihiro (syndrome de) | n2=en:eicosapentaenoic acid | rel=r_associated | relid=0 | w=10
  2201. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eicosapentaenoic acid-enriched nutritional supplement
    n1=Okihiro (syndrome de) | n2=en:eicosapentaenoic acid-enriched nutritional supplement | rel=r_associated | relid=0 | w=10
  2202. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eif4e antisense oligonucleotide isis 183750
    n1=Okihiro (syndrome de) | n2=en:eif4e antisense oligonucleotide isis 183750 | rel=r_associated | relid=0 | w=10
  2203. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:elacytarabine
    n1=Okihiro (syndrome de) | n2=en:elacytarabine | rel=r_associated | relid=0 | w=10
  2204. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:electrokinetically modified water
    n1=Okihiro (syndrome de) | n2=en:electrokinetically modified water | rel=r_associated | relid=0 | w=10
  2205. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:electrolyte-free parenteral nutrition emulsion
    n1=Okihiro (syndrome de) | n2=en:electrolyte-free parenteral nutrition emulsion | rel=r_associated | relid=0 | w=10
  2206. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:elesclomol
    n1=Okihiro (syndrome de) | n2=en:elesclomol | rel=r_associated | relid=0 | w=10
  2207. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:elesclomol sodium
    n1=Okihiro (syndrome de) | n2=en:elesclomol sodium | rel=r_associated | relid=0 | w=10
  2208. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:elfazepam
    n1=Okihiro (syndrome de) | n2=en:elfazepam | rel=r_associated | relid=0 | w=10
  2209. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:elinafide
    n1=Okihiro (syndrome de) | n2=en:elinafide | rel=r_associated | relid=0 | w=10
  2210. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:elisidepsin
    n1=Okihiro (syndrome de) | n2=en:elisidepsin | rel=r_associated | relid=0 | w=10
  2211. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ellagic acid/annona muricata supplement
    n1=Okihiro (syndrome de) | n2=en:ellagic acid/annona muricata supplement | rel=r_associated | relid=0 | w=10
  2212. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:elliptinium acetate
    n1=Okihiro (syndrome de) | n2=en:elliptinium acetate | rel=r_associated | relid=0 | w=10
  2213. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:elopiprazole
    n1=Okihiro (syndrome de) | n2=en:elopiprazole | rel=r_associated | relid=0 | w=10
  2214. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:elosulfase alfa
    n1=Okihiro (syndrome de) | n2=en:elosulfase alfa | rel=r_associated | relid=0 | w=10
  2215. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:elotuzumab
    n1=Okihiro (syndrome de) | n2=en:elotuzumab | rel=r_associated | relid=0 | w=10
  2216. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:elsamitrucin
    n1=Okihiro (syndrome de) | n2=en:elsamitrucin | rel=r_associated | relid=0 | w=10
  2217. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:elsiglutide
    n1=Okihiro (syndrome de) | n2=en:elsiglutide | rel=r_associated | relid=0 | w=10
  2218. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eltrombopag olamine
    n1=Okihiro (syndrome de) | n2=en:eltrombopag olamine | rel=r_associated | relid=0 | w=10
  2219. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:emactuzumab
    n1=Okihiro (syndrome de) | n2=en:emactuzumab | rel=r_associated | relid=0 | w=10
  2220. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:embolic agent
    n1=Okihiro (syndrome de) | n2=en:embolic agent | rel=r_associated | relid=0 | w=10
  2221. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:emepepimut-s
    n1=Okihiro (syndrome de) | n2=en:emepepimut-s | rel=r_associated | relid=0 | w=10
  2222. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:emitefur
    n1=Okihiro (syndrome de) | n2=en:emitefur | rel=r_associated | relid=0 | w=10
  2223. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:emollients
    n1=Okihiro (syndrome de) | n2=en:emollients | rel=r_associated | relid=0 | w=10
  2224. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:emricasan
    n1=Okihiro (syndrome de) | n2=en:emricasan | rel=r_associated | relid=0 | w=10
  2225. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:emtricitabine
    n1=Okihiro (syndrome de) | n2=en:emtricitabine | rel=r_associated | relid=0 | w=10
  2226. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enadenotucirev
    n1=Okihiro (syndrome de) | n2=en:enadenotucirev | rel=r_associated | relid=0 | w=10
  2227. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enalapril maleate
    n1=Okihiro (syndrome de) | n2=en:enalapril maleate | rel=r_associated | relid=0 | w=10
  2228. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enavatuzumab
    n1=Okihiro (syndrome de) | n2=en:enavatuzumab | rel=r_associated | relid=0 | w=10
  2229. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enclomiphene citrate
    n1=Okihiro (syndrome de) | n2=en:enclomiphene citrate | rel=r_associated | relid=0 | w=10
  2230. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:endothelin b receptor agonist spi-1620
    n1=Okihiro (syndrome de) | n2=en:endothelin b receptor agonist spi-1620 | rel=r_associated | relid=0 | w=10
  2231. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enfuvirtide
    n1=Okihiro (syndrome de) | n2=en:enfuvirtide | rel=r_associated | relid=0 | w=10
  2232. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eniluracil
    n1=Okihiro (syndrome de) | n2=en:eniluracil | rel=r_associated | relid=0 | w=10
  2233. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enobosarm
    n1=Okihiro (syndrome de) | n2=en:enobosarm | rel=r_associated | relid=0 | w=10
  2234. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enoxaparin
    n1=Okihiro (syndrome de) | n2=en:enoxaparin | rel=r_associated | relid=0 | w=10
  2235. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enoximone
    n1=Okihiro (syndrome de) | n2=en:enoximone | rel=r_associated | relid=0 | w=10
  2236. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ensituximab
    n1=Okihiro (syndrome de) | n2=en:ensituximab | rel=r_associated | relid=0 | w=10
  2237. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:entecavir
    n1=Okihiro (syndrome de) | n2=en:entecavir | rel=r_associated | relid=0 | w=10
  2238. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enteric transport medium
    n1=Okihiro (syndrome de) | n2=en:enteric transport medium | rel=r_associated | relid=0 | w=10
  2239. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enteric-coated trpm8 agonist d-3263 hydrochloride
    n1=Okihiro (syndrome de) | n2=en:enteric-coated trpm8 agonist d-3263 hydrochloride | rel=r_associated | relid=0 | w=10
  2240. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enteric-coated zoledronic acid tablet mer-101
    n1=Okihiro (syndrome de) | n2=en:enteric-coated zoledronic acid tablet mer-101 | rel=r_associated | relid=0 | w=10
  2241. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:entinostat
    n1=Okihiro (syndrome de) | n2=en:entinostat | rel=r_associated | relid=0 | w=10
  2242. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:entire olecranon
    n1=Okihiro (syndrome de) | n2=en:entire olecranon | rel=r_associated | relid=0 | w=10
  2243. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:entire proximal end of ulna
    n1=Okihiro (syndrome de) | n2=en:entire proximal end of ulna | rel=r_associated | relid=0 | w=10
  2244. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:entolimod
    n1=Okihiro (syndrome de) | n2=en:entolimod | rel=r_associated | relid=0 | w=10
  2245. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:entospletinib
    n1=Okihiro (syndrome de) | n2=en:entospletinib | rel=r_associated | relid=0 | w=10
  2246. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:entrectinib
    n1=Okihiro (syndrome de) | n2=en:entrectinib | rel=r_associated | relid=0 | w=10
  2247. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enzalutamide
    n1=Okihiro (syndrome de) | n2=en:enzalutamide | rel=r_associated | relid=0 | w=10
  2248. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enzastaurin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:enzastaurin hydrochloride | rel=r_associated | relid=0 | w=10
  2249. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enzymatically-hydrolyzed whey protein-based nutritional supplement
    n1=Okihiro (syndrome de) | n2=en:enzymatically-hydrolyzed whey protein-based nutritional supplement | rel=r_associated | relid=0 | w=10
  2250. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enzyme agent
    n1=Okihiro (syndrome de) | n2=en:enzyme agent | rel=r_associated | relid=0 | w=10
  2251. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:enzyme inhibitor
    n1=Okihiro (syndrome de) | n2=en:enzyme inhibitor | rel=r_associated | relid=0 | w=10
  2252. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ep4 receptor antagonist aat-007
    n1=Okihiro (syndrome de) | n2=en:ep4 receptor antagonist aat-007 | rel=r_associated | relid=0 | w=10
  2253. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epacadostat
    n1=Okihiro (syndrome de) | n2=en:epacadostat | rel=r_associated | relid=0 | w=10
  2254. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epcam-specific car-expressing autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:epcam-specific car-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  2255. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epha2-targeting dopc-encapsulated sirna
    n1=Okihiro (syndrome de) | n2=en:epha2-targeting dopc-encapsulated sirna | rel=r_associated | relid=0 | w=10
  2256. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ephedra sinica stem
    n1=Okihiro (syndrome de) | n2=en:ephedra sinica stem | rel=r_associated | relid=0 | w=10
  2257. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epicondyle
    n1=Okihiro (syndrome de) | n2=en:epicondyle | rel=r_associated | relid=0 | w=10
  2258. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epidermal growth factor ointment
    n1=Okihiro (syndrome de) | n2=en:epidermal growth factor ointment | rel=r_associated | relid=0 | w=10
  2259. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epigallocatechin gallate
    n1=Okihiro (syndrome de) | n2=en:epigallocatechin gallate | rel=r_associated | relid=0 | w=10
  2260. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epiphysis of the bone
    n1=Okihiro (syndrome de) | n2=en:epiphysis of the bone | rel=r_associated | relid=0 | w=10
  2261. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epirubicin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:epirubicin hydrochloride | rel=r_associated | relid=0 | w=10
  2262. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epithelial cell adhesion molecule
    n1=Okihiro (syndrome de) | n2=en:epithelial cell adhesion molecule | rel=r_associated | relid=0 | w=10
  2263. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eplerenone
    n1=Okihiro (syndrome de) | n2=en:eplerenone | rel=r_associated | relid=0 | w=10
  2264. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epoch regimen
    n1=Okihiro (syndrome de) | n2=en:epoch regimen | rel=r_associated | relid=0 | w=10
  2265. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epoetin alfa
    n1=Okihiro (syndrome de) | n2=en:epoetin alfa | rel=r_associated | relid=0 | w=10
  2266. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epoetin beta
    n1=Okihiro (syndrome de) | n2=en:epoetin beta | rel=r_associated | relid=0 | w=10
  2267. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epoetin zeta
    n1=Okihiro (syndrome de) | n2=en:epoetin zeta | rel=r_associated | relid=0 | w=10
  2268. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epothilone analog utd1
    n1=Okihiro (syndrome de) | n2=en:epothilone analog utd1 | rel=r_associated | relid=0 | w=10
  2269. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epothilone d
    n1=Okihiro (syndrome de) | n2=en:epothilone d | rel=r_associated | relid=0 | w=10
  2270. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epothilone kos-1584
    n1=Okihiro (syndrome de) | n2=en:epothilone kos-1584 | rel=r_associated | relid=0 | w=10
  2271. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:epratuzumab
    n1=Okihiro (syndrome de) | n2=en:epratuzumab | rel=r_associated | relid=0 | w=10
  2272. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eprodisate disodium
    n1=Okihiro (syndrome de) | n2=en:eprodisate disodium | rel=r_associated | relid=0 | w=10
  2273. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eptifibatide
    n1=Okihiro (syndrome de) | n2=en:eptifibatide | rel=r_associated | relid=0 | w=10
  2274. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:era36 modulator icaritin
    n1=Okihiro (syndrome de) | n2=en:era36 modulator icaritin | rel=r_associated | relid=0 | w=10
  2275. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:erastin analogue prlx 93936
    n1=Okihiro (syndrome de) | n2=en:erastin analogue prlx 93936 | rel=r_associated | relid=0 | w=10
  2276. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:erb-38 immunotoxin
    n1=Okihiro (syndrome de) | n2=en:erb-38 immunotoxin | rel=r_associated | relid=0 | w=10
  2277. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:erbb-2 inhibitor arry-380
    n1=Okihiro (syndrome de) | n2=en:erbb-2 inhibitor arry-380 | rel=r_associated | relid=0 | w=10
  2278. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ergocalciferol
    n1=Okihiro (syndrome de) | n2=en:ergocalciferol | rel=r_associated | relid=0 | w=10
  2279. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ergoline
    n1=Okihiro (syndrome de) | n2=en:ergoline | rel=r_associated | relid=0 | w=10
  2280. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ergoline derivative
    n1=Okihiro (syndrome de) | n2=en:ergoline derivative | rel=r_associated | relid=0 | w=10
  2281. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eribulin mesylate
    n1=Okihiro (syndrome de) | n2=en:eribulin mesylate | rel=r_associated | relid=0 | w=10
  2282. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eritoran tetrasodium
    n1=Okihiro (syndrome de) | n2=en:eritoran tetrasodium | rel=r_associated | relid=0 | w=10
  2283. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:erizepine
    n1=Okihiro (syndrome de) | n2=en:erizepine | rel=r_associated | relid=0 | w=10
  2284. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:erk inhibitor cc-90003
    n1=Okihiro (syndrome de) | n2=en:erk inhibitor cc-90003 | rel=r_associated | relid=0 | w=10
  2285. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:erk inhibitor gdc-0994
    n1=Okihiro (syndrome de) | n2=en:erk inhibitor gdc-0994 | rel=r_associated | relid=0 | w=10
  2286. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:erk inhibitor ltt462
    n1=Okihiro (syndrome de) | n2=en:erk inhibitor ltt462 | rel=r_associated | relid=0 | w=10
  2287. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:erk inhibitor mk-8353
    n1=Okihiro (syndrome de) | n2=en:erk inhibitor mk-8353 | rel=r_associated | relid=0 | w=10
  2288. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:erlotinib hydrochloride
    n1=Okihiro (syndrome de) | n2=en:erlotinib hydrochloride | rel=r_associated | relid=0 | w=10
  2289. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ertapenem sodium
    n1=Okihiro (syndrome de) | n2=en:ertapenem sodium | rel=r_associated | relid=0 | w=10
  2290. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ertumaxomab
    n1=Okihiro (syndrome de) | n2=en:ertumaxomab | rel=r_associated | relid=0 | w=10
  2291. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:erythrocyte-encapsulated l-asparaginase suspension
    n1=Okihiro (syndrome de) | n2=en:erythrocyte-encapsulated l-asparaginase suspension | rel=r_associated | relid=0 | w=10
  2292. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:erythromycin
    n1=Okihiro (syndrome de) | n2=en:erythromycin | rel=r_associated | relid=0 | w=10
  2293. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:erythromycin topical cream
    n1=Okihiro (syndrome de) | n2=en:erythromycin topical cream | rel=r_associated | relid=0 | w=10
  2294. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:erythropoietin
    n1=Okihiro (syndrome de) | n2=en:erythropoietin | rel=r_associated | relid=0 | w=10
  2295. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:escitalopram oxalate
    n1=Okihiro (syndrome de) | n2=en:escitalopram oxalate | rel=r_associated | relid=0 | w=10
  2296. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eslicarbazepine
    n1=Okihiro (syndrome de) | n2=en:eslicarbazepine | rel=r_associated | relid=0 | w=10
  2297. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:esmolol
    n1=Okihiro (syndrome de) | n2=en:esmolol | rel=r_associated | relid=0 | w=10
  2298. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:esomeprazole magnesium
    n1=Okihiro (syndrome de) | n2=en:esomeprazole magnesium | rel=r_associated | relid=0 | w=10
  2299. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:esorubicin
    n1=Okihiro (syndrome de) | n2=en:esorubicin | rel=r_associated | relid=0 | w=10
  2300. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:essential oil
    n1=Okihiro (syndrome de) | n2=en:essential oil | rel=r_associated | relid=0 | w=10
  2301. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:essiac
    n1=Okihiro (syndrome de) | n2=en:essiac | rel=r_associated | relid=0 | w=10
  2302. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:estazolam
    n1=Okihiro (syndrome de) | n2=en:estazolam | rel=r_associated | relid=0 | w=10
  2303. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:estradiol vaginal ring
    n1=Okihiro (syndrome de) | n2=en:estradiol vaginal ring | rel=r_associated | relid=0 | w=10
  2304. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:estradiol valerate
    n1=Okihiro (syndrome de) | n2=en:estradiol valerate | rel=r_associated | relid=0 | w=10
  2305. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:estradiol/norethindrone acetate tablet
    n1=Okihiro (syndrome de) | n2=en:estradiol/norethindrone acetate tablet | rel=r_associated | relid=0 | w=10
  2306. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:estramustine phosphate sodium
    n1=Okihiro (syndrome de) | n2=en:estramustine phosphate sodium | rel=r_associated | relid=0 | w=10
  2307. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:estriol vaginal gel
    n1=Okihiro (syndrome de) | n2=en:estriol vaginal gel | rel=r_associated | relid=0 | w=10
  2308. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:estrogen receptor agonist gtx-758
    n1=Okihiro (syndrome de) | n2=en:estrogen receptor agonist gtx-758 | rel=r_associated | relid=0 | w=10
  2309. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:estrogens, conjugated
    n1=Okihiro (syndrome de) | n2=en:estrogens, conjugated | rel=r_associated | relid=0 | w=10
  2310. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:estrogens, esterified (usp)
    n1=Okihiro (syndrome de) | n2=en:estrogens, esterified (usp) | rel=r_associated | relid=0 | w=10
  2311. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eszopiclone
    n1=Okihiro (syndrome de) | n2=en:eszopiclone | rel=r_associated | relid=0 | w=10
  2312. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:etalocib
    n1=Okihiro (syndrome de) | n2=en:etalocib | rel=r_associated | relid=0 | w=10
  2313. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:etanercept
    n1=Okihiro (syndrome de) | n2=en:etanercept | rel=r_associated | relid=0 | w=10
  2314. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:etanidazole
    n1=Okihiro (syndrome de) | n2=en:etanidazole | rel=r_associated | relid=0 | w=10
  2315. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:etaracizumab
    n1=Okihiro (syndrome de) | n2=en:etaracizumab | rel=r_associated | relid=0 | w=10
  2316. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethacridine
    n1=Okihiro (syndrome de) | n2=en:ethacridine | rel=r_associated | relid=0 | w=10
  2317. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethacrynic acid
    n1=Okihiro (syndrome de) | n2=en:ethacrynic acid | rel=r_associated | relid=0 | w=10
  2318. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethambutol
    n1=Okihiro (syndrome de) | n2=en:ethambutol | rel=r_associated | relid=0 | w=10
  2319. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethaselen
    n1=Okihiro (syndrome de) | n2=en:ethaselen | rel=r_associated | relid=0 | w=10
  2320. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethchlorvynol
    n1=Okihiro (syndrome de) | n2=en:ethchlorvynol | rel=r_associated | relid=0 | w=10
  2321. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethers
    n1=Okihiro (syndrome de) | n2=en:ethers | rel=r_associated | relid=0 | w=10
  2322. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethinyl estradiol
    n1=Okihiro (syndrome de) | n2=en:ethinyl estradiol | rel=r_associated | relid=0 | w=10
  2323. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethinyl estradiol/levonorgestrel
    n1=Okihiro (syndrome de) | n2=en:ethinyl estradiol/levonorgestrel | rel=r_associated | relid=0 | w=10
  2324. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethinyl estradiol/norethindrone
    n1=Okihiro (syndrome de) | n2=en:ethinyl estradiol/norethindrone | rel=r_associated | relid=0 | w=10
  2325. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethiodized oil
    n1=Okihiro (syndrome de) | n2=en:ethiodized oil | rel=r_associated | relid=0 | w=10
  2326. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethionamide
    n1=Okihiro (syndrome de) | n2=en:ethionamide | rel=r_associated | relid=0 | w=10
  2327. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethosuximide
    n1=Okihiro (syndrome de) | n2=en:ethosuximide | rel=r_associated | relid=0 | w=10
  2328. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethyl alcohol mouthwash
    n1=Okihiro (syndrome de) | n2=en:ethyl alcohol mouthwash | rel=r_associated | relid=0 | w=10
  2329. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethyl carfluzepate
    n1=Okihiro (syndrome de) | n2=en:ethyl carfluzepate | rel=r_associated | relid=0 | w=10
  2330. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethyl dirazepate
    n1=Okihiro (syndrome de) | n2=en:ethyl dirazepate | rel=r_associated | relid=0 | w=10
  2331. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethyl loflazepate
    n1=Okihiro (syndrome de) | n2=en:ethyl loflazepate | rel=r_associated | relid=0 | w=10
  2332. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethylchlorformate
    n1=Okihiro (syndrome de) | n2=en:ethylchlorformate | rel=r_associated | relid=0 | w=10
  2333. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ethylchlorformate vaccine
    n1=Okihiro (syndrome de) | n2=en:ethylchlorformate vaccine | rel=r_associated | relid=0 | w=10
  2334. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:etidronate-cytarabine conjugate mbc-11
    n1=Okihiro (syndrome de) | n2=en:etidronate-cytarabine conjugate mbc-11 | rel=r_associated | relid=0 | w=10
  2335. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:etidronic acid
    n1=Okihiro (syndrome de) | n2=en:etidronic acid | rel=r_associated | relid=0 | w=10
  2336. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:etizolam
    n1=Okihiro (syndrome de) | n2=en:etizolam | rel=r_associated | relid=0 | w=10
  2337. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:etodolac
    n1=Okihiro (syndrome de) | n2=en:etodolac | rel=r_associated | relid=0 | w=10
  2338. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:etoglucid
    n1=Okihiro (syndrome de) | n2=en:etoglucid | rel=r_associated | relid=0 | w=10
  2339. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:etomidate
    n1=Okihiro (syndrome de) | n2=en:etomidate | rel=r_associated | relid=0 | w=10
  2340. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:etoposide
    n1=Okihiro (syndrome de) | n2=en:etoposide | rel=r_associated | relid=0 | w=10
  2341. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:etoposide phosphate
    n1=Okihiro (syndrome de) | n2=en:etoposide phosphate | rel=r_associated | relid=0 | w=10
  2342. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:etoposide prodrug cap7.1
    n1=Okihiro (syndrome de) | n2=en:etoposide prodrug cap7.1 | rel=r_associated | relid=0 | w=10
  2343. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:etoricoxib
    n1=Okihiro (syndrome de) | n2=en:etoricoxib | rel=r_associated | relid=0 | w=10
  2344. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ets-family transcription factor inhibitor tk216
    n1=Okihiro (syndrome de) | n2=en:ets-family transcription factor inhibitor tk216 | rel=r_associated | relid=0 | w=10
  2345. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eucalyptol
    n1=Okihiro (syndrome de) | n2=en:eucalyptol | rel=r_associated | relid=0 | w=10
  2346. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eucalyptus extract
    n1=Okihiro (syndrome de) | n2=en:eucalyptus extract | rel=r_associated | relid=0 | w=10
  2347. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eucerin
    n1=Okihiro (syndrome de) | n2=en:eucerin | rel=r_associated | relid=0 | w=10
  2348. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eutectic mixture of local anesthetics
    n1=Okihiro (syndrome de) | n2=en:eutectic mixture of local anesthetics | rel=r_associated | relid=0 | w=10
  2349. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:evans blue
    n1=Okihiro (syndrome de) | n2=en:evans blue | rel=r_associated | relid=0 | w=10
  2350. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:evaux spring water-based cream
    n1=Okihiro (syndrome de) | n2=en:evaux spring water-based cream | rel=r_associated | relid=0 | w=10
  2351. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:evaux spring water-based topical spray
    n1=Okihiro (syndrome de) | n2=en:evaux spring water-based topical spray | rel=r_associated | relid=0 | w=10
  2352. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:evaux thermal spring water-based solution
    n1=Okihiro (syndrome de) | n2=en:evaux thermal spring water-based solution | rel=r_associated | relid=0 | w=10
  2353. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:evening primrose extract
    n1=Okihiro (syndrome de) | n2=en:evening primrose extract | rel=r_associated | relid=0 | w=10
  2354. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:everolimus
    n1=Okihiro (syndrome de) | n2=en:everolimus | rel=r_associated | relid=0 | w=10
  2355. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:everolimus tablets for oral suspension
    n1=Okihiro (syndrome de) | n2=en:everolimus tablets for oral suspension | rel=r_associated | relid=0 | w=10
  2356. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ex vivo-activated autologous lymph node lymphocytes
    n1=Okihiro (syndrome de) | n2=en:ex vivo-activated autologous lymph node lymphocytes | rel=r_associated | relid=0 | w=10
  2357. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ex vivo-expanded her2-specific t cells
    n1=Okihiro (syndrome de) | n2=en:ex vivo-expanded her2-specific t cells | rel=r_associated | relid=0 | w=10
  2358. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:exatecan mesylate
    n1=Okihiro (syndrome de) | n2=en:exatecan mesylate | rel=r_associated | relid=0 | w=10
  2359. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:exemestane
    n1=Okihiro (syndrome de) | n2=en:exemestane | rel=r_associated | relid=0 | w=10
  2360. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:exenatide
    n1=Okihiro (syndrome de) | n2=en:exenatide | rel=r_associated | relid=0 | w=10
  2361. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:exisulind
    n1=Okihiro (syndrome de) | n2=en:exisulind | rel=r_associated | relid=0 | w=10
  2362. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:expanded umbilical cord blood product hsc835
    n1=Okihiro (syndrome de) | n2=en:expanded umbilical cord blood product hsc835 | rel=r_associated | relid=0 | w=10
  2363. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:expectorant/mucolytic
    n1=Okihiro (syndrome de) | n2=en:expectorant/mucolytic | rel=r_associated | relid=0 | w=10
  2364. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:extended release bupivacaine hydrochloride resorbable matrix formulation
    n1=Okihiro (syndrome de) | n2=en:extended release bupivacaine hydrochloride resorbable matrix formulation | rel=r_associated | relid=0 | w=10
  2365. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:extended release flucytosine
    n1=Okihiro (syndrome de) | n2=en:extended release flucytosine | rel=r_associated | relid=0 | w=10
  2366. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:extended-release onapristone
    n1=Okihiro (syndrome de) | n2=en:extended-release onapristone | rel=r_associated | relid=0 | w=10
  2367. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:external malleolus
    n1=Okihiro (syndrome de) | n2=en:external malleolus | rel=r_associated | relid=0 | w=10
  2368. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:eye agent
    n1=Okihiro (syndrome de) | n2=en:eye agent | rel=r_associated | relid=0 | w=10
  2369. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ezatiostat hydrochloride
    n1=Okihiro (syndrome de) | n2=en:ezatiostat hydrochloride | rel=r_associated | relid=0 | w=10
  2370. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ezetimibe
    n1=Okihiro (syndrome de) | n2=en:ezetimibe | rel=r_associated | relid=0 | w=10
  2371. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ezetimibe/simvastatin
    n1=Okihiro (syndrome de) | n2=en:ezetimibe/simvastatin | rel=r_associated | relid=0 | w=10
  2372. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ezh1/2 inhibitor ds-3201
    n1=Okihiro (syndrome de) | n2=en:ezh1/2 inhibitor ds-3201 | rel=r_associated | relid=0 | w=10
  2373. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ezh2 inhibitor cpi-1205
    n1=Okihiro (syndrome de) | n2=en:ezh2 inhibitor cpi-1205 | rel=r_associated | relid=0 | w=10
  2374. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:f-18 16 alpha-fluoroestradiol
    n1=Okihiro (syndrome de) | n2=en:f-18 16 alpha-fluoroestradiol | rel=r_associated | relid=0 | w=10
  2375. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:f-18 fluoroethyltyrosine
    n1=Okihiro (syndrome de) | n2=en:f-18 fluoroethyltyrosine | rel=r_associated | relid=0 | w=10
  2376. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:f16-il2 fusion protein
    n1=Okihiro (syndrome de) | n2=en:f16-il2 fusion protein | rel=r_associated | relid=0 | w=10
  2377. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fact complex-targeting curaxin cbl0137
    n1=Okihiro (syndrome de) | n2=en:fact complex-targeting curaxin cbl0137 | rel=r_associated | relid=0 | w=10
  2378. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:factor viia inhibitor pci-27483
    n1=Okihiro (syndrome de) | n2=en:factor viia inhibitor pci-27483 | rel=r_associated | relid=0 | w=10
  2379. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:factor viiia
    n1=Okihiro (syndrome de) | n2=en:factor viiia | rel=r_associated | relid=0 | w=10
  2380. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fadrozole hydrochloride
    n1=Okihiro (syndrome de) | n2=en:fadrozole hydrochloride | rel=r_associated | relid=0 | w=10
  2381. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fak inhibitor gsk2256098
    n1=Okihiro (syndrome de) | n2=en:fak inhibitor gsk2256098 | rel=r_associated | relid=0 | w=10
  2382. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fak inhibitor pf-00562271
    n1=Okihiro (syndrome de) | n2=en:fak inhibitor pf-00562271 | rel=r_associated | relid=0 | w=10
  2383. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fak inhibitor vs-4718
    n1=Okihiro (syndrome de) | n2=en:fak inhibitor vs-4718 | rel=r_associated | relid=0 | w=10
  2384. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:falimarev
    n1=Okihiro (syndrome de) | n2=en:falimarev | rel=r_associated | relid=0 | w=10
  2385. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:famitinib
    n1=Okihiro (syndrome de) | n2=en:famitinib | rel=r_associated | relid=0 | w=10
  2386. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:famotidine
    n1=Okihiro (syndrome de) | n2=en:famotidine | rel=r_associated | relid=0 | w=10
  2387. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fap-specific cd8-positive t cells
    n1=Okihiro (syndrome de) | n2=en:fap-specific cd8-positive t cells | rel=r_associated | relid=0 | w=10
  2388. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:farampator
    n1=Okihiro (syndrome de) | n2=en:farampator | rel=r_associated | relid=0 | w=10
  2389. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:farletuzumab
    n1=Okihiro (syndrome de) | n2=en:farletuzumab | rel=r_associated | relid=0 | w=10
  2390. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fas receptor agonist apo010
    n1=Okihiro (syndrome de) | n2=en:fas receptor agonist apo010 | rel=r_associated | relid=0 | w=10
  2391. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fas-chimera transgene-expressing endothelial tumor cell-targeting adenovector vb-111
    n1=Okihiro (syndrome de) | n2=en:fas-chimera transgene-expressing endothelial tumor cell-targeting adenovector vb-111 | rel=r_associated | relid=0 | w=10
  2392. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fasn inhibitor tvb-2640
    n1=Okihiro (syndrome de) | n2=en:fasn inhibitor tvb-2640 | rel=r_associated | relid=0 | w=10
  2393. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fat emulsion
    n1=Okihiro (syndrome de) | n2=en:fat emulsion | rel=r_associated | relid=0 | w=10
  2394. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fazarabine
    n1=Okihiro (syndrome de) | n2=en:fazarabine | rel=r_associated | relid=0 | w=10
  2395. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fda established names and unique ingredient identifier codes terminology
    n1=Okihiro (syndrome de) | n2=en:fda established names and unique ingredient identifier codes terminology | rel=r_associated | relid=0 | w=10
  2396. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:febuxostat
    n1=Okihiro (syndrome de) | n2=en:febuxostat | rel=r_associated | relid=0 | w=10
  2397. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:femoral neck
    n1=Okihiro (syndrome de) | n2=en:femoral neck | rel=r_associated | relid=0 | w=10
  2398. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:femoral shaft
    n1=Okihiro (syndrome de) | n2=en:femoral shaft | rel=r_associated | relid=0 | w=10
  2399. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fenimide
    n1=Okihiro (syndrome de) | n2=en:fenimide | rel=r_associated | relid=0 | w=10
  2400. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fenofibrate
    n1=Okihiro (syndrome de) | n2=en:fenofibrate | rel=r_associated | relid=0 | w=10
  2401. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fenretinide
    n1=Okihiro (syndrome de) | n2=en:fenretinide | rel=r_associated | relid=0 | w=10
  2402. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fenretinide lipid matrix
    n1=Okihiro (syndrome de) | n2=en:fenretinide lipid matrix | rel=r_associated | relid=0 | w=10
  2403. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fentanyl buccal soluble film
    n1=Okihiro (syndrome de) | n2=en:fentanyl buccal soluble film | rel=r_associated | relid=0 | w=10
  2404. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fentanyl citrate
    n1=Okihiro (syndrome de) | n2=en:fentanyl citrate | rel=r_associated | relid=0 | w=10
  2405. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fentanyl citrate buccal tablet
    n1=Okihiro (syndrome de) | n2=en:fentanyl citrate buccal tablet | rel=r_associated | relid=0 | w=10
  2406. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fentanyl citrate pectin-based nasal spray
    n1=Okihiro (syndrome de) | n2=en:fentanyl citrate pectin-based nasal spray | rel=r_associated | relid=0 | w=10
  2407. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fentanyl citrate-containing nasal spray
    n1=Okihiro (syndrome de) | n2=en:fentanyl citrate-containing nasal spray | rel=r_associated | relid=0 | w=10
  2408. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fentanyl matrix transdermal patch
    n1=Okihiro (syndrome de) | n2=en:fentanyl matrix transdermal patch | rel=r_associated | relid=0 | w=10
  2409. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fentanyl sublingual spray
    n1=Okihiro (syndrome de) | n2=en:fentanyl sublingual spray | rel=r_associated | relid=0 | w=10
  2410. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fermented soybean protein beverage
    n1=Okihiro (syndrome de) | n2=en:fermented soybean protein beverage | rel=r_associated | relid=0 | w=10
  2411. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fermented wheat germ extract
    n1=Okihiro (syndrome de) | n2=en:fermented wheat germ extract | rel=r_associated | relid=0 | w=10
  2412. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ferric carboxymaltose solution
    n1=Okihiro (syndrome de) | n2=en:ferric carboxymaltose solution | rel=r_associated | relid=0 | w=10
  2413. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ferrosoferric oxide
    n1=Okihiro (syndrome de) | n2=en:ferrosoferric oxide | rel=r_associated | relid=0 | w=10
  2414. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ferrous fumarate
    n1=Okihiro (syndrome de) | n2=en:ferrous fumarate | rel=r_associated | relid=0 | w=10
  2415. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ferrous sulfate
    n1=Okihiro (syndrome de) | n2=en:ferrous sulfate | rel=r_associated | relid=0 | w=10
  2416. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fertility agents
    n1=Okihiro (syndrome de) | n2=en:fertility agents | rel=r_associated | relid=0 | w=10
  2417. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ferumoxides injectable solution
    n1=Okihiro (syndrome de) | n2=en:ferumoxides injectable solution | rel=r_associated | relid=0 | w=10
  2418. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ferumoxsil oral suspension
    n1=Okihiro (syndrome de) | n2=en:ferumoxsil oral suspension | rel=r_associated | relid=0 | w=10
  2419. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ferumoxtran-10
    n1=Okihiro (syndrome de) | n2=en:ferumoxtran-10 | rel=r_associated | relid=0 | w=10
  2420. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fesoterodine fumarate
    n1=Okihiro (syndrome de) | n2=en:fesoterodine fumarate | rel=r_associated | relid=0 | w=10
  2421. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fexofenadine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:fexofenadine hydrochloride | rel=r_associated | relid=0 | w=10
  2422. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fgf receptor antagonist hgs1036
    n1=Okihiro (syndrome de) | n2=en:fgf receptor antagonist hgs1036 | rel=r_associated | relid=0 | w=10
  2423. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fgf/fgfr pathway inhibitor e7090
    n1=Okihiro (syndrome de) | n2=en:fgf/fgfr pathway inhibitor e7090 | rel=r_associated | relid=0 | w=10
  2424. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fgf401 inhibitor fgf401
    n1=Okihiro (syndrome de) | n2=en:fgf401 inhibitor fgf401 | rel=r_associated | relid=0 | w=10
  2425. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fgfr inhibitor asp5878
    n1=Okihiro (syndrome de) | n2=en:fgfr inhibitor asp5878 | rel=r_associated | relid=0 | w=10
  2426. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fgfr inhibitor azd4547
    n1=Okihiro (syndrome de) | n2=en:fgfr inhibitor azd4547 | rel=r_associated | relid=0 | w=10
  2427. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fgfr inhibitor debio 1347
    n1=Okihiro (syndrome de) | n2=en:fgfr inhibitor debio 1347 | rel=r_associated | relid=0 | w=10
  2428. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fgfr inhibitor incb054828
    n1=Okihiro (syndrome de) | n2=en:fgfr inhibitor incb054828 | rel=r_associated | relid=0 | w=10
  2429. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fgfr inhibitor ly2874455
    n1=Okihiro (syndrome de) | n2=en:fgfr inhibitor ly2874455 | rel=r_associated | relid=0 | w=10
  2430. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fgfr inhibitor tas-120
    n1=Okihiro (syndrome de) | n2=en:fgfr inhibitor tas-120 | rel=r_associated | relid=0 | w=10
  2431. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999
    n1=Okihiro (syndrome de) | n2=en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999 | rel=r_associated | relid=0 | w=10
  2432. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fgfr4 inhibitor blu-554
    n1=Okihiro (syndrome de) | n2=en:fgfr4 inhibitor blu-554 | rel=r_associated | relid=0 | w=10
  2433. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fiber
    n1=Okihiro (syndrome de) | n2=en:fiber | rel=r_associated | relid=0 | w=10
  2434. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fibrate antihyperlipidemic
    n1=Okihiro (syndrome de) | n2=en:fibrate antihyperlipidemic | rel=r_associated | relid=0 | w=10
  2435. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fibrin sealant
    n1=Okihiro (syndrome de) | n2=en:fibrin sealant | rel=r_associated | relid=0 | w=10
  2436. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fibrinogen
    n1=Okihiro (syndrome de) | n2=en:fibrinogen | rel=r_associated | relid=0 | w=10
  2437. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fibular shaft
    n1=Okihiro (syndrome de) | n2=en:fibular shaft | rel=r_associated | relid=0 | w=10
  2438. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ficlatuzumab
    n1=Okihiro (syndrome de) | n2=en:ficlatuzumab | rel=r_associated | relid=0 | w=10
  2439. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fidaxomicin
    n1=Okihiro (syndrome de) | n2=en:fidaxomicin | rel=r_associated | relid=0 | w=10
  2440. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:figitumumab
    n1=Okihiro (syndrome de) | n2=en:figitumumab | rel=r_associated | relid=0 | w=10
  2441. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:filgrastim
    n1=Okihiro (syndrome de) | n2=en:filgrastim | rel=r_associated | relid=0 | w=10
  2442. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:filgrastim-primed peripheral blood progenitor cells
    n1=Okihiro (syndrome de) | n2=en:filgrastim-primed peripheral blood progenitor cells | rel=r_associated | relid=0 | w=10
  2443. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:finasteride
    n1=Okihiro (syndrome de) | n2=en:finasteride | rel=r_associated | relid=0 | w=10
  2444. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fingolimod
    n1=Okihiro (syndrome de) | n2=en:fingolimod | rel=r_associated | relid=0 | w=10
  2445. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fingolimod hydrochloride
    n1=Okihiro (syndrome de) | n2=en:fingolimod hydrochloride | rel=r_associated | relid=0 | w=10
  2446. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:firtecan pegol
    n1=Okihiro (syndrome de) | n2=en:firtecan pegol | rel=r_associated | relid=0 | w=10
  2447. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fish oil/glycerol/egg lecithin-based emulsion
    n1=Okihiro (syndrome de) | n2=en:fish oil/glycerol/egg lecithin-based emulsion | rel=r_associated | relid=0 | w=10
  2448. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flanvotumab
    n1=Okihiro (syndrome de) | n2=en:flanvotumab | rel=r_associated | relid=0 | w=10
  2449. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flavonoid tablet
    n1=Okihiro (syndrome de) | n2=en:flavonoid tablet | rel=r_associated | relid=0 | w=10
  2450. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flavoxate
    n1=Okihiro (syndrome de) | n2=en:flavoxate | rel=r_associated | relid=0 | w=10
  2451. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flaxseed
    n1=Okihiro (syndrome de) | n2=en:flaxseed | rel=r_associated | relid=0 | w=10
  2452. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flecainide acetate
    n1=Okihiro (syndrome de) | n2=en:flecainide acetate | rel=r_associated | relid=0 | w=10
  2453. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fletazepam
    n1=Okihiro (syndrome de) | n2=en:fletazepam | rel=r_associated | relid=0 | w=10
  2454. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:floxuridine
    n1=Okihiro (syndrome de) | n2=en:floxuridine | rel=r_associated | relid=0 | w=10
  2455. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flp injection
    n1=Okihiro (syndrome de) | n2=en:flp injection | rel=r_associated | relid=0 | w=10
  2456. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flt3/abl/aurora kinase inhibitor kw-2449
    n1=Okihiro (syndrome de) | n2=en:flt3/abl/aurora kinase inhibitor kw-2449 | rel=r_associated | relid=0 | w=10
  2457. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flt3/cdk4/6 inhibitor flx925
    n1=Okihiro (syndrome de) | n2=en:flt3/cdk4/6 inhibitor flx925 | rel=r_associated | relid=0 | w=10
  2458. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flt3/kit kinase inhibitor akn-028
    n1=Okihiro (syndrome de) | n2=en:flt3/kit kinase inhibitor akn-028 | rel=r_associated | relid=0 | w=10
  2459. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flu matrix peptide p58-66
    n1=Okihiro (syndrome de) | n2=en:flu matrix peptide p58-66 | rel=r_associated | relid=0 | w=10
  2460. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluanisone
    n1=Okihiro (syndrome de) | n2=en:fluanisone | rel=r_associated | relid=0 | w=10
  2461. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluciclatide f-18
    n1=Okihiro (syndrome de) | n2=en:fluciclatide f-18 | rel=r_associated | relid=0 | w=10
  2462. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluciclovine (18f)
    n1=Okihiro (syndrome de) | n2=en:fluciclovine (18f) | rel=r_associated | relid=0 | w=10
  2463. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flucindole
    n1=Okihiro (syndrome de) | n2=en:flucindole | rel=r_associated | relid=0 | w=10
  2464. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluconazole
    n1=Okihiro (syndrome de) | n2=en:fluconazole | rel=r_associated | relid=0 | w=10
  2465. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flucytosine
    n1=Okihiro (syndrome de) | n2=en:flucytosine | rel=r_associated | relid=0 | w=10
  2466. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fludarabine phosphate
    n1=Okihiro (syndrome de) | n2=en:fludarabine phosphate | rel=r_associated | relid=0 | w=10
  2467. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fludeoxyglucose f-18
    n1=Okihiro (syndrome de) | n2=en:fludeoxyglucose f-18 | rel=r_associated | relid=0 | w=10
  2468. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fludiazepam
    n1=Okihiro (syndrome de) | n2=en:fludiazepam | rel=r_associated | relid=0 | w=10
  2469. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fludrocortisone acetate
    n1=Okihiro (syndrome de) | n2=en:fludrocortisone acetate | rel=r_associated | relid=0 | w=10
  2470. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flumatinib mesylate
    n1=Okihiro (syndrome de) | n2=en:flumatinib mesylate | rel=r_associated | relid=0 | w=10
  2471. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flumazenil
    n1=Okihiro (syndrome de) | n2=en:flumazenil | rel=r_associated | relid=0 | w=10
  2472. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flunitrazepam
    n1=Okihiro (syndrome de) | n2=en:flunitrazepam | rel=r_associated | relid=0 | w=10
  2473. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluocinonide
    n1=Okihiro (syndrome de) | n2=en:fluocinonide | rel=r_associated | relid=0 | w=10
  2474. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorescein
    n1=Okihiro (syndrome de) | n2=en:fluorescein | rel=r_associated | relid=0 | w=10
  2475. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorescein sodium injection
    n1=Okihiro (syndrome de) | n2=en:fluorescein sodium injection | rel=r_associated | relid=0 | w=10
  2476. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorescence imaging agent emi-137
    n1=Okihiro (syndrome de) | n2=en:fluorescence imaging agent emi-137 | rel=r_associated | relid=0 | w=10
  2477. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorescent antibody sgm-101
    n1=Okihiro (syndrome de) | n2=en:fluorescent antibody sgm-101 | rel=r_associated | relid=0 | w=10
  2478. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorescent crgdy peg-cy5.5 c dots
    n1=Okihiro (syndrome de) | n2=en:fluorescent crgdy peg-cy5.5 c dots | rel=r_associated | relid=0 | w=10
  2479. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorescent imaging ligand otl38
    n1=Okihiro (syndrome de) | n2=en:fluorescent imaging ligand otl38 | rel=r_associated | relid=0 | w=10
  2480. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorescent protease-activated peptide avb-620
    n1=Okihiro (syndrome de) | n2=en:fluorescent protease-activated peptide avb-620 | rel=r_associated | relid=0 | w=10
  2481. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorides
    n1=Okihiro (syndrome de) | n2=en:fluorides | rel=r_associated | relid=0 | w=10
  2482. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine 18 f fludarabine
    n1=Okihiro (syndrome de) | n2=en:fluorine 18 f fludarabine | rel=r_associated | relid=0 | w=10
  2483. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 4-l-fluoroglutamine (2s,4r)
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 4-l-fluoroglutamine (2s,4r) | rel=r_associated | relid=0 | w=10
  2484. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 5-fluoro-2-deoxycytidine
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 5-fluoro-2-deoxycytidine | rel=r_associated | relid=0 | w=10
  2485. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 alfatide ii
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 alfatide ii | rel=r_associated | relid=0 | w=10
  2486. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 ara-g
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 ara-g | rel=r_associated | relid=0 | w=10
  2487. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 bay 85-8050
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 bay 85-8050 | rel=r_associated | relid=0 | w=10
  2488. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 bay 86-9596
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 bay 86-9596 | rel=r_associated | relid=0 | w=10
  2489. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 bay1075553
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 bay1075553 | rel=r_associated | relid=0 | w=10
  2490. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 choline
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 choline | rel=r_associated | relid=0 | w=10
  2491. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 cp18 peptide
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 cp18 peptide | rel=r_associated | relid=0 | w=10
  2492. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 d-fmau
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 d-fmau | rel=r_associated | relid=0 | w=10
  2493. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 dabrafenib
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 dabrafenib | rel=r_associated | relid=0 | w=10
  2494. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 dcfbc
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 dcfbc | rel=r_associated | relid=0 | w=10
  2495. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 dcfpyl
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 dcfpyl | rel=r_associated | relid=0 | w=10
  2496. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 ef5
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 ef5 | rel=r_associated | relid=0 | w=10
  2497. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 fdht
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 fdht | rel=r_associated | relid=0 | w=10
  2498. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 feqa
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 feqa | rel=r_associated | relid=0 | w=10
  2499. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 fluoro furanyl norprogesterone
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 fluoro furanyl norprogesterone | rel=r_associated | relid=0 | w=10
  2500. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 fluoro-peg6-ipqa
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 fluoro-peg6-ipqa | rel=r_associated | relid=0 | w=10
  2501. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 fluorobenzyl triphenyl phosphonium
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 fluorobenzyl triphenyl phosphonium | rel=r_associated | relid=0 | w=10
  2502. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 fluorodopa
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 fluorodopa | rel=r_associated | relid=0 | w=10
  2503. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 fluoroethylcholine
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 fluoroethylcholine | rel=r_associated | relid=0 | w=10
  2504. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 fluoromethylcholine
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 fluoromethylcholine | rel=r_associated | relid=0 | w=10
  2505. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 fluorthanatrace
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 fluorthanatrace | rel=r_associated | relid=0 | w=10
  2506. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 fmdht
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 fmdht | rel=r_associated | relid=0 | w=10
  2507. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 fp-r01-mg-f2
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 fp-r01-mg-f2 | rel=r_associated | relid=0 | w=10
  2508. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 galacto-rgd peptide
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 galacto-rgd peptide | rel=r_associated | relid=0 | w=10
  2509. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 iso-1
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 iso-1 | rel=r_associated | relid=0 | w=10
  2510. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 l-glutamate derivative bay94-9392
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 l-glutamate derivative bay94-9392 | rel=r_associated | relid=0 | w=10
  2511. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 rgd-k5
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 rgd-k5 | rel=r_associated | relid=0 | w=10
  2512. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 ski-249380
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 ski-249380 | rel=r_associated | relid=0 | w=10
  2513. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18 sodium fluoride
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18 sodium fluoride | rel=r_associated | relid=0 | w=10
  2514. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18-av-133
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18-av-133 | rel=r_associated | relid=0 | w=10
  2515. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18-labeled s-(3-fluoropropyl)homocysteine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18-labeled s-(3-fluoropropyl)homocysteine hydrochloride | rel=r_associated | relid=0 | w=10
  2516. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f 18-vm4-037
    n1=Okihiro (syndrome de) | n2=en:fluorine f 18-vm4-037 | rel=r_associated | relid=0 | w=10
  2517. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f-18 6-fluorodopamine
    n1=Okihiro (syndrome de) | n2=en:fluorine f-18 6-fluorodopamine | rel=r_associated | relid=0 | w=10
  2518. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f-18 fluoropaclitaxel
    n1=Okihiro (syndrome de) | n2=en:fluorine f-18 fluoropaclitaxel | rel=r_associated | relid=0 | w=10
  2519. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f-18 hx4
    n1=Okihiro (syndrome de) | n2=en:fluorine f-18 hx4 | rel=r_associated | relid=0 | w=10
  2520. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorine f-18 ml-10
    n1=Okihiro (syndrome de) | n2=en:fluorine f-18 ml-10 | rel=r_associated | relid=0 | w=10
  2521. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorodeoxygalactose f-18
    n1=Okihiro (syndrome de) | n2=en:fluorodeoxygalactose f-18 | rel=r_associated | relid=0 | w=10
  2522. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorometholone acetate ophthalmic suspension
    n1=Okihiro (syndrome de) | n2=en:fluorometholone acetate ophthalmic suspension | rel=r_associated | relid=0 | w=10
  2523. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorothymidine f-18
    n1=Okihiro (syndrome de) | n2=en:fluorothymidine f-18 | rel=r_associated | relid=0 | w=10
  2524. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorouracil
    n1=Okihiro (syndrome de) | n2=en:fluorouracil | rel=r_associated | relid=0 | w=10
  2525. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorouracil implant
    n1=Okihiro (syndrome de) | n2=en:fluorouracil implant | rel=r_associated | relid=0 | w=10
  2526. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluorouracil-e therapeutic implant
    n1=Okihiro (syndrome de) | n2=en:fluorouracil-e therapeutic implant | rel=r_associated | relid=0 | w=10
  2527. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluosol-da
    n1=Okihiro (syndrome de) | n2=en:fluosol-da | rel=r_associated | relid=0 | w=10
  2528. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluoxetine
    n1=Okihiro (syndrome de) | n2=en:fluoxetine | rel=r_associated | relid=0 | w=10
  2529. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluoxetine 25 mg / olanzapine 12 mg oral capsule [symbyax]
    n1=Okihiro (syndrome de) | n2=en:fluoxetine 25 mg / olanzapine 12 mg oral capsule [symbyax] | rel=r_associated | relid=0 | w=10
  2530. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluoxetine 25 mg / olanzapine 3 mg oral capsule [symbyax]
    n1=Okihiro (syndrome de) | n2=en:fluoxetine 25 mg / olanzapine 3 mg oral capsule [symbyax] | rel=r_associated | relid=0 | w=10
  2531. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluoxetine 25 mg / olanzapine 6 mg oral capsule [symbyax]
    n1=Okihiro (syndrome de) | n2=en:fluoxetine 25 mg / olanzapine 6 mg oral capsule [symbyax] | rel=r_associated | relid=0 | w=10
  2532. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluoxetine 50 mg / olanzapine 12 mg oral capsule [symbyax]
    n1=Okihiro (syndrome de) | n2=en:fluoxetine 50 mg / olanzapine 12 mg oral capsule [symbyax] | rel=r_associated | relid=0 | w=10
  2533. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluoxetine 50 mg / olanzapine 6 mg oral capsule [symbyax]
    n1=Okihiro (syndrome de) | n2=en:fluoxetine 50 mg / olanzapine 6 mg oral capsule [symbyax] | rel=r_associated | relid=0 | w=10
  2534. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluoxymesterone
    n1=Okihiro (syndrome de) | n2=en:fluoxymesterone | rel=r_associated | relid=0 | w=10
  2535. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluphenazine
    n1=Okihiro (syndrome de) | n2=en:fluphenazine | rel=r_associated | relid=0 | w=10
  2536. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluphenazine decanoate
    n1=Okihiro (syndrome de) | n2=en:fluphenazine decanoate | rel=r_associated | relid=0 | w=10
  2537. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluphenazine enanthate
    n1=Okihiro (syndrome de) | n2=en:fluphenazine enanthate | rel=r_associated | relid=0 | w=10
  2538. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluphenazine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:fluphenazine hydrochloride | rel=r_associated | relid=0 | w=10
  2539. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flurazepam
    n1=Okihiro (syndrome de) | n2=en:flurazepam | rel=r_associated | relid=0 | w=10
  2540. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flurazepam hydrochloride
    n1=Okihiro (syndrome de) | n2=en:flurazepam hydrochloride | rel=r_associated | relid=0 | w=10
  2541. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flurazepam monohydrochloride
    n1=Okihiro (syndrome de) | n2=en:flurazepam monohydrochloride | rel=r_associated | relid=0 | w=10
  2542. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flurbiprofen
    n1=Okihiro (syndrome de) | n2=en:flurbiprofen | rel=r_associated | relid=0 | w=10
  2543. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flurocitabine
    n1=Okihiro (syndrome de) | n2=en:flurocitabine | rel=r_associated | relid=0 | w=10
  2544. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluspiperone
    n1=Okihiro (syndrome de) | n2=en:fluspiperone | rel=r_associated | relid=0 | w=10
  2545. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flutamide
    n1=Okihiro (syndrome de) | n2=en:flutamide | rel=r_associated | relid=0 | w=10
  2546. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flutazolam
    n1=Okihiro (syndrome de) | n2=en:flutazolam | rel=r_associated | relid=0 | w=10
  2547. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flutemazepam
    n1=Okihiro (syndrome de) | n2=en:flutemazepam | rel=r_associated | relid=0 | w=10
  2548. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flutemetamol f 18
    n1=Okihiro (syndrome de) | n2=en:flutemetamol f 18 | rel=r_associated | relid=0 | w=10
  2549. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluticasone + vilanterol
    n1=Okihiro (syndrome de) | n2=en:fluticasone + vilanterol | rel=r_associated | relid=0 | w=10
  2550. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluticasone propionate
    n1=Okihiro (syndrome de) | n2=en:fluticasone propionate | rel=r_associated | relid=0 | w=10
  2551. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:flutoprazepam
    n1=Okihiro (syndrome de) | n2=en:flutoprazepam | rel=r_associated | relid=0 | w=10
  2552. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluvastatin sodium
    n1=Okihiro (syndrome de) | n2=en:fluvastatin sodium | rel=r_associated | relid=0 | w=10
  2553. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluvoxamine
    n1=Okihiro (syndrome de) | n2=en:fluvoxamine | rel=r_associated | relid=0 | w=10
  2554. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluvoxamine maleate
    n1=Okihiro (syndrome de) | n2=en:fluvoxamine maleate | rel=r_associated | relid=0 | w=10
  2555. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fluzoparib
    n1=Okihiro (syndrome de) | n2=en:fluzoparib | rel=r_associated | relid=0 | w=10
  2556. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fms inhibitor jnj-40346527
    n1=Okihiro (syndrome de) | n2=en:fms inhibitor jnj-40346527 | rel=r_associated | relid=0 | w=10
  2557. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fms/trk tyrosine kinase inhibitor plx7486
    n1=Okihiro (syndrome de) | n2=en:fms/trk tyrosine kinase inhibitor plx7486 | rel=r_associated | relid=0 | w=10
  2558. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folate binding protein e39 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:folate binding protein e39 peptide vaccine | rel=r_associated | relid=0 | w=10
  2559. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folate binding protein j65 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:folate binding protein j65 peptide vaccine | rel=r_associated | relid=0 | w=10
  2560. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folate receptor alpha-loaded dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:folate receptor alpha-loaded dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  2561. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folate receptor targeted epothilone bms753493
    n1=Okihiro (syndrome de) | n2=en:folate receptor targeted epothilone bms753493 | rel=r_associated | relid=0 | w=10
  2562. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folate receptor-targeted technetium tc-99m ec20
    n1=Okihiro (syndrome de) | n2=en:folate receptor-targeted technetium tc-99m ec20 | rel=r_associated | relid=0 | w=10
  2563. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folate receptor-targeted tubulysin conjugate ec1456
    n1=Okihiro (syndrome de) | n2=en:folate receptor-targeted tubulysin conjugate ec1456 | rel=r_associated | relid=0 | w=10
  2564. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folate receptor-targeted vinca alkaloid ec0489
    n1=Okihiro (syndrome de) | n2=en:folate receptor-targeted vinca alkaloid ec0489 | rel=r_associated | relid=0 | w=10
  2565. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225
    n1=Okihiro (syndrome de) | n2=en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225 | rel=r_associated | relid=0 | w=10
  2566. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folate-fitc
    n1=Okihiro (syndrome de) | n2=en:folate-fitc | rel=r_associated | relid=0 | w=10
  2567. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folfiri regimen
    n1=Okihiro (syndrome de) | n2=en:folfiri regimen | rel=r_associated | relid=0 | w=10
  2568. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folfiri-bevacizumab regimen
    n1=Okihiro (syndrome de) | n2=en:folfiri-bevacizumab regimen | rel=r_associated | relid=0 | w=10
  2569. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folfiri-cetuximab regimen
    n1=Okihiro (syndrome de) | n2=en:folfiri-cetuximab regimen | rel=r_associated | relid=0 | w=10
  2570. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folfirinox regimen
    n1=Okihiro (syndrome de) | n2=en:folfirinox regimen | rel=r_associated | relid=0 | w=10
  2571. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folfox regimen
    n1=Okihiro (syndrome de) | n2=en:folfox regimen | rel=r_associated | relid=0 | w=10
  2572. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folic acid
    n1=Okihiro (syndrome de) | n2=en:folic acid | rel=r_associated | relid=0 | w=10
  2573. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:folitixorin
    n1=Okihiro (syndrome de) | n2=en:folitixorin | rel=r_associated | relid=0 | w=10
  2574. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fomivirsen
    n1=Okihiro (syndrome de) | n2=en:fomivirsen | rel=r_associated | relid=0 | w=10
  2575. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fondaparinux sodium
    n1=Okihiro (syndrome de) | n2=en:fondaparinux sodium | rel=r_associated | relid=0 | w=10
  2576. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:foramen magnum
    n1=Okihiro (syndrome de) | n2=en:foramen magnum | rel=r_associated | relid=0 | w=10
  2577. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:foretinib
    n1=Okihiro (syndrome de) | n2=en:foretinib | rel=r_associated | relid=0 | w=10
  2578. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:formestane
    n1=Okihiro (syndrome de) | n2=en:formestane | rel=r_associated | relid=0 | w=10
  2579. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:formoterol fumarate oral
    n1=Okihiro (syndrome de) | n2=en:formoterol fumarate oral | rel=r_associated | relid=0 | w=10
  2580. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:formoterol fumarate/roxithromycin
    n1=Okihiro (syndrome de) | n2=en:formoterol fumarate/roxithromycin | rel=r_associated | relid=0 | w=10
  2581. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:forodesine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:forodesine hydrochloride | rel=r_associated | relid=0 | w=10
  2582. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fosamprenavir
    n1=Okihiro (syndrome de) | n2=en:fosamprenavir | rel=r_associated | relid=0 | w=10
  2583. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fosaprepitant dimeglumine
    n1=Okihiro (syndrome de) | n2=en:fosaprepitant dimeglumine | rel=r_associated | relid=0 | w=10
  2584. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fosazepam
    n1=Okihiro (syndrome de) | n2=en:fosazepam | rel=r_associated | relid=0 | w=10
  2585. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fosbretabulin disodium
    n1=Okihiro (syndrome de) | n2=en:fosbretabulin disodium | rel=r_associated | relid=0 | w=10
  2586. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fosbretabulin tromethamine
    n1=Okihiro (syndrome de) | n2=en:fosbretabulin tromethamine | rel=r_associated | relid=0 | w=10
  2587. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:foscarnet
    n1=Okihiro (syndrome de) | n2=en:foscarnet | rel=r_associated | relid=0 | w=10
  2588. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:foscarnet sodium
    n1=Okihiro (syndrome de) | n2=en:foscarnet sodium | rel=r_associated | relid=0 | w=10
  2589. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fosenazide
    n1=Okihiro (syndrome de) | n2=en:fosenazide | rel=r_associated | relid=0 | w=10
  2590. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fosfestrol
    n1=Okihiro (syndrome de) | n2=en:fosfestrol | rel=r_associated | relid=0 | w=10
  2591. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fosfomycin
    n1=Okihiro (syndrome de) | n2=en:fosfomycin | rel=r_associated | relid=0 | w=10
  2592. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fosfomycin tromethamine
    n1=Okihiro (syndrome de) | n2=en:fosfomycin tromethamine | rel=r_associated | relid=0 | w=10
  2593. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fosquidone
    n1=Okihiro (syndrome de) | n2=en:fosquidone | rel=r_associated | relid=0 | w=10
  2594. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fostamatinib disodium
    n1=Okihiro (syndrome de) | n2=en:fostamatinib disodium | rel=r_associated | relid=0 | w=10
  2595. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fostriecin
    n1=Okihiro (syndrome de) | n2=en:fostriecin | rel=r_associated | relid=0 | w=10
  2596. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fotemustine
    n1=Okihiro (syndrome de) | n2=en:fotemustine | rel=r_associated | relid=0 | w=10
  2597. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fowlpox virus vaccine vector
    n1=Okihiro (syndrome de) | n2=en:fowlpox virus vaccine vector | rel=r_associated | relid=0 | w=10
  2598. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fowlpox-ny-eso-1 vaccine
    n1=Okihiro (syndrome de) | n2=en:fowlpox-ny-eso-1 vaccine | rel=r_associated | relid=0 | w=10
  2599. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fowlpox-psa-tricom vaccine
    n1=Okihiro (syndrome de) | n2=en:fowlpox-psa-tricom vaccine | rel=r_associated | relid=0 | w=10
  2600. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:freeze-dried black raspberry bioadhesive gel
    n1=Okihiro (syndrome de) | n2=en:freeze-dried black raspberry bioadhesive gel | rel=r_associated | relid=0 | w=10
  2601. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:french maritime pine bark extract
    n1=Okihiro (syndrome de) | n2=en:french maritime pine bark extract | rel=r_associated | relid=0 | w=10
  2602. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fresolimumab
    n1=Okihiro (syndrome de) | n2=en:fresolimumab | rel=r_associated | relid=0 | w=10
  2603. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:freund's adjuvant
    n1=Okihiro (syndrome de) | n2=en:freund's adjuvant | rel=r_associated | relid=0 | w=10
  2604. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fructooligosaccharide supplement
    n1=Okihiro (syndrome de) | n2=en:fructooligosaccharide supplement | rel=r_associated | relid=0 | w=10
  2605. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fructooligosaccharide/lactobacillus paracasei/lactobacillus rhamnosus/lactobacillus acidophilus/bifidobacterium lactis probiotic supplement
    n1=Okihiro (syndrome de) | n2=en:fructooligosaccharide/lactobacillus paracasei/lactobacillus rhamnosus/lactobacillus acidophilus/bifidobacterium lactis probiotic supplement | rel=r_associated | relid=0 | w=10
  2606. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fruit and vegetable extract
    n1=Okihiro (syndrome de) | n2=en:fruit and vegetable extract | rel=r_associated | relid=0 | w=10
  2607. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fruquintinib
    n1=Okihiro (syndrome de) | n2=en:fruquintinib | rel=r_associated | relid=0 | w=10
  2608. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ft-2102
    n1=Okihiro (syndrome de) | n2=en:ft-2102 | rel=r_associated | relid=0 | w=10
  2609. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fu-lv regimen
    n1=Okihiro (syndrome de) | n2=en:fu-lv regimen | rel=r_associated | relid=0 | w=10
  2610. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fulranumab
    n1=Okihiro (syndrome de) | n2=en:fulranumab | rel=r_associated | relid=0 | w=10
  2611. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fulvestrant
    n1=Okihiro (syndrome de) | n2=en:fulvestrant | rel=r_associated | relid=0 | w=10
  2612. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fumagillin-derived polymer conjugate xmt-1107
    n1=Okihiro (syndrome de) | n2=en:fumagillin-derived polymer conjugate xmt-1107 | rel=r_associated | relid=0 | w=10
  2613. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:furosemide
    n1=Okihiro (syndrome de) | n2=en:furosemide | rel=r_associated | relid=0 | w=10
  2614. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fursultiamine
    n1=Okihiro (syndrome de) | n2=en:fursultiamine | rel=r_associated | relid=0 | w=10
  2615. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fusidic acid
    n1=Okihiro (syndrome de) | n2=en:fusidic acid | rel=r_associated | relid=0 | w=10
  2616. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:fusidic acid/betamethasone valerate topical cream
    n1=Okihiro (syndrome de) | n2=en:fusidic acid/betamethasone valerate topical cream | rel=r_associated | relid=0 | w=10
  2617. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:g-quadruplex stabilizer bmvc
    n1=Okihiro (syndrome de) | n2=en:g-quadruplex stabilizer bmvc | rel=r_associated | relid=0 | w=10
  2618. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:g207
    n1=Okihiro (syndrome de) | n2=en:g207 | rel=r_associated | relid=0 | w=10
  2619. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:g250 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:g250 peptide vaccine | rel=r_associated | relid=0 | w=10
  2620. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ga-68-labeled f(ab') 2- trastuzumab
    n1=Okihiro (syndrome de) | n2=en:ga-68-labeled f(ab') 2- trastuzumab | rel=r_associated | relid=0 | w=10
  2621. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gaba a antagonists [moa]
    n1=Okihiro (syndrome de) | n2=en:gaba a antagonists [moa] | rel=r_associated | relid=0 | w=10
  2622. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gabapentin
    n1=Okihiro (syndrome de) | n2=en:gabapentin | rel=r_associated | relid=0 | w=10
  2623. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gabapentin enacarbil
    n1=Okihiro (syndrome de) | n2=en:gabapentin enacarbil | rel=r_associated | relid=0 | w=10
  2624. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gadobenate dimeglumine
    n1=Okihiro (syndrome de) | n2=en:gadobenate dimeglumine | rel=r_associated | relid=0 | w=10
  2625. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gadobutrol
    n1=Okihiro (syndrome de) | n2=en:gadobutrol | rel=r_associated | relid=0 | w=10
  2626. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gadodiamide
    n1=Okihiro (syndrome de) | n2=en:gadodiamide | rel=r_associated | relid=0 | w=10
  2627. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gadofosveset trisodium
    n1=Okihiro (syndrome de) | n2=en:gadofosveset trisodium | rel=r_associated | relid=0 | w=10
  2628. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gadolinium and/or gadolinium compound
    n1=Okihiro (syndrome de) | n2=en:gadolinium and/or gadolinium compound | rel=r_associated | relid=0 | w=10
  2629. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gadolinium-chelate
    n1=Okihiro (syndrome de) | n2=en:gadolinium-chelate | rel=r_associated | relid=0 | w=10
  2630. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gadopentetate dimeglumine
    n1=Okihiro (syndrome de) | n2=en:gadopentetate dimeglumine | rel=r_associated | relid=0 | w=10
  2631. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gadoterate meglumine
    n1=Okihiro (syndrome de) | n2=en:gadoterate meglumine | rel=r_associated | relid=0 | w=10
  2632. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gadoteridol
    n1=Okihiro (syndrome de) | n2=en:gadoteridol | rel=r_associated | relid=0 | w=10
  2633. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gadoxetate disodium
    n1=Okihiro (syndrome de) | n2=en:gadoxetate disodium | rel=r_associated | relid=0 | w=10
  2634. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gag:267-274 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:gag:267-274 peptide vaccine | rel=r_associated | relid=0 | w=10
  2635. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:galactomannan derivative
    n1=Okihiro (syndrome de) | n2=en:galactomannan derivative | rel=r_associated | relid=0 | w=10
  2636. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:galactose
    n1=Okihiro (syndrome de) | n2=en:galactose | rel=r_associated | relid=0 | w=10
  2637. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:galantamine hydrobromide
    n1=Okihiro (syndrome de) | n2=en:galantamine hydrobromide | rel=r_associated | relid=0 | w=10
  2638. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:galectin inhibitor gr-md-02
    n1=Okihiro (syndrome de) | n2=en:galectin inhibitor gr-md-02 | rel=r_associated | relid=0 | w=10
  2639. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:galectin-1 inhibitor otx008
    n1=Okihiro (syndrome de) | n2=en:galectin-1 inhibitor otx008 | rel=r_associated | relid=0 | w=10
  2640. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:galeterone
    n1=Okihiro (syndrome de) | n2=en:galeterone | rel=r_associated | relid=0 | w=10
  2641. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:galiximab
    n1=Okihiro (syndrome de) | n2=en:galiximab | rel=r_associated | relid=0 | w=10
  2642. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium citrate ga-67
    n1=Okihiro (syndrome de) | n2=en:gallium citrate ga-67 | rel=r_associated | relid=0 | w=10
  2643. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68 citrate
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68 citrate | rel=r_associated | relid=0 | w=10
  2644. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68 dota-jr11
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68 dota-jr11 | rel=r_associated | relid=0 | w=10
  2645. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68 ops202
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68 ops202 | rel=r_associated | relid=0 | w=10
  2646. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-dota-exendin-4
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-dota-exendin-4 | rel=r_associated | relid=0 | w=10
  2647. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-dotanoc
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-dotanoc | rel=r_associated | relid=0 | w=10
  2648. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-dotatate
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-dotatate | rel=r_associated | relid=0 | w=10
  2649. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-edotreotide
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-edotreotide | rel=r_associated | relid=0 | w=10
  2650. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-labeled affibody aby-025
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-labeled affibody aby-025 | rel=r_associated | relid=0 | w=10
  2651. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-labeled bnota-prgd2
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-labeled bnota-prgd2 | rel=r_associated | relid=0 | w=10
  2652. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-labeled dota di-hsg peptide imp-288
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-labeled dota di-hsg peptide imp-288 | rel=r_associated | relid=0 | w=10
  2653. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-labeled grpr antagonist bay86-7548
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-labeled grpr antagonist bay86-7548 | rel=r_associated | relid=0 | w=10
  2654. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-labeled mln6907
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-labeled mln6907 | rel=r_associated | relid=0 | w=10
  2655. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-labeled psma ligand glu-urea-lys(ahx)-hbed-cc
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-labeled psma ligand glu-urea-lys(ahx)-hbed-cc | rel=r_associated | relid=0 | w=10
  2656. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-labeled-nodaga-mj9
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-labeled-nodaga-mj9 | rel=r_associated | relid=0 | w=10
  2657. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-neb
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-neb | rel=r_associated | relid=0 | w=10
  2658. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-nota-aca-bbn(7-14)
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-nota-aca-bbn(7-14) | rel=r_associated | relid=0 | w=10
  2659. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-nota-ae105
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-nota-ae105 | rel=r_associated | relid=0 | w=10
  2660. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-nota-bbn(7-14)-rgd
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-nota-bbn(7-14)-rgd | rel=r_associated | relid=0 | w=10
  2661. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-nota-nfb
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-nota-nfb | rel=r_associated | relid=0 | w=10
  2662. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium ga 68-rgd
    n1=Okihiro (syndrome de) | n2=en:gallium ga 68-rgd | rel=r_associated | relid=0 | w=10
  2663. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium maltolate
    n1=Okihiro (syndrome de) | n2=en:gallium maltolate | rel=r_associated | relid=0 | w=10
  2664. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gallium nitrate
    n1=Okihiro (syndrome de) | n2=en:gallium nitrate | rel=r_associated | relid=0 | w=10
  2665. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:galnac-anti-c5 sirna aln-cc5
    n1=Okihiro (syndrome de) | n2=en:galnac-anti-c5 sirna aln-cc5 | rel=r_associated | relid=0 | w=10
  2666. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:galunisertib
    n1=Okihiro (syndrome de) | n2=en:galunisertib | rel=r_associated | relid=0 | w=10
  2667. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gamboge resin extract tsb-9-w1
    n1=Okihiro (syndrome de) | n2=en:gamboge resin extract tsb-9-w1 | rel=r_associated | relid=0 | w=10
  2668. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gamma secretase inhibitor pf-03084014
    n1=Okihiro (syndrome de) | n2=en:gamma secretase inhibitor pf-03084014 | rel=r_associated | relid=0 | w=10
  2669. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gamma-delta tocotrienol
    n1=Okihiro (syndrome de) | n2=en:gamma-delta tocotrienol | rel=r_associated | relid=0 | w=10
  2670. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gamma-secretase inhibitor ly3039478
    n1=Okihiro (syndrome de) | n2=en:gamma-secretase inhibitor ly3039478 | rel=r_associated | relid=0 | w=10
  2671. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gamma-secretase inhibitor ro4929097
    n1=Okihiro (syndrome de) | n2=en:gamma-secretase inhibitor ro4929097 | rel=r_associated | relid=0 | w=10
  2672. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ganciclovir
    n1=Okihiro (syndrome de) | n2=en:ganciclovir | rel=r_associated | relid=0 | w=10
  2673. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gandotinib
    n1=Okihiro (syndrome de) | n2=en:gandotinib | rel=r_associated | relid=0 | w=10
  2674. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ganetespib
    n1=Okihiro (syndrome de) | n2=en:ganetespib | rel=r_associated | relid=0 | w=10
  2675. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ganglioside gd2
    n1=Okihiro (syndrome de) | n2=en:ganglioside gd2 | rel=r_associated | relid=0 | w=10
  2676. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ganglioside gm2
    n1=Okihiro (syndrome de) | n2=en:ganglioside gm2 | rel=r_associated | relid=0 | w=10
  2677. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ganitumab
    n1=Okihiro (syndrome de) | n2=en:ganitumab | rel=r_associated | relid=0 | w=10
  2678. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ganoderma lucidum spores powder capsule
    n1=Okihiro (syndrome de) | n2=en:ganoderma lucidum spores powder capsule | rel=r_associated | relid=0 | w=10
  2679. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:garlic extract
    n1=Okihiro (syndrome de) | n2=en:garlic extract | rel=r_associated | relid=0 | w=10
  2680. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gastrin immunotoxin
    n1=Okihiro (syndrome de) | n2=en:gastrin immunotoxin | rel=r_associated | relid=0 | w=10
  2681. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gastroenteral dosage form product
    n1=Okihiro (syndrome de) | n2=en:gastroenteral dosage form product | rel=r_associated | relid=0 | w=10
  2682. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gastrointestinal agents
    n1=Okihiro (syndrome de) | n2=en:gastrointestinal agents | rel=r_associated | relid=0 | w=10
  2683. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gataparsen sodium
    n1=Okihiro (syndrome de) | n2=en:gataparsen sodium | rel=r_associated | relid=0 | w=10
  2684. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gavilimomab
    n1=Okihiro (syndrome de) | n2=en:gavilimomab | rel=r_associated | relid=0 | w=10
  2685. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gd2 lactone/gd3 lactone-klh conjugate bivalent vaccine
    n1=Okihiro (syndrome de) | n2=en:gd2 lactone/gd3 lactone-klh conjugate bivalent vaccine | rel=r_associated | relid=0 | w=10
  2686. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gd2-car-expressing autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:gd2-car-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  2687. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gd2-klh vaccine
    n1=Okihiro (syndrome de) | n2=en:gd2-klh vaccine | rel=r_associated | relid=0 | w=10
  2688. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gdc-0349
    n1=Okihiro (syndrome de) | n2=en:gdc-0349 | rel=r_associated | relid=0 | w=10
  2689. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gedatolisib
    n1=Okihiro (syndrome de) | n2=en:gedatolisib | rel=r_associated | relid=0 | w=10
  2690. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gefitinib
    n1=Okihiro (syndrome de) | n2=en:gefitinib | rel=r_associated | relid=0 | w=10
  2691. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gel protein, gelonium multiflorum
    n1=Okihiro (syndrome de) | n2=en:gel protein, gelonium multiflorum | rel=r_associated | relid=0 | w=10
  2692. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gelatin
    n1=Okihiro (syndrome de) | n2=en:gelatin | rel=r_associated | relid=0 | w=10
  2693. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gem 231
    n1=Okihiro (syndrome de) | n2=en:gem 231 | rel=r_associated | relid=0 | w=10
  2694. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gemcitabine elaidate
    n1=Okihiro (syndrome de) | n2=en:gemcitabine elaidate | rel=r_associated | relid=0 | w=10
  2695. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gemcitabine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:gemcitabine hydrochloride | rel=r_associated | relid=0 | w=10
  2696. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gemcitabine hydrochloride emulsion
    n1=Okihiro (syndrome de) | n2=en:gemcitabine hydrochloride emulsion | rel=r_associated | relid=0 | w=10
  2697. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gemcitabine prodrug ly2334737
    n1=Okihiro (syndrome de) | n2=en:gemcitabine prodrug ly2334737 | rel=r_associated | relid=0 | w=10
  2698. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gemcitabine-cisplatin regimen
    n1=Okihiro (syndrome de) | n2=en:gemcitabine-cisplatin regimen | rel=r_associated | relid=0 | w=10
  2699. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gemcitabine-erlotinib regimen
    n1=Okihiro (syndrome de) | n2=en:gemcitabine-erlotinib regimen | rel=r_associated | relid=0 | w=10
  2700. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gemcitabine-oxaliplatin regimen
    n1=Okihiro (syndrome de) | n2=en:gemcitabine-oxaliplatin regimen | rel=r_associated | relid=0 | w=10
  2701. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gemcitabine-phosphoramidate hydrochloride nuc-1031
    n1=Okihiro (syndrome de) | n2=en:gemcitabine-phosphoramidate hydrochloride nuc-1031 | rel=r_associated | relid=0 | w=10
  2702. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gemfibrozil
    n1=Okihiro (syndrome de) | n2=en:gemfibrozil | rel=r_associated | relid=0 | w=10
  2703. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gemigliptin
    n1=Okihiro (syndrome de) | n2=en:gemigliptin | rel=r_associated | relid=0 | w=10
  2704. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gemtuzumab ozogamicin
    n1=Okihiro (syndrome de) | n2=en:gemtuzumab ozogamicin | rel=r_associated | relid=0 | w=10
  2705. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gene-modified hiv-protected hematopoietic stem cells
    n1=Okihiro (syndrome de) | n2=en:gene-modified hiv-protected hematopoietic stem cells | rel=r_associated | relid=0 | w=10
  2706. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:generic drug
    n1=Okihiro (syndrome de) | n2=en:generic drug | rel=r_associated | relid=0 | w=10
  2707. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:genetically engineered ny-eso-1-specific t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:genetically engineered ny-eso-1-specific t lymphocytes | rel=r_associated | relid=0 | w=10
  2708. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:genetically-modified mage-a3-expressing mg1 maraba virus vaccine
    n1=Okihiro (syndrome de) | n2=en:genetically-modified mage-a3-expressing mg1 maraba virus vaccine | rel=r_associated | relid=0 | w=10
  2709. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:genistein
    n1=Okihiro (syndrome de) | n2=en:genistein | rel=r_associated | relid=0 | w=10
  2710. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:genital system agent
    n1=Okihiro (syndrome de) | n2=en:genital system agent | rel=r_associated | relid=0 | w=10
  2711. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gentamicin
    n1=Okihiro (syndrome de) | n2=en:gentamicin | rel=r_associated | relid=0 | w=10
  2712. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gentian violet
    n1=Okihiro (syndrome de) | n2=en:gentian violet | rel=r_associated | relid=0 | w=10
  2713. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:geranylgeranyltransferase i inhibitor
    n1=Okihiro (syndrome de) | n2=en:geranylgeranyltransferase i inhibitor | rel=r_associated | relid=0 | w=10
  2714. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ghrelin peptide analogue
    n1=Okihiro (syndrome de) | n2=en:ghrelin peptide analogue | rel=r_associated | relid=0 | w=10
  2715. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gi-4000 vaccine
    n1=Okihiro (syndrome de) | n2=en:gi-4000 vaccine | rel=r_associated | relid=0 | w=10
  2716. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gidazepam
    n1=Okihiro (syndrome de) | n2=en:gidazepam | rel=r_associated | relid=0 | w=10
  2717. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gilteritinib
    n1=Okihiro (syndrome de) | n2=en:gilteritinib | rel=r_associated | relid=0 | w=10
  2718. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gimatecan
    n1=Okihiro (syndrome de) | n2=en:gimatecan | rel=r_associated | relid=0 | w=10
  2719. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gimeracil
    n1=Okihiro (syndrome de) | n2=en:gimeracil | rel=r_associated | relid=0 | w=10
  2720. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ginger extract
    n1=Okihiro (syndrome de) | n2=en:ginger extract | rel=r_associated | relid=0 | w=10
  2721. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ginkgo
    n1=Okihiro (syndrome de) | n2=en:ginkgo | rel=r_associated | relid=0 | w=10
  2722. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ginseng compound
    n1=Okihiro (syndrome de) | n2=en:ginseng compound | rel=r_associated | relid=0 | w=10
  2723. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ginsenoside rg3 capsule
    n1=Okihiro (syndrome de) | n2=en:ginsenoside rg3 capsule | rel=r_associated | relid=0 | w=10
  2724. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:girentuximab
    n1=Okihiro (syndrome de) | n2=en:girentuximab | rel=r_associated | relid=0 | w=10
  2725. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gitr agonist medi1873
    n1=Okihiro (syndrome de) | n2=en:gitr agonist medi1873 | rel=r_associated | relid=0 | w=10
  2726. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gitrl rna-transfected autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:gitrl rna-transfected autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  2727. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:givinostat
    n1=Okihiro (syndrome de) | n2=en:givinostat | rel=r_associated | relid=0 | w=10
  2728. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gk567
    n1=Okihiro (syndrome de) | n2=en:gk567 | rel=r_associated | relid=0 | w=10
  2729. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glatiramer
    n1=Okihiro (syndrome de) | n2=en:glatiramer | rel=r_associated | relid=0 | w=10
  2730. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glembatumumab vedotin
    n1=Okihiro (syndrome de) | n2=en:glembatumumab vedotin | rel=r_associated | relid=0 | w=10
  2731. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glibornuride
    n1=Okihiro (syndrome de) | n2=en:glibornuride | rel=r_associated | relid=0 | w=10
  2732. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gliclazide
    n1=Okihiro (syndrome de) | n2=en:gliclazide | rel=r_associated | relid=0 | w=10
  2733. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glimepiride
    n1=Okihiro (syndrome de) | n2=en:glimepiride | rel=r_associated | relid=0 | w=10
  2734. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glioblastoma cancer vaccine erc1671
    n1=Okihiro (syndrome de) | n2=en:glioblastoma cancer vaccine erc1671 | rel=r_associated | relid=0 | w=10
  2735. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glioblastoma multiforme multipeptide vaccine ima950
    n1=Okihiro (syndrome de) | n2=en:glioblastoma multiforme multipeptide vaccine ima950 | rel=r_associated | relid=0 | w=10
  2736. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  2737. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glioma-associated peptide-loaded dendritic cell vaccine sl-701
    n1=Okihiro (syndrome de) | n2=en:glioma-associated peptide-loaded dendritic cell vaccine sl-701 | rel=r_associated | relid=0 | w=10
  2738. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glipizide
    n1=Okihiro (syndrome de) | n2=en:glipizide | rel=r_associated | relid=0 | w=10
  2739. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gliquidone
    n1=Okihiro (syndrome de) | n2=en:gliquidone | rel=r_associated | relid=0 | w=10
  2740. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glisoxepide
    n1=Okihiro (syndrome de) | n2=en:glisoxepide | rel=r_associated | relid=0 | w=10
  2741. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:globo h-dt vaccine obi-833
    n1=Okihiro (syndrome de) | n2=en:globo h-dt vaccine obi-833 | rel=r_associated | relid=0 | w=10
  2742. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:globo h-gm2-lewis-y-muc1-32-mer-tf(c)-tn(c)-klh conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:globo h-gm2-lewis-y-muc1-32-mer-tf(c)-tn(c)-klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  2743. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:globo h-klh immunostimulant opt-822
    n1=Okihiro (syndrome de) | n2=en:globo h-klh immunostimulant opt-822 | rel=r_associated | relid=0 | w=10
  2744. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  2745. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:globulin component macrophage-activating factor
    n1=Okihiro (syndrome de) | n2=en:globulin component macrophage-activating factor | rel=r_associated | relid=0 | w=10
  2746. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glse compound
    n1=Okihiro (syndrome de) | n2=en:glse compound | rel=r_associated | relid=0 | w=10
  2747. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glucagon
    n1=Okihiro (syndrome de) | n2=en:glucagon | rel=r_associated | relid=0 | w=10
  2748. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glucarpidase
    n1=Okihiro (syndrome de) | n2=en:glucarpidase | rel=r_associated | relid=0 | w=10
  2749. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glucocorticoid receptor antagonist cort125134
    n1=Okihiro (syndrome de) | n2=en:glucocorticoid receptor antagonist cort125134 | rel=r_associated | relid=0 | w=10
  2750. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glucosamine
    n1=Okihiro (syndrome de) | n2=en:glucosamine | rel=r_associated | relid=0 | w=10
  2751. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glucosamine sulfate/chondroitin sulfate tablet
    n1=Okihiro (syndrome de) | n2=en:glucosamine sulfate/chondroitin sulfate tablet | rel=r_associated | relid=0 | w=10
  2752. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glucosylceramidase
    n1=Okihiro (syndrome de) | n2=en:glucosylceramidase | rel=r_associated | relid=0 | w=10
  2753. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glucuronic acid
    n1=Okihiro (syndrome de) | n2=en:glucuronic acid | rel=r_associated | relid=0 | w=10
  2754. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glufosfamide
    n1=Okihiro (syndrome de) | n2=en:glufosfamide | rel=r_associated | relid=0 | w=10
  2755. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glutamic acid
    n1=Okihiro (syndrome de) | n2=en:glutamic acid | rel=r_associated | relid=0 | w=10
  2756. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glutaminase inhibitor cb-839
    n1=Okihiro (syndrome de) | n2=en:glutaminase inhibitor cb-839 | rel=r_associated | relid=0 | w=10
  2757. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glutaminase-asparaginase
    n1=Okihiro (syndrome de) | n2=en:glutaminase-asparaginase | rel=r_associated | relid=0 | w=10
  2758. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glutamine
    n1=Okihiro (syndrome de) | n2=en:glutamine | rel=r_associated | relid=0 | w=10
  2759. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glutathione
    n1=Okihiro (syndrome de) | n2=en:glutathione | rel=r_associated | relid=0 | w=10
  2760. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glutathione disulfide nov-002
    n1=Okihiro (syndrome de) | n2=en:glutathione disulfide nov-002 | rel=r_associated | relid=0 | w=10
  2761. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glutathione pegylated liposomal doxorubicin hydrochloride formulation 2b3-101
    n1=Okihiro (syndrome de) | n2=en:glutathione pegylated liposomal doxorubicin hydrochloride formulation 2b3-101 | rel=r_associated | relid=0 | w=10
  2762. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gluten-free compact nutritional supplement drink
    n1=Okihiro (syndrome de) | n2=en:gluten-free compact nutritional supplement drink | rel=r_associated | relid=0 | w=10
  2763. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gluten-free dha/epa/gla/antioxidant-rich nutritional liquid
    n1=Okihiro (syndrome de) | n2=en:gluten-free dha/epa/gla/antioxidant-rich nutritional liquid | rel=r_associated | relid=0 | w=10
  2764. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gluten-free/fiber-enriched compact nutritional supplement drink
    n1=Okihiro (syndrome de) | n2=en:gluten-free/fiber-enriched compact nutritional supplement drink | rel=r_associated | relid=0 | w=10
  2765. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glutethimide
    n1=Okihiro (syndrome de) | n2=en:glutethimide | rel=r_associated | relid=0 | w=10
  2766. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glyburide
    n1=Okihiro (syndrome de) | n2=en:glyburide | rel=r_associated | relid=0 | w=10
  2767. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glycerin cream (10%)
    n1=Okihiro (syndrome de) | n2=en:glycerin cream (10%) | rel=r_associated | relid=0 | w=10
  2768. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glycerin enema
    n1=Okihiro (syndrome de) | n2=en:glycerin enema | rel=r_associated | relid=0 | w=10
  2769. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glyceryl trioleate
    n1=Okihiro (syndrome de) | n2=en:glyceryl trioleate | rel=r_associated | relid=0 | w=10
  2770. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glycine
    n1=Okihiro (syndrome de) | n2=en:glycine | rel=r_associated | relid=0 | w=10
  2771. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glycooptimized trastuzumab-gex
    n1=Okihiro (syndrome de) | n2=en:glycooptimized trastuzumab-gex | rel=r_associated | relid=0 | w=10
  2772. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glycopeptide antibiotic
    n1=Okihiro (syndrome de) | n2=en:glycopeptide antibiotic | rel=r_associated | relid=0 | w=10
  2773. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glycopyrrolate
    n1=Okihiro (syndrome de) | n2=en:glycopyrrolate | rel=r_associated | relid=0 | w=10
  2774. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glycoside
    n1=Okihiro (syndrome de) | n2=en:glycoside | rel=r_associated | relid=0 | w=10
  2775. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glycosylated recombinant human g-csf avi-014
    n1=Okihiro (syndrome de) | n2=en:glycosylated recombinant human g-csf avi-014 | rel=r_associated | relid=0 | w=10
  2776. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glycosylated recombinant human interleukin-7
    n1=Okihiro (syndrome de) | n2=en:glycosylated recombinant human interleukin-7 | rel=r_associated | relid=0 | w=10
  2777. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glycyrrhiza glabra root
    n1=Okihiro (syndrome de) | n2=en:glycyrrhiza glabra root | rel=r_associated | relid=0 | w=10
  2778. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glycyrrhizin
    n1=Okihiro (syndrome de) | n2=en:glycyrrhizin | rel=r_associated | relid=0 | w=10
  2779. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glymidine
    n1=Okihiro (syndrome de) | n2=en:glymidine | rel=r_associated | relid=0 | w=10
  2780. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:glyt2/5ht2a antagonist vvz-149
    n1=Okihiro (syndrome de) | n2=en:glyt2/5ht2a antagonist vvz-149 | rel=r_associated | relid=0 | w=10
  2781. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gm-csf-encoding oncolytic adenovirus cgtg-102
    n1=Okihiro (syndrome de) | n2=en:gm-csf-encoding oncolytic adenovirus cgtg-102 | rel=r_associated | relid=0 | w=10
  2782. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gm-k562 cell vaccine
    n1=Okihiro (syndrome de) | n2=en:gm-k562 cell vaccine | rel=r_associated | relid=0 | w=10
  2783. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gm.cd40l cell vaccine
    n1=Okihiro (syndrome de) | n2=en:gm.cd40l cell vaccine | rel=r_associated | relid=0 | w=10
  2784. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gm2-klh vaccine
    n1=Okihiro (syndrome de) | n2=en:gm2-klh vaccine | rel=r_associated | relid=0 | w=10
  2785. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gm2/gd2/gd3 lactone-klh conjugate trivalent vaccine
    n1=Okihiro (syndrome de) | n2=en:gm2/gd2/gd3 lactone-klh conjugate trivalent vaccine | rel=r_associated | relid=0 | w=10
  2786. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gnrh antagonist tak-385
    n1=Okihiro (syndrome de) | n2=en:gnrh antagonist tak-385 | rel=r_associated | relid=0 | w=10
  2787. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gold and/or gold compound
    n1=Okihiro (syndrome de) | n2=en:gold and/or gold compound | rel=r_associated | relid=0 | w=10
  2788. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gold sodium thiomalate
    n1=Okihiro (syndrome de) | n2=en:gold sodium thiomalate | rel=r_associated | relid=0 | w=10
  2789. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:goldenrod
    n1=Okihiro (syndrome de) | n2=en:goldenrod | rel=r_associated | relid=0 | w=10
  2790. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:golnerminogene pradenovec
    n1=Okihiro (syndrome de) | n2=en:golnerminogene pradenovec | rel=r_associated | relid=0 | w=10
  2791. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:golotimod
    n1=Okihiro (syndrome de) | n2=en:golotimod | rel=r_associated | relid=0 | w=10
  2792. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:golvatinib
    n1=Okihiro (syndrome de) | n2=en:golvatinib | rel=r_associated | relid=0 | w=10
  2793. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gomiliximab
    n1=Okihiro (syndrome de) | n2=en:gomiliximab | rel=r_associated | relid=0 | w=10
  2794. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gonadotropin
    n1=Okihiro (syndrome de) | n2=en:gonadotropin | rel=r_associated | relid=0 | w=10
  2795. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gonadotropin-releasing hormone analog
    n1=Okihiro (syndrome de) | n2=en:gonadotropin-releasing hormone analog | rel=r_associated | relid=0 | w=10
  2796. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:goserelin acetate
    n1=Okihiro (syndrome de) | n2=en:goserelin acetate | rel=r_associated | relid=0 | w=10
  2797. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gossypol
    n1=Okihiro (syndrome de) | n2=en:gossypol | rel=r_associated | relid=0 | w=10
  2798. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gout suppressants
    n1=Okihiro (syndrome de) | n2=en:gout suppressants | rel=r_associated | relid=0 | w=10
  2799. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gp100 antigen
    n1=Okihiro (syndrome de) | n2=en:gp100 antigen | rel=r_associated | relid=0 | w=10
  2800. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gp100-fowlpox vaccine
    n1=Okihiro (syndrome de) | n2=en:gp100-fowlpox vaccine | rel=r_associated | relid=0 | w=10
  2801. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gp100:154-162 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:gp100:154-162 peptide vaccine | rel=r_associated | relid=0 | w=10
  2802. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gp100:209-217(210m) peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:gp100:209-217(210m) peptide vaccine | rel=r_associated | relid=0 | w=10
  2803. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gp100:280-288(288v) peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:gp100:280-288(288v) peptide vaccine | rel=r_associated | relid=0 | w=10
  2804. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gp2 peptide/gm-csf vaccine
    n1=Okihiro (syndrome de) | n2=en:gp2 peptide/gm-csf vaccine | rel=r_associated | relid=0 | w=10
  2805. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gp2013
    n1=Okihiro (syndrome de) | n2=en:gp2013 | rel=r_associated | relid=0 | w=10
  2806. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gp209-2m antigen
    n1=Okihiro (syndrome de) | n2=en:gp209-2m antigen | rel=r_associated | relid=0 | w=10
  2807. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gp96-secreting allogeneic bladder cancer cell vaccine hs-410
    n1=Okihiro (syndrome de) | n2=en:gp96-secreting allogeneic bladder cancer cell vaccine hs-410 | rel=r_associated | relid=0 | w=10
  2808. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gpi 1485
    n1=Okihiro (syndrome de) | n2=en:gpi 1485 | rel=r_associated | relid=0 | w=10
  2809. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gpi-0100
    n1=Okihiro (syndrome de) | n2=en:gpi-0100 | rel=r_associated | relid=0 | w=10
  2810. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gramicidin
    n1=Okihiro (syndrome de) | n2=en:gramicidin | rel=r_associated | relid=0 | w=10
  2811. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:granisetron hydrochloride
    n1=Okihiro (syndrome de) | n2=en:granisetron hydrochloride | rel=r_associated | relid=0 | w=10
  2812. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:granisetron hydrochloride nasal spray
    n1=Okihiro (syndrome de) | n2=en:granisetron hydrochloride nasal spray | rel=r_associated | relid=0 | w=10
  2813. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:granisetron transdermal patch
    n1=Okihiro (syndrome de) | n2=en:granisetron transdermal patch | rel=r_associated | relid=0 | w=10
  2814. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:greater tuberosity
    n1=Okihiro (syndrome de) | n2=en:greater tuberosity | rel=r_associated | relid=0 | w=10
  2815. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:green tea
    n1=Okihiro (syndrome de) | n2=en:green tea | rel=r_associated | relid=0 | w=10
  2816. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:green tea (dietary)
    n1=Okihiro (syndrome de) | n2=en:green tea (dietary) | rel=r_associated | relid=0 | w=10
  2817. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:green tea extract
    n1=Okihiro (syndrome de) | n2=en:green tea extract | rel=r_associated | relid=0 | w=10
  2818. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:green tea extract-based antioxidant supplement
    n1=Okihiro (syndrome de) | n2=en:green tea extract-based antioxidant supplement | rel=r_associated | relid=0 | w=10
  2819. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:green tea lozenge
    n1=Okihiro (syndrome de) | n2=en:green tea lozenge | rel=r_associated | relid=0 | w=10
  2820. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:griseofulvin and derivatives
    n1=Okihiro (syndrome de) | n2=en:griseofulvin and derivatives | rel=r_associated | relid=0 | w=10
  2821. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gs/pan-notch inhibitor bms-906024
    n1=Okihiro (syndrome de) | n2=en:gs/pan-notch inhibitor bms-906024 | rel=r_associated | relid=0 | w=10
  2822. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gs/pan-notch inhibitor bms-986115
    n1=Okihiro (syndrome de) | n2=en:gs/pan-notch inhibitor bms-986115 | rel=r_associated | relid=0 | w=10
  2823. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gsk-3 inhibitor ly2090314
    n1=Okihiro (syndrome de) | n2=en:gsk-3 inhibitor ly2090314 | rel=r_associated | relid=0 | w=10
  2824. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gti-2040
    n1=Okihiro (syndrome de) | n2=en:gti-2040 | rel=r_associated | relid=0 | w=10
  2825. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:guadecitabine
    n1=Okihiro (syndrome de) | n2=en:guadecitabine | rel=r_associated | relid=0 | w=10
  2826. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:guaifenesin and derivatives
    n1=Okihiro (syndrome de) | n2=en:guaifenesin and derivatives | rel=r_associated | relid=0 | w=10
  2827. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:guanabenz acetate
    n1=Okihiro (syndrome de) | n2=en:guanabenz acetate | rel=r_associated | relid=0 | w=10
  2828. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:guanazole
    n1=Okihiro (syndrome de) | n2=en:guanazole | rel=r_associated | relid=0 | w=10
  2829. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:guanidine
    n1=Okihiro (syndrome de) | n2=en:guanidine | rel=r_associated | relid=0 | w=10
  2830. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:guanine nucleoside analog
    n1=Okihiro (syndrome de) | n2=en:guanine nucleoside analog | rel=r_associated | relid=0 | w=10
  2831. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:guar gum
    n1=Okihiro (syndrome de) | n2=en:guar gum | rel=r_associated | relid=0 | w=10
  2832. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:guarana supplement
    n1=Okihiro (syndrome de) | n2=en:guarana supplement | rel=r_associated | relid=0 | w=10
  2833. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gusperimus trihydrochloride
    n1=Okihiro (syndrome de) | n2=en:gusperimus trihydrochloride | rel=r_associated | relid=0 | w=10
  2834. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gvax lung cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:gvax lung cancer vaccine | rel=r_associated | relid=0 | w=10
  2835. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gvax pancreatic cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:gvax pancreatic cancer vaccine | rel=r_associated | relid=0 | w=10
  2836. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:gvax prostate cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:gvax prostate cancer vaccine | rel=r_associated | relid=0 | w=10
  2837. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:h1299 tumor cell lysate vaccine
    n1=Okihiro (syndrome de) | n2=en:h1299 tumor cell lysate vaccine | rel=r_associated | relid=0 | w=10
  2838. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:haemophilus influenzae b vaccine
    n1=Okihiro (syndrome de) | n2=en:haemophilus influenzae b vaccine | rel=r_associated | relid=0 | w=10
  2839. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hafnium oxide-containing nanoparticles nbtxr3
    n1=Okihiro (syndrome de) | n2=en:hafnium oxide-containing nanoparticles nbtxr3 | rel=r_associated | relid=0 | w=10
  2840. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:halazepam
    n1=Okihiro (syndrome de) | n2=en:halazepam | rel=r_associated | relid=0 | w=10
  2841. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:halofantrine
    n1=Okihiro (syndrome de) | n2=en:halofantrine | rel=r_associated | relid=0 | w=10
  2842. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:halofuginone hydrobromide
    n1=Okihiro (syndrome de) | n2=en:halofuginone hydrobromide | rel=r_associated | relid=0 | w=10
  2843. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:halometasone
    n1=Okihiro (syndrome de) | n2=en:halometasone | rel=r_associated | relid=0 | w=10
  2844. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:halopemide
    n1=Okihiro (syndrome de) | n2=en:halopemide | rel=r_associated | relid=0 | w=10
  2845. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:haloperidol
    n1=Okihiro (syndrome de) | n2=en:haloperidol | rel=r_associated | relid=0 | w=10
  2846. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:haloprogin
    n1=Okihiro (syndrome de) | n2=en:haloprogin | rel=r_associated | relid=0 | w=10
  2847. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:haloxazolam
    n1=Okihiro (syndrome de) | n2=en:haloxazolam | rel=r_associated | relid=0 | w=10
  2848. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hcv antigen therapeutic bivalent vaccine v5
    n1=Okihiro (syndrome de) | n2=en:hcv antigen therapeutic bivalent vaccine v5 | rel=r_associated | relid=0 | w=10
  2849. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hcv dna vaccine ino-8000
    n1=Okihiro (syndrome de) | n2=en:hcv dna vaccine ino-8000 | rel=r_associated | relid=0 | w=10
  2850. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hdac inhibitor 4sc-202
    n1=Okihiro (syndrome de) | n2=en:hdac inhibitor 4sc-202 | rel=r_associated | relid=0 | w=10
  2851. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hdac inhibitor acy-241
    n1=Okihiro (syndrome de) | n2=en:hdac inhibitor acy-241 | rel=r_associated | relid=0 | w=10
  2852. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hdac inhibitor ar-42
    n1=Okihiro (syndrome de) | n2=en:hdac inhibitor ar-42 | rel=r_associated | relid=0 | w=10
  2853. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hdac inhibitor cg200745
    n1=Okihiro (syndrome de) | n2=en:hdac inhibitor cg200745 | rel=r_associated | relid=0 | w=10
  2854. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hdac inhibitor chr-2845
    n1=Okihiro (syndrome de) | n2=en:hdac inhibitor chr-2845 | rel=r_associated | relid=0 | w=10
  2855. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hdac inhibitor chr-3996
    n1=Okihiro (syndrome de) | n2=en:hdac inhibitor chr-3996 | rel=r_associated | relid=0 | w=10
  2856. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hdac inhibitor cxd101
    n1=Okihiro (syndrome de) | n2=en:hdac inhibitor cxd101 | rel=r_associated | relid=0 | w=10
  2857. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hdac inhibitor mpt0e028
    n1=Okihiro (syndrome de) | n2=en:hdac inhibitor mpt0e028 | rel=r_associated | relid=0 | w=10
  2858. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hdac inhibitor obp-801
    n1=Okihiro (syndrome de) | n2=en:hdac inhibitor obp-801 | rel=r_associated | relid=0 | w=10
  2859. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hdac inhibitor shp-141
    n1=Okihiro (syndrome de) | n2=en:hdac inhibitor shp-141 | rel=r_associated | relid=0 | w=10
  2860. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hdac/egfr/her2 inhibitor cudc-101
    n1=Okihiro (syndrome de) | n2=en:hdac/egfr/her2 inhibitor cudc-101 | rel=r_associated | relid=0 | w=10
  2861. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hdm2 antagonist jnj-26854165
    n1=Okihiro (syndrome de) | n2=en:hdm2 antagonist jnj-26854165 | rel=r_associated | relid=0 | w=10
  2862. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hdm2 inhibitor hdm201
    n1=Okihiro (syndrome de) | n2=en:hdm2 inhibitor hdm201 | rel=r_associated | relid=0 | w=10
  2863. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hdm2 inhibitor mk-8242
    n1=Okihiro (syndrome de) | n2=en:hdm2 inhibitor mk-8242 | rel=r_associated | relid=0 | w=10
  2864. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:head of the femur
    n1=Okihiro (syndrome de) | n2=en:head of the femur | rel=r_associated | relid=0 | w=10
  2865. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:head of the fibula
    n1=Okihiro (syndrome de) | n2=en:head of the fibula | rel=r_associated | relid=0 | w=10
  2866. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:head of the humerus
    n1=Okihiro (syndrome de) | n2=en:head of the humerus | rel=r_associated | relid=0 | w=10
  2867. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:head of the tibia
    n1=Okihiro (syndrome de) | n2=en:head of the tibia | rel=r_associated | relid=0 | w=10
  2868. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:heat-killed mycobacterial product imm-101
    n1=Okihiro (syndrome de) | n2=en:heat-killed mycobacterial product imm-101 | rel=r_associated | relid=0 | w=10
  2869. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:heat-treated varicella-zoster virus vaccine v212
    n1=Okihiro (syndrome de) | n2=en:heat-treated varicella-zoster virus vaccine v212 | rel=r_associated | relid=0 | w=10
  2870. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hedgehog inhibitor pf-04449913
    n1=Okihiro (syndrome de) | n2=en:hedgehog inhibitor pf-04449913 | rel=r_associated | relid=0 | w=10
  2871. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hematologic agents
    n1=Okihiro (syndrome de) | n2=en:hematologic agents | rel=r_associated | relid=0 | w=10
  2872. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hematoporphyrin derivative
    n1=Okihiro (syndrome de) | n2=en:hematoporphyrin derivative | rel=r_associated | relid=0 | w=10
  2873. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hemiasterlin analog e7974
    n1=Okihiro (syndrome de) | n2=en:hemiasterlin analog e7974 | rel=r_associated | relid=0 | w=10
  2874. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hemorrhoid preparation
    n1=Okihiro (syndrome de) | n2=en:hemorrhoid preparation | rel=r_associated | relid=0 | w=10
  2875. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:henatinib maleate
    n1=Okihiro (syndrome de) | n2=en:henatinib maleate | rel=r_associated | relid=0 | w=10
  2876. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:heparan sulfate glycosaminoglycan mimetic m402
    n1=Okihiro (syndrome de) | n2=en:heparan sulfate glycosaminoglycan mimetic m402 | rel=r_associated | relid=0 | w=10
  2877. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:heparan sulfate glycosaminoglycan mimetic nanopolymer mouthwash
    n1=Okihiro (syndrome de) | n2=en:heparan sulfate glycosaminoglycan mimetic nanopolymer mouthwash | rel=r_associated | relid=0 | w=10
  2878. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:heparin
    n1=Okihiro (syndrome de) | n2=en:heparin | rel=r_associated | relid=0 | w=10
  2879. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:heparin derivative sst0001
    n1=Okihiro (syndrome de) | n2=en:heparin derivative sst0001 | rel=r_associated | relid=0 | w=10
  2880. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hepatitis a vaccine
    n1=Okihiro (syndrome de) | n2=en:hepatitis a vaccine | rel=r_associated | relid=0 | w=10
  2881. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hepatitis b antigen vaccine
    n1=Okihiro (syndrome de) | n2=en:hepatitis b antigen vaccine | rel=r_associated | relid=0 | w=10
  2882. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hepatitis b vaccine
    n1=Okihiro (syndrome de) | n2=en:hepatitis b vaccine | rel=r_associated | relid=0 | w=10
  2883. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hepatitis b virus antibody
    n1=Okihiro (syndrome de) | n2=en:hepatitis b virus antibody | rel=r_associated | relid=0 | w=10
  2884. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hepatitis b virus recombinant vaccine
    n1=Okihiro (syndrome de) | n2=en:hepatitis b virus recombinant vaccine | rel=r_associated | relid=0 | w=10
  2885. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hepsulfam
    n1=Okihiro (syndrome de) | n2=en:hepsulfam | rel=r_associated | relid=0 | w=10
  2886. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:heptaminol
    n1=Okihiro (syndrome de) | n2=en:heptaminol | rel=r_associated | relid=0 | w=10
  2887. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:her-2-neu, cea peptides, gm-csf, montanide isa-51 vaccine
    n1=Okihiro (syndrome de) | n2=en:her-2-neu, cea peptides, gm-csf, montanide isa-51 vaccine | rel=r_associated | relid=0 | w=10
  2888. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:her-2-positive b-cell peptide antigen p467-dt-crm197/montanide vaccine imu-131
    n1=Okihiro (syndrome de) | n2=en:her-2-positive b-cell peptide antigen p467-dt-crm197/montanide vaccine imu-131 | rel=r_associated | relid=0 | w=10
  2889. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:her-2/neu intracellular domain protein
    n1=Okihiro (syndrome de) | n2=en:her-2/neu intracellular domain protein | rel=r_associated | relid=0 | w=10
  2890. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:her-2/neu peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:her-2/neu peptide vaccine | rel=r_associated | relid=0 | w=10
  2891. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:her2 ecd+tm virus-like replicon particles vaccine avx901
    n1=Okihiro (syndrome de) | n2=en:her2 ecd+tm virus-like replicon particles vaccine avx901 | rel=r_associated | relid=0 | w=10
  2892. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:her2-pulsed autologous type-1 polarized dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:her2-pulsed autologous type-1 polarized dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  2893. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:her2-targeted liposomal doxorubicin hydrochloride mm-302
    n1=Okihiro (syndrome de) | n2=en:her2-targeted liposomal doxorubicin hydrochloride mm-302 | rel=r_associated | relid=0 | w=10
  2894. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:her2-targeting antibody fc fragment fs102
    n1=Okihiro (syndrome de) | n2=en:her2-targeting antibody fc fragment fs102 | rel=r_associated | relid=0 | w=10
  2895. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:her2bi-armed activated t cells
    n1=Okihiro (syndrome de) | n2=en:her2bi-armed activated t cells | rel=r_associated | relid=0 | w=10
  2896. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:herba scutellaria barbata
    n1=Okihiro (syndrome de) | n2=en:herba scutellaria barbata | rel=r_associated | relid=0 | w=10
  2897. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:herbal medicine (product)
    n1=Okihiro (syndrome de) | n2=en:herbal medicine (product) | rel=r_associated | relid=0 | w=10
  2898. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:herbal medicine agent
    n1=Okihiro (syndrome de) | n2=en:herbal medicine agent | rel=r_associated | relid=0 | w=10
  2899. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:herbal polysaccharide saliva substitute
    n1=Okihiro (syndrome de) | n2=en:herbal polysaccharide saliva substitute | rel=r_associated | relid=0 | w=10
  2900. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:herpes zoster vaccine gsk1437173a
    n1=Okihiro (syndrome de) | n2=en:herpes zoster vaccine gsk1437173a | rel=r_associated | relid=0 | w=10
  2901. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hetastarch
    n1=Okihiro (syndrome de) | n2=en:hetastarch | rel=r_associated | relid=0 | w=10
  2902. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:heterodimeric interleukin-15
    n1=Okihiro (syndrome de) | n2=en:heterodimeric interleukin-15 | rel=r_associated | relid=0 | w=10
  2903. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hexamethylene bisacetamide
    n1=Okihiro (syndrome de) | n2=en:hexamethylene bisacetamide | rel=r_associated | relid=0 | w=10
  2904. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hexaminolevulinate
    n1=Okihiro (syndrome de) | n2=en:hexaminolevulinate | rel=r_associated | relid=0 | w=10
  2905. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hexaminolevulinate hydrochloride
    n1=Okihiro (syndrome de) | n2=en:hexaminolevulinate hydrochloride | rel=r_associated | relid=0 | w=10
  2906. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hif-1alpha inhibitor px-478
    n1=Okihiro (syndrome de) | n2=en:hif-1alpha inhibitor px-478 | rel=r_associated | relid=0 | w=10
  2907. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hif-2alpha inhibitor pt2385
    n1=Okihiro (syndrome de) | n2=en:hif-2alpha inhibitor pt2385 | rel=r_associated | relid=0 | w=10
  2908. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:high-selenium baker's yeast
    n1=Okihiro (syndrome de) | n2=en:high-selenium baker's yeast | rel=r_associated | relid=0 | w=10
  2909. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:high-selenium brassica juncea
    n1=Okihiro (syndrome de) | n2=en:high-selenium brassica juncea | rel=r_associated | relid=0 | w=10
  2910. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:high-titer rsv immune globulin ri-001
    n1=Okihiro (syndrome de) | n2=en:high-titer rsv immune globulin ri-001 | rel=r_associated | relid=0 | w=10
  2911. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:highly purified staphylococcal protein a prtx-100
    n1=Okihiro (syndrome de) | n2=en:highly purified staphylococcal protein a prtx-100 | rel=r_associated | relid=0 | w=10
  2912. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:histamine dihydrochloride
    n1=Okihiro (syndrome de) | n2=en:histamine dihydrochloride | rel=r_associated | relid=0 | w=10
  2913. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:histamine h1 receptor antagonists [moa]
    n1=Okihiro (syndrome de) | n2=en:histamine h1 receptor antagonists [moa] | rel=r_associated | relid=0 | w=10
  2914. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:histone-lysine n-methyltransferase ezh2 inhibitor gsk2816126
    n1=Okihiro (syndrome de) | n2=en:histone-lysine n-methyltransferase ezh2 inhibitor gsk2816126 | rel=r_associated | relid=0 | w=10
  2915. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:histrelin acetate
    n1=Okihiro (syndrome de) | n2=en:histrelin acetate | rel=r_associated | relid=0 | w=10
  2916. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*0201 restricted tert(572y)/tert(572) peptides vaccine vx-001
    n1=Okihiro (syndrome de) | n2=en:hla-a*0201 restricted tert(572y)/tert(572) peptides vaccine vx-001 | rel=r_associated | relid=0 | w=10
  2917. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*0201-restricted trp2-gp100-epha2-her2 multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*0201-restricted trp2-gp100-epha2-her2 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  2918. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*0201-restricted urlc10-vegfr1-vegfr2 multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*0201-restricted urlc10-vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  2919. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*0201-restricted vegfr1 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*0201-restricted vegfr1 peptide vaccine | rel=r_associated | relid=0 | w=10
  2920. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*0201-restricted vegfr1-vegfr2 multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*0201-restricted vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  2921. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*2402-restricted cdca1-a24-56 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*2402-restricted cdca1-a24-56 peptide vaccine | rel=r_associated | relid=0 | w=10
  2922. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*2402-restricted cdca1-kif20a multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*2402-restricted cdca1-kif20a multipeptide vaccine | rel=r_associated | relid=0 | w=10
  2923. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*2402-restricted koc1-ttk-co16-depdc1-mphosph1 multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*2402-restricted koc1-ttk-co16-depdc1-mphosph1 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  2924. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*2402-restricted multipeptide vaccine s-488410
    n1=Okihiro (syndrome de) | n2=en:hla-a*2402-restricted multipeptide vaccine s-488410 | rel=r_associated | relid=0 | w=10
  2925. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*2402-restricted urlc10 peptides vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*2402-restricted urlc10 peptides vaccine | rel=r_associated | relid=0 | w=10
  2926. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*2402-restricted urlc10-cdca1-kif20a multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*2402-restricted urlc10-cdca1-kif20a multipeptide vaccine | rel=r_associated | relid=0 | w=10
  2927. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*2402-restricted urlc10-cdca1-vegfr1-vegfr2 multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*2402-restricted urlc10-cdca1-vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  2928. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*2402-restricted urlc10-koc1-vegfr1-vegfr2 multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*2402-restricted urlc10-koc1-vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  2929. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*2402-restricted urlc10-ttk-koc1 multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*2402-restricted urlc10-ttk-koc1 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  2930. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*2402-restricted urlc10-ttk-vegfr1-vegfr2 multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*2402-restricted urlc10-ttk-vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  2931. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*2402-restricted vegfr1 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*2402-restricted vegfr1 peptide vaccine | rel=r_associated | relid=0 | w=10
  2932. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*2402-restricted vegfr1/2 multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*2402-restricted vegfr1/2 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  2933. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a*2404-restricted rnf43-tomm34-vegfr1-vegfr2 multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a*2404-restricted rnf43-tomm34-vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  2934. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a1-binding mage-1/mage-3 multipeptide-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a1-binding mage-1/mage-3 multipeptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  2935. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a1, a2, b35-restricted survivin peptides/montanide isa-51 vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a1, a2, b35-restricted survivin peptides/montanide isa-51 vaccine | rel=r_associated | relid=0 | w=10
  2936. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a2-binding tyr/mart-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a2-binding tyr/mart-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  2937. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a2-restricted synthetic glioma antigen peptides vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a2-restricted synthetic glioma antigen peptides vaccine | rel=r_associated | relid=0 | w=10
  2938. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-a2, a3-restricted fgf-5 peptides/montanide isa-51 vaccine
    n1=Okihiro (syndrome de) | n2=en:hla-a2, a3-restricted fgf-5 peptides/montanide isa-51 vaccine | rel=r_associated | relid=0 | w=10
  2939. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-dp0401/0402-restricted mage-a3-reactive t cell receptor-transduced autologous t cells
    n1=Okihiro (syndrome de) | n2=en:hla-dp0401/0402-restricted mage-a3-reactive t cell receptor-transduced autologous t cells | rel=r_associated | relid=0 | w=10
  2940. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hla-matched donor mononuclear cell-enriched leukocytes apocell
    n1=Okihiro (syndrome de) | n2=en:hla-matched donor mononuclear cell-enriched leukocytes apocell | rel=r_associated | relid=0 | w=10
  2941. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hmg-coa reductase inhibitor
    n1=Okihiro (syndrome de) | n2=en:hmg-coa reductase inhibitor | rel=r_associated | relid=0 | w=10
  2942. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ho 166 dotmp
    n1=Okihiro (syndrome de) | n2=en:ho 166 dotmp | rel=r_associated | relid=0 | w=10
  2943. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ho/02/02
    n1=Okihiro (syndrome de) | n2=en:ho/02/02 | rel=r_associated | relid=0 | w=10
  2944. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hodgkin's antigens-gm-csf-expressing cell vaccine
    n1=Okihiro (syndrome de) | n2=en:hodgkin's antigens-gm-csf-expressing cell vaccine | rel=r_associated | relid=0 | w=10
  2945. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:holmium ho 166 poly(l-lactic acid) microspheres
    n1=Okihiro (syndrome de) | n2=en:holmium ho 166 poly(l-lactic acid) microspheres | rel=r_associated | relid=0 | w=10
  2946. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:homeopathic remedies
    n1=Okihiro (syndrome de) | n2=en:homeopathic remedies | rel=r_associated | relid=0 | w=10
  2947. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:honey
    n1=Okihiro (syndrome de) | n2=en:honey | rel=r_associated | relid=0 | w=10
  2948. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:honey-containing mouthwash
    n1=Okihiro (syndrome de) | n2=en:honey-containing mouthwash | rel=r_associated | relid=0 | w=10
  2949. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hops extract
    n1=Okihiro (syndrome de) | n2=en:hops extract | rel=r_associated | relid=0 | w=10
  2950. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hormone, hormone metabolite, hormone precursor, synthetic hormone substitute, and/or hormone antagonist
    n1=Okihiro (syndrome de) | n2=en:hormone, hormone metabolite, hormone precursor, synthetic hormone substitute, and/or hormone antagonist | rel=r_associated | relid=0 | w=10
  2951. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hormones, synthetic substitutes and antagonists
    n1=Okihiro (syndrome de) | n2=en:hormones, synthetic substitutes and antagonists | rel=r_associated | relid=0 | w=10
  2952. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:horse blood extract
    n1=Okihiro (syndrome de) | n2=en:horse blood extract | rel=r_associated | relid=0 | w=10
  2953. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:host dendritic cell vaccine-001 mssm/biir
    n1=Okihiro (syndrome de) | n2=en:host dendritic cell vaccine-001 mssm/biir | rel=r_associated | relid=0 | w=10
  2954. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hpph
    n1=Okihiro (syndrome de) | n2=en:hpph | rel=r_associated | relid=0 | w=10
  2955. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hpv 16 e7 antigen-expressing lactobacillis casei vaccine bls-ilb-e710c
    n1=Okihiro (syndrome de) | n2=en:hpv 16 e7 antigen-expressing lactobacillis casei vaccine bls-ilb-e710c | rel=r_associated | relid=0 | w=10
  2956. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hpv 16 e7:12-20 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hpv 16 e7:12-20 peptide vaccine | rel=r_associated | relid=0 | w=10
  2957. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hpv 16 e7:86-93 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hpv 16 e7:86-93 peptide vaccine | rel=r_associated | relid=0 | w=10
  2958. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hpv dna plasmids therapeutic vaccine vgx-3100
    n1=Okihiro (syndrome de) | n2=en:hpv dna plasmids therapeutic vaccine vgx-3100 | rel=r_associated | relid=0 | w=10
  2959. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hpv e1/e2 interaction inhibitor gel ap611074
    n1=Okihiro (syndrome de) | n2=en:hpv e1/e2 interaction inhibitor gel ap611074 | rel=r_associated | relid=0 | w=10
  2960. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hpv e6/e7 dna vaccine gx-188e
    n1=Okihiro (syndrome de) | n2=en:hpv e6/e7 dna vaccine gx-188e | rel=r_associated | relid=0 | w=10
  2961. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hpv-16 e6 peptides vaccine/candida albicans extract
    n1=Okihiro (syndrome de) | n2=en:hpv-16 e6 peptides vaccine/candida albicans extract | rel=r_associated | relid=0 | w=10
  2962. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hpv-6-targeting immunotherapeutic vaccine ino-3106
    n1=Okihiro (syndrome de) | n2=en:hpv-6-targeting immunotherapeutic vaccine ino-3106 | rel=r_associated | relid=0 | w=10
  2963. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin
    n1=Okihiro (syndrome de) | n2=en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin | rel=r_associated | relid=0 | w=10
  2964. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsp70-peptide tkd/il-2-activated autologous natural killer cells
    n1=Okihiro (syndrome de) | n2=en:hsp70-peptide tkd/il-2-activated autologous natural killer cells | rel=r_associated | relid=0 | w=10
  2965. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsp90 antagonist kw-2478
    n1=Okihiro (syndrome de) | n2=en:hsp90 antagonist kw-2478 | rel=r_associated | relid=0 | w=10
  2966. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsp90 inhibitor ab-010
    n1=Okihiro (syndrome de) | n2=en:hsp90 inhibitor ab-010 | rel=r_associated | relid=0 | w=10
  2967. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsp90 inhibitor auy922
    n1=Okihiro (syndrome de) | n2=en:hsp90 inhibitor auy922 | rel=r_associated | relid=0 | w=10
  2968. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsp90 inhibitor biib021
    n1=Okihiro (syndrome de) | n2=en:hsp90 inhibitor biib021 | rel=r_associated | relid=0 | w=10
  2969. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsp90 inhibitor biib028
    n1=Okihiro (syndrome de) | n2=en:hsp90 inhibitor biib028 | rel=r_associated | relid=0 | w=10
  2970. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsp90 inhibitor debio 0932
    n1=Okihiro (syndrome de) | n2=en:hsp90 inhibitor debio 0932 | rel=r_associated | relid=0 | w=10
  2971. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsp90 inhibitor ds-2248
    n1=Okihiro (syndrome de) | n2=en:hsp90 inhibitor ds-2248 | rel=r_associated | relid=0 | w=10
  2972. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsp90 inhibitor hsp990
    n1=Okihiro (syndrome de) | n2=en:hsp90 inhibitor hsp990 | rel=r_associated | relid=0 | w=10
  2973. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsp90 inhibitor mpc-3100
    n1=Okihiro (syndrome de) | n2=en:hsp90 inhibitor mpc-3100 | rel=r_associated | relid=0 | w=10
  2974. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsp90 inhibitor pu-h71
    n1=Okihiro (syndrome de) | n2=en:hsp90 inhibitor pu-h71 | rel=r_associated | relid=0 | w=10
  2975. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsp90 inhibitor snx-5542 mesylate
    n1=Okihiro (syndrome de) | n2=en:hsp90 inhibitor snx-5542 mesylate | rel=r_associated | relid=0 | w=10
  2976. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsp90 inhibitor xl888
    n1=Okihiro (syndrome de) | n2=en:hsp90 inhibitor xl888 | rel=r_associated | relid=0 | w=10
  2977. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsv-1 hf10
    n1=Okihiro (syndrome de) | n2=en:hsv-1 hf10 | rel=r_associated | relid=0 | w=10
  2978. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hsv-tk-transduced donor lymphocytes
    n1=Okihiro (syndrome de) | n2=en:hsv-tk-transduced donor lymphocytes | rel=r_associated | relid=0 | w=10
  2979. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:htert i540/r572y/d988y multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:htert i540/r572y/d988y multipeptide vaccine | rel=r_associated | relid=0 | w=10
  2980. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:htert mrna/survivin peptide-double-loaded autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:htert mrna/survivin peptide-double-loaded autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  2981. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:htert multipeptide/montanide isa-51 vg/imiquimod gx 301
    n1=Okihiro (syndrome de) | n2=en:htert multipeptide/montanide isa-51 vg/imiquimod gx 301 | rel=r_associated | relid=0 | w=10
  2982. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:htert vaccine v934/v935
    n1=Okihiro (syndrome de) | n2=en:htert vaccine v934/v935 | rel=r_associated | relid=0 | w=10
  2983. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:htert-encoding dna vaccine invac-1
    n1=Okihiro (syndrome de) | n2=en:htert-encoding dna vaccine invac-1 | rel=r_associated | relid=0 | w=10
  2984. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:htert-lamp mrna-loaded autologous dendritic cell vaccine grnvac1
    n1=Okihiro (syndrome de) | n2=en:htert-lamp mrna-loaded autologous dendritic cell vaccine grnvac1 | rel=r_associated | relid=0 | w=10
  2985. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:htert/survivin/cmv multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:htert/survivin/cmv multipeptide vaccine | rel=r_associated | relid=0 | w=10
  2986. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:htert/survivin/melanoma tumor cell-derived mrna-transfected dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:htert/survivin/melanoma tumor cell-derived mrna-transfected dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  2987. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hu14.18-il2 fusion protein
    n1=Okihiro (syndrome de) | n2=en:hu14.18-il2 fusion protein | rel=r_associated | relid=0 | w=10
  2988. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:huachansu
    n1=Okihiro (syndrome de) | n2=en:huachansu | rel=r_associated | relid=0 | w=10
  2989. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:huaier extract granule
    n1=Okihiro (syndrome de) | n2=en:huaier extract granule | rel=r_associated | relid=0 | w=10
  2990. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:huang lian
    n1=Okihiro (syndrome de) | n2=en:huang lian | rel=r_associated | relid=0 | w=10
  2991. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hubc1-huil12 fusion protein as1409
    n1=Okihiro (syndrome de) | n2=en:hubc1-huil12 fusion protein as1409 | rel=r_associated | relid=0 | w=10
  2992. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human combinatorial antibody library-based monoclonal antibody vay736
    n1=Okihiro (syndrome de) | n2=en:human combinatorial antibody library-based monoclonal antibody vay736 | rel=r_associated | relid=0 | w=10
  2993. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human gp100 plasmid dna vaccine
    n1=Okihiro (syndrome de) | n2=en:human gp100 plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  2994. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human lactoferrin peptide hlf1-11
    n1=Okihiro (syndrome de) | n2=en:human lactoferrin peptide hlf1-11 | rel=r_associated | relid=0 | w=10
  2995. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human menopausal gonadotropin
    n1=Okihiro (syndrome de) | n2=en:human menopausal gonadotropin | rel=r_associated | relid=0 | w=10
  2996. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human mhc non-restricted cytotoxic t-cell line tall-104
    n1=Okihiro (syndrome de) | n2=en:human mhc non-restricted cytotoxic t-cell line tall-104 | rel=r_associated | relid=0 | w=10
  2997. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human monoclonal antibody 216
    n1=Okihiro (syndrome de) | n2=en:human monoclonal antibody 216 | rel=r_associated | relid=0 | w=10
  2998. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human monoclonal antibody b11-hcg beta fusion protein cdx-1307
    n1=Okihiro (syndrome de) | n2=en:human monoclonal antibody b11-hcg beta fusion protein cdx-1307 | rel=r_associated | relid=0 | w=10
  2999. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human myeloid progenitor cells clt-008
    n1=Okihiro (syndrome de) | n2=en:human myeloid progenitor cells clt-008 | rel=r_associated | relid=0 | w=10
  3000. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human papilloma virus l1 virus-like particle v504 vaccine
    n1=Okihiro (syndrome de) | n2=en:human papilloma virus l1 virus-like particle v504 vaccine | rel=r_associated | relid=0 | w=10
  3001. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human papillomavirus 16/18 l1 virus-like particle/as04 vaccine
    n1=Okihiro (syndrome de) | n2=en:human papillomavirus 16/18 l1 virus-like particle/as04 vaccine | rel=r_associated | relid=0 | w=10
  3002. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human papillomavirus tumor antigen vaccine
    n1=Okihiro (syndrome de) | n2=en:human papillomavirus tumor antigen vaccine | rel=r_associated | relid=0 | w=10
  3003. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human papillomavirus vaccine v503
    n1=Okihiro (syndrome de) | n2=en:human papillomavirus vaccine v503 | rel=r_associated | relid=0 | w=10
  3004. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human polio virus antibody
    n1=Okihiro (syndrome de) | n2=en:human polio virus antibody | rel=r_associated | relid=0 | w=10
  3005. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human prostate-specific membrane antigen plasmid dna vaccine
    n1=Okihiro (syndrome de) | n2=en:human prostate-specific membrane antigen plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  3006. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human protease inhibitor protein
    n1=Okihiro (syndrome de) | n2=en:human protease inhibitor protein | rel=r_associated | relid=0 | w=10
  3007. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human rabies vaccines
    n1=Okihiro (syndrome de) | n2=en:human rabies vaccines | rel=r_associated | relid=0 | w=10
  3008. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human trefoil factor 1-secreting lactococcus lactis ag013
    n1=Okihiro (syndrome de) | n2=en:human trefoil factor 1-secreting lactococcus lactis ag013 | rel=r_associated | relid=0 | w=10
  3009. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:human varicella zoster immune globulin
    n1=Okihiro (syndrome de) | n2=en:human varicella zoster immune globulin | rel=r_associated | relid=0 | w=10
  3010. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:humanized monoclonal antibody 3f8
    n1=Okihiro (syndrome de) | n2=en:humanized monoclonal antibody 3f8 | rel=r_associated | relid=0 | w=10
  3011. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:humeral shaft
    n1=Okihiro (syndrome de) | n2=en:humeral shaft | rel=r_associated | relid=0 | w=10
  3012. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hvegf26-104/rfase peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:hvegf26-104/rfase peptide vaccine | rel=r_associated | relid=0 | w=10
  3013. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hyaluronic acid
    n1=Okihiro (syndrome de) | n2=en:hyaluronic acid | rel=r_associated | relid=0 | w=10
  3014. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hyaluronic acid-based hydrating vaginal gel
    n1=Okihiro (syndrome de) | n2=en:hyaluronic acid-based hydrating vaginal gel | rel=r_associated | relid=0 | w=10
  3015. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hyaluronic acid-containing topical cream
    n1=Okihiro (syndrome de) | n2=en:hyaluronic acid-containing topical cream | rel=r_associated | relid=0 | w=10
  3016. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hyb2055
    n1=Okihiro (syndrome de) | n2=en:hyb2055 | rel=r_associated | relid=0 | w=10
  3017. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hycanthone
    n1=Okihiro (syndrome de) | n2=en:hycanthone | rel=r_associated | relid=0 | w=10
  3018. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydralazine
    n1=Okihiro (syndrome de) | n2=en:hydralazine | rel=r_associated | relid=0 | w=10
  3019. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydralazine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:hydralazine hydrochloride | rel=r_associated | relid=0 | w=10
  3020. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydrated sodium calcium aluminosilicate
    n1=Okihiro (syndrome de) | n2=en:hydrated sodium calcium aluminosilicate | rel=r_associated | relid=0 | w=10
  3021. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydrazine sulfate
    n1=Okihiro (syndrome de) | n2=en:hydrazine sulfate | rel=r_associated | relid=0 | w=10
  3022. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydrocodone
    n1=Okihiro (syndrome de) | n2=en:hydrocodone | rel=r_associated | relid=0 | w=10
  3023. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydrocodone/acetaminophen
    n1=Okihiro (syndrome de) | n2=en:hydrocodone/acetaminophen | rel=r_associated | relid=0 | w=10
  3024. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydrocortisone sodium succinate
    n1=Okihiro (syndrome de) | n2=en:hydrocortisone sodium succinate | rel=r_associated | relid=0 | w=10
  3025. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydromorphone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:hydromorphone hydrochloride | rel=r_associated | relid=0 | w=10
  3026. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydroxychloroquine
    n1=Okihiro (syndrome de) | n2=en:hydroxychloroquine | rel=r_associated | relid=0 | w=10
  3027. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydroxyethylflurazepam
    n1=Okihiro (syndrome de) | n2=en:hydroxyethylflurazepam | rel=r_associated | relid=0 | w=10
  3028. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydroxyphenamate
    n1=Okihiro (syndrome de) | n2=en:hydroxyphenamate | rel=r_associated | relid=0 | w=10
  3029. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydroxyprogesterone caproate
    n1=Okihiro (syndrome de) | n2=en:hydroxyprogesterone caproate | rel=r_associated | relid=0 | w=10
  3030. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydroxypropylcellulose
    n1=Okihiro (syndrome de) | n2=en:hydroxypropylcellulose | rel=r_associated | relid=0 | w=10
  3031. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydroxytriazolam
    n1=Okihiro (syndrome de) | n2=en:hydroxytriazolam | rel=r_associated | relid=0 | w=10
  3032. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydroxytyrosol
    n1=Okihiro (syndrome de) | n2=en:hydroxytyrosol | rel=r_associated | relid=0 | w=10
  3033. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hydroxyurea
    n1=Okihiro (syndrome de) | n2=en:hydroxyurea | rel=r_associated | relid=0 | w=10
  3034. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hyperbaric oxygen
    n1=Okihiro (syndrome de) | n2=en:hyperbaric oxygen | rel=r_associated | relid=0 | w=10
  3035. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hypercvad regimen
    n1=Okihiro (syndrome de) | n2=en:hypercvad regimen | rel=r_associated | relid=0 | w=10
  3036. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hyperglycemic agent
    n1=Okihiro (syndrome de) | n2=en:hyperglycemic agent | rel=r_associated | relid=0 | w=10
  3037. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hypericum oil
    n1=Okihiro (syndrome de) | n2=en:hypericum oil | rel=r_associated | relid=0 | w=10
  3038. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hyperimmune bovine colostrum
    n1=Okihiro (syndrome de) | n2=en:hyperimmune bovine colostrum | rel=r_associated | relid=0 | w=10
  3039. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hyperpolarized carbon c 13 pyruvate
    n1=Okihiro (syndrome de) | n2=en:hyperpolarized carbon c 13 pyruvate | rel=r_associated | relid=0 | w=10
  3040. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hyperpolarized helium 3
    n1=Okihiro (syndrome de) | n2=en:hyperpolarized helium 3 | rel=r_associated | relid=0 | w=10
  3041. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hyperpolarized xenon 129
    n1=Okihiro (syndrome de) | n2=en:hyperpolarized xenon 129 | rel=r_associated | relid=0 | w=10
  3042. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hypertonic saline
    n1=Okihiro (syndrome de) | n2=en:hypertonic saline | rel=r_associated | relid=0 | w=10
  3043. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hypoglycemic agents
    n1=Okihiro (syndrome de) | n2=en:hypoglycemic agents | rel=r_associated | relid=0 | w=10
  3044. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hypoxia-activated prodrug th-302
    n1=Okihiro (syndrome de) | n2=en:hypoxia-activated prodrug th-302 | rel=r_associated | relid=0 | w=10
  3045. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hypoxia-activated prodrug th-4000
    n1=Okihiro (syndrome de) | n2=en:hypoxia-activated prodrug th-4000 | rel=r_associated | relid=0 | w=10
  3046. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:hypromelloses
    n1=Okihiro (syndrome de) | n2=en:hypromelloses | rel=r_associated | relid=0 | w=10
  3047. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:i 123 monoclonal antibody 81c6
    n1=Okihiro (syndrome de) | n2=en:i 123 monoclonal antibody 81c6 | rel=r_associated | relid=0 | w=10
  3048. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:i 131 antiferritin immunoglobulin
    n1=Okihiro (syndrome de) | n2=en:i 131 antiferritin immunoglobulin | rel=r_associated | relid=0 | w=10
  3049. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:i 131 monoclonal antibody a33
    n1=Okihiro (syndrome de) | n2=en:i 131 monoclonal antibody a33 | rel=r_associated | relid=0 | w=10
  3050. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:i 131 monoclonal antibody cc49
    n1=Okihiro (syndrome de) | n2=en:i 131 monoclonal antibody cc49 | rel=r_associated | relid=0 | w=10
  3051. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:i 131 monoclonal antibody f19
    n1=Okihiro (syndrome de) | n2=en:i 131 monoclonal antibody f19 | rel=r_associated | relid=0 | w=10
  3052. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:i 131 monoclonal antibody lym-1
    n1=Okihiro (syndrome de) | n2=en:i 131 monoclonal antibody lym-1 | rel=r_associated | relid=0 | w=10
  3053. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iap inhibitor at-406
    n1=Okihiro (syndrome de) | n2=en:iap inhibitor at-406 | rel=r_associated | relid=0 | w=10
  3054. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iap inhibitor hgs1029
    n1=Okihiro (syndrome de) | n2=en:iap inhibitor hgs1029 | rel=r_associated | relid=0 | w=10
  3055. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iapa-based dendritic cells/cytotoxic t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:iapa-based dendritic cells/cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  3056. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ibandronate sodium
    n1=Okihiro (syndrome de) | n2=en:ibandronate sodium | rel=r_associated | relid=0 | w=10
  3057. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ibritumomab tiuxetan
    n1=Okihiro (syndrome de) | n2=en:ibritumomab tiuxetan | rel=r_associated | relid=0 | w=10
  3058. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ibrutinib
    n1=Okihiro (syndrome de) | n2=en:ibrutinib | rel=r_associated | relid=0 | w=10
  3059. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ibuprofen
    n1=Okihiro (syndrome de) | n2=en:ibuprofen | rel=r_associated | relid=0 | w=10
  3060. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ibuprofen + oxycodone
    n1=Okihiro (syndrome de) | n2=en:ibuprofen + oxycodone | rel=r_associated | relid=0 | w=10
  3061. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ibuprofen injection
    n1=Okihiro (syndrome de) | n2=en:ibuprofen injection | rel=r_associated | relid=0 | w=10
  3062. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ibutilide
    n1=Okihiro (syndrome de) | n2=en:ibutilide | rel=r_associated | relid=0 | w=10
  3063. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ic9-gd2-cd28-ox40-expressing t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:ic9-gd2-cd28-ox40-expressing t lymphocytes | rel=r_associated | relid=0 | w=10
  3064. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:icatibant
    n1=Okihiro (syndrome de) | n2=en:icatibant | rel=r_associated | relid=0 | w=10
  3065. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ice regimen
    n1=Okihiro (syndrome de) | n2=en:ice regimen | rel=r_associated | relid=0 | w=10
  3066. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iclazepam
    n1=Okihiro (syndrome de) | n2=en:iclazepam | rel=r_associated | relid=0 | w=10
  3067. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:icodextrin solution
    n1=Okihiro (syndrome de) | n2=en:icodextrin solution | rel=r_associated | relid=0 | w=10
  3068. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:icotinib hydrochloride
    n1=Okihiro (syndrome de) | n2=en:icotinib hydrochloride | rel=r_associated | relid=0 | w=10
  3069. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:icrucumab
    n1=Okihiro (syndrome de) | n2=en:icrucumab | rel=r_associated | relid=0 | w=10
  3070. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:idarubicin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:idarubicin hydrochloride | rel=r_associated | relid=0 | w=10
  3071. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:idarubicin-eluting beads
    n1=Okihiro (syndrome de) | n2=en:idarubicin-eluting beads | rel=r_associated | relid=0 | w=10
  3072. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:idasanutlin
    n1=Okihiro (syndrome de) | n2=en:idasanutlin | rel=r_associated | relid=0 | w=10
  3073. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:idelalisib
    n1=Okihiro (syndrome de) | n2=en:idelalisib | rel=r_associated | relid=0 | w=10
  3074. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:idh1 inhibitor ag-120
    n1=Okihiro (syndrome de) | n2=en:idh1 inhibitor ag-120 | rel=r_associated | relid=0 | w=10
  3075. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:idh1(r132) inhibitor idh305
    n1=Okihiro (syndrome de) | n2=en:idh1(r132) inhibitor idh305 | rel=r_associated | relid=0 | w=10
  3076. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:idh1r132h mutation-targeting idh1 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:idh1r132h mutation-targeting idh1 peptide vaccine | rel=r_associated | relid=0 | w=10
  3077. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:idh1r132h-specific peptide vaccine pepidh1m
    n1=Okihiro (syndrome de) | n2=en:idh1r132h-specific peptide vaccine pepidh1m | rel=r_associated | relid=0 | w=10
  3078. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:idh2 inhibitor ag-221
    n1=Okihiro (syndrome de) | n2=en:idh2 inhibitor ag-221 | rel=r_associated | relid=0 | w=10
  3079. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:idiotype-pulsed autologous dendritic cell vaccine apc8020
    n1=Okihiro (syndrome de) | n2=en:idiotype-pulsed autologous dendritic cell vaccine apc8020 | rel=r_associated | relid=0 | w=10
  3080. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ido inhibitor nlg919
    n1=Okihiro (syndrome de) | n2=en:ido inhibitor nlg919 | rel=r_associated | relid=0 | w=10
  3081. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:idoxifene
    n1=Okihiro (syndrome de) | n2=en:idoxifene | rel=r_associated | relid=0 | w=10
  3082. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:idoxuridine
    n1=Okihiro (syndrome de) | n2=en:idoxuridine | rel=r_associated | relid=0 | w=10
  3083. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:idronoxil
    n1=Okihiro (syndrome de) | n2=en:idronoxil | rel=r_associated | relid=0 | w=10
  3084. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ifosfamide
    n1=Okihiro (syndrome de) | n2=en:ifosfamide | rel=r_associated | relid=0 | w=10
  3085. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:igf ligand neutralizing antibody bi 836845
    n1=Okihiro (syndrome de) | n2=en:igf ligand neutralizing antibody bi 836845 | rel=r_associated | relid=0 | w=10
  3086. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:igf-1r antisense oligodeoxynucleotide-treated autologous glioma cells
    n1=Okihiro (syndrome de) | n2=en:igf-1r antisense oligodeoxynucleotide-treated autologous glioma cells | rel=r_associated | relid=0 | w=10
  3087. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:igf-1r inhibitor pl225b
    n1=Okihiro (syndrome de) | n2=en:igf-1r inhibitor pl225b | rel=r_associated | relid=0 | w=10
  3088. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:igf-1r/ir inhibitor kw-2450
    n1=Okihiro (syndrome de) | n2=en:igf-1r/ir inhibitor kw-2450 | rel=r_associated | relid=0 | w=10
  3089. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:igf-methotrexate conjugate
    n1=Okihiro (syndrome de) | n2=en:igf-methotrexate conjugate | rel=r_associated | relid=0 | w=10
  3090. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ih636 grape seed proanthocyanidin extract
    n1=Okihiro (syndrome de) | n2=en:ih636 grape seed proanthocyanidin extract | rel=r_associated | relid=0 | w=10
  3091. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:il-10 immunomodulator mk-1966
    n1=Okihiro (syndrome de) | n2=en:il-10 immunomodulator mk-1966 | rel=r_associated | relid=0 | w=10
  3092. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:il-12-expressing hsv-1
    n1=Okihiro (syndrome de) | n2=en:il-12-expressing hsv-1 | rel=r_associated | relid=0 | w=10
  3093. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:il-12-expressing mesenchymal stem cell vaccine gx-051
    n1=Okihiro (syndrome de) | n2=en:il-12-expressing mesenchymal stem cell vaccine gx-051 | rel=r_associated | relid=0 | w=10
  3094. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:il-2 plasmid dna/lipid complex
    n1=Okihiro (syndrome de) | n2=en:il-2 plasmid dna/lipid complex | rel=r_associated | relid=0 | w=10
  3095. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:il-2 recombinant fusion protein alt-801
    n1=Okihiro (syndrome de) | n2=en:il-2 recombinant fusion protein alt-801 | rel=r_associated | relid=0 | w=10
  3096. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:il-2/lptn gene-modified allogeneic neuroblastoma tumor cell vaccine
    n1=Okihiro (syndrome de) | n2=en:il-2/lptn gene-modified allogeneic neuroblastoma tumor cell vaccine | rel=r_associated | relid=0 | w=10
  3097. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  3098. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:il4-pseudomonas exotoxin fusion protein prx321
    n1=Okihiro (syndrome de) | n2=en:il4-pseudomonas exotoxin fusion protein prx321 | rel=r_associated | relid=0 | w=10
  3099. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ilaprazole
    n1=Okihiro (syndrome de) | n2=en:ilaprazole | rel=r_associated | relid=0 | w=10
  3100. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iloperidone
    n1=Okihiro (syndrome de) | n2=en:iloperidone | rel=r_associated | relid=0 | w=10
  3101. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iloprost
    n1=Okihiro (syndrome de) | n2=en:iloprost | rel=r_associated | relid=0 | w=10
  3102. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ilorasertib
    n1=Okihiro (syndrome de) | n2=en:ilorasertib | rel=r_associated | relid=0 | w=10
  3103. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ilx-295501
    n1=Okihiro (syndrome de) | n2=en:ilx-295501 | rel=r_associated | relid=0 | w=10
  3104. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ilx23-7553
    n1=Okihiro (syndrome de) | n2=en:ilx23-7553 | rel=r_associated | relid=0 | w=10
  3105. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imalumab
    n1=Okihiro (syndrome de) | n2=en:imalumab | rel=r_associated | relid=0 | w=10
  3106. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imatinib mesylate
    n1=Okihiro (syndrome de) | n2=en:imatinib mesylate | rel=r_associated | relid=0 | w=10
  3107. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imetelstat sodium
    n1=Okihiro (syndrome de) | n2=en:imetelstat sodium | rel=r_associated | relid=0 | w=10
  3108. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imexon
    n1=Okihiro (syndrome de) | n2=en:imexon | rel=r_associated | relid=0 | w=10
  3109. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imiclopazine
    n1=Okihiro (syndrome de) | n2=en:imiclopazine | rel=r_associated | relid=0 | w=10
  3110. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imidazole antifungal
    n1=Okihiro (syndrome de) | n2=en:imidazole antifungal | rel=r_associated | relid=0 | w=10
  3111. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imidazole mustard
    n1=Okihiro (syndrome de) | n2=en:imidazole mustard | rel=r_associated | relid=0 | w=10
  3112. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imidazolyl ethanamide pentandioic acid
    n1=Okihiro (syndrome de) | n2=en:imidazolyl ethanamide pentandioic acid | rel=r_associated | relid=0 | w=10
  3113. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imipenem
    n1=Okihiro (syndrome de) | n2=en:imipenem | rel=r_associated | relid=0 | w=10
  3114. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imipenem-cilastatin sodium
    n1=Okihiro (syndrome de) | n2=en:imipenem-cilastatin sodium | rel=r_associated | relid=0 | w=10
  3115. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imiquimod
    n1=Okihiro (syndrome de) | n2=en:imiquimod | rel=r_associated | relid=0 | w=10
  3116. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imisopasem manganese
    n1=Okihiro (syndrome de) | n2=en:imisopasem manganese | rel=r_associated | relid=0 | w=10
  3117. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immediate-release onapristone
    n1=Okihiro (syndrome de) | n2=en:immediate-release onapristone | rel=r_associated | relid=0 | w=10
  3118. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immediate-release oral liquid formulation oxymorphone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:immediate-release oral liquid formulation oxymorphone hydrochloride | rel=r_associated | relid=0 | w=10
  3119. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immediate-release tablet afuresertib
    n1=Okihiro (syndrome de) | n2=en:immediate-release tablet afuresertib | rel=r_associated | relid=0 | w=10
  3120. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immunoadjuvant qs-dg
    n1=Okihiro (syndrome de) | n2=en:immunoadjuvant qs-dg | rel=r_associated | relid=0 | w=10
  3121. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immunoconjugate ro5479599
    n1=Okihiro (syndrome de) | n2=en:immunoconjugate ro5479599 | rel=r_associated | relid=0 | w=10
  3122. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immunocytokine nhs-il12
    n1=Okihiro (syndrome de) | n2=en:immunocytokine nhs-il12 | rel=r_associated | relid=0 | w=10
  3123. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immunocytokine nhs-il2-lt
    n1=Okihiro (syndrome de) | n2=en:immunocytokine nhs-il2-lt | rel=r_associated | relid=0 | w=10
  3124. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immunomodulator ohr/avr118
    n1=Okihiro (syndrome de) | n2=en:immunomodulator ohr/avr118 | rel=r_associated | relid=0 | w=10
  3125. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immunomodulators
    n1=Okihiro (syndrome de) | n2=en:immunomodulators | rel=r_associated | relid=0 | w=10
  3126. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immunomodulatory agent cc-11006
    n1=Okihiro (syndrome de) | n2=en:immunomodulatory agent cc-11006 | rel=r_associated | relid=0 | w=10
  3127. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immunotherapeutic agent
    n1=Okihiro (syndrome de) | n2=en:immunotherapeutic agent | rel=r_associated | relid=0 | w=10
  3128. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immunotherapeutic combination product cmb305
    n1=Okihiro (syndrome de) | n2=en:immunotherapeutic combination product cmb305 | rel=r_associated | relid=0 | w=10
  3129. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immunotherapeutic gsk1572932a
    n1=Okihiro (syndrome de) | n2=en:immunotherapeutic gsk1572932a | rel=r_associated | relid=0 | w=10
  3130. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immunotherapy regimen mkc-1106-mt
    n1=Okihiro (syndrome de) | n2=en:immunotherapy regimen mkc-1106-mt | rel=r_associated | relid=0 | w=10
  3131. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immunotoxin cmd-193
    n1=Okihiro (syndrome de) | n2=en:immunotoxin cmd-193 | rel=r_associated | relid=0 | w=10
  3132. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:immunotoxin d2c7-(scdsfv)-pe38kdel
    n1=Okihiro (syndrome de) | n2=en:immunotoxin d2c7-(scdsfv)-pe38kdel | rel=r_associated | relid=0 | w=10
  3133. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imp321
    n1=Okihiro (syndrome de) | n2=en:imp321 | rel=r_associated | relid=0 | w=10
  3134. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imreg-1
    n1=Okihiro (syndrome de) | n2=en:imreg-1 | rel=r_associated | relid=0 | w=10
  3135. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imt-1012 immunotherapeutic vaccine
    n1=Okihiro (syndrome de) | n2=en:imt-1012 immunotherapeutic vaccine | rel=r_associated | relid=0 | w=10
  3136. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:imuvert
    n1=Okihiro (syndrome de) | n2=en:imuvert | rel=r_associated | relid=0 | w=10
  3137. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:in 111 folic acid
    n1=Okihiro (syndrome de) | n2=en:in 111 folic acid | rel=r_associated | relid=0 | w=10
  3138. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:in 111 monoclonal antibody b3
    n1=Okihiro (syndrome de) | n2=en:in 111 monoclonal antibody b3 | rel=r_associated | relid=0 | w=10
  3139. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:in 111 monoclonal antibody hu3s193
    n1=Okihiro (syndrome de) | n2=en:in 111 monoclonal antibody hu3s193 | rel=r_associated | relid=0 | w=10
  3140. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:in 111 monoclonal antibody ll2
    n1=Okihiro (syndrome de) | n2=en:in 111 monoclonal antibody ll2 | rel=r_associated | relid=0 | w=10
  3141. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:in 111 monoclonal antibody lym-1
    n1=Okihiro (syndrome de) | n2=en:in 111 monoclonal antibody lym-1 | rel=r_associated | relid=0 | w=10
  3142. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:in 111 monoclonal antibody m170
    n1=Okihiro (syndrome de) | n2=en:in 111 monoclonal antibody m170 | rel=r_associated | relid=0 | w=10
  3143. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:in 111 monoclonal antibody mn-14
    n1=Okihiro (syndrome de) | n2=en:in 111 monoclonal antibody mn-14 | rel=r_associated | relid=0 | w=10
  3144. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:in 111 satumomab pendetide
    n1=Okihiro (syndrome de) | n2=en:in 111 satumomab pendetide | rel=r_associated | relid=0 | w=10
  3145. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:inactivated poliovirus vaccine
    n1=Okihiro (syndrome de) | n2=en:inactivated poliovirus vaccine | rel=r_associated | relid=0 | w=10
  3146. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:inalimarev
    n1=Okihiro (syndrome de) | n2=en:inalimarev | rel=r_associated | relid=0 | w=10
  3147. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:incomplete freund's adjuvant
    n1=Okihiro (syndrome de) | n2=en:incomplete freund's adjuvant | rel=r_associated | relid=0 | w=10
  3148. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:incyclinide
    n1=Okihiro (syndrome de) | n2=en:incyclinide | rel=r_associated | relid=0 | w=10
  3149. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indecainide
    n1=Okihiro (syndrome de) | n2=en:indecainide | rel=r_associated | relid=0 | w=10
  3150. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indibulin
    n1=Okihiro (syndrome de) | n2=en:indibulin | rel=r_associated | relid=0 | w=10
  3151. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indicine-n-oxide
    n1=Okihiro (syndrome de) | n2=en:indicine-n-oxide | rel=r_associated | relid=0 | w=10
  3152. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indinavir
    n1=Okihiro (syndrome de) | n2=en:indinavir | rel=r_associated | relid=0 | w=10
  3153. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indinavir sulfate
    n1=Okihiro (syndrome de) | n2=en:indinavir sulfate | rel=r_associated | relid=0 | w=10
  3154. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indisulam
    n1=Okihiro (syndrome de) | n2=en:indisulam | rel=r_associated | relid=0 | w=10
  3155. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111 anti-cd45 monoclonal antibody bc8
    n1=Okihiro (syndrome de) | n2=en:indium in 111 anti-cd45 monoclonal antibody bc8 | rel=r_associated | relid=0 | w=10
  3156. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111 anti-egfr monoclonal antibody abt-806
    n1=Okihiro (syndrome de) | n2=en:indium in 111 anti-egfr monoclonal antibody abt-806 | rel=r_associated | relid=0 | w=10
  3157. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111 bevacizumab
    n1=Okihiro (syndrome de) | n2=en:indium in 111 bevacizumab | rel=r_associated | relid=0 | w=10
  3158. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111 capromab pendetide
    n1=Okihiro (syndrome de) | n2=en:indium in 111 capromab pendetide | rel=r_associated | relid=0 | w=10
  3159. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111 chimeric monoclonal antibody 806
    n1=Okihiro (syndrome de) | n2=en:indium in 111 chimeric monoclonal antibody 806 | rel=r_associated | relid=0 | w=10
  3160. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111 chx-a dtpa trastuzumab
    n1=Okihiro (syndrome de) | n2=en:indium in 111 chx-a dtpa trastuzumab | rel=r_associated | relid=0 | w=10
  3161. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111 girentuximab
    n1=Okihiro (syndrome de) | n2=en:indium in 111 girentuximab | rel=r_associated | relid=0 | w=10
  3162. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111 her2-specific high-affinity protein aby-025
    n1=Okihiro (syndrome de) | n2=en:indium in 111 her2-specific high-affinity protein aby-025 | rel=r_associated | relid=0 | w=10
  3163. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111 monoclonal antibody bre-3
    n1=Okihiro (syndrome de) | n2=en:indium in 111 monoclonal antibody bre-3 | rel=r_associated | relid=0 | w=10
  3164. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111 monoclonal antibody hupam4
    n1=Okihiro (syndrome de) | n2=en:indium in 111 monoclonal antibody hupam4 | rel=r_associated | relid=0 | w=10
  3165. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111 pentetate
    n1=Okihiro (syndrome de) | n2=en:indium in 111 pentetate | rel=r_associated | relid=0 | w=10
  3166. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111 pertuzumab
    n1=Okihiro (syndrome de) | n2=en:indium in 111 pertuzumab | rel=r_associated | relid=0 | w=10
  3167. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111-cmd-193
    n1=Okihiro (syndrome de) | n2=en:indium in 111-cmd-193 | rel=r_associated | relid=0 | w=10
  3168. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111-dota-biotin
    n1=Okihiro (syndrome de) | n2=en:indium in 111-dota-biotin | rel=r_associated | relid=0 | w=10
  3169. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111-dota-di-hsg peptide imp-288
    n1=Okihiro (syndrome de) | n2=en:indium in 111-dota-di-hsg peptide imp-288 | rel=r_associated | relid=0 | w=10
  3170. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111-dota-exendin-4
    n1=Okihiro (syndrome de) | n2=en:indium in 111-dota-exendin-4 | rel=r_associated | relid=0 | w=10
  3171. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111-labeled autologous peripheral blood mononuclear cells
    n1=Okihiro (syndrome de) | n2=en:indium in 111-labeled autologous peripheral blood mononuclear cells | rel=r_associated | relid=0 | w=10
  3172. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111-labeled autologous polymorphonuclear leukocytes
    n1=Okihiro (syndrome de) | n2=en:indium in 111-labeled autologous polymorphonuclear leukocytes | rel=r_associated | relid=0 | w=10
  3173. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111-labeled macroaggregated albumin
    n1=Okihiro (syndrome de) | n2=en:indium in 111-labeled macroaggregated albumin | rel=r_associated | relid=0 | w=10
  3174. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in 111/yttrium y90-dota-biotin
    n1=Okihiro (syndrome de) | n2=en:indium in 111/yttrium y90-dota-biotin | rel=r_associated | relid=0 | w=10
  3175. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in-111 ibritumomab tiuxetan
    n1=Okihiro (syndrome de) | n2=en:indium in-111 ibritumomab tiuxetan | rel=r_associated | relid=0 | w=10
  3176. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indium in-111 pentetreotide
    n1=Okihiro (syndrome de) | n2=en:indium in-111 pentetreotide | rel=r_associated | relid=0 | w=10
  3177. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indocyanine green solution
    n1=Okihiro (syndrome de) | n2=en:indocyanine green solution | rel=r_associated | relid=0 | w=10
  3178. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indocyanine green/albumin solution
    n1=Okihiro (syndrome de) | n2=en:indocyanine green/albumin solution | rel=r_associated | relid=0 | w=10
  3179. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indole-3-carbinol
    n1=Okihiro (syndrome de) | n2=en:indole-3-carbinol | rel=r_associated | relid=0 | w=10
  3180. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indole-3-carbinol/calcium/schizandra/vitamin d3/milk thistle/stinging nettle/lignan-based nutritional capsule
    n1=Okihiro (syndrome de) | n2=en:indole-3-carbinol/calcium/schizandra/vitamin d3/milk thistle/stinging nettle/lignan-based nutritional capsule | rel=r_associated | relid=0 | w=10
  3181. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indoleamine 2,3-dioxygenase peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:indoleamine 2,3-dioxygenase peptide vaccine | rel=r_associated | relid=0 | w=10
  3182. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indomethacin
    n1=Okihiro (syndrome de) | n2=en:indomethacin | rel=r_associated | relid=0 | w=10
  3183. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:indoximod
    n1=Okihiro (syndrome de) | n2=en:indoximod | rel=r_associated | relid=0 | w=10
  3184. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:inducible cd4+cd25+ regulatory t cells
    n1=Okihiro (syndrome de) | n2=en:inducible cd4+cd25+ regulatory t cells | rel=r_associated | relid=0 | w=10
  3185. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:inecalcitol
    n1=Okihiro (syndrome de) | n2=en:inecalcitol | rel=r_associated | relid=0 | w=10
  3186. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:infliximab
    n1=Okihiro (syndrome de) | n2=en:infliximab | rel=r_associated | relid=0 | w=10
  3187. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ingenol derivative leo 43204 gel
    n1=Okihiro (syndrome de) | n2=en:ingenol derivative leo 43204 gel | rel=r_associated | relid=0 | w=10
  3188. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ingenol mebutate
    n1=Okihiro (syndrome de) | n2=en:ingenol mebutate | rel=r_associated | relid=0 | w=10
  3189. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ingenol mebutate gel
    n1=Okihiro (syndrome de) | n2=en:ingenol mebutate gel | rel=r_associated | relid=0 | w=10
  3190. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iniparib
    n1=Okihiro (syndrome de) | n2=en:iniparib | rel=r_associated | relid=0 | w=10
  3191. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:injectable astragalus membranaceus polysaccharide
    n1=Okihiro (syndrome de) | n2=en:injectable astragalus membranaceus polysaccharide | rel=r_associated | relid=0 | w=10
  3192. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:injectable liposomal vinorelbine
    n1=Okihiro (syndrome de) | n2=en:injectable liposomal vinorelbine | rel=r_associated | relid=0 | w=10
  3193. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:innate defense regulator sgx942
    n1=Okihiro (syndrome de) | n2=en:innate defense regulator sgx942 | rel=r_associated | relid=0 | w=10
  3194. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:innate immunostimulator rbbx-01
    n1=Okihiro (syndrome de) | n2=en:innate immunostimulator rbbx-01 | rel=r_associated | relid=0 | w=10
  3195. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ino-1001
    n1=Okihiro (syndrome de) | n2=en:ino-1001 | rel=r_associated | relid=0 | w=10
  3196. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:inosine 5'-monophosphate dehydrogenase inhibitor ff-10501-01
    n1=Okihiro (syndrome de) | n2=en:inosine 5'-monophosphate dehydrogenase inhibitor ff-10501-01 | rel=r_associated | relid=0 | w=10
  3197. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:inosine dialdehyde
    n1=Okihiro (syndrome de) | n2=en:inosine dialdehyde | rel=r_associated | relid=0 | w=10
  3198. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:inosine pranobex
    n1=Okihiro (syndrome de) | n2=en:inosine pranobex | rel=r_associated | relid=0 | w=10
  3199. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:inositol
    n1=Okihiro (syndrome de) | n2=en:inositol | rel=r_associated | relid=0 | w=10
  3200. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:inotropic agent
    n1=Okihiro (syndrome de) | n2=en:inotropic agent | rel=r_associated | relid=0 | w=10
  3201. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:inotuzumab ozogamicin
    n1=Okihiro (syndrome de) | n2=en:inotuzumab ozogamicin | rel=r_associated | relid=0 | w=10
  3202. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ins316
    n1=Okihiro (syndrome de) | n2=en:ins316 | rel=r_associated | relid=0 | w=10
  3203. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:insulin aspart
    n1=Okihiro (syndrome de) | n2=en:insulin aspart | rel=r_associated | relid=0 | w=10
  3204. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:insulin degludec
    n1=Okihiro (syndrome de) | n2=en:insulin degludec | rel=r_associated | relid=0 | w=10
  3205. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:insulin glargine
    n1=Okihiro (syndrome de) | n2=en:insulin glargine | rel=r_associated | relid=0 | w=10
  3206. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:insulin lispro
    n1=Okihiro (syndrome de) | n2=en:insulin lispro | rel=r_associated | relid=0 | w=10
  3207. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:insulin sensitizer s-707106
    n1=Okihiro (syndrome de) | n2=en:insulin sensitizer s-707106 | rel=r_associated | relid=0 | w=10
  3208. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:insulin, nph
    n1=Okihiro (syndrome de) | n2=en:insulin, nph | rel=r_associated | relid=0 | w=10
  3209. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:insulin, regular
    n1=Okihiro (syndrome de) | n2=en:insulin, regular | rel=r_associated | relid=0 | w=10
  3210. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:integrin receptor antagonist glpg0187
    n1=Okihiro (syndrome de) | n2=en:integrin receptor antagonist glpg0187 | rel=r_associated | relid=0 | w=10
  3211. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:interferon alfa-n1 lymphoblastoid
    n1=Okihiro (syndrome de) | n2=en:interferon alfa-n1 lymphoblastoid | rel=r_associated | relid=0 | w=10
  3212. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:interferon alfa-n3
    n1=Okihiro (syndrome de) | n2=en:interferon alfa-n3 | rel=r_associated | relid=0 | w=10
  3213. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:interferon alfacon-1
    n1=Okihiro (syndrome de) | n2=en:interferon alfacon-1 | rel=r_associated | relid=0 | w=10
  3214. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:interferon beta-secreting mesenchymal stem cells
    n1=Okihiro (syndrome de) | n2=en:interferon beta-secreting mesenchymal stem cells | rel=r_associated | relid=0 | w=10
  3215. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:interferon-alpha
    n1=Okihiro (syndrome de) | n2=en:interferon-alpha | rel=r_associated | relid=0 | w=10
  3216. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:interferon-gamma-expressing adenovirus vaccine asn-002
    n1=Okihiro (syndrome de) | n2=en:interferon-gamma-expressing adenovirus vaccine asn-002 | rel=r_associated | relid=0 | w=10
  3217. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:interleukin-10
    n1=Okihiro (syndrome de) | n2=en:interleukin-10 | rel=r_associated | relid=0 | w=10
  3218. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:interleukin-12 gene
    n1=Okihiro (syndrome de) | n2=en:interleukin-12 gene | rel=r_associated | relid=0 | w=10
  3219. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:interleukin-2 fusion protein msb0010445
    n1=Okihiro (syndrome de) | n2=en:interleukin-2 fusion protein msb0010445 | rel=r_associated | relid=0 | w=10
  3220. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:interleukin-2 gene
    n1=Okihiro (syndrome de) | n2=en:interleukin-2 gene | rel=r_associated | relid=0 | w=10
  3221. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:interleukin-2 liposome
    n1=Okihiro (syndrome de) | n2=en:interleukin-2 liposome | rel=r_associated | relid=0 | w=10
  3222. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:interleukin-4 pe38kdel immunotoxin
    n1=Okihiro (syndrome de) | n2=en:interleukin-4 pe38kdel immunotoxin | rel=r_associated | relid=0 | w=10
  3223. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:interleukin-6
    n1=Okihiro (syndrome de) | n2=en:interleukin-6 | rel=r_associated | relid=0 | w=10
  3224. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:intermediate-affinity interleukin-2 receptor agonist alks 4230
    n1=Okihiro (syndrome de) | n2=en:intermediate-affinity interleukin-2 receptor agonist alks 4230 | rel=r_associated | relid=0 | w=10
  3225. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:intetumumab
    n1=Okihiro (syndrome de) | n2=en:intetumumab | rel=r_associated | relid=0 | w=10
  3226. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:intoplicine
    n1=Okihiro (syndrome de) | n2=en:intoplicine | rel=r_associated | relid=0 | w=10
  3227. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:intranasal ketamine
    n1=Okihiro (syndrome de) | n2=en:intranasal ketamine | rel=r_associated | relid=0 | w=10
  3228. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:intrinsic factor
    n1=Okihiro (syndrome de) | n2=en:intrinsic factor | rel=r_associated | relid=0 | w=10
  3229. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:inulin
    n1=Okihiro (syndrome de) | n2=en:inulin | rel=r_associated | relid=0 | w=10
  3230. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:invertase
    n1=Okihiro (syndrome de) | n2=en:invertase | rel=r_associated | relid=0 | w=10
  3231. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:investigational new drug
    n1=Okihiro (syndrome de) | n2=en:investigational new drug | rel=r_associated | relid=0 | w=10
  3232. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iobenguane i-124
    n1=Okihiro (syndrome de) | n2=en:iobenguane i-124 | rel=r_associated | relid=0 | w=10
  3233. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iobenguane i-131
    n1=Okihiro (syndrome de) | n2=en:iobenguane i-131 | rel=r_associated | relid=0 | w=10
  3234. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iobenguane sulfate i-123
    n1=Okihiro (syndrome de) | n2=en:iobenguane sulfate i-123 | rel=r_associated | relid=0 | w=10
  3235. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iobitridol
    n1=Okihiro (syndrome de) | n2=en:iobitridol | rel=r_associated | relid=0 | w=10
  3236. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodinated contrast agent
    n1=Okihiro (syndrome de) | n2=en:iodinated contrast agent | rel=r_associated | relid=0 | w=10
  3237. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine 131-6-beta-iodomethyl-19-norcholesterol
    n1=Okihiro (syndrome de) | n2=en:iodine 131-6-beta-iodomethyl-19-norcholesterol | rel=r_associated | relid=0 | w=10
  3238. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine compounds
    n1=Okihiro (syndrome de) | n2=en:iodine compounds | rel=r_associated | relid=0 | w=10
  3239. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 123 anti-cea recombinant diabody t84.66
    n1=Okihiro (syndrome de) | n2=en:iodine i 123 anti-cea recombinant diabody t84.66 | rel=r_associated | relid=0 | w=10
  3240. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 123 iodobenzamide
    n1=Okihiro (syndrome de) | n2=en:iodine i 123 iodobenzamide | rel=r_associated | relid=0 | w=10
  3241. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 124
    n1=Okihiro (syndrome de) | n2=en:iodine i 124 | rel=r_associated | relid=0 | w=10
  3242. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 124 anti-phosphatidylserine monoclonal antibody pgn650
    n1=Okihiro (syndrome de) | n2=en:iodine i 124 anti-phosphatidylserine monoclonal antibody pgn650 | rel=r_associated | relid=0 | w=10
  3243. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 124 cpd-1028
    n1=Okihiro (syndrome de) | n2=en:iodine i 124 cpd-1028 | rel=r_associated | relid=0 | w=10
  3244. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 124 iododeoxyuridine
    n1=Okihiro (syndrome de) | n2=en:iodine i 124 iododeoxyuridine | rel=r_associated | relid=0 | w=10
  3245. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 124 monoclonal antibody 3f8
    n1=Okihiro (syndrome de) | n2=en:iodine i 124 monoclonal antibody 3f8 | rel=r_associated | relid=0 | w=10
  3246. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 124 monoclonal antibody 8h9
    n1=Okihiro (syndrome de) | n2=en:iodine i 124 monoclonal antibody 8h9 | rel=r_associated | relid=0 | w=10
  3247. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 124 monoclonal antibody a33
    n1=Okihiro (syndrome de) | n2=en:iodine i 124 monoclonal antibody a33 | rel=r_associated | relid=0 | w=10
  3248. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 124 nm404
    n1=Okihiro (syndrome de) | n2=en:iodine i 124 nm404 | rel=r_associated | relid=0 | w=10
  3249. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 124 phospholipid ether analogue clr1404
    n1=Okihiro (syndrome de) | n2=en:iodine i 124 phospholipid ether analogue clr1404 | rel=r_associated | relid=0 | w=10
  3250. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 124 pu-ad
    n1=Okihiro (syndrome de) | n2=en:iodine i 124 pu-ad | rel=r_associated | relid=0 | w=10
  3251. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 124-crgdy-peg-c dots
    n1=Okihiro (syndrome de) | n2=en:iodine i 124-crgdy-peg-c dots | rel=r_associated | relid=0 | w=10
  3252. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 124-iodo-azomycin galactopyranoside
    n1=Okihiro (syndrome de) | n2=en:iodine i 124-iodo-azomycin galactopyranoside | rel=r_associated | relid=0 | w=10
  3253. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 124-labeled anti-psca a11 minibody
    n1=Okihiro (syndrome de) | n2=en:iodine i 124-labeled anti-psca a11 minibody | rel=r_associated | relid=0 | w=10
  3254. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 124-labeled hsp90 inhibitor puh71
    n1=Okihiro (syndrome de) | n2=en:iodine i 124-labeled hsp90 inhibitor puh71 | rel=r_associated | relid=0 | w=10
  3255. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 125-anti-egfr-425 monoclonal antibody
    n1=Okihiro (syndrome de) | n2=en:iodine i 125-anti-egfr-425 monoclonal antibody | rel=r_associated | relid=0 | w=10
  3256. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 anti-fibronectin antibody fragment l19-sip
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 anti-fibronectin antibody fragment l19-sip | rel=r_associated | relid=0 | w=10
  3257. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 ethiodized oil
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 ethiodized oil | rel=r_associated | relid=0 | w=10
  3258. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 monoclonal antibody 3f8
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 monoclonal antibody 3f8 | rel=r_associated | relid=0 | w=10
  3259. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 monoclonal antibody 81c6
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 monoclonal antibody 81c6 | rel=r_associated | relid=0 | w=10
  3260. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 monoclonal antibody 8h9
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 monoclonal antibody 8h9 | rel=r_associated | relid=0 | w=10
  3261. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 monoclonal antibody bc8
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 monoclonal antibody bc8 | rel=r_associated | relid=0 | w=10
  3262. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 monoclonal antibody cc49-deltach2
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 monoclonal antibody cc49-deltach2 | rel=r_associated | relid=0 | w=10
  3263. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 monoclonal antibody f16sip
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 monoclonal antibody f16sip | rel=r_associated | relid=0 | w=10
  3264. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 monoclonal antibody g-250
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 monoclonal antibody g-250 | rel=r_associated | relid=0 | w=10
  3265. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 monoclonal antibody muj591
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 monoclonal antibody muj591 | rel=r_associated | relid=0 | w=10
  3266. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 monoclonal antibody tnt-1/b
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 monoclonal antibody tnt-1/b | rel=r_associated | relid=0 | w=10
  3267. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 nm404
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 nm404 | rel=r_associated | relid=0 | w=10
  3268. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 phospholipid ether analogue clr1404
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 phospholipid ether analogue clr1404 | rel=r_associated | relid=0 | w=10
  3269. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 rituximab
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 rituximab | rel=r_associated | relid=0 | w=10
  3270. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 sgmib-anti-her2 vhh1
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 sgmib-anti-her2 vhh1 | rel=r_associated | relid=0 | w=10
  3271. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 tenatumomab
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 tenatumomab | rel=r_associated | relid=0 | w=10
  3272. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 tm-601
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 tm-601 | rel=r_associated | relid=0 | w=10
  3273. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131 tositumomab
    n1=Okihiro (syndrome de) | n2=en:iodine i 131 tositumomab | rel=r_associated | relid=0 | w=10
  3274. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i 131-labeled anti-cea/anti-hsg bispecific monoclonal antibody tf2
    n1=Okihiro (syndrome de) | n2=en:iodine i 131-labeled anti-cea/anti-hsg bispecific monoclonal antibody tf2 | rel=r_associated | relid=0 | w=10
  3275. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i-123
    n1=Okihiro (syndrome de) | n2=en:iodine i-123 | rel=r_associated | relid=0 | w=10
  3276. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i-123 adam
    n1=Okihiro (syndrome de) | n2=en:iodine i-123 adam | rel=r_associated | relid=0 | w=10
  3277. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i-123 iodometomidate
    n1=Okihiro (syndrome de) | n2=en:iodine i-123 iodometomidate | rel=r_associated | relid=0 | w=10
  3278. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i-123 mip-1095
    n1=Okihiro (syndrome de) | n2=en:iodine i-123 mip-1095 | rel=r_associated | relid=0 | w=10
  3279. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i-124 fiau
    n1=Okihiro (syndrome de) | n2=en:iodine i-124 fiau | rel=r_associated | relid=0 | w=10
  3280. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i-124 girentuximab
    n1=Okihiro (syndrome de) | n2=en:iodine i-124 girentuximab | rel=r_associated | relid=0 | w=10
  3281. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i-125
    n1=Okihiro (syndrome de) | n2=en:iodine i-125 | rel=r_associated | relid=0 | w=10
  3282. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine i-131
    n1=Okihiro (syndrome de) | n2=en:iodine i-131 | rel=r_associated | relid=0 | w=10
  3283. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodine norcholestenol
    n1=Okihiro (syndrome de) | n2=en:iodine norcholestenol | rel=r_associated | relid=0 | w=10
  3284. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodixanol
    n1=Okihiro (syndrome de) | n2=en:iodixanol | rel=r_associated | relid=0 | w=10
  3285. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodocholesterol i^131^
    n1=Okihiro (syndrome de) | n2=en:iodocholesterol i^131^ | rel=r_associated | relid=0 | w=10
  3286. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iodophore product
    n1=Okihiro (syndrome de) | n2=en:iodophore product | rel=r_associated | relid=0 | w=10
  3287. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ioflubenzamide i-131
    n1=Okihiro (syndrome de) | n2=en:ioflubenzamide i-131 | rel=r_associated | relid=0 | w=10
  3288. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iofolastat i123
    n1=Okihiro (syndrome de) | n2=en:iofolastat i123 | rel=r_associated | relid=0 | w=10
  3289. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iohexol
    n1=Okihiro (syndrome de) | n2=en:iohexol | rel=r_associated | relid=0 | w=10
  3290. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ionic silver-impregnated sodium carboxymethylcellulose antimicrobial dressing
    n1=Okihiro (syndrome de) | n2=en:ionic silver-impregnated sodium carboxymethylcellulose antimicrobial dressing | rel=r_associated | relid=0 | w=10
  3291. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ionomycin
    n1=Okihiro (syndrome de) | n2=en:ionomycin | rel=r_associated | relid=0 | w=10
  3292. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iopanoic acid
    n1=Okihiro (syndrome de) | n2=en:iopanoic acid | rel=r_associated | relid=0 | w=10
  3293. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iopromide
    n1=Okihiro (syndrome de) | n2=en:iopromide | rel=r_associated | relid=0 | w=10
  3294. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ipafricept
    n1=Okihiro (syndrome de) | n2=en:ipafricept | rel=r_associated | relid=0 | w=10
  3295. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ipamorelin
    n1=Okihiro (syndrome de) | n2=en:ipamorelin | rel=r_associated | relid=0 | w=10
  3296. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ipatasertib
    n1=Okihiro (syndrome de) | n2=en:ipatasertib | rel=r_associated | relid=0 | w=10
  3297. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ipecac
    n1=Okihiro (syndrome de) | n2=en:ipecac | rel=r_associated | relid=0 | w=10
  3298. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ipilimumab
    n1=Okihiro (syndrome de) | n2=en:ipilimumab | rel=r_associated | relid=0 | w=10
  3299. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ipodic acid
    n1=Okihiro (syndrome de) | n2=en:ipodic acid | rel=r_associated | relid=0 | w=10
  3300. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ipomeanol
    n1=Okihiro (syndrome de) | n2=en:ipomeanol | rel=r_associated | relid=0 | w=10
  3301. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ipp-204106n
    n1=Okihiro (syndrome de) | n2=en:ipp-204106n | rel=r_associated | relid=0 | w=10
  3302. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iproplatin
    n1=Okihiro (syndrome de) | n2=en:iproplatin | rel=r_associated | relid=0 | w=10
  3303. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iratumumab
    n1=Okihiro (syndrome de) | n2=en:iratumumab | rel=r_associated | relid=0 | w=10
  3304. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iridium ir 192
    n1=Okihiro (syndrome de) | n2=en:iridium ir 192 | rel=r_associated | relid=0 | w=10
  3305. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:irinotecan
    n1=Okihiro (syndrome de) | n2=en:irinotecan | rel=r_associated | relid=0 | w=10
  3306. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:irinotecan hydrochloride
    n1=Okihiro (syndrome de) | n2=en:irinotecan hydrochloride | rel=r_associated | relid=0 | w=10
  3307. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:irinotecan-eluting beads
    n1=Okihiro (syndrome de) | n2=en:irinotecan-eluting beads | rel=r_associated | relid=0 | w=10
  3308. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:irinotecan/p-glycoprotein inhibitor hm30181ak combination tablet
    n1=Okihiro (syndrome de) | n2=en:irinotecan/p-glycoprotein inhibitor hm30181ak combination tablet | rel=r_associated | relid=0 | w=10
  3309. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:irofulven
    n1=Okihiro (syndrome de) | n2=en:irofulven | rel=r_associated | relid=0 | w=10
  3310. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iron
    n1=Okihiro (syndrome de) | n2=en:iron | rel=r_associated | relid=0 | w=10
  3311. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iron and/or iron compound
    n1=Okihiro (syndrome de) | n2=en:iron and/or iron compound | rel=r_associated | relid=0 | w=10
  3312. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iron dextran complex
    n1=Okihiro (syndrome de) | n2=en:iron dextran complex | rel=r_associated | relid=0 | w=10
  3313. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iron isomaltoside 1000
    n1=Okihiro (syndrome de) | n2=en:iron isomaltoside 1000 | rel=r_associated | relid=0 | w=10
  3314. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iron sucrose injection
    n1=Okihiro (syndrome de) | n2=en:iron sucrose injection | rel=r_associated | relid=0 | w=10
  3315. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:irosustat
    n1=Okihiro (syndrome de) | n2=en:irosustat | rel=r_associated | relid=0 | w=10
  3316. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:irritants
    n1=Okihiro (syndrome de) | n2=en:irritants | rel=r_associated | relid=0 | w=10
  3317. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:irx-2
    n1=Okihiro (syndrome de) | n2=en:irx-2 | rel=r_associated | relid=0 | w=10
  3318. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:isavuconazole
    n1=Okihiro (syndrome de) | n2=en:isavuconazole | rel=r_associated | relid=0 | w=10
  3319. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ischial tuberosity
    n1=Okihiro (syndrome de) | n2=en:ischial tuberosity | rel=r_associated | relid=0 | w=10
  3320. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iseganan hydrochloride
    n1=Okihiro (syndrome de) | n2=en:iseganan hydrochloride | rel=r_associated | relid=0 | w=10
  3321. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:isis 2503
    n1=Okihiro (syndrome de) | n2=en:isis 2503 | rel=r_associated | relid=0 | w=10
  3322. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:isis 3521
    n1=Okihiro (syndrome de) | n2=en:isis 3521 | rel=r_associated | relid=0 | w=10
  3323. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:isis 5132
    n1=Okihiro (syndrome de) | n2=en:isis 5132 | rel=r_associated | relid=0 | w=10
  3324. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iso-fludelone
    n1=Okihiro (syndrome de) | n2=en:iso-fludelone | rel=r_associated | relid=0 | w=10
  3325. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:isoflurane
    n1=Okihiro (syndrome de) | n2=en:isoflurane | rel=r_associated | relid=0 | w=10
  3326. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:isoniazid
    n1=Okihiro (syndrome de) | n2=en:isoniazid | rel=r_associated | relid=0 | w=10
  3327. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:isoquercetin
    n1=Okihiro (syndrome de) | n2=en:isoquercetin | rel=r_associated | relid=0 | w=10
  3328. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:isosorbide
    n1=Okihiro (syndrome de) | n2=en:isosorbide | rel=r_associated | relid=0 | w=10
  3329. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:isosulfan blue
    n1=Okihiro (syndrome de) | n2=en:isosulfan blue | rel=r_associated | relid=0 | w=10
  3330. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:isotretinoin
    n1=Okihiro (syndrome de) | n2=en:isotretinoin | rel=r_associated | relid=0 | w=10
  3331. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:isoxsuprine
    n1=Okihiro (syndrome de) | n2=en:isoxsuprine | rel=r_associated | relid=0 | w=10
  3332. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ispinesib
    n1=Okihiro (syndrome de) | n2=en:ispinesib | rel=r_associated | relid=0 | w=10
  3333. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:iss 1018 cpg oligodeoxynucleotide
    n1=Okihiro (syndrome de) | n2=en:iss 1018 cpg oligodeoxynucleotide | rel=r_associated | relid=0 | w=10
  3334. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:itraconazole
    n1=Okihiro (syndrome de) | n2=en:itraconazole | rel=r_associated | relid=0 | w=10
  3335. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:itraconazole dispersion in polymer matrix
    n1=Okihiro (syndrome de) | n2=en:itraconazole dispersion in polymer matrix | rel=r_associated | relid=0 | w=10
  3336. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ivabradine
    n1=Okihiro (syndrome de) | n2=en:ivabradine | rel=r_associated | relid=0 | w=10
  3337. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ivac mutanome vaccine
    n1=Okihiro (syndrome de) | n2=en:ivac mutanome vaccine | rel=r_associated | relid=0 | w=10
  3338. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ivermectin
    n1=Okihiro (syndrome de) | n2=en:ivermectin | rel=r_associated | relid=0 | w=10
  3339. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ixabepilone
    n1=Okihiro (syndrome de) | n2=en:ixabepilone | rel=r_associated | relid=0 | w=10
  3340. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ixazomib citrate
    n1=Okihiro (syndrome de) | n2=en:ixazomib citrate | rel=r_associated | relid=0 | w=10
  3341. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:j5 antiserum
    n1=Okihiro (syndrome de) | n2=en:j5 antiserum | rel=r_associated | relid=0 | w=10
  3342. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:jak inhibitor incb047986
    n1=Okihiro (syndrome de) | n2=en:jak inhibitor incb047986 | rel=r_associated | relid=0 | w=10
  3343. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:jak1 inhibitor incb039110
    n1=Okihiro (syndrome de) | n2=en:jak1 inhibitor incb039110 | rel=r_associated | relid=0 | w=10
  3344. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:jak1 inhibitor incb052793
    n1=Okihiro (syndrome de) | n2=en:jak1 inhibitor incb052793 | rel=r_associated | relid=0 | w=10
  3345. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:jak2 inhibitor azd1480
    n1=Okihiro (syndrome de) | n2=en:jak2 inhibitor azd1480 | rel=r_associated | relid=0 | w=10
  3346. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:jak2 inhibitor bms-911543
    n1=Okihiro (syndrome de) | n2=en:jak2 inhibitor bms-911543 | rel=r_associated | relid=0 | w=10
  3347. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:jak2 inhibitor tg101348
    n1=Okihiro (syndrome de) | n2=en:jak2 inhibitor tg101348 | rel=r_associated | relid=0 | w=10
  3348. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:jak2 inhibitor wp1066
    n1=Okihiro (syndrome de) | n2=en:jak2 inhibitor wp1066 | rel=r_associated | relid=0 | w=10
  3349. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:jak2 inhibitor xl019
    n1=Okihiro (syndrome de) | n2=en:jak2 inhibitor xl019 | rel=r_associated | relid=0 | w=10
  3350. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:jak2/src inhibitor ns-018
    n1=Okihiro (syndrome de) | n2=en:jak2/src inhibitor ns-018 | rel=r_associated | relid=0 | w=10
  3351. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:jaw bone
    n1=Okihiro (syndrome de) | n2=en:jaw bone | rel=r_associated | relid=0 | w=10
  3352. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:jeb regimen
    n1=Okihiro (syndrome de) | n2=en:jeb regimen | rel=r_associated | relid=0 | w=10
  3353. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:jin fu kang
    n1=Okihiro (syndrome de) | n2=en:jin fu kang | rel=r_associated | relid=0 | w=10
  3354. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:joint
    n1=Okihiro (syndrome de) | n2=en:joint | rel=r_associated | relid=0 | w=10
  3355. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:jugular foramen
    n1=Okihiro (syndrome de) | n2=en:jugular foramen | rel=r_associated | relid=0 | w=10
  3356. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:juniper tar
    n1=Okihiro (syndrome de) | n2=en:juniper tar | rel=r_associated | relid=0 | w=10
  3357. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:juven
    n1=Okihiro (syndrome de) | n2=en:juven | rel=r_associated | relid=0 | w=10
  3358. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:kanamycin sulfate
    n1=Okihiro (syndrome de) | n2=en:kanamycin sulfate | rel=r_associated | relid=0 | w=10
  3359. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:kanglaite
    n1=Okihiro (syndrome de) | n2=en:kanglaite | rel=r_associated | relid=0 | w=10
  3360. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:kava preparation
    n1=Okihiro (syndrome de) | n2=en:kava preparation | rel=r_associated | relid=0 | w=10
  3361. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:kava-based supplement
    n1=Okihiro (syndrome de) | n2=en:kava-based supplement | rel=r_associated | relid=0 | w=10
  3362. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:kelp preparation
    n1=Okihiro (syndrome de) | n2=en:kelp preparation | rel=r_associated | relid=0 | w=10
  3363. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ketamine
    n1=Okihiro (syndrome de) | n2=en:ketamine | rel=r_associated | relid=0 | w=10
  3364. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ketamine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:ketamine hydrochloride | rel=r_associated | relid=0 | w=10
  3365. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ketamine/amitriptyline np-h cream
    n1=Okihiro (syndrome de) | n2=en:ketamine/amitriptyline np-h cream | rel=r_associated | relid=0 | w=10
  3366. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ketazolam
    n1=Okihiro (syndrome de) | n2=en:ketazolam | rel=r_associated | relid=0 | w=10
  3367. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ketoconazole
    n1=Okihiro (syndrome de) | n2=en:ketoconazole | rel=r_associated | relid=0 | w=10
  3368. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ketoprofen
    n1=Okihiro (syndrome de) | n2=en:ketoprofen | rel=r_associated | relid=0 | w=10
  3369. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ketorolac
    n1=Okihiro (syndrome de) | n2=en:ketorolac | rel=r_associated | relid=0 | w=10
  3370. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ketorolac + phenylephrine
    n1=Okihiro (syndrome de) | n2=en:ketorolac + phenylephrine | rel=r_associated | relid=0 | w=10
  3371. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ketorolac tromethamine
    n1=Okihiro (syndrome de) | n2=en:ketorolac tromethamine | rel=r_associated | relid=0 | w=10
  3372. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:keyhole limpet hemocyanin
    n1=Okihiro (syndrome de) | n2=en:keyhole limpet hemocyanin | rel=r_associated | relid=0 | w=10
  3373. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:kit/pdgfr inhibitor dcc-2618
    n1=Okihiro (syndrome de) | n2=en:kit/pdgfr inhibitor dcc-2618 | rel=r_associated | relid=0 | w=10
  3374. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:klebsiella pneumoniae glycoprotein
    n1=Okihiro (syndrome de) | n2=en:klebsiella pneumoniae glycoprotein | rel=r_associated | relid=0 | w=10
  3375. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:klh-fitc
    n1=Okihiro (syndrome de) | n2=en:klh-fitc | rel=r_associated | relid=0 | w=10
  3376. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:krn5500
    n1=Okihiro (syndrome de) | n2=en:krn5500 | rel=r_associated | relid=0 | w=10
  3377. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ksa-klh conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:ksa-klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  3378. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ksp inhibitor arry-520
    n1=Okihiro (syndrome de) | n2=en:ksp inhibitor arry-520 | rel=r_associated | relid=0 | w=10
  3379. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ksp inhibitor azd4877
    n1=Okihiro (syndrome de) | n2=en:ksp inhibitor azd4877 | rel=r_associated | relid=0 | w=10
  3380. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:kunecatechins ointment
    n1=Okihiro (syndrome de) | n2=en:kunecatechins ointment | rel=r_associated | relid=0 | w=10
  3381. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:kw-2149
    n1=Okihiro (syndrome de) | n2=en:kw-2149 | rel=r_associated | relid=0 | w=10
  3382. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:l-377,202
    n1=Okihiro (syndrome de) | n2=en:l-377,202 | rel=r_associated | relid=0 | w=10
  3383. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:l-4-chlorokynurenine
    n1=Okihiro (syndrome de) | n2=en:l-4-chlorokynurenine | rel=r_associated | relid=0 | w=10
  3384. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:l-778,123
    n1=Okihiro (syndrome de) | n2=en:l-778,123 | rel=r_associated | relid=0 | w=10
  3385. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:l-arginine/korean ginseng/ginkgo biloba/damiana-based supplement
    n1=Okihiro (syndrome de) | n2=en:l-arginine/korean ginseng/ginkgo biloba/damiana-based supplement | rel=r_associated | relid=0 | w=10
  3386. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:l-carnitine l-tartrate
    n1=Okihiro (syndrome de) | n2=en:l-carnitine l-tartrate | rel=r_associated | relid=0 | w=10
  3387. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:l-gossypol
    n1=Okihiro (syndrome de) | n2=en:l-gossypol | rel=r_associated | relid=0 | w=10
  3388. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:l-leucyl-l-leucine methyl ester
    n1=Okihiro (syndrome de) | n2=en:l-leucyl-l-leucine methyl ester | rel=r_associated | relid=0 | w=10
  3389. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:l-lysine
    n1=Okihiro (syndrome de) | n2=en:l-lysine | rel=r_associated | relid=0 | w=10
  3390. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:l-menthol preparation npo-11
    n1=Okihiro (syndrome de) | n2=en:l-menthol preparation npo-11 | rel=r_associated | relid=0 | w=10
  3391. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:l-methylfolate
    n1=Okihiro (syndrome de) | n2=en:l-methylfolate | rel=r_associated | relid=0 | w=10
  3392. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:l-ornithine l-aspartate
    n1=Okihiro (syndrome de) | n2=en:l-ornithine l-aspartate | rel=r_associated | relid=0 | w=10
  3393. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:l-tryptophan/thymine-based supplement
    n1=Okihiro (syndrome de) | n2=en:l-tryptophan/thymine-based supplement | rel=r_associated | relid=0 | w=10
  3394. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:l19-il2 monoclonal antibody-cytokine fusion protein
    n1=Okihiro (syndrome de) | n2=en:l19-il2 monoclonal antibody-cytokine fusion protein | rel=r_associated | relid=0 | w=10
  3395. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:labetuzumab-sn-38 immunoconjugate immu-130
    n1=Okihiro (syndrome de) | n2=en:labetuzumab-sn-38 immunoconjugate immu-130 | rel=r_associated | relid=0 | w=10
  3396. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:labradimil
    n1=Okihiro (syndrome de) | n2=en:labradimil | rel=r_associated | relid=0 | w=10
  3397. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lacosamide
    n1=Okihiro (syndrome de) | n2=en:lacosamide | rel=r_associated | relid=0 | w=10
  3398. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactated ringer solution
    n1=Okihiro (syndrome de) | n2=en:lactated ringer solution | rel=r_associated | relid=0 | w=10
  3399. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactobacillus acidophilus
    n1=Okihiro (syndrome de) | n2=en:lactobacillus acidophilus | rel=r_associated | relid=0 | w=10
  3400. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactobacillus acidophilus/estriol vaginal tablet
    n1=Okihiro (syndrome de) | n2=en:lactobacillus acidophilus/estriol vaginal tablet | rel=r_associated | relid=0 | w=10
  3401. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactobacillus acidophilus/streptococcus thermophilus/bifidobacterium lactis/l. rhamnosus/b. longum/b. bifidum-based probiotic supplement
    n1=Okihiro (syndrome de) | n2=en:lactobacillus acidophilus/streptococcus thermophilus/bifidobacterium lactis/l. rhamnosus/b. longum/b. bifidum-based probiotic supplement | rel=r_associated | relid=0 | w=10
  3402. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactobacillus brevis cd2 lozenge
    n1=Okihiro (syndrome de) | n2=en:lactobacillus brevis cd2 lozenge | rel=r_associated | relid=0 | w=10
  3403. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactobacillus fermented extract
    n1=Okihiro (syndrome de) | n2=en:lactobacillus fermented extract | rel=r_associated | relid=0 | w=10
  3404. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactobacillus plantarum 299v/lactobacillus acidophilus/bifidobacterium lactis probiotic supplement
    n1=Okihiro (syndrome de) | n2=en:lactobacillus plantarum 299v/lactobacillus acidophilus/bifidobacterium lactis probiotic supplement | rel=r_associated | relid=0 | w=10
  3405. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactobacillus plantarum strain 299
    n1=Okihiro (syndrome de) | n2=en:lactobacillus plantarum strain 299 | rel=r_associated | relid=0 | w=10
  3406. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactobacillus plantarum strain 299v
    n1=Okihiro (syndrome de) | n2=en:lactobacillus plantarum strain 299v | rel=r_associated | relid=0 | w=10
  3407. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactobacillus rhamnosus gg
    n1=Okihiro (syndrome de) | n2=en:lactobacillus rhamnosus gg | rel=r_associated | relid=0 | w=10
  3408. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactobacillus rhamnosus gg agent
    n1=Okihiro (syndrome de) | n2=en:lactobacillus rhamnosus gg agent | rel=r_associated | relid=0 | w=10
  3409. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactobacillus rhamnosus/l. jensenii/l. crispatus/l. gasseri oral supplement
    n1=Okihiro (syndrome de) | n2=en:lactobacillus rhamnosus/l. jensenii/l. crispatus/l. gasseri oral supplement | rel=r_associated | relid=0 | w=10
  3410. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactobacillus-based probiotic capsule
    n1=Okihiro (syndrome de) | n2=en:lactobacillus-based probiotic capsule | rel=r_associated | relid=0 | w=10
  3411. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactoferrin-derived lytic peptide ltx-315
    n1=Okihiro (syndrome de) | n2=en:lactoferrin-derived lytic peptide ltx-315 | rel=r_associated | relid=0 | w=10
  3412. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lactoperoxidase/lysozyme/lactoferrin-based prebiotic vaginal lubricant
    n1=Okihiro (syndrome de) | n2=en:lactoperoxidase/lysozyme/lactoferrin-based prebiotic vaginal lubricant | rel=r_associated | relid=0 | w=10
  3413. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:laetrile
    n1=Okihiro (syndrome de) | n2=en:laetrile | rel=r_associated | relid=0 | w=10
  3414. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lamellar body mimetic mouth spray lms-611
    n1=Okihiro (syndrome de) | n2=en:lamellar body mimetic mouth spray lms-611 | rel=r_associated | relid=0 | w=10
  3415. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lamivudine
    n1=Okihiro (syndrome de) | n2=en:lamivudine | rel=r_associated | relid=0 | w=10
  3416. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lamotrigine
    n1=Okihiro (syndrome de) | n2=en:lamotrigine | rel=r_associated | relid=0 | w=10
  3417. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:laniquidar
    n1=Okihiro (syndrome de) | n2=en:laniquidar | rel=r_associated | relid=0 | w=10
  3418. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lanreotide acetate
    n1=Okihiro (syndrome de) | n2=en:lanreotide acetate | rel=r_associated | relid=0 | w=10
  3419. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lanreotide acetate copolymer microparticles
    n1=Okihiro (syndrome de) | n2=en:lanreotide acetate copolymer microparticles | rel=r_associated | relid=0 | w=10
  3420. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lanreotide long-acting aqueous gel
    n1=Okihiro (syndrome de) | n2=en:lanreotide long-acting aqueous gel | rel=r_associated | relid=0 | w=10
  3421. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lapachone
    n1=Okihiro (syndrome de) | n2=en:lapachone | rel=r_associated | relid=0 | w=10
  3422. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lapatinib ditosylate
    n1=Okihiro (syndrome de) | n2=en:lapatinib ditosylate | rel=r_associated | relid=0 | w=10
  3423. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lapuleucel-t
    n1=Okihiro (syndrome de) | n2=en:lapuleucel-t | rel=r_associated | relid=0 | w=10
  3424. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:largetrifoliolious bugbane rhizome supplement
    n1=Okihiro (syndrome de) | n2=en:largetrifoliolious bugbane rhizome supplement | rel=r_associated | relid=0 | w=10
  3425. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:laromustine
    n1=Okihiro (syndrome de) | n2=en:laromustine | rel=r_associated | relid=0 | w=10
  3426. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:laronidase
    n1=Okihiro (syndrome de) | n2=en:laronidase | rel=r_associated | relid=0 | w=10
  3427. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:larotaxel
    n1=Okihiro (syndrome de) | n2=en:larotaxel | rel=r_associated | relid=0 | w=10
  3428. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:las41007
    n1=Okihiro (syndrome de) | n2=en:las41007 | rel=r_associated | relid=0 | w=10
  3429. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lasw1510
    n1=Okihiro (syndrome de) | n2=en:lasw1510 | rel=r_associated | relid=0 | w=10
  3430. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lawsone
    n1=Okihiro (syndrome de) | n2=en:lawsone | rel=r_associated | relid=0 | w=10
  3431. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lead pb 212 tcmc-trastuzumab
    n1=Okihiro (syndrome de) | n2=en:lead pb 212 tcmc-trastuzumab | rel=r_associated | relid=0 | w=10
  3432. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:leflunomide
    n1=Okihiro (syndrome de) | n2=en:leflunomide | rel=r_associated | relid=0 | w=10
  3433. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:left olecranon
    n1=Okihiro (syndrome de) | n2=en:left olecranon | rel=r_associated | relid=0 | w=10
  3434. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lenalidomide
    n1=Okihiro (syndrome de) | n2=en:lenalidomide | rel=r_associated | relid=0 | w=10
  3435. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lenapenem
    n1=Okihiro (syndrome de) | n2=en:lenapenem | rel=r_associated | relid=0 | w=10
  3436. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lenograstim
    n1=Okihiro (syndrome de) | n2=en:lenograstim | rel=r_associated | relid=0 | w=10
  3437. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lenperone
    n1=Okihiro (syndrome de) | n2=en:lenperone | rel=r_associated | relid=0 | w=10
  3438. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lenti-d/abcd1-transduced autologous hematopoietic stem cells
    n1=Okihiro (syndrome de) | n2=en:lenti-d/abcd1-transduced autologous hematopoietic stem cells | rel=r_associated | relid=0 | w=10
  3439. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lentivirus vector ccr5 shrna/trim5alpha/tar decoy-transduced autologous cd34-positive hematopoietic progenitor cells
    n1=Okihiro (syndrome de) | n2=en:lentivirus vector ccr5 shrna/trim5alpha/tar decoy-transduced autologous cd34-positive hematopoietic progenitor cells | rel=r_associated | relid=0 | w=10
  3440. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells
    n1=Okihiro (syndrome de) | n2=en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells | rel=r_associated | relid=0 | w=10
  3441. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lenvatinib mesylate
    n1=Okihiro (syndrome de) | n2=en:lenvatinib mesylate | rel=r_associated | relid=0 | w=10
  3442. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lenzilumab
    n1=Okihiro (syndrome de) | n2=en:lenzilumab | rel=r_associated | relid=0 | w=10
  3443. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lepirudin
    n1=Okihiro (syndrome de) | n2=en:lepirudin | rel=r_associated | relid=0 | w=10
  3444. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:leridistim
    n1=Okihiro (syndrome de) | n2=en:leridistim | rel=r_associated | relid=0 | w=10
  3445. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lerisetron
    n1=Okihiro (syndrome de) | n2=en:lerisetron | rel=r_associated | relid=0 | w=10
  3446. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lesinurad
    n1=Okihiro (syndrome de) | n2=en:lesinurad | rel=r_associated | relid=0 | w=10
  3447. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lesser tuberosity
    n1=Okihiro (syndrome de) | n2=en:lesser tuberosity | rel=r_associated | relid=0 | w=10
  3448. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lestaurtinib
    n1=Okihiro (syndrome de) | n2=en:lestaurtinib | rel=r_associated | relid=0 | w=10
  3449. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:letermovir
    n1=Okihiro (syndrome de) | n2=en:letermovir | rel=r_associated | relid=0 | w=10
  3450. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:letrozole
    n1=Okihiro (syndrome de) | n2=en:letrozole | rel=r_associated | relid=0 | w=10
  3451. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:leucine-enhanced essential amino acid dietary supplement
    n1=Okihiro (syndrome de) | n2=en:leucine-enhanced essential amino acid dietary supplement | rel=r_associated | relid=0 | w=10
  3452. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:leucovorin calcium
    n1=Okihiro (syndrome de) | n2=en:leucovorin calcium | rel=r_associated | relid=0 | w=10
  3453. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:leukemic apoptotic corpse-pulsed autologous dendritic cells
    n1=Okihiro (syndrome de) | n2=en:leukemic apoptotic corpse-pulsed autologous dendritic cells | rel=r_associated | relid=0 | w=10
  3454. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:leukotriene antagonists
    n1=Okihiro (syndrome de) | n2=en:leukotriene antagonists | rel=r_associated | relid=0 | w=10
  3455. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:leuprolide acetate
    n1=Okihiro (syndrome de) | n2=en:leuprolide acetate | rel=r_associated | relid=0 | w=10
  3456. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:leuprolide mesylate injectable suspension
    n1=Okihiro (syndrome de) | n2=en:leuprolide mesylate injectable suspension | rel=r_associated | relid=0 | w=10
  3457. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levamisole
    n1=Okihiro (syndrome de) | n2=en:levamisole | rel=r_associated | relid=0 | w=10
  3458. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levamisole hydrochloride
    n1=Okihiro (syndrome de) | n2=en:levamisole hydrochloride | rel=r_associated | relid=0 | w=10
  3459. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levetiracetam
    n1=Okihiro (syndrome de) | n2=en:levetiracetam | rel=r_associated | relid=0 | w=10
  3460. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levobupivacaine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:levobupivacaine hydrochloride | rel=r_associated | relid=0 | w=10
  3461. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levocarnitine
    n1=Okihiro (syndrome de) | n2=en:levocarnitine | rel=r_associated | relid=0 | w=10
  3462. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levocetirizine dihydrochloride
    n1=Okihiro (syndrome de) | n2=en:levocetirizine dihydrochloride | rel=r_associated | relid=0 | w=10
  3463. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levodopa
    n1=Okihiro (syndrome de) | n2=en:levodopa | rel=r_associated | relid=0 | w=10
  3464. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levofloxacin
    n1=Okihiro (syndrome de) | n2=en:levofloxacin | rel=r_associated | relid=0 | w=10
  3465. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levoleucovorin
    n1=Okihiro (syndrome de) | n2=en:levoleucovorin | rel=r_associated | relid=0 | w=10
  3466. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levoleucovorin calcium
    n1=Okihiro (syndrome de) | n2=en:levoleucovorin calcium | rel=r_associated | relid=0 | w=10
  3467. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levonantradol
    n1=Okihiro (syndrome de) | n2=en:levonantradol | rel=r_associated | relid=0 | w=10
  3468. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levonorgestrel
    n1=Okihiro (syndrome de) | n2=en:levonorgestrel | rel=r_associated | relid=0 | w=10
  3469. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levonorgestrel-releasing intrauterine system
    n1=Okihiro (syndrome de) | n2=en:levonorgestrel-releasing intrauterine system | rel=r_associated | relid=0 | w=10
  3470. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levothyroxine sodium
    n1=Okihiro (syndrome de) | n2=en:levothyroxine sodium | rel=r_associated | relid=0 | w=10
  3471. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:levotofisopam
    n1=Okihiro (syndrome de) | n2=en:levotofisopam | rel=r_associated | relid=0 | w=10
  3472. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lexatumumab
    n1=Okihiro (syndrome de) | n2=en:lexatumumab | rel=r_associated | relid=0 | w=10
  3473. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lexibulin
    n1=Okihiro (syndrome de) | n2=en:lexibulin | rel=r_associated | relid=0 | w=10
  3474. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liarozole fumarate
    n1=Okihiro (syndrome de) | n2=en:liarozole fumarate | rel=r_associated | relid=0 | w=10
  3475. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:licartin
    n1=Okihiro (syndrome de) | n2=en:licartin | rel=r_associated | relid=0 | w=10
  3476. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lidocaine
    n1=Okihiro (syndrome de) | n2=en:lidocaine | rel=r_associated | relid=0 | w=10
  3477. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lidocaine patch
    n1=Okihiro (syndrome de) | n2=en:lidocaine patch | rel=r_associated | relid=0 | w=10
  3478. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:light-emitting oncolytic vaccinia virus gl-onc1
    n1=Okihiro (syndrome de) | n2=en:light-emitting oncolytic vaccinia virus gl-onc1 | rel=r_associated | relid=0 | w=10
  3479. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:limonene
    n1=Okihiro (syndrome de) | n2=en:limonene | rel=r_associated | relid=0 | w=10
  3480. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:linaclotide acetate
    n1=Okihiro (syndrome de) | n2=en:linaclotide acetate | rel=r_associated | relid=0 | w=10
  3481. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:linagliptin + metformin
    n1=Okihiro (syndrome de) | n2=en:linagliptin + metformin | rel=r_associated | relid=0 | w=10
  3482. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lincomycin and derivatives
    n1=Okihiro (syndrome de) | n2=en:lincomycin and derivatives | rel=r_associated | relid=0 | w=10
  3483. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:linezolid
    n1=Okihiro (syndrome de) | n2=en:linezolid | rel=r_associated | relid=0 | w=10
  3484. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:linifanib
    n1=Okihiro (syndrome de) | n2=en:linifanib | rel=r_associated | relid=0 | w=10
  3485. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:linoleyl carbonate-paclitaxel
    n1=Okihiro (syndrome de) | n2=en:linoleyl carbonate-paclitaxel | rel=r_associated | relid=0 | w=10
  3486. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:linseed oil
    n1=Okihiro (syndrome de) | n2=en:linseed oil | rel=r_associated | relid=0 | w=10
  3487. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:linsitinib
    n1=Okihiro (syndrome de) | n2=en:linsitinib | rel=r_associated | relid=0 | w=10
  3488. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lintuzumab
    n1=Okihiro (syndrome de) | n2=en:lintuzumab | rel=r_associated | relid=0 | w=10
  3489. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liothyronine
    n1=Okihiro (syndrome de) | n2=en:liothyronine | rel=r_associated | relid=0 | w=10
  3490. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liothyronine i-131
    n1=Okihiro (syndrome de) | n2=en:liothyronine i-131 | rel=r_associated | relid=0 | w=10
  3491. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liothyronine sodium
    n1=Okihiro (syndrome de) | n2=en:liothyronine sodium | rel=r_associated | relid=0 | w=10
  3492. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lipegfilgrastim
    n1=Okihiro (syndrome de) | n2=en:lipegfilgrastim | rel=r_associated | relid=0 | w=10
  3493. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lipid
    n1=Okihiro (syndrome de) | n2=en:lipid | rel=r_associated | relid=0 | w=10
  3494. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lipid encapsulated anti-plk1 sirna tkm-plk1
    n1=Okihiro (syndrome de) | n2=en:lipid encapsulated anti-plk1 sirna tkm-plk1 | rel=r_associated | relid=0 | w=10
  3495. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lipogranuloma
    n1=Okihiro (syndrome de) | n2=en:lipogranuloma | rel=r_associated | relid=0 | w=10
  3496. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lipopolysaccharide
    n1=Okihiro (syndrome de) | n2=en:lipopolysaccharide | rel=r_associated | relid=0 | w=10
  3497. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal amphotericin b
    n1=Okihiro (syndrome de) | n2=en:liposomal amphotericin b | rel=r_associated | relid=0 | w=10
  3498. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal bupivacaine
    n1=Okihiro (syndrome de) | n2=en:liposomal bupivacaine | rel=r_associated | relid=0 | w=10
  3499. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal c-raf antisense oligonucleotide
    n1=Okihiro (syndrome de) | n2=en:liposomal c-raf antisense oligonucleotide | rel=r_associated | relid=0 | w=10
  3500. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal curcumin
    n1=Okihiro (syndrome de) | n2=en:liposomal curcumin | rel=r_associated | relid=0 | w=10
  3501. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal cytarabine
    n1=Okihiro (syndrome de) | n2=en:liposomal cytarabine | rel=r_associated | relid=0 | w=10
  3502. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal cytarabine-daunorubicin cpx-351
    n1=Okihiro (syndrome de) | n2=en:liposomal cytarabine-daunorubicin cpx-351 | rel=r_associated | relid=0 | w=10
  3503. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal daunorubicin citrate
    n1=Okihiro (syndrome de) | n2=en:liposomal daunorubicin citrate | rel=r_associated | relid=0 | w=10
  3504. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal docetaxel
    n1=Okihiro (syndrome de) | n2=en:liposomal docetaxel | rel=r_associated | relid=0 | w=10
  3505. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal eribulin mesylate
    n1=Okihiro (syndrome de) | n2=en:liposomal eribulin mesylate | rel=r_associated | relid=0 | w=10
  3506. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal hpv-16 e6/e7 multipeptide vaccine pds0101
    n1=Okihiro (syndrome de) | n2=en:liposomal hpv-16 e6/e7 multipeptide vaccine pds0101 | rel=r_associated | relid=0 | w=10
  3507. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal irinotecan
    n1=Okihiro (syndrome de) | n2=en:liposomal irinotecan | rel=r_associated | relid=0 | w=10
  3508. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal mitoxantrone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:liposomal mitoxantrone hydrochloride | rel=r_associated | relid=0 | w=10
  3509. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal mnsod plasmid
    n1=Okihiro (syndrome de) | n2=en:liposomal mnsod plasmid | rel=r_associated | relid=0 | w=10
  3510. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal muc1/pet-lipid a vaccine
    n1=Okihiro (syndrome de) | n2=en:liposomal muc1/pet-lipid a vaccine | rel=r_associated | relid=0 | w=10
  3511. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal nddp
    n1=Okihiro (syndrome de) | n2=en:liposomal nddp | rel=r_associated | relid=0 | w=10
  3512. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal oxaliplatin
    n1=Okihiro (syndrome de) | n2=en:liposomal oxaliplatin | rel=r_associated | relid=0 | w=10
  3513. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal rhenium re 186
    n1=Okihiro (syndrome de) | n2=en:liposomal rhenium re 186 | rel=r_associated | relid=0 | w=10
  3514. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposomal sn-38
    n1=Okihiro (syndrome de) | n2=en:liposomal sn-38 | rel=r_associated | relid=0 | w=10
  3515. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposome-encapsulated doxorubicin citrate
    n1=Okihiro (syndrome de) | n2=en:liposome-encapsulated doxorubicin citrate | rel=r_associated | relid=0 | w=10
  3516. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposome-encapsulated mir-34 mimic mrx34
    n1=Okihiro (syndrome de) | n2=en:liposome-encapsulated mir-34 mimic mrx34 | rel=r_associated | relid=0 | w=10
  3517. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposome-encapsulated rb94 plasmid dna gene therapy agent sgt-94
    n1=Okihiro (syndrome de) | n2=en:liposome-encapsulated rb94 plasmid dna gene therapy agent sgt-94 | rel=r_associated | relid=0 | w=10
  3518. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposome-encapsulated recombinant human cu/zn superoxide-dismutase
    n1=Okihiro (syndrome de) | n2=en:liposome-encapsulated recombinant human cu/zn superoxide-dismutase | rel=r_associated | relid=0 | w=10
  3519. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liposome-incorporated grb2 antisense oligodeoxynucleotide
    n1=Okihiro (syndrome de) | n2=en:liposome-incorporated grb2 antisense oligodeoxynucleotide | rel=r_associated | relid=0 | w=10
  3520. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liraglutide
    n1=Okihiro (syndrome de) | n2=en:liraglutide | rel=r_associated | relid=0 | w=10
  3521. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lirilumab
    n1=Okihiro (syndrome de) | n2=en:lirilumab | rel=r_associated | relid=0 | w=10
  3522. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lisdexamfetamine dimesylate
    n1=Okihiro (syndrome de) | n2=en:lisdexamfetamine dimesylate | rel=r_associated | relid=0 | w=10
  3523. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lisinopril
    n1=Okihiro (syndrome de) | n2=en:lisinopril | rel=r_associated | relid=0 | w=10
  3524. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lisofylline
    n1=Okihiro (syndrome de) | n2=en:lisofylline | rel=r_associated | relid=0 | w=10
  3525. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:listeria monocytogenes-llo-psa vaccine adxs31-142
    n1=Okihiro (syndrome de) | n2=en:listeria monocytogenes-llo-psa vaccine adxs31-142 | rel=r_associated | relid=0 | w=10
  3526. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lithium
    n1=Okihiro (syndrome de) | n2=en:lithium | rel=r_associated | relid=0 | w=10
  3527. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lithium and/or lithium compound
    n1=Okihiro (syndrome de) | n2=en:lithium and/or lithium compound | rel=r_associated | relid=0 | w=10
  3528. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lithium carbonate
    n1=Okihiro (syndrome de) | n2=en:lithium carbonate | rel=r_associated | relid=0 | w=10
  3529. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lithium citrate
    n1=Okihiro (syndrome de) | n2=en:lithium citrate | rel=r_associated | relid=0 | w=10
  3530. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:litronesib
    n1=Okihiro (syndrome de) | n2=en:litronesib | rel=r_associated | relid=0 | w=10
  3531. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:live attenuated measles virus vaccine
    n1=Okihiro (syndrome de) | n2=en:live attenuated measles virus vaccine | rel=r_associated | relid=0 | w=10
  3532. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:live freeze-dried lactic acid bacteria probiotic
    n1=Okihiro (syndrome de) | n2=en:live freeze-dried lactic acid bacteria probiotic | rel=r_associated | relid=0 | w=10
  3533. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:live-attenuated double-deleted listeria monocytogenes bacteria jnj-64041809
    n1=Okihiro (syndrome de) | n2=en:live-attenuated double-deleted listeria monocytogenes bacteria jnj-64041809 | rel=r_associated | relid=0 | w=10
  3534. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:live-attenuated listeria encoding human mesothelin vaccine crs-207
    n1=Okihiro (syndrome de) | n2=en:live-attenuated listeria encoding human mesothelin vaccine crs-207 | rel=r_associated | relid=0 | w=10
  3535. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:live-attenuated listeria monocytogenes encoding egfrviii-mesothelin vaccine jnj-64041757
    n1=Okihiro (syndrome de) | n2=en:live-attenuated listeria monocytogenes encoding egfrviii-mesothelin vaccine jnj-64041757 | rel=r_associated | relid=0 | w=10
  3536. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:live-attenuated listeria monocytogenes-encoding egfrviii-ny-eso-1 vaccine adu-623
    n1=Okihiro (syndrome de) | n2=en:live-attenuated listeria monocytogenes-encoding egfrviii-ny-eso-1 vaccine adu-623 | rel=r_associated | relid=0 | w=10
  3537. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:liver extract
    n1=Okihiro (syndrome de) | n2=en:liver extract | rel=r_associated | relid=0 | w=10
  3538. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lmb-1 immunotoxin
    n1=Okihiro (syndrome de) | n2=en:lmb-1 immunotoxin | rel=r_associated | relid=0 | w=10
  3539. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lmb-2 immunotoxin
    n1=Okihiro (syndrome de) | n2=en:lmb-2 immunotoxin | rel=r_associated | relid=0 | w=10
  3540. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lmb-7 immunotoxin
    n1=Okihiro (syndrome de) | n2=en:lmb-7 immunotoxin | rel=r_associated | relid=0 | w=10
  3541. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lmb-9 immunotoxin
    n1=Okihiro (syndrome de) | n2=en:lmb-9 immunotoxin | rel=r_associated | relid=0 | w=10
  3542. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lmdda-llo-chher2 fusion protein-secreting live-attenuated listeria cancer vaccine adxs31-164
    n1=Okihiro (syndrome de) | n2=en:lmdda-llo-chher2 fusion protein-secreting live-attenuated listeria cancer vaccine adxs31-164 | rel=r_associated | relid=0 | w=10
  3543. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lmp-2:340-349 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:lmp-2:340-349 peptide vaccine | rel=r_associated | relid=0 | w=10
  3544. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lmp-2:419-427 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:lmp-2:419-427 peptide vaccine | rel=r_associated | relid=0 | w=10
  3545. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lmp1/barf1/ebna1-specific cytotoxic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:lmp1/barf1/ebna1-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  3546. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lmp2a-specific cytotoxic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:lmp2a-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  3547. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lna-based antimir-155 mrg-106
    n1=Okihiro (syndrome de) | n2=en:lna-based antimir-155 mrg-106 | rel=r_associated | relid=0 | w=10
  3548. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lobaplatin
    n1=Okihiro (syndrome de) | n2=en:lobaplatin | rel=r_associated | relid=0 | w=10
  3549. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:locust bean gum extract
    n1=Okihiro (syndrome de) | n2=en:locust bean gum extract | rel=r_associated | relid=0 | w=10
  3550. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lofendazam
    n1=Okihiro (syndrome de) | n2=en:lofendazam | rel=r_associated | relid=0 | w=10
  3551. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lometrexol
    n1=Okihiro (syndrome de) | n2=en:lometrexol | rel=r_associated | relid=0 | w=10
  3552. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lomustine
    n1=Okihiro (syndrome de) | n2=en:lomustine | rel=r_associated | relid=0 | w=10
  3553. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lonafarnib
    n1=Okihiro (syndrome de) | n2=en:lonafarnib | rel=r_associated | relid=0 | w=10
  3554. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lonaprisan
    n1=Okihiro (syndrome de) | n2=en:lonaprisan | rel=r_associated | relid=0 | w=10
  3555. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:long peptide vaccine 7
    n1=Okihiro (syndrome de) | n2=en:long peptide vaccine 7 | rel=r_associated | relid=0 | w=10
  3556. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:long-acting granulocyte colony-stimulating factor analog spi-2012
    n1=Okihiro (syndrome de) | n2=en:long-acting granulocyte colony-stimulating factor analog spi-2012 | rel=r_associated | relid=0 | w=10
  3557. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:long-acting release pasireotide
    n1=Okihiro (syndrome de) | n2=en:long-acting release pasireotide | rel=r_associated | relid=0 | w=10
  3558. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lonidamine
    n1=Okihiro (syndrome de) | n2=en:lonidamine | rel=r_associated | relid=0 | w=10
  3559. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:loop diuretic
    n1=Okihiro (syndrome de) | n2=en:loop diuretic | rel=r_associated | relid=0 | w=10
  3560. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:loperamide
    n1=Okihiro (syndrome de) | n2=en:loperamide | rel=r_associated | relid=0 | w=10
  3561. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:loperamide hydrochloride
    n1=Okihiro (syndrome de) | n2=en:loperamide hydrochloride | rel=r_associated | relid=0 | w=10
  3562. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lopinavir
    n1=Okihiro (syndrome de) | n2=en:lopinavir | rel=r_associated | relid=0 | w=10
  3563. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lopirazepam
    n1=Okihiro (syndrome de) | n2=en:lopirazepam | rel=r_associated | relid=0 | w=10
  3564. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:loprazolam
    n1=Okihiro (syndrome de) | n2=en:loprazolam | rel=r_associated | relid=0 | w=10
  3565. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:loratadine
    n1=Okihiro (syndrome de) | n2=en:loratadine | rel=r_associated | relid=0 | w=10
  3566. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lorazepam
    n1=Okihiro (syndrome de) | n2=en:lorazepam | rel=r_associated | relid=0 | w=10
  3567. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lormetazepam
    n1=Okihiro (syndrome de) | n2=en:lormetazepam | rel=r_associated | relid=0 | w=10
  3568. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lorpiprazole
    n1=Okihiro (syndrome de) | n2=en:lorpiprazole | rel=r_associated | relid=0 | w=10
  3569. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lorvotuzumab mertansine
    n1=Okihiro (syndrome de) | n2=en:lorvotuzumab mertansine | rel=r_associated | relid=0 | w=10
  3570. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:losartan potassium
    n1=Okihiro (syndrome de) | n2=en:losartan potassium | rel=r_associated | relid=0 | w=10
  3571. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:losoxantrone
    n1=Okihiro (syndrome de) | n2=en:losoxantrone | rel=r_associated | relid=0 | w=10
  3572. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lovastatin
    n1=Okihiro (syndrome de) | n2=en:lovastatin | rel=r_associated | relid=0 | w=10
  3573. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:loxapine
    n1=Okihiro (syndrome de) | n2=en:loxapine | rel=r_associated | relid=0 | w=10
  3574. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:loxapine succinate
    n1=Okihiro (syndrome de) | n2=en:loxapine succinate | rel=r_associated | relid=0 | w=10
  3575. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:loxoribine
    n1=Okihiro (syndrome de) | n2=en:loxoribine | rel=r_associated | relid=0 | w=10
  3576. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lps/cd40l-activated klh- and melanoma/hiv peptides-loaded autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:lps/cd40l-activated klh- and melanoma/hiv peptides-loaded autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  3577. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lsd1 inhibitor gsk2879552
    n1=Okihiro (syndrome de) | n2=en:lsd1 inhibitor gsk2879552 | rel=r_associated | relid=0 | w=10
  3578. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lubiprostone
    n1=Okihiro (syndrome de) | n2=en:lubiprostone | rel=r_associated | relid=0 | w=10
  3579. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lucanthone
    n1=Okihiro (syndrome de) | n2=en:lucanthone | rel=r_associated | relid=0 | w=10
  3580. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lucatumumab
    n1=Okihiro (syndrome de) | n2=en:lucatumumab | rel=r_associated | relid=0 | w=10
  3581. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lucitanib
    n1=Okihiro (syndrome de) | n2=en:lucitanib | rel=r_associated | relid=0 | w=10
  3582. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lugol's solution
    n1=Okihiro (syndrome de) | n2=en:lugol's solution | rel=r_associated | relid=0 | w=10
  3583. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lumbar curve
    n1=Okihiro (syndrome de) | n2=en:lumbar curve | rel=r_associated | relid=0 | w=10
  3584. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lumbar spine
    n1=Okihiro (syndrome de) | n2=en:lumbar spine | rel=r_associated | relid=0 | w=10
  3585. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lung tumor associated antigen
    n1=Okihiro (syndrome de) | n2=en:lung tumor associated antigen | rel=r_associated | relid=0 | w=10
  3586. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lung-targeted immunomodulator qbkpn
    n1=Okihiro (syndrome de) | n2=en:lung-targeted immunomodulator qbkpn | rel=r_associated | relid=0 | w=10
  3587. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lurasidone
    n1=Okihiro (syndrome de) | n2=en:lurasidone | rel=r_associated | relid=0 | w=10
  3588. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lurbinectedin
    n1=Okihiro (syndrome de) | n2=en:lurbinectedin | rel=r_associated | relid=0 | w=10
  3589. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lurtotecan
    n1=Okihiro (syndrome de) | n2=en:lurtotecan | rel=r_associated | relid=0 | w=10
  3590. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lurtotecan liposome
    n1=Okihiro (syndrome de) | n2=en:lurtotecan liposome | rel=r_associated | relid=0 | w=10
  3591. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lusaperidone
    n1=Okihiro (syndrome de) | n2=en:lusaperidone | rel=r_associated | relid=0 | w=10
  3592. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:luspatercept
    n1=Okihiro (syndrome de) | n2=en:luspatercept | rel=r_associated | relid=0 | w=10
  3593. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lutetium lu 177 dota-biotin
    n1=Okihiro (syndrome de) | n2=en:lutetium lu 177 dota-biotin | rel=r_associated | relid=0 | w=10
  3594. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lutetium lu 177 dota-jr11
    n1=Okihiro (syndrome de) | n2=en:lutetium lu 177 dota-jr11 | rel=r_associated | relid=0 | w=10
  3595. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lutetium lu 177 dota-tetulomab
    n1=Okihiro (syndrome de) | n2=en:lutetium lu 177 dota-tetulomab | rel=r_associated | relid=0 | w=10
  3596. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lutetium lu 177 monoclonal antibody cc49
    n1=Okihiro (syndrome de) | n2=en:lutetium lu 177 monoclonal antibody cc49 | rel=r_associated | relid=0 | w=10
  3597. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lutetium lu 177 monoclonal antibody j591
    n1=Okihiro (syndrome de) | n2=en:lutetium lu 177 monoclonal antibody j591 | rel=r_associated | relid=0 | w=10
  3598. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lutetium lu 177 peptide receptor radionuclide
    n1=Okihiro (syndrome de) | n2=en:lutetium lu 177 peptide receptor radionuclide | rel=r_associated | relid=0 | w=10
  3599. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lutetium lu 177 pp-f11n
    n1=Okihiro (syndrome de) | n2=en:lutetium lu 177 pp-f11n | rel=r_associated | relid=0 | w=10
  3600. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lutetium lu 177-dota-di-hsg peptide imp-288
    n1=Okihiro (syndrome de) | n2=en:lutetium lu 177-dota-di-hsg peptide imp-288 | rel=r_associated | relid=0 | w=10
  3601. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lutetium lu 177-dota-octreotate
    n1=Okihiro (syndrome de) | n2=en:lutetium lu 177-dota-octreotate | rel=r_associated | relid=0 | w=10
  3602. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lutetium lu 177-dota-tate
    n1=Okihiro (syndrome de) | n2=en:lutetium lu 177-dota-tate | rel=r_associated | relid=0 | w=10
  3603. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lutetium lu 177-edotreotide
    n1=Okihiro (syndrome de) | n2=en:lutetium lu 177-edotreotide | rel=r_associated | relid=0 | w=10
  3604. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lutetium lu-177 capromab
    n1=Okihiro (syndrome de) | n2=en:lutetium lu-177 capromab | rel=r_associated | relid=0 | w=10
  3605. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lutetium lu-177 girentuximab
    n1=Okihiro (syndrome de) | n2=en:lutetium lu-177 girentuximab | rel=r_associated | relid=0 | w=10
  3606. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lv.il-2/b7.1-transduced aml blast vaccine
    n1=Okihiro (syndrome de) | n2=en:lv.il-2/b7.1-transduced aml blast vaccine | rel=r_associated | relid=0 | w=10
  3607. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ly-170052
    n1=Okihiro (syndrome de) | n2=en:ly-170052 | rel=r_associated | relid=0 | w=10
  3608. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ly2624587
    n1=Okihiro (syndrome de) | n2=en:ly2624587 | rel=r_associated | relid=0 | w=10
  3609. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ly2880070
    n1=Okihiro (syndrome de) | n2=en:ly2880070 | rel=r_associated | relid=0 | w=10
  3610. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ly6k/vegfr1/vegfr2 multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:ly6k/vegfr1/vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  3611. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lycopene
    n1=Okihiro (syndrome de) | n2=en:lycopene | rel=r_associated | relid=0 | w=10
  3612. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lymphokine-activated killer cells
    n1=Okihiro (syndrome de) | n2=en:lymphokine-activated killer cells | rel=r_associated | relid=0 | w=10
  3613. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lymphoma taa-specific cytotoxic t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:lymphoma taa-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=10
  3614. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lyophilized black raspberry lozenge
    n1=Okihiro (syndrome de) | n2=en:lyophilized black raspberry lozenge | rel=r_associated | relid=0 | w=10
  3615. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lyophilized black raspberry saliva substitute
    n1=Okihiro (syndrome de) | n2=en:lyophilized black raspberry saliva substitute | rel=r_associated | relid=0 | w=10
  3616. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lysine-specific demethylase 1 inhibitor incb059872
    n1=Okihiro (syndrome de) | n2=en:lysine-specific demethylase 1 inhibitor incb059872 | rel=r_associated | relid=0 | w=10
  3617. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:lyso-thermosensitive liposome doxorubicin
    n1=Okihiro (syndrome de) | n2=en:lyso-thermosensitive liposome doxorubicin | rel=r_associated | relid=0 | w=10
  3618. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:m-azidopyrimethamine
    n1=Okihiro (syndrome de) | n2=en:m-azidopyrimethamine | rel=r_associated | relid=0 | w=10
  3619. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:m87o-transduced cd34+ peripheral blood stem cells
    n1=Okihiro (syndrome de) | n2=en:m87o-transduced cd34+ peripheral blood stem cells | rel=r_associated | relid=0 | w=10
  3620. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mac321
    n1=Okihiro (syndrome de) | n2=en:mac321 | rel=r_associated | relid=0 | w=10
  3621. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:macimorelin
    n1=Okihiro (syndrome de) | n2=en:macimorelin | rel=r_associated | relid=0 | w=10
  3622. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:macitentan
    n1=Okihiro (syndrome de) | n2=en:macitentan | rel=r_associated | relid=0 | w=10
  3623. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:macrogol 3350-based iso-osmotic laxative
    n1=Okihiro (syndrome de) | n2=en:macrogol 3350-based iso-osmotic laxative | rel=r_associated | relid=0 | w=10
  3624. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:macrolide antibiotic
    n1=Okihiro (syndrome de) | n2=en:macrolide antibiotic | rel=r_associated | relid=0 | w=10
  3625. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:macrolide immunosuppressant
    n1=Okihiro (syndrome de) | n2=en:macrolide immunosuppressant | rel=r_associated | relid=0 | w=10
  3626. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mafoprazine
    n1=Okihiro (syndrome de) | n2=en:mafoprazine | rel=r_associated | relid=0 | w=10
  3627. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mafosfamide
    n1=Okihiro (syndrome de) | n2=en:mafosfamide | rel=r_associated | relid=0 | w=10
  3628. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mag-tn3/as15 vaccine
    n1=Okihiro (syndrome de) | n2=en:mag-tn3/as15 vaccine | rel=r_associated | relid=0 | w=10
  3629. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mage-10.a2
    n1=Okihiro (syndrome de) | n2=en:mage-10.a2 | rel=r_associated | relid=0 | w=10
  3630. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mage-12 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:mage-12 peptide vaccine | rel=r_associated | relid=0 | w=10
  3631. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mage-3.a1 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:mage-3.a1 peptide vaccine | rel=r_associated | relid=0 | w=10
  3632. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mage-a1, her-2/neu, fbp peptides cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:mage-a1, her-2/neu, fbp peptides cancer vaccine | rel=r_associated | relid=0 | w=10
  3633. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mage-a1/mage-a3/ny-eso-1 peptides vaccine
    n1=Okihiro (syndrome de) | n2=en:mage-a1/mage-a3/ny-eso-1 peptides vaccine | rel=r_associated | relid=0 | w=10
  3634. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mage-a3 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:mage-a3 peptide vaccine | rel=r_associated | relid=0 | w=10
  3635. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mage-a3 reactive t cell receptor-transduced autologous t cells
    n1=Okihiro (syndrome de) | n2=en:mage-a3 reactive t cell receptor-transduced autologous t cells | rel=r_associated | relid=0 | w=10
  3636. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mage-a3-expressing adenovirus type 5 vaccine
    n1=Okihiro (syndrome de) | n2=en:mage-a3-expressing adenovirus type 5 vaccine | rel=r_associated | relid=0 | w=10
  3637. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mage-a3/12-specific tcr gene-transduced autologous pbls
    n1=Okihiro (syndrome de) | n2=en:mage-a3/12-specific tcr gene-transduced autologous pbls | rel=r_associated | relid=0 | w=10
  3638. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mage-a3/hpv 16 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:mage-a3/hpv 16 peptide vaccine | rel=r_associated | relid=0 | w=10
  3639. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mage-a4-specific tcr gene-transduced autologous t lymphocytes tbi-1201
    n1=Okihiro (syndrome de) | n2=en:mage-a4-specific tcr gene-transduced autologous t lymphocytes tbi-1201 | rel=r_associated | relid=0 | w=10
  3640. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:magnesium carbonate
    n1=Okihiro (syndrome de) | n2=en:magnesium carbonate | rel=r_associated | relid=0 | w=10
  3641. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:magnesium citrate
    n1=Okihiro (syndrome de) | n2=en:magnesium citrate | rel=r_associated | relid=0 | w=10
  3642. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:magnesium hydroxide
    n1=Okihiro (syndrome de) | n2=en:magnesium hydroxide | rel=r_associated | relid=0 | w=10
  3643. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:magnesium isoglycyrrhizinate
    n1=Okihiro (syndrome de) | n2=en:magnesium isoglycyrrhizinate | rel=r_associated | relid=0 | w=10
  3644. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:magnesium l-threonate
    n1=Okihiro (syndrome de) | n2=en:magnesium l-threonate | rel=r_associated | relid=0 | w=10
  3645. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:magnesium oxide
    n1=Okihiro (syndrome de) | n2=en:magnesium oxide | rel=r_associated | relid=0 | w=10
  3646. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:magnesium salt
    n1=Okihiro (syndrome de) | n2=en:magnesium salt | rel=r_associated | relid=0 | w=10
  3647. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:magnesium stearate
    n1=Okihiro (syndrome de) | n2=en:magnesium stearate | rel=r_associated | relid=0 | w=10
  3648. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:magnesium sulfate
    n1=Okihiro (syndrome de) | n2=en:magnesium sulfate | rel=r_associated | relid=0 | w=10
  3649. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:magnesium trisilicate
    n1=Okihiro (syndrome de) | n2=en:magnesium trisilicate | rel=r_associated | relid=0 | w=10
  3650. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:magnesium valproate
    n1=Okihiro (syndrome de) | n2=en:magnesium valproate | rel=r_associated | relid=0 | w=10
  3651. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:maitake mushroom extract
    n1=Okihiro (syndrome de) | n2=en:maitake mushroom extract | rel=r_associated | relid=0 | w=10
  3652. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:malignant glioma tumor lysate-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:malignant glioma tumor lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  3653. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:maltodextrin
    n1=Okihiro (syndrome de) | n2=en:maltodextrin | rel=r_associated | relid=0 | w=10
  3654. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:maltose
    n1=Okihiro (syndrome de) | n2=en:maltose | rel=r_associated | relid=0 | w=10
  3655. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mammaglobin-a dna vaccine
    n1=Okihiro (syndrome de) | n2=en:mammaglobin-a dna vaccine | rel=r_associated | relid=0 | w=10
  3656. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mangafodipir trisodium
    n1=Okihiro (syndrome de) | n2=en:mangafodipir trisodium | rel=r_associated | relid=0 | w=10
  3657. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mannitol
    n1=Okihiro (syndrome de) | n2=en:mannitol | rel=r_associated | relid=0 | w=10
  3658. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mannose-binding lectin
    n1=Okihiro (syndrome de) | n2=en:mannose-binding lectin | rel=r_associated | relid=0 | w=10
  3659. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:manuka honey
    n1=Okihiro (syndrome de) | n2=en:manuka honey | rel=r_associated | relid=0 | w=10
  3660. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mapatumumab
    n1=Okihiro (syndrome de) | n2=en:mapatumumab | rel=r_associated | relid=0 | w=10
  3661. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:maraviroc
    n1=Okihiro (syndrome de) | n2=en:maraviroc | rel=r_associated | relid=0 | w=10
  3662. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:marcellomycin
    n1=Okihiro (syndrome de) | n2=en:marcellomycin | rel=r_associated | relid=0 | w=10
  3663. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:margetuximab
    n1=Okihiro (syndrome de) | n2=en:margetuximab | rel=r_associated | relid=0 | w=10
  3664. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:maribavir
    n1=Okihiro (syndrome de) | n2=en:maribavir | rel=r_associated | relid=0 | w=10
  3665. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:marijuana
    n1=Okihiro (syndrome de) | n2=en:marijuana | rel=r_associated | relid=0 | w=10
  3666. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:marimastat
    n1=Okihiro (syndrome de) | n2=en:marimastat | rel=r_associated | relid=0 | w=10
  3667. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:marizomib
    n1=Okihiro (syndrome de) | n2=en:marizomib | rel=r_associated | relid=0 | w=10
  3668. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mart-1 reactive cd8+ lymphocytes
    n1=Okihiro (syndrome de) | n2=en:mart-1 reactive cd8+ lymphocytes | rel=r_associated | relid=0 | w=10
  3669. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mart-1:26-35(27l) peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:mart-1:26-35(27l) peptide vaccine | rel=r_associated | relid=0 | w=10
  3670. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mart-1:27-35 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:mart-1:27-35 peptide vaccine | rel=r_associated | relid=0 | w=10
  3671. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mart-1/gp100/tyrosinase/mage-a3 peptides-loaded irradiated allogeneic plasmacytoid dendritic cells
    n1=Okihiro (syndrome de) | n2=en:mart-1/gp100/tyrosinase/mage-a3 peptides-loaded irradiated allogeneic plasmacytoid dendritic cells | rel=r_associated | relid=0 | w=10
  3672. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:masitinib mesylate
    n1=Okihiro (syndrome de) | n2=en:masitinib mesylate | rel=r_associated | relid=0 | w=10
  3673. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:masoprocol
    n1=Okihiro (syndrome de) | n2=en:masoprocol | rel=r_associated | relid=0 | w=10
  3674. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mast cell stabilizer
    n1=Okihiro (syndrome de) | n2=en:mast cell stabilizer | rel=r_associated | relid=0 | w=10
  3675. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mast cell stabilizer tf002
    n1=Okihiro (syndrome de) | n2=en:mast cell stabilizer tf002 | rel=r_associated | relid=0 | w=10
  3676. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mastoid process
    n1=Okihiro (syndrome de) | n2=en:mastoid process | rel=r_associated | relid=0 | w=10
  3677. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:materia medica
    n1=Okihiro (syndrome de) | n2=en:materia medica | rel=r_associated | relid=0 | w=10
  3678. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:matricaria recutita gel
    n1=Okihiro (syndrome de) | n2=en:matricaria recutita gel | rel=r_associated | relid=0 | w=10
  3679. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:matricaria recutita topical infusion
    n1=Okihiro (syndrome de) | n2=en:matricaria recutita topical infusion | rel=r_associated | relid=0 | w=10
  3680. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:matuzumab
    n1=Okihiro (syndrome de) | n2=en:matuzumab | rel=r_associated | relid=0 | w=10
  3681. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:maxzide
    n1=Okihiro (syndrome de) | n2=en:maxzide | rel=r_associated | relid=0 | w=10
  3682. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:maytansine
    n1=Okihiro (syndrome de) | n2=en:maytansine | rel=r_associated | relid=0 | w=10
  3683. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mcl-1 inhibitor amg 176
    n1=Okihiro (syndrome de) | n2=en:mcl-1 inhibitor amg 176 | rel=r_associated | relid=0 | w=10
  3684. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mcpyv tag-specific polyclonal autologous cd8-positive t cells
    n1=Okihiro (syndrome de) | n2=en:mcpyv tag-specific polyclonal autologous cd8-positive t cells | rel=r_associated | relid=0 | w=10
  3685. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mcs-5
    n1=Okihiro (syndrome de) | n2=en:mcs-5 | rel=r_associated | relid=0 | w=10
  3686. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mct/lct lipid emulsion
    n1=Okihiro (syndrome de) | n2=en:mct/lct lipid emulsion | rel=r_associated | relid=0 | w=10
  3687. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mct/lct/fish oil omega-3 fatty acid lipid emulsion
    n1=Okihiro (syndrome de) | n2=en:mct/lct/fish oil omega-3 fatty acid lipid emulsion | rel=r_associated | relid=0 | w=10
  3688. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mdm2 antagonist ro5045337
    n1=Okihiro (syndrome de) | n2=en:mdm2 antagonist ro5045337 | rel=r_associated | relid=0 | w=10
  3689. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mdm2 antagonist ro6839921
    n1=Okihiro (syndrome de) | n2=en:mdm2 antagonist ro6839921 | rel=r_associated | relid=0 | w=10
  3690. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mdm2 inhibitor amg-232
    n1=Okihiro (syndrome de) | n2=en:mdm2 inhibitor amg-232 | rel=r_associated | relid=0 | w=10
  3691. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mdm2 inhibitor ds-3032b
    n1=Okihiro (syndrome de) | n2=en:mdm2 inhibitor ds-3032b | rel=r_associated | relid=0 | w=10
  3692. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mdm2/mdmx inhibitor alrn-6924
    n1=Okihiro (syndrome de) | n2=en:mdm2/mdmx inhibitor alrn-6924 | rel=r_associated | relid=0 | w=10
  3693. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mdr modulator cbt-1
    n1=Okihiro (syndrome de) | n2=en:mdr modulator cbt-1 | rel=r_associated | relid=0 | w=10
  3694. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mdx-1379 melanoma vaccine
    n1=Okihiro (syndrome de) | n2=en:mdx-1379 melanoma vaccine | rel=r_associated | relid=0 | w=10
  3695. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:me-143
    n1=Okihiro (syndrome de) | n2=en:me-143 | rel=r_associated | relid=0 | w=10
  3696. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:measles vaccine
    n1=Okihiro (syndrome de) | n2=en:measles vaccine | rel=r_associated | relid=0 | w=10
  3697. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:measles/mumps/rubella vaccine
    n1=Okihiro (syndrome de) | n2=en:measles/mumps/rubella vaccine | rel=r_associated | relid=0 | w=10
  3698. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mebendazole
    n1=Okihiro (syndrome de) | n2=en:mebendazole | rel=r_associated | relid=0 | w=10
  3699. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mebutamate
    n1=Okihiro (syndrome de) | n2=en:mebutamate | rel=r_associated | relid=0 | w=10
  3700. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mechlorethamine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:mechlorethamine hydrochloride | rel=r_associated | relid=0 | w=10
  3701. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mechlorethamine hydrochloride gel
    n1=Okihiro (syndrome de) | n2=en:mechlorethamine hydrochloride gel | rel=r_associated | relid=0 | w=10
  3702. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:meclocycline sulfosalicylate
    n1=Okihiro (syndrome de) | n2=en:meclocycline sulfosalicylate | rel=r_associated | relid=0 | w=10
  3703. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:meclofenamate sodium
    n1=Okihiro (syndrome de) | n2=en:meclofenamate sodium | rel=r_associated | relid=0 | w=10
  3704. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:meclonazepam
    n1=Okihiro (syndrome de) | n2=en:meclonazepam | rel=r_associated | relid=0 | w=10
  3705. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mecysteine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:mecysteine hydrochloride | rel=r_associated | relid=0 | w=10
  3706. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:medazepam
    n1=Okihiro (syndrome de) | n2=en:medazepam | rel=r_associated | relid=0 | w=10
  3707. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:medazepam hydrochloride
    n1=Okihiro (syndrome de) | n2=en:medazepam hydrochloride | rel=r_associated | relid=0 | w=10
  3708. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:medical gases
    n1=Okihiro (syndrome de) | n2=en:medical gases | rel=r_associated | relid=0 | w=10
  3709. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:medical marijuana
    n1=Okihiro (syndrome de) | n2=en:medical marijuana | rel=r_associated | relid=0 | w=10
  3710. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:medication
    n1=Okihiro (syndrome de) | n2=en:medication | rel=r_associated | relid=0 | w=10
  3711. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:medroxyprogesterone
    n1=Okihiro (syndrome de) | n2=en:medroxyprogesterone | rel=r_associated | relid=0 | w=10
  3712. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mefloquine
    n1=Okihiro (syndrome de) | n2=en:mefloquine | rel=r_associated | relid=0 | w=10
  3713. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:megestrol acetate
    n1=Okihiro (syndrome de) | n2=en:megestrol acetate | rel=r_associated | relid=0 | w=10
  3714. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:meglumine ioxithalamate
    n1=Okihiro (syndrome de) | n2=en:meglumine ioxithalamate | rel=r_associated | relid=0 | w=10
  3715. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mek 1/2 inhibitor as703988/msc2015103b
    n1=Okihiro (syndrome de) | n2=en:mek 1/2 inhibitor as703988/msc2015103b | rel=r_associated | relid=0 | w=10
  3716. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mek inhibitor azd8330
    n1=Okihiro (syndrome de) | n2=en:mek inhibitor azd8330 | rel=r_associated | relid=0 | w=10
  3717. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mek inhibitor ci-1040
    n1=Okihiro (syndrome de) | n2=en:mek inhibitor ci-1040 | rel=r_associated | relid=0 | w=10
  3718. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mek inhibitor gdc-0623
    n1=Okihiro (syndrome de) | n2=en:mek inhibitor gdc-0623 | rel=r_associated | relid=0 | w=10
  3719. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mek inhibitor ro4987655
    n1=Okihiro (syndrome de) | n2=en:mek inhibitor ro4987655 | rel=r_associated | relid=0 | w=10
  3720. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mek inhibitor tak-733
    n1=Okihiro (syndrome de) | n2=en:mek inhibitor tak-733 | rel=r_associated | relid=0 | w=10
  3721. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mek inhibitor wx-554
    n1=Okihiro (syndrome de) | n2=en:mek inhibitor wx-554 | rel=r_associated | relid=0 | w=10
  3722. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mek-1/mekk-1 inhibitor e6201
    n1=Okihiro (syndrome de) | n2=en:mek-1/mekk-1 inhibitor e6201 | rel=r_associated | relid=0 | w=10
  3723. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mek/aurora kinase inhibitor bi 847325
    n1=Okihiro (syndrome de) | n2=en:mek/aurora kinase inhibitor bi 847325 | rel=r_associated | relid=0 | w=10
  3724. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:melan-a vlp vaccine
    n1=Okihiro (syndrome de) | n2=en:melan-a vlp vaccine | rel=r_associated | relid=0 | w=10
  3725. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:melan-a/mage-3.dp4 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:melan-a/mage-3.dp4 peptide vaccine | rel=r_associated | relid=0 | w=10
  3726. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:melanoma antigen recognized by t-cells 1
    n1=Okihiro (syndrome de) | n2=en:melanoma antigen recognized by t-cells 1 | rel=r_associated | relid=0 | w=10
  3727. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:melanoma helper peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:melanoma helper peptide vaccine | rel=r_associated | relid=0 | w=10
  3728. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:melanoma trp2 ctl epitope vaccine scib1
    n1=Okihiro (syndrome de) | n2=en:melanoma trp2 ctl epitope vaccine scib1 | rel=r_associated | relid=0 | w=10
  3729. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:melitac 12.1 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:melitac 12.1 peptide vaccine | rel=r_associated | relid=0 | w=10
  3730. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:melk inhibitor ots167
    n1=Okihiro (syndrome de) | n2=en:melk inhibitor ots167 | rel=r_associated | relid=0 | w=10
  3731. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mellaril
    n1=Okihiro (syndrome de) | n2=en:mellaril | rel=r_associated | relid=0 | w=10
  3732. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:meloxicam
    n1=Okihiro (syndrome de) | n2=en:meloxicam | rel=r_associated | relid=0 | w=10
  3733. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:melperone
    n1=Okihiro (syndrome de) | n2=en:melperone | rel=r_associated | relid=0 | w=10
  3734. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:melphalan hydrochloride
    n1=Okihiro (syndrome de) | n2=en:melphalan hydrochloride | rel=r_associated | relid=0 | w=10
  3735. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:melphalan hydrochloride/sulfobutyl ether beta-cyclodextrin complex
    n1=Okihiro (syndrome de) | n2=en:melphalan hydrochloride/sulfobutyl ether beta-cyclodextrin complex | rel=r_associated | relid=0 | w=10
  3736. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:melphalan-flufenamide prodrug
    n1=Okihiro (syndrome de) | n2=en:melphalan-flufenamide prodrug | rel=r_associated | relid=0 | w=10
  3737. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:memantine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:memantine hydrochloride | rel=r_associated | relid=0 | w=10
  3738. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:membrane-disrupting peptide ep-100
    n1=Okihiro (syndrome de) | n2=en:membrane-disrupting peptide ep-100 | rel=r_associated | relid=0 | w=10
  3739. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:menadione topical lotion
    n1=Okihiro (syndrome de) | n2=en:menadione topical lotion | rel=r_associated | relid=0 | w=10
  3740. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:menatetrenone
    n1=Okihiro (syndrome de) | n2=en:menatetrenone | rel=r_associated | relid=0 | w=10
  3741. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:meningococcal vaccine
    n1=Okihiro (syndrome de) | n2=en:meningococcal vaccine | rel=r_associated | relid=0 | w=10
  3742. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:menitrazepam
    n1=Okihiro (syndrome de) | n2=en:menitrazepam | rel=r_associated | relid=0 | w=10
  3743. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:menogaril
    n1=Okihiro (syndrome de) | n2=en:menogaril | rel=r_associated | relid=0 | w=10
  3744. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:menthol
    n1=Okihiro (syndrome de) | n2=en:menthol | rel=r_associated | relid=0 | w=10
  3745. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:meperidine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:meperidine hydrochloride | rel=r_associated | relid=0 | w=10
  3746. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mepivacaine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:mepivacaine hydrochloride | rel=r_associated | relid=0 | w=10
  3747. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:merbarone
    n1=Okihiro (syndrome de) | n2=en:merbarone | rel=r_associated | relid=0 | w=10
  3748. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mercaptopurine
    n1=Okihiro (syndrome de) | n2=en:mercaptopurine | rel=r_associated | relid=0 | w=10
  3749. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mercaptopurine anhydrous
    n1=Okihiro (syndrome de) | n2=en:mercaptopurine anhydrous | rel=r_associated | relid=0 | w=10
  3750. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mercaptopurine oral suspension
    n1=Okihiro (syndrome de) | n2=en:mercaptopurine oral suspension | rel=r_associated | relid=0 | w=10
  3751. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mercurial diuretic
    n1=Okihiro (syndrome de) | n2=en:mercurial diuretic | rel=r_associated | relid=0 | w=10
  3752. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mercuric chloride
    n1=Okihiro (syndrome de) | n2=en:mercuric chloride | rel=r_associated | relid=0 | w=10
  3753. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mercuric oxide
    n1=Okihiro (syndrome de) | n2=en:mercuric oxide | rel=r_associated | relid=0 | w=10
  3754. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:merestinib
    n1=Okihiro (syndrome de) | n2=en:merestinib | rel=r_associated | relid=0 | w=10
  3755. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:meropenem
    n1=Okihiro (syndrome de) | n2=en:meropenem | rel=r_associated | relid=0 | w=10
  3756. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mesalamine
    n1=Okihiro (syndrome de) | n2=en:mesalamine | rel=r_associated | relid=0 | w=10
  3757. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mesna
    n1=Okihiro (syndrome de) | n2=en:mesna | rel=r_associated | relid=0 | w=10
  3758. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mesoridazine
    n1=Okihiro (syndrome de) | n2=en:mesoridazine | rel=r_associated | relid=0 | w=10
  3759. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mesoridazine besylate
    n1=Okihiro (syndrome de) | n2=en:mesoridazine besylate | rel=r_associated | relid=0 | w=10
  3760. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes
    n1=Okihiro (syndrome de) | n2=en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  3761. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  3762. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:met tyrosine kinase inhibitor bms-777607
    n1=Okihiro (syndrome de) | n2=en:met tyrosine kinase inhibitor bms-777607 | rel=r_associated | relid=0 | w=10
  3763. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:met tyrosine kinase inhibitor emd 1204831
    n1=Okihiro (syndrome de) | n2=en:met tyrosine kinase inhibitor emd 1204831 | rel=r_associated | relid=0 | w=10
  3764. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:met tyrosine kinase inhibitor pf-04217903
    n1=Okihiro (syndrome de) | n2=en:met tyrosine kinase inhibitor pf-04217903 | rel=r_associated | relid=0 | w=10
  3765. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:met tyrosine kinase inhibitor sar125844
    n1=Okihiro (syndrome de) | n2=en:met tyrosine kinase inhibitor sar125844 | rel=r_associated | relid=0 | w=10
  3766. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:met tyrosine kinase inhibitor sgx523
    n1=Okihiro (syndrome de) | n2=en:met tyrosine kinase inhibitor sgx523 | rel=r_associated | relid=0 | w=10
  3767. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:meta-fluorine f 18 fluorobenzylguanidine
    n1=Okihiro (syndrome de) | n2=en:meta-fluorine f 18 fluorobenzylguanidine | rel=r_associated | relid=0 | w=10
  3768. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metaclazepam
    n1=Okihiro (syndrome de) | n2=en:metaclazepam | rel=r_associated | relid=0 | w=10
  3769. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metaclazepam hydrochloride
    n1=Okihiro (syndrome de) | n2=en:metaclazepam hydrochloride | rel=r_associated | relid=0 | w=10
  3770. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metahexamide
    n1=Okihiro (syndrome de) | n2=en:metahexamide | rel=r_associated | relid=0 | w=10
  3771. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metap2 inhibitor sdx-7320
    n1=Okihiro (syndrome de) | n2=en:metap2 inhibitor sdx-7320 | rel=r_associated | relid=0 | w=10
  3772. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metaphysis
    n1=Okihiro (syndrome de) | n2=en:metaphysis | rel=r_associated | relid=0 | w=10
  3773. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metatinib tromethamine
    n1=Okihiro (syndrome de) | n2=en:metatinib tromethamine | rel=r_associated | relid=0 | w=10
  3774. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metformin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:metformin hydrochloride | rel=r_associated | relid=0 | w=10
  3775. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methadone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:methadone hydrochloride | rel=r_associated | relid=0 | w=10
  3776. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methanol extraction residue of bcg
    n1=Okihiro (syndrome de) | n2=en:methanol extraction residue of bcg | rel=r_associated | relid=0 | w=10
  3777. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methazolamide
    n1=Okihiro (syndrome de) | n2=en:methazolamide | rel=r_associated | relid=0 | w=10
  3778. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methenamine
    n1=Okihiro (syndrome de) | n2=en:methenamine | rel=r_associated | relid=0 | w=10
  3779. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methimazole
    n1=Okihiro (syndrome de) | n2=en:methimazole | rel=r_associated | relid=0 | w=10
  3780. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methionine c 11
    n1=Okihiro (syndrome de) | n2=en:methionine c 11 | rel=r_associated | relid=0 | w=10
  3781. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methotrexate
    n1=Okihiro (syndrome de) | n2=en:methotrexate | rel=r_associated | relid=0 | w=10
  3782. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methotrexate-e therapeutic implant
    n1=Okihiro (syndrome de) | n2=en:methotrexate-e therapeutic implant | rel=r_associated | relid=0 | w=10
  3783. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methotrexate-encapsulating autologous tumor-derived microparticles
    n1=Okihiro (syndrome de) | n2=en:methotrexate-encapsulating autologous tumor-derived microparticles | rel=r_associated | relid=0 | w=10
  3784. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methoxsalen
    n1=Okihiro (syndrome de) | n2=en:methoxsalen | rel=r_associated | relid=0 | w=10
  3785. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methoxy polyethylene glycol-epoetin beta
    n1=Okihiro (syndrome de) | n2=en:methoxy polyethylene glycol-epoetin beta | rel=r_associated | relid=0 | w=10
  3786. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methoxyamine
    n1=Okihiro (syndrome de) | n2=en:methoxyamine | rel=r_associated | relid=0 | w=10
  3787. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methoxyflurane
    n1=Okihiro (syndrome de) | n2=en:methoxyflurane | rel=r_associated | relid=0 | w=10
  3788. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methyl hydroxyethyl cellulose
    n1=Okihiro (syndrome de) | n2=en:methyl hydroxyethyl cellulose | rel=r_associated | relid=0 | w=10
  3789. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methyl-5-aminolevulinate hydrochloride cream
    n1=Okihiro (syndrome de) | n2=en:methyl-5-aminolevulinate hydrochloride cream | rel=r_associated | relid=0 | w=10
  3790. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methylbenzethonium chloride
    n1=Okihiro (syndrome de) | n2=en:methylbenzethonium chloride | rel=r_associated | relid=0 | w=10
  3791. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methylcellulose
    n1=Okihiro (syndrome de) | n2=en:methylcellulose | rel=r_associated | relid=0 | w=10
  3792. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methylene blue
    n1=Okihiro (syndrome de) | n2=en:methylene blue | rel=r_associated | relid=0 | w=10
  3793. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methylene dimethane sulfonate
    n1=Okihiro (syndrome de) | n2=en:methylene dimethane sulfonate | rel=r_associated | relid=0 | w=10
  3794. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methylmercaptopurine riboside
    n1=Okihiro (syndrome de) | n2=en:methylmercaptopurine riboside | rel=r_associated | relid=0 | w=10
  3795. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methylnaltrexone
    n1=Okihiro (syndrome de) | n2=en:methylnaltrexone | rel=r_associated | relid=0 | w=10
  3796. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methylphenidate and derivative
    n1=Okihiro (syndrome de) | n2=en:methylphenidate and derivative | rel=r_associated | relid=0 | w=10
  3797. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methylphenidate hydrochloride
    n1=Okihiro (syndrome de) | n2=en:methylphenidate hydrochloride | rel=r_associated | relid=0 | w=10
  3798. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methylprednisolone
    n1=Okihiro (syndrome de) | n2=en:methylprednisolone | rel=r_associated | relid=0 | w=10
  3799. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methylselenocysteine
    n1=Okihiro (syndrome de) | n2=en:methylselenocysteine | rel=r_associated | relid=0 | w=10
  3800. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:methyltestosterone
    n1=Okihiro (syndrome de) | n2=en:methyltestosterone | rel=r_associated | relid=0 | w=10
  3801. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metiapine
    n1=Okihiro (syndrome de) | n2=en:metiapine | rel=r_associated | relid=0 | w=10
  3802. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metoclopramide
    n1=Okihiro (syndrome de) | n2=en:metoclopramide | rel=r_associated | relid=0 | w=10
  3803. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metoclopramide hydrochloride
    n1=Okihiro (syndrome de) | n2=en:metoclopramide hydrochloride | rel=r_associated | relid=0 | w=10
  3804. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metoprine
    n1=Okihiro (syndrome de) | n2=en:metoprine | rel=r_associated | relid=0 | w=10
  3805. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metoprolol
    n1=Okihiro (syndrome de) | n2=en:metoprolol | rel=r_associated | relid=0 | w=10
  3806. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metreleptin
    n1=Okihiro (syndrome de) | n2=en:metreleptin | rel=r_associated | relid=0 | w=10
  3807. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metronidazole
    n1=Okihiro (syndrome de) | n2=en:metronidazole | rel=r_associated | relid=0 | w=10
  3808. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metronidazole hydrochloride
    n1=Okihiro (syndrome de) | n2=en:metronidazole hydrochloride | rel=r_associated | relid=0 | w=10
  3809. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metyrapone
    n1=Okihiro (syndrome de) | n2=en:metyrapone | rel=r_associated | relid=0 | w=10
  3810. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:metyrosine
    n1=Okihiro (syndrome de) | n2=en:metyrosine | rel=r_associated | relid=0 | w=10
  3811. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mexazolam
    n1=Okihiro (syndrome de) | n2=en:mexazolam | rel=r_associated | relid=0 | w=10
  3812. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mezilamine
    n1=Okihiro (syndrome de) | n2=en:mezilamine | rel=r_associated | relid=0 | w=10
  3813. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mezlocillin
    n1=Okihiro (syndrome de) | n2=en:mezlocillin | rel=r_associated | relid=0 | w=10
  3814. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mfe23 scfv-expressing autologous anti-cea mfez t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:mfe23 scfv-expressing autologous anti-cea mfez t lymphocytes | rel=r_associated | relid=0 | w=10
  3815. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mg 98
    n1=Okihiro (syndrome de) | n2=en:mg 98 | rel=r_associated | relid=0 | w=10
  3816. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mgmtp140k-encoding retroviral vector
    n1=Okihiro (syndrome de) | n2=en:mgmtp140k-encoding retroviral vector | rel=r_associated | relid=0 | w=10
  3817. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mibefradil dihydrochloride
    n1=Okihiro (syndrome de) | n2=en:mibefradil dihydrochloride | rel=r_associated | relid=0 | w=10
  3818. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:micafungin
    n1=Okihiro (syndrome de) | n2=en:micafungin | rel=r_associated | relid=0 | w=10
  3819. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:micafungin sodium
    n1=Okihiro (syndrome de) | n2=en:micafungin sodium | rel=r_associated | relid=0 | w=10
  3820. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:micellar nanoparticle-encapsulated cisplatin nc-6004
    n1=Okihiro (syndrome de) | n2=en:micellar nanoparticle-encapsulated cisplatin nc-6004 | rel=r_associated | relid=0 | w=10
  3821. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:micronutrient-fortified probiotic yogurt
    n1=Okihiro (syndrome de) | n2=en:micronutrient-fortified probiotic yogurt | rel=r_associated | relid=0 | w=10
  3822. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:microtubule-targeted agent bal101553
    n1=Okihiro (syndrome de) | n2=en:microtubule-targeted agent bal101553 | rel=r_associated | relid=0 | w=10
  3823. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:midazolam
    n1=Okihiro (syndrome de) | n2=en:midazolam | rel=r_associated | relid=0 | w=10
  3824. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:midazolam hydrochloride
    n1=Okihiro (syndrome de) | n2=en:midazolam hydrochloride | rel=r_associated | relid=0 | w=10
  3825. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:midazolam-containing buccal liquid
    n1=Okihiro (syndrome de) | n2=en:midazolam-containing buccal liquid | rel=r_associated | relid=0 | w=10
  3826. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:midostaurin
    n1=Okihiro (syndrome de) | n2=en:midostaurin | rel=r_associated | relid=0 | w=10
  3827. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mifamurtide
    n1=Okihiro (syndrome de) | n2=en:mifamurtide | rel=r_associated | relid=0 | w=10
  3828. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mifepristone
    n1=Okihiro (syndrome de) | n2=en:mifepristone | rel=r_associated | relid=0 | w=10
  3829. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:miglitol
    n1=Okihiro (syndrome de) | n2=en:miglitol | rel=r_associated | relid=0 | w=10
  3830. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:miglustat
    n1=Okihiro (syndrome de) | n2=en:miglustat | rel=r_associated | relid=0 | w=10
  3831. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:miha-loaded pd-l1/l2-silenced dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:miha-loaded pd-l1/l2-silenced dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  3832. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:milatuzumab
    n1=Okihiro (syndrome de) | n2=en:milatuzumab | rel=r_associated | relid=0 | w=10
  3833. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:milatuzumab-doxorubicin antibody-drug conjugate
    n1=Okihiro (syndrome de) | n2=en:milatuzumab-doxorubicin antibody-drug conjugate | rel=r_associated | relid=0 | w=10
  3834. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:milk protein-based energy drink
    n1=Okihiro (syndrome de) | n2=en:milk protein-based energy drink | rel=r_associated | relid=0 | w=10
  3835. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:milk thistle
    n1=Okihiro (syndrome de) | n2=en:milk thistle | rel=r_associated | relid=0 | w=10
  3836. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:milodistim
    n1=Okihiro (syndrome de) | n2=en:milodistim | rel=r_associated | relid=0 | w=10
  3837. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:miltefosine
    n1=Okihiro (syndrome de) | n2=en:miltefosine | rel=r_associated | relid=0 | w=10
  3838. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mimotope-p10s-padre peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:mimotope-p10s-padre peptide vaccine | rel=r_associated | relid=0 | w=10
  3839. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mineral oil
    n1=Okihiro (syndrome de) | n2=en:mineral oil | rel=r_associated | relid=0 | w=10
  3840. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:minocycline hydrochloride
    n1=Okihiro (syndrome de) | n2=en:minocycline hydrochloride | rel=r_associated | relid=0 | w=10
  3841. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:minocycline-edta
    n1=Okihiro (syndrome de) | n2=en:minocycline-edta | rel=r_associated | relid=0 | w=10
  3842. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:minoxidil
    n1=Okihiro (syndrome de) | n2=en:minoxidil | rel=r_associated | relid=0 | w=10
  3843. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:miotics
    n1=Okihiro (syndrome de) | n2=en:miotics | rel=r_associated | relid=0 | w=10
  3844. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mipsagargin
    n1=Okihiro (syndrome de) | n2=en:mipsagargin | rel=r_associated | relid=0 | w=10
  3845. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mirabegron
    n1=Okihiro (syndrome de) | n2=en:mirabegron | rel=r_associated | relid=0 | w=10
  3846. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:miracle mouthwash plus hydrocortisone
    n1=Okihiro (syndrome de) | n2=en:miracle mouthwash plus hydrocortisone | rel=r_associated | relid=0 | w=10
  3847. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mirtazapine
    n1=Okihiro (syndrome de) | n2=en:mirtazapine | rel=r_associated | relid=0 | w=10
  3848. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mirvetuximab soravtansine
    n1=Okihiro (syndrome de) | n2=en:mirvetuximab soravtansine | rel=r_associated | relid=0 | w=10
  3849. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:misonidazole
    n1=Okihiro (syndrome de) | n2=en:misonidazole | rel=r_associated | relid=0 | w=10
  3850. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:misoprostol
    n1=Okihiro (syndrome de) | n2=en:misoprostol | rel=r_associated | relid=0 | w=10
  3851. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mistletoe extract
    n1=Okihiro (syndrome de) | n2=en:mistletoe extract | rel=r_associated | relid=0 | w=10
  3852. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mitoflaxone
    n1=Okihiro (syndrome de) | n2=en:mitoflaxone | rel=r_associated | relid=0 | w=10
  3853. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mitogen
    n1=Okihiro (syndrome de) | n2=en:mitogen | rel=r_associated | relid=0 | w=10
  3854. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mitoguazone
    n1=Okihiro (syndrome de) | n2=en:mitoguazone | rel=r_associated | relid=0 | w=10
  3855. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mitolactol
    n1=Okihiro (syndrome de) | n2=en:mitolactol | rel=r_associated | relid=0 | w=10
  3856. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mitomycin
    n1=Okihiro (syndrome de) | n2=en:mitomycin | rel=r_associated | relid=0 | w=10
  3857. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mitotane
    n1=Okihiro (syndrome de) | n2=en:mitotane | rel=r_associated | relid=0 | w=10
  3858. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mitoxantrone
    n1=Okihiro (syndrome de) | n2=en:mitoxantrone | rel=r_associated | relid=0 | w=10
  3859. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mitoxantrone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:mitoxantrone hydrochloride | rel=r_associated | relid=0 | w=10
  3860. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mitozolomide
    n1=Okihiro (syndrome de) | n2=en:mitozolomide | rel=r_associated | relid=0 | w=10
  3861. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mivobulin isethionate
    n1=Okihiro (syndrome de) | n2=en:mivobulin isethionate | rel=r_associated | relid=0 | w=10
  3862. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mixed bacteria vaccine
    n1=Okihiro (syndrome de) | n2=en:mixed bacteria vaccine | rel=r_associated | relid=0 | w=10
  3863. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mixed vespid venom
    n1=Okihiro (syndrome de) | n2=en:mixed vespid venom | rel=r_associated | relid=0 | w=10
  3864. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mk-1248
    n1=Okihiro (syndrome de) | n2=en:mk-1248 | rel=r_associated | relid=0 | w=10
  3865. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mk-4280
    n1=Okihiro (syndrome de) | n2=en:mk-4280 | rel=r_associated | relid=0 | w=10
  3866. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mk-6592
    n1=Okihiro (syndrome de) | n2=en:mk-6592 | rel=r_associated | relid=0 | w=10
  3867. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mk-8808
    n1=Okihiro (syndrome de) | n2=en:mk-8808 | rel=r_associated | relid=0 | w=10
  3868. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mk0429
    n1=Okihiro (syndrome de) | n2=en:mk0429 | rel=r_associated | relid=0 | w=10
  3869. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mk0731
    n1=Okihiro (syndrome de) | n2=en:mk0731 | rel=r_associated | relid=0 | w=10
  3870. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mkc-1
    n1=Okihiro (syndrome de) | n2=en:mkc-1 | rel=r_associated | relid=0 | w=10
  3871. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mknk1 inhibitor bay 1143269
    n1=Okihiro (syndrome de) | n2=en:mknk1 inhibitor bay 1143269 | rel=r_associated | relid=0 | w=10
  3872. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mln2704
    n1=Okihiro (syndrome de) | n2=en:mln2704 | rel=r_associated | relid=0 | w=10
  3873. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mnk1/2 inhibitor eft508
    n1=Okihiro (syndrome de) | n2=en:mnk1/2 inhibitor eft508 | rel=r_associated | relid=0 | w=10
  3874. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mnsod mimetic bmx-001
    n1=Okihiro (syndrome de) | n2=en:mnsod mimetic bmx-001 | rel=r_associated | relid=0 | w=10
  3875. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mocetinostat
    n1=Okihiro (syndrome de) | n2=en:mocetinostat | rel=r_associated | relid=0 | w=10
  3876. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:modafinil
    n1=Okihiro (syndrome de) | n2=en:modafinil | rel=r_associated | relid=0 | w=10
  3877. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:modified citrus pectin supplement
    n1=Okihiro (syndrome de) | n2=en:modified citrus pectin supplement | rel=r_associated | relid=0 | w=10
  3878. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:modified vaccinia ankara (bavarian nordic)-her2 vaccine
    n1=Okihiro (syndrome de) | n2=en:modified vaccinia ankara (bavarian nordic)-her2 vaccine | rel=r_associated | relid=0 | w=10
  3879. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:modified vaccinia virus ankara vaccine expressing p53
    n1=Okihiro (syndrome de) | n2=en:modified vaccinia virus ankara vaccine expressing p53 | rel=r_associated | relid=0 | w=10
  3880. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:modified-release calcifediol capsule
    n1=Okihiro (syndrome de) | n2=en:modified-release calcifediol capsule | rel=r_associated | relid=0 | w=10
  3881. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mogamulizumab
    n1=Okihiro (syndrome de) | n2=en:mogamulizumab | rel=r_associated | relid=0 | w=10
  3882. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:molindone
    n1=Okihiro (syndrome de) | n2=en:molindone | rel=r_associated | relid=0 | w=10
  3883. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:molindone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:molindone hydrochloride | rel=r_associated | relid=0 | w=10
  3884. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:molybdenum
    n1=Okihiro (syndrome de) | n2=en:molybdenum | rel=r_associated | relid=0 | w=10
  3885. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:momelotinib
    n1=Okihiro (syndrome de) | n2=en:momelotinib | rel=r_associated | relid=0 | w=10
  3886. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mometasone furoate
    n1=Okihiro (syndrome de) | n2=en:mometasone furoate | rel=r_associated | relid=0 | w=10
  3887. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monalizumab
    n1=Okihiro (syndrome de) | n2=en:monalizumab | rel=r_associated | relid=0 | w=10
  3888. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoacetyldiglyceride ec-18
    n1=Okihiro (syndrome de) | n2=en:monoacetyldiglyceride ec-18 | rel=r_associated | relid=0 | w=10
  3889. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoamine oxidase inhibitor
    n1=Okihiro (syndrome de) | n2=en:monoamine oxidase inhibitor | rel=r_associated | relid=0 | w=10
  3890. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monobenzone
    n1=Okihiro (syndrome de) | n2=en:monobenzone | rel=r_associated | relid=0 | w=10
  3891. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monocarboxylate transporter 1 inhibitor azd3965
    n1=Okihiro (syndrome de) | n2=en:monocarboxylate transporter 1 inhibitor azd3965 | rel=r_associated | relid=0 | w=10
  3892. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody 105ad7 anti-idiotype vaccine
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody 105ad7 anti-idiotype vaccine | rel=r_associated | relid=0 | w=10
  3893. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody 11d10
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody 11d10 | rel=r_associated | relid=0 | w=10
  3894. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody 11d10 anti-idiotype vaccine
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody 11d10 anti-idiotype vaccine | rel=r_associated | relid=0 | w=10
  3895. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody 14g2a
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody 14g2a | rel=r_associated | relid=0 | w=10
  3896. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody 3622w94
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody 3622w94 | rel=r_associated | relid=0 | w=10
  3897. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody 3f8
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody 3f8 | rel=r_associated | relid=0 | w=10
  3898. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody 3h1 anti-idiotype vaccine
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody 3h1 anti-idiotype vaccine | rel=r_associated | relid=0 | w=10
  3899. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody 4b5 anti-idiotype vaccine
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody 4b5 anti-idiotype vaccine | rel=r_associated | relid=0 | w=10
  3900. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody a1g4 anti-idiotype vaccine
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody a1g4 anti-idiotype vaccine | rel=r_associated | relid=0 | w=10
  3901. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody a27.15
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody a27.15 | rel=r_associated | relid=0 | w=10
  3902. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody a33
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody a33 | rel=r_associated | relid=0 | w=10
  3903. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody abgn-7
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody abgn-7 | rel=r_associated | relid=0 | w=10
  3904. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody agent
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody agent | rel=r_associated | relid=0 | w=10
  3905. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody amg 228
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody amg 228 | rel=r_associated | relid=0 | w=10
  3906. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody c-58
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody c-58 | rel=r_associated | relid=0 | w=10
  3907. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody cal
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody cal | rel=r_associated | relid=0 | w=10
  3908. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody cbe-11
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody cbe-11 | rel=r_associated | relid=0 | w=10
  3909. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody cc49
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody cc49 | rel=r_associated | relid=0 | w=10
  3910. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody cc49-delta ch2
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody cc49-delta ch2 | rel=r_associated | relid=0 | w=10
  3911. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody cc49-streptavidin conjugate
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody cc49-streptavidin conjugate | rel=r_associated | relid=0 | w=10
  3912. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody cd19
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody cd19 | rel=r_associated | relid=0 | w=10
  3913. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody cep-37250/khk2804
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody cep-37250/khk2804 | rel=r_associated | relid=0 | w=10
  3914. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody d6.12
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody d6.12 | rel=r_associated | relid=0 | w=10
  3915. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody e2.3
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody e2.3 | rel=r_associated | relid=0 | w=10
  3916. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody f19
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody f19 | rel=r_associated | relid=0 | w=10
  3917. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody gd2 anti-idiotype vaccine
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody gd2 anti-idiotype vaccine | rel=r_associated | relid=0 | w=10
  3918. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody hefi-1
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody hefi-1 | rel=r_associated | relid=0 | w=10
  3919. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody hu3s193
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody hu3s193 | rel=r_associated | relid=0 | w=10
  3920. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody huafp31
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody huafp31 | rel=r_associated | relid=0 | w=10
  3921. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody huhmfg1
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody huhmfg1 | rel=r_associated | relid=0 | w=10
  3922. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody huj591
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody huj591 | rel=r_associated | relid=0 | w=10
  3923. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody hupam4
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody hupam4 | rel=r_associated | relid=0 | w=10
  3924. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody idec-159
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody idec-159 | rel=r_associated | relid=0 | w=10
  3925. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody ing-1
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody ing-1 | rel=r_associated | relid=0 | w=10
  3926. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody l6
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody l6 | rel=r_associated | relid=0 | w=10
  3927. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody lym-1
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody lym-1 | rel=r_associated | relid=0 | w=10
  3928. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody m170
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody m170 | rel=r_associated | relid=0 | w=10
  3929. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody me1-14 f(ab')2
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody me1-14 f(ab')2 | rel=r_associated | relid=0 | w=10
  3930. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody mga271
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody mga271 | rel=r_associated | relid=0 | w=10
  3931. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody mik-beta-1
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody mik-beta-1 | rel=r_associated | relid=0 | w=10
  3932. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody mono-dga-rfb4
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody mono-dga-rfb4 | rel=r_associated | relid=0 | w=10
  3933. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody muj591
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody muj591 | rel=r_associated | relid=0 | w=10
  3934. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody mx35 f(ab')2
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody mx35 f(ab')2 | rel=r_associated | relid=0 | w=10
  3935. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody r24
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody r24 | rel=r_associated | relid=0 | w=10
  3936. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody rav12
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody rav12 | rel=r_associated | relid=0 | w=10
  3937. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody sgn-30
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody sgn-30 | rel=r_associated | relid=0 | w=10
  3938. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal antibody t101
    n1=Okihiro (syndrome de) | n2=en:monoclonal antibody t101 | rel=r_associated | relid=0 | w=10
  3939. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoclonal t-cell receptor anti-cd3 scfv fusion protein imcgp100
    n1=Okihiro (syndrome de) | n2=en:monoclonal t-cell receptor anti-cd3 scfv fusion protein imcgp100 | rel=r_associated | relid=0 | w=10
  3940. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monoctanoin
    n1=Okihiro (syndrome de) | n2=en:monoctanoin | rel=r_associated | relid=0 | w=10
  3941. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monophosphoryl lipid a
    n1=Okihiro (syndrome de) | n2=en:monophosphoryl lipid a | rel=r_associated | relid=0 | w=10
  3942. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:monosialotetrahexosylganglioside
    n1=Okihiro (syndrome de) | n2=en:monosialotetrahexosylganglioside | rel=r_associated | relid=0 | w=10
  3943. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:montanide isa 51 vg
    n1=Okihiro (syndrome de) | n2=en:montanide isa 51 vg | rel=r_associated | relid=0 | w=10
  3944. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:montanide isa 720
    n1=Okihiro (syndrome de) | n2=en:montanide isa 720 | rel=r_associated | relid=0 | w=10
  3945. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:montelukast sodium
    n1=Okihiro (syndrome de) | n2=en:montelukast sodium | rel=r_associated | relid=0 | w=10
  3946. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mopidamol
    n1=Okihiro (syndrome de) | n2=en:mopidamol | rel=r_associated | relid=0 | w=10
  3947. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mopp regimen
    n1=Okihiro (syndrome de) | n2=en:mopp regimen | rel=r_associated | relid=0 | w=10
  3948. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:morinda citrifolia fruit extract
    n1=Okihiro (syndrome de) | n2=en:morinda citrifolia fruit extract | rel=r_associated | relid=0 | w=10
  3949. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:morphine
    n1=Okihiro (syndrome de) | n2=en:morphine | rel=r_associated | relid=0 | w=10
  3950. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:morphine sulfate
    n1=Okihiro (syndrome de) | n2=en:morphine sulfate | rel=r_associated | relid=0 | w=10
  3951. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:morphine sulfate sustained-release tablet
    n1=Okihiro (syndrome de) | n2=en:morphine sulfate sustained-release tablet | rel=r_associated | relid=0 | w=10
  3952. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mosapride
    n1=Okihiro (syndrome de) | n2=en:mosapride | rel=r_associated | relid=0 | w=10
  3953. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:motesanib diphosphate
    n1=Okihiro (syndrome de) | n2=en:motesanib diphosphate | rel=r_associated | relid=0 | w=10
  3954. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:motexafin gadolinium
    n1=Okihiro (syndrome de) | n2=en:motexafin gadolinium | rel=r_associated | relid=0 | w=10
  3955. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:motexafin lutetium
    n1=Okihiro (syndrome de) | n2=en:motexafin lutetium | rel=r_associated | relid=0 | w=10
  3956. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:motrazepam
    n1=Okihiro (syndrome de) | n2=en:motrazepam | rel=r_associated | relid=0 | w=10
  3957. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mouse gp100 plasmid dna vaccine
    n1=Okihiro (syndrome de) | n2=en:mouse gp100 plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  3958. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mouse prostate-specific membrane antigen plasmid dna vaccine
    n1=Okihiro (syndrome de) | n2=en:mouse prostate-specific membrane antigen plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  3959. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mouse renal adenocarcinoma cell-encapsulated agarose-agarose macrobeads
    n1=Okihiro (syndrome de) | n2=en:mouse renal adenocarcinoma cell-encapsulated agarose-agarose macrobeads | rel=r_associated | relid=0 | w=10
  3960. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mov-gamma chimeric receptor gene
    n1=Okihiro (syndrome de) | n2=en:mov-gamma chimeric receptor gene | rel=r_associated | relid=0 | w=10
  3961. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:moxalactam
    n1=Okihiro (syndrome de) | n2=en:moxalactam | rel=r_associated | relid=0 | w=10
  3962. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:moxetumomab pasudotox
    n1=Okihiro (syndrome de) | n2=en:moxetumomab pasudotox | rel=r_associated | relid=0 | w=10
  3963. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:moxifloxacin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:moxifloxacin hydrochloride | rel=r_associated | relid=0 | w=10
  3964. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mps1 inhibitor bay 1217389
    n1=Okihiro (syndrome de) | n2=en:mps1 inhibitor bay 1217389 | rel=r_associated | relid=0 | w=10
  3965. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mps1 kinase inhibitor bay1161909
    n1=Okihiro (syndrome de) | n2=en:mps1 kinase inhibitor bay1161909 | rel=r_associated | relid=0 | w=10
  3966. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mrna-derived lung cancer vaccine cv9202
    n1=Okihiro (syndrome de) | n2=en:mrna-derived lung cancer vaccine cv9202 | rel=r_associated | relid=0 | w=10
  3967. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mrna-derived prostate cancer vaccine cv9103
    n1=Okihiro (syndrome de) | n2=en:mrna-derived prostate cancer vaccine cv9103 | rel=r_associated | relid=0 | w=10
  3968. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mrna-derived prostate cancer vaccine cv9104
    n1=Okihiro (syndrome de) | n2=en:mrna-derived prostate cancer vaccine cv9104 | rel=r_associated | relid=0 | w=10
  3969. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mtf-1 inhibitor apto-253 hcl
    n1=Okihiro (syndrome de) | n2=en:mtf-1 inhibitor apto-253 hcl | rel=r_associated | relid=0 | w=10
  3970. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mtig7192a
    n1=Okihiro (syndrome de) | n2=en:mtig7192a | rel=r_associated | relid=0 | w=10
  3971. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mtor kinase inhibitor azd8055
    n1=Okihiro (syndrome de) | n2=en:mtor kinase inhibitor azd8055 | rel=r_associated | relid=0 | w=10
  3972. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mtor kinase inhibitor cc-223
    n1=Okihiro (syndrome de) | n2=en:mtor kinase inhibitor cc-223 | rel=r_associated | relid=0 | w=10
  3973. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mtor kinase inhibitor osi-027
    n1=Okihiro (syndrome de) | n2=en:mtor kinase inhibitor osi-027 | rel=r_associated | relid=0 | w=10
  3974. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mtor1/2 kinase inhibitor me-344
    n1=Okihiro (syndrome de) | n2=en:mtor1/2 kinase inhibitor me-344 | rel=r_associated | relid=0 | w=10
  3975. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mtorc1/2 kinase inhibitor bi 860585
    n1=Okihiro (syndrome de) | n2=en:mtorc1/2 kinase inhibitor bi 860585 | rel=r_associated | relid=0 | w=10
  3976. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mtorc1/mtorc2/dhfr inhibitor abtl0812
    n1=Okihiro (syndrome de) | n2=en:mtorc1/mtorc2/dhfr inhibitor abtl0812 | rel=r_associated | relid=0 | w=10
  3977. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:muc-1 antigen
    n1=Okihiro (syndrome de) | n2=en:muc-1 antigen | rel=r_associated | relid=0 | w=10
  3978. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:muc-1 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:muc-1 peptide vaccine | rel=r_associated | relid=0 | w=10
  3979. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:muc-2-globo h-klh conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:muc-2-globo h-klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  3980. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:muc-2-klh vaccine
    n1=Okihiro (syndrome de) | n2=en:muc-2-klh vaccine | rel=r_associated | relid=0 | w=10
  3981. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:muc1 antigen/sb as-2
    n1=Okihiro (syndrome de) | n2=en:muc1 antigen/sb as-2 | rel=r_associated | relid=0 | w=10
  3982. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:muc1 peptide-poly-iclc adjuvant vaccine
    n1=Okihiro (syndrome de) | n2=en:muc1 peptide-poly-iclc adjuvant vaccine | rel=r_associated | relid=0 | w=10
  3983. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:muc1-klh conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:muc1-klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  3984. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:muc1-klh vaccine/qs21
    n1=Okihiro (syndrome de) | n2=en:muc1-klh vaccine/qs21 | rel=r_associated | relid=0 | w=10
  3985. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:muc1-targeted peptide go-203-2c
    n1=Okihiro (syndrome de) | n2=en:muc1-targeted peptide go-203-2c | rel=r_associated | relid=0 | w=10
  3986. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:muc16-targeted antibody-drug conjugate dmuc5754a
    n1=Okihiro (syndrome de) | n2=en:muc16-targeted antibody-drug conjugate dmuc5754a | rel=r_associated | relid=0 | w=10
  3987. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mucoadhesive hydrogel gargle
    n1=Okihiro (syndrome de) | n2=en:mucoadhesive hydrogel gargle | rel=r_associated | relid=0 | w=10
  3988. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mucoadhesive oral wound rinse
    n1=Okihiro (syndrome de) | n2=en:mucoadhesive oral wound rinse | rel=r_associated | relid=0 | w=10
  3989. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mucoadhesive paclitaxel formulation
    n1=Okihiro (syndrome de) | n2=en:mucoadhesive paclitaxel formulation | rel=r_associated | relid=0 | w=10
  3990. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mucoprotective agent xer2020
    n1=Okihiro (syndrome de) | n2=en:mucoprotective agent xer2020 | rel=r_associated | relid=0 | w=10
  3991. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multi-agc kinase inhibitor at13148
    n1=Okihiro (syndrome de) | n2=en:multi-agc kinase inhibitor at13148 | rel=r_associated | relid=0 | w=10
  3992. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multi-epitope folate receptor alpha peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:multi-epitope folate receptor alpha peptide vaccine | rel=r_associated | relid=0 | w=10
  3993. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multi-epitope melanoma peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:multi-epitope melanoma peptide vaccine | rel=r_associated | relid=0 | w=10
  3994. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multi-glioblastoma-peptide-targeting autologous dendritic cell vaccine ict-107
    n1=Okihiro (syndrome de) | n2=en:multi-glioblastoma-peptide-targeting autologous dendritic cell vaccine ict-107 | rel=r_associated | relid=0 | w=10
  3995. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multi-peptide cmv-modified vaccinia ankara vaccine
    n1=Okihiro (syndrome de) | n2=en:multi-peptide cmv-modified vaccinia ankara vaccine | rel=r_associated | relid=0 | w=10
  3996. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multi-subtype natural human leukocyte interferon alpha
    n1=Okihiro (syndrome de) | n2=en:multi-subtype natural human leukocyte interferon alpha | rel=r_associated | relid=0 | w=10
  3997. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multi-targeted cyclin-dependent protein kinase inhibitor rgb-286638
    n1=Okihiro (syndrome de) | n2=en:multi-targeted cyclin-dependent protein kinase inhibitor rgb-286638 | rel=r_associated | relid=0 | w=10
  3998. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multicarotenoid supplement mcs-8
    n1=Okihiro (syndrome de) | n2=en:multicarotenoid supplement mcs-8 | rel=r_associated | relid=0 | w=10
  3999. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multidrug resistance modulator
    n1=Okihiro (syndrome de) | n2=en:multidrug resistance modulator | rel=r_associated | relid=0 | w=10
  4000. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multifunctional/multitargeted anticancer agent omn54
    n1=Okihiro (syndrome de) | n2=en:multifunctional/multitargeted anticancer agent omn54 | rel=r_associated | relid=0 | w=10
  4001. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multikinase inhibitor 4sc-203
    n1=Okihiro (syndrome de) | n2=en:multikinase inhibitor 4sc-203 | rel=r_associated | relid=0 | w=10
  4002. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multikinase inhibitor arry614
    n1=Okihiro (syndrome de) | n2=en:multikinase inhibitor arry614 | rel=r_associated | relid=0 | w=10
  4003. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multikinase inhibitor at9283
    n1=Okihiro (syndrome de) | n2=en:multikinase inhibitor at9283 | rel=r_associated | relid=0 | w=10
  4004. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multikinase inhibitor sar103168
    n1=Okihiro (syndrome de) | n2=en:multikinase inhibitor sar103168 | rel=r_associated | relid=0 | w=10
  4005. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multipeptide vaccine s-588210
    n1=Okihiro (syndrome de) | n2=en:multipeptide vaccine s-588210 | rel=r_associated | relid=0 | w=10
  4006. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multitargeted kinase inhibitor mgcd516
    n1=Okihiro (syndrome de) | n2=en:multitargeted kinase inhibitor mgcd516 | rel=r_associated | relid=0 | w=10
  4007. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multitargeted tyrosine kinase inhibitor jnj-26483327
    n1=Okihiro (syndrome de) | n2=en:multitargeted tyrosine kinase inhibitor jnj-26483327 | rel=r_associated | relid=0 | w=10
  4008. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multitargeted tyrosine kinase inhibitor mgcd265
    n1=Okihiro (syndrome de) | n2=en:multitargeted tyrosine kinase inhibitor mgcd265 | rel=r_associated | relid=0 | w=10
  4009. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:multivitamin
    n1=Okihiro (syndrome de) | n2=en:multivitamin | rel=r_associated | relid=0 | w=10
  4010. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mupirocin
    n1=Okihiro (syndrome de) | n2=en:mupirocin | rel=r_associated | relid=0 | w=10
  4011. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mureletecan
    n1=Okihiro (syndrome de) | n2=en:mureletecan | rel=r_associated | relid=0 | w=10
  4012. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:murine tyrp2 plasmid dna vaccine
    n1=Okihiro (syndrome de) | n2=en:murine tyrp2 plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  4013. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:muromonab-cd3
    n1=Okihiro (syndrome de) | n2=en:muromonab-cd3 | rel=r_associated | relid=0 | w=10
  4014. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:muscadine grape skin extract
    n1=Okihiro (syndrome de) | n2=en:muscadine grape skin extract | rel=r_associated | relid=0 | w=10
  4015. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:muscarinic agonist apd515
    n1=Okihiro (syndrome de) | n2=en:muscarinic agonist apd515 | rel=r_associated | relid=0 | w=10
  4016. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:muscle relaxant
    n1=Okihiro (syndrome de) | n2=en:muscle relaxant | rel=r_associated | relid=0 | w=10
  4017. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mutagen
    n1=Okihiro (syndrome de) | n2=en:mutagen | rel=r_associated | relid=0 | w=10
  4018. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mutant p53 activator coti-2
    n1=Okihiro (syndrome de) | n2=en:mutant p53 activator coti-2 | rel=r_associated | relid=0 | w=10
  4019. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mutant p53 peptide pulsed dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:mutant p53 peptide pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  4020. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mutant-selective egfr inhibitor pf-06459988
    n1=Okihiro (syndrome de) | n2=en:mutant-selective egfr inhibitor pf-06459988 | rel=r_associated | relid=0 | w=10
  4021. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mva-ebna1/lmp2 vaccine
    n1=Okihiro (syndrome de) | n2=en:mva-ebna1/lmp2 vaccine | rel=r_associated | relid=0 | w=10
  4022. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mva-fcu1 tg4023
    n1=Okihiro (syndrome de) | n2=en:mva-fcu1 tg4023 | rel=r_associated | relid=0 | w=10
  4023. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mva-muc1-il2 vaccine
    n1=Okihiro (syndrome de) | n2=en:mva-muc1-il2 vaccine | rel=r_associated | relid=0 | w=10
  4024. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mva-psa/pap prostate cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:mva-psa/pap prostate cancer vaccine | rel=r_associated | relid=0 | w=10
  4025. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mvf-her-2(597-626)/mvf-her-2 (266-296) peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:mvf-her-2(597-626)/mvf-her-2 (266-296) peptide vaccine | rel=r_associated | relid=0 | w=10
  4026. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mvf-her-2(628-647)-crl 1005 vaccine
    n1=Okihiro (syndrome de) | n2=en:mvf-her-2(628-647)-crl 1005 vaccine | rel=r_associated | relid=0 | w=10
  4027. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mvx-1-loaded macrocapsule/autologous tumor cell vaccine mvx-onco-1
    n1=Okihiro (syndrome de) | n2=en:mvx-1-loaded macrocapsule/autologous tumor cell vaccine mvx-onco-1 | rel=r_associated | relid=0 | w=10
  4028. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:myc-targeting sirna dcr-myc
    n1=Okihiro (syndrome de) | n2=en:myc-targeting sirna dcr-myc | rel=r_associated | relid=0 | w=10
  4029. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mycobacterial cell wall-dna complex
    n1=Okihiro (syndrome de) | n2=en:mycobacterial cell wall-dna complex | rel=r_associated | relid=0 | w=10
  4030. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mycobacterium tuberculosis arabinomannan z-100
    n1=Okihiro (syndrome de) | n2=en:mycobacterium tuberculosis arabinomannan z-100 | rel=r_associated | relid=0 | w=10
  4031. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mycobacterium w
    n1=Okihiro (syndrome de) | n2=en:mycobacterium w | rel=r_associated | relid=0 | w=10
  4032. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mycophenolate mofetil
    n1=Okihiro (syndrome de) | n2=en:mycophenolate mofetil | rel=r_associated | relid=0 | w=10
  4033. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:mycophenolic acid
    n1=Okihiro (syndrome de) | n2=en:mycophenolic acid | rel=r_associated | relid=0 | w=10
  4034. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:n-methylformamide
    n1=Okihiro (syndrome de) | n2=en:n-methylformamide | rel=r_associated | relid=0 | w=10
  4035. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:na-17/mage-3.a2/ny-eso-1 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:na-17/mage-3.a2/ny-eso-1 peptide vaccine | rel=r_associated | relid=0 | w=10
  4036. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:na17-a antigen
    n1=Okihiro (syndrome de) | n2=en:na17-a antigen | rel=r_associated | relid=0 | w=10
  4037. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:na17.a2 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:na17.a2 peptide vaccine | rel=r_associated | relid=0 | w=10
  4038. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nabazenil
    n1=Okihiro (syndrome de) | n2=en:nabazenil | rel=r_associated | relid=0 | w=10
  4039. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nabilone
    n1=Okihiro (syndrome de) | n2=en:nabilone | rel=r_associated | relid=0 | w=10
  4040. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nabiximols
    n1=Okihiro (syndrome de) | n2=en:nabiximols | rel=r_associated | relid=0 | w=10
  4041. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nadolol
    n1=Okihiro (syndrome de) | n2=en:nadolol | rel=r_associated | relid=0 | w=10
  4042. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nadroparin calcium
    n1=Okihiro (syndrome de) | n2=en:nadroparin calcium | rel=r_associated | relid=0 | w=10
  4043. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nafarelin
    n1=Okihiro (syndrome de) | n2=en:nafarelin | rel=r_associated | relid=0 | w=10
  4044. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nafazatrom
    n1=Okihiro (syndrome de) | n2=en:nafazatrom | rel=r_associated | relid=0 | w=10
  4045. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nafoxidine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:nafoxidine hydrochloride | rel=r_associated | relid=0 | w=10
  4046. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nafronyl
    n1=Okihiro (syndrome de) | n2=en:nafronyl | rel=r_associated | relid=0 | w=10
  4047. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nalmefene
    n1=Okihiro (syndrome de) | n2=en:nalmefene | rel=r_associated | relid=0 | w=10
  4048. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:naloxegol
    n1=Okihiro (syndrome de) | n2=en:naloxegol | rel=r_associated | relid=0 | w=10
  4049. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:naloxone
    n1=Okihiro (syndrome de) | n2=en:naloxone | rel=r_associated | relid=0 | w=10
  4050. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:naloxone + oxycodone
    n1=Okihiro (syndrome de) | n2=en:naloxone + oxycodone | rel=r_associated | relid=0 | w=10
  4051. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:naloxone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:naloxone hydrochloride | rel=r_associated | relid=0 | w=10
  4052. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:naltrexone
    n1=Okihiro (syndrome de) | n2=en:naltrexone | rel=r_associated | relid=0 | w=10
  4053. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:naltrexone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:naltrexone hydrochloride | rel=r_associated | relid=0 | w=10
  4054. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nandrolone decanoate
    n1=Okihiro (syndrome de) | n2=en:nandrolone decanoate | rel=r_associated | relid=0 | w=10
  4055. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nanocell-encapsulated mir-16-based microrna mimic
    n1=Okihiro (syndrome de) | n2=en:nanocell-encapsulated mir-16-based microrna mimic | rel=r_associated | relid=0 | w=10
  4056. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nanoparticle albumin-bound docetaxel
    n1=Okihiro (syndrome de) | n2=en:nanoparticle albumin-bound docetaxel | rel=r_associated | relid=0 | w=10
  4057. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nanoparticle albumin-bound rapamycin
    n1=Okihiro (syndrome de) | n2=en:nanoparticle albumin-bound rapamycin | rel=r_associated | relid=0 | w=10
  4058. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nanoparticle albumin-bound thiocolchicine dimer nab-5404
    n1=Okihiro (syndrome de) | n2=en:nanoparticle albumin-bound thiocolchicine dimer nab-5404 | rel=r_associated | relid=0 | w=10
  4059. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nanoparticle-encapsulated docetaxel
    n1=Okihiro (syndrome de) | n2=en:nanoparticle-encapsulated docetaxel | rel=r_associated | relid=0 | w=10
  4060. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nanoparticle-encapsulated doxorubicin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:nanoparticle-encapsulated doxorubicin hydrochloride | rel=r_associated | relid=0 | w=10
  4061. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nanosomal docetaxel lipid suspension
    n1=Okihiro (syndrome de) | n2=en:nanosomal docetaxel lipid suspension | rel=r_associated | relid=0 | w=10
  4062. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:napabucasin
    n1=Okihiro (syndrome de) | n2=en:napabucasin | rel=r_associated | relid=0 | w=10
  4063. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:naphthalimide analogue unbs5162
    n1=Okihiro (syndrome de) | n2=en:naphthalimide analogue unbs5162 | rel=r_associated | relid=0 | w=10
  4064. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:naphthoquinones
    n1=Okihiro (syndrome de) | n2=en:naphthoquinones | rel=r_associated | relid=0 | w=10
  4065. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:naproxen
    n1=Okihiro (syndrome de) | n2=en:naproxen | rel=r_associated | relid=0 | w=10
  4066. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:narnatumab
    n1=Okihiro (syndrome de) | n2=en:narnatumab | rel=r_associated | relid=0 | w=10
  4067. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nasal dosage form product
    n1=Okihiro (syndrome de) | n2=en:nasal dosage form product | rel=r_associated | relid=0 | w=10
  4068. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nasal saline irrigation solution
    n1=Okihiro (syndrome de) | n2=en:nasal saline irrigation solution | rel=r_associated | relid=0 | w=10
  4069. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nasal turbinate
    n1=Okihiro (syndrome de) | n2=en:nasal turbinate | rel=r_associated | relid=0 | w=10
  4070. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:natalizumab
    n1=Okihiro (syndrome de) | n2=en:natalizumab | rel=r_associated | relid=0 | w=10
  4071. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:natamycin
    n1=Okihiro (syndrome de) | n2=en:natamycin | rel=r_associated | relid=0 | w=10
  4072. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nateglinide
    n1=Okihiro (syndrome de) | n2=en:nateglinide | rel=r_associated | relid=0 | w=10
  4073. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:natural ifn-alpha opc-18
    n1=Okihiro (syndrome de) | n2=en:natural ifn-alpha opc-18 | rel=r_associated | relid=0 | w=10
  4074. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:natural killer cells zrx101
    n1=Okihiro (syndrome de) | n2=en:natural killer cells zrx101 | rel=r_associated | relid=0 | w=10
  4075. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:navitoclax
    n1=Okihiro (syndrome de) | n2=en:navitoclax | rel=r_associated | relid=0 | w=10
  4076. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:navy bean powder
    n1=Okihiro (syndrome de) | n2=en:navy bean powder | rel=r_associated | relid=0 | w=10
  4077. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ncmtrna oligonucleotide andes-1537
    n1=Okihiro (syndrome de) | n2=en:ncmtrna oligonucleotide andes-1537 | rel=r_associated | relid=0 | w=10
  4078. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nd-420
    n1=Okihiro (syndrome de) | n2=en:nd-420 | rel=r_associated | relid=0 | w=10
  4079. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:necitumumab
    n1=Okihiro (syndrome de) | n2=en:necitumumab | rel=r_associated | relid=0 | w=10
  4080. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:neck of the humerus
    n1=Okihiro (syndrome de) | n2=en:neck of the humerus | rel=r_associated | relid=0 | w=10
  4081. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nedaplatin
    n1=Okihiro (syndrome de) | n2=en:nedaplatin | rel=r_associated | relid=0 | w=10
  4082. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nefopam
    n1=Okihiro (syndrome de) | n2=en:nefopam | rel=r_associated | relid=0 | w=10
  4083. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nefopam hydrochloride
    n1=Okihiro (syndrome de) | n2=en:nefopam hydrochloride | rel=r_associated | relid=0 | w=10
  4084. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:neihulizumab
    n1=Okihiro (syndrome de) | n2=en:neihulizumab | rel=r_associated | relid=0 | w=10
  4085. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nelarabine
    n1=Okihiro (syndrome de) | n2=en:nelarabine | rel=r_associated | relid=0 | w=10
  4086. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nelfinavir
    n1=Okihiro (syndrome de) | n2=en:nelfinavir | rel=r_associated | relid=0 | w=10
  4087. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nelfinavir mesylate
    n1=Okihiro (syndrome de) | n2=en:nelfinavir mesylate | rel=r_associated | relid=0 | w=10
  4088. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nelipepimut-s plus gm-csf vaccine
    n1=Okihiro (syndrome de) | n2=en:nelipepimut-s plus gm-csf vaccine | rel=r_associated | relid=0 | w=10
  4089. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nemonapride
    n1=Okihiro (syndrome de) | n2=en:nemonapride | rel=r_associated | relid=0 | w=10
  4090. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:neoantigen-based glioblastoma vaccine
    n1=Okihiro (syndrome de) | n2=en:neoantigen-based glioblastoma vaccine | rel=r_associated | relid=0 | w=10
  4091. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:neoantigen-based melanoma-poly-iclc vaccine
    n1=Okihiro (syndrome de) | n2=en:neoantigen-based melanoma-poly-iclc vaccine | rel=r_associated | relid=0 | w=10
  4092. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:neomycin
    n1=Okihiro (syndrome de) | n2=en:neomycin | rel=r_associated | relid=0 | w=10
  4093. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nepidermin
    n1=Okihiro (syndrome de) | n2=en:nepidermin | rel=r_associated | relid=0 | w=10
  4094. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:neratinib
    n1=Okihiro (syndrome de) | n2=en:neratinib | rel=r_associated | relid=0 | w=10
  4095. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nesiritide
    n1=Okihiro (syndrome de) | n2=en:nesiritide | rel=r_associated | relid=0 | w=10
  4096. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nesvacumab
    n1=Okihiro (syndrome de) | n2=en:nesvacumab | rel=r_associated | relid=0 | w=10
  4097. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:netazepide
    n1=Okihiro (syndrome de) | n2=en:netazepide | rel=r_associated | relid=0 | w=10
  4098. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:netupitant
    n1=Okihiro (syndrome de) | n2=en:netupitant | rel=r_associated | relid=0 | w=10
  4099. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:netupitant/palonosetron hydrochloride
    n1=Okihiro (syndrome de) | n2=en:netupitant/palonosetron hydrochloride | rel=r_associated | relid=0 | w=10
  4100. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:neuromuscular blocking agents
    n1=Okihiro (syndrome de) | n2=en:neuromuscular blocking agents | rel=r_associated | relid=0 | w=10
  4101. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:neuropharmacologic agent
    n1=Okihiro (syndrome de) | n2=en:neuropharmacologic agent | rel=r_associated | relid=0 | w=10
  4102. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:neutrophil activation probe imaging agent
    n1=Okihiro (syndrome de) | n2=en:neutrophil activation probe imaging agent | rel=r_associated | relid=0 | w=10
  4103. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nevirapine
    n1=Okihiro (syndrome de) | n2=en:nevirapine | rel=r_associated | relid=0 | w=10
  4104. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ng-nitro-l-arginine
    n1=Okihiro (syndrome de) | n2=en:ng-nitro-l-arginine | rel=r_associated | relid=0 | w=10
  4105. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ngfr-transduced autologous t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:ngfr-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  4106. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:niacin
    n1=Okihiro (syndrome de) | n2=en:niacin | rel=r_associated | relid=0 | w=10
  4107. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:niacinamide
    n1=Okihiro (syndrome de) | n2=en:niacinamide | rel=r_associated | relid=0 | w=10
  4108. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nicardipine
    n1=Okihiro (syndrome de) | n2=en:nicardipine | rel=r_associated | relid=0 | w=10
  4109. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:niclosamide
    n1=Okihiro (syndrome de) | n2=en:niclosamide | rel=r_associated | relid=0 | w=10
  4110. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nicotine
    n1=Okihiro (syndrome de) | n2=en:nicotine | rel=r_associated | relid=0 | w=10
  4111. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nicotine gum
    n1=Okihiro (syndrome de) | n2=en:nicotine gum | rel=r_associated | relid=0 | w=10
  4112. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nicotine lozenge
    n1=Okihiro (syndrome de) | n2=en:nicotine lozenge | rel=r_associated | relid=0 | w=10
  4113. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nicotine nasal spray
    n1=Okihiro (syndrome de) | n2=en:nicotine nasal spray | rel=r_associated | relid=0 | w=10
  4114. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nicotine patch
    n1=Okihiro (syndrome de) | n2=en:nicotine patch | rel=r_associated | relid=0 | w=10
  4115. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nifursemizone
    n1=Okihiro (syndrome de) | n2=en:nifursemizone | rel=r_associated | relid=0 | w=10
  4116. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nifurtimox
    n1=Okihiro (syndrome de) | n2=en:nifurtimox | rel=r_associated | relid=0 | w=10
  4117. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nilotinib
    n1=Okihiro (syndrome de) | n2=en:nilotinib | rel=r_associated | relid=0 | w=10
  4118. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nilutamide
    n1=Okihiro (syndrome de) | n2=en:nilutamide | rel=r_associated | relid=0 | w=10
  4119. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nimetazepam
    n1=Okihiro (syndrome de) | n2=en:nimetazepam | rel=r_associated | relid=0 | w=10
  4120. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nimodipine
    n1=Okihiro (syndrome de) | n2=en:nimodipine | rel=r_associated | relid=0 | w=10
  4121. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nimorazole
    n1=Okihiro (syndrome de) | n2=en:nimorazole | rel=r_associated | relid=0 | w=10
  4122. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nimotuzumab
    n1=Okihiro (syndrome de) | n2=en:nimotuzumab | rel=r_associated | relid=0 | w=10
  4123. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nimustine
    n1=Okihiro (syndrome de) | n2=en:nimustine | rel=r_associated | relid=0 | w=10
  4124. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nintedanib
    n1=Okihiro (syndrome de) | n2=en:nintedanib | rel=r_associated | relid=0 | w=10
  4125. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:niraparib
    n1=Okihiro (syndrome de) | n2=en:niraparib | rel=r_associated | relid=0 | w=10
  4126. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nitazoxanide
    n1=Okihiro (syndrome de) | n2=en:nitazoxanide | rel=r_associated | relid=0 | w=10
  4127. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nitisinone
    n1=Okihiro (syndrome de) | n2=en:nitisinone | rel=r_associated | relid=0 | w=10
  4128. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nitrate-based vasodilating agent
    n1=Okihiro (syndrome de) | n2=en:nitrate-based vasodilating agent | rel=r_associated | relid=0 | w=10
  4129. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nitrazepam
    n1=Okihiro (syndrome de) | n2=en:nitrazepam | rel=r_associated | relid=0 | w=10
  4130. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nitric oxide-releasing acetylsalicylic acid derivative
    n1=Okihiro (syndrome de) | n2=en:nitric oxide-releasing acetylsalicylic acid derivative | rel=r_associated | relid=0 | w=10
  4131. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nitrogen mustard compound
    n1=Okihiro (syndrome de) | n2=en:nitrogen mustard compound | rel=r_associated | relid=0 | w=10
  4132. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nitroglycerin
    n1=Okihiro (syndrome de) | n2=en:nitroglycerin | rel=r_associated | relid=0 | w=10
  4133. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nitroglycerin transdermal patch
    n1=Okihiro (syndrome de) | n2=en:nitroglycerin transdermal patch | rel=r_associated | relid=0 | w=10
  4134. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nitroglycerin/sodium citrate/ethanol solution
    n1=Okihiro (syndrome de) | n2=en:nitroglycerin/sodium citrate/ethanol solution | rel=r_associated | relid=0 | w=10
  4135. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nivolumab
    n1=Okihiro (syndrome de) | n2=en:nivolumab | rel=r_associated | relid=0 | w=10
  4136. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nm-3
    n1=Okihiro (syndrome de) | n2=en:nm-3 | rel=r_associated | relid=0 | w=10
  4137. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nolatrexed dihydrochloride
    n1=Okihiro (syndrome de) | n2=en:nolatrexed dihydrochloride | rel=r_associated | relid=0 | w=10
  4138. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:non-adjuvanted a(h1n1) influenza vaccine
    n1=Okihiro (syndrome de) | n2=en:non-adjuvanted a(h1n1) influenza vaccine | rel=r_associated | relid=0 | w=10
  4139. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:non-small cell lung cancer mrna-derived vaccine cv9201
    n1=Okihiro (syndrome de) | n2=en:non-small cell lung cancer mrna-derived vaccine cv9201 | rel=r_associated | relid=0 | w=10
  4140. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nondepolarizing agent
    n1=Okihiro (syndrome de) | n2=en:nondepolarizing agent | rel=r_associated | relid=0 | w=10
  4141. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nonenzyme proteolytic agent
    n1=Okihiro (syndrome de) | n2=en:nonenzyme proteolytic agent | rel=r_associated | relid=0 | w=10
  4142. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nonsteroidal anti-androgens
    n1=Okihiro (syndrome de) | n2=en:nonsteroidal anti-androgens | rel=r_associated | relid=0 | w=10
  4143. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:norclozapine
    n1=Okihiro (syndrome de) | n2=en:norclozapine | rel=r_associated | relid=0 | w=10
  4144. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nordazepam
    n1=Okihiro (syndrome de) | n2=en:nordazepam | rel=r_associated | relid=0 | w=10
  4145. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:norepinephrine, dl-
    n1=Okihiro (syndrome de) | n2=en:norepinephrine, dl- | rel=r_associated | relid=0 | w=10
  4146. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:norethindrone acetate
    n1=Okihiro (syndrome de) | n2=en:norethindrone acetate | rel=r_associated | relid=0 | w=10
  4147. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:norgestimate
    n1=Okihiro (syndrome de) | n2=en:norgestimate | rel=r_associated | relid=0 | w=10
  4148. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:norgestrel
    n1=Okihiro (syndrome de) | n2=en:norgestrel | rel=r_associated | relid=0 | w=10
  4149. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nortetrazepam
    n1=Okihiro (syndrome de) | n2=en:nortetrazepam | rel=r_associated | relid=0 | w=10
  4150. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:north american ginseng extract afx-2
    n1=Okihiro (syndrome de) | n2=en:north american ginseng extract afx-2 | rel=r_associated | relid=0 | w=10
  4151. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nortriptyline hydrochloride
    n1=Okihiro (syndrome de) | n2=en:nortriptyline hydrochloride | rel=r_associated | relid=0 | w=10
  4152. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:noscapine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:noscapine hydrochloride | rel=r_associated | relid=0 | w=10
  4153. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nostrums
    n1=Okihiro (syndrome de) | n2=en:nostrums | rel=r_associated | relid=0 | w=10
  4154. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:notch signaling inhibitor pf-06650808
    n1=Okihiro (syndrome de) | n2=en:notch signaling inhibitor pf-06650808 | rel=r_associated | relid=0 | w=10
  4155. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:notch signaling pathway inhibitor mk0752
    n1=Okihiro (syndrome de) | n2=en:notch signaling pathway inhibitor mk0752 | rel=r_associated | relid=0 | w=10
  4156. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:novobiocin
    n1=Okihiro (syndrome de) | n2=en:novobiocin | rel=r_associated | relid=0 | w=10
  4157. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nrf2 activator rta 408
    n1=Okihiro (syndrome de) | n2=en:nrf2 activator rta 408 | rel=r_associated | relid=0 | w=10
  4158. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ns-9
    n1=Okihiro (syndrome de) | n2=en:ns-9 | rel=r_associated | relid=0 | w=10
  4159. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ns5b polymerase inhibitor bms-791325
    n1=Okihiro (syndrome de) | n2=en:ns5b polymerase inhibitor bms-791325 | rel=r_associated | relid=0 | w=10
  4160. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nsclc antigen-loaded dendritic cell-derived exosomesnon-small cell lung cancer tumor antigen-loaded dendritic cell-derived exosomes
    n1=Okihiro (syndrome de) | n2=en:nsclc antigen-loaded dendritic cell-derived exosomesnon-small cell lung cancer tumor antigen-loaded dendritic cell-derived exosomes | rel=r_associated | relid=0 | w=10
  4161. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ntrk/ros1 inhibitor ds-6051b
    n1=Okihiro (syndrome de) | n2=en:ntrk/ros1 inhibitor ds-6051b | rel=r_associated | relid=0 | w=10
  4162. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nucleoside analog dfp-10917
    n1=Okihiro (syndrome de) | n2=en:nucleoside analog dfp-10917 | rel=r_associated | relid=0 | w=10
  4163. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nucleotide analogue gs 9219
    n1=Okihiro (syndrome de) | n2=en:nucleotide analogue gs 9219 | rel=r_associated | relid=0 | w=10
  4164. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nutraceutical tbl-12
    n1=Okihiro (syndrome de) | n2=en:nutraceutical tbl-12 | rel=r_associated | relid=0 | w=10
  4165. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nutrient-rich whole wheat flour supplement
    n1=Okihiro (syndrome de) | n2=en:nutrient-rich whole wheat flour supplement | rel=r_associated | relid=0 | w=10
  4166. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nutritional supplement drink
    n1=Okihiro (syndrome de) | n2=en:nutritional supplement drink | rel=r_associated | relid=0 | w=10
  4167. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nv1020
    n1=Okihiro (syndrome de) | n2=en:nv1020 | rel=r_associated | relid=0 | w=10
  4168. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nx-1207
    n1=Okihiro (syndrome de) | n2=en:nx-1207 | rel=r_associated | relid=0 | w=10
  4169. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ny-eso-1 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:ny-eso-1 peptide vaccine | rel=r_associated | relid=0 | w=10
  4170. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ny-eso-1 plasmid dna cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:ny-eso-1 plasmid dna cancer vaccine | rel=r_associated | relid=0 | w=10
  4171. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ny-eso-1 protein vaccine plus montanide isa-51 vg
    n1=Okihiro (syndrome de) | n2=en:ny-eso-1 protein vaccine plus montanide isa-51 vg | rel=r_associated | relid=0 | w=10
  4172. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ny-eso-1 reactive tcr retroviral vector transduced autologous pbl
    n1=Okihiro (syndrome de) | n2=en:ny-eso-1 reactive tcr retroviral vector transduced autologous pbl | rel=r_associated | relid=0 | w=10
  4173. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ny-eso-1-specific cd4-positive t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:ny-eso-1-specific cd4-positive t lymphocytes | rel=r_associated | relid=0 | w=10
  4174. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ny-eso-1-specific tcr gene-transduced t lymphocytes tbi-1301
    n1=Okihiro (syndrome de) | n2=en:ny-eso-1-specific tcr gene-transduced t lymphocytes tbi-1301 | rel=r_associated | relid=0 | w=10
  4175. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ny-eso-1(157-165) peptide-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:ny-eso-1(157-165) peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  4176. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ny-eso-1/gla-se vaccine id-g305
    n1=Okihiro (syndrome de) | n2=en:ny-eso-1/gla-se vaccine id-g305 | rel=r_associated | relid=0 | w=10
  4177. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ny-eso-1/lage-1 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:ny-eso-1/lage-1 peptide vaccine | rel=r_associated | relid=0 | w=10
  4178. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ny-eso-1/mage-a4/prame/survivin/ssx-specific autologous cytotoxic t lymphoyctes
    n1=Okihiro (syndrome de) | n2=en:ny-eso-1/mage-a4/prame/survivin/ssx-specific autologous cytotoxic t lymphoyctes | rel=r_associated | relid=0 | w=10
  4179. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ny-eso-1/mart-1 peptide-pulsed dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:ny-eso-1/mart-1 peptide-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  4180. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ny-eso-1/prame/mage-a3/wt-1 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:ny-eso-1/prame/mage-a3/wt-1 peptide vaccine | rel=r_associated | relid=0 | w=10
  4181. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ny-eso-1b peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:ny-eso-1b peptide vaccine | rel=r_associated | relid=0 | w=10
  4182. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ny-eso-b
    n1=Okihiro (syndrome de) | n2=en:ny-eso-b | rel=r_associated | relid=0 | w=10
  4183. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:nystatin
    n1=Okihiro (syndrome de) | n2=en:nystatin | rel=r_associated | relid=0 | w=10
  4184. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:o [preparations]
    n1=Okihiro (syndrome de) | n2=en:o [preparations] | rel=r_associated | relid=0 | w=10
  4185. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:o-chloroacetylcarbamoylfumagillol
    n1=Okihiro (syndrome de) | n2=en:o-chloroacetylcarbamoylfumagillol | rel=r_associated | relid=0 | w=10
  4186. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:o-phthalaldehyde
    n1=Okihiro (syndrome de) | n2=en:o-phthalaldehyde | rel=r_associated | relid=0 | w=10
  4187. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:o6-benzylguanine
    n1=Okihiro (syndrome de) | n2=en:o6-benzylguanine | rel=r_associated | relid=0 | w=10
  4188. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oak bark
    n1=Okihiro (syndrome de) | n2=en:oak bark | rel=r_associated | relid=0 | w=10
  4189. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oat biscuit
    n1=Okihiro (syndrome de) | n2=en:oat biscuit | rel=r_associated | relid=0 | w=10
  4190. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oat extract
    n1=Okihiro (syndrome de) | n2=en:oat extract | rel=r_associated | relid=0 | w=10
  4191. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oat/psyllium/wheat
    n1=Okihiro (syndrome de) | n2=en:oat/psyllium/wheat | rel=r_associated | relid=0 | w=10
  4192. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:obatoclax mesylate
    n1=Okihiro (syndrome de) | n2=en:obatoclax mesylate | rel=r_associated | relid=0 | w=10
  4193. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:obinutuzumab
    n1=Okihiro (syndrome de) | n2=en:obinutuzumab | rel=r_associated | relid=0 | w=10
  4194. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oblimersen sodium
    n1=Okihiro (syndrome de) | n2=en:oblimersen sodium | rel=r_associated | relid=0 | w=10
  4195. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:obturator foramen
    n1=Okihiro (syndrome de) | n2=en:obturator foramen | rel=r_associated | relid=0 | w=10
  4196. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ocaperidone
    n1=Okihiro (syndrome de) | n2=en:ocaperidone | rel=r_associated | relid=0 | w=10
  4197. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ocaratuzumab
    n1=Okihiro (syndrome de) | n2=en:ocaratuzumab | rel=r_associated | relid=0 | w=10
  4198. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ocrelizumab
    n1=Okihiro (syndrome de) | n2=en:ocrelizumab | rel=r_associated | relid=0 | w=10
  4199. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ocriplasmin
    n1=Okihiro (syndrome de) | n2=en:ocriplasmin | rel=r_associated | relid=0 | w=10
  4200. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octinoxate
    n1=Okihiro (syndrome de) | n2=en:octinoxate | rel=r_associated | relid=0 | w=10
  4201. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octisalate
    n1=Okihiro (syndrome de) | n2=en:octisalate | rel=r_associated | relid=0 | w=10
  4202. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octoxynol 2
    n1=Okihiro (syndrome de) | n2=en:octoxynol 2 | rel=r_associated | relid=0 | w=10
  4203. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octoxynol 3
    n1=Okihiro (syndrome de) | n2=en:octoxynol 3 | rel=r_associated | relid=0 | w=10
  4204. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octoxynol 9
    n1=Okihiro (syndrome de) | n2=en:octoxynol 9 | rel=r_associated | relid=0 | w=10
  4205. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octoxynol-1
    n1=Okihiro (syndrome de) | n2=en:octoxynol-1 | rel=r_associated | relid=0 | w=10
  4206. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octoxynol-5
    n1=Okihiro (syndrome de) | n2=en:octoxynol-5 | rel=r_associated | relid=0 | w=10
  4207. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octreotide
    n1=Okihiro (syndrome de) | n2=en:octreotide | rel=r_associated | relid=0 | w=10
  4208. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octreotide acetate
    n1=Okihiro (syndrome de) | n2=en:octreotide acetate | rel=r_associated | relid=0 | w=10
  4209. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octreotide pamoate
    n1=Okihiro (syndrome de) | n2=en:octreotide pamoate | rel=r_associated | relid=0 | w=10
  4210. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octyl dimethyl paba
    n1=Okihiro (syndrome de) | n2=en:octyl dimethyl paba | rel=r_associated | relid=0 | w=10
  4211. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octyl hydroxystearate
    n1=Okihiro (syndrome de) | n2=en:octyl hydroxystearate | rel=r_associated | relid=0 | w=10
  4212. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octyl methoxycinnamate/octyl salicylate/oxybenzone
    n1=Okihiro (syndrome de) | n2=en:octyl methoxycinnamate/octyl salicylate/oxybenzone | rel=r_associated | relid=0 | w=10
  4213. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octyl methoxycinnamate/octyl salicylate/oxybenzone/titanium diox
    n1=Okihiro (syndrome de) | n2=en:octyl methoxycinnamate/octyl salicylate/oxybenzone/titanium diox | rel=r_associated | relid=0 | w=10
  4214. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octyl methoxycinnamate/oxybenzone/titanium dioxide
    n1=Okihiro (syndrome de) | n2=en:octyl methoxycinnamate/oxybenzone/titanium dioxide | rel=r_associated | relid=0 | w=10
  4215. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:octyphenylpolyethylene glycol
    n1=Okihiro (syndrome de) | n2=en:octyphenylpolyethylene glycol | rel=r_associated | relid=0 | w=10
  4216. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ocuclenz
    n1=Okihiro (syndrome de) | n2=en:ocuclenz | rel=r_associated | relid=0 | w=10
  4217. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ocular dosage form product
    n1=Okihiro (syndrome de) | n2=en:ocular dosage form product | rel=r_associated | relid=0 | w=10
  4218. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ocv-103
    n1=Okihiro (syndrome de) | n2=en:ocv-103 | rel=r_associated | relid=0 | w=10
  4219. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ocv-104
    n1=Okihiro (syndrome de) | n2=en:ocv-104 | rel=r_associated | relid=0 | w=10
  4220. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:odanacatib
    n1=Okihiro (syndrome de) | n2=en:odanacatib | rel=r_associated | relid=0 | w=10
  4221. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:odontoid process
    n1=Okihiro (syndrome de) | n2=en:odontoid process | rel=r_associated | relid=0 | w=10
  4222. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oepa regimen
    n1=Okihiro (syndrome de) | n2=en:oepa regimen | rel=r_associated | relid=0 | w=10
  4223. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ofatumumab
    n1=Okihiro (syndrome de) | n2=en:ofatumumab | rel=r_associated | relid=0 | w=10
  4224. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:off regimen
    n1=Okihiro (syndrome de) | n2=en:off regimen | rel=r_associated | relid=0 | w=10
  4225. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ofloxacin
    n1=Okihiro (syndrome de) | n2=en:ofloxacin | rel=r_associated | relid=0 | w=10
  4226. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oglufanide disodium
    n1=Okihiro (syndrome de) | n2=en:oglufanide disodium | rel=r_associated | relid=0 | w=10
  4227. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oil granuloma
    n1=Okihiro (syndrome de) | n2=en:oil granuloma | rel=r_associated | relid=0 | w=10
  4228. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oil in water emulsion
    n1=Okihiro (syndrome de) | n2=en:oil in water emulsion | rel=r_associated | relid=0 | w=10
  4229. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oil/water
    n1=Okihiro (syndrome de) | n2=en:oil/water | rel=r_associated | relid=0 | w=10
  4230. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ointment bases
    n1=Okihiro (syndrome de) | n2=en:ointment bases | rel=r_associated | relid=0 | w=10
  4231. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:OKT3
    n1=Okihiro (syndrome de) | n2=en:OKT3 | rel=r_associated | relid=0 | w=10
  4232. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine
    n1=Okihiro (syndrome de) | n2=en:olanzapine | rel=r_associated | relid=0 | w=10
  4233. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 10 mg disintegrating oral tablet [zyprexa]
    n1=Okihiro (syndrome de) | n2=en:olanzapine 10 mg disintegrating oral tablet [zyprexa] | rel=r_associated | relid=0 | w=10
  4234. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 10 mg injection [zyprexa]
    n1=Okihiro (syndrome de) | n2=en:olanzapine 10 mg injection [zyprexa] | rel=r_associated | relid=0 | w=10
  4235. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 10 mg oral tablet [zyprexa]
    n1=Okihiro (syndrome de) | n2=en:olanzapine 10 mg oral tablet [zyprexa] | rel=r_associated | relid=0 | w=10
  4236. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 10mg dispersible tablet
    n1=Okihiro (syndrome de) | n2=en:olanzapine 10mg dispersible tablet | rel=r_associated | relid=0 | w=10
  4237. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 10mg powder for injection
    n1=Okihiro (syndrome de) | n2=en:olanzapine 10mg powder for injection | rel=r_associated | relid=0 | w=10
  4238. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 10mg tablet
    n1=Okihiro (syndrome de) | n2=en:olanzapine 10mg tablet | rel=r_associated | relid=0 | w=10
  4239. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 12mg/fluoxetine 25mg capsule
    n1=Okihiro (syndrome de) | n2=en:olanzapine 12mg/fluoxetine 25mg capsule | rel=r_associated | relid=0 | w=10
  4240. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 12mg/fluoxetine 50mg capsule
    n1=Okihiro (syndrome de) | n2=en:olanzapine 12mg/fluoxetine 50mg capsule | rel=r_associated | relid=0 | w=10
  4241. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 15 mg disintegrating oral tablet [zyprexa]
    n1=Okihiro (syndrome de) | n2=en:olanzapine 15 mg disintegrating oral tablet [zyprexa] | rel=r_associated | relid=0 | w=10
  4242. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 15 mg oral tablet [zyprexa]
    n1=Okihiro (syndrome de) | n2=en:olanzapine 15 mg oral tablet [zyprexa] | rel=r_associated | relid=0 | w=10
  4243. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 15mg dispersible tablet
    n1=Okihiro (syndrome de) | n2=en:olanzapine 15mg dispersible tablet | rel=r_associated | relid=0 | w=10
  4244. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 15mg tablet
    n1=Okihiro (syndrome de) | n2=en:olanzapine 15mg tablet | rel=r_associated | relid=0 | w=10
  4245. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 2.5 mg oral tablet [zyprexa]
    n1=Okihiro (syndrome de) | n2=en:olanzapine 2.5 mg oral tablet [zyprexa] | rel=r_associated | relid=0 | w=10
  4246. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 2.5mg tablet
    n1=Okihiro (syndrome de) | n2=en:olanzapine 2.5mg tablet | rel=r_associated | relid=0 | w=10
  4247. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 20 mg disintegrating oral tablet [zyprexa]
    n1=Okihiro (syndrome de) | n2=en:olanzapine 20 mg disintegrating oral tablet [zyprexa] | rel=r_associated | relid=0 | w=10
  4248. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 20 mg oral tablet [zyprexa]
    n1=Okihiro (syndrome de) | n2=en:olanzapine 20 mg oral tablet [zyprexa] | rel=r_associated | relid=0 | w=10
  4249. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 20mg disintegrating tablet
    n1=Okihiro (syndrome de) | n2=en:olanzapine 20mg disintegrating tablet | rel=r_associated | relid=0 | w=10
  4250. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 20mg tablet
    n1=Okihiro (syndrome de) | n2=en:olanzapine 20mg tablet | rel=r_associated | relid=0 | w=10
  4251. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 210 mg injection [zyprexa]
    n1=Okihiro (syndrome de) | n2=en:olanzapine 210 mg injection [zyprexa] | rel=r_associated | relid=0 | w=10
  4252. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 300 mg injection
    n1=Okihiro (syndrome de) | n2=en:olanzapine 300 mg injection | rel=r_associated | relid=0 | w=10
  4253. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 300 mg injection [zyprexa]
    n1=Okihiro (syndrome de) | n2=en:olanzapine 300 mg injection [zyprexa] | rel=r_associated | relid=0 | w=10
  4254. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 3mg/fluoxetine 25mg capsule
    n1=Okihiro (syndrome de) | n2=en:olanzapine 3mg/fluoxetine 25mg capsule | rel=r_associated | relid=0 | w=10
  4255. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 405 mg injection
    n1=Okihiro (syndrome de) | n2=en:olanzapine 405 mg injection | rel=r_associated | relid=0 | w=10
  4256. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 405 mg injection [zyprexa]
    n1=Okihiro (syndrome de) | n2=en:olanzapine 405 mg injection [zyprexa] | rel=r_associated | relid=0 | w=10
  4257. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 5 mg disintegrating oral tablet [zyprexa]
    n1=Okihiro (syndrome de) | n2=en:olanzapine 5 mg disintegrating oral tablet [zyprexa] | rel=r_associated | relid=0 | w=10
  4258. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 5 mg oral tablet [zyprexa]
    n1=Okihiro (syndrome de) | n2=en:olanzapine 5 mg oral tablet [zyprexa] | rel=r_associated | relid=0 | w=10
  4259. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 5mg dispersible tablet
    n1=Okihiro (syndrome de) | n2=en:olanzapine 5mg dispersible tablet | rel=r_associated | relid=0 | w=10
  4260. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 5mg tablet
    n1=Okihiro (syndrome de) | n2=en:olanzapine 5mg tablet | rel=r_associated | relid=0 | w=10
  4261. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 6mg/fluoxetine 25mg capsule
    n1=Okihiro (syndrome de) | n2=en:olanzapine 6mg/fluoxetine 25mg capsule | rel=r_associated | relid=0 | w=10
  4262. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 6mg/fluoxetine 50mg capsule
    n1=Okihiro (syndrome de) | n2=en:olanzapine 6mg/fluoxetine 50mg capsule | rel=r_associated | relid=0 | w=10
  4263. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 7.5 mg oral tablet [zyprexa]
    n1=Okihiro (syndrome de) | n2=en:olanzapine 7.5 mg oral tablet [zyprexa] | rel=r_associated | relid=0 | w=10
  4264. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine 7.5mg tablet
    n1=Okihiro (syndrome de) | n2=en:olanzapine 7.5mg tablet | rel=r_associated | relid=0 | w=10
  4265. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine measurement
    n1=Okihiro (syndrome de) | n2=en:olanzapine measurement | rel=r_associated | relid=0 | w=10
  4266. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine pamoate
    n1=Okihiro (syndrome de) | n2=en:olanzapine pamoate | rel=r_associated | relid=0 | w=10
  4267. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine pamoate monohydrate
    n1=Okihiro (syndrome de) | n2=en:olanzapine pamoate monohydrate | rel=r_associated | relid=0 | w=10
  4268. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine:mass:pt:dose:qn
    n1=Okihiro (syndrome de) | n2=en:olanzapine:mass:pt:dose:qn | rel=r_associated | relid=0 | w=10
  4269. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine:mcnc:pt:bld:qn
    n1=Okihiro (syndrome de) | n2=en:olanzapine:mcnc:pt:bld:qn | rel=r_associated | relid=0 | w=10
  4270. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine:mcnc:pt:body fld:qn
    n1=Okihiro (syndrome de) | n2=en:olanzapine:mcnc:pt:body fld:qn | rel=r_associated | relid=0 | w=10
  4271. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine:mcnc:pt:ser/plas:qn
    n1=Okihiro (syndrome de) | n2=en:olanzapine:mcnc:pt:ser/plas:qn | rel=r_associated | relid=0 | w=10
  4272. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine:mcnc:pt:urine:qn:confirm
    n1=Okihiro (syndrome de) | n2=en:olanzapine:mcnc:pt:urine:qn:confirm | rel=r_associated | relid=0 | w=10
  4273. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine:mcnt:pt:tiss:qn
    n1=Okihiro (syndrome de) | n2=en:olanzapine:mcnt:pt:tiss:qn | rel=r_associated | relid=0 | w=10
  4274. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine:scnc:pt:gast fld:qn
    n1=Okihiro (syndrome de) | n2=en:olanzapine:scnc:pt:gast fld:qn | rel=r_associated | relid=0 | w=10
  4275. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine:scnc:pt:ser/plas:qn
    n1=Okihiro (syndrome de) | n2=en:olanzapine:scnc:pt:ser/plas:qn | rel=r_associated | relid=0 | w=10
  4276. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine:scnc:pt:urine:qn
    n1=Okihiro (syndrome de) | n2=en:olanzapine:scnc:pt:urine:qn | rel=r_associated | relid=0 | w=10
  4277. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine:scnc:pt:xxx:qn
    n1=Okihiro (syndrome de) | n2=en:olanzapine:scnc:pt:xxx:qn | rel=r_associated | relid=0 | w=10
  4278. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olanzapine:threshold:pt:urine:ord
    n1=Okihiro (syndrome de) | n2=en:olanzapine:threshold:pt:urine:ord | rel=r_associated | relid=0 | w=10
  4279. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olaparib
    n1=Okihiro (syndrome de) | n2=en:olaparib | rel=r_associated | relid=0 | w=10
  4280. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olaratumab
    n1=Okihiro (syndrome de) | n2=en:olaratumab | rel=r_associated | relid=0 | w=10
  4281. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oleandrin
    n1=Okihiro (syndrome de) | n2=en:oleandrin | rel=r_associated | relid=0 | w=10
  4282. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olecranectomy
    n1=Okihiro (syndrome de) | n2=en:olecranectomy | rel=r_associated | relid=0 | w=10
  4283. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olecranon
    n1=Okihiro (syndrome de) | n2=en:olecranon | rel=r_associated | relid=0 | w=10
  4284. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olecranon process
    n1=Okihiro (syndrome de) | n2=en:olecranon process | rel=r_associated | relid=0 | w=10
  4285. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olecranon process of ulna
    n1=Okihiro (syndrome de) | n2=en:olecranon process of ulna | rel=r_associated | relid=0 | w=10
  4286. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oleic acid
    n1=Okihiro (syndrome de) | n2=en:oleic acid | rel=r_associated | relid=0 | w=10
  4287. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olein
    n1=Okihiro (syndrome de) | n2=en:olein | rel=r_associated | relid=0 | w=10
  4288. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oleo
    n1=Okihiro (syndrome de) | n2=en:oleo | rel=r_associated | relid=0 | w=10
  4289. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oleoma
    n1=Okihiro (syndrome de) | n2=en:oleoma | rel=r_associated | relid=0 | w=10
  4290. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oleth-2
    n1=Okihiro (syndrome de) | n2=en:oleth-2 | rel=r_associated | relid=0 | w=10
  4291. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oleth-3-phosphate
    n1=Okihiro (syndrome de) | n2=en:oleth-3-phosphate | rel=r_associated | relid=0 | w=10
  4292. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oleuropein
    n1=Okihiro (syndrome de) | n2=en:oleuropein | rel=r_associated | relid=0 | w=10
  4293. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oleyl alcohol
    n1=Okihiro (syndrome de) | n2=en:oleyl alcohol | rel=r_associated | relid=0 | w=10
  4294. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oleyl ether
    n1=Okihiro (syndrome de) | n2=en:oleyl ether | rel=r_associated | relid=0 | w=10
  4295. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oligofructose
    n1=Okihiro (syndrome de) | n2=en:oligofructose | rel=r_associated | relid=0 | w=10
  4296. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oligofructose-enriched inulin
    n1=Okihiro (syndrome de) | n2=en:oligofructose-enriched inulin | rel=r_associated | relid=0 | w=10
  4297. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oligonucleotide spc2996
    n1=Okihiro (syndrome de) | n2=en:oligonucleotide spc2996 | rel=r_associated | relid=0 | w=10
  4298. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olivamine
    n1=Okihiro (syndrome de) | n2=en:olivamine | rel=r_associated | relid=0 | w=10
  4299. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olive leaf extract
    n1=Okihiro (syndrome de) | n2=en:olive leaf extract | rel=r_associated | relid=0 | w=10
  4300. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olive oil
    n1=Okihiro (syndrome de) | n2=en:olive oil | rel=r_associated | relid=0 | w=10
  4301. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olive oil extract/curcumin-based capsule
    n1=Okihiro (syndrome de) | n2=en:olive oil extract/curcumin-based capsule | rel=r_associated | relid=0 | w=10
  4302. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olive oil/soya oil/egg lecithin-based emulsion
    n1=Okihiro (syndrome de) | n2=en:olive oil/soya oil/egg lecithin-based emulsion | rel=r_associated | relid=0 | w=10
  4303. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olive oil/soybean oil/multi-amino acid/glucose parenteral nutrition emulsion
    n1=Okihiro (syndrome de) | n2=en:olive oil/soybean oil/multi-amino acid/glucose parenteral nutrition emulsion | rel=r_associated | relid=0 | w=10
  4304. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olmesartan
    n1=Okihiro (syndrome de) | n2=en:olmesartan | rel=r_associated | relid=0 | w=10
  4305. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olodaterol
    n1=Okihiro (syndrome de) | n2=en:olodaterol | rel=r_associated | relid=0 | w=10
  4306. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olodaterol + tiotropium
    n1=Okihiro (syndrome de) | n2=en:olodaterol + tiotropium | rel=r_associated | relid=0 | w=10
  4307. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olopatadine
    n1=Okihiro (syndrome de) | n2=en:olopatadine | rel=r_associated | relid=0 | w=10
  4308. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:olsalazine
    n1=Okihiro (syndrome de) | n2=en:olsalazine | rel=r_associated | relid=0 | w=10
  4309. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oltipraz
    n1=Okihiro (syndrome de) | n2=en:oltipraz | rel=r_associated | relid=0 | w=10
  4310. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:omacetaxine
    n1=Okihiro (syndrome de) | n2=en:omacetaxine | rel=r_associated | relid=0 | w=10
  4311. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:omacetaxine mepesuccinate
    n1=Okihiro (syndrome de) | n2=en:omacetaxine mepesuccinate | rel=r_associated | relid=0 | w=10
  4312. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:omalizumab
    n1=Okihiro (syndrome de) | n2=en:omalizumab | rel=r_associated | relid=0 | w=10
  4313. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:omapatrilat
    n1=Okihiro (syndrome de) | n2=en:omapatrilat | rel=r_associated | relid=0 | w=10
  4314. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ombitasvir/paritaprevir/ritonavir
    n1=Okihiro (syndrome de) | n2=en:ombitasvir/paritaprevir/ritonavir | rel=r_associated | relid=0 | w=10
  4315. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ombrabulin
    n1=Okihiro (syndrome de) | n2=en:ombrabulin | rel=r_associated | relid=0 | w=10
  4316. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:omega 3-marine triglycerides
    n1=Okihiro (syndrome de) | n2=en:omega 3-marine triglycerides | rel=r_associated | relid=0 | w=10
  4317. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:omega-3 acid
    n1=Okihiro (syndrome de) | n2=en:omega-3 acid | rel=r_associated | relid=0 | w=10
  4318. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:omega-3 fatty acid
    n1=Okihiro (syndrome de) | n2=en:omega-3 fatty acid | rel=r_associated | relid=0 | w=10
  4319. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:omeprazole
    n1=Okihiro (syndrome de) | n2=en:omeprazole | rel=r_associated | relid=0 | w=10
  4320. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:omeprazole + sodium bicarbonate
    n1=Okihiro (syndrome de) | n2=en:omeprazole + sodium bicarbonate | rel=r_associated | relid=0 | w=10
  4321. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:omiganan pentahydrochloride
    n1=Okihiro (syndrome de) | n2=en:omiganan pentahydrochloride | rel=r_associated | relid=0 | w=10
  4322. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:onalespib
    n1=Okihiro (syndrome de) | n2=en:onalespib | rel=r_associated | relid=0 | w=10
  4323. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:onartuzumab
    n1=Okihiro (syndrome de) | n2=en:onartuzumab | rel=r_associated | relid=0 | w=10
  4324. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oncolytic adenovirus ad5-dnx-2401
    n1=Okihiro (syndrome de) | n2=en:oncolytic adenovirus ad5-dnx-2401 | rel=r_associated | relid=0 | w=10
  4325. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oncolytic adenovirus encoding gm-csf
    n1=Okihiro (syndrome de) | n2=en:oncolytic adenovirus encoding gm-csf | rel=r_associated | relid=0 | w=10
  4326. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oncolytic adenovirus icovir5-infected autologous mesenchymal stem cells
    n1=Okihiro (syndrome de) | n2=en:oncolytic adenovirus icovir5-infected autologous mesenchymal stem cells | rel=r_associated | relid=0 | w=10
  4327. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oncolytic herpes simplex virus-1-encoding gm-csf
    n1=Okihiro (syndrome de) | n2=en:oncolytic herpes simplex virus-1-encoding gm-csf | rel=r_associated | relid=0 | w=10
  4328. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oncolytic hsv-1 rrp450
    n1=Okihiro (syndrome de) | n2=en:oncolytic hsv-1 rrp450 | rel=r_associated | relid=0 | w=10
  4329. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oncolytic hsv1716
    n1=Okihiro (syndrome de) | n2=en:oncolytic hsv1716 | rel=r_associated | relid=0 | w=10
  4330. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oncolytic measles virus encoding thyroidal sodium iodide symporter
    n1=Okihiro (syndrome de) | n2=en:oncolytic measles virus encoding thyroidal sodium iodide symporter | rel=r_associated | relid=0 | w=10
  4331. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oncolytic newcastle disease virus
    n1=Okihiro (syndrome de) | n2=en:oncolytic newcastle disease virus | rel=r_associated | relid=0 | w=10
  4332. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ondansetron
    n1=Okihiro (syndrome de) | n2=en:ondansetron | rel=r_associated | relid=0 | w=10
  4333. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ondansetron hydrochloride
    n1=Okihiro (syndrome de) | n2=en:ondansetron hydrochloride | rel=r_associated | relid=0 | w=10
  4334. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:onion extract
    n1=Okihiro (syndrome de) | n2=en:onion extract | rel=r_associated | relid=0 | w=10
  4335. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:onyx-015
    n1=Okihiro (syndrome de) | n2=en:onyx-015 | rel=r_associated | relid=0 | w=10
  4336. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:opadry olive green
    n1=Okihiro (syndrome de) | n2=en:opadry olive green | rel=r_associated | relid=0 | w=10
  4337. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:opb-111001
    n1=Okihiro (syndrome de) | n2=en:opb-111001 | rel=r_associated | relid=0 | w=10
  4338. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:opcs/green tea/spirullina/curcumin/antrodia camphorate/fermented soymilk extract capsule
    n1=Okihiro (syndrome de) | n2=en:opcs/green tea/spirullina/curcumin/antrodia camphorate/fermented soymilk extract capsule | rel=r_associated | relid=0 | w=10
  4339. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:opebacan
    n1=Okihiro (syndrome de) | n2=en:opebacan | rel=r_associated | relid=0 | w=10
  4340. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:opioid agonist gic-1001
    n1=Okihiro (syndrome de) | n2=en:opioid agonist gic-1001 | rel=r_associated | relid=0 | w=10
  4341. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:opioid agonist gic-1002
    n1=Okihiro (syndrome de) | n2=en:opioid agonist gic-1002 | rel=r_associated | relid=0 | w=10
  4342. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:opioid growth factor
    n1=Okihiro (syndrome de) | n2=en:opioid growth factor | rel=r_associated | relid=0 | w=10
  4343. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:opium
    n1=Okihiro (syndrome de) | n2=en:opium | rel=r_associated | relid=0 | w=10
  4344. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:opium tincture
    n1=Okihiro (syndrome de) | n2=en:opium tincture | rel=r_associated | relid=0 | w=10
  4345. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oppa regimen
    n1=Okihiro (syndrome de) | n2=en:oppa regimen | rel=r_associated | relid=0 | w=10
  4346. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oprelvekin
    n1=Okihiro (syndrome de) | n2=en:oprelvekin | rel=r_associated | relid=0 | w=10
  4347. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oprozomib
    n1=Okihiro (syndrome de) | n2=en:oprozomib | rel=r_associated | relid=0 | w=10
  4348. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:optimental
    n1=Okihiro (syndrome de) | n2=en:optimental | rel=r_associated | relid=0 | w=10
  4349. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:optipore
    n1=Okihiro (syndrome de) | n2=en:optipore | rel=r_associated | relid=0 | w=10
  4350. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:orabase
    n1=Okihiro (syndrome de) | n2=en:orabase | rel=r_associated | relid=0 | w=10
  4351. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oral aminolevulinic acid hydrochloride
    n1=Okihiro (syndrome de) | n2=en:oral aminolevulinic acid hydrochloride | rel=r_associated | relid=0 | w=10
  4352. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oral azacitidine
    n1=Okihiro (syndrome de) | n2=en:oral azacitidine | rel=r_associated | relid=0 | w=10
  4353. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oral dosage form product
    n1=Okihiro (syndrome de) | n2=en:oral dosage form product | rel=r_associated | relid=0 | w=10
  4354. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oral fludarabine phosphate
    n1=Okihiro (syndrome de) | n2=en:oral fludarabine phosphate | rel=r_associated | relid=0 | w=10
  4355. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oral hsp90 inhibitor ipi-493
    n1=Okihiro (syndrome de) | n2=en:oral hsp90 inhibitor ipi-493 | rel=r_associated | relid=0 | w=10
  4356. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oral ixabepilone
    n1=Okihiro (syndrome de) | n2=en:oral ixabepilone | rel=r_associated | relid=0 | w=10
  4357. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oral medication
    n1=Okihiro (syndrome de) | n2=en:oral medication | rel=r_associated | relid=0 | w=10
  4358. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oral microencapsulated diindolylmethane
    n1=Okihiro (syndrome de) | n2=en:oral microencapsulated diindolylmethane | rel=r_associated | relid=0 | w=10
  4359. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oral milataxel
    n1=Okihiro (syndrome de) | n2=en:oral milataxel | rel=r_associated | relid=0 | w=10
  4360. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oral picoplatin
    n1=Okihiro (syndrome de) | n2=en:oral picoplatin | rel=r_associated | relid=0 | w=10
  4361. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oral rehydration solution os-1
    n1=Okihiro (syndrome de) | n2=en:oral rehydration solution os-1 | rel=r_associated | relid=0 | w=10
  4362. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oral sodium phenylbutyrate
    n1=Okihiro (syndrome de) | n2=en:oral sodium phenylbutyrate | rel=r_associated | relid=0 | w=10
  4363. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oral topotecan hydrochloride
    n1=Okihiro (syndrome de) | n2=en:oral topotecan hydrochloride | rel=r_associated | relid=0 | w=10
  4364. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oramagicrx
    n1=Okihiro (syndrome de) | n2=en:oramagicrx | rel=r_associated | relid=0 | w=10
  4365. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:orange juice
    n1=Okihiro (syndrome de) | n2=en:orange juice | rel=r_associated | relid=0 | w=10
  4366. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:orange oil extract
    n1=Okihiro (syndrome de) | n2=en:orange oil extract | rel=r_associated | relid=0 | w=10
  4367. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:orange syrup vehicle
    n1=Okihiro (syndrome de) | n2=en:orange syrup vehicle | rel=r_associated | relid=0 | w=10
  4368. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:orantinib
    n1=Okihiro (syndrome de) | n2=en:orantinib | rel=r_associated | relid=0 | w=10
  4369. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oraxol
    n1=Okihiro (syndrome de) | n2=en:oraxol | rel=r_associated | relid=0 | w=10
  4370. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:orbit
    n1=Okihiro (syndrome de) | n2=en:orbit | rel=r_associated | relid=0 | w=10
  4371. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oregano preparation
    n1=Okihiro (syndrome de) | n2=en:oregano preparation | rel=r_associated | relid=0 | w=10
  4372. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oregovomab
    n1=Okihiro (syndrome de) | n2=en:oregovomab | rel=r_associated | relid=0 | w=10
  4373. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:organic sulfone compound
    n1=Okihiro (syndrome de) | n2=en:organic sulfone compound | rel=r_associated | relid=0 | w=10
  4374. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oritavancin
    n1=Okihiro (syndrome de) | n2=en:oritavancin | rel=r_associated | relid=0 | w=10
  4375. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:orlistat
    n1=Okihiro (syndrome de) | n2=en:orlistat | rel=r_associated | relid=0 | w=10
  4376. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ormaplatin
    n1=Okihiro (syndrome de) | n2=en:ormaplatin | rel=r_associated | relid=0 | w=10
  4377. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oropharyngeal dosage form product
    n1=Okihiro (syndrome de) | n2=en:oropharyngeal dosage form product | rel=r_associated | relid=0 | w=10
  4378. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:orris root extract
    n1=Okihiro (syndrome de) | n2=en:orris root extract | rel=r_associated | relid=0 | w=10
  4379. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ortataxel
    n1=Okihiro (syndrome de) | n2=en:ortataxel | rel=r_associated | relid=0 | w=10
  4380. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:orteronel
    n1=Okihiro (syndrome de) | n2=en:orteronel | rel=r_associated | relid=0 | w=10
  4381. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oscillococcinum
    n1=Okihiro (syndrome de) | n2=en:oscillococcinum | rel=r_associated | relid=0 | w=10
  4382. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ose 2101
    n1=Okihiro (syndrome de) | n2=en:ose 2101 | rel=r_associated | relid=0 | w=10
  4383. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oseltamivir
    n1=Okihiro (syndrome de) | n2=en:oseltamivir | rel=r_associated | relid=0 | w=10
  4384. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oseltamivir phosphate
    n1=Okihiro (syndrome de) | n2=en:oseltamivir phosphate | rel=r_associated | relid=0 | w=10
  4385. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oshadi d
    n1=Okihiro (syndrome de) | n2=en:oshadi d | rel=r_associated | relid=0 | w=10
  4386. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oshadi r
    n1=Okihiro (syndrome de) | n2=en:oshadi r | rel=r_associated | relid=0 | w=10
  4387. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:osi-7904l
    n1=Okihiro (syndrome de) | n2=en:osi-7904l | rel=r_associated | relid=0 | w=10
  4388. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:osimertinib
    n1=Okihiro (syndrome de) | n2=en:osimertinib | rel=r_associated | relid=0 | w=10
  4389. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:osmolite
    n1=Okihiro (syndrome de) | n2=en:osmolite | rel=r_associated | relid=0 | w=10
  4390. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ospemifene
    n1=Okihiro (syndrome de) | n2=en:ospemifene | rel=r_associated | relid=0 | w=10
  4391. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:osteo bi-flex
    n1=Okihiro (syndrome de) | n2=en:osteo bi-flex | rel=r_associated | relid=0 | w=10
  4392. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:otd70derm
    n1=Okihiro (syndrome de) | n2=en:otd70derm | rel=r_associated | relid=0 | w=10
  4393. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oteracil potassium
    n1=Okihiro (syndrome de) | n2=en:oteracil potassium | rel=r_associated | relid=0 | w=10
  4394. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:otic preparation
    n1=Okihiro (syndrome de) | n2=en:otic preparation | rel=r_associated | relid=0 | w=10
  4395. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:otlertuzumab
    n1=Okihiro (syndrome de) | n2=en:otlertuzumab | rel=r_associated | relid=0 | w=10
  4396. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:otsgc-a24 vaccine
    n1=Okihiro (syndrome de) | n2=en:otsgc-a24 vaccine | rel=r_associated | relid=0 | w=10
  4397. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ova bip peptide
    n1=Okihiro (syndrome de) | n2=en:ova bip peptide | rel=r_associated | relid=0 | w=10
  4398. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ovapuldencel-t
    n1=Okihiro (syndrome de) | n2=en:ovapuldencel-t | rel=r_associated | relid=0 | w=10
  4399. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ovarian cancer peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:ovarian cancer peptide vaccine | rel=r_associated | relid=0 | w=10
  4400. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ovarian cancer stem cell/htert/survivin mrnas-loaded autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:ovarian cancer stem cell/htert/survivin mrnas-loaded autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  4401. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ovarian tumor antigen-activated autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:ovarian tumor antigen-activated autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  4402. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:over the counter product
    n1=Okihiro (syndrome de) | n2=en:over the counter product | rel=r_associated | relid=0 | w=10
  4403. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ovine digoxin immune fab
    n1=Okihiro (syndrome de) | n2=en:ovine digoxin immune fab | rel=r_associated | relid=0 | w=10
  4404. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ovine submaxillary mucin
    n1=Okihiro (syndrome de) | n2=en:ovine submaxillary mucin | rel=r_associated | relid=0 | w=10
  4405. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ovulation test
    n1=Okihiro (syndrome de) | n2=en:ovulation test | rel=r_associated | relid=0 | w=10
  4406. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ox bile extract
    n1=Okihiro (syndrome de) | n2=en:ox bile extract | rel=r_associated | relid=0 | w=10
  4407. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxacillin
    n1=Okihiro (syndrome de) | n2=en:oxacillin | rel=r_associated | relid=0 | w=10
  4408. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxacillin sodium
    n1=Okihiro (syndrome de) | n2=en:oxacillin sodium | rel=r_associated | relid=0 | w=10
  4409. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxaflumazine
    n1=Okihiro (syndrome de) | n2=en:oxaflumazine | rel=r_associated | relid=0 | w=10
  4410. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxalic acid
    n1=Okihiro (syndrome de) | n2=en:oxalic acid | rel=r_associated | relid=0 | w=10
  4411. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxaliplatin
    n1=Okihiro (syndrome de) | n2=en:oxaliplatin | rel=r_associated | relid=0 | w=10
  4412. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxaliplatin-encapsulated transferrin-conjugated n-glutaryl phosphatidylethanolamine liposome
    n1=Okihiro (syndrome de) | n2=en:oxaliplatin-encapsulated transferrin-conjugated n-glutaryl phosphatidylethanolamine liposome | rel=r_associated | relid=0 | w=10
  4413. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxamniquine
    n1=Okihiro (syndrome de) | n2=en:oxamniquine | rel=r_associated | relid=0 | w=10
  4414. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxandrolone
    n1=Okihiro (syndrome de) | n2=en:oxandrolone | rel=r_associated | relid=0 | w=10
  4415. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxazepam
    n1=Okihiro (syndrome de) | n2=en:oxazepam | rel=r_associated | relid=0 | w=10
  4416. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxazepam hemisuccinate
    n1=Okihiro (syndrome de) | n2=en:oxazepam hemisuccinate | rel=r_associated | relid=0 | w=10
  4417. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxazepam monosodium succinate
    n1=Okihiro (syndrome de) | n2=en:oxazepam monosodium succinate | rel=r_associated | relid=0 | w=10
  4418. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxcarbazepine
    n1=Okihiro (syndrome de) | n2=en:oxcarbazepine | rel=r_associated | relid=0 | w=10
  4419. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxidized avidin
    n1=Okihiro (syndrome de) | n2=en:oxidized avidin | rel=r_associated | relid=0 | w=10
  4420. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxidopamine
    n1=Okihiro (syndrome de) | n2=en:oxidopamine | rel=r_associated | relid=0 | w=10
  4421. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxidronate
    n1=Okihiro (syndrome de) | n2=en:oxidronate | rel=r_associated | relid=0 | w=10
  4422. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxitriptan
    n1=Okihiro (syndrome de) | n2=en:oxitriptan | rel=r_associated | relid=0 | w=10
  4423. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxphos inhibitor vlx600
    n1=Okihiro (syndrome de) | n2=en:oxphos inhibitor vlx600 | rel=r_associated | relid=0 | w=10
  4424. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxtriphylline
    n1=Okihiro (syndrome de) | n2=en:oxtriphylline | rel=r_associated | relid=0 | w=10
  4425. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxybenzone
    n1=Okihiro (syndrome de) | n2=en:oxybenzone | rel=r_associated | relid=0 | w=10
  4426. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxybenzone, padimate o drug combination
    n1=Okihiro (syndrome de) | n2=en:oxybenzone, padimate o drug combination | rel=r_associated | relid=0 | w=10
  4427. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxybenzone/padimate o/para-aminobenzoic acid/sd alcohol 40
    n1=Okihiro (syndrome de) | n2=en:oxybenzone/padimate o/para-aminobenzoic acid/sd alcohol 40 | rel=r_associated | relid=0 | w=10
  4428. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxybenzone/padimate o/sd alcohol 40
    n1=Okihiro (syndrome de) | n2=en:oxybenzone/padimate o/sd alcohol 40 | rel=r_associated | relid=0 | w=10
  4429. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxybenzone/para-aminobenzoic acid
    n1=Okihiro (syndrome de) | n2=en:oxybenzone/para-aminobenzoic acid | rel=r_associated | relid=0 | w=10
  4430. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxybenzone/petrolatum
    n1=Okihiro (syndrome de) | n2=en:oxybenzone/petrolatum | rel=r_associated | relid=0 | w=10
  4431. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxychlorosene
    n1=Okihiro (syndrome de) | n2=en:oxychlorosene | rel=r_associated | relid=0 | w=10
  4432. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxycodone
    n1=Okihiro (syndrome de) | n2=en:oxycodone | rel=r_associated | relid=0 | w=10
  4433. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxycodone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:oxycodone hydrochloride | rel=r_associated | relid=0 | w=10
  4434. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxycodone hydrochloride/naloxone hydrochloride prolonged-release tablet
    n1=Okihiro (syndrome de) | n2=en:oxycodone hydrochloride/naloxone hydrochloride prolonged-release tablet | rel=r_associated | relid=0 | w=10
  4435. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxycodone/acetaminophen
    n1=Okihiro (syndrome de) | n2=en:oxycodone/acetaminophen | rel=r_associated | relid=0 | w=10
  4436. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxygen
    n1=Okihiro (syndrome de) | n2=en:oxygen | rel=r_associated | relid=0 | w=10
  4437. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxygen/sodium chloride
    n1=Okihiro (syndrome de) | n2=en:oxygen/sodium chloride | rel=r_associated | relid=0 | w=10
  4438. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxymetazoline
    n1=Okihiro (syndrome de) | n2=en:oxymetazoline | rel=r_associated | relid=0 | w=10
  4439. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxymetholone
    n1=Okihiro (syndrome de) | n2=en:oxymetholone | rel=r_associated | relid=0 | w=10
  4440. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxymorphone
    n1=Okihiro (syndrome de) | n2=en:oxymorphone | rel=r_associated | relid=0 | w=10
  4441. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxymorphone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:oxymorphone hydrochloride | rel=r_associated | relid=0 | w=10
  4442. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxypendyl
    n1=Okihiro (syndrome de) | n2=en:oxypendyl | rel=r_associated | relid=0 | w=10
  4443. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxypertine
    n1=Okihiro (syndrome de) | n2=en:oxypertine | rel=r_associated | relid=0 | w=10
  4444. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxyphenbutazone
    n1=Okihiro (syndrome de) | n2=en:oxyphenbutazone | rel=r_associated | relid=0 | w=10
  4445. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxyphencyclimine
    n1=Okihiro (syndrome de) | n2=en:oxyphencyclimine | rel=r_associated | relid=0 | w=10
  4446. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxyphenonium
    n1=Okihiro (syndrome de) | n2=en:oxyphenonium | rel=r_associated | relid=0 | w=10
  4447. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxyquinoline
    n1=Okihiro (syndrome de) | n2=en:oxyquinoline | rel=r_associated | relid=0 | w=10
  4448. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxysept
    n1=Okihiro (syndrome de) | n2=en:oxysept | rel=r_associated | relid=0 | w=10
  4449. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxytetracycline / phenazopyridine / sulfamethizole
    n1=Okihiro (syndrome de) | n2=en:oxytetracycline / phenazopyridine / sulfamethizole | rel=r_associated | relid=0 | w=10
  4450. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxytetracycline / polymyxin b
    n1=Okihiro (syndrome de) | n2=en:oxytetracycline / polymyxin b | rel=r_associated | relid=0 | w=10
  4451. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxytocics
    n1=Okihiro (syndrome de) | n2=en:oxytocics | rel=r_associated | relid=0 | w=10
  4452. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:oxytocin
    n1=Okihiro (syndrome de) | n2=en:oxytocin | rel=r_associated | relid=0 | w=10
  4453. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ozarelix
    n1=Okihiro (syndrome de) | n2=en:ozarelix | rel=r_associated | relid=0 | w=10
  4454. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p-cadherin antagonist pf-03732010
    n1=Okihiro (syndrome de) | n2=en:p-cadherin antagonist pf-03732010 | rel=r_associated | relid=0 | w=10
  4455. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p-cadherin inhibitor pca062
    n1=Okihiro (syndrome de) | n2=en:p-cadherin inhibitor pca062 | rel=r_associated | relid=0 | w=10
  4456. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p-cadherin-targeting agent pf-06671008
    n1=Okihiro (syndrome de) | n2=en:p-cadherin-targeting agent pf-06671008 | rel=r_associated | relid=0 | w=10
  4457. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p-glycoprotein inhibitor hm30181ak
    n1=Okihiro (syndrome de) | n2=en:p-glycoprotein inhibitor hm30181ak | rel=r_associated | relid=0 | w=10
  4458. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p-p68 inhibitor rx-5902
    n1=Okihiro (syndrome de) | n2=en:p-p68 inhibitor rx-5902 | rel=r_associated | relid=0 | w=10
  4459. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p-tefb inhibitor bay1143572
    n1=Okihiro (syndrome de) | n2=en:p-tefb inhibitor bay1143572 | rel=r_associated | relid=0 | w=10
  4460. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p.dom-wt1-126 dna vaccine
    n1=Okihiro (syndrome de) | n2=en:p.dom-wt1-126 dna vaccine | rel=r_associated | relid=0 | w=10
  4461. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p.dom-wt1-37 dna vaccine
    n1=Okihiro (syndrome de) | n2=en:p.dom-wt1-37 dna vaccine | rel=r_associated | relid=0 | w=10
  4462. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p110beta/delta pi3k inhibitor gs-9820
    n1=Okihiro (syndrome de) | n2=en:p110beta/delta pi3k inhibitor gs-9820 | rel=r_associated | relid=0 | w=10
  4463. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p16_37-63 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:p16_37-63 peptide vaccine | rel=r_associated | relid=0 | w=10
  4464. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p38 mapk inhibitor ly2228820 dimesylate
    n1=Okihiro (syndrome de) | n2=en:p38 mapk inhibitor ly2228820 dimesylate | rel=r_associated | relid=0 | w=10
  4465. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p38 mapk inhibitor ly3007113
    n1=Okihiro (syndrome de) | n2=en:p38 mapk inhibitor ly3007113 | rel=r_associated | relid=0 | w=10
  4466. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p501-as15 vaccine
    n1=Okihiro (syndrome de) | n2=en:p501-as15 vaccine | rel=r_associated | relid=0 | w=10
  4467. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p53 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:p53 peptide vaccine | rel=r_associated | relid=0 | w=10
  4468. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p53-hdm2 interaction inhibitor mi-773
    n1=Okihiro (syndrome de) | n2=en:p53-hdm2 interaction inhibitor mi-773 | rel=r_associated | relid=0 | w=10
  4469. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p53-synthetic long peptides vaccine
    n1=Okihiro (syndrome de) | n2=en:p53-synthetic long peptides vaccine | rel=r_associated | relid=0 | w=10
  4470. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p53/hdm2 interaction inhibitor cgm097
    n1=Okihiro (syndrome de) | n2=en:p53/hdm2 interaction inhibitor cgm097 | rel=r_associated | relid=0 | w=10
  4471. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p70s6k inhibitor ly2584702
    n1=Okihiro (syndrome de) | n2=en:p70s6k inhibitor ly2584702 | rel=r_associated | relid=0 | w=10
  4472. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p70s6k/akt inhibitor msc2363318a
    n1=Okihiro (syndrome de) | n2=en:p70s6k/akt inhibitor msc2363318a | rel=r_associated | relid=0 | w=10
  4473. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:p97 inhibitor cb-5083
    n1=Okihiro (syndrome de) | n2=en:p97 inhibitor cb-5083 | rel=r_associated | relid=0 | w=10
  4474. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pa-1-stk ovarian carcinoma vaccine
    n1=Okihiro (syndrome de) | n2=en:pa-1-stk ovarian carcinoma vaccine | rel=r_associated | relid=0 | w=10
  4475. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paclitaxel
    n1=Okihiro (syndrome de) | n2=en:paclitaxel | rel=r_associated | relid=0 | w=10
  4476. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paclitaxel albumin-stabilized nanoparticle formulation
    n1=Okihiro (syndrome de) | n2=en:paclitaxel albumin-stabilized nanoparticle formulation | rel=r_associated | relid=0 | w=10
  4477. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paclitaxel injection concentrate for nanodispersion
    n1=Okihiro (syndrome de) | n2=en:paclitaxel injection concentrate for nanodispersion | rel=r_associated | relid=0 | w=10
  4478. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paclitaxel liposome
    n1=Okihiro (syndrome de) | n2=en:paclitaxel liposome | rel=r_associated | relid=0 | w=10
  4479. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paclitaxel poliglumex
    n1=Okihiro (syndrome de) | n2=en:paclitaxel poliglumex | rel=r_associated | relid=0 | w=10
  4480. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paclitaxel trevatide
    n1=Okihiro (syndrome de) | n2=en:paclitaxel trevatide | rel=r_associated | relid=0 | w=10
  4481. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paclitaxel vitamin e-based emulsion
    n1=Okihiro (syndrome de) | n2=en:paclitaxel vitamin e-based emulsion | rel=r_associated | relid=0 | w=10
  4482. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paclitaxel-loaded polymeric micelle
    n1=Okihiro (syndrome de) | n2=en:paclitaxel-loaded polymeric micelle | rel=r_associated | relid=0 | w=10
  4483. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pacritinib
    n1=Okihiro (syndrome de) | n2=en:pacritinib | rel=r_associated | relid=0 | w=10
  4484. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pad regimen
    n1=Okihiro (syndrome de) | n2=en:pad regimen | rel=r_associated | relid=0 | w=10
  4485. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:padeliporfin
    n1=Okihiro (syndrome de) | n2=en:padeliporfin | rel=r_associated | relid=0 | w=10
  4486. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:padre 965.10
    n1=Okihiro (syndrome de) | n2=en:padre 965.10 | rel=r_associated | relid=0 | w=10
  4487. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:padre-cmv fusion peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:padre-cmv fusion peptide vaccine | rel=r_associated | relid=0 | w=10
  4488. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pak4 inhibitor pf-03758309
    n1=Okihiro (syndrome de) | n2=en:pak4 inhibitor pf-03758309 | rel=r_associated | relid=0 | w=10
  4489. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pak4/nampt inhibitor kpt-9274
    n1=Okihiro (syndrome de) | n2=en:pak4/nampt inhibitor kpt-9274 | rel=r_associated | relid=0 | w=10
  4490. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:palbociclib
    n1=Okihiro (syndrome de) | n2=en:palbociclib | rel=r_associated | relid=0 | w=10
  4491. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:palifermin
    n1=Okihiro (syndrome de) | n2=en:palifermin | rel=r_associated | relid=0 | w=10
  4492. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:palifosfamide
    n1=Okihiro (syndrome de) | n2=en:palifosfamide | rel=r_associated | relid=0 | w=10
  4493. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:palifosfamide tromethamine
    n1=Okihiro (syndrome de) | n2=en:palifosfamide tromethamine | rel=r_associated | relid=0 | w=10
  4494. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paliperidone
    n1=Okihiro (syndrome de) | n2=en:paliperidone | rel=r_associated | relid=0 | w=10
  4495. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paliperidone palmitate
    n1=Okihiro (syndrome de) | n2=en:paliperidone palmitate | rel=r_associated | relid=0 | w=10
  4496. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:palivizumab
    n1=Okihiro (syndrome de) | n2=en:palivizumab | rel=r_associated | relid=0 | w=10
  4497. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:palladium pd-103
    n1=Okihiro (syndrome de) | n2=en:palladium pd-103 | rel=r_associated | relid=0 | w=10
  4498. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:palladium-bacteriopheophorbide
    n1=Okihiro (syndrome de) | n2=en:palladium-bacteriopheophorbide | rel=r_associated | relid=0 | w=10
  4499. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:palm extract phytonutrient supplement
    n1=Okihiro (syndrome de) | n2=en:palm extract phytonutrient supplement | rel=r_associated | relid=0 | w=10
  4500. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:palonosetron hydrochloride
    n1=Okihiro (syndrome de) | n2=en:palonosetron hydrochloride | rel=r_associated | relid=0 | w=10
  4501. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pamidronate disodium
    n1=Okihiro (syndrome de) | n2=en:pamidronate disodium | rel=r_associated | relid=0 | w=10
  4502. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan fgfr inhibitor arq 087
    n1=Okihiro (syndrome de) | n2=en:pan fgfr inhibitor arq 087 | rel=r_associated | relid=0 | w=10
  4503. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan fgfr inhibitor prn1371
    n1=Okihiro (syndrome de) | n2=en:pan fgfr inhibitor prn1371 | rel=r_associated | relid=0 | w=10
  4504. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan fgfr kinase inhibitor bgj398
    n1=Okihiro (syndrome de) | n2=en:pan fgfr kinase inhibitor bgj398 | rel=r_associated | relid=0 | w=10
  4505. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan her/vegfr2 receptor tyrosine kinase inhibitor bms-690514
    n1=Okihiro (syndrome de) | n2=en:pan her/vegfr2 receptor tyrosine kinase inhibitor bms-690514 | rel=r_associated | relid=0 | w=10
  4506. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-akt inhibitor arq751
    n1=Okihiro (syndrome de) | n2=en:pan-akt inhibitor arq751 | rel=r_associated | relid=0 | w=10
  4507. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-akt kinase inhibitor gsk690693
    n1=Okihiro (syndrome de) | n2=en:pan-akt kinase inhibitor gsk690693 | rel=r_associated | relid=0 | w=10
  4508. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-fgfr tyrosine kinase inhibitor bay1163877
    n1=Okihiro (syndrome de) | n2=en:pan-fgfr tyrosine kinase inhibitor bay1163877 | rel=r_associated | relid=0 | w=10
  4509. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-fgfr tyrosine kinase inhibitor jnj-42756493
    n1=Okihiro (syndrome de) | n2=en:pan-fgfr tyrosine kinase inhibitor jnj-42756493 | rel=r_associated | relid=0 | w=10
  4510. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-her kinase inhibitor ac480
    n1=Okihiro (syndrome de) | n2=en:pan-her kinase inhibitor ac480 | rel=r_associated | relid=0 | w=10
  4511. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-idh mutant inhibitor ag-881
    n1=Okihiro (syndrome de) | n2=en:pan-idh mutant inhibitor ag-881 | rel=r_associated | relid=0 | w=10
  4512. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-pi3k inhibitor clr457
    n1=Okihiro (syndrome de) | n2=en:pan-pi3k inhibitor clr457 | rel=r_associated | relid=0 | w=10
  4513. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-pi3k/mtor inhibitor pqr309
    n1=Okihiro (syndrome de) | n2=en:pan-pi3k/mtor inhibitor pqr309 | rel=r_associated | relid=0 | w=10
  4514. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-pi3k/mtor inhibitor sf1126
    n1=Okihiro (syndrome de) | n2=en:pan-pi3k/mtor inhibitor sf1126 | rel=r_associated | relid=0 | w=10
  4515. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-pim inhibitor incb053914
    n1=Okihiro (syndrome de) | n2=en:pan-pim inhibitor incb053914 | rel=r_associated | relid=0 | w=10
  4516. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-pim kinase inhibitor azd1208
    n1=Okihiro (syndrome de) | n2=en:pan-pim kinase inhibitor azd1208 | rel=r_associated | relid=0 | w=10
  4517. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-raf inhibitor lxh254
    n1=Okihiro (syndrome de) | n2=en:pan-raf inhibitor lxh254 | rel=r_associated | relid=0 | w=10
  4518. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-raf inhibitor ly3009120
    n1=Okihiro (syndrome de) | n2=en:pan-raf inhibitor ly3009120 | rel=r_associated | relid=0 | w=10
  4519. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-raf kinase inhibitor cct3833
    n1=Okihiro (syndrome de) | n2=en:pan-raf kinase inhibitor cct3833 | rel=r_associated | relid=0 | w=10
  4520. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-raf kinase inhibitor tak-580
    n1=Okihiro (syndrome de) | n2=en:pan-raf kinase inhibitor tak-580 | rel=r_associated | relid=0 | w=10
  4521. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-selectin antagonist gmi-1070
    n1=Okihiro (syndrome de) | n2=en:pan-selectin antagonist gmi-1070 | rel=r_associated | relid=0 | w=10
  4522. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pan-vegfr/tie2 tyrosine kinase inhibitor cep-11981
    n1=Okihiro (syndrome de) | n2=en:pan-vegfr/tie2 tyrosine kinase inhibitor cep-11981 | rel=r_associated | relid=0 | w=10
  4523. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:panamesine
    n1=Okihiro (syndrome de) | n2=en:panamesine | rel=r_associated | relid=0 | w=10
  4524. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pancrelipase
    n1=Okihiro (syndrome de) | n2=en:pancrelipase | rel=r_associated | relid=0 | w=10
  4525. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:panitumumab
    n1=Okihiro (syndrome de) | n2=en:panitumumab | rel=r_associated | relid=0 | w=10
  4526. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:panitumumab-irdye800
    n1=Okihiro (syndrome de) | n2=en:panitumumab-irdye800 | rel=r_associated | relid=0 | w=10
  4527. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:panobinostat
    n1=Okihiro (syndrome de) | n2=en:panobinostat | rel=r_associated | relid=0 | w=10
  4528. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pantoprazole sodium
    n1=Okihiro (syndrome de) | n2=en:pantoprazole sodium | rel=r_associated | relid=0 | w=10
  4529. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pantothenic acid
    n1=Okihiro (syndrome de) | n2=en:pantothenic acid | rel=r_associated | relid=0 | w=10
  4530. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:papaverine
    n1=Okihiro (syndrome de) | n2=en:papaverine | rel=r_associated | relid=0 | w=10
  4531. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:parabens and derivatives
    n1=Okihiro (syndrome de) | n2=en:parabens and derivatives | rel=r_associated | relid=0 | w=10
  4532. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paramethadione
    n1=Okihiro (syndrome de) | n2=en:paramethadione | rel=r_associated | relid=0 | w=10
  4533. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:parathyroid hormone-related protein (1-36)
    n1=Okihiro (syndrome de) | n2=en:parathyroid hormone-related protein (1-36) | rel=r_associated | relid=0 | w=10
  4534. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:parecoxib sodium
    n1=Okihiro (syndrome de) | n2=en:parecoxib sodium | rel=r_associated | relid=0 | w=10
  4535. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:parenteral dosage form product
    n1=Okihiro (syndrome de) | n2=en:parenteral dosage form product | rel=r_associated | relid=0 | w=10
  4536. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paricalcitol
    n1=Okihiro (syndrome de) | n2=en:paricalcitol | rel=r_associated | relid=0 | w=10
  4537. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paromomycin sulfate
    n1=Okihiro (syndrome de) | n2=en:paromomycin sulfate | rel=r_associated | relid=0 | w=10
  4538. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paroxetine
    n1=Okihiro (syndrome de) | n2=en:paroxetine | rel=r_associated | relid=0 | w=10
  4539. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:paroxetine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:paroxetine hydrochloride | rel=r_associated | relid=0 | w=10
  4540. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:parp 1/2 inhibitor e7449
    n1=Okihiro (syndrome de) | n2=en:parp 1/2 inhibitor e7449 | rel=r_associated | relid=0 | w=10
  4541. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:parp inhibitor azd2461
    n1=Okihiro (syndrome de) | n2=en:parp inhibitor azd2461 | rel=r_associated | relid=0 | w=10
  4542. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:parp inhibitor bgb-290
    n1=Okihiro (syndrome de) | n2=en:parp inhibitor bgb-290 | rel=r_associated | relid=0 | w=10
  4543. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:parp inhibitor cep-9722
    n1=Okihiro (syndrome de) | n2=en:parp inhibitor cep-9722 | rel=r_associated | relid=0 | w=10
  4544. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:parp inhibitor e7016
    n1=Okihiro (syndrome de) | n2=en:parp inhibitor e7016 | rel=r_associated | relid=0 | w=10
  4545. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:parp-1/2 inhibitor abt-767
    n1=Okihiro (syndrome de) | n2=en:parp-1/2 inhibitor abt-767 | rel=r_associated | relid=0 | w=10
  4546. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:parsatuzumab
    n1=Okihiro (syndrome de) | n2=en:parsatuzumab | rel=r_associated | relid=0 | w=10
  4547. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:parvovirus h-1
    n1=Okihiro (syndrome de) | n2=en:parvovirus h-1 | rel=r_associated | relid=0 | w=10
  4548. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pasireotide
    n1=Okihiro (syndrome de) | n2=en:pasireotide | rel=r_associated | relid=0 | w=10
  4549. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:passiflora incarnata extract
    n1=Okihiro (syndrome de) | n2=en:passiflora incarnata extract | rel=r_associated | relid=0 | w=10
  4550. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:patent blue v dye
    n1=Okihiro (syndrome de) | n2=en:patent blue v dye | rel=r_associated | relid=0 | w=10
  4551. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:patient-specific follicular lymphoma-derived anti-idiotype vaccine
    n1=Okihiro (syndrome de) | n2=en:patient-specific follicular lymphoma-derived anti-idiotype vaccine | rel=r_associated | relid=0 | w=10
  4552. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:patritumab
    n1=Okihiro (syndrome de) | n2=en:patritumab | rel=r_associated | relid=0 | w=10
  4553. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:patupilone
    n1=Okihiro (syndrome de) | n2=en:patupilone | rel=r_associated | relid=0 | w=10
  4554. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pazopanib hydrochloride
    n1=Okihiro (syndrome de) | n2=en:pazopanib hydrochloride | rel=r_associated | relid=0 | w=10
  4555. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pbcar3 phosphopeptide-tetanus peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:pbcar3 phosphopeptide-tetanus peptide vaccine | rel=r_associated | relid=0 | w=10
  4556. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pbcar3/pirs2-phosphopeptide-tetanus peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:pbcar3/pirs2-phosphopeptide-tetanus peptide vaccine | rel=r_associated | relid=0 | w=10
  4557. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pbi-shrna stmn1 lipoplex
    n1=Okihiro (syndrome de) | n2=en:pbi-shrna stmn1 lipoplex | rel=r_associated | relid=0 | w=10
  4558. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pbn derivative okn-007
    n1=Okihiro (syndrome de) | n2=en:pbn derivative okn-007 | rel=r_associated | relid=0 | w=10
  4559. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pbtl cd19car-28 zeta
    n1=Okihiro (syndrome de) | n2=en:pbtl cd19car-28 zeta | rel=r_associated | relid=0 | w=10
  4560. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pc-spes
    n1=Okihiro (syndrome de) | n2=en:pc-spes | rel=r_associated | relid=0 | w=10
  4561. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pcnu
    n1=Okihiro (syndrome de) | n2=en:pcnu | rel=r_associated | relid=0 | w=10
  4562. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pcv regimen
    n1=Okihiro (syndrome de) | n2=en:pcv regimen | rel=r_associated | relid=0 | w=10
  4563. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pd l 506
    n1=Okihiro (syndrome de) | n2=en:pd l 506 | rel=r_associated | relid=0 | w=10
  4564. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pd0325901
    n1=Okihiro (syndrome de) | n2=en:pd0325901 | rel=r_associated | relid=0 | w=10
  4565. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pdcd-1 knockout autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:pdcd-1 knockout autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  4566. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pdgfr alpha/kit mutant-specific inhibitor blu-285
    n1=Okihiro (syndrome de) | n2=en:pdgfr alpha/kit mutant-specific inhibitor blu-285 | rel=r_associated | relid=0 | w=10
  4567. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pdk1 inhibitor ar-12
    n1=Okihiro (syndrome de) | n2=en:pdk1 inhibitor ar-12 | rel=r_associated | relid=0 | w=10
  4568. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pdm08
    n1=Okihiro (syndrome de) | n2=en:pdm08 | rel=r_associated | relid=0 | w=10
  4569. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pe/hpv16 e7/kdel fusion protein tvgv-1
    n1=Okihiro (syndrome de) | n2=en:pe/hpv16 e7/kdel fusion protein tvgv-1 | rel=r_associated | relid=0 | w=10
  4570. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pediatric nutritional supplement drink
    n1=Okihiro (syndrome de) | n2=en:pediatric nutritional supplement drink | rel=r_associated | relid=0 | w=10
  4571. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pediatric terminology
    n1=Okihiro (syndrome de) | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=10
  4572. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pedicle of vertebral arch
    n1=Okihiro (syndrome de) | n2=en:pedicle of vertebral arch | rel=r_associated | relid=0 | w=10
  4573. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pefloxacin
    n1=Okihiro (syndrome de) | n2=en:pefloxacin | rel=r_associated | relid=0 | w=10
  4574. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peg recombinant human megakaryocyte growth and development factor
    n1=Okihiro (syndrome de) | n2=en:peg recombinant human megakaryocyte growth and development factor | rel=r_associated | relid=0 | w=10
  4575. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peg-3350/sodium sulfate/sodium chloride/potassium chloride/sodium ascorbate/ascorbic acid-based laxative
    n1=Okihiro (syndrome de) | n2=en:peg-3350/sodium sulfate/sodium chloride/potassium chloride/sodium ascorbate/ascorbic acid-based laxative | rel=r_associated | relid=0 | w=10
  4576. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peg-based laxative ner1006
    n1=Okihiro (syndrome de) | n2=en:peg-based laxative ner1006 | rel=r_associated | relid=0 | w=10
  4577. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peg-interleukin-2
    n1=Okihiro (syndrome de) | n2=en:peg-interleukin-2 | rel=r_associated | relid=0 | w=10
  4578. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peg-linked l-rna oligonucleotide hepcidin-targeting agent nox-h94
    n1=Okihiro (syndrome de) | n2=en:peg-linked l-rna oligonucleotide hepcidin-targeting agent nox-h94 | rel=r_associated | relid=0 | w=10
  4579. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peg-pei-cholesterol lipopolymer-encased il-12 dna plasmid vector gen-1
    n1=Okihiro (syndrome de) | n2=en:peg-pei-cholesterol lipopolymer-encased il-12 dna plasmid vector gen-1 | rel=r_associated | relid=0 | w=10
  4580. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peg-proline-interferon alfa-2b
    n1=Okihiro (syndrome de) | n2=en:peg-proline-interferon alfa-2b | rel=r_associated | relid=0 | w=10
  4581. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegamotecan
    n1=Okihiro (syndrome de) | n2=en:pegamotecan | rel=r_associated | relid=0 | w=10
  4582. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegaspargase
    n1=Okihiro (syndrome de) | n2=en:pegaspargase | rel=r_associated | relid=0 | w=10
  4583. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegdinetanib
    n1=Okihiro (syndrome de) | n2=en:pegdinetanib | rel=r_associated | relid=0 | w=10
  4584. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegfilgrastim
    n1=Okihiro (syndrome de) | n2=en:pegfilgrastim | rel=r_associated | relid=0 | w=10
  4585. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegfilgrastim anti-neutropenic factor
    n1=Okihiro (syndrome de) | n2=en:pegfilgrastim anti-neutropenic factor | rel=r_associated | relid=0 | w=10
  4586. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegfilgrastim biosimilar la-ep2006
    n1=Okihiro (syndrome de) | n2=en:pegfilgrastim biosimilar la-ep2006 | rel=r_associated | relid=0 | w=10
  4587. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peginesatide
    n1=Okihiro (syndrome de) | n2=en:peginesatide | rel=r_associated | relid=0 | w=10
  4588. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peginterferon alfa-2a
    n1=Okihiro (syndrome de) | n2=en:peginterferon alfa-2a | rel=r_associated | relid=0 | w=10
  4589. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peginterferon alfa-2b
    n1=Okihiro (syndrome de) | n2=en:peginterferon alfa-2b | rel=r_associated | relid=0 | w=10
  4590. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegol sihematide
    n1=Okihiro (syndrome de) | n2=en:pegol sihematide | rel=r_associated | relid=0 | w=10
  4591. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegvisomant
    n1=Okihiro (syndrome de) | n2=en:pegvisomant | rel=r_associated | relid=0 | w=10
  4592. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated anti-gfr antibody fragment
    n1=Okihiro (syndrome de) | n2=en:pegylated anti-gfr antibody fragment | rel=r_associated | relid=0 | w=10
  4593. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated arginine deiminase
    n1=Okihiro (syndrome de) | n2=en:pegylated arginine deiminase | rel=r_associated | relid=0 | w=10
  4594. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated granulocyte colony stimulating factor maxy-g34
    n1=Okihiro (syndrome de) | n2=en:pegylated granulocyte colony stimulating factor maxy-g34 | rel=r_associated | relid=0 | w=10
  4595. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated human recombinant arginase 1 aeb1102
    n1=Okihiro (syndrome de) | n2=en:pegylated human recombinant arginase 1 aeb1102 | rel=r_associated | relid=0 | w=10
  4596. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated interferon alfa
    n1=Okihiro (syndrome de) | n2=en:pegylated interferon alfa | rel=r_associated | relid=0 | w=10
  4597. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated irinotecan
    n1=Okihiro (syndrome de) | n2=en:pegylated irinotecan | rel=r_associated | relid=0 | w=10
  4598. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated liposomal belotecan
    n1=Okihiro (syndrome de) | n2=en:pegylated liposomal belotecan | rel=r_associated | relid=0 | w=10
  4599. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated liposomal doxorubicin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:pegylated liposomal doxorubicin hydrochloride | rel=r_associated | relid=0 | w=10
  4600. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated liposomal irinotecan
    n1=Okihiro (syndrome de) | n2=en:pegylated liposomal irinotecan | rel=r_associated | relid=0 | w=10
  4601. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated liposomal mitomycin c lipid-based prodrug
    n1=Okihiro (syndrome de) | n2=en:pegylated liposomal mitomycin c lipid-based prodrug | rel=r_associated | relid=0 | w=10
  4602. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated liposomal nanoparticle-based docetaxel prodrug mnk-010
    n1=Okihiro (syndrome de) | n2=en:pegylated liposomal nanoparticle-based docetaxel prodrug mnk-010 | rel=r_associated | relid=0 | w=10
  4603. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated paclitaxel
    n1=Okihiro (syndrome de) | n2=en:pegylated paclitaxel | rel=r_associated | relid=0 | w=10
  4604. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated recombinant human arginase i bct-100
    n1=Okihiro (syndrome de) | n2=en:pegylated recombinant human arginase i bct-100 | rel=r_associated | relid=0 | w=10
  4605. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated recombinant human hyaluronidase ph20
    n1=Okihiro (syndrome de) | n2=en:pegylated recombinant human hyaluronidase ph20 | rel=r_associated | relid=0 | w=10
  4606. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated recombinant human interleukin-10 am0010
    n1=Okihiro (syndrome de) | n2=en:pegylated recombinant human interleukin-10 am0010 | rel=r_associated | relid=0 | w=10
  4607. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pegylated recombinant l-asparaginase erwinia chrysanthemi
    n1=Okihiro (syndrome de) | n2=en:pegylated recombinant l-asparaginase erwinia chrysanthemi | rel=r_associated | relid=0 | w=10
  4608. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peldesine
    n1=Okihiro (syndrome de) | n2=en:peldesine | rel=r_associated | relid=0 | w=10
  4609. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pelitinib
    n1=Okihiro (syndrome de) | n2=en:pelitinib | rel=r_associated | relid=0 | w=10
  4610. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pelitrexol
    n1=Okihiro (syndrome de) | n2=en:pelitrexol | rel=r_associated | relid=0 | w=10
  4611. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pelvic curve
    n1=Okihiro (syndrome de) | n2=en:pelvic curve | rel=r_associated | relid=0 | w=10
  4612. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pembrolizumab
    n1=Okihiro (syndrome de) | n2=en:pembrolizumab | rel=r_associated | relid=0 | w=10
  4613. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pemetrexed disodium
    n1=Okihiro (syndrome de) | n2=en:pemetrexed disodium | rel=r_associated | relid=0 | w=10
  4614. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pemoline
    n1=Okihiro (syndrome de) | n2=en:pemoline | rel=r_associated | relid=0 | w=10
  4615. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:penberol
    n1=Okihiro (syndrome de) | n2=en:penberol | rel=r_associated | relid=0 | w=10
  4616. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:penclomedine
    n1=Okihiro (syndrome de) | n2=en:penclomedine | rel=r_associated | relid=0 | w=10
  4617. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:penicillamine
    n1=Okihiro (syndrome de) | n2=en:penicillamine | rel=r_associated | relid=0 | w=10
  4618. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:penicillin v potassium
    n1=Okihiro (syndrome de) | n2=en:penicillin v potassium | rel=r_associated | relid=0 | w=10
  4619. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pentagastrin
    n1=Okihiro (syndrome de) | n2=en:pentagastrin | rel=r_associated | relid=0 | w=10
  4620. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pentamethylmelamine
    n1=Okihiro (syndrome de) | n2=en:pentamethylmelamine | rel=r_associated | relid=0 | w=10
  4621. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pentamidine
    n1=Okihiro (syndrome de) | n2=en:pentamidine | rel=r_associated | relid=0 | w=10
  4622. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pentamidine isethionate
    n1=Okihiro (syndrome de) | n2=en:pentamidine isethionate | rel=r_associated | relid=0 | w=10
  4623. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pentavalent klh conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:pentavalent klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  4624. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pentazocine and derivatives
    n1=Okihiro (syndrome de) | n2=en:pentazocine and derivatives | rel=r_associated | relid=0 | w=10
  4625. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pentetic acid
    n1=Okihiro (syndrome de) | n2=en:pentetic acid | rel=r_associated | relid=0 | w=10
  4626. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pentetic acid calcium
    n1=Okihiro (syndrome de) | n2=en:pentetic acid calcium | rel=r_associated | relid=0 | w=10
  4627. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pentetreotide
    n1=Okihiro (syndrome de) | n2=en:pentetreotide | rel=r_associated | relid=0 | w=10
  4628. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pentiapine maleate
    n1=Okihiro (syndrome de) | n2=en:pentiapine maleate | rel=r_associated | relid=0 | w=10
  4629. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pentosan polysulfate sodium
    n1=Okihiro (syndrome de) | n2=en:pentosan polysulfate sodium | rel=r_associated | relid=0 | w=10
  4630. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pentostatin
    n1=Okihiro (syndrome de) | n2=en:pentostatin | rel=r_associated | relid=0 | w=10
  4631. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pentoxifylline
    n1=Okihiro (syndrome de) | n2=en:pentoxifylline | rel=r_associated | relid=0 | w=10
  4632. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pentoxyverine
    n1=Okihiro (syndrome de) | n2=en:pentoxyverine | rel=r_associated | relid=0 | w=10
  4633. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pep-3-klh conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:pep-3-klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  4634. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pep-cmv vaccine
    n1=Okihiro (syndrome de) | n2=en:pep-cmv vaccine | rel=r_associated | relid=0 | w=10
  4635. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peplomycin
    n1=Okihiro (syndrome de) | n2=en:peplomycin | rel=r_associated | relid=0 | w=10
  4636. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peptichemio
    n1=Okihiro (syndrome de) | n2=en:peptichemio | rel=r_associated | relid=0 | w=10
  4637. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peptide 946 melanoma vaccine
    n1=Okihiro (syndrome de) | n2=en:peptide 946 melanoma vaccine | rel=r_associated | relid=0 | w=10
  4638. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peptide 946-tetanus peptide conjugate melanoma vaccine
    n1=Okihiro (syndrome de) | n2=en:peptide 946-tetanus peptide conjugate melanoma vaccine | rel=r_associated | relid=0 | w=10
  4639. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peptides hydrolases
    n1=Okihiro (syndrome de) | n2=en:peptides hydrolases | rel=r_associated | relid=0 | w=10
  4640. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:perampanel
    n1=Okihiro (syndrome de) | n2=en:perampanel | rel=r_associated | relid=0 | w=10
  4641. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:peretinoin
    n1=Okihiro (syndrome de) | n2=en:peretinoin | rel=r_associated | relid=0 | w=10
  4642. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:perflenapent emulsion
    n1=Okihiro (syndrome de) | n2=en:perflenapent emulsion | rel=r_associated | relid=0 | w=10
  4643. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:perflubron
    n1=Okihiro (syndrome de) | n2=en:perflubron | rel=r_associated | relid=0 | w=10
  4644. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:perflubutane
    n1=Okihiro (syndrome de) | n2=en:perflubutane | rel=r_associated | relid=0 | w=10
  4645. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:perflutren
    n1=Okihiro (syndrome de) | n2=en:perflutren | rel=r_associated | relid=0 | w=10
  4646. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:perflutren lipid microspheres
    n1=Okihiro (syndrome de) | n2=en:perflutren lipid microspheres | rel=r_associated | relid=0 | w=10
  4647. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:perflutren protein-type a microspheres
    n1=Okihiro (syndrome de) | n2=en:perflutren protein-type a microspheres | rel=r_associated | relid=0 | w=10
  4648. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:perfosfamide
    n1=Okihiro (syndrome de) | n2=en:perfosfamide | rel=r_associated | relid=0 | w=10
  4649. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:periciazine
    n1=Okihiro (syndrome de) | n2=en:periciazine | rel=r_associated | relid=0 | w=10
  4650. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:perifosine
    n1=Okihiro (syndrome de) | n2=en:perifosine | rel=r_associated | relid=0 | w=10
  4651. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:perillyl alcohol
    n1=Okihiro (syndrome de) | n2=en:perillyl alcohol | rel=r_associated | relid=0 | w=10
  4652. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:perimetazine
    n1=Okihiro (syndrome de) | n2=en:perimetazine | rel=r_associated | relid=0 | w=10
  4653. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:perindopril erbumine
    n1=Okihiro (syndrome de) | n2=en:perindopril erbumine | rel=r_associated | relid=0 | w=10
  4654. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:periosteum of proximal epiphysis of ulna
    n1=Okihiro (syndrome de) | n2=en:periosteum of proximal epiphysis of ulna | rel=r_associated | relid=0 | w=10
  4655. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:perphenazine
    n1=Okihiro (syndrome de) | n2=en:perphenazine | rel=r_associated | relid=0 | w=10
  4656. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:persic oil
    n1=Okihiro (syndrome de) | n2=en:persic oil | rel=r_associated | relid=0 | w=10
  4657. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:personalized polyepitope plasmid dna breast cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:personalized polyepitope plasmid dna breast cancer vaccine | rel=r_associated | relid=0 | w=10
  4658. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:personalized synthetic long peptide breast cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:personalized synthetic long peptide breast cancer vaccine | rel=r_associated | relid=0 | w=10
  4659. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pertussis vaccine
    n1=Okihiro (syndrome de) | n2=en:pertussis vaccine | rel=r_associated | relid=0 | w=10
  4660. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pertuzumab
    n1=Okihiro (syndrome de) | n2=en:pertuzumab | rel=r_associated | relid=0 | w=10
  4661. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pesticide
    n1=Okihiro (syndrome de) | n2=en:pesticide | rel=r_associated | relid=0 | w=10
  4662. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:petrolatum-mineral oil-lanolin-ceresin ointment
    n1=Okihiro (syndrome de) | n2=en:petrolatum-mineral oil-lanolin-ceresin ointment | rel=r_associated | relid=0 | w=10
  4663. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:petrous apex
    n1=Okihiro (syndrome de) | n2=en:petrous apex | rel=r_associated | relid=0 | w=10
  4664. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pevonedistat
    n1=Okihiro (syndrome de) | n2=en:pevonedistat | rel=r_associated | relid=0 | w=10
  4665. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pexastimogene-devacirepvec
    n1=Okihiro (syndrome de) | n2=en:pexastimogene-devacirepvec | rel=r_associated | relid=0 | w=10
  4666. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pexidartinib
    n1=Okihiro (syndrome de) | n2=en:pexidartinib | rel=r_associated | relid=0 | w=10
  4667. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pg13-cd19-h3 (anti-cd19 car) retroviral vector-transduced peripheral blood lymphocytes
    n1=Okihiro (syndrome de) | n2=en:pg13-cd19-h3 (anti-cd19 car) retroviral vector-transduced peripheral blood lymphocytes | rel=r_associated | relid=0 | w=10
  4668. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pgg beta-glucan
    n1=Okihiro (syndrome de) | n2=en:pgg beta-glucan | rel=r_associated | relid=0 | w=10
  4669. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pgla/peg copolymer-based paclitaxel
    n1=Okihiro (syndrome de) | n2=en:pgla/peg copolymer-based paclitaxel | rel=r_associated | relid=0 | w=10
  4670. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ph20 hyaluronidase-expressing adenovirus vcn-01
    n1=Okihiro (syndrome de) | n2=en:ph20 hyaluronidase-expressing adenovirus vcn-01 | rel=r_associated | relid=0 | w=10
  4671. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phaleria macrocarpa extract dlbs-1425
    n1=Okihiro (syndrome de) | n2=en:phaleria macrocarpa extract dlbs-1425 | rel=r_associated | relid=0 | w=10
  4672. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pharmaceutic aids
    n1=Okihiro (syndrome de) | n2=en:pharmaceutic aids | rel=r_associated | relid=0 | w=10
  4673. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pharmaceutical base or inactive agent
    n1=Okihiro (syndrome de) | n2=en:pharmaceutical base or inactive agent | rel=r_associated | relid=0 | w=10
  4674. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pharmaceutical dosage form
    n1=Okihiro (syndrome de) | n2=en:pharmaceutical dosage form | rel=r_associated | relid=0 | w=10
  4675. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pharmaceutical fluid or solution agent
    n1=Okihiro (syndrome de) | n2=en:pharmaceutical fluid or solution agent | rel=r_associated | relid=0 | w=10
  4676. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pharmaceutical preparations, dental
    n1=Okihiro (syndrome de) | n2=en:pharmaceutical preparations, dental | rel=r_associated | relid=0 | w=10
  4677. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phellodendron amurense bark extract
    n1=Okihiro (syndrome de) | n2=en:phellodendron amurense bark extract | rel=r_associated | relid=0 | w=10
  4678. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenacemide
    n1=Okihiro (syndrome de) | n2=en:phenacemide | rel=r_associated | relid=0 | w=10
  4679. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenazepam
    n1=Okihiro (syndrome de) | n2=en:phenazepam | rel=r_associated | relid=0 | w=10
  4680. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenazopyridine
    n1=Okihiro (syndrome de) | n2=en:phenazopyridine | rel=r_associated | relid=0 | w=10
  4681. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenelzine sulfate
    n1=Okihiro (syndrome de) | n2=en:phenelzine sulfate | rel=r_associated | relid=0 | w=10
  4682. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenesterin
    n1=Okihiro (syndrome de) | n2=en:phenesterin | rel=r_associated | relid=0 | w=10
  4683. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenethyl isothiocyanate
    n1=Okihiro (syndrome de) | n2=en:phenethyl isothiocyanate | rel=r_associated | relid=0 | w=10
  4684. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenethyl isothiocyanate-containing watercress juice
    n1=Okihiro (syndrome de) | n2=en:phenethyl isothiocyanate-containing watercress juice | rel=r_associated | relid=0 | w=10
  4685. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenformin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:phenformin hydrochloride | rel=r_associated | relid=0 | w=10
  4686. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenobarbital
    n1=Okihiro (syndrome de) | n2=en:phenobarbital | rel=r_associated | relid=0 | w=10
  4687. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenol
    n1=Okihiro (syndrome de) | n2=en:phenol | rel=r_associated | relid=0 | w=10
  4688. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenothiazine
    n1=Okihiro (syndrome de) | n2=en:phenothiazine | rel=r_associated | relid=0 | w=10
  4689. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenothiazine derivatives
    n1=Okihiro (syndrome de) | n2=en:phenothiazine derivatives | rel=r_associated | relid=0 | w=10
  4690. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenothiazine tranquilizers
    n1=Okihiro (syndrome de) | n2=en:phenothiazine tranquilizers | rel=r_associated | relid=0 | w=10
  4691. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenothiazine/related antipsychotics
    n1=Okihiro (syndrome de) | n2=en:phenothiazine/related antipsychotics | rel=r_associated | relid=0 | w=10
  4692. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenoxybenzamine
    n1=Okihiro (syndrome de) | n2=en:phenoxybenzamine | rel=r_associated | relid=0 | w=10
  4693. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenoxybenzamine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:phenoxybenzamine hydrochloride | rel=r_associated | relid=0 | w=10
  4694. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenprocoumon
    n1=Okihiro (syndrome de) | n2=en:phenprocoumon | rel=r_associated | relid=0 | w=10
  4695. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phentolamine mesylate
    n1=Okihiro (syndrome de) | n2=en:phentolamine mesylate | rel=r_associated | relid=0 | w=10
  4696. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenyl acetate
    n1=Okihiro (syndrome de) | n2=en:phenyl acetate | rel=r_associated | relid=0 | w=10
  4697. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenylalkylamine
    n1=Okihiro (syndrome de) | n2=en:phenylalkylamine | rel=r_associated | relid=0 | w=10
  4698. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenylbutylpiperadine derivative antipsychotic agent
    n1=Okihiro (syndrome de) | n2=en:phenylbutylpiperadine derivative antipsychotic agent | rel=r_associated | relid=0 | w=10
  4699. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenylheptylamine derivative
    n1=Okihiro (syndrome de) | n2=en:phenylheptylamine derivative | rel=r_associated | relid=0 | w=10
  4700. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenylpiperazine antidepressant
    n1=Okihiro (syndrome de) | n2=en:phenylpiperazine antidepressant | rel=r_associated | relid=0 | w=10
  4701. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phenyltriazine derivative anticonvulsant
    n1=Okihiro (syndrome de) | n2=en:phenyltriazine derivative anticonvulsant | rel=r_associated | relid=0 | w=10
  4702. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phosphaplatin pt-112
    n1=Okihiro (syndrome de) | n2=en:phosphaplatin pt-112 | rel=r_associated | relid=0 | w=10
  4703. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phosphatidylcholine-bound silybin
    n1=Okihiro (syndrome de) | n2=en:phosphatidylcholine-bound silybin | rel=r_associated | relid=0 | w=10
  4704. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phosphomannopentaose sulfate
    n1=Okihiro (syndrome de) | n2=en:phosphomannopentaose sulfate | rel=r_associated | relid=0 | w=10
  4705. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phosphorodiamidate morpholino oligomer avi-4126
    n1=Okihiro (syndrome de) | n2=en:phosphorodiamidate morpholino oligomer avi-4126 | rel=r_associated | relid=0 | w=10
  4706. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phosphorus p-32
    n1=Okihiro (syndrome de) | n2=en:phosphorus p-32 | rel=r_associated | relid=0 | w=10
  4707. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:photocyanine
    n1=Okihiro (syndrome de) | n2=en:photocyanine | rel=r_associated | relid=0 | w=10
  4708. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:photosensitizer luz 11
    n1=Okihiro (syndrome de) | n2=en:photosensitizer luz 11 | rel=r_associated | relid=0 | w=10
  4709. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:photosensitizing agent
    n1=Okihiro (syndrome de) | n2=en:photosensitizing agent | rel=r_associated | relid=0 | w=10
  4710. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phytochemical
    n1=Okihiro (syndrome de) | n2=en:phytochemical | rel=r_associated | relid=0 | w=10
  4711. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phytochlorin sodium-polyvinylpyrrolidone complex
    n1=Okihiro (syndrome de) | n2=en:phytochlorin sodium-polyvinylpyrrolidone complex | rel=r_associated | relid=0 | w=10
  4712. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:phytonadione
    n1=Okihiro (syndrome de) | n2=en:phytonadione | rel=r_associated | relid=0 | w=10
  4713. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k alpha inhibitor mln1117
    n1=Okihiro (syndrome de) | n2=en:pi3k alpha inhibitor mln1117 | rel=r_associated | relid=0 | w=10
  4714. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k alpha/beta inhibitor bay1082439
    n1=Okihiro (syndrome de) | n2=en:pi3k alpha/beta inhibitor bay1082439 | rel=r_associated | relid=0 | w=10
  4715. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k alpha/mtor inhibitor pwt33597 mesylate
    n1=Okihiro (syndrome de) | n2=en:pi3k alpha/mtor inhibitor pwt33597 mesylate | rel=r_associated | relid=0 | w=10
  4716. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k delta/gamma inhibitor ipi-145
    n1=Okihiro (syndrome de) | n2=en:pi3k delta/gamma inhibitor ipi-145 | rel=r_associated | relid=0 | w=10
  4717. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k delta/gamma inhibitor rp6530
    n1=Okihiro (syndrome de) | n2=en:pi3k delta/gamma inhibitor rp6530 | rel=r_associated | relid=0 | w=10
  4718. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k family kinase inhibitor xl147
    n1=Okihiro (syndrome de) | n2=en:pi3k family kinase inhibitor xl147 | rel=r_associated | relid=0 | w=10
  4719. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k inhibitor acp-319
    n1=Okihiro (syndrome de) | n2=en:pi3k inhibitor acp-319 | rel=r_associated | relid=0 | w=10
  4720. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k inhibitor bgt226
    n1=Okihiro (syndrome de) | n2=en:pi3k inhibitor bgt226 | rel=r_associated | relid=0 | w=10
  4721. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k inhibitor ch5132799
    n1=Okihiro (syndrome de) | n2=en:pi3k inhibitor ch5132799 | rel=r_associated | relid=0 | w=10
  4722. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k inhibitor gdc-0084
    n1=Okihiro (syndrome de) | n2=en:pi3k inhibitor gdc-0084 | rel=r_associated | relid=0 | w=10
  4723. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k inhibitor gdc-0941 bismesylate
    n1=Okihiro (syndrome de) | n2=en:pi3k inhibitor gdc-0941 bismesylate | rel=r_associated | relid=0 | w=10
  4724. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k inhibitor gsk1059615
    n1=Okihiro (syndrome de) | n2=en:pi3k inhibitor gsk1059615 | rel=r_associated | relid=0 | w=10
  4725. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k inhibitor gsk2126458
    n1=Okihiro (syndrome de) | n2=en:pi3k inhibitor gsk2126458 | rel=r_associated | relid=0 | w=10
  4726. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k inhibitor px-866
    n1=Okihiro (syndrome de) | n2=en:pi3k inhibitor px-866 | rel=r_associated | relid=0 | w=10
  4727. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k inhibitor wx-037
    n1=Okihiro (syndrome de) | n2=en:pi3k inhibitor wx-037 | rel=r_associated | relid=0 | w=10
  4728. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k inhibitor zstk474
    n1=Okihiro (syndrome de) | n2=en:pi3k inhibitor zstk474 | rel=r_associated | relid=0 | w=10
  4729. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k p110beta/delta inhibitor ka2237
    n1=Okihiro (syndrome de) | n2=en:pi3k p110beta/delta inhibitor ka2237 | rel=r_associated | relid=0 | w=10
  4730. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k-beta inhibitor gsk2636771
    n1=Okihiro (syndrome de) | n2=en:pi3k-beta inhibitor gsk2636771 | rel=r_associated | relid=0 | w=10
  4731. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k-beta inhibitor sar260301
    n1=Okihiro (syndrome de) | n2=en:pi3k-beta inhibitor sar260301 | rel=r_associated | relid=0 | w=10
  4732. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k-delta inhibitor amg 319
    n1=Okihiro (syndrome de) | n2=en:pi3k-delta inhibitor amg 319 | rel=r_associated | relid=0 | w=10
  4733. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k-delta inhibitor incb050465
    n1=Okihiro (syndrome de) | n2=en:pi3k-delta inhibitor incb050465 | rel=r_associated | relid=0 | w=10
  4734. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k-delta inhibitor pwt143
    n1=Okihiro (syndrome de) | n2=en:pi3k-delta inhibitor pwt143 | rel=r_associated | relid=0 | w=10
  4735. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k-delta inhibitor tgr-1202
    n1=Okihiro (syndrome de) | n2=en:pi3k-delta inhibitor tgr-1202 | rel=r_associated | relid=0 | w=10
  4736. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k-gamma inhibitor ipi-549
    n1=Okihiro (syndrome de) | n2=en:pi3k-gamma inhibitor ipi-549 | rel=r_associated | relid=0 | w=10
  4737. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k/hdac inhibitor cudc-907
    n1=Okihiro (syndrome de) | n2=en:pi3k/hdac inhibitor cudc-907 | rel=r_associated | relid=0 | w=10
  4738. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k/mtor inhibitor bez235
    n1=Okihiro (syndrome de) | n2=en:pi3k/mtor inhibitor bez235 | rel=r_associated | relid=0 | w=10
  4739. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k/mtor inhibitor ly3023414
    n1=Okihiro (syndrome de) | n2=en:pi3k/mtor inhibitor ly3023414 | rel=r_associated | relid=0 | w=10
  4740. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k/mtor kinase inhibitor ds-7423
    n1=Okihiro (syndrome de) | n2=en:pi3k/mtor kinase inhibitor ds-7423 | rel=r_associated | relid=0 | w=10
  4741. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k/mtor kinase inhibitor pf-04691502
    n1=Okihiro (syndrome de) | n2=en:pi3k/mtor kinase inhibitor pf-04691502 | rel=r_associated | relid=0 | w=10
  4742. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k/mtor kinase inhibitor vs-5584
    n1=Okihiro (syndrome de) | n2=en:pi3k/mtor kinase inhibitor vs-5584 | rel=r_associated | relid=0 | w=10
  4743. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k/mtor/alk-1/dna-pk inhibitor p7170
    n1=Okihiro (syndrome de) | n2=en:pi3k/mtor/alk-1/dna-pk inhibitor p7170 | rel=r_associated | relid=0 | w=10
  4744. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3k/mtorc1/mtorc2 inhibitor dcbci0901
    n1=Okihiro (syndrome de) | n2=en:pi3k/mtorc1/mtorc2 inhibitor dcbci0901 | rel=r_associated | relid=0 | w=10
  4745. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3ka/mtor inhibitor pki-179
    n1=Okihiro (syndrome de) | n2=en:pi3ka/mtor inhibitor pki-179 | rel=r_associated | relid=0 | w=10
  4746. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3kalpha inhibitor azd8835
    n1=Okihiro (syndrome de) | n2=en:pi3kalpha inhibitor azd8835 | rel=r_associated | relid=0 | w=10
  4747. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3kbeta inhibitor azd8186
    n1=Okihiro (syndrome de) | n2=en:pi3kbeta inhibitor azd8186 | rel=r_associated | relid=0 | w=10
  4748. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3kdelta inhibitor gs-9901
    n1=Okihiro (syndrome de) | n2=en:pi3kdelta inhibitor gs-9901 | rel=r_associated | relid=0 | w=10
  4749. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pi3kdelta inhibitor incb040093
    n1=Okihiro (syndrome de) | n2=en:pi3kdelta inhibitor incb040093 | rel=r_associated | relid=0 | w=10
  4750. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pibenzimol
    n1=Okihiro (syndrome de) | n2=en:pibenzimol | rel=r_associated | relid=0 | w=10
  4751. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pibrozelesin
    n1=Okihiro (syndrome de) | n2=en:pibrozelesin | rel=r_associated | relid=0 | w=10
  4752. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:picibanil
    n1=Okihiro (syndrome de) | n2=en:picibanil | rel=r_associated | relid=0 | w=10
  4753. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:picobenzide
    n1=Okihiro (syndrome de) | n2=en:picobenzide | rel=r_associated | relid=0 | w=10
  4754. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:picoplatin
    n1=Okihiro (syndrome de) | n2=en:picoplatin | rel=r_associated | relid=0 | w=10
  4755. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:picropodophyllin
    n1=Okihiro (syndrome de) | n2=en:picropodophyllin | rel=r_associated | relid=0 | w=10
  4756. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pidilizumab
    n1=Okihiro (syndrome de) | n2=en:pidilizumab | rel=r_associated | relid=0 | w=10
  4757. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pigmenting agent
    n1=Okihiro (syndrome de) | n2=en:pigmenting agent | rel=r_associated | relid=0 | w=10
  4758. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pilocarpine
    n1=Okihiro (syndrome de) | n2=en:pilocarpine | rel=r_associated | relid=0 | w=10
  4759. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pilocarpine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:pilocarpine hydrochloride | rel=r_associated | relid=0 | w=10
  4760. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pim kinase inhibitor lgh447
    n1=Okihiro (syndrome de) | n2=en:pim kinase inhibitor lgh447 | rel=r_associated | relid=0 | w=10
  4761. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pim kinase inhibitor sgi-1776
    n1=Okihiro (syndrome de) | n2=en:pim kinase inhibitor sgi-1776 | rel=r_associated | relid=0 | w=10
  4762. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pimasertib
    n1=Okihiro (syndrome de) | n2=en:pimasertib | rel=r_associated | relid=0 | w=10
  4763. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pimecrolimus
    n1=Okihiro (syndrome de) | n2=en:pimecrolimus | rel=r_associated | relid=0 | w=10
  4764. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pimonidazole
    n1=Okihiro (syndrome de) | n2=en:pimonidazole | rel=r_associated | relid=0 | w=10
  4765. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pimonidazole hydrochloride
    n1=Okihiro (syndrome de) | n2=en:pimonidazole hydrochloride | rel=r_associated | relid=0 | w=10
  4766. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pimozide
    n1=Okihiro (syndrome de) | n2=en:pimozide | rel=r_associated | relid=0 | w=10
  4767. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pinaverium bromide
    n1=Okihiro (syndrome de) | n2=en:pinaverium bromide | rel=r_associated | relid=0 | w=10
  4768. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pinazepam
    n1=Okihiro (syndrome de) | n2=en:pinazepam | rel=r_associated | relid=0 | w=10
  4769. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pioglitazone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:pioglitazone hydrochloride | rel=r_associated | relid=0 | w=10
  4770. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pipendoxifene
    n1=Okihiro (syndrome de) | n2=en:pipendoxifene | rel=r_associated | relid=0 | w=10
  4771. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:piperacetazine
    n1=Okihiro (syndrome de) | n2=en:piperacetazine | rel=r_associated | relid=0 | w=10
  4772. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:piperacillin sodium
    n1=Okihiro (syndrome de) | n2=en:piperacillin sodium | rel=r_associated | relid=0 | w=10
  4773. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:piperacillin-tazobactam
    n1=Okihiro (syndrome de) | n2=en:piperacillin-tazobactam | rel=r_associated | relid=0 | w=10
  4774. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:piperazine
    n1=Okihiro (syndrome de) | n2=en:piperazine | rel=r_associated | relid=0 | w=10
  4775. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:piperazinedione
    n1=Okihiro (syndrome de) | n2=en:piperazinedione | rel=r_associated | relid=0 | w=10
  4776. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:piperine extract (standardized)
    n1=Okihiro (syndrome de) | n2=en:piperine extract (standardized) | rel=r_associated | relid=0 | w=10
  4777. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pipotiazine
    n1=Okihiro (syndrome de) | n2=en:pipotiazine | rel=r_associated | relid=0 | w=10
  4778. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pipotiazine palmitate
    n1=Okihiro (syndrome de) | n2=en:pipotiazine palmitate | rel=r_associated | relid=0 | w=10
  4779. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pirarubicin
    n1=Okihiro (syndrome de) | n2=en:pirarubicin | rel=r_associated | relid=0 | w=10
  4780. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pirfenidone
    n1=Okihiro (syndrome de) | n2=en:pirfenidone | rel=r_associated | relid=0 | w=10
  4781. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:piritramide
    n1=Okihiro (syndrome de) | n2=en:piritramide | rel=r_associated | relid=0 | w=10
  4782. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:piritrexim
    n1=Okihiro (syndrome de) | n2=en:piritrexim | rel=r_associated | relid=0 | w=10
  4783. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pirotinib
    n1=Okihiro (syndrome de) | n2=en:pirotinib | rel=r_associated | relid=0 | w=10
  4784. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:piroxantrone
    n1=Okihiro (syndrome de) | n2=en:piroxantrone | rel=r_associated | relid=0 | w=10
  4785. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:piroxicam
    n1=Okihiro (syndrome de) | n2=en:piroxicam | rel=r_associated | relid=0 | w=10
  4786. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pirs2 phosphopeptide-tetanus peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:pirs2 phosphopeptide-tetanus peptide vaccine | rel=r_associated | relid=0 | w=10
  4787. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pivaloyloxymethylbutyrate
    n1=Okihiro (syndrome de) | n2=en:pivaloyloxymethylbutyrate | rel=r_associated | relid=0 | w=10
  4788. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pivoxazepam
    n1=Okihiro (syndrome de) | n2=en:pivoxazepam | rel=r_associated | relid=0 | w=10
  4789. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pixantrone dimaleate
    n1=Okihiro (syndrome de) | n2=en:pixantrone dimaleate | rel=r_associated | relid=0 | w=10
  4790. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:placebo administration
    n1=Okihiro (syndrome de) | n2=en:placebo administration | rel=r_associated | relid=0 | w=10
  4791. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pladienolide derivative e7107
    n1=Okihiro (syndrome de) | n2=en:pladienolide derivative e7107 | rel=r_associated | relid=0 | w=10
  4792. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:plague vaccine
    n1=Okihiro (syndrome de) | n2=en:plague vaccine | rel=r_associated | relid=0 | w=10
  4793. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:plant extracts
    n1=Okihiro (syndrome de) | n2=en:plant extracts | rel=r_associated | relid=0 | w=10
  4794. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:plant-derived hematopoiesis enhancer pg2
    n1=Okihiro (syndrome de) | n2=en:plant-derived hematopoiesis enhancer pg2 | rel=r_associated | relid=0 | w=10
  4795. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:plasmacytoid dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:plasmacytoid dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  4796. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:plasmid encoding antiangiogenic metargidin peptide
    n1=Okihiro (syndrome de) | n2=en:plasmid encoding antiangiogenic metargidin peptide | rel=r_associated | relid=0 | w=10
  4797. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:platinum and/or platinum compound
    n1=Okihiro (syndrome de) | n2=en:platinum and/or platinum compound | rel=r_associated | relid=0 | w=10
  4798. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:plectin-1 targeting agent ptp-01
    n1=Okihiro (syndrome de) | n2=en:plectin-1 targeting agent ptp-01 | rel=r_associated | relid=0 | w=10
  4799. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pled-based mnsod mimetic
    n1=Okihiro (syndrome de) | n2=en:pled-based mnsod mimetic | rel=r_associated | relid=0 | w=10
  4800. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pleiotropic pathway modifier cc-122 hydrochloride
    n1=Okihiro (syndrome de) | n2=en:pleiotropic pathway modifier cc-122 hydrochloride | rel=r_associated | relid=0 | w=10
  4801. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:plerixafor
    n1=Okihiro (syndrome de) | n2=en:plerixafor | rel=r_associated | relid=0 | w=10
  4802. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:plevitrexed
    n1=Okihiro (syndrome de) | n2=en:plevitrexed | rel=r_associated | relid=0 | w=10
  4803. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:plicamycin
    n1=Okihiro (syndrome de) | n2=en:plicamycin | rel=r_associated | relid=0 | w=10
  4804. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:plinabulin
    n1=Okihiro (syndrome de) | n2=en:plinabulin | rel=r_associated | relid=0 | w=10
  4805. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:plitidepsin
    n1=Okihiro (syndrome de) | n2=en:plitidepsin | rel=r_associated | relid=0 | w=10
  4806. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:plk1 inhibitor tak-960
    n1=Okihiro (syndrome de) | n2=en:plk1 inhibitor tak-960 | rel=r_associated | relid=0 | w=10
  4807. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:plozalizumab
    n1=Okihiro (syndrome de) | n2=en:plozalizumab | rel=r_associated | relid=0 | w=10
  4808. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:plx73086
    n1=Okihiro (syndrome de) | n2=en:plx73086 | rel=r_associated | relid=0 | w=10
  4809. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pm00104
    n1=Okihiro (syndrome de) | n2=en:pm00104 | rel=r_associated | relid=0 | w=10
  4810. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pneumococcal 13-valent conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:pneumococcal 13-valent conjugate vaccine | rel=r_associated | relid=0 | w=10
  4811. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pneumococcal 7-valent conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:pneumococcal 7-valent conjugate vaccine | rel=r_associated | relid=0 | w=10
  4812. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pneumococcal polyvalent vaccine
    n1=Okihiro (syndrome de) | n2=en:pneumococcal polyvalent vaccine | rel=r_associated | relid=0 | w=10
  4813. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pngvl3-hicd vaccine
    n1=Okihiro (syndrome de) | n2=en:pngvl3-hicd vaccine | rel=r_associated | relid=0 | w=10
  4814. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pngvl4a-crt/e7(detox) dna vaccine
    n1=Okihiro (syndrome de) | n2=en:pngvl4a-crt/e7(detox) dna vaccine | rel=r_associated | relid=0 | w=10
  4815. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pngvl4a-sig/e7(detox)/hsp70 dna vaccine
    n1=Okihiro (syndrome de) | n2=en:pngvl4a-sig/e7(detox)/hsp70 dna vaccine | rel=r_associated | relid=0 | w=10
  4816. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pnp-expressing ovine atadenovirus fp253
    n1=Okihiro (syndrome de) | n2=en:pnp-expressing ovine atadenovirus fp253 | rel=r_associated | relid=0 | w=10
  4817. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pol i inhibitor cx5461
    n1=Okihiro (syndrome de) | n2=en:pol i inhibitor cx5461 | rel=r_associated | relid=0 | w=10
  4818. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polaprezinc
    n1=Okihiro (syndrome de) | n2=en:polaprezinc | rel=r_associated | relid=0 | w=10
  4819. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polatuzumab vedotin
    n1=Okihiro (syndrome de) | n2=en:polatuzumab vedotin | rel=r_associated | relid=0 | w=10
  4820. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:policosanol
    n1=Okihiro (syndrome de) | n2=en:policosanol | rel=r_associated | relid=0 | w=10
  4821. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polifeprosan 20 with carmustine implant
    n1=Okihiro (syndrome de) | n2=en:polifeprosan 20 with carmustine implant | rel=r_associated | relid=0 | w=10
  4822. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polihexanide solution
    n1=Okihiro (syndrome de) | n2=en:polihexanide solution | rel=r_associated | relid=0 | w=10
  4823. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polo-like kinase 1 inhibitor gsk461364
    n1=Okihiro (syndrome de) | n2=en:polo-like kinase 1 inhibitor gsk461364 | rel=r_associated | relid=0 | w=10
  4824. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polo-like kinase 1 inhibitor mk1496
    n1=Okihiro (syndrome de) | n2=en:polo-like kinase 1 inhibitor mk1496 | rel=r_associated | relid=0 | w=10
  4825. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polo-like kinase 1 inhibitor nms-1286937
    n1=Okihiro (syndrome de) | n2=en:polo-like kinase 1 inhibitor nms-1286937 | rel=r_associated | relid=0 | w=10
  4826. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polo-like kinase 4 inhibitor cfi-400945 fumarate
    n1=Okihiro (syndrome de) | n2=en:polo-like kinase 4 inhibitor cfi-400945 fumarate | rel=r_associated | relid=0 | w=10
  4827. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:poly au
    n1=Okihiro (syndrome de) | n2=en:poly au | rel=r_associated | relid=0 | w=10
  4828. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:poly ic
    n1=Okihiro (syndrome de) | n2=en:poly ic | rel=r_associated | relid=0 | w=10
  4829. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:poly iclc
    n1=Okihiro (syndrome de) | n2=en:poly iclc | rel=r_associated | relid=0 | w=10
  4830. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:poly-alendronate dextran-guanidine conjugate
    n1=Okihiro (syndrome de) | n2=en:poly-alendronate dextran-guanidine conjugate | rel=r_associated | relid=0 | w=10
  4831. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:poly-gamma glutamic acid
    n1=Okihiro (syndrome de) | n2=en:poly-gamma glutamic acid | rel=r_associated | relid=0 | w=10
  4832. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polyacrylamide hydrogel
    n1=Okihiro (syndrome de) | n2=en:polyacrylamide hydrogel | rel=r_associated | relid=0 | w=10
  4833. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polyamine analogue pg11047
    n1=Okihiro (syndrome de) | n2=en:polyamine analogue pg11047 | rel=r_associated | relid=0 | w=10
  4834. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polycarbophil/carbomer/glycerin/palm oil glyceride/mineral oil-containing vaginal moisturizer
    n1=Okihiro (syndrome de) | n2=en:polycarbophil/carbomer/glycerin/palm oil glyceride/mineral oil-containing vaginal moisturizer | rel=r_associated | relid=0 | w=10
  4835. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polydextrose
    n1=Okihiro (syndrome de) | n2=en:polydextrose | rel=r_associated | relid=0 | w=10
  4836. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polyethylene glycol
    n1=Okihiro (syndrome de) | n2=en:polyethylene glycol | rel=r_associated | relid=0 | w=10
  4837. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polyethylene glycol 3350-containing enema ner1008
    n1=Okihiro (syndrome de) | n2=en:polyethylene glycol 3350-containing enema ner1008 | rel=r_associated | relid=0 | w=10
  4838. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polyethylene glycol polymer surgical sealant
    n1=Okihiro (syndrome de) | n2=en:polyethylene glycol polymer surgical sealant | rel=r_associated | relid=0 | w=10
  4839. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polyethylene glycol recombinant endostatin
    n1=Okihiro (syndrome de) | n2=en:polyethylene glycol recombinant endostatin | rel=r_associated | relid=0 | w=10
  4840. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polyethyleneglycol-7-ethyl-10-hydroxycamptothecin dfp-13318
    n1=Okihiro (syndrome de) | n2=en:polyethyleneglycol-7-ethyl-10-hydroxycamptothecin dfp-13318 | rel=r_associated | relid=0 | w=10
  4841. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polyglutamate camptothecin
    n1=Okihiro (syndrome de) | n2=en:polyglutamate camptothecin | rel=r_associated | relid=0 | w=10
  4842. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polymeric camptothecin prodrug xmt-1001
    n1=Okihiro (syndrome de) | n2=en:polymeric camptothecin prodrug xmt-1001 | rel=r_associated | relid=0 | w=10
  4843. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polymyxin b
    n1=Okihiro (syndrome de) | n2=en:polymyxin b | rel=r_associated | relid=0 | w=10
  4844. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polysaccharide-k
    n1=Okihiro (syndrome de) | n2=en:polysaccharide-k | rel=r_associated | relid=0 | w=10
  4845. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polysorbates
    n1=Okihiro (syndrome de) | n2=en:polysorbates | rel=r_associated | relid=0 | w=10
  4846. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polyunsaturated fatty acid
    n1=Okihiro (syndrome de) | n2=en:polyunsaturated fatty acid | rel=r_associated | relid=0 | w=10
  4847. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polyvalent antigen-klh conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:polyvalent antigen-klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  4848. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polyvalent melanoma vaccine
    n1=Okihiro (syndrome de) | n2=en:polyvalent melanoma vaccine | rel=r_associated | relid=0 | w=10
  4849. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:polyvinylpyrrolidone-sodium hyaluronate gel
    n1=Okihiro (syndrome de) | n2=en:polyvinylpyrrolidone-sodium hyaluronate gel | rel=r_associated | relid=0 | w=10
  4850. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pomalidomide
    n1=Okihiro (syndrome de) | n2=en:pomalidomide | rel=r_associated | relid=0 | w=10
  4851. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pomegranate juice
    n1=Okihiro (syndrome de) | n2=en:pomegranate juice | rel=r_associated | relid=0 | w=10
  4852. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pomegranate liquid extract
    n1=Okihiro (syndrome de) | n2=en:pomegranate liquid extract | rel=r_associated | relid=0 | w=10
  4853. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pomegranate-extract pill
    n1=Okihiro (syndrome de) | n2=en:pomegranate-extract pill | rel=r_associated | relid=0 | w=10
  4854. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ponatinib hydrochloride
    n1=Okihiro (syndrome de) | n2=en:ponatinib hydrochloride | rel=r_associated | relid=0 | w=10
  4855. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ponesimod
    n1=Okihiro (syndrome de) | n2=en:ponesimod | rel=r_associated | relid=0 | w=10
  4856. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:poractant alfa
    n1=Okihiro (syndrome de) | n2=en:poractant alfa | rel=r_associated | relid=0 | w=10
  4857. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:porcine derived substance
    n1=Okihiro (syndrome de) | n2=en:porcine derived substance | rel=r_associated | relid=0 | w=10
  4858. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:porcupine inhibitor etc-1922159
    n1=Okihiro (syndrome de) | n2=en:porcupine inhibitor etc-1922159 | rel=r_associated | relid=0 | w=10
  4859. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:porcupine inhibitor wnt974
    n1=Okihiro (syndrome de) | n2=en:porcupine inhibitor wnt974 | rel=r_associated | relid=0 | w=10
  4860. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:porfimer sodium
    n1=Okihiro (syndrome de) | n2=en:porfimer sodium | rel=r_associated | relid=0 | w=10
  4861. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:porfiromycin
    n1=Okihiro (syndrome de) | n2=en:porfiromycin | rel=r_associated | relid=0 | w=10
  4862. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:porphyrins and derivatives
    n1=Okihiro (syndrome de) | n2=en:porphyrins and derivatives | rel=r_associated | relid=0 | w=10
  4863. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:posaconazole
    n1=Okihiro (syndrome de) | n2=en:posaconazole | rel=r_associated | relid=0 | w=10
  4864. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:posterior foramen magnum
    n1=Okihiro (syndrome de) | n2=en:posterior foramen magnum | rel=r_associated | relid=0 | w=10
  4865. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:potassium-sparing diuretic
    n1=Okihiro (syndrome de) | n2=en:potassium-sparing diuretic | rel=r_associated | relid=0 | w=10
  4866. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:povidone
    n1=Okihiro (syndrome de) | n2=en:povidone | rel=r_associated | relid=0 | w=10
  4867. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:povidone-iodine
    n1=Okihiro (syndrome de) | n2=en:povidone-iodine | rel=r_associated | relid=0 | w=10
  4868. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:poziotinib
    n1=Okihiro (syndrome de) | n2=en:poziotinib | rel=r_associated | relid=0 | w=10
  4869. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ppe-expressing replication-defective hsv-1 vector np2
    n1=Okihiro (syndrome de) | n2=en:ppe-expressing replication-defective hsv-1 vector np2 | rel=r_associated | relid=0 | w=10
  4870. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ppi-2458
    n1=Okihiro (syndrome de) | n2=en:ppi-2458 | rel=r_associated | relid=0 | w=10
  4871. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pr-104
    n1=Okihiro (syndrome de) | n2=en:pr-104 | rel=r_associated | relid=0 | w=10
  4872. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pr1 leukemia peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:pr1 leukemia peptide vaccine | rel=r_associated | relid=0 | w=10
  4873. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pracinostat
    n1=Okihiro (syndrome de) | n2=en:pracinostat | rel=r_associated | relid=0 | w=10
  4874. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pralatrexate
    n1=Okihiro (syndrome de) | n2=en:pralatrexate | rel=r_associated | relid=0 | w=10
  4875. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prame-targeting t-cell receptor/inducible caspase 9 bpx-701
    n1=Okihiro (syndrome de) | n2=en:prame-targeting t-cell receptor/inducible caspase 9 bpx-701 | rel=r_associated | relid=0 | w=10
  4876. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pramipexole dihydrochloride
    n1=Okihiro (syndrome de) | n2=en:pramipexole dihydrochloride | rel=r_associated | relid=0 | w=10
  4877. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pramocaine
    n1=Okihiro (syndrome de) | n2=en:pramocaine | rel=r_associated | relid=0 | w=10
  4878. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prasterone
    n1=Okihiro (syndrome de) | n2=en:prasterone | rel=r_associated | relid=0 | w=10
  4879. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pravastatin sodium
    n1=Okihiro (syndrome de) | n2=en:pravastatin sodium | rel=r_associated | relid=0 | w=10
  4880. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prazepam
    n1=Okihiro (syndrome de) | n2=en:prazepam | rel=r_associated | relid=0 | w=10
  4881. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:preclamol
    n1=Okihiro (syndrome de) | n2=en:preclamol | rel=r_associated | relid=0 | w=10
  4882. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prednimustine
    n1=Okihiro (syndrome de) | n2=en:prednimustine | rel=r_associated | relid=0 | w=10
  4883. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prednisolone
    n1=Okihiro (syndrome de) | n2=en:prednisolone | rel=r_associated | relid=0 | w=10
  4884. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prednisone
    n1=Okihiro (syndrome de) | n2=en:prednisone | rel=r_associated | relid=0 | w=10
  4885. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pregabalin
    n1=Okihiro (syndrome de) | n2=en:pregabalin | rel=r_associated | relid=0 | w=10
  4886. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:preimplantation factor pif-1
    n1=Okihiro (syndrome de) | n2=en:preimplantation factor pif-1 | rel=r_associated | relid=0 | w=10
  4887. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:premazepam
    n1=Okihiro (syndrome de) | n2=en:premazepam | rel=r_associated | relid=0 | w=10
  4888. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prescription drugs
    n1=Okihiro (syndrome de) | n2=en:prescription drugs | rel=r_associated | relid=0 | w=10
  4889. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prexasertib
    n1=Okihiro (syndrome de) | n2=en:prexasertib | rel=r_associated | relid=0 | w=10
  4890. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pridinol
    n1=Okihiro (syndrome de) | n2=en:pridinol | rel=r_associated | relid=0 | w=10
  4891. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prilocaine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:prilocaine hydrochloride | rel=r_associated | relid=0 | w=10
  4892. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prima-1 analog apr-246
    n1=Okihiro (syndrome de) | n2=en:prima-1 analog apr-246 | rel=r_associated | relid=0 | w=10
  4893. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:primary prostate cancer tissue/htert/survivin mrna-loaded autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:primary prostate cancer tissue/htert/survivin mrna-loaded autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  4894. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prinomastat
    n1=Okihiro (syndrome de) | n2=en:prinomastat | rel=r_associated | relid=0 | w=10
  4895. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prinomide tromethamine
    n1=Okihiro (syndrome de) | n2=en:prinomide tromethamine | rel=r_associated | relid=0 | w=10
  4896. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:probenecid
    n1=Okihiro (syndrome de) | n2=en:probenecid | rel=r_associated | relid=0 | w=10
  4897. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:probucol
    n1=Okihiro (syndrome de) | n2=en:probucol | rel=r_associated | relid=0 | w=10
  4898. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:procarbazine
    n1=Okihiro (syndrome de) | n2=en:procarbazine | rel=r_associated | relid=0 | w=10
  4899. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:procarbazine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:procarbazine hydrochloride | rel=r_associated | relid=0 | w=10
  4900. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:procaspase activating compound-1 vo-100
    n1=Okihiro (syndrome de) | n2=en:procaspase activating compound-1 vo-100 | rel=r_associated | relid=0 | w=10
  4901. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prochlorperazine
    n1=Okihiro (syndrome de) | n2=en:prochlorperazine | rel=r_associated | relid=0 | w=10
  4902. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prodrugs
    n1=Okihiro (syndrome de) | n2=en:prodrugs | rel=r_associated | relid=0 | w=10
  4903. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:product bases and inactive substances
    n1=Okihiro (syndrome de) | n2=en:product bases and inactive substances | rel=r_associated | relid=0 | w=10
  4904. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:proflavine
    n1=Okihiro (syndrome de) | n2=en:proflavine | rel=r_associated | relid=0 | w=10
  4905. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:proflavine hemisulfate
    n1=Okihiro (syndrome de) | n2=en:proflavine hemisulfate | rel=r_associated | relid=0 | w=10
  4906. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:proflazepam
    n1=Okihiro (syndrome de) | n2=en:proflazepam | rel=r_associated | relid=0 | w=10
  4907. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:progenipoietin
    n1=Okihiro (syndrome de) | n2=en:progenipoietin | rel=r_associated | relid=0 | w=10
  4908. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:progesterone derivative
    n1=Okihiro (syndrome de) | n2=en:progesterone derivative | rel=r_associated | relid=0 | w=10
  4909. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:progesterone vaginal insert
    n1=Okihiro (syndrome de) | n2=en:progesterone vaginal insert | rel=r_associated | relid=0 | w=10
  4910. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:progestin
    n1=Okihiro (syndrome de) | n2=en:progestin | rel=r_associated | relid=0 | w=10
  4911. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prohibitin-targeting peptide 1
    n1=Okihiro (syndrome de) | n2=en:prohibitin-targeting peptide 1 | rel=r_associated | relid=0 | w=10
  4912. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:proliferant agent
    n1=Okihiro (syndrome de) | n2=en:proliferant agent | rel=r_associated | relid=0 | w=10
  4913. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:promazine
    n1=Okihiro (syndrome de) | n2=en:promazine | rel=r_associated | relid=0 | w=10
  4914. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:promazine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:promazine hydrochloride | rel=r_associated | relid=0 | w=10
  4915. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:promegapoietin
    n1=Okihiro (syndrome de) | n2=en:promegapoietin | rel=r_associated | relid=0 | w=10
  4916. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:promestriene
    n1=Okihiro (syndrome de) | n2=en:promestriene | rel=r_associated | relid=0 | w=10
  4917. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:promethazine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:promethazine hydrochloride | rel=r_associated | relid=0 | w=10
  4918. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pronase oral solution
    n1=Okihiro (syndrome de) | n2=en:pronase oral solution | rel=r_associated | relid=0 | w=10
  4919. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:propacetamol
    n1=Okihiro (syndrome de) | n2=en:propacetamol | rel=r_associated | relid=0 | w=10
  4920. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:propafenone
    n1=Okihiro (syndrome de) | n2=en:propafenone | rel=r_associated | relid=0 | w=10
  4921. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:propiomazine
    n1=Okihiro (syndrome de) | n2=en:propiomazine | rel=r_associated | relid=0 | w=10
  4922. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:propiomazine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:propiomazine hydrochloride | rel=r_associated | relid=0 | w=10
  4923. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:propionylpromazine
    n1=Okihiro (syndrome de) | n2=en:propionylpromazine | rel=r_associated | relid=0 | w=10
  4924. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:propiopromazine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:propiopromazine hydrochloride | rel=r_associated | relid=0 | w=10
  4925. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:propofol
    n1=Okihiro (syndrome de) | n2=en:propofol | rel=r_associated | relid=0 | w=10
  4926. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:propoxyphene
    n1=Okihiro (syndrome de) | n2=en:propoxyphene | rel=r_associated | relid=0 | w=10
  4927. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:propranolol hydrochloride
    n1=Okihiro (syndrome de) | n2=en:propranolol hydrochloride | rel=r_associated | relid=0 | w=10
  4928. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:propylthiouracil
    n1=Okihiro (syndrome de) | n2=en:propylthiouracil | rel=r_associated | relid=0 | w=10
  4929. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prostaglandin
    n1=Okihiro (syndrome de) | n2=en:prostaglandin | rel=r_associated | relid=0 | w=10
  4930. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prostate cancer vaccine ony-p1
    n1=Okihiro (syndrome de) | n2=en:prostate cancer vaccine ony-p1 | rel=r_associated | relid=0 | w=10
  4931. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prostate cancer vaccine pf-06755990
    n1=Okihiro (syndrome de) | n2=en:prostate cancer vaccine pf-06755990 | rel=r_associated | relid=0 | w=10
  4932. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prostate cancer vaccine pf-06755992
    n1=Okihiro (syndrome de) | n2=en:prostate cancer vaccine pf-06755992 | rel=r_associated | relid=0 | w=10
  4933. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prostate health cocktail dietary supplement
    n1=Okihiro (syndrome de) | n2=en:prostate health cocktail dietary supplement | rel=r_associated | relid=0 | w=10
  4934. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prostate tumor antigen-activated autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:prostate tumor antigen-activated autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  4935. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prostatic acid phosphatase-sargramostim fusion protein
    n1=Okihiro (syndrome de) | n2=en:prostatic acid phosphatase-sargramostim fusion protein | rel=r_associated | relid=0 | w=10
  4936. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:protein e7, human papillomavirus type 16
    n1=Okihiro (syndrome de) | n2=en:protein e7, human papillomavirus type 16 | rel=r_associated | relid=0 | w=10
  4937. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:protein kinase c inhibitor lxs196
    n1=Okihiro (syndrome de) | n2=en:protein kinase c inhibitor lxs196 | rel=r_associated | relid=0 | w=10
  4938. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:protein phosphatase 2a inhibitor lb-100
    n1=Okihiro (syndrome de) | n2=en:protein phosphatase 2a inhibitor lb-100 | rel=r_associated | relid=0 | w=10
  4939. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:protein stabilized liposomal docetaxel nanoparticles
    n1=Okihiro (syndrome de) | n2=en:protein stabilized liposomal docetaxel nanoparticles | rel=r_associated | relid=0 | w=10
  4940. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:protein tyrosine kinase 2 inhibitor bi 853520
    n1=Okihiro (syndrome de) | n2=en:protein tyrosine kinase 2 inhibitor bi 853520 | rel=r_associated | relid=0 | w=10
  4941. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prothipendyl
    n1=Okihiro (syndrome de) | n2=en:prothipendyl | rel=r_associated | relid=0 | w=10
  4942. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:prothipendyl hydrochloride
    n1=Okihiro (syndrome de) | n2=en:prothipendyl hydrochloride | rel=r_associated | relid=0 | w=10
  4943. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:protirelin
    n1=Okihiro (syndrome de) | n2=en:protirelin | rel=r_associated | relid=0 | w=10
  4944. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:proton pump inhibitor
    n1=Okihiro (syndrome de) | n2=en:proton pump inhibitor | rel=r_associated | relid=0 | w=10
  4945. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:proximal epiphysis of left ulna
    n1=Okihiro (syndrome de) | n2=en:proximal epiphysis of left ulna | rel=r_associated | relid=0 | w=10
  4946. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:proximal epiphysis of right ulna
    n1=Okihiro (syndrome de) | n2=en:proximal epiphysis of right ulna | rel=r_associated | relid=0 | w=10
  4947. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:proximal epiphysis proper of ulna
    n1=Okihiro (syndrome de) | n2=en:proximal epiphysis proper of ulna | rel=r_associated | relid=0 | w=10
  4948. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:proximal ulnar epiphysis
    n1=Okihiro (syndrome de) | n2=en:proximal ulnar epiphysis | rel=r_associated | relid=0 | w=10
  4949. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:psa rna-pulsed dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:psa rna-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  4950. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:psa-pap/klh-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:psa-pap/klh-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  4951. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:psa:154-163(155l) peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:psa:154-163(155l) peptide vaccine | rel=r_associated | relid=0 | w=10
  4952. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:psa/il-2/gm-csf vaccine
    n1=Okihiro (syndrome de) | n2=en:psa/il-2/gm-csf vaccine | rel=r_associated | relid=0 | w=10
  4953. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:psa/psma dna plasmid ino-5150
    n1=Okihiro (syndrome de) | n2=en:psa/psma dna plasmid ino-5150 | rel=r_associated | relid=0 | w=10
  4954. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pseudomonas aeruginosa preparation
    n1=Okihiro (syndrome de) | n2=en:pseudomonas aeruginosa preparation | rel=r_associated | relid=0 | w=10
  4955. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:psicrip-mfg-s-tk1-67
    n1=Okihiro (syndrome de) | n2=en:psicrip-mfg-s-tk1-67 | rel=r_associated | relid=0 | w=10
  4956. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:psilocybine
    n1=Okihiro (syndrome de) | n2=en:psilocybine | rel=r_associated | relid=0 | w=10
  4957. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:psma-targeted docetaxel nanoparticles bind-014
    n1=Okihiro (syndrome de) | n2=en:psma-targeted docetaxel nanoparticles bind-014 | rel=r_associated | relid=0 | w=10
  4958. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:psma-targeted tubulysin b-containing conjugate ec1169
    n1=Okihiro (syndrome de) | n2=en:psma-targeted tubulysin b-containing conjugate ec1169 | rel=r_associated | relid=0 | w=10
  4959. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:psma/tarp peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:psma/tarp peptide vaccine | rel=r_associated | relid=0 | w=10
  4960. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:psoralen
    n1=Okihiro (syndrome de) | n2=en:psoralen | rel=r_associated | relid=0 | w=10
  4961. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:psychopharmacologic agent
    n1=Okihiro (syndrome de) | n2=en:psychopharmacologic agent | rel=r_associated | relid=0 | w=10
  4962. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:psyllium and derivatives
    n1=Okihiro (syndrome de) | n2=en:psyllium and derivatives | rel=r_associated | relid=0 | w=10
  4963. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ptef-b/cdk9 inhibitor bay1251152
    n1=Okihiro (syndrome de) | n2=en:ptef-b/cdk9 inhibitor bay1251152 | rel=r_associated | relid=0 | w=10
  4964. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ptvg-hp plasmid dna vaccine
    n1=Okihiro (syndrome de) | n2=en:ptvg-hp plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  4965. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pumpkin seed oil
    n1=Okihiro (syndrome de) | n2=en:pumpkin seed oil | rel=r_associated | relid=0 | w=10
  4966. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pumvc3-higfbp-2 multi-epitope plasmid dna vaccine
    n1=Okihiro (syndrome de) | n2=en:pumvc3-higfbp-2 multi-epitope plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  4967. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pumvc3-igfbp2-her2-igf1r plasmid dna vaccine
    n1=Okihiro (syndrome de) | n2=en:pumvc3-igfbp2-her2-igf1r plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  4968. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:purine antagonist
    n1=Okihiro (syndrome de) | n2=en:purine antagonist | rel=r_associated | relid=0 | w=10
  4969. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:purple grape juice
    n1=Okihiro (syndrome de) | n2=en:purple grape juice | rel=r_associated | relid=0 | w=10
  4970. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pv-10
    n1=Okihiro (syndrome de) | n2=en:pv-10 | rel=r_associated | relid=0 | w=10
  4971. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pv701
    n1=Okihiro (syndrome de) | n2=en:pv701 | rel=r_associated | relid=0 | w=10
  4972. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pva microporous hydrospheres
    n1=Okihiro (syndrome de) | n2=en:pva microporous hydrospheres | rel=r_associated | relid=0 | w=10
  4973. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pva microporous hydrospheres/doxorubicin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:pva microporous hydrospheres/doxorubicin hydrochloride | rel=r_associated | relid=0 | w=10
  4974. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pvaxrcpsav53l dna vaccine
    n1=Okihiro (syndrome de) | n2=en:pvaxrcpsav53l dna vaccine | rel=r_associated | relid=0 | w=10
  4975. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyrantel
    n1=Okihiro (syndrome de) | n2=en:pyrantel | rel=r_associated | relid=0 | w=10
  4976. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyrazinamide
    n1=Okihiro (syndrome de) | n2=en:pyrazinamide | rel=r_associated | relid=0 | w=10
  4977. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyrazine diazohydroxide
    n1=Okihiro (syndrome de) | n2=en:pyrazine diazohydroxide | rel=r_associated | relid=0 | w=10
  4978. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyrazofurin
    n1=Okihiro (syndrome de) | n2=en:pyrazofurin | rel=r_associated | relid=0 | w=10
  4979. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyrazole derivative
    n1=Okihiro (syndrome de) | n2=en:pyrazole derivative | rel=r_associated | relid=0 | w=10
  4980. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyrazoloacridine
    n1=Okihiro (syndrome de) | n2=en:pyrazoloacridine | rel=r_associated | relid=0 | w=10
  4981. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyrethrins
    n1=Okihiro (syndrome de) | n2=en:pyrethrins | rel=r_associated | relid=0 | w=10
  4982. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyridoxine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:pyridoxine hydrochloride | rel=r_associated | relid=0 | w=10
  4983. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyridyl cyanoguanidine chs 828
    n1=Okihiro (syndrome de) | n2=en:pyridyl cyanoguanidine chs 828 | rel=r_associated | relid=0 | w=10
  4984. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyrimethamine
    n1=Okihiro (syndrome de) | n2=en:pyrimethamine | rel=r_associated | relid=0 | w=10
  4985. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyrimethamine-sulfadoxine
    n1=Okihiro (syndrome de) | n2=en:pyrimethamine-sulfadoxine | rel=r_associated | relid=0 | w=10
  4986. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyrimidine antagonist
    n1=Okihiro (syndrome de) | n2=en:pyrimidine antagonist | rel=r_associated | relid=0 | w=10
  4987. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyrogen
    n1=Okihiro (syndrome de) | n2=en:pyrogen | rel=r_associated | relid=0 | w=10
  4988. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyrotinib
    n1=Okihiro (syndrome de) | n2=en:pyrotinib | rel=r_associated | relid=0 | w=10
  4989. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyroxamide
    n1=Okihiro (syndrome de) | n2=en:pyroxamide | rel=r_associated | relid=0 | w=10
  4990. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:pyruvate kinase inhibitor tln-232
    n1=Okihiro (syndrome de) | n2=en:pyruvate kinase inhibitor tln-232 | rel=r_associated | relid=0 | w=10
  4991. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:qs21
    n1=Okihiro (syndrome de) | n2=en:qs21 | rel=r_associated | relid=0 | w=10
  4992. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine
    n1=Okihiro (syndrome de) | n2=en:quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine | rel=r_associated | relid=0 | w=10
  4993. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quarfloxin
    n1=Okihiro (syndrome de) | n2=en:quarfloxin | rel=r_associated | relid=0 | w=10
  4994. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quaternary ammonium polyethylenimine nanoparticles
    n1=Okihiro (syndrome de) | n2=en:quaternary ammonium polyethylenimine nanoparticles | rel=r_associated | relid=0 | w=10
  4995. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quazepam
    n1=Okihiro (syndrome de) | n2=en:quazepam | rel=r_associated | relid=0 | w=10
  4996. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quercetin
    n1=Okihiro (syndrome de) | n2=en:quercetin | rel=r_associated | relid=0 | w=10
  4997. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quercus stenophylla extract
    n1=Okihiro (syndrome de) | n2=en:quercus stenophylla extract | rel=r_associated | relid=0 | w=10
  4998. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quetiapine
    n1=Okihiro (syndrome de) | n2=en:quetiapine | rel=r_associated | relid=0 | w=10
  4999. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quetiapine fumarate
    n1=Okihiro (syndrome de) | n2=en:quetiapine fumarate | rel=r_associated | relid=0 | w=10
  5000. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quinacrine
    n1=Okihiro (syndrome de) | n2=en:quinacrine | rel=r_associated | relid=0 | w=10
  5001. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quinacrine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:quinacrine hydrochloride | rel=r_associated | relid=0 | w=10
  5002. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quinagolide
    n1=Okihiro (syndrome de) | n2=en:quinagolide | rel=r_associated | relid=0 | w=10
  5003. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quinidine
    n1=Okihiro (syndrome de) | n2=en:quinidine | rel=r_associated | relid=0 | w=10
  5004. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quinine
    n1=Okihiro (syndrome de) | n2=en:quinine | rel=r_associated | relid=0 | w=10
  5005. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quinoline
    n1=Okihiro (syndrome de) | n2=en:quinoline | rel=r_associated | relid=0 | w=10
  5006. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quinupristin
    n1=Okihiro (syndrome de) | n2=en:quinupristin | rel=r_associated | relid=0 | w=10
  5007. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quisinostat
    n1=Okihiro (syndrome de) | n2=en:quisinostat | rel=r_associated | relid=0 | w=10
  5008. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:quizartinib
    n1=Okihiro (syndrome de) | n2=en:quizartinib | rel=r_associated | relid=0 | w=10
  5009. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:r 7160
    n1=Okihiro (syndrome de) | n2=en:r 7160 | rel=r_associated | relid=0 | w=10
  5010. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:r-(-)-gossypol acetic acid
    n1=Okihiro (syndrome de) | n2=en:r-(-)-gossypol acetic acid | rel=r_associated | relid=0 | w=10
  5011. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:r-chop regimen
    n1=Okihiro (syndrome de) | n2=en:r-chop regimen | rel=r_associated | relid=0 | w=10
  5012. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:r-cvp regimen
    n1=Okihiro (syndrome de) | n2=en:r-cvp regimen | rel=r_associated | relid=0 | w=10
  5013. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:r-epoch regimen
    n1=Okihiro (syndrome de) | n2=en:r-epoch regimen | rel=r_associated | relid=0 | w=10
  5014. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:r-ice regimen
    n1=Okihiro (syndrome de) | n2=en:r-ice regimen | rel=r_associated | relid=0 | w=10
  5015. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:r(+)xk469
    n1=Okihiro (syndrome de) | n2=en:r(+)xk469 | rel=r_associated | relid=0 | w=10
  5016. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:r1 cooling gel plus r2 moisturizing/sun protecting lotion
    n1=Okihiro (syndrome de) | n2=en:r1 cooling gel plus r2 moisturizing/sun protecting lotion | rel=r_associated | relid=0 | w=10
  5017. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rabeprazole sodium
    n1=Okihiro (syndrome de) | n2=en:rabeprazole sodium | rel=r_associated | relid=0 | w=10
  5018. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rabusertib
    n1=Okihiro (syndrome de) | n2=en:rabusertib | rel=r_associated | relid=0 | w=10
  5019. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:raclopride
    n1=Okihiro (syndrome de) | n2=en:raclopride | rel=r_associated | relid=0 | w=10
  5020. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:racotumomab
    n1=Okihiro (syndrome de) | n2=en:racotumomab | rel=r_associated | relid=0 | w=10
  5021. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:radiopharmaceutical agent
    n1=Okihiro (syndrome de) | n2=en:radiopharmaceutical agent | rel=r_associated | relid=0 | w=10
  5022. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:radiopharmaceutical bay1862864
    n1=Okihiro (syndrome de) | n2=en:radiopharmaceutical bay1862864 | rel=r_associated | relid=0 | w=10
  5023. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:radiopharmaceutical compound
    n1=Okihiro (syndrome de) | n2=en:radiopharmaceutical compound | rel=r_associated | relid=0 | w=10
  5024. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:radioprotective agent
    n1=Okihiro (syndrome de) | n2=en:radioprotective agent | rel=r_associated | relid=0 | w=10
  5025. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:radiosensitizer rrx-001
    n1=Okihiro (syndrome de) | n2=en:radiosensitizer rrx-001 | rel=r_associated | relid=0 | w=10
  5026. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:radiosensitizing agent
    n1=Okihiro (syndrome de) | n2=en:radiosensitizing agent | rel=r_associated | relid=0 | w=10
  5027. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:radium ra 223 dichloride
    n1=Okihiro (syndrome de) | n2=en:radium ra 223 dichloride | rel=r_associated | relid=0 | w=10
  5028. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:radius shaft
    n1=Okihiro (syndrome de) | n2=en:radius shaft | rel=r_associated | relid=0 | w=10
  5029. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:radix angelicae sinensis/radix astragali herbal supplement
    n1=Okihiro (syndrome de) | n2=en:radix angelicae sinensis/radix astragali herbal supplement | rel=r_associated | relid=0 | w=10
  5030. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:radotinib hydrochloride
    n1=Okihiro (syndrome de) | n2=en:radotinib hydrochloride | rel=r_associated | relid=0 | w=10
  5031. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:raf kinase inhibitor hm95573
    n1=Okihiro (syndrome de) | n2=en:raf kinase inhibitor hm95573 | rel=r_associated | relid=0 | w=10
  5032. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:raf kinase inhibitor lgx818
    n1=Okihiro (syndrome de) | n2=en:raf kinase inhibitor lgx818 | rel=r_associated | relid=0 | w=10
  5033. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:raf kinase inhibitor xl281
    n1=Okihiro (syndrome de) | n2=en:raf kinase inhibitor xl281 | rel=r_associated | relid=0 | w=10
  5034. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:raf/mek serine/threonine kinase inhibitor ro5126766
    n1=Okihiro (syndrome de) | n2=en:raf/mek serine/threonine kinase inhibitor ro5126766 | rel=r_associated | relid=0 | w=10
  5035. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:raloxifene
    n1=Okihiro (syndrome de) | n2=en:raloxifene | rel=r_associated | relid=0 | w=10
  5036. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:raltegravir potassium
    n1=Okihiro (syndrome de) | n2=en:raltegravir potassium | rel=r_associated | relid=0 | w=10
  5037. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:raltitrexed
    n1=Okihiro (syndrome de) | n2=en:raltitrexed | rel=r_associated | relid=0 | w=10
  5038. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ramelteon
    n1=Okihiro (syndrome de) | n2=en:ramelteon | rel=r_associated | relid=0 | w=10
  5039. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ramipril
    n1=Okihiro (syndrome de) | n2=en:ramipril | rel=r_associated | relid=0 | w=10
  5040. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ramosetron hydrochloride
    n1=Okihiro (syndrome de) | n2=en:ramosetron hydrochloride | rel=r_associated | relid=0 | w=10
  5041. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ramucirumab
    n1=Okihiro (syndrome de) | n2=en:ramucirumab | rel=r_associated | relid=0 | w=10
  5042. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ranibizumab
    n1=Okihiro (syndrome de) | n2=en:ranibizumab | rel=r_associated | relid=0 | w=10
  5043. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ranimustine
    n1=Okihiro (syndrome de) | n2=en:ranimustine | rel=r_associated | relid=0 | w=10
  5044. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ranitidine hydrochloride/bismuth potassium citrate/sucralfate hydrate formulation
    n1=Okihiro (syndrome de) | n2=en:ranitidine hydrochloride/bismuth potassium citrate/sucralfate hydrate formulation | rel=r_associated | relid=0 | w=10
  5045. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ranolazine
    n1=Okihiro (syndrome de) | n2=en:ranolazine | rel=r_associated | relid=0 | w=10
  5046. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ranpirnase
    n1=Okihiro (syndrome de) | n2=en:ranpirnase | rel=r_associated | relid=0 | w=10
  5047. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rapamycin-polarized th1/tc1 autologous t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:rapamycin-polarized th1/tc1 autologous t lymphocytes | rel=r_associated | relid=0 | w=10
  5048. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rar-alpha agonist vtp195183
    n1=Okihiro (syndrome de) | n2=en:rar-alpha agonist vtp195183 | rel=r_associated | relid=0 | w=10
  5049. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ras peptide cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:ras peptide cancer vaccine | rel=r_associated | relid=0 | w=10
  5050. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rasburicase
    n1=Okihiro (syndrome de) | n2=en:rasburicase | rel=r_associated | relid=0 | w=10
  5051. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:raspberry extract
    n1=Okihiro (syndrome de) | n2=en:raspberry extract | rel=r_associated | relid=0 | w=10
  5052. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rauwolfia alkaloids
    n1=Okihiro (syndrome de) | n2=en:rauwolfia alkaloids | rel=r_associated | relid=0 | w=10
  5053. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ravuconazole
    n1=Okihiro (syndrome de) | n2=en:ravuconazole | rel=r_associated | relid=0 | w=10
  5054. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:razoxane
    n1=Okihiro (syndrome de) | n2=en:razoxane | rel=r_associated | relid=0 | w=10
  5055. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rbl001/rbl002 vaccine
    n1=Okihiro (syndrome de) | n2=en:rbl001/rbl002 vaccine | rel=r_associated | relid=0 | w=10
  5056. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:realgar-indigo naturalis formulation
    n1=Okihiro (syndrome de) | n2=en:realgar-indigo naturalis formulation | rel=r_associated | relid=0 | w=10
  5057. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rebamipide
    n1=Okihiro (syndrome de) | n2=en:rebamipide | rel=r_associated | relid=0 | w=10
  5058. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rebastinib tosylate
    n1=Okihiro (syndrome de) | n2=en:rebastinib tosylate | rel=r_associated | relid=0 | w=10
  5059. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rebimastat
    n1=Okihiro (syndrome de) | n2=en:rebimastat | rel=r_associated | relid=0 | w=10
  5060. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:receptor tyrosine kinase inhibitor r1530
    n1=Okihiro (syndrome de) | n2=en:receptor tyrosine kinase inhibitor r1530 | rel=r_associated | relid=0 | w=10
  5061. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:reclazepam
    n1=Okihiro (syndrome de) | n2=en:reclazepam | rel=r_associated | relid=0 | w=10
  5062. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant 70-kd heat-shock protein
    n1=Okihiro (syndrome de) | n2=en:recombinant 70-kd heat-shock protein | rel=r_associated | relid=0 | w=10
  5063. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant adenovirus 5 encoding tumor necrosis factor-related apoptosis-inducing ligand
    n1=Okihiro (syndrome de) | n2=en:recombinant adenovirus 5 encoding tumor necrosis factor-related apoptosis-inducing ligand | rel=r_associated | relid=0 | w=10
  5064. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant adenovirus encoding p53
    n1=Okihiro (syndrome de) | n2=en:recombinant adenovirus encoding p53 | rel=r_associated | relid=0 | w=10
  5065. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant adenovirus-hifn-beta
    n1=Okihiro (syndrome de) | n2=en:recombinant adenovirus-hifn-beta | rel=r_associated | relid=0 | w=10
  5066. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant adenovirus-interferon sch 721015
    n1=Okihiro (syndrome de) | n2=en:recombinant adenovirus-interferon sch 721015 | rel=r_associated | relid=0 | w=10
  5067. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant adenovirus-interferon/syn3
    n1=Okihiro (syndrome de) | n2=en:recombinant adenovirus-interferon/syn3 | rel=r_associated | relid=0 | w=10
  5068. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant adenovirus-l523s vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant adenovirus-l523s vaccine | rel=r_associated | relid=0 | w=10
  5069. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant adenovirus-p53 sch-58500
    n1=Okihiro (syndrome de) | n2=en:recombinant adenovirus-p53 sch-58500 | rel=r_associated | relid=0 | w=10
  5070. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant anti-wt1 immunotherapeutic gsk2302024a
    n1=Okihiro (syndrome de) | n2=en:recombinant anti-wt1 immunotherapeutic gsk2302024a | rel=r_associated | relid=0 | w=10
  5071. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant attenuated salmonella typhimurium expressing il-2
    n1=Okihiro (syndrome de) | n2=en:recombinant attenuated salmonella typhimurium expressing il-2 | rel=r_associated | relid=0 | w=10
  5072. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant b. pertussis adenylate cyclase toxin-tyrosinase a2 epitope vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant b. pertussis adenylate cyclase toxin-tyrosinase a2 epitope vaccine | rel=r_associated | relid=0 | w=10
  5073. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant bispecific single-chain antibody rm28
    n1=Okihiro (syndrome de) | n2=en:recombinant bispecific single-chain antibody rm28 | rel=r_associated | relid=0 | w=10
  5074. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant cd40-ligand
    n1=Okihiro (syndrome de) | n2=en:recombinant cd40-ligand | rel=r_associated | relid=0 | w=10
  5075. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant cell-surface anchored sialidase das181
    n1=Okihiro (syndrome de) | n2=en:recombinant cell-surface anchored sialidase das181 | rel=r_associated | relid=0 | w=10
  5076. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant dher2 vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant dher2 vaccine | rel=r_associated | relid=0 | w=10
  5077. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant dna-l523s vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant dna-l523s vaccine | rel=r_associated | relid=0 | w=10
  5078. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant ephb4-hsa fusion protein
    n1=Okihiro (syndrome de) | n2=en:recombinant ephb4-hsa fusion protein | rel=r_associated | relid=0 | w=10
  5079. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant flt3 ligand
    n1=Okihiro (syndrome de) | n2=en:recombinant flt3 ligand | rel=r_associated | relid=0 | w=10
  5080. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant fowlpox gm-csf vaccine adjuvant
    n1=Okihiro (syndrome de) | n2=en:recombinant fowlpox gm-csf vaccine adjuvant | rel=r_associated | relid=0 | w=10
  5081. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant fowlpox-b7.1 vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant fowlpox-b7.1 vaccine | rel=r_associated | relid=0 | w=10
  5082. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant fowlpox-cea(6d)/tricom vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant fowlpox-cea(6d)/tricom vaccine | rel=r_associated | relid=0 | w=10
  5083. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant fowlpox-prostate specific antigen vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant fowlpox-prostate specific antigen vaccine | rel=r_associated | relid=0 | w=10
  5084. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant fowlpox-tricom vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant fowlpox-tricom vaccine | rel=r_associated | relid=0 | w=10
  5085. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant fowlpox-tyrosinase vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant fowlpox-tyrosinase vaccine | rel=r_associated | relid=0 | w=10
  5086. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant gonadorelin
    n1=Okihiro (syndrome de) | n2=en:recombinant gonadorelin | rel=r_associated | relid=0 | w=10
  5087. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant granulocyte-macrophage colony-stimulating factor
    n1=Okihiro (syndrome de) | n2=en:recombinant granulocyte-macrophage colony-stimulating factor | rel=r_associated | relid=0 | w=10
  5088. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human 6ckine
    n1=Okihiro (syndrome de) | n2=en:recombinant human 6ckine | rel=r_associated | relid=0 | w=10
  5089. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human adenovirus type 5 h101
    n1=Okihiro (syndrome de) | n2=en:recombinant human adenovirus type 5 h101 | rel=r_associated | relid=0 | w=10
  5090. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human albumin-human granulocyte colony-stimulating factor
    n1=Okihiro (syndrome de) | n2=en:recombinant human albumin-human granulocyte colony-stimulating factor | rel=r_associated | relid=0 | w=10
  5091. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human angiotensin converting enzyme 2 apn01
    n1=Okihiro (syndrome de) | n2=en:recombinant human angiotensin converting enzyme 2 apn01 | rel=r_associated | relid=0 | w=10
  5092. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human apolipoprotein(a) kringle v mg1102
    n1=Okihiro (syndrome de) | n2=en:recombinant human apolipoprotein(a) kringle v mg1102 | rel=r_associated | relid=0 | w=10
  5093. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human chorionic gonadotropin
    n1=Okihiro (syndrome de) | n2=en:recombinant human chorionic gonadotropin | rel=r_associated | relid=0 | w=10
  5094. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human egf-rp64k/montanide isa 51 vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant human egf-rp64k/montanide isa 51 vaccine | rel=r_associated | relid=0 | w=10
  5095. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human endostatin
    n1=Okihiro (syndrome de) | n2=en:recombinant human endostatin | rel=r_associated | relid=0 | w=10
  5096. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human fusion protein l19tnfalpha
    n1=Okihiro (syndrome de) | n2=en:recombinant human fusion protein l19tnfalpha | rel=r_associated | relid=0 | w=10
  5097. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human granulocyte colony stimulating factor
    n1=Okihiro (syndrome de) | n2=en:recombinant human granulocyte colony stimulating factor | rel=r_associated | relid=0 | w=10
  5098. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human hsp110-gp100 chaperone complex vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant human hsp110-gp100 chaperone complex vaccine | rel=r_associated | relid=0 | w=10
  5099. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human hyaluronidase
    n1=Okihiro (syndrome de) | n2=en:recombinant human hyaluronidase | rel=r_associated | relid=0 | w=10
  5100. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human interleukin-15
    n1=Okihiro (syndrome de) | n2=en:recombinant human interleukin-15 | rel=r_associated | relid=0 | w=10
  5101. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human papillomavirus nonavalent vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant human papillomavirus nonavalent vaccine | rel=r_associated | relid=0 | w=10
  5102. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant human serum amyloid p/pentraxin 2
    n1=Okihiro (syndrome de) | n2=en:recombinant human serum amyloid p/pentraxin 2 | rel=r_associated | relid=0 | w=10
  5103. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interferon
    n1=Okihiro (syndrome de) | n2=en:recombinant interferon | rel=r_associated | relid=0 | w=10
  5104. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interferon alfa
    n1=Okihiro (syndrome de) | n2=en:recombinant interferon alfa | rel=r_associated | relid=0 | w=10
  5105. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interferon alfa-1b
    n1=Okihiro (syndrome de) | n2=en:recombinant interferon alfa-1b | rel=r_associated | relid=0 | w=10
  5106. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interferon alfa-2a
    n1=Okihiro (syndrome de) | n2=en:recombinant interferon alfa-2a | rel=r_associated | relid=0 | w=10
  5107. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interferon alfa-2b
    n1=Okihiro (syndrome de) | n2=en:recombinant interferon alfa-2b | rel=r_associated | relid=0 | w=10
  5108. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interferon alpha 2b-like protein
    n1=Okihiro (syndrome de) | n2=en:recombinant interferon alpha 2b-like protein | rel=r_associated | relid=0 | w=10
  5109. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interferon beta
    n1=Okihiro (syndrome de) | n2=en:recombinant interferon beta | rel=r_associated | relid=0 | w=10
  5110. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interferon gamma
    n1=Okihiro (syndrome de) | n2=en:recombinant interferon gamma | rel=r_associated | relid=0 | w=10
  5111. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interleukin 2 moiety
    n1=Okihiro (syndrome de) | n2=en:recombinant interleukin 2 moiety | rel=r_associated | relid=0 | w=10
  5112. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interleukin-1-alpha
    n1=Okihiro (syndrome de) | n2=en:recombinant interleukin-1-alpha | rel=r_associated | relid=0 | w=10
  5113. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interleukin-1-beta
    n1=Okihiro (syndrome de) | n2=en:recombinant interleukin-1-beta | rel=r_associated | relid=0 | w=10
  5114. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interleukin-12
    n1=Okihiro (syndrome de) | n2=en:recombinant interleukin-12 | rel=r_associated | relid=0 | w=10
  5115. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interleukin-18
    n1=Okihiro (syndrome de) | n2=en:recombinant interleukin-18 | rel=r_associated | relid=0 | w=10
  5116. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interleukin-3
    n1=Okihiro (syndrome de) | n2=en:recombinant interleukin-3 | rel=r_associated | relid=0 | w=10
  5117. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant interleukin-7
    n1=Okihiro (syndrome de) | n2=en:recombinant interleukin-7 | rel=r_associated | relid=0 | w=10
  5118. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant leukocyte interleukin
    n1=Okihiro (syndrome de) | n2=en:recombinant leukocyte interleukin | rel=r_associated | relid=0 | w=10
  5119. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant macrophage colony-stimulating factor
    n1=Okihiro (syndrome de) | n2=en:recombinant macrophage colony-stimulating factor | rel=r_associated | relid=0 | w=10
  5120. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant mage-3.1 antigen
    n1=Okihiro (syndrome de) | n2=en:recombinant mage-3.1 antigen | rel=r_associated | relid=0 | w=10
  5121. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant mip1-alpha variant eci301
    n1=Okihiro (syndrome de) | n2=en:recombinant mip1-alpha variant eci301 | rel=r_associated | relid=0 | w=10
  5122. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant modified vaccinia ankara-5t4 vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant modified vaccinia ankara-5t4 vaccine | rel=r_associated | relid=0 | w=10
  5123. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant nematode anticoagulant protein c2
    n1=Okihiro (syndrome de) | n2=en:recombinant nematode anticoagulant protein c2 | rel=r_associated | relid=0 | w=10
  5124. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant oncolytic poliovirus pvs-ripo
    n1=Okihiro (syndrome de) | n2=en:recombinant oncolytic poliovirus pvs-ripo | rel=r_associated | relid=0 | w=10
  5125. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant oxytocin
    n1=Okihiro (syndrome de) | n2=en:recombinant oxytocin | rel=r_associated | relid=0 | w=10
  5126. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant parathyroid hormone
    n1=Okihiro (syndrome de) | n2=en:recombinant parathyroid hormone | rel=r_associated | relid=0 | w=10
  5127. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant platelet factor 4
    n1=Okihiro (syndrome de) | n2=en:recombinant platelet factor 4 | rel=r_associated | relid=0 | w=10
  5128. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant prame protein plus as15 adjuvant gsk2302025a
    n1=Okihiro (syndrome de) | n2=en:recombinant prame protein plus as15 adjuvant gsk2302025a | rel=r_associated | relid=0 | w=10
  5129. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant saccharomyces cerevisia-cea(610d)-expressing vaccine gi-6207
    n1=Okihiro (syndrome de) | n2=en:recombinant saccharomyces cerevisia-cea(610d)-expressing vaccine gi-6207 | rel=r_associated | relid=0 | w=10
  5130. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant soluble human cd4 protein
    n1=Okihiro (syndrome de) | n2=en:recombinant soluble human cd4 protein | rel=r_associated | relid=0 | w=10
  5131. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant soluble t4
    n1=Okihiro (syndrome de) | n2=en:recombinant soluble t4 | rel=r_associated | relid=0 | w=10
  5132. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant super-compound interferon
    n1=Okihiro (syndrome de) | n2=en:recombinant super-compound interferon | rel=r_associated | relid=0 | w=10
  5133. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant thymosin
    n1=Okihiro (syndrome de) | n2=en:recombinant thymosin | rel=r_associated | relid=0 | w=10
  5134. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant thyroglobulin
    n1=Okihiro (syndrome de) | n2=en:recombinant thyroglobulin | rel=r_associated | relid=0 | w=10
  5135. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant thyroid-stimulating hormone
    n1=Okihiro (syndrome de) | n2=en:recombinant thyroid-stimulating hormone | rel=r_associated | relid=0 | w=10
  5136. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant thyrotropin alfa
    n1=Okihiro (syndrome de) | n2=en:recombinant thyrotropin alfa | rel=r_associated | relid=0 | w=10
  5137. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant transforming growth factor-beta-2
    n1=Okihiro (syndrome de) | n2=en:recombinant transforming growth factor-beta-2 | rel=r_associated | relid=0 | w=10
  5138. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant tumor necrosis factor family protein
    n1=Okihiro (syndrome de) | n2=en:recombinant tumor necrosis factor family protein | rel=r_associated | relid=0 | w=10
  5139. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant tyrosinase-related protein-2
    n1=Okihiro (syndrome de) | n2=en:recombinant tyrosinase-related protein-2 | rel=r_associated | relid=0 | w=10
  5140. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant urokinase
    n1=Okihiro (syndrome de) | n2=en:recombinant urokinase | rel=r_associated | relid=0 | w=10
  5141. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant vaccinia df3/muc1 vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant vaccinia df3/muc1 vaccine | rel=r_associated | relid=0 | w=10
  5142. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant vaccinia psa vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant vaccinia psa vaccine | rel=r_associated | relid=0 | w=10
  5143. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant vaccinia viral vector ro5217790
    n1=Okihiro (syndrome de) | n2=en:recombinant vaccinia viral vector ro5217790 | rel=r_associated | relid=0 | w=10
  5144. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant vaccinia-b7.1 vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant vaccinia-b7.1 vaccine | rel=r_associated | relid=0 | w=10
  5145. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant vaccinia-cea(6d)-tricom vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant vaccinia-cea(6d)-tricom vaccine | rel=r_associated | relid=0 | w=10
  5146. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant vaccinia-muc-1 vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant vaccinia-muc-1 vaccine | rel=r_associated | relid=0 | w=10
  5147. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant vaccinia-multiepitope melanoma peptides-b7.1-b7.2 vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant vaccinia-multiepitope melanoma peptides-b7.1-b7.2 vaccine | rel=r_associated | relid=0 | w=10
  5148. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant vaccinia-ny-eso-1 vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant vaccinia-ny-eso-1 vaccine | rel=r_associated | relid=0 | w=10
  5149. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant vaccinia-tricom vaccine
    n1=Okihiro (syndrome de) | n2=en:recombinant vaccinia-tricom vaccine | rel=r_associated | relid=0 | w=10
  5150. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:recombinant vesicular stomatitis virus-expressing interferon-beta
    n1=Okihiro (syndrome de) | n2=en:recombinant vesicular stomatitis virus-expressing interferon-beta | rel=r_associated | relid=0 | w=10
  5151. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rectal dosage form product
    n1=Okihiro (syndrome de) | n2=en:rectal dosage form product | rel=r_associated | relid=0 | w=10
  5152. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:red beet extract
    n1=Okihiro (syndrome de) | n2=en:red beet extract | rel=r_associated | relid=0 | w=10
  5153. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:red clover preparation
    n1=Okihiro (syndrome de) | n2=en:red clover preparation | rel=r_associated | relid=0 | w=10
  5154. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:red tomato juice
    n1=Okihiro (syndrome de) | n2=en:red tomato juice | rel=r_associated | relid=0 | w=10
  5155. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:reduced glutathione-l-cysteine-anthocyanins gel
    n1=Okihiro (syndrome de) | n2=en:reduced glutathione-l-cysteine-anthocyanins gel | rel=r_associated | relid=0 | w=10
  5156. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:refametinib
    n1=Okihiro (syndrome de) | n2=en:refametinib | rel=r_associated | relid=0 | w=10
  5157. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:regadenoson
    n1=Okihiro (syndrome de) | n2=en:regadenoson | rel=r_associated | relid=0 | w=10
  5158. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:regorafenib
    n1=Okihiro (syndrome de) | n2=en:regorafenib | rel=r_associated | relid=0 | w=10
  5159. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:relcovaptan
    n1=Okihiro (syndrome de) | n2=en:relcovaptan | rel=r_associated | relid=0 | w=10
  5160. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:remestemcel-l
    n1=Okihiro (syndrome de) | n2=en:remestemcel-l | rel=r_associated | relid=0 | w=10
  5161. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:remifentanil hydrochloride
    n1=Okihiro (syndrome de) | n2=en:remifentanil hydrochloride | rel=r_associated | relid=0 | w=10
  5162. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:renal agents
    n1=Okihiro (syndrome de) | n2=en:renal agents | rel=r_associated | relid=0 | w=10
  5163. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:renal cell carcinoma peptides vaccine ima901
    n1=Okihiro (syndrome de) | n2=en:renal cell carcinoma peptides vaccine ima901 | rel=r_associated | relid=0 | w=10
  5164. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:renal cell carcinoma/cd40l rna-transfected autologous dendritic cell vaccine ags-003
    n1=Okihiro (syndrome de) | n2=en:renal cell carcinoma/cd40l rna-transfected autologous dendritic cell vaccine ags-003 | rel=r_associated | relid=0 | w=10
  5165. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:repaglinide
    n1=Okihiro (syndrome de) | n2=en:repaglinide | rel=r_associated | relid=0 | w=10
  5166. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:reparixin
    n1=Okihiro (syndrome de) | n2=en:reparixin | rel=r_associated | relid=0 | w=10
  5167. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:replacement agent
    n1=Okihiro (syndrome de) | n2=en:replacement agent | rel=r_associated | relid=0 | w=10
  5168. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:reproductive system drug
    n1=Okihiro (syndrome de) | n2=en:reproductive system drug | rel=r_associated | relid=0 | w=10
  5169. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:resiniferatoxin
    n1=Okihiro (syndrome de) | n2=en:resiniferatoxin | rel=r_associated | relid=0 | w=10
  5170. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:resiquimod
    n1=Okihiro (syndrome de) | n2=en:resiquimod | rel=r_associated | relid=0 | w=10
  5171. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:resiquimod topical gel
    n1=Okihiro (syndrome de) | n2=en:resiquimod topical gel | rel=r_associated | relid=0 | w=10
  5172. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:resistant starch
    n1=Okihiro (syndrome de) | n2=en:resistant starch | rel=r_associated | relid=0 | w=10
  5173. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:resminostat
    n1=Okihiro (syndrome de) | n2=en:resminostat | rel=r_associated | relid=0 | w=10
  5174. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:resorcinol
    n1=Okihiro (syndrome de) | n2=en:resorcinol | rel=r_associated | relid=0 | w=10
  5175. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:respiratory form lucinactant
    n1=Okihiro (syndrome de) | n2=en:respiratory form lucinactant | rel=r_associated | relid=0 | w=10
  5176. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:respiratory form tiotropium
    n1=Okihiro (syndrome de) | n2=en:respiratory form tiotropium | rel=r_associated | relid=0 | w=10
  5177. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:respiratory system agents
    n1=Okihiro (syndrome de) | n2=en:respiratory system agents | rel=r_associated | relid=0 | w=10
  5178. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:resveratrol
    n1=Okihiro (syndrome de) | n2=en:resveratrol | rel=r_associated | relid=0 | w=10
  5179. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:resveratrol formulation srt501
    n1=Okihiro (syndrome de) | n2=en:resveratrol formulation srt501 | rel=r_associated | relid=0 | w=10
  5180. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:retaspimycin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:retaspimycin hydrochloride | rel=r_associated | relid=0 | w=10
  5181. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:retinoic acid agent
    n1=Okihiro (syndrome de) | n2=en:retinoic acid agent | rel=r_associated | relid=0 | w=10
  5182. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:retinoid 9cuab30
    n1=Okihiro (syndrome de) | n2=en:retinoid 9cuab30 | rel=r_associated | relid=0 | w=10
  5183. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:retinoid analogue nrx 195183
    n1=Okihiro (syndrome de) | n2=en:retinoid analogue nrx 195183 | rel=r_associated | relid=0 | w=10
  5184. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:retinyl acetate
    n1=Okihiro (syndrome de) | n2=en:retinyl acetate | rel=r_associated | relid=0 | w=10
  5185. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:retrovector encoding mutant anti-cyclin g1
    n1=Okihiro (syndrome de) | n2=en:retrovector encoding mutant anti-cyclin g1 | rel=r_associated | relid=0 | w=10
  5186. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:retrovirus vector ln
    n1=Okihiro (syndrome de) | n2=en:retrovirus vector ln | rel=r_associated | relid=0 | w=10
  5187. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:reversible anticholinesterase
    n1=Okihiro (syndrome de) | n2=en:reversible anticholinesterase | rel=r_associated | relid=0 | w=10
  5188. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:revm10 gene
    n1=Okihiro (syndrome de) | n2=en:revm10 gene | rel=r_associated | relid=0 | w=10
  5189. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:revm10 gene/polas gene
    n1=Okihiro (syndrome de) | n2=en:revm10 gene/polas gene | rel=r_associated | relid=0 | w=10
  5190. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rexinoid nrx 194204
    n1=Okihiro (syndrome de) | n2=en:rexinoid nrx 194204 | rel=r_associated | relid=0 | w=10
  5191. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rft5-dga immunotoxin
    n1=Okihiro (syndrome de) | n2=en:rft5-dga immunotoxin | rel=r_associated | relid=0 | w=10
  5192. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rg 12915
    n1=Okihiro (syndrome de) | n2=en:rg 12915 | rel=r_associated | relid=0 | w=10
  5193. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rhenium re 188 bmeda-labeled liposomes
    n1=Okihiro (syndrome de) | n2=en:rhenium re 188 bmeda-labeled liposomes | rel=r_associated | relid=0 | w=10
  5194. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rhenium re 188 p2045
    n1=Okihiro (syndrome de) | n2=en:rhenium re 188 p2045 | rel=r_associated | relid=0 | w=10
  5195. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rhenium re-186 hydroxyethylidene diphosphonate
    n1=Okihiro (syndrome de) | n2=en:rhenium re-186 hydroxyethylidene diphosphonate | rel=r_associated | relid=0 | w=10
  5196. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rhenium re-188 ethiodized oil
    n1=Okihiro (syndrome de) | n2=en:rhenium re-188 ethiodized oil | rel=r_associated | relid=0 | w=10
  5197. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rhizoxin
    n1=Okihiro (syndrome de) | n2=en:rhizoxin | rel=r_associated | relid=0 | w=10
  5198. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rhubarb/licorice herbal supplement
    n1=Okihiro (syndrome de) | n2=en:rhubarb/licorice herbal supplement | rel=r_associated | relid=0 | w=10
  5199. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rib head
    n1=Okihiro (syndrome de) | n2=en:rib head | rel=r_associated | relid=0 | w=10
  5200. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rib shaft
    n1=Okihiro (syndrome de) | n2=en:rib shaft | rel=r_associated | relid=0 | w=10
  5201. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rib tubercle
    n1=Okihiro (syndrome de) | n2=en:rib tubercle | rel=r_associated | relid=0 | w=10
  5202. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ribavirin
    n1=Okihiro (syndrome de) | n2=en:ribavirin | rel=r_associated | relid=0 | w=10
  5203. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ribociclib
    n1=Okihiro (syndrome de) | n2=en:ribociclib | rel=r_associated | relid=0 | w=10
  5204. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:riboflavin
    n1=Okihiro (syndrome de) | n2=en:riboflavin | rel=r_associated | relid=0 | w=10
  5205. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ribonuclease qbi-139
    n1=Okihiro (syndrome de) | n2=en:ribonuclease qbi-139 | rel=r_associated | relid=0 | w=10
  5206. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ribosome-inactivating protein cy503
    n1=Okihiro (syndrome de) | n2=en:ribosome-inactivating protein cy503 | rel=r_associated | relid=0 | w=10
  5207. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ribozyme rpi.4610
    n1=Okihiro (syndrome de) | n2=en:ribozyme rpi.4610 | rel=r_associated | relid=0 | w=10
  5208. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rice bran
    n1=Okihiro (syndrome de) | n2=en:rice bran | rel=r_associated | relid=0 | w=10
  5209. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ricin immunoconjugate
    n1=Okihiro (syndrome de) | n2=en:ricin immunoconjugate | rel=r_associated | relid=0 | w=10
  5210. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ricolinostat
    n1=Okihiro (syndrome de) | n2=en:ricolinostat | rel=r_associated | relid=0 | w=10
  5211. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ridaforolimus
    n1=Okihiro (syndrome de) | n2=en:ridaforolimus | rel=r_associated | relid=0 | w=10
  5212. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rifabutin
    n1=Okihiro (syndrome de) | n2=en:rifabutin | rel=r_associated | relid=0 | w=10
  5213. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rifampin
    n1=Okihiro (syndrome de) | n2=en:rifampin | rel=r_associated | relid=0 | w=10
  5214. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rifaximin
    n1=Okihiro (syndrome de) | n2=en:rifaximin | rel=r_associated | relid=0 | w=10
  5215. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:right olecranon
    n1=Okihiro (syndrome de) | n2=en:right olecranon | rel=r_associated | relid=0 | w=10
  5216. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rigosertib sodium
    n1=Okihiro (syndrome de) | n2=en:rigosertib sodium | rel=r_associated | relid=0 | w=10
  5217. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rilapine
    n1=Okihiro (syndrome de) | n2=en:rilapine | rel=r_associated | relid=0 | w=10
  5218. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rilimogene galvacirepvec
    n1=Okihiro (syndrome de) | n2=en:rilimogene galvacirepvec | rel=r_associated | relid=0 | w=10
  5219. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rilotumumab
    n1=Okihiro (syndrome de) | n2=en:rilotumumab | rel=r_associated | relid=0 | w=10
  5220. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:riluzole
    n1=Okihiro (syndrome de) | n2=en:riluzole | rel=r_associated | relid=0 | w=10
  5221. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rimiducid
    n1=Okihiro (syndrome de) | n2=en:rimiducid | rel=r_associated | relid=0 | w=10
  5222. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rimonabant
    n1=Okihiro (syndrome de) | n2=en:rimonabant | rel=r_associated | relid=0 | w=10
  5223. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rindopepimut
    n1=Okihiro (syndrome de) | n2=en:rindopepimut | rel=r_associated | relid=0 | w=10
  5224. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rintatolimod
    n1=Okihiro (syndrome de) | n2=en:rintatolimod | rel=r_associated | relid=0 | w=10
  5225. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ripazepam
    n1=Okihiro (syndrome de) | n2=en:ripazepam | rel=r_associated | relid=0 | w=10
  5226. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:risedronate sodium
    n1=Okihiro (syndrome de) | n2=en:risedronate sodium | rel=r_associated | relid=0 | w=10
  5227. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:risperidone
    n1=Okihiro (syndrome de) | n2=en:risperidone | rel=r_associated | relid=0 | w=10
  5228. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ritonavir
    n1=Okihiro (syndrome de) | n2=en:ritonavir | rel=r_associated | relid=0 | w=10
  5229. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rituximab
    n1=Okihiro (syndrome de) | n2=en:rituximab | rel=r_associated | relid=0 | w=10
  5230. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rivaroxaban
    n1=Okihiro (syndrome de) | n2=en:rivaroxaban | rel=r_associated | relid=0 | w=10
  5231. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rivastigmine tartrate
    n1=Okihiro (syndrome de) | n2=en:rivastigmine tartrate | rel=r_associated | relid=0 | w=10
  5232. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rizatriptan benzoate
    n1=Okihiro (syndrome de) | n2=en:rizatriptan benzoate | rel=r_associated | relid=0 | w=10
  5233. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rk-0202
    n1=Okihiro (syndrome de) | n2=en:rk-0202 | rel=r_associated | relid=0 | w=10
  5234. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rna electroporated cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:rna electroporated cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  5235. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rnr inhibitor coh29
    n1=Okihiro (syndrome de) | n2=en:rnr inhibitor coh29 | rel=r_associated | relid=0 | w=10
  5236. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ro 15-4513
    n1=Okihiro (syndrome de) | n2=en:ro 15-4513 | rel=r_associated | relid=0 | w=10
  5237. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ro6874813
    n1=Okihiro (syndrome de) | n2=en:ro6874813 | rel=r_associated | relid=0 | w=10
  5238. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ro6895882
    n1=Okihiro (syndrome de) | n2=en:ro6895882 | rel=r_associated | relid=0 | w=10
  5239. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:robatumumab
    n1=Okihiro (syndrome de) | n2=en:robatumumab | rel=r_associated | relid=0 | w=10
  5240. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rocuronium bromide
    n1=Okihiro (syndrome de) | n2=en:rocuronium bromide | rel=r_associated | relid=0 | w=10
  5241. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rofecoxib
    n1=Okihiro (syndrome de) | n2=en:rofecoxib | rel=r_associated | relid=0 | w=10
  5242. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:roflumilast
    n1=Okihiro (syndrome de) | n2=en:roflumilast | rel=r_associated | relid=0 | w=10
  5243. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rogletimide
    n1=Okihiro (syndrome de) | n2=en:rogletimide | rel=r_associated | relid=0 | w=10
  5244. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rolapitant hydrochloride
    n1=Okihiro (syndrome de) | n2=en:rolapitant hydrochloride | rel=r_associated | relid=0 | w=10
  5245. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:romidepsin
    n1=Okihiro (syndrome de) | n2=en:romidepsin | rel=r_associated | relid=0 | w=10
  5246. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:romiplostim
    n1=Okihiro (syndrome de) | n2=en:romiplostim | rel=r_associated | relid=0 | w=10
  5247. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:roniciclib
    n1=Okihiro (syndrome de) | n2=en:roniciclib | rel=r_associated | relid=0 | w=10
  5248. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ropidoxuridine
    n1=Okihiro (syndrome de) | n2=en:ropidoxuridine | rel=r_associated | relid=0 | w=10
  5249. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ropinirole hydrochloride
    n1=Okihiro (syndrome de) | n2=en:ropinirole hydrochloride | rel=r_associated | relid=0 | w=10
  5250. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ropivacaine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:ropivacaine hydrochloride | rel=r_associated | relid=0 | w=10
  5251. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:roquinimex
    n1=Okihiro (syndrome de) | n2=en:roquinimex | rel=r_associated | relid=0 | w=10
  5252. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ror1 car-specific autologous t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:ror1 car-specific autologous t-lymphocytes | rel=r_associated | relid=0 | w=10
  5253. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rosabulin
    n1=Okihiro (syndrome de) | n2=en:rosabulin | rel=r_associated | relid=0 | w=10
  5254. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rose bengal sodium
    n1=Okihiro (syndrome de) | n2=en:rose bengal sodium | rel=r_associated | relid=0 | w=10
  5255. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rosiglitazone maleate
    n1=Okihiro (syndrome de) | n2=en:rosiglitazone maleate | rel=r_associated | relid=0 | w=10
  5256. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rosuvastatin calcium
    n1=Okihiro (syndrome de) | n2=en:rosuvastatin calcium | rel=r_associated | relid=0 | w=10
  5257. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rotavirus vaccine
    n1=Okihiro (syndrome de) | n2=en:rotavirus vaccine | rel=r_associated | relid=0 | w=10
  5258. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rotigotine
    n1=Okihiro (syndrome de) | n2=en:rotigotine | rel=r_associated | relid=0 | w=10
  5259. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:roxithromycin
    n1=Okihiro (syndrome de) | n2=en:roxithromycin | rel=r_associated | relid=0 | w=10
  5260. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rsv fusion inhibitor gs-5806
    n1=Okihiro (syndrome de) | n2=en:rsv fusion inhibitor gs-5806 | rel=r_associated | relid=0 | w=10
  5261. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rubella/mumps vaccine
    n1=Okihiro (syndrome de) | n2=en:rubella/mumps vaccine | rel=r_associated | relid=0 | w=10
  5262. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rubidium rb-82
    n1=Okihiro (syndrome de) | n2=en:rubidium rb-82 | rel=r_associated | relid=0 | w=10
  5263. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rubitecan
    n1=Okihiro (syndrome de) | n2=en:rubitecan | rel=r_associated | relid=0 | w=10
  5264. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rucaparib phosphate
    n1=Okihiro (syndrome de) | n2=en:rucaparib phosphate | rel=r_associated | relid=0 | w=10
  5265. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ruthenium ru-106
    n1=Okihiro (syndrome de) | n2=en:ruthenium ru-106 | rel=r_associated | relid=0 | w=10
  5266. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ruthenium-based transferrin targeting agent nkp-1339
    n1=Okihiro (syndrome de) | n2=en:ruthenium-based transferrin targeting agent nkp-1339 | rel=r_associated | relid=0 | w=10
  5267. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:rutin
    n1=Okihiro (syndrome de) | n2=en:rutin | rel=r_associated | relid=0 | w=10
  5268. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ruxolitinib phosphate
    n1=Okihiro (syndrome de) | n2=en:ruxolitinib phosphate | rel=r_associated | relid=0 | w=10
  5269. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:s-3304
    n1=Okihiro (syndrome de) | n2=en:s-3304 | rel=r_associated | relid=0 | w=10
  5270. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:s-adenosyl-l-methionine disulfate p-toluene-sulfonate
    n1=Okihiro (syndrome de) | n2=en:s-adenosyl-l-methionine disulfate p-toluene-sulfonate | rel=r_associated | relid=0 | w=10
  5271. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:s-adenosylmethionine
    n1=Okihiro (syndrome de) | n2=en:s-adenosylmethionine | rel=r_associated | relid=0 | w=10
  5272. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:s-equol
    n1=Okihiro (syndrome de) | n2=en:s-equol | rel=r_associated | relid=0 | w=10
  5273. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:s1p receptor agonist krp203
    n1=Okihiro (syndrome de) | n2=en:s1p receptor agonist krp203 | rel=r_associated | relid=0 | w=10
  5274. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sabarubicin
    n1=Okihiro (syndrome de) | n2=en:sabarubicin | rel=r_associated | relid=0 | w=10
  5275. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:saccharomyces boulardii preparation
    n1=Okihiro (syndrome de) | n2=en:saccharomyces boulardii preparation | rel=r_associated | relid=0 | w=10
  5276. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:saccharomyces boulardii probiotic supplement
    n1=Okihiro (syndrome de) | n2=en:saccharomyces boulardii probiotic supplement | rel=r_associated | relid=0 | w=10
  5277. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sacituzumab govitecan
    n1=Okihiro (syndrome de) | n2=en:sacituzumab govitecan | rel=r_associated | relid=0 | w=10
  5278. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sacral tuberosity
    n1=Okihiro (syndrome de) | n2=en:sacral tuberosity | rel=r_associated | relid=0 | w=10
  5279. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sacrosidase
    n1=Okihiro (syndrome de) | n2=en:sacrosidase | rel=r_associated | relid=0 | w=10
  5280. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sacrum
    n1=Okihiro (syndrome de) | n2=en:sacrum | rel=r_associated | relid=0 | w=10
  5281. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:safingol
    n1=Okihiro (syndrome de) | n2=en:safingol | rel=r_associated | relid=0 | w=10
  5282. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sagopilone
    n1=Okihiro (syndrome de) | n2=en:sagopilone | rel=r_associated | relid=0 | w=10
  5283. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:salicylate
    n1=Okihiro (syndrome de) | n2=en:salicylate | rel=r_associated | relid=0 | w=10
  5284. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:salirasib
    n1=Okihiro (syndrome de) | n2=en:salirasib | rel=r_associated | relid=0 | w=10
  5285. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:salmonella vnp20009
    n1=Okihiro (syndrome de) | n2=en:salmonella vnp20009 | rel=r_associated | relid=0 | w=10
  5286. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:salvia hispanica seed
    n1=Okihiro (syndrome de) | n2=en:salvia hispanica seed | rel=r_associated | relid=0 | w=10
  5287. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:salvia officinalis extract tablet
    n1=Okihiro (syndrome de) | n2=en:salvia officinalis extract tablet | rel=r_associated | relid=0 | w=10
  5288. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sam68 modulator cwp232291
    n1=Okihiro (syndrome de) | n2=en:sam68 modulator cwp232291 | rel=r_associated | relid=0 | w=10
  5289. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:samarium sm-153 lexidronam pentasodium
    n1=Okihiro (syndrome de) | n2=en:samarium sm-153 lexidronam pentasodium | rel=r_associated | relid=0 | w=10
  5290. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:saob-0401
    n1=Okihiro (syndrome de) | n2=en:saob-0401 | rel=r_associated | relid=0 | w=10
  5291. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sapacitabine
    n1=Okihiro (syndrome de) | n2=en:sapacitabine | rel=r_associated | relid=0 | w=10
  5292. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sapanisertib
    n1=Okihiro (syndrome de) | n2=en:sapanisertib | rel=r_associated | relid=0 | w=10
  5293. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:saperconazole
    n1=Okihiro (syndrome de) | n2=en:saperconazole | rel=r_associated | relid=0 | w=10
  5294. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sapitinib
    n1=Okihiro (syndrome de) | n2=en:sapitinib | rel=r_associated | relid=0 | w=10
  5295. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:saponin-based immunoadjuvant obi-821
    n1=Okihiro (syndrome de) | n2=en:saponin-based immunoadjuvant obi-821 | rel=r_associated | relid=0 | w=10
  5296. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:saponin-cholesterol-phospholipid adjuvant
    n1=Okihiro (syndrome de) | n2=en:saponin-cholesterol-phospholipid adjuvant | rel=r_associated | relid=0 | w=10
  5297. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:saquinavir
    n1=Okihiro (syndrome de) | n2=en:saquinavir | rel=r_associated | relid=0 | w=10
  5298. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:saquinavir mesylate
    n1=Okihiro (syndrome de) | n2=en:saquinavir mesylate | rel=r_associated | relid=0 | w=10
  5299. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:saracatinib
    n1=Okihiro (syndrome de) | n2=en:saracatinib | rel=r_associated | relid=0 | w=10
  5300. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sarcnu
    n1=Okihiro (syndrome de) | n2=en:sarcnu | rel=r_associated | relid=0 | w=10
  5301. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sardomozide
    n1=Okihiro (syndrome de) | n2=en:sardomozide | rel=r_associated | relid=0 | w=10
  5302. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant
    n1=Okihiro (syndrome de) | n2=en:sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant | rel=r_associated | relid=0 | w=10
  5303. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sargramostim plasmid dna melanoma vaccine adjuvant
    n1=Okihiro (syndrome de) | n2=en:sargramostim plasmid dna melanoma vaccine adjuvant | rel=r_associated | relid=0 | w=10
  5304. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sargramostim plasmid dna pancreatic tumor cell vaccine
    n1=Okihiro (syndrome de) | n2=en:sargramostim plasmid dna pancreatic tumor cell vaccine | rel=r_associated | relid=0 | w=10
  5305. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sargramostim plasmid dna sarcoma vaccine
    n1=Okihiro (syndrome de) | n2=en:sargramostim plasmid dna sarcoma vaccine | rel=r_associated | relid=0 | w=10
  5306. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:saridegib
    n1=Okihiro (syndrome de) | n2=en:saridegib | rel=r_associated | relid=0 | w=10
  5307. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:satraplatin
    n1=Okihiro (syndrome de) | n2=en:satraplatin | rel=r_associated | relid=0 | w=10
  5308. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:saw palmetto berry extract
    n1=Okihiro (syndrome de) | n2=en:saw palmetto berry extract | rel=r_associated | relid=0 | w=10
  5309. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:saxagliptin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:saxagliptin hydrochloride | rel=r_associated | relid=0 | w=10
  5310. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sb as-2
    n1=Okihiro (syndrome de) | n2=en:sb as-2 | rel=r_associated | relid=0 | w=10
  5311. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sb injection
    n1=Okihiro (syndrome de) | n2=en:sb injection | rel=r_associated | relid=0 | w=10
  5312. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sb-743921
    n1=Okihiro (syndrome de) | n2=en:sb-743921 | rel=r_associated | relid=0 | w=10
  5313. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sb-as02b adjuvant
    n1=Okihiro (syndrome de) | n2=en:sb-as02b adjuvant | rel=r_associated | relid=0 | w=10
  5314. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sb-as15 adjuvant
    n1=Okihiro (syndrome de) | n2=en:sb-as15 adjuvant | rel=r_associated | relid=0 | w=10
  5315. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:scarlet red
    n1=Okihiro (syndrome de) | n2=en:scarlet red | rel=r_associated | relid=0 | w=10
  5316. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:scb01a
    n1=Okihiro (syndrome de) | n2=en:scb01a | rel=r_associated | relid=0 | w=10
  5317. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sdf-1-targeted agent nox-a12
    n1=Okihiro (syndrome de) | n2=en:sdf-1-targeted agent nox-a12 | rel=r_associated | relid=0 | w=10
  5318. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:secretin human
    n1=Okihiro (syndrome de) | n2=en:secretin human | rel=r_associated | relid=0 | w=10
  5319. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sedoxantrone trihydrochloride
    n1=Okihiro (syndrome de) | n2=en:sedoxantrone trihydrochloride | rel=r_associated | relid=0 | w=10
  5320. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:selatinib ditosilate
    n1=Okihiro (syndrome de) | n2=en:selatinib ditosilate | rel=r_associated | relid=0 | w=10
  5321. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:selective androgen receptor modulator ly2452473
    n1=Okihiro (syndrome de) | n2=en:selective androgen receptor modulator ly2452473 | rel=r_associated | relid=0 | w=10
  5322. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:selective estrogen receptor degrader arn-810
    n1=Okihiro (syndrome de) | n2=en:selective estrogen receptor degrader arn-810 | rel=r_associated | relid=0 | w=10
  5323. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:selective estrogen receptor degrader azd9496
    n1=Okihiro (syndrome de) | n2=en:selective estrogen receptor degrader azd9496 | rel=r_associated | relid=0 | w=10
  5324. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:selective estrogen receptor degrader lsz102
    n1=Okihiro (syndrome de) | n2=en:selective estrogen receptor degrader lsz102 | rel=r_associated | relid=0 | w=10
  5325. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:selective estrogen receptor degrader srn-927
    n1=Okihiro (syndrome de) | n2=en:selective estrogen receptor degrader srn-927 | rel=r_associated | relid=0 | w=10
  5326. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:selective estrogen receptor degrader/modulator rad1901
    n1=Okihiro (syndrome de) | n2=en:selective estrogen receptor degrader/modulator rad1901 | rel=r_associated | relid=0 | w=10
  5327. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:selenium
    n1=Okihiro (syndrome de) | n2=en:selenium | rel=r_associated | relid=0 | w=10
  5328. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:seliciclib
    n1=Okihiro (syndrome de) | n2=en:seliciclib | rel=r_associated | relid=0 | w=10
  5329. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:selinexor
    n1=Okihiro (syndrome de) | n2=en:selinexor | rel=r_associated | relid=0 | w=10
  5330. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sella turcica
    n1=Okihiro (syndrome de) | n2=en:sella turcica | rel=r_associated | relid=0 | w=10
  5331. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:selumetinib
    n1=Okihiro (syndrome de) | n2=en:selumetinib | rel=r_associated | relid=0 | w=10
  5332. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:semaxanib
    n1=Okihiro (syndrome de) | n2=en:semaxanib | rel=r_associated | relid=0 | w=10
  5333. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:semuloparin
    n1=Okihiro (syndrome de) | n2=en:semuloparin | rel=r_associated | relid=0 | w=10
  5334. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:semustine
    n1=Okihiro (syndrome de) | n2=en:semustine | rel=r_associated | relid=0 | w=10
  5335. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:seneca valley virus-001
    n1=Okihiro (syndrome de) | n2=en:seneca valley virus-001 | rel=r_associated | relid=0 | w=10
  5336. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:senna extract
    n1=Okihiro (syndrome de) | n2=en:senna extract | rel=r_associated | relid=0 | w=10
  5337. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:senna fruit
    n1=Okihiro (syndrome de) | n2=en:senna fruit | rel=r_associated | relid=0 | w=10
  5338. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sennosides
    n1=Okihiro (syndrome de) | n2=en:sennosides | rel=r_associated | relid=0 | w=10
  5339. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:seocalcitol
    n1=Okihiro (syndrome de) | n2=en:seocalcitol | rel=r_associated | relid=0 | w=10
  5340. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sepantronium bromide
    n1=Okihiro (syndrome de) | n2=en:sepantronium bromide | rel=r_associated | relid=0 | w=10
  5341. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:seribantumab
    n1=Okihiro (syndrome de) | n2=en:seribantumab | rel=r_associated | relid=0 | w=10
  5342. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:serine protease inhibitor wx-671
    n1=Okihiro (syndrome de) | n2=en:serine protease inhibitor wx-671 | rel=r_associated | relid=0 | w=10
  5343. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:serine/threonine kinase inhibitor xl418
    n1=Okihiro (syndrome de) | n2=en:serine/threonine kinase inhibitor xl418 | rel=r_associated | relid=0 | w=10
  5344. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:serotonin 5-ht1 receptor agonists
    n1=Okihiro (syndrome de) | n2=en:serotonin 5-ht1 receptor agonists | rel=r_associated | relid=0 | w=10
  5345. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:serotonin antagonists [moa]
    n1=Okihiro (syndrome de) | n2=en:serotonin antagonists [moa] | rel=r_associated | relid=0 | w=10
  5346. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:serotonin uptake inhibitors
    n1=Okihiro (syndrome de) | n2=en:serotonin uptake inhibitors | rel=r_associated | relid=0 | w=10
  5347. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sertindole
    n1=Okihiro (syndrome de) | n2=en:sertindole | rel=r_associated | relid=0 | w=10
  5348. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sertraline
    n1=Okihiro (syndrome de) | n2=en:sertraline | rel=r_associated | relid=0 | w=10
  5349. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sertraline hydrochloride
    n1=Okihiro (syndrome de) | n2=en:sertraline hydrochloride | rel=r_associated | relid=0 | w=10
  5350. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:serum-derived bovine immunoglobulin protein isolate
    n1=Okihiro (syndrome de) | n2=en:serum-derived bovine immunoglobulin protein isolate | rel=r_associated | relid=0 | w=10
  5351. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sevacizumab
    n1=Okihiro (syndrome de) | n2=en:sevacizumab | rel=r_associated | relid=0 | w=10
  5352. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sevelamer
    n1=Okihiro (syndrome de) | n2=en:sevelamer | rel=r_associated | relid=0 | w=10
  5353. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sevoflurane
    n1=Okihiro (syndrome de) | n2=en:sevoflurane | rel=r_associated | relid=0 | w=10
  5354. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sh u04722
    n1=Okihiro (syndrome de) | n2=en:sh u04722 | rel=r_associated | relid=0 | w=10
  5355. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:shark cartilage
    n1=Okihiro (syndrome de) | n2=en:shark cartilage | rel=r_associated | relid=0 | w=10
  5356. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:shark cartilage extract ae-941
    n1=Okihiro (syndrome de) | n2=en:shark cartilage extract ae-941 | rel=r_associated | relid=0 | w=10
  5357. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sheddase inhibitor incb007839
    n1=Okihiro (syndrome de) | n2=en:sheddase inhibitor incb007839 | rel=r_associated | relid=0 | w=10
  5358. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sheng-mai san
    n1=Okihiro (syndrome de) | n2=en:sheng-mai san | rel=r_associated | relid=0 | w=10
  5359. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sheng-yu-tang
    n1=Okihiro (syndrome de) | n2=en:sheng-yu-tang | rel=r_associated | relid=0 | w=10
  5360. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:shi pi yin herbal decoction
    n1=Okihiro (syndrome de) | n2=en:shi pi yin herbal decoction | rel=r_associated | relid=0 | w=10
  5361. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:shiitake mushroom preparation
    n1=Okihiro (syndrome de) | n2=en:shiitake mushroom preparation | rel=r_associated | relid=0 | w=10
  5362. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sho-saiko-to
    n1=Okihiro (syndrome de) | n2=en:sho-saiko-to | rel=r_associated | relid=0 | w=10
  5363. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:short chain fatty acid hqk-1004
    n1=Okihiro (syndrome de) | n2=en:short chain fatty acid hqk-1004 | rel=r_associated | relid=0 | w=10
  5364. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:shu yu wan formula
    n1=Okihiro (syndrome de) | n2=en:shu yu wan formula | rel=r_associated | relid=0 | w=10
  5365. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sialyl lewis-keyhole limpet hemocyanin conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:sialyl lewis-keyhole limpet hemocyanin conjugate vaccine | rel=r_associated | relid=0 | w=10
  5366. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sialyl tn antigen
    n1=Okihiro (syndrome de) | n2=en:sialyl tn antigen | rel=r_associated | relid=0 | w=10
  5367. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sibutramine
    n1=Okihiro (syndrome de) | n2=en:sibutramine | rel=r_associated | relid=0 | w=10
  5368. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sig12d loder
    n1=Okihiro (syndrome de) | n2=en:sig12d loder | rel=r_associated | relid=0 | w=10
  5369. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:silatecan ar-67
    n1=Okihiro (syndrome de) | n2=en:silatecan ar-67 | rel=r_associated | relid=0 | w=10
  5370. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sildenafil
    n1=Okihiro (syndrome de) | n2=en:sildenafil | rel=r_associated | relid=0 | w=10
  5371. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sildenafil citrate
    n1=Okihiro (syndrome de) | n2=en:sildenafil citrate | rel=r_associated | relid=0 | w=10
  5372. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:silicon
    n1=Okihiro (syndrome de) | n2=en:silicon | rel=r_associated | relid=0 | w=10
  5373. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:silicon phthalocyanine 4
    n1=Okihiro (syndrome de) | n2=en:silicon phthalocyanine 4 | rel=r_associated | relid=0 | w=10
  5374. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:silmitasertib
    n1=Okihiro (syndrome de) | n2=en:silmitasertib | rel=r_associated | relid=0 | w=10
  5375. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:silodosin
    n1=Okihiro (syndrome de) | n2=en:silodosin | rel=r_associated | relid=0 | w=10
  5376. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:siltuximab
    n1=Okihiro (syndrome de) | n2=en:siltuximab | rel=r_associated | relid=0 | w=10
  5377. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:silver nitrate
    n1=Okihiro (syndrome de) | n2=en:silver nitrate | rel=r_associated | relid=0 | w=10
  5378. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:silver sulfadiazine
    n1=Okihiro (syndrome de) | n2=en:silver sulfadiazine | rel=r_associated | relid=0 | w=10
  5379. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:silymarin
    n1=Okihiro (syndrome de) | n2=en:silymarin | rel=r_associated | relid=0 | w=10
  5380. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:simethicone
    n1=Okihiro (syndrome de) | n2=en:simethicone | rel=r_associated | relid=0 | w=10
  5381. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:simmitecan hydrochloride
    n1=Okihiro (syndrome de) | n2=en:simmitecan hydrochloride | rel=r_associated | relid=0 | w=10
  5382. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:simo decoction
    n1=Okihiro (syndrome de) | n2=en:simo decoction | rel=r_associated | relid=0 | w=10
  5383. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:simotinib hydrochloride
    n1=Okihiro (syndrome de) | n2=en:simotinib hydrochloride | rel=r_associated | relid=0 | w=10
  5384. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:simple syrup vehicle
    n1=Okihiro (syndrome de) | n2=en:simple syrup vehicle | rel=r_associated | relid=0 | w=10
  5385. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:simtuzumab
    n1=Okihiro (syndrome de) | n2=en:simtuzumab | rel=r_associated | relid=0 | w=10
  5386. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:simvastatin
    n1=Okihiro (syndrome de) | n2=en:simvastatin | rel=r_associated | relid=0 | w=10
  5387. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:siplizumab
    n1=Okihiro (syndrome de) | n2=en:siplizumab | rel=r_associated | relid=0 | w=10
  5388. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sipuleucel-t
    n1=Okihiro (syndrome de) | n2=en:sipuleucel-t | rel=r_associated | relid=0 | w=10
  5389. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sirna-expressing sv40 vector
    n1=Okihiro (syndrome de) | n2=en:sirna-expressing sv40 vector | rel=r_associated | relid=0 | w=10
  5390. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sirna-transfected peripheral blood mononuclear cells apn401
    n1=Okihiro (syndrome de) | n2=en:sirna-transfected peripheral blood mononuclear cells apn401 | rel=r_associated | relid=0 | w=10
  5391. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sirolimus
    n1=Okihiro (syndrome de) | n2=en:sirolimus | rel=r_associated | relid=0 | w=10
  5392. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sirpa-fc fusion protein tti-621
    n1=Okihiro (syndrome de) | n2=en:sirpa-fc fusion protein tti-621 | rel=r_associated | relid=0 | w=10
  5393. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sitagliptin phosphate
    n1=Okihiro (syndrome de) | n2=en:sitagliptin phosphate | rel=r_associated | relid=0 | w=10
  5394. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sivifene
    n1=Okihiro (syndrome de) | n2=en:sivifene | rel=r_associated | relid=0 | w=10
  5395. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sizofiran
    n1=Okihiro (syndrome de) | n2=en:sizofiran | rel=r_associated | relid=0 | w=10
  5396. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:skeletal muscle relaxants
    n1=Okihiro (syndrome de) | n2=en:skeletal muscle relaxants | rel=r_associated | relid=0 | w=10
  5397. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:skull
    n1=Okihiro (syndrome de) | n2=en:skull | rel=r_associated | relid=0 | w=10
  5398. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:skullcap
    n1=Okihiro (syndrome de) | n2=en:skullcap | rel=r_associated | relid=0 | w=10
  5399. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:smac mimetic gdc-0152
    n1=Okihiro (syndrome de) | n2=en:smac mimetic gdc-0152 | rel=r_associated | relid=0 | w=10
  5400. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:smac mimetic gdc-0917
    n1=Okihiro (syndrome de) | n2=en:smac mimetic gdc-0917 | rel=r_associated | relid=0 | w=10
  5401. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:smac mimetic lcl161
    n1=Okihiro (syndrome de) | n2=en:smac mimetic lcl161 | rel=r_associated | relid=0 | w=10
  5402. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:smoked plum
    n1=Okihiro (syndrome de) | n2=en:smoked plum | rel=r_associated | relid=0 | w=10
  5403. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:smokeless tobacco
    n1=Okihiro (syndrome de) | n2=en:smokeless tobacco | rel=r_associated | relid=0 | w=10
  5404. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:smooth muscle relaxant
    n1=Okihiro (syndrome de) | n2=en:smooth muscle relaxant | rel=r_associated | relid=0 | w=10
  5405. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:smoothened antagonist bms-833923
    n1=Okihiro (syndrome de) | n2=en:smoothened antagonist bms-833923 | rel=r_associated | relid=0 | w=10
  5406. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:smoothened antagonist lde225 topical
    n1=Okihiro (syndrome de) | n2=en:smoothened antagonist lde225 topical | rel=r_associated | relid=0 | w=10
  5407. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:smoothened antagonist leq506
    n1=Okihiro (syndrome de) | n2=en:smoothened antagonist leq506 | rel=r_associated | relid=0 | w=10
  5408. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:smoothened antagonist tak-441
    n1=Okihiro (syndrome de) | n2=en:smoothened antagonist tak-441 | rel=r_associated | relid=0 | w=10
  5409. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sn-38-loaded polymeric micelles nk012
    n1=Okihiro (syndrome de) | n2=en:sn-38-loaded polymeric micelles nk012 | rel=r_associated | relid=0 | w=10
  5410. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sns01-t nanoparticles
    n1=Okihiro (syndrome de) | n2=en:sns01-t nanoparticles | rel=r_associated | relid=0 | w=10
  5411. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:soblidotin
    n1=Okihiro (syndrome de) | n2=en:soblidotin | rel=r_associated | relid=0 | w=10
  5412. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium alginate microspheres
    n1=Okihiro (syndrome de) | n2=en:sodium alginate microspheres | rel=r_associated | relid=0 | w=10
  5413. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium bicarbonate
    n1=Okihiro (syndrome de) | n2=en:sodium bicarbonate | rel=r_associated | relid=0 | w=10
  5414. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium bicarbonate solution
    n1=Okihiro (syndrome de) | n2=en:sodium bicarbonate solution | rel=r_associated | relid=0 | w=10
  5415. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium bicarbonate/potassium bicarbonate/anhydrous citric acid
    n1=Okihiro (syndrome de) | n2=en:sodium bicarbonate/potassium bicarbonate/anhydrous citric acid | rel=r_associated | relid=0 | w=10
  5416. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium borate anhydrous
    n1=Okihiro (syndrome de) | n2=en:sodium borate anhydrous | rel=r_associated | relid=0 | w=10
  5417. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium borocaptate
    n1=Okihiro (syndrome de) | n2=en:sodium borocaptate | rel=r_associated | relid=0 | w=10
  5418. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium butyrate
    n1=Okihiro (syndrome de) | n2=en:sodium butyrate | rel=r_associated | relid=0 | w=10
  5419. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium carboxymethylcellulose dressing
    n1=Okihiro (syndrome de) | n2=en:sodium carboxymethylcellulose dressing | rel=r_associated | relid=0 | w=10
  5420. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium chromate cr-51
    n1=Okihiro (syndrome de) | n2=en:sodium chromate cr-51 | rel=r_associated | relid=0 | w=10
  5421. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium citrate
    n1=Okihiro (syndrome de) | n2=en:sodium citrate | rel=r_associated | relid=0 | w=10
  5422. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium citrate and citric acid
    n1=Okihiro (syndrome de) | n2=en:sodium citrate and citric acid | rel=r_associated | relid=0 | w=10
  5423. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium dibunate
    n1=Okihiro (syndrome de) | n2=en:sodium dibunate | rel=r_associated | relid=0 | w=10
  5424. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium dichloroacetate
    n1=Okihiro (syndrome de) | n2=en:sodium dichloroacetate | rel=r_associated | relid=0 | w=10
  5425. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium ferric gluconate complex in sucrose
    n1=Okihiro (syndrome de) | n2=en:sodium ferric gluconate complex in sucrose | rel=r_associated | relid=0 | w=10
  5426. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium fluoride
    n1=Okihiro (syndrome de) | n2=en:sodium fluoride | rel=r_associated | relid=0 | w=10
  5427. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium gluconate
    n1=Okihiro (syndrome de) | n2=en:sodium gluconate | rel=r_associated | relid=0 | w=10
  5428. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium glycididazole
    n1=Okihiro (syndrome de) | n2=en:sodium glycididazole | rel=r_associated | relid=0 | w=10
  5429. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium hyaluronate topical hydrogel
    n1=Okihiro (syndrome de) | n2=en:sodium hyaluronate topical hydrogel | rel=r_associated | relid=0 | w=10
  5430. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium iodide i-131
    n1=Okihiro (syndrome de) | n2=en:sodium iodide i-131 | rel=r_associated | relid=0 | w=10
  5431. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium lauryl sulfate
    n1=Okihiro (syndrome de) | n2=en:sodium lauryl sulfate | rel=r_associated | relid=0 | w=10
  5432. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium metaarsenite
    n1=Okihiro (syndrome de) | n2=en:sodium metaarsenite | rel=r_associated | relid=0 | w=10
  5433. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium morrhuate
    n1=Okihiro (syndrome de) | n2=en:sodium morrhuate | rel=r_associated | relid=0 | w=10
  5434. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium oxybate
    n1=Okihiro (syndrome de) | n2=en:sodium oxybate | rel=r_associated | relid=0 | w=10
  5435. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium phenylbutyrate
    n1=Okihiro (syndrome de) | n2=en:sodium phenylbutyrate | rel=r_associated | relid=0 | w=10
  5436. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium phosphate
    n1=Okihiro (syndrome de) | n2=en:sodium phosphate | rel=r_associated | relid=0 | w=10
  5437. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium phosphate/sodium biphosphate laxative
    n1=Okihiro (syndrome de) | n2=en:sodium phosphate/sodium biphosphate laxative | rel=r_associated | relid=0 | w=10
  5438. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium picosulfate/magnesium oxide/citric acid laxative
    n1=Okihiro (syndrome de) | n2=en:sodium picosulfate/magnesium oxide/citric acid laxative | rel=r_associated | relid=0 | w=10
  5439. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium pyrophosphate
    n1=Okihiro (syndrome de) | n2=en:sodium pyrophosphate | rel=r_associated | relid=0 | w=10
  5440. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium ricinoleate
    n1=Okihiro (syndrome de) | n2=en:sodium ricinoleate | rel=r_associated | relid=0 | w=10
  5441. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium salicylate
    n1=Okihiro (syndrome de) | n2=en:sodium salicylate | rel=r_associated | relid=0 | w=10
  5442. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium selenite
    n1=Okihiro (syndrome de) | n2=en:sodium selenite | rel=r_associated | relid=0 | w=10
  5443. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium stibogluconate
    n1=Okihiro (syndrome de) | n2=en:sodium stibogluconate | rel=r_associated | relid=0 | w=10
  5444. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium sulfate/potassium sulfate/magnesium sulfate-based laxative
    n1=Okihiro (syndrome de) | n2=en:sodium sulfate/potassium sulfate/magnesium sulfate-based laxative | rel=r_associated | relid=0 | w=10
  5445. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sodium thiosulfate
    n1=Okihiro (syndrome de) | n2=en:sodium thiosulfate | rel=r_associated | relid=0 | w=10
  5446. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sofosbuvir
    n1=Okihiro (syndrome de) | n2=en:sofosbuvir | rel=r_associated | relid=0 | w=10
  5447. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:solifenacin succinate
    n1=Okihiro (syndrome de) | n2=en:solifenacin succinate | rel=r_associated | relid=0 | w=10
  5448. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:solitomab
    n1=Okihiro (syndrome de) | n2=en:solitomab | rel=r_associated | relid=0 | w=10
  5449. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:solution
    n1=Okihiro (syndrome de) | n2=en:solution | rel=r_associated | relid=0 | w=10
  5450. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:somatropin
    n1=Okihiro (syndrome de) | n2=en:somatropin | rel=r_associated | relid=0 | w=10
  5451. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sonepcizumab
    n1=Okihiro (syndrome de) | n2=en:sonepcizumab | rel=r_associated | relid=0 | w=10
  5452. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sonepiprazole
    n1=Okihiro (syndrome de) | n2=en:sonepiprazole | rel=r_associated | relid=0 | w=10
  5453. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sonidegib
    n1=Okihiro (syndrome de) | n2=en:sonidegib | rel=r_associated | relid=0 | w=10
  5454. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sorafenib tosylate
    n1=Okihiro (syndrome de) | n2=en:sorafenib tosylate | rel=r_associated | relid=0 | w=10
  5455. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sorghum bicolor supplement
    n1=Okihiro (syndrome de) | n2=en:sorghum bicolor supplement | rel=r_associated | relid=0 | w=10
  5456. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sorivudine
    n1=Okihiro (syndrome de) | n2=en:sorivudine | rel=r_associated | relid=0 | w=10
  5457. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sotagliflozin
    n1=Okihiro (syndrome de) | n2=en:sotagliflozin | rel=r_associated | relid=0 | w=10
  5458. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sotatercept
    n1=Okihiro (syndrome de) | n2=en:sotatercept | rel=r_associated | relid=0 | w=10
  5459. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sotrastaurin acetate
    n1=Okihiro (syndrome de) | n2=en:sotrastaurin acetate | rel=r_associated | relid=0 | w=10
  5460. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:soy isoflavones
    n1=Okihiro (syndrome de) | n2=en:soy isoflavones | rel=r_associated | relid=0 | w=10
  5461. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:soy lecithin/glycerol dioleate-based oral spray
    n1=Okihiro (syndrome de) | n2=en:soy lecithin/glycerol dioleate-based oral spray | rel=r_associated | relid=0 | w=10
  5462. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:soy protein isolate
    n1=Okihiro (syndrome de) | n2=en:soy protein isolate | rel=r_associated | relid=0 | w=10
  5463. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:soybean oil
    n1=Okihiro (syndrome de) | n2=en:soybean oil | rel=r_associated | relid=0 | w=10
  5464. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sparfosic acid
    n1=Okihiro (syndrome de) | n2=en:sparfosic acid | rel=r_associated | relid=0 | w=10
  5465. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sparteine sulfate
    n1=Okihiro (syndrome de) | n2=en:sparteine sulfate | rel=r_associated | relid=0 | w=10
  5466. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:spebrutinib
    n1=Okihiro (syndrome de) | n2=en:spebrutinib | rel=r_associated | relid=0 | w=10
  5467. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sphingosine kinase-2 inhibitor abc294640
    n1=Okihiro (syndrome de) | n2=en:sphingosine kinase-2 inhibitor abc294640 | rel=r_associated | relid=0 | w=10
  5468. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:spiclomazine
    n1=Okihiro (syndrome de) | n2=en:spiclomazine | rel=r_associated | relid=0 | w=10
  5469. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:spinous process
    n1=Okihiro (syndrome de) | n2=en:spinous process | rel=r_associated | relid=0 | w=10
  5470. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:spiramide
    n1=Okihiro (syndrome de) | n2=en:spiramide | rel=r_associated | relid=0 | w=10
  5471. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:spiramycin
    n1=Okihiro (syndrome de) | n2=en:spiramycin | rel=r_associated | relid=0 | w=10
  5472. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:spirogermanium
    n1=Okihiro (syndrome de) | n2=en:spirogermanium | rel=r_associated | relid=0 | w=10
  5473. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:spiromustine
    n1=Okihiro (syndrome de) | n2=en:spiromustine | rel=r_associated | relid=0 | w=10
  5474. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:spironolactone
    n1=Okihiro (syndrome de) | n2=en:spironolactone | rel=r_associated | relid=0 | w=10
  5475. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:spiroplatin
    n1=Okihiro (syndrome de) | n2=en:spiroplatin | rel=r_associated | relid=0 | w=10
  5476. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:spleen tyrosine kinase inhibitor tak-659
    n1=Okihiro (syndrome de) | n2=en:spleen tyrosine kinase inhibitor tak-659 | rel=r_associated | relid=0 | w=10
  5477. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:squalamine lactate
    n1=Okihiro (syndrome de) | n2=en:squalamine lactate | rel=r_associated | relid=0 | w=10
  5478. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sr-t100 gel
    n1=Okihiro (syndrome de) | n2=en:sr-t100 gel | rel=r_associated | relid=0 | w=10
  5479. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sr31747a
    n1=Okihiro (syndrome de) | n2=en:sr31747a | rel=r_associated | relid=0 | w=10
  5480. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:src kinase inhibitor kx2-391
    n1=Okihiro (syndrome de) | n2=en:src kinase inhibitor kx2-391 | rel=r_associated | relid=0 | w=10
  5481. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:src kinase inhibitor kx2-391 ointment
    n1=Okihiro (syndrome de) | n2=en:src kinase inhibitor kx2-391 ointment | rel=r_associated | relid=0 | w=10
  5482. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:src/abl kinase inhibitor azd0424
    n1=Okihiro (syndrome de) | n2=en:src/abl kinase inhibitor azd0424 | rel=r_associated | relid=0 | w=10
  5483. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:src/tubulin inhibitor kx02
    n1=Okihiro (syndrome de) | n2=en:src/tubulin inhibitor kx02 | rel=r_associated | relid=0 | w=10
  5484. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ss1(dsfv)-pe38 immunotoxin
    n1=Okihiro (syndrome de) | n2=en:ss1(dsfv)-pe38 immunotoxin | rel=r_associated | relid=0 | w=10
  5485. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ssr411298
    n1=Okihiro (syndrome de) | n2=en:ssr411298 | rel=r_associated | relid=0 | w=10
  5486. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:st. john's wort
    n1=Okihiro (syndrome de) | n2=en:st. john's wort | rel=r_associated | relid=0 | w=10
  5487. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:stabilized sulphur hexafluoride microbubble-based contrast agent
    n1=Okihiro (syndrome de) | n2=en:stabilized sulphur hexafluoride microbubble-based contrast agent | rel=r_associated | relid=0 | w=10
  5488. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:standardized freeze-dried table grape powder
    n1=Okihiro (syndrome de) | n2=en:standardized freeze-dried table grape powder | rel=r_associated | relid=0 | w=10
  5489. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:stanford v regimen
    n1=Okihiro (syndrome de) | n2=en:stanford v regimen | rel=r_associated | relid=0 | w=10
  5490. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:stanozolol
    n1=Okihiro (syndrome de) | n2=en:stanozolol | rel=r_associated | relid=0 | w=10
  5491. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:staphage lysate
    n1=Okihiro (syndrome de) | n2=en:staphage lysate | rel=r_associated | relid=0 | w=10
  5492. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:staphylococcal enterotoxin a
    n1=Okihiro (syndrome de) | n2=en:staphylococcal enterotoxin a | rel=r_associated | relid=0 | w=10
  5493. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:staphylococcal enterotoxin b
    n1=Okihiro (syndrome de) | n2=en:staphylococcal enterotoxin b | rel=r_associated | relid=0 | w=10
  5494. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:staphylococcus aureus protein a
    n1=Okihiro (syndrome de) | n2=en:staphylococcus aureus protein a | rel=r_associated | relid=0 | w=10
  5495. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:starch, corn
    n1=Okihiro (syndrome de) | n2=en:starch, corn | rel=r_associated | relid=0 | w=10
  5496. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:stat inhibitor opb-111077
    n1=Okihiro (syndrome de) | n2=en:stat inhibitor opb-111077 | rel=r_associated | relid=0 | w=10
  5497. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:stat3 antisense oligonucleotide isis 481464
    n1=Okihiro (syndrome de) | n2=en:stat3 antisense oligonucleotide isis 481464 | rel=r_associated | relid=0 | w=10
  5498. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:stat3 decoy oligonucleotide
    n1=Okihiro (syndrome de) | n2=en:stat3 decoy oligonucleotide | rel=r_associated | relid=0 | w=10
  5499. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:stat3 inhibitor opb-31121
    n1=Okihiro (syndrome de) | n2=en:stat3 inhibitor opb-31121 | rel=r_associated | relid=0 | w=10
  5500. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:stat3 inhibitor opb-51602
    n1=Okihiro (syndrome de) | n2=en:stat3 inhibitor opb-51602 | rel=r_associated | relid=0 | w=10
  5501. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:stavudine
    n1=Okihiro (syndrome de) | n2=en:stavudine | rel=r_associated | relid=0 | w=10
  5502. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sternal manubrium
    n1=Okihiro (syndrome de) | n2=en:sternal manubrium | rel=r_associated | relid=0 | w=10
  5503. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:stimulant/agonist
    n1=Okihiro (syndrome de) | n2=en:stimulant/agonist | rel=r_associated | relid=0 | w=10
  5504. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sting-activating cyclic dinucleotide agonist miw815
    n1=Okihiro (syndrome de) | n2=en:sting-activating cyclic dinucleotide agonist miw815 | rel=r_associated | relid=0 | w=10
  5505. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:storax
    n1=Okihiro (syndrome de) | n2=en:storax | rel=r_associated | relid=0 | w=10
  5506. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:strawberry-blackberry-black raspberry-blueberry mixture
    n1=Okihiro (syndrome de) | n2=en:strawberry-blackberry-black raspberry-blueberry mixture | rel=r_associated | relid=0 | w=10
  5507. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:street drugs
    n1=Okihiro (syndrome de) | n2=en:street drugs | rel=r_associated | relid=0 | w=10
  5508. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:streptavidin
    n1=Okihiro (syndrome de) | n2=en:streptavidin | rel=r_associated | relid=0 | w=10
  5509. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:streptonigrin
    n1=Okihiro (syndrome de) | n2=en:streptonigrin | rel=r_associated | relid=0 | w=10
  5510. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:streptozocin
    n1=Okihiro (syndrome de) | n2=en:streptozocin | rel=r_associated | relid=0 | w=10
  5511. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:strontium chloride sr-89
    n1=Okihiro (syndrome de) | n2=en:strontium chloride sr-89 | rel=r_associated | relid=0 | w=10
  5512. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:structure of articular circumference of ulna
    n1=Okihiro (syndrome de) | n2=en:structure of articular circumference of ulna | rel=r_associated | relid=0 | w=10
  5513. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:structure of coronoid process of ulna
    n1=Okihiro (syndrome de) | n2=en:structure of coronoid process of ulna | rel=r_associated | relid=0 | w=10
  5514. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:structure of olecranon
    n1=Okihiro (syndrome de) | n2=en:structure of olecranon | rel=r_associated | relid=0 | w=10
  5515. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:structure of proximal shaft of ulna
    n1=Okihiro (syndrome de) | n2=en:structure of proximal shaft of ulna | rel=r_associated | relid=0 | w=10
  5516. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:structure of radial notch of ulna
    n1=Okihiro (syndrome de) | n2=en:structure of radial notch of ulna | rel=r_associated | relid=0 | w=10
  5517. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:structure of styloid process of ulna
    n1=Okihiro (syndrome de) | n2=en:structure of styloid process of ulna | rel=r_associated | relid=0 | w=10
  5518. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:structure of trochlear fossa of ulna
    n1=Okihiro (syndrome de) | n2=en:structure of trochlear fossa of ulna | rel=r_associated | relid=0 | w=10
  5519. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:structure of ulnar tuberosity
    n1=Okihiro (syndrome de) | n2=en:structure of ulnar tuberosity | rel=r_associated | relid=0 | w=10
  5520. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:su014813
    n1=Okihiro (syndrome de) | n2=en:su014813 | rel=r_associated | relid=0 | w=10
  5521. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:substance p-saporin
    n1=Okihiro (syndrome de) | n2=en:substance p-saporin | rel=r_associated | relid=0 | w=10
  5522. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:substance p/neurokinin 1 receptor antagonist
    n1=Okihiro (syndrome de) | n2=en:substance p/neurokinin 1 receptor antagonist | rel=r_associated | relid=0 | w=10
  5523. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:succinimides
    n1=Okihiro (syndrome de) | n2=en:succinimides | rel=r_associated | relid=0 | w=10
  5524. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sucralfate
    n1=Okihiro (syndrome de) | n2=en:sucralfate | rel=r_associated | relid=0 | w=10
  5525. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sufentanil citrate
    n1=Okihiro (syndrome de) | n2=en:sufentanil citrate | rel=r_associated | relid=0 | w=10
  5526. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sufentanil transdermal system
    n1=Okihiro (syndrome de) | n2=en:sufentanil transdermal system | rel=r_associated | relid=0 | w=10
  5527. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sufosfamide
    n1=Okihiro (syndrome de) | n2=en:sufosfamide | rel=r_associated | relid=0 | w=10
  5528. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sugammadex sodium
    n1=Okihiro (syndrome de) | n2=en:sugammadex sodium | rel=r_associated | relid=0 | w=10
  5529. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sulazepam
    n1=Okihiro (syndrome de) | n2=en:sulazepam | rel=r_associated | relid=0 | w=10
  5530. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sulfasalazine
    n1=Okihiro (syndrome de) | n2=en:sulfasalazine | rel=r_associated | relid=0 | w=10
  5531. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sulfate-based laxative bli850
    n1=Okihiro (syndrome de) | n2=en:sulfate-based laxative bli850 | rel=r_associated | relid=0 | w=10
  5532. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sulfatinib
    n1=Okihiro (syndrome de) | n2=en:sulfatinib | rel=r_associated | relid=0 | w=10
  5533. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sulfinpyrazone
    n1=Okihiro (syndrome de) | n2=en:sulfinpyrazone | rel=r_associated | relid=0 | w=10
  5534. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sulforaphane
    n1=Okihiro (syndrome de) | n2=en:sulforaphane | rel=r_associated | relid=0 | w=10
  5535. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sulforaphane-cyclodextrin complex
    n1=Okihiro (syndrome de) | n2=en:sulforaphane-cyclodextrin complex | rel=r_associated | relid=0 | w=10
  5536. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sulforidazine
    n1=Okihiro (syndrome de) | n2=en:sulforidazine | rel=r_associated | relid=0 | w=10
  5537. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sulfur and/or sulfur compound
    n1=Okihiro (syndrome de) | n2=en:sulfur and/or sulfur compound | rel=r_associated | relid=0 | w=10
  5538. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sulfur hexafluoride
    n1=Okihiro (syndrome de) | n2=en:sulfur hexafluoride | rel=r_associated | relid=0 | w=10
  5539. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sulindac
    n1=Okihiro (syndrome de) | n2=en:sulindac | rel=r_associated | relid=0 | w=10
  5540. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sulmepride
    n1=Okihiro (syndrome de) | n2=en:sulmepride | rel=r_associated | relid=0 | w=10
  5541. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sulofenur
    n1=Okihiro (syndrome de) | n2=en:sulofenur | rel=r_associated | relid=0 | w=10
  5542. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sultopride
    n1=Okihiro (syndrome de) | n2=en:sultopride | rel=r_associated | relid=0 | w=10
  5543. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sumac/black cumin powder
    n1=Okihiro (syndrome de) | n2=en:sumac/black cumin powder | rel=r_associated | relid=0 | w=10
  5544. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sumatriptan succinate
    n1=Okihiro (syndrome de) | n2=en:sumatriptan succinate | rel=r_associated | relid=0 | w=10
  5545. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sun protection agent md-3511356
    n1=Okihiro (syndrome de) | n2=en:sun protection agent md-3511356 | rel=r_associated | relid=0 | w=10
  5546. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sun's soup
    n1=Okihiro (syndrome de) | n2=en:sun's soup | rel=r_associated | relid=0 | w=10
  5547. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sunitinib malate
    n1=Okihiro (syndrome de) | n2=en:sunitinib malate | rel=r_associated | relid=0 | w=10
  5548. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sunless tanning lotion
    n1=Okihiro (syndrome de) | n2=en:sunless tanning lotion | rel=r_associated | relid=0 | w=10
  5549. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sunscreen
    n1=Okihiro (syndrome de) | n2=en:sunscreen | rel=r_associated | relid=0 | w=10
  5550. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803
    n1=Okihiro (syndrome de) | n2=en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803 | rel=r_associated | relid=0 | w=10
  5551. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:supersaturated calcium phosphate rinse
    n1=Okihiro (syndrome de) | n2=en:supersaturated calcium phosphate rinse | rel=r_associated | relid=0 | w=10
  5552. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:suramin
    n1=Okihiro (syndrome de) | n2=en:suramin | rel=r_associated | relid=0 | w=10
  5553. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:surface-active agent
    n1=Okihiro (syndrome de) | n2=en:surface-active agent | rel=r_associated | relid=0 | w=10
  5554. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:suriclone
    n1=Okihiro (syndrome de) | n2=en:suriclone | rel=r_associated | relid=0 | w=10
  5555. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:survivin antigen
    n1=Okihiro (syndrome de) | n2=en:survivin antigen | rel=r_associated | relid=0 | w=10
  5556. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:survivin antigen vaccine dpx-survivac
    n1=Okihiro (syndrome de) | n2=en:survivin antigen vaccine dpx-survivac | rel=r_associated | relid=0 | w=10
  5557. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:survivin mrna antagonist ezn-3042
    n1=Okihiro (syndrome de) | n2=en:survivin mrna antagonist ezn-3042 | rel=r_associated | relid=0 | w=10
  5558. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:survivin sur1m2 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:survivin sur1m2 peptide vaccine | rel=r_associated | relid=0 | w=10
  5559. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:survivin/p53/her2 antigen-loaded autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:survivin/p53/her2 antigen-loaded autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  5560. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sustained-release lipid inhaled cisplatin
    n1=Okihiro (syndrome de) | n2=en:sustained-release lipid inhaled cisplatin | rel=r_associated | relid=0 | w=10
  5561. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sustained-release mitomycin c hydrogel formulation
    n1=Okihiro (syndrome de) | n2=en:sustained-release mitomycin c hydrogel formulation | rel=r_associated | relid=0 | w=10
  5562. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:suvorexant
    n1=Okihiro (syndrome de) | n2=en:suvorexant | rel=r_associated | relid=0 | w=10
  5563. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:svn53-67/m57-klh peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:svn53-67/m57-klh peptide vaccine | rel=r_associated | relid=0 | w=10
  5564. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:syk inhibitor hmpl-523
    n1=Okihiro (syndrome de) | n2=en:syk inhibitor hmpl-523 | rel=r_associated | relid=0 | w=10
  5565. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:syk-jak inhibitor prt062070
    n1=Okihiro (syndrome de) | n2=en:syk-jak inhibitor prt062070 | rel=r_associated | relid=0 | w=10
  5566. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:symbyax
    n1=Okihiro (syndrome de) | n2=en:symbyax | rel=r_associated | relid=0 | w=10
  5567. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:sympathomimetics
    n1=Okihiro (syndrome de) | n2=en:sympathomimetics | rel=r_associated | relid=0 | w=10
  5568. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synbiotic supplement
    n1=Okihiro (syndrome de) | n2=en:synbiotic supplement | rel=r_associated | relid=0 | w=10
  5569. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synchrotope ta2m plasmid dna vaccine
    n1=Okihiro (syndrome de) | n2=en:synchrotope ta2m plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  5570. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synchrovax sem plasmid dna vaccine
    n1=Okihiro (syndrome de) | n2=en:synchrovax sem plasmid dna vaccine | rel=r_associated | relid=0 | w=10
  5571. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  5572. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synthetic breast cancer peptides-tetanus toxoid-montanide isa-51 vaccine
    n1=Okihiro (syndrome de) | n2=en:synthetic breast cancer peptides-tetanus toxoid-montanide isa-51 vaccine | rel=r_associated | relid=0 | w=10
  5573. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synthetic breast cancer peptides-tetanus toxoid-poly iclc vaccine
    n1=Okihiro (syndrome de) | n2=en:synthetic breast cancer peptides-tetanus toxoid-poly iclc vaccine | rel=r_associated | relid=0 | w=10
  5574. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synthetic cytotoxic triazine derivative
    n1=Okihiro (syndrome de) | n2=en:synthetic cytotoxic triazine derivative | rel=r_associated | relid=0 | w=10
  5575. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synthetic glioblastoma mutated tumor-specific peptides vaccine therapy apvac2
    n1=Okihiro (syndrome de) | n2=en:synthetic glioblastoma mutated tumor-specific peptides vaccine therapy apvac2 | rel=r_associated | relid=0 | w=10
  5576. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synthetic glioblastoma tumor-associated peptides vaccine therapy apvac1
    n1=Okihiro (syndrome de) | n2=en:synthetic glioblastoma tumor-associated peptides vaccine therapy apvac1 | rel=r_associated | relid=0 | w=10
  5577. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synthetic htert dna vaccine ino-1400
    n1=Okihiro (syndrome de) | n2=en:synthetic htert dna vaccine ino-1400 | rel=r_associated | relid=0 | w=10
  5578. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synthetic human papillomavirus 16 e6 peptide
    n1=Okihiro (syndrome de) | n2=en:synthetic human papillomavirus 16 e6 peptide | rel=r_associated | relid=0 | w=10
  5579. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synthetic hypericin
    n1=Okihiro (syndrome de) | n2=en:synthetic hypericin | rel=r_associated | relid=0 | w=10
  5580. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synthetic long e6/e7 peptides vaccine hpv-01
    n1=Okihiro (syndrome de) | n2=en:synthetic long e6/e7 peptides vaccine hpv-01 | rel=r_associated | relid=0 | w=10
  5581. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synthetic melanoma-associated antigens vaccine
    n1=Okihiro (syndrome de) | n2=en:synthetic melanoma-associated antigens vaccine | rel=r_associated | relid=0 | w=10
  5582. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:synthetic peptides e-pra and e-psm vaccine
    n1=Okihiro (syndrome de) | n2=en:synthetic peptides e-pra and e-psm vaccine | rel=r_associated | relid=0 | w=10
  5583. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:syp-0704a
    n1=Okihiro (syndrome de) | n2=en:syp-0704a | rel=r_associated | relid=0 | w=10
  5584. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:t-type calcium channel blocker abt-639
    n1=Okihiro (syndrome de) | n2=en:t-type calcium channel blocker abt-639 | rel=r_associated | relid=0 | w=10
  5585. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:t1e28z car-expressing autologous cd4-positive t lymphocytes
    n1=Okihiro (syndrome de) | n2=en:t1e28z car-expressing autologous cd4-positive t lymphocytes | rel=r_associated | relid=0 | w=10
  5586. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:t4n5 liposomal lotion
    n1=Okihiro (syndrome de) | n2=en:t4n5 liposomal lotion | rel=r_associated | relid=0 | w=10
  5587. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:t900607
    n1=Okihiro (syndrome de) | n2=en:t900607 | rel=r_associated | relid=0 | w=10
  5588. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tabalumab
    n1=Okihiro (syndrome de) | n2=en:tabalumab | rel=r_associated | relid=0 | w=10
  5589. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tac regimen
    n1=Okihiro (syndrome de) | n2=en:tac regimen | rel=r_associated | relid=0 | w=10
  5590. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tacedinaline
    n1=Okihiro (syndrome de) | n2=en:tacedinaline | rel=r_associated | relid=0 | w=10
  5591. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tacrolimus
    n1=Okihiro (syndrome de) | n2=en:tacrolimus | rel=r_associated | relid=0 | w=10
  5592. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tadalafil
    n1=Okihiro (syndrome de) | n2=en:tadalafil | rel=r_associated | relid=0 | w=10
  5593. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tafamidis meglumine
    n1=Okihiro (syndrome de) | n2=en:tafamidis meglumine | rel=r_associated | relid=0 | w=10
  5594. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tak-448
    n1=Okihiro (syndrome de) | n2=en:tak-448 | rel=r_associated | relid=0 | w=10
  5595. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:talabostat mesylate
    n1=Okihiro (syndrome de) | n2=en:talabostat mesylate | rel=r_associated | relid=0 | w=10
  5596. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:talactoferrin alfa
    n1=Okihiro (syndrome de) | n2=en:talactoferrin alfa | rel=r_associated | relid=0 | w=10
  5597. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:taladegib
    n1=Okihiro (syndrome de) | n2=en:taladegib | rel=r_associated | relid=0 | w=10
  5598. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:talampanel
    n1=Okihiro (syndrome de) | n2=en:talampanel | rel=r_associated | relid=0 | w=10
  5599. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:talaporfin sodium
    n1=Okihiro (syndrome de) | n2=en:talaporfin sodium | rel=r_associated | relid=0 | w=10
  5600. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:talazoparib
    n1=Okihiro (syndrome de) | n2=en:talazoparib | rel=r_associated | relid=0 | w=10
  5601. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:talc
    n1=Okihiro (syndrome de) | n2=en:talc | rel=r_associated | relid=0 | w=10
  5602. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:taliglucerase alfa
    n1=Okihiro (syndrome de) | n2=en:taliglucerase alfa | rel=r_associated | relid=0 | w=10
  5603. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:talimogene laherparepvec
    n1=Okihiro (syndrome de) | n2=en:talimogene laherparepvec | rel=r_associated | relid=0 | w=10
  5604. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tallimustine
    n1=Okihiro (syndrome de) | n2=en:tallimustine | rel=r_associated | relid=0 | w=10
  5605. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:talmapimod
    n1=Okihiro (syndrome de) | n2=en:talmapimod | rel=r_associated | relid=0 | w=10
  5606. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:talotrexin ammonium
    n1=Okihiro (syndrome de) | n2=en:talotrexin ammonium | rel=r_associated | relid=0 | w=10
  5607. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:taltirelin hydrate
    n1=Okihiro (syndrome de) | n2=en:taltirelin hydrate | rel=r_associated | relid=0 | w=10
  5608. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tamibarotene
    n1=Okihiro (syndrome de) | n2=en:tamibarotene | rel=r_associated | relid=0 | w=10
  5609. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tamoxifen
    n1=Okihiro (syndrome de) | n2=en:tamoxifen | rel=r_associated | relid=0 | w=10
  5610. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tamoxifen citrate
    n1=Okihiro (syndrome de) | n2=en:tamoxifen citrate | rel=r_associated | relid=0 | w=10
  5611. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tamsulosin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:tamsulosin hydrochloride | rel=r_associated | relid=0 | w=10
  5612. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tandutinib
    n1=Okihiro (syndrome de) | n2=en:tandutinib | rel=r_associated | relid=0 | w=10
  5613. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tanespimycin
    n1=Okihiro (syndrome de) | n2=en:tanespimycin | rel=r_associated | relid=0 | w=10
  5614. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tanezumab
    n1=Okihiro (syndrome de) | n2=en:tanezumab | rel=r_associated | relid=0 | w=10
  5615. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tangerine tomato juice
    n1=Okihiro (syndrome de) | n2=en:tangerine tomato juice | rel=r_associated | relid=0 | w=10
  5616. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tanibirumab
    n1=Okihiro (syndrome de) | n2=en:tanibirumab | rel=r_associated | relid=0 | w=10
  5617. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tanomastat
    n1=Okihiro (syndrome de) | n2=en:tanomastat | rel=r_associated | relid=0 | w=10
  5618. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tapentadol hydrochloride
    n1=Okihiro (syndrome de) | n2=en:tapentadol hydrochloride | rel=r_associated | relid=0 | w=10
  5619. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tarenflurbil
    n1=Okihiro (syndrome de) | n2=en:tarenflurbil | rel=r_associated | relid=0 | w=10
  5620. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tarextumab
    n1=Okihiro (syndrome de) | n2=en:tarextumab | rel=r_associated | relid=0 | w=10
  5621. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tariquidar
    n1=Okihiro (syndrome de) | n2=en:tariquidar | rel=r_associated | relid=0 | w=10
  5622. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tarp 27-35 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:tarp 27-35 peptide vaccine | rel=r_associated | relid=0 | w=10
  5623. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tarp 29-37-9v peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:tarp 29-37-9v peptide vaccine | rel=r_associated | relid=0 | w=10
  5624. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tas-108
    n1=Okihiro (syndrome de) | n2=en:tas-108 | rel=r_associated | relid=0 | w=10
  5625. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:taselisib
    n1=Okihiro (syndrome de) | n2=en:taselisib | rel=r_associated | relid=0 | w=10
  5626. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tasidotin
    n1=Okihiro (syndrome de) | n2=en:tasidotin | rel=r_associated | relid=0 | w=10
  5627. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tasisulam sodium
    n1=Okihiro (syndrome de) | n2=en:tasisulam sodium | rel=r_associated | relid=0 | w=10
  5628. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tasquinimod
    n1=Okihiro (syndrome de) | n2=en:tasquinimod | rel=r_associated | relid=0 | w=10
  5629. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:taurolidine
    n1=Okihiro (syndrome de) | n2=en:taurolidine | rel=r_associated | relid=0 | w=10
  5630. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tauromustine
    n1=Okihiro (syndrome de) | n2=en:tauromustine | rel=r_associated | relid=0 | w=10
  5631. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:taxane analogue mst-997
    n1=Okihiro (syndrome de) | n2=en:taxane analogue mst-997 | rel=r_associated | relid=0 | w=10
  5632. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:taxane analogue tpi 287
    n1=Okihiro (syndrome de) | n2=en:taxane analogue tpi 287 | rel=r_associated | relid=0 | w=10
  5633. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:taxane derivative
    n1=Okihiro (syndrome de) | n2=en:taxane derivative | rel=r_associated | relid=0 | w=10
  5634. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:taxol analogue sid 530
    n1=Okihiro (syndrome de) | n2=en:taxol analogue sid 530 | rel=r_associated | relid=0 | w=10
  5635. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tazarotene
    n1=Okihiro (syndrome de) | n2=en:tazarotene | rel=r_associated | relid=0 | w=10
  5636. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tazemetostat
    n1=Okihiro (syndrome de) | n2=en:tazemetostat | rel=r_associated | relid=0 | w=10
  5637. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tazobactam sodium
    n1=Okihiro (syndrome de) | n2=en:tazobactam sodium | rel=r_associated | relid=0 | w=10
  5638. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tc 99m monoclonal antibody 170
    n1=Okihiro (syndrome de) | n2=en:tc 99m monoclonal antibody 170 | rel=r_associated | relid=0 | w=10
  5639. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tea tree oil
    n1=Okihiro (syndrome de) | n2=en:tea tree oil | rel=r_associated | relid=0 | w=10
  5640. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc 94m sestamibi
    n1=Okihiro (syndrome de) | n2=en:technetium tc 94m sestamibi | rel=r_associated | relid=0 | w=10
  5641. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc 99 hydrazinonicotinamide-tricine-linked interleukin-2
    n1=Okihiro (syndrome de) | n2=en:technetium tc 99 hydrazinonicotinamide-tricine-linked interleukin-2 | rel=r_associated | relid=0 | w=10
  5642. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc 99m epratuzumab
    n1=Okihiro (syndrome de) | n2=en:technetium tc 99m epratuzumab | rel=r_associated | relid=0 | w=10
  5643. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc 99m galactosyl human serum albumin
    n1=Okihiro (syndrome de) | n2=en:technetium tc 99m galactosyl human serum albumin | rel=r_associated | relid=0 | w=10
  5644. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc 99m mip 1405
    n1=Okihiro (syndrome de) | n2=en:technetium tc 99m mip 1405 | rel=r_associated | relid=0 | w=10
  5645. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc 99m trofolastat
    n1=Okihiro (syndrome de) | n2=en:technetium tc 99m trofolastat | rel=r_associated | relid=0 | w=10
  5646. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc 99m-3prgd2
    n1=Okihiro (syndrome de) | n2=en:technetium tc 99m-3prgd2 | rel=r_associated | relid=0 | w=10
  5647. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc 99m-labeled albumin microspheres
    n1=Okihiro (syndrome de) | n2=en:technetium tc 99m-labeled albumin microspheres | rel=r_associated | relid=0 | w=10
  5648. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc 99m-labeled rhenium sulfide nanocolloid
    n1=Okihiro (syndrome de) | n2=en:technetium tc 99m-labeled rhenium sulfide nanocolloid | rel=r_associated | relid=0 | w=10
  5649. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc 99m-labeled tilmanocept
    n1=Okihiro (syndrome de) | n2=en:technetium tc 99m-labeled tilmanocept | rel=r_associated | relid=0 | w=10
  5650. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m | rel=r_associated | relid=0 | w=10
  5651. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m albumin aggregated
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m albumin aggregated | rel=r_associated | relid=0 | w=10
  5652. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m demobesin-4
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m demobesin-4 | rel=r_associated | relid=0 | w=10
  5653. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m dextran
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m dextran | rel=r_associated | relid=0 | w=10
  5654. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m dtpa
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m dtpa | rel=r_associated | relid=0 | w=10
  5655. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m ethylenedicysteine-deoxyglucose
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m ethylenedicysteine-deoxyglucose | rel=r_associated | relid=0 | w=10
  5656. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m glycopeptide
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m glycopeptide | rel=r_associated | relid=0 | w=10
  5657. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m human serum albumin colloid
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m human serum albumin colloid | rel=r_associated | relid=0 | w=10
  5658. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m hydroxydiphosphonate
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m hydroxydiphosphonate | rel=r_associated | relid=0 | w=10
  5659. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m mebrofenin
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m mebrofenin | rel=r_associated | relid=0 | w=10
  5660. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m medronate
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m medronate | rel=r_associated | relid=0 | w=10
  5661. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m sestamibi
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m sestamibi | rel=r_associated | relid=0 | w=10
  5662. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m sodium pertechnetate
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m sodium pertechnetate | rel=r_associated | relid=0 | w=10
  5663. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m sulfur colloid
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m sulfur colloid | rel=r_associated | relid=0 | w=10
  5664. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:technetium tc-99m-nc100692
    n1=Okihiro (syndrome de) | n2=en:technetium tc-99m-nc100692 | rel=r_associated | relid=0 | w=10
  5665. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tecogalan sodium
    n1=Okihiro (syndrome de) | n2=en:tecogalan sodium | rel=r_associated | relid=0 | w=10
  5666. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:teduglutide
    n1=Okihiro (syndrome de) | n2=en:teduglutide | rel=r_associated | relid=0 | w=10
  5667. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:teflutixol
    n1=Okihiro (syndrome de) | n2=en:teflutixol | rel=r_associated | relid=0 | w=10
  5668. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tegafur
    n1=Okihiro (syndrome de) | n2=en:tegafur | rel=r_associated | relid=0 | w=10
  5669. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tegafur-gimeracil-oteracil potassium
    n1=Okihiro (syndrome de) | n2=en:tegafur-gimeracil-oteracil potassium | rel=r_associated | relid=0 | w=10
  5670. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tegafur-gimeracil-oteracil potassium-leucovorin calcium oral formulation
    n1=Okihiro (syndrome de) | n2=en:tegafur-gimeracil-oteracil potassium-leucovorin calcium oral formulation | rel=r_associated | relid=0 | w=10
  5671. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tegafur-uracil
    n1=Okihiro (syndrome de) | n2=en:tegafur-uracil | rel=r_associated | relid=0 | w=10
  5672. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tegaserod
    n1=Okihiro (syndrome de) | n2=en:tegaserod | rel=r_associated | relid=0 | w=10
  5673. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:teglarinad chloride
    n1=Okihiro (syndrome de) | n2=en:teglarinad chloride | rel=r_associated | relid=0 | w=10
  5674. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:teicoplanin
    n1=Okihiro (syndrome de) | n2=en:teicoplanin | rel=r_associated | relid=0 | w=10
  5675. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:telaprevir
    n1=Okihiro (syndrome de) | n2=en:telaprevir | rel=r_associated | relid=0 | w=10
  5676. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:telapristone acetate
    n1=Okihiro (syndrome de) | n2=en:telapristone acetate | rel=r_associated | relid=0 | w=10
  5677. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:telatinib mesylate
    n1=Okihiro (syndrome de) | n2=en:telatinib mesylate | rel=r_associated | relid=0 | w=10
  5678. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:telavancin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:telavancin hydrochloride | rel=r_associated | relid=0 | w=10
  5679. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:telbivudine
    n1=Okihiro (syndrome de) | n2=en:telbivudine | rel=r_associated | relid=0 | w=10
  5680. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:telomerase peptide vaccine gv1001
    n1=Okihiro (syndrome de) | n2=en:telomerase peptide vaccine gv1001 | rel=r_associated | relid=0 | w=10
  5681. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:telomerase-specific type 5 adenovirus obp-301
    n1=Okihiro (syndrome de) | n2=en:telomerase-specific type 5 adenovirus obp-301 | rel=r_associated | relid=0 | w=10
  5682. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:telomerase: 540-548 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:telomerase: 540-548 peptide vaccine | rel=r_associated | relid=0 | w=10
  5683. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:telotristat etiprate
    n1=Okihiro (syndrome de) | n2=en:telotristat etiprate | rel=r_associated | relid=0 | w=10
  5684. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:teloxantrone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:teloxantrone hydrochloride | rel=r_associated | relid=0 | w=10
  5685. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:temazepam
    n1=Okihiro (syndrome de) | n2=en:temazepam | rel=r_associated | relid=0 | w=10
  5686. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:temoporfin
    n1=Okihiro (syndrome de) | n2=en:temoporfin | rel=r_associated | relid=0 | w=10
  5687. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:temozolomide
    n1=Okihiro (syndrome de) | n2=en:temozolomide | rel=r_associated | relid=0 | w=10
  5688. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:temsirolimus
    n1=Okihiro (syndrome de) | n2=en:temsirolimus | rel=r_associated | relid=0 | w=10
  5689. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tenifatecan
    n1=Okihiro (syndrome de) | n2=en:tenifatecan | rel=r_associated | relid=0 | w=10
  5690. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tenilapine
    n1=Okihiro (syndrome de) | n2=en:tenilapine | rel=r_associated | relid=0 | w=10
  5691. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:teniposide
    n1=Okihiro (syndrome de) | n2=en:teniposide | rel=r_associated | relid=0 | w=10
  5692. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tenofovir
    n1=Okihiro (syndrome de) | n2=en:tenofovir | rel=r_associated | relid=0 | w=10
  5693. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tenofovir disoproxil fumarate
    n1=Okihiro (syndrome de) | n2=en:tenofovir disoproxil fumarate | rel=r_associated | relid=0 | w=10
  5694. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tepotinib
    n1=Okihiro (syndrome de) | n2=en:tepotinib | rel=r_associated | relid=0 | w=10
  5695. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:teprotumumab
    n1=Okihiro (syndrome de) | n2=en:teprotumumab | rel=r_associated | relid=0 | w=10
  5696. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:terameprocol
    n1=Okihiro (syndrome de) | n2=en:terameprocol | rel=r_associated | relid=0 | w=10
  5697. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:teratogen
    n1=Okihiro (syndrome de) | n2=en:teratogen | rel=r_associated | relid=0 | w=10
  5698. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:terazosin
    n1=Okihiro (syndrome de) | n2=en:terazosin | rel=r_associated | relid=0 | w=10
  5699. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:terbequinil
    n1=Okihiro (syndrome de) | n2=en:terbequinil | rel=r_associated | relid=0 | w=10
  5700. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:terephthalamidine
    n1=Okihiro (syndrome de) | n2=en:terephthalamidine | rel=r_associated | relid=0 | w=10
  5701. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tergenpumatucel-l
    n1=Okihiro (syndrome de) | n2=en:tergenpumatucel-l | rel=r_associated | relid=0 | w=10
  5702. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:teroxirone
    n1=Okihiro (syndrome de) | n2=en:teroxirone | rel=r_associated | relid=0 | w=10
  5703. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tesetaxel
    n1=Okihiro (syndrome de) | n2=en:tesetaxel | rel=r_associated | relid=0 | w=10
  5704. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tesevatinib
    n1=Okihiro (syndrome de) | n2=en:tesevatinib | rel=r_associated | relid=0 | w=10
  5705. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tesmilifene
    n1=Okihiro (syndrome de) | n2=en:tesmilifene | rel=r_associated | relid=0 | w=10
  5706. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:testolactone
    n1=Okihiro (syndrome de) | n2=en:testolactone | rel=r_associated | relid=0 | w=10
  5707. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:testosterone cypionate
    n1=Okihiro (syndrome de) | n2=en:testosterone cypionate | rel=r_associated | relid=0 | w=10
  5708. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:testosterone enanthate
    n1=Okihiro (syndrome de) | n2=en:testosterone enanthate | rel=r_associated | relid=0 | w=10
  5709. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:testosterone gel
    n1=Okihiro (syndrome de) | n2=en:testosterone gel | rel=r_associated | relid=0 | w=10
  5710. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:testosterone undecanoate
    n1=Okihiro (syndrome de) | n2=en:testosterone undecanoate | rel=r_associated | relid=0 | w=10
  5711. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:testosterone vaginal cream
    n1=Okihiro (syndrome de) | n2=en:testosterone vaginal cream | rel=r_associated | relid=0 | w=10
  5712. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tetanus peptide melanoma vaccine
    n1=Okihiro (syndrome de) | n2=en:tetanus peptide melanoma vaccine | rel=r_associated | relid=0 | w=10
  5713. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tetanus toxoid helper peptide
    n1=Okihiro (syndrome de) | n2=en:tetanus toxoid helper peptide | rel=r_associated | relid=0 | w=10
  5714. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tetanus toxoid vaccine
    n1=Okihiro (syndrome de) | n2=en:tetanus toxoid vaccine | rel=r_associated | relid=0 | w=10
  5715. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tetanus-cmv fusion peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:tetanus-cmv fusion peptide vaccine | rel=r_associated | relid=0 | w=10
  5716. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tetracaine
    n1=Okihiro (syndrome de) | n2=en:tetracaine | rel=r_associated | relid=0 | w=10
  5717. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tetracyclic antidepressant
    n1=Okihiro (syndrome de) | n2=en:tetracyclic antidepressant | rel=r_associated | relid=0 | w=10
  5718. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tetracycline antibiotic
    n1=Okihiro (syndrome de) | n2=en:tetracycline antibiotic | rel=r_associated | relid=0 | w=10
  5719. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tetracycline hydrochloride
    n1=Okihiro (syndrome de) | n2=en:tetracycline hydrochloride | rel=r_associated | relid=0 | w=10
  5720. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tetradecanoylphorbol acetate
    n1=Okihiro (syndrome de) | n2=en:tetradecanoylphorbol acetate | rel=r_associated | relid=0 | w=10
  5721. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tetrahydrouridine
    n1=Okihiro (syndrome de) | n2=en:tetrahydrouridine | rel=r_associated | relid=0 | w=10
  5722. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tetraphenyl chlorin disulfonate
    n1=Okihiro (syndrome de) | n2=en:tetraphenyl chlorin disulfonate | rel=r_associated | relid=0 | w=10
  5723. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tetravalent rna-lipoplex cancer vaccine
    n1=Okihiro (syndrome de) | n2=en:tetravalent rna-lipoplex cancer vaccine | rel=r_associated | relid=0 | w=10
  5724. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tetrazepam
    n1=Okihiro (syndrome de) | n2=en:tetrazepam | rel=r_associated | relid=0 | w=10
  5725. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tetrodotoxin
    n1=Okihiro (syndrome de) | n2=en:tetrodotoxin | rel=r_associated | relid=0 | w=10
  5726. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tezacitabine
    n1=Okihiro (syndrome de) | n2=en:tezacitabine | rel=r_associated | relid=0 | w=10
  5727. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tf(c)-klh conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:tf(c)-klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  5728. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tgf-beta-resistant lmp-specific cytotoxic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:tgf-beta-resistant lmp-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  5729. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tgfa-pe38 immunotoxin
    n1=Okihiro (syndrome de) | n2=en:tgfa-pe38 immunotoxin | rel=r_associated | relid=0 | w=10
  5730. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tgfbdnrii-transduced autologous tumor infiltrating lymphocytes
    n1=Okihiro (syndrome de) | n2=en:tgfbdnrii-transduced autologous tumor infiltrating lymphocytes | rel=r_associated | relid=0 | w=10
  5731. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thalicarpine
    n1=Okihiro (syndrome de) | n2=en:thalicarpine | rel=r_associated | relid=0 | w=10
  5732. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thalidomide
    n1=Okihiro (syndrome de) | n2=en:thalidomide | rel=r_associated | relid=0 | w=10
  5733. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:theophylline
    n1=Okihiro (syndrome de) | n2=en:theophylline | rel=r_associated | relid=0 | w=10
  5734. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:theramide
    n1=Okihiro (syndrome de) | n2=en:theramide | rel=r_associated | relid=0 | w=10
  5735. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic allogeneic cytotoxic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:therapeutic allogeneic cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  5736. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic allogeneic lymphocytes
    n1=Okihiro (syndrome de) | n2=en:therapeutic allogeneic lymphocytes | rel=r_associated | relid=0 | w=10
  5737. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic androstanolone
    n1=Okihiro (syndrome de) | n2=en:therapeutic androstanolone | rel=r_associated | relid=0 | w=10
  5738. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic angiotensin-(1-7)
    n1=Okihiro (syndrome de) | n2=en:therapeutic angiotensin-(1-7) | rel=r_associated | relid=0 | w=10
  5739. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic autologous dendritic cells
    n1=Okihiro (syndrome de) | n2=en:therapeutic autologous dendritic cells | rel=r_associated | relid=0 | w=10
  5740. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic autologous lymphocytes
    n1=Okihiro (syndrome de) | n2=en:therapeutic autologous lymphocytes | rel=r_associated | relid=0 | w=10
  5741. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic breast/ovarian/prostate peptide cancer vaccine dpx-0907
    n1=Okihiro (syndrome de) | n2=en:therapeutic breast/ovarian/prostate peptide cancer vaccine dpx-0907 | rel=r_associated | relid=0 | w=10
  5742. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic cortisone
    n1=Okihiro (syndrome de) | n2=en:therapeutic cortisone | rel=r_associated | relid=0 | w=10
  5743. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic dendritic cells/cytokine-induced killer cells
    n1=Okihiro (syndrome de) | n2=en:therapeutic dendritic cells/cytokine-induced killer cells | rel=r_associated | relid=0 | w=10
  5744. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic epinephrine
    n1=Okihiro (syndrome de) | n2=en:therapeutic epinephrine | rel=r_associated | relid=0 | w=10
  5745. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic estetrol
    n1=Okihiro (syndrome de) | n2=en:therapeutic estetrol | rel=r_associated | relid=0 | w=10
  5746. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic estradiol
    n1=Okihiro (syndrome de) | n2=en:therapeutic estradiol | rel=r_associated | relid=0 | w=10
  5747. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic estrogen
    n1=Okihiro (syndrome de) | n2=en:therapeutic estrogen | rel=r_associated | relid=0 | w=10
  5748. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic estrone
    n1=Okihiro (syndrome de) | n2=en:therapeutic estrone | rel=r_associated | relid=0 | w=10
  5749. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic gamma delta t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:therapeutic gamma delta t-lymphocytes | rel=r_associated | relid=0 | w=10
  5750. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic hemin
    n1=Okihiro (syndrome de) | n2=en:therapeutic hemin | rel=r_associated | relid=0 | w=10
  5751. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic hepatitis c immune globulin
    n1=Okihiro (syndrome de) | n2=en:therapeutic hepatitis c immune globulin | rel=r_associated | relid=0 | w=10
  5752. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic hydrocortisone
    n1=Okihiro (syndrome de) | n2=en:therapeutic hydrocortisone | rel=r_associated | relid=0 | w=10
  5753. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic immune globulin
    n1=Okihiro (syndrome de) | n2=en:therapeutic immune globulin | rel=r_associated | relid=0 | w=10
  5754. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic insulin
    n1=Okihiro (syndrome de) | n2=en:therapeutic insulin | rel=r_associated | relid=0 | w=10
  5755. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic melatonin
    n1=Okihiro (syndrome de) | n2=en:therapeutic melatonin | rel=r_associated | relid=0 | w=10
  5756. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic progesterone
    n1=Okihiro (syndrome de) | n2=en:therapeutic progesterone | rel=r_associated | relid=0 | w=10
  5757. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic testosterone
    n1=Okihiro (syndrome de) | n2=en:therapeutic testosterone | rel=r_associated | relid=0 | w=10
  5758. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:therapeutic tumor infiltrating lymphocytes
    n1=Okihiro (syndrome de) | n2=en:therapeutic tumor infiltrating lymphocytes | rel=r_associated | relid=0 | w=10
  5759. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thiabendazole
    n1=Okihiro (syndrome de) | n2=en:thiabendazole | rel=r_associated | relid=0 | w=10
  5760. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thiamine
    n1=Okihiro (syndrome de) | n2=en:thiamine | rel=r_associated | relid=0 | w=10
  5761. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thiarabine
    n1=Okihiro (syndrome de) | n2=en:thiarabine | rel=r_associated | relid=0 | w=10
  5762. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thiazide diuretic
    n1=Okihiro (syndrome de) | n2=en:thiazide diuretic | rel=r_associated | relid=0 | w=10
  5763. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thiethylperazine malate
    n1=Okihiro (syndrome de) | n2=en:thiethylperazine malate | rel=r_associated | relid=0 | w=10
  5764. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thioguanine
    n1=Okihiro (syndrome de) | n2=en:thioguanine | rel=r_associated | relid=0 | w=10
  5765. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thioinosine
    n1=Okihiro (syndrome de) | n2=en:thioinosine | rel=r_associated | relid=0 | w=10
  5766. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thioproperazine
    n1=Okihiro (syndrome de) | n2=en:thioproperazine | rel=r_associated | relid=0 | w=10
  5767. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thioproperazine mesylate
    n1=Okihiro (syndrome de) | n2=en:thioproperazine mesylate | rel=r_associated | relid=0 | w=10
  5768. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thioredoxin-1 inhibitor px-12
    n1=Okihiro (syndrome de) | n2=en:thioredoxin-1 inhibitor px-12 | rel=r_associated | relid=0 | w=10
  5769. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thioridazine
    n1=Okihiro (syndrome de) | n2=en:thioridazine | rel=r_associated | relid=0 | w=10
  5770. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thioridazine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:thioridazine hydrochloride | rel=r_associated | relid=0 | w=10
  5771. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thiotepa
    n1=Okihiro (syndrome de) | n2=en:thiotepa | rel=r_associated | relid=0 | w=10
  5772. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thiothixene
    n1=Okihiro (syndrome de) | n2=en:thiothixene | rel=r_associated | relid=0 | w=10
  5773. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thiothixene hydrochloride
    n1=Okihiro (syndrome de) | n2=en:thiothixene hydrochloride | rel=r_associated | relid=0 | w=10
  5774. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thioureidobutyronitrile
    n1=Okihiro (syndrome de) | n2=en:thioureidobutyronitrile | rel=r_associated | relid=0 | w=10
  5775. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thioxanthene derivative antipsychotic agent
    n1=Okihiro (syndrome de) | n2=en:thioxanthene derivative antipsychotic agent | rel=r_associated | relid=0 | w=10
  5776. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thl-p
    n1=Okihiro (syndrome de) | n2=en:thl-p | rel=r_associated | relid=0 | w=10
  5777. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thomsen-friedenreich antigen
    n1=Okihiro (syndrome de) | n2=en:thomsen-friedenreich antigen | rel=r_associated | relid=0 | w=10
  5778. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thoracic spine
    n1=Okihiro (syndrome de) | n2=en:thoracic spine | rel=r_associated | relid=0 | w=10
  5779. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:threonine tyrosine kinase inhibitor cfi-402257
    n1=Okihiro (syndrome de) | n2=en:threonine tyrosine kinase inhibitor cfi-402257 | rel=r_associated | relid=0 | w=10
  5780. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thrombolytic agent
    n1=Okihiro (syndrome de) | n2=en:thrombolytic agent | rel=r_associated | relid=0 | w=10
  5781. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thrombopoietin receptor agonist lgd-4665
    n1=Okihiro (syndrome de) | n2=en:thrombopoietin receptor agonist lgd-4665 | rel=r_associated | relid=0 | w=10
  5782. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thymidine
    n1=Okihiro (syndrome de) | n2=en:thymidine | rel=r_associated | relid=0 | w=10
  5783. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thymidylate synthase inhibitor dfp-11207
    n1=Okihiro (syndrome de) | n2=en:thymidylate synthase inhibitor dfp-11207 | rel=r_associated | relid=0 | w=10
  5784. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thymopentin
    n1=Okihiro (syndrome de) | n2=en:thymopentin | rel=r_associated | relid=0 | w=10
  5785. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thyroid extract
    n1=Okihiro (syndrome de) | n2=en:thyroid extract | rel=r_associated | relid=0 | w=10
  5786. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thyroid hormone
    n1=Okihiro (syndrome de) | n2=en:thyroid hormone | rel=r_associated | relid=0 | w=10
  5787. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thyroid-stimulating hormone
    n1=Okihiro (syndrome de) | n2=en:thyroid-stimulating hormone | rel=r_associated | relid=0 | w=10
  5788. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:thyroxine
    n1=Okihiro (syndrome de) | n2=en:thyroxine | rel=r_associated | relid=0 | w=10
  5789. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tiagabine
    n1=Okihiro (syndrome de) | n2=en:tiagabine | rel=r_associated | relid=0 | w=10
  5790. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tiazofurin
    n1=Okihiro (syndrome de) | n2=en:tiazofurin | rel=r_associated | relid=0 | w=10
  5791. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tibial shaft
    n1=Okihiro (syndrome de) | n2=en:tibial shaft | rel=r_associated | relid=0 | w=10
  5792. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tibolone
    n1=Okihiro (syndrome de) | n2=en:tibolone | rel=r_associated | relid=0 | w=10
  5793. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ticarcillin
    n1=Okihiro (syndrome de) | n2=en:ticarcillin | rel=r_associated | relid=0 | w=10
  5794. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ticlopidine
    n1=Okihiro (syndrome de) | n2=en:ticlopidine | rel=r_associated | relid=0 | w=10
  5795. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tienocarbine
    n1=Okihiro (syndrome de) | n2=en:tienocarbine | rel=r_associated | relid=0 | w=10
  5796. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tigapotide
    n1=Okihiro (syndrome de) | n2=en:tigapotide | rel=r_associated | relid=0 | w=10
  5797. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tigatuzumab
    n1=Okihiro (syndrome de) | n2=en:tigatuzumab | rel=r_associated | relid=0 | w=10
  5798. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tigecycline
    n1=Okihiro (syndrome de) | n2=en:tigecycline | rel=r_associated | relid=0 | w=10
  5799. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:til 1383i t cell receptor-transduced autologous t cells
    n1=Okihiro (syndrome de) | n2=en:til 1383i t cell receptor-transduced autologous t cells | rel=r_associated | relid=0 | w=10
  5800. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tilarginine
    n1=Okihiro (syndrome de) | n2=en:tilarginine | rel=r_associated | relid=0 | w=10
  5801. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tilozepine
    n1=Okihiro (syndrome de) | n2=en:tilozepine | rel=r_associated | relid=0 | w=10
  5802. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:timcodar dimesylate
    n1=Okihiro (syndrome de) | n2=en:timcodar dimesylate | rel=r_associated | relid=0 | w=10
  5803. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:timelotem
    n1=Okihiro (syndrome de) | n2=en:timelotem | rel=r_associated | relid=0 | w=10
  5804. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:timirdine
    n1=Okihiro (syndrome de) | n2=en:timirdine | rel=r_associated | relid=0 | w=10
  5805. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:timolol maleate gel forming solution
    n1=Okihiro (syndrome de) | n2=en:timolol maleate gel forming solution | rel=r_associated | relid=0 | w=10
  5806. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:timonacic
    n1=Okihiro (syndrome de) | n2=en:timonacic | rel=r_associated | relid=0 | w=10
  5807. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tin ethyl etiopurpurin
    n1=Okihiro (syndrome de) | n2=en:tin ethyl etiopurpurin | rel=r_associated | relid=0 | w=10
  5808. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tin sn 117m dtpa
    n1=Okihiro (syndrome de) | n2=en:tin sn 117m dtpa | rel=r_associated | relid=0 | w=10
  5809. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tinidazole
    n1=Okihiro (syndrome de) | n2=en:tinidazole | rel=r_associated | relid=0 | w=10
  5810. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tinzaparin sodium
    n1=Okihiro (syndrome de) | n2=en:tinzaparin sodium | rel=r_associated | relid=0 | w=10
  5811. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tiomolibdate diammonium
    n1=Okihiro (syndrome de) | n2=en:tiomolibdate diammonium | rel=r_associated | relid=0 | w=10
  5812. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tiotropium bromide monohydrate
    n1=Okihiro (syndrome de) | n2=en:tiotropium bromide monohydrate | rel=r_associated | relid=0 | w=10
  5813. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tipifarnib
    n1=Okihiro (syndrome de) | n2=en:tipifarnib | rel=r_associated | relid=0 | w=10
  5814. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tipranavir
    n1=Okihiro (syndrome de) | n2=en:tipranavir | rel=r_associated | relid=0 | w=10
  5815. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tirapazamine
    n1=Okihiro (syndrome de) | n2=en:tirapazamine | rel=r_associated | relid=0 | w=10
  5816. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tirofiban
    n1=Okihiro (syndrome de) | n2=en:tirofiban | rel=r_associated | relid=0 | w=10
  5817. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:titanium dioxide/zinc oxide sunscreen
    n1=Okihiro (syndrome de) | n2=en:titanium dioxide/zinc oxide sunscreen | rel=r_associated | relid=0 | w=10
  5818. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tivantinib
    n1=Okihiro (syndrome de) | n2=en:tivantinib | rel=r_associated | relid=0 | w=10
  5819. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tivozanib
    n1=Okihiro (syndrome de) | n2=en:tivozanib | rel=r_associated | relid=0 | w=10
  5820. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tizanidine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:tizanidine hydrochloride | rel=r_associated | relid=0 | w=10
  5821. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tlr 7/8 agonist medi9197
    n1=Okihiro (syndrome de) | n2=en:tlr 7/8 agonist medi9197 | rel=r_associated | relid=0 | w=10
  5822. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tlr agonist cadi-05
    n1=Okihiro (syndrome de) | n2=en:tlr agonist cadi-05 | rel=r_associated | relid=0 | w=10
  5823. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tlr-directed cationic lipid-dna complex jvrs-100
    n1=Okihiro (syndrome de) | n2=en:tlr-directed cationic lipid-dna complex jvrs-100 | rel=r_associated | relid=0 | w=10
  5824. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tlr4 agonist gla-se
    n1=Okihiro (syndrome de) | n2=en:tlr4 agonist gla-se | rel=r_associated | relid=0 | w=10
  5825. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tlr4 agonist gsk1795091
    n1=Okihiro (syndrome de) | n2=en:tlr4 agonist gsk1795091 | rel=r_associated | relid=0 | w=10
  5826. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tlr7 agonist 852a
    n1=Okihiro (syndrome de) | n2=en:tlr7 agonist 852a | rel=r_associated | relid=0 | w=10
  5827. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tlr7 agonist ana773 tosylate
    n1=Okihiro (syndrome de) | n2=en:tlr7 agonist ana773 tosylate | rel=r_associated | relid=0 | w=10
  5828. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tlr7/8/9 antagonist imo-8400
    n1=Okihiro (syndrome de) | n2=en:tlr7/8/9 antagonist imo-8400 | rel=r_associated | relid=0 | w=10
  5829. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tlr8 agonist vtx-2337
    n1=Okihiro (syndrome de) | n2=en:tlr8 agonist vtx-2337 | rel=r_associated | relid=0 | w=10
  5830. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tlr9 agonist duk-cpg-001
    n1=Okihiro (syndrome de) | n2=en:tlr9 agonist duk-cpg-001 | rel=r_associated | relid=0 | w=10
  5831. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tlr9 agonist emd 1201081
    n1=Okihiro (syndrome de) | n2=en:tlr9 agonist emd 1201081 | rel=r_associated | relid=0 | w=10
  5832. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tlr9 agonist mgn1703
    n1=Okihiro (syndrome de) | n2=en:tlr9 agonist mgn1703 | rel=r_associated | relid=0 | w=10
  5833. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tlr9 agonist sd-101
    n1=Okihiro (syndrome de) | n2=en:tlr9 agonist sd-101 | rel=r_associated | relid=0 | w=10
  5834. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tn(c)-klh conjugate vaccine
    n1=Okihiro (syndrome de) | n2=en:tn(c)-klh conjugate vaccine | rel=r_associated | relid=0 | w=10
  5835. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tobramycin sulfate
    n1=Okihiro (syndrome de) | n2=en:tobramycin sulfate | rel=r_associated | relid=0 | w=10
  5836. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tocilizumab
    n1=Okihiro (syndrome de) | n2=en:tocilizumab | rel=r_associated | relid=0 | w=10
  5837. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tocladesine
    n1=Okihiro (syndrome de) | n2=en:tocladesine | rel=r_associated | relid=0 | w=10
  5838. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tocolytic agents
    n1=Okihiro (syndrome de) | n2=en:tocolytic agents | rel=r_associated | relid=0 | w=10
  5839. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tocopherol
    n1=Okihiro (syndrome de) | n2=en:tocopherol | rel=r_associated | relid=0 | w=10
  5840. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tocophersolan
    n1=Okihiro (syndrome de) | n2=en:tocophersolan | rel=r_associated | relid=0 | w=10
  5841. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tocotrienol
    n1=Okihiro (syndrome de) | n2=en:tocotrienol | rel=r_associated | relid=0 | w=10
  5842. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tocotrienol-rich fraction
    n1=Okihiro (syndrome de) | n2=en:tocotrienol-rich fraction | rel=r_associated | relid=0 | w=10
  5843. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tofacitinib
    n1=Okihiro (syndrome de) | n2=en:tofacitinib | rel=r_associated | relid=0 | w=10
  5844. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tolazamide
    n1=Okihiro (syndrome de) | n2=en:tolazamide | rel=r_associated | relid=0 | w=10
  5845. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tolbutamide
    n1=Okihiro (syndrome de) | n2=en:tolbutamide | rel=r_associated | relid=0 | w=10
  5846. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tolfenamic acid
    n1=Okihiro (syndrome de) | n2=en:tolfenamic acid | rel=r_associated | relid=0 | w=10
  5847. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:toll-like receptor 9 agonist imo-2125
    n1=Okihiro (syndrome de) | n2=en:toll-like receptor 9 agonist imo-2125 | rel=r_associated | relid=0 | w=10
  5848. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tolpiprazole
    n1=Okihiro (syndrome de) | n2=en:tolpiprazole | rel=r_associated | relid=0 | w=10
  5849. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tolufazepam
    n1=Okihiro (syndrome de) | n2=en:tolufazepam | rel=r_associated | relid=0 | w=10
  5850. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tolvaptan
    n1=Okihiro (syndrome de) | n2=en:tolvaptan | rel=r_associated | relid=0 | w=10
  5851. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tomato-soy juice
    n1=Okihiro (syndrome de) | n2=en:tomato-soy juice | rel=r_associated | relid=0 | w=10
  5852. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tooth socket
    n1=Okihiro (syndrome de) | n2=en:tooth socket | rel=r_associated | relid=0 | w=10
  5853. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical agent ad17137
    n1=Okihiro (syndrome de) | n2=en:topical agent ad17137 | rel=r_associated | relid=0 | w=10
  5854. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical betulinic acid
    n1=Okihiro (syndrome de) | n2=en:topical betulinic acid | rel=r_associated | relid=0 | w=10
  5855. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical calcitriol
    n1=Okihiro (syndrome de) | n2=en:topical calcitriol | rel=r_associated | relid=0 | w=10
  5856. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical cocaine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:topical cocaine hydrochloride | rel=r_associated | relid=0 | w=10
  5857. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical dosage form
    n1=Okihiro (syndrome de) | n2=en:topical dosage form | rel=r_associated | relid=0 | w=10
  5858. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical fluorouracil
    n1=Okihiro (syndrome de) | n2=en:topical fluorouracil | rel=r_associated | relid=0 | w=10
  5859. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical gemcitabine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:topical gemcitabine hydrochloride | rel=r_associated | relid=0 | w=10
  5860. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical keratin
    n1=Okihiro (syndrome de) | n2=en:topical keratin | rel=r_associated | relid=0 | w=10
  5861. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical lfx453
    n1=Okihiro (syndrome de) | n2=en:topical lfx453 | rel=r_associated | relid=0 | w=10
  5862. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical menthol cream
    n1=Okihiro (syndrome de) | n2=en:topical menthol cream | rel=r_associated | relid=0 | w=10
  5863. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical myristyl nicotinate cream
    n1=Okihiro (syndrome de) | n2=en:topical myristyl nicotinate cream | rel=r_associated | relid=0 | w=10
  5864. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical phenylephrine solution
    n1=Okihiro (syndrome de) | n2=en:topical phenylephrine solution | rel=r_associated | relid=0 | w=10
  5865. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical piperidine nitroxide mts-01
    n1=Okihiro (syndrome de) | n2=en:topical piperidine nitroxide mts-01 | rel=r_associated | relid=0 | w=10
  5866. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical pvdf/sirolimus
    n1=Okihiro (syndrome de) | n2=en:topical pvdf/sirolimus | rel=r_associated | relid=0 | w=10
  5867. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical sirolimus
    n1=Okihiro (syndrome de) | n2=en:topical sirolimus | rel=r_associated | relid=0 | w=10
  5868. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical trichloroacetic acid
    n1=Okihiro (syndrome de) | n2=en:topical trichloroacetic acid | rel=r_associated | relid=0 | w=10
  5869. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical vitamin e
    n1=Okihiro (syndrome de) | n2=en:topical vitamin e | rel=r_associated | relid=0 | w=10
  5870. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topical wound spray hp802-247
    n1=Okihiro (syndrome de) | n2=en:topical wound spray hp802-247 | rel=r_associated | relid=0 | w=10
  5871. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topiramate
    n1=Okihiro (syndrome de) | n2=en:topiramate | rel=r_associated | relid=0 | w=10
  5872. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topoisomerase i inhibitor genz-644282
    n1=Okihiro (syndrome de) | n2=en:topoisomerase i inhibitor genz-644282 | rel=r_associated | relid=0 | w=10
  5873. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topoisomerase i inhibitor lmp400
    n1=Okihiro (syndrome de) | n2=en:topoisomerase i inhibitor lmp400 | rel=r_associated | relid=0 | w=10
  5874. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topoisomerase i inhibitor lmp776
    n1=Okihiro (syndrome de) | n2=en:topoisomerase i inhibitor lmp776 | rel=r_associated | relid=0 | w=10
  5875. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topoisomerase i/ii inhibitor nev-801
    n1=Okihiro (syndrome de) | n2=en:topoisomerase i/ii inhibitor nev-801 | rel=r_associated | relid=0 | w=10
  5876. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topotecan
    n1=Okihiro (syndrome de) | n2=en:topotecan | rel=r_associated | relid=0 | w=10
  5877. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topotecan hydrochloride
    n1=Okihiro (syndrome de) | n2=en:topotecan hydrochloride | rel=r_associated | relid=0 | w=10
  5878. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topotecan hydrochloride liposomes
    n1=Okihiro (syndrome de) | n2=en:topotecan hydrochloride liposomes | rel=r_associated | relid=0 | w=10
  5879. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:topsalysin
    n1=Okihiro (syndrome de) | n2=en:topsalysin | rel=r_associated | relid=0 | w=10
  5880. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:torc1/2 kinase inhibitor ds-3078a
    n1=Okihiro (syndrome de) | n2=en:torc1/2 kinase inhibitor ds-3078a | rel=r_associated | relid=0 | w=10
  5881. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:toremifene
    n1=Okihiro (syndrome de) | n2=en:toremifene | rel=r_associated | relid=0 | w=10
  5882. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tosedostat
    n1=Okihiro (syndrome de) | n2=en:tosedostat | rel=r_associated | relid=0 | w=10
  5883. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tositumomab
    n1=Okihiro (syndrome de) | n2=en:tositumomab | rel=r_associated | relid=0 | w=10
  5884. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tositumomab and iodine i 131 tositumomab
    n1=Okihiro (syndrome de) | n2=en:tositumomab and iodine i 131 tositumomab | rel=r_associated | relid=0 | w=10
  5885. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:total tumor rna-loaded dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:total tumor rna-loaded dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  5886. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:toxicodendron extract
    n1=Okihiro (syndrome de) | n2=en:toxicodendron extract | rel=r_associated | relid=0 | w=10
  5887. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tozasertib lactate
    n1=Okihiro (syndrome de) | n2=en:tozasertib lactate | rel=r_associated | relid=0 | w=10
  5888. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tp40 immunotoxin
    n1=Okihiro (syndrome de) | n2=en:tp40 immunotoxin | rel=r_associated | relid=0 | w=10
  5889. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tpf regimen
    n1=Okihiro (syndrome de) | n2=en:tpf regimen | rel=r_associated | relid=0 | w=10
  5890. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tpo receptor agonist ono-7746
    n1=Okihiro (syndrome de) | n2=en:tpo receptor agonist ono-7746 | rel=r_associated | relid=0 | w=10
  5891. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trabectedin
    n1=Okihiro (syndrome de) | n2=en:trabectedin | rel=r_associated | relid=0 | w=10
  5892. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trabedersen
    n1=Okihiro (syndrome de) | n2=en:trabedersen | rel=r_associated | relid=0 | w=10
  5893. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:traboxopine
    n1=Okihiro (syndrome de) | n2=en:traboxopine | rel=r_associated | relid=0 | w=10
  5894. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tragacanth
    n1=Okihiro (syndrome de) | n2=en:tragacanth | rel=r_associated | relid=0 | w=10
  5895. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trametinib
    n1=Okihiro (syndrome de) | n2=en:trametinib | rel=r_associated | relid=0 | w=10
  5896. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tranexamic acid
    n1=Okihiro (syndrome de) | n2=en:tranexamic acid | rel=r_associated | relid=0 | w=10
  5897. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trans sodium crocetinate
    n1=Okihiro (syndrome de) | n2=en:trans sodium crocetinate | rel=r_associated | relid=0 | w=10
  5898. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:transdermal 17beta-estradiol gel bhr-200
    n1=Okihiro (syndrome de) | n2=en:transdermal 17beta-estradiol gel bhr-200 | rel=r_associated | relid=0 | w=10
  5899. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:transdermal 4-hydroxytestosterone
    n1=Okihiro (syndrome de) | n2=en:transdermal 4-hydroxytestosterone | rel=r_associated | relid=0 | w=10
  5900. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:transdermal estrogen
    n1=Okihiro (syndrome de) | n2=en:transdermal estrogen | rel=r_associated | relid=0 | w=10
  5901. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:transferrin receptor-targeted anti-rrm2 sirna calaa-01
    n1=Okihiro (syndrome de) | n2=en:transferrin receptor-targeted anti-rrm2 sirna calaa-01 | rel=r_associated | relid=0 | w=10
  5902. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:transferrin receptor-targeted liposomal p53 cdna
    n1=Okihiro (syndrome de) | n2=en:transferrin receptor-targeted liposomal p53 cdna | rel=r_associated | relid=0 | w=10
  5903. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:transferrin-crm107
    n1=Okihiro (syndrome de) | n2=en:transferrin-crm107 | rel=r_associated | relid=0 | w=10
  5904. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:transgenic lymphocyte immunization vaccine
    n1=Okihiro (syndrome de) | n2=en:transgenic lymphocyte immunization vaccine | rel=r_associated | relid=0 | w=10
  5905. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:transthyretin antisense oligonucleotide isis-ttr rx
    n1=Okihiro (syndrome de) | n2=en:transthyretin antisense oligonucleotide isis-ttr rx | rel=r_associated | relid=0 | w=10
  5906. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tranylcypromine sulfate
    n1=Okihiro (syndrome de) | n2=en:tranylcypromine sulfate | rel=r_associated | relid=0 | w=10
  5907. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trastuzumab
    n1=Okihiro (syndrome de) | n2=en:trastuzumab | rel=r_associated | relid=0 | w=10
  5908. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trastuzumab emtansine
    n1=Okihiro (syndrome de) | n2=en:trastuzumab emtansine | rel=r_associated | relid=0 | w=10
  5909. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trastuzumab vc-seco-duba
    n1=Okihiro (syndrome de) | n2=en:trastuzumab vc-seco-duba | rel=r_associated | relid=0 | w=10
  5910. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:traumeel s
    n1=Okihiro (syndrome de) | n2=en:traumeel s | rel=r_associated | relid=0 | w=10
  5911. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:treatment-resistant
    n1=Okihiro (syndrome de) | n2=en:treatment-resistant | rel=r_associated | relid=0 | w=10
  5912. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trebananib
    n1=Okihiro (syndrome de) | n2=en:trebananib | rel=r_associated | relid=0 | w=10
  5913. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tremelimumab
    n1=Okihiro (syndrome de) | n2=en:tremelimumab | rel=r_associated | relid=0 | w=10
  5914. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:treosulfan
    n1=Okihiro (syndrome de) | n2=en:treosulfan | rel=r_associated | relid=0 | w=10
  5915. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tretinoin
    n1=Okihiro (syndrome de) | n2=en:tretinoin | rel=r_associated | relid=0 | w=10
  5916. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tretinoin liposome
    n1=Okihiro (syndrome de) | n2=en:tretinoin liposome | rel=r_associated | relid=0 | w=10
  5917. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tri-virus/gd2-specific allogeneic cytotoxic t-lymphocytes
    n1=Okihiro (syndrome de) | n2=en:tri-virus/gd2-specific allogeneic cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=10
  5918. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triamcinolone
    n1=Okihiro (syndrome de) | n2=en:triamcinolone | rel=r_associated | relid=0 | w=10
  5919. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triamcinolone acetonide
    n1=Okihiro (syndrome de) | n2=en:triamcinolone acetonide | rel=r_associated | relid=0 | w=10
  5920. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triapine
    n1=Okihiro (syndrome de) | n2=en:triapine | rel=r_associated | relid=0 | w=10
  5921. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triazene derivative trin2755
    n1=Okihiro (syndrome de) | n2=en:triazene derivative trin2755 | rel=r_associated | relid=0 | w=10
  5922. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triazinate
    n1=Okihiro (syndrome de) | n2=en:triazinate | rel=r_associated | relid=0 | w=10
  5923. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triazolam
    n1=Okihiro (syndrome de) | n2=en:triazolam | rel=r_associated | relid=0 | w=10
  5924. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triazole antifungals
    n1=Okihiro (syndrome de) | n2=en:triazole antifungals | rel=r_associated | relid=0 | w=10
  5925. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tributyrin
    n1=Okihiro (syndrome de) | n2=en:tributyrin | rel=r_associated | relid=0 | w=10
  5926. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trichloromonofluoromethane
    n1=Okihiro (syndrome de) | n2=en:trichloromonofluoromethane | rel=r_associated | relid=0 | w=10
  5927. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triciribine phosphate
    n1=Okihiro (syndrome de) | n2=en:triciribine phosphate | rel=r_associated | relid=0 | w=10
  5928. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triclodazol
    n1=Okihiro (syndrome de) | n2=en:triclodazol | rel=r_associated | relid=0 | w=10
  5929. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tricyclic antidepressant
    n1=Okihiro (syndrome de) | n2=en:tricyclic antidepressant | rel=r_associated | relid=0 | w=10
  5930. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trientine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:trientine hydrochloride | rel=r_associated | relid=0 | w=10
  5931. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triethylenemelamine
    n1=Okihiro (syndrome de) | n2=en:triethylenemelamine | rel=r_associated | relid=0 | w=10
  5932. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trifluoperazine
    n1=Okihiro (syndrome de) | n2=en:trifluoperazine | rel=r_associated | relid=0 | w=10
  5933. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trifluoperazine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:trifluoperazine hydrochloride | rel=r_associated | relid=0 | w=10
  5934. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trifluperidol
    n1=Okihiro (syndrome de) | n2=en:trifluperidol | rel=r_associated | relid=0 | w=10
  5935. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triflupromazine
    n1=Okihiro (syndrome de) | n2=en:triflupromazine | rel=r_associated | relid=0 | w=10
  5936. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triflupromazine hydrochloride
    n1=Okihiro (syndrome de) | n2=en:triflupromazine hydrochloride | rel=r_associated | relid=0 | w=10
  5937. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trifluridine
    n1=Okihiro (syndrome de) | n2=en:trifluridine | rel=r_associated | relid=0 | w=10
  5938. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trifluridine/tipiracil hydrochloride combination agent tas-102
    n1=Okihiro (syndrome de) | n2=en:trifluridine/tipiracil hydrochloride combination agent tas-102 | rel=r_associated | relid=0 | w=10
  5939. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trilostane
    n1=Okihiro (syndrome de) | n2=en:trilostane | rel=r_associated | relid=0 | w=10
  5940. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trimethadione
    n1=Okihiro (syndrome de) | n2=en:trimethadione | rel=r_associated | relid=0 | w=10
  5941. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trimethoprim
    n1=Okihiro (syndrome de) | n2=en:trimethoprim | rel=r_associated | relid=0 | w=10
  5942. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trimethoprim and derivatives
    n1=Okihiro (syndrome de) | n2=en:trimethoprim and derivatives | rel=r_associated | relid=0 | w=10
  5943. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trimethoprim-sulfamethoxazole
    n1=Okihiro (syndrome de) | n2=en:trimethoprim-sulfamethoxazole | rel=r_associated | relid=0 | w=10
  5944. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trimethylcolchicinic acid
    n1=Okihiro (syndrome de) | n2=en:trimethylcolchicinic acid | rel=r_associated | relid=0 | w=10
  5945. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trimetrexate glucuronate
    n1=Okihiro (syndrome de) | n2=en:trimetrexate glucuronate | rel=r_associated | relid=0 | w=10
  5946. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trioxifene mesylate
    n1=Okihiro (syndrome de) | n2=en:trioxifene mesylate | rel=r_associated | relid=0 | w=10
  5947. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trioxsalen
    n1=Okihiro (syndrome de) | n2=en:trioxsalen | rel=r_associated | relid=0 | w=10
  5948. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triptolide analog
    n1=Okihiro (syndrome de) | n2=en:triptolide analog | rel=r_associated | relid=0 | w=10
  5949. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triptorelin
    n1=Okihiro (syndrome de) | n2=en:triptorelin | rel=r_associated | relid=0 | w=10
  5950. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:triptorelin pamoate
    n1=Okihiro (syndrome de) | n2=en:triptorelin pamoate | rel=r_associated | relid=0 | w=10
  5951. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tris-acryl gelatin microspheres
    n1=Okihiro (syndrome de) | n2=en:tris-acryl gelatin microspheres | rel=r_associated | relid=0 | w=10
  5952. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trivalent influenza vaccine
    n1=Okihiro (syndrome de) | n2=en:trivalent influenza vaccine | rel=r_associated | relid=0 | w=10
  5953. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trivalent live-attenuated influenza vaccine
    n1=Okihiro (syndrome de) | n2=en:trivalent live-attenuated influenza vaccine | rel=r_associated | relid=0 | w=10
  5954. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trk inhibitor azd6918
    n1=Okihiro (syndrome de) | n2=en:trk inhibitor azd6918 | rel=r_associated | relid=0 | w=10
  5955. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trk inhibitor loxo-101
    n1=Okihiro (syndrome de) | n2=en:trk inhibitor loxo-101 | rel=r_associated | relid=0 | w=10
  5956. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trochanter
    n1=Okihiro (syndrome de) | n2=en:trochanter | rel=r_associated | relid=0 | w=10
  5957. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trodusquemine
    n1=Okihiro (syndrome de) | n2=en:trodusquemine | rel=r_associated | relid=0 | w=10
  5958. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trofosfamide
    n1=Okihiro (syndrome de) | n2=en:trofosfamide | rel=r_associated | relid=0 | w=10
  5959. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:troglitazone
    n1=Okihiro (syndrome de) | n2=en:troglitazone | rel=r_associated | relid=0 | w=10
  5960. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trolamine
    n1=Okihiro (syndrome de) | n2=en:trolamine | rel=r_associated | relid=0 | w=10
  5961. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tropisetron
    n1=Okihiro (syndrome de) | n2=en:tropisetron | rel=r_associated | relid=0 | w=10
  5962. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tropisetron hydrochloride
    n1=Okihiro (syndrome de) | n2=en:tropisetron hydrochloride | rel=r_associated | relid=0 | w=10
  5963. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tropomyosin receptor kinase inhibitor azd7451
    n1=Okihiro (syndrome de) | n2=en:tropomyosin receptor kinase inhibitor azd7451 | rel=r_associated | relid=0 | w=10
  5964. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:troxacitabine
    n1=Okihiro (syndrome de) | n2=en:troxacitabine | rel=r_associated | relid=0 | w=10
  5965. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trp2 mrna-electroporated autologous langerhans-type dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:trp2 mrna-electroporated autologous langerhans-type dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  5966. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:trpv6 calcium channel inhibitor sor-c13
    n1=Okihiro (syndrome de) | n2=en:trpv6 calcium channel inhibitor sor-c13 | rel=r_associated | relid=0 | w=10
  5967. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tsp-1 mimetic fusion protein cvx-045
    n1=Okihiro (syndrome de) | n2=en:tsp-1 mimetic fusion protein cvx-045 | rel=r_associated | relid=0 | w=10
  5968. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tti-237
    n1=Okihiro (syndrome de) | n2=en:tti-237 | rel=r_associated | relid=0 | w=10
  5969. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tubercidin
    n1=Okihiro (syndrome de) | n2=en:tubercidin | rel=r_associated | relid=0 | w=10
  5970. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tuberculum sellae
    n1=Okihiro (syndrome de) | n2=en:tuberculum sellae | rel=r_associated | relid=0 | w=10
  5971. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tubulin inhibitor alb 109564(a)
    n1=Okihiro (syndrome de) | n2=en:tubulin inhibitor alb 109564(a) | rel=r_associated | relid=0 | w=10
  5972. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tubulin polymerization inhibitor ckd-516
    n1=Okihiro (syndrome de) | n2=en:tubulin polymerization inhibitor ckd-516 | rel=r_associated | relid=0 | w=10
  5973. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tubulin-binding agent ssr97225
    n1=Okihiro (syndrome de) | n2=en:tubulin-binding agent ssr97225 | rel=r_associated | relid=0 | w=10
  5974. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tuclazepam
    n1=Okihiro (syndrome de) | n2=en:tuclazepam | rel=r_associated | relid=0 | w=10
  5975. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tucotuzumab celmoleukin
    n1=Okihiro (syndrome de) | n2=en:tucotuzumab celmoleukin | rel=r_associated | relid=0 | w=10
  5976. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tumor cell-derived dribbles vaccine
    n1=Okihiro (syndrome de) | n2=en:tumor cell-derived dribbles vaccine | rel=r_associated | relid=0 | w=10
  5977. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tumor peptide-loaded myeloid dendritic cells
    n1=Okihiro (syndrome de) | n2=en:tumor peptide-loaded myeloid dendritic cells | rel=r_associated | relid=0 | w=10
  5978. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tumor-associated antigen peptide vaccine grn-1201
    n1=Okihiro (syndrome de) | n2=en:tumor-associated antigen peptide vaccine grn-1201 | rel=r_associated | relid=0 | w=10
  5979. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tumor-cells apoptosis factor hormone-peptide
    n1=Okihiro (syndrome de) | n2=en:tumor-cells apoptosis factor hormone-peptide | rel=r_associated | relid=0 | w=10
  5980. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tumor-homing peptide irgd
    n1=Okihiro (syndrome de) | n2=en:tumor-homing peptide irgd | rel=r_associated | relid=0 | w=10
  5981. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tw1025 supplement
    n1=Okihiro (syndrome de) | n2=en:tw1025 supplement | rel=r_associated | relid=0 | w=10
  5982. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tyloxapol
    n1=Okihiro (syndrome de) | n2=en:tyloxapol | rel=r_associated | relid=0 | w=10
  5983. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:typhoid vaccine
    n1=Okihiro (syndrome de) | n2=en:typhoid vaccine | rel=r_associated | relid=0 | w=10
  5984. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tyroserleutide
    n1=Okihiro (syndrome de) | n2=en:tyroserleutide | rel=r_associated | relid=0 | w=10
  5985. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tyrosinase peptide
    n1=Okihiro (syndrome de) | n2=en:tyrosinase peptide | rel=r_associated | relid=0 | w=10
  5986. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tyrosinase related protein-1
    n1=Okihiro (syndrome de) | n2=en:tyrosinase related protein-1 | rel=r_associated | relid=0 | w=10
  5987. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tyrosinase-klh
    n1=Okihiro (syndrome de) | n2=en:tyrosinase-klh | rel=r_associated | relid=0 | w=10
  5988. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tyrosine kinase inhibitor
    n1=Okihiro (syndrome de) | n2=en:tyrosine kinase inhibitor | rel=r_associated | relid=0 | w=10
  5989. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tyrosine kinase inhibitor osi-930
    n1=Okihiro (syndrome de) | n2=en:tyrosine kinase inhibitor osi-930 | rel=r_associated | relid=0 | w=10
  5990. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:tyrosine kinase inhibitor xl228
    n1=Okihiro (syndrome de) | n2=en:tyrosine kinase inhibitor xl228 | rel=r_associated | relid=0 | w=10
  5991. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:uae inhibitor tak-243
    n1=Okihiro (syndrome de) | n2=en:uae inhibitor tak-243 | rel=r_associated | relid=0 | w=10
  5992. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ubenimex
    n1=Okihiro (syndrome de) | n2=en:ubenimex | rel=r_associated | relid=0 | w=10
  5993. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ubidecarenone injectable nanosuspension
    n1=Okihiro (syndrome de) | n2=en:ubidecarenone injectable nanosuspension | rel=r_associated | relid=0 | w=10
  5994. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ublituximab
    n1=Okihiro (syndrome de) | n2=en:ublituximab | rel=r_associated | relid=0 | w=10
  5995. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:udenafil
    n1=Okihiro (syndrome de) | n2=en:udenafil | rel=r_associated | relid=0 | w=10
  5996. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:uldazepam
    n1=Okihiro (syndrome de) | n2=en:uldazepam | rel=r_associated | relid=0 | w=10
  5997. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ulimorelin hyrdrochloride
    n1=Okihiro (syndrome de) | n2=en:ulimorelin hyrdrochloride | rel=r_associated | relid=0 | w=10
  5998. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ulinastatin
    n1=Okihiro (syndrome de) | n2=en:ulinastatin | rel=r_associated | relid=0 | w=10
  5999. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ulipristal acetate
    n1=Okihiro (syndrome de) | n2=en:ulipristal acetate | rel=r_associated | relid=0 | w=10
  6000. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ulixertinib
    n1=Okihiro (syndrome de) | n2=en:ulixertinib | rel=r_associated | relid=0 | w=10
  6001. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ulnar shaft
    n1=Okihiro (syndrome de) | n2=en:ulnar shaft | rel=r_associated | relid=0 | w=10
  6002. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ulocuplumab
    n1=Okihiro (syndrome de) | n2=en:ulocuplumab | rel=r_associated | relid=0 | w=10
  6003. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ulvwf multimer-targeting agent arc1779
    n1=Okihiro (syndrome de) | n2=en:ulvwf multimer-targeting agent arc1779 | rel=r_associated | relid=0 | w=10
  6004. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:umbilical cord blood-derived hematopoietic cd34-positive progenitor cells
    n1=Okihiro (syndrome de) | n2=en:umbilical cord blood-derived hematopoietic cd34-positive progenitor cells | rel=r_associated | relid=0 | w=10
  6005. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:umbilical cord blood-derived mesenchymal stem cells
    n1=Okihiro (syndrome de) | n2=en:umbilical cord blood-derived mesenchymal stem cells | rel=r_associated | relid=0 | w=10
  6006. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:umbilical cord blood-derived natural killer cells
    n1=Okihiro (syndrome de) | n2=en:umbilical cord blood-derived natural killer cells | rel=r_associated | relid=0 | w=10
  6007. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:umeclidinium
    n1=Okihiro (syndrome de) | n2=en:umeclidinium | rel=r_associated | relid=0 | w=10
  6008. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:uncaria tomentosa extract
    n1=Okihiro (syndrome de) | n2=en:uncaria tomentosa extract | rel=r_associated | relid=0 | w=10
  6009. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:uniformly-labeled [u-13c]glucose
    n1=Okihiro (syndrome de) | n2=en:uniformly-labeled [u-13c]glucose | rel=r_associated | relid=0 | w=10
  6010. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:upper clivus
    n1=Okihiro (syndrome de) | n2=en:upper clivus | rel=r_associated | relid=0 | w=10
  6011. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:uracil
    n1=Okihiro (syndrome de) | n2=en:uracil | rel=r_associated | relid=0 | w=10
  6012. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:uracil ointment
    n1=Okihiro (syndrome de) | n2=en:uracil ointment | rel=r_associated | relid=0 | w=10
  6013. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:urea
    n1=Okihiro (syndrome de) | n2=en:urea | rel=r_associated | relid=0 | w=10
  6014. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:urea and derivatives
    n1=Okihiro (syndrome de) | n2=en:urea and derivatives | rel=r_associated | relid=0 | w=10
  6015. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:urea/lactic acid-based topical cream
    n1=Okihiro (syndrome de) | n2=en:urea/lactic acid-based topical cream | rel=r_associated | relid=0 | w=10
  6016. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:urelumab
    n1=Okihiro (syndrome de) | n2=en:urelumab | rel=r_associated | relid=0 | w=10
  6017. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:uridine
    n1=Okihiro (syndrome de) | n2=en:uridine | rel=r_associated | relid=0 | w=10
  6018. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:uridine triacetate
    n1=Okihiro (syndrome de) | n2=en:uridine triacetate | rel=r_associated | relid=0 | w=10
  6019. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:urlc10 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:urlc10 peptide vaccine | rel=r_associated | relid=0 | w=10
  6020. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:urlc10-cdca1-koc1 multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:urlc10-cdca1-koc1 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  6021. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:urlc10-ttk-koc1-vegfr1-vegfr2 multipeptide vaccine
    n1=Okihiro (syndrome de) | n2=en:urlc10-ttk-koc1-vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=10
  6022. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:urokinase-derived peptide a6
    n1=Okihiro (syndrome de) | n2=en:urokinase-derived peptide a6 | rel=r_associated | relid=0 | w=10
  6023. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ursodiol
    n1=Okihiro (syndrome de) | n2=en:ursodiol | rel=r_associated | relid=0 | w=10
  6024. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:usp14/uchl5 inhibitor vlx1570
    n1=Okihiro (syndrome de) | n2=en:usp14/uchl5 inhibitor vlx1570 | rel=r_associated | relid=0 | w=10
  6025. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ustekinumab
    n1=Okihiro (syndrome de) | n2=en:ustekinumab | rel=r_associated | relid=0 | w=10
  6026. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:uv1 telomerase peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:uv1 telomerase peptide vaccine | rel=r_associated | relid=0 | w=10
  6027. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:v930 vaccine
    n1=Okihiro (syndrome de) | n2=en:v930 vaccine | rel=r_associated | relid=0 | w=10
  6028. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vaccine-sensitized draining lymph node cells
    n1=Okihiro (syndrome de) | n2=en:vaccine-sensitized draining lymph node cells | rel=r_associated | relid=0 | w=10
  6029. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vaccinia cea vaccine
    n1=Okihiro (syndrome de) | n2=en:vaccinia cea vaccine | rel=r_associated | relid=0 | w=10
  6030. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vaccinia virus dd-cdsr
    n1=Okihiro (syndrome de) | n2=en:vaccinia virus dd-cdsr | rel=r_associated | relid=0 | w=10
  6031. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vaccinia-gm-csf vaccine
    n1=Okihiro (syndrome de) | n2=en:vaccinia-gm-csf vaccine | rel=r_associated | relid=0 | w=10
  6032. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vaccinia-tyrosinase vaccine
    n1=Okihiro (syndrome de) | n2=en:vaccinia-tyrosinase vaccine | rel=r_associated | relid=0 | w=10
  6033. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vaccinium myrtillus/macleaya cordata/echinacea angustifolia extract granules
    n1=Okihiro (syndrome de) | n2=en:vaccinium myrtillus/macleaya cordata/echinacea angustifolia extract granules | rel=r_associated | relid=0 | w=10
  6034. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vadastuximab talirine
    n1=Okihiro (syndrome de) | n2=en:vadastuximab talirine | rel=r_associated | relid=0 | w=10
  6035. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vadimezan
    n1=Okihiro (syndrome de) | n2=en:vadimezan | rel=r_associated | relid=0 | w=10
  6036. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vaginal dosage form product
    n1=Okihiro (syndrome de) | n2=en:vaginal dosage form product | rel=r_associated | relid=0 | w=10
  6037. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:valacyclovir
    n1=Okihiro (syndrome de) | n2=en:valacyclovir | rel=r_associated | relid=0 | w=10
  6038. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:valdecoxib
    n1=Okihiro (syndrome de) | n2=en:valdecoxib | rel=r_associated | relid=0 | w=10
  6039. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:valerian
    n1=Okihiro (syndrome de) | n2=en:valerian | rel=r_associated | relid=0 | w=10
  6040. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:valerian root
    n1=Okihiro (syndrome de) | n2=en:valerian root | rel=r_associated | relid=0 | w=10
  6041. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:valganciclovir
    n1=Okihiro (syndrome de) | n2=en:valganciclovir | rel=r_associated | relid=0 | w=10
  6042. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:valproic acid
    n1=Okihiro (syndrome de) | n2=en:valproic acid | rel=r_associated | relid=0 | w=10
  6043. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:valrubicin
    n1=Okihiro (syndrome de) | n2=en:valrubicin | rel=r_associated | relid=0 | w=10
  6044. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:valsartan
    n1=Okihiro (syndrome de) | n2=en:valsartan | rel=r_associated | relid=0 | w=10
  6045. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:valspodar
    n1=Okihiro (syndrome de) | n2=en:valspodar | rel=r_associated | relid=0 | w=10
  6046. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vamp regimen
    n1=Okihiro (syndrome de) | n2=en:vamp regimen | rel=r_associated | relid=0 | w=10
  6047. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vanadium and/or vanadium compound
    n1=Okihiro (syndrome de) | n2=en:vanadium and/or vanadium compound | rel=r_associated | relid=0 | w=10
  6048. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vancomycin
    n1=Okihiro (syndrome de) | n2=en:vancomycin | rel=r_associated | relid=0 | w=10
  6049. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vandetanib
    n1=Okihiro (syndrome de) | n2=en:vandetanib | rel=r_associated | relid=0 | w=10
  6050. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vandortuzumab vedotin
    n1=Okihiro (syndrome de) | n2=en:vandortuzumab vedotin | rel=r_associated | relid=0 | w=10
  6051. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vantictumab
    n1=Okihiro (syndrome de) | n2=en:vantictumab | rel=r_associated | relid=0 | w=10
  6052. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vapreotide
    n1=Okihiro (syndrome de) | n2=en:vapreotide | rel=r_associated | relid=0 | w=10
  6053. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vardenafil hydrochloride trihydrate
    n1=Okihiro (syndrome de) | n2=en:vardenafil hydrochloride trihydrate | rel=r_associated | relid=0 | w=10
  6054. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:varenicline
    n1=Okihiro (syndrome de) | n2=en:varenicline | rel=r_associated | relid=0 | w=10
  6055. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:varicella-zoster virus strain oka/merck live antigen
    n1=Okihiro (syndrome de) | n2=en:varicella-zoster virus strain oka/merck live antigen | rel=r_associated | relid=0 | w=10
  6056. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:varlilumab
    n1=Okihiro (syndrome de) | n2=en:varlilumab | rel=r_associated | relid=0 | w=10
  6057. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:varlitinib
    n1=Okihiro (syndrome de) | n2=en:varlitinib | rel=r_associated | relid=0 | w=10
  6058. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vascular disrupting agent bnc105p
    n1=Okihiro (syndrome de) | n2=en:vascular disrupting agent bnc105p | rel=r_associated | relid=0 | w=10
  6059. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vascular disrupting agent zd6126
    n1=Okihiro (syndrome de) | n2=en:vascular disrupting agent zd6126 | rel=r_associated | relid=0 | w=10
  6060. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vascular endothelial growth factor antisense oligonucleotide
    n1=Okihiro (syndrome de) | n2=en:vascular endothelial growth factor antisense oligonucleotide | rel=r_associated | relid=0 | w=10
  6061. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vasopressins
    n1=Okihiro (syndrome de) | n2=en:vasopressins | rel=r_associated | relid=0 | w=10
  6062. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vatalanib
    n1=Okihiro (syndrome de) | n2=en:vatalanib | rel=r_associated | relid=0 | w=10
  6063. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vcl-cb01 vaccine
    n1=Okihiro (syndrome de) | n2=en:vcl-cb01 vaccine | rel=r_associated | relid=0 | w=10
  6064. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vecuronium bromide
    n1=Okihiro (syndrome de) | n2=en:vecuronium bromide | rel=r_associated | relid=0 | w=10
  6065. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vedolizumab
    n1=Okihiro (syndrome de) | n2=en:vedolizumab | rel=r_associated | relid=0 | w=10
  6066. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vegf inhibitor ptc299
    n1=Okihiro (syndrome de) | n2=en:vegf inhibitor ptc299 | rel=r_associated | relid=0 | w=10
  6067. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vegf/hgf-targeting darpin mp0250
    n1=Okihiro (syndrome de) | n2=en:vegf/hgf-targeting darpin mp0250 | rel=r_associated | relid=0 | w=10
  6068. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vegfr inhibitor krn951
    n1=Okihiro (syndrome de) | n2=en:vegfr inhibitor krn951 | rel=r_associated | relid=0 | w=10
  6069. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vegfr-2 dna vaccine vxm01
    n1=Okihiro (syndrome de) | n2=en:vegfr-2 dna vaccine vxm01 | rel=r_associated | relid=0 | w=10
  6070. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vegfr/fgfr inhibitor odm-203
    n1=Okihiro (syndrome de) | n2=en:vegfr/fgfr inhibitor odm-203 | rel=r_associated | relid=0 | w=10
  6071. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vegfr/pdgfr dual kinase inhibitor x-82
    n1=Okihiro (syndrome de) | n2=en:vegfr/pdgfr dual kinase inhibitor x-82 | rel=r_associated | relid=0 | w=10
  6072. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vegfr/pdgfr tyrosine kinase inhibitor tak-593
    n1=Okihiro (syndrome de) | n2=en:vegfr/pdgfr tyrosine kinase inhibitor tak-593 | rel=r_associated | relid=0 | w=10
  6073. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vegfr1-1084 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:vegfr1-1084 peptide vaccine | rel=r_associated | relid=0 | w=10
  6074. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vegfr2 tyrosine kinase inhibitor pf-00337210
    n1=Okihiro (syndrome de) | n2=en:vegfr2 tyrosine kinase inhibitor pf-00337210 | rel=r_associated | relid=0 | w=10
  6075. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vegfr2-169 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:vegfr2-169 peptide vaccine | rel=r_associated | relid=0 | w=10
  6076. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vegfr2-targeted contrast agent br55
    n1=Okihiro (syndrome de) | n2=en:vegfr2-targeted contrast agent br55 | rel=r_associated | relid=0 | w=10
  6077. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:veip regimen
    n1=Okihiro (syndrome de) | n2=en:veip regimen | rel=r_associated | relid=0 | w=10
  6078. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:velafermin
    n1=Okihiro (syndrome de) | n2=en:velafermin | rel=r_associated | relid=0 | w=10
  6079. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:veliparib
    n1=Okihiro (syndrome de) | n2=en:veliparib | rel=r_associated | relid=0 | w=10
  6080. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:veltuzumab
    n1=Okihiro (syndrome de) | n2=en:veltuzumab | rel=r_associated | relid=0 | w=10
  6081. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vemurafenib
    n1=Okihiro (syndrome de) | n2=en:vemurafenib | rel=r_associated | relid=0 | w=10
  6082. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:venetoclax
    n1=Okihiro (syndrome de) | n2=en:venetoclax | rel=r_associated | relid=0 | w=10
  6083. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:venlafaxine
    n1=Okihiro (syndrome de) | n2=en:venlafaxine | rel=r_associated | relid=0 | w=10
  6084. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vepoloxamer
    n1=Okihiro (syndrome de) | n2=en:vepoloxamer | rel=r_associated | relid=0 | w=10
  6085. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:verapamil
    n1=Okihiro (syndrome de) | n2=en:verapamil | rel=r_associated | relid=0 | w=10
  6086. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:verpasep caltespen
    n1=Okihiro (syndrome de) | n2=en:verpasep caltespen | rel=r_associated | relid=0 | w=10
  6087. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vertebral body
    n1=Okihiro (syndrome de) | n2=en:vertebral body | rel=r_associated | relid=0 | w=10
  6088. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vertebral canal
    n1=Okihiro (syndrome de) | n2=en:vertebral canal | rel=r_associated | relid=0 | w=10
  6089. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vertebral column
    n1=Okihiro (syndrome de) | n2=en:vertebral column | rel=r_associated | relid=0 | w=10
  6090. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:verteporfin
    n1=Okihiro (syndrome de) | n2=en:verteporfin | rel=r_associated | relid=0 | w=10
  6091. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:verubulin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:verubulin hydrochloride | rel=r_associated | relid=0 | w=10
  6092. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:veterinary drugs
    n1=Okihiro (syndrome de) | n2=en:veterinary drugs | rel=r_associated | relid=0 | w=10
  6093. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:viagenpumatucel-l
    n1=Okihiro (syndrome de) | n2=en:viagenpumatucel-l | rel=r_associated | relid=0 | w=10
  6094. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vidarabine
    n1=Okihiro (syndrome de) | n2=en:vidarabine | rel=r_associated | relid=0 | w=10
  6095. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vigabatrin
    n1=Okihiro (syndrome de) | n2=en:vigabatrin | rel=r_associated | relid=0 | w=10
  6096. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vilazodone
    n1=Okihiro (syndrome de) | n2=en:vilazodone | rel=r_associated | relid=0 | w=10
  6097. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vildagliptin
    n1=Okihiro (syndrome de) | n2=en:vildagliptin | rel=r_associated | relid=0 | w=10
  6098. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vinblastine
    n1=Okihiro (syndrome de) | n2=en:vinblastine | rel=r_associated | relid=0 | w=10
  6099. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vinblastine sulfate
    n1=Okihiro (syndrome de) | n2=en:vinblastine sulfate | rel=r_associated | relid=0 | w=10
  6100. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vinca alkaloid compound
    n1=Okihiro (syndrome de) | n2=en:vinca alkaloid compound | rel=r_associated | relid=0 | w=10
  6101. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vincristine sulfate
    n1=Okihiro (syndrome de) | n2=en:vincristine sulfate | rel=r_associated | relid=0 | w=10
  6102. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vincristine sulfate liposome
    n1=Okihiro (syndrome de) | n2=en:vincristine sulfate liposome | rel=r_associated | relid=0 | w=10
  6103. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vindesine
    n1=Okihiro (syndrome de) | n2=en:vindesine | rel=r_associated | relid=0 | w=10
  6104. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vinflunine
    n1=Okihiro (syndrome de) | n2=en:vinflunine | rel=r_associated | relid=0 | w=10
  6105. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vinfosiltine
    n1=Okihiro (syndrome de) | n2=en:vinfosiltine | rel=r_associated | relid=0 | w=10
  6106. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vinorelbine tartrate
    n1=Okihiro (syndrome de) | n2=en:vinorelbine tartrate | rel=r_associated | relid=0 | w=10
  6107. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vinorelbine tartrate emulsion
    n1=Okihiro (syndrome de) | n2=en:vinorelbine tartrate emulsion | rel=r_associated | relid=0 | w=10
  6108. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vinorelbine tartrate oral
    n1=Okihiro (syndrome de) | n2=en:vinorelbine tartrate oral | rel=r_associated | relid=0 | w=10
  6109. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vintafolide
    n1=Okihiro (syndrome de) | n2=en:vintafolide | rel=r_associated | relid=0 | w=10
  6110. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vinzolidine
    n1=Okihiro (syndrome de) | n2=en:vinzolidine | rel=r_associated | relid=0 | w=10
  6111. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:viomycin
    n1=Okihiro (syndrome de) | n2=en:viomycin | rel=r_associated | relid=0 | w=10
  6112. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vip regimen
    n1=Okihiro (syndrome de) | n2=en:vip regimen | rel=r_associated | relid=0 | w=10
  6113. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:virulizin
    n1=Okihiro (syndrome de) | n2=en:virulizin | rel=r_associated | relid=0 | w=10
  6114. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:visilizumab
    n1=Okihiro (syndrome de) | n2=en:visilizumab | rel=r_associated | relid=0 | w=10
  6115. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vismodegib
    n1=Okihiro (syndrome de) | n2=en:vismodegib | rel=r_associated | relid=0 | w=10
  6116. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vistusertib
    n1=Okihiro (syndrome de) | n2=en:vistusertib | rel=r_associated | relid=0 | w=10
  6117. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vitamin
    n1=Okihiro (syndrome de) | n2=en:vitamin | rel=r_associated | relid=0 | w=10
  6118. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vitamin / trace element
    n1=Okihiro (syndrome de) | n2=en:vitamin / trace element | rel=r_associated | relid=0 | w=10
  6119. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vitamin a compound
    n1=Okihiro (syndrome de) | n2=en:vitamin a compound | rel=r_associated | relid=0 | w=10
  6120. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vitamin b12 - category
    n1=Okihiro (syndrome de) | n2=en:vitamin b12 - category | rel=r_associated | relid=0 | w=10
  6121. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vitamin b6
    n1=Okihiro (syndrome de) | n2=en:vitamin b6 | rel=r_associated | relid=0 | w=10
  6122. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vitamin e compound
    n1=Okihiro (syndrome de) | n2=en:vitamin e compound | rel=r_associated | relid=0 | w=10
  6123. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vitamin k1-containing urea skin cream
    n1=Okihiro (syndrome de) | n2=en:vitamin k1-containing urea skin cream | rel=r_associated | relid=0 | w=10
  6124. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vitespen
    n1=Okihiro (syndrome de) | n2=en:vitespen | rel=r_associated | relid=0 | w=10
  6125. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vlp-encapsulated tlr9 agonist cmp-001
    n1=Okihiro (syndrome de) | n2=en:vlp-encapsulated tlr9 agonist cmp-001 | rel=r_associated | relid=0 | w=10
  6126. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vocimagene amiretrorepvec
    n1=Okihiro (syndrome de) | n2=en:vocimagene amiretrorepvec | rel=r_associated | relid=0 | w=10
  6127. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:voglibose
    n1=Okihiro (syndrome de) | n2=en:voglibose | rel=r_associated | relid=0 | w=10
  6128. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:volasertib
    n1=Okihiro (syndrome de) | n2=en:volasertib | rel=r_associated | relid=0 | w=10
  6129. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:volitinib
    n1=Okihiro (syndrome de) | n2=en:volitinib | rel=r_associated | relid=0 | w=10
  6130. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:volociximab
    n1=Okihiro (syndrome de) | n2=en:volociximab | rel=r_associated | relid=0 | w=10
  6131. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vomer
    n1=Okihiro (syndrome de) | n2=en:vomer | rel=r_associated | relid=0 | w=10
  6132. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:von hippel-lindau peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:von hippel-lindau peptide vaccine | rel=r_associated | relid=0 | w=10
  6133. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:voriconazole
    n1=Okihiro (syndrome de) | n2=en:voriconazole | rel=r_associated | relid=0 | w=10
  6134. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vorinostat
    n1=Okihiro (syndrome de) | n2=en:vorinostat | rel=r_associated | relid=0 | w=10
  6135. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vorozole
    n1=Okihiro (syndrome de) | n2=en:vorozole | rel=r_associated | relid=0 | w=10
  6136. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vorsetuzumab-mafodotin
    n1=Okihiro (syndrome de) | n2=en:vorsetuzumab-mafodotin | rel=r_associated | relid=0 | w=10
  6137. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vortioxetine hydrobromide
    n1=Okihiro (syndrome de) | n2=en:vortioxetine hydrobromide | rel=r_associated | relid=0 | w=10
  6138. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vosaroxin
    n1=Okihiro (syndrome de) | n2=en:vosaroxin | rel=r_associated | relid=0 | w=10
  6139. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:voxtalisib
    n1=Okihiro (syndrome de) | n2=en:voxtalisib | rel=r_associated | relid=0 | w=10
  6140. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:vx-803
    n1=Okihiro (syndrome de) | n2=en:vx-803 | rel=r_associated | relid=0 | w=10
  6141. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ward's triangle
    n1=Okihiro (syndrome de) | n2=en:ward's triangle | rel=r_associated | relid=0 | w=10
  6142. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:warfarin
    n1=Okihiro (syndrome de) | n2=en:warfarin | rel=r_associated | relid=0 | w=10
  6143. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:water o-15
    n1=Okihiro (syndrome de) | n2=en:water o-15 | rel=r_associated | relid=0 | w=10
  6144. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:water-based vaginal lubricant
    n1=Okihiro (syndrome de) | n2=en:water-based vaginal lubricant | rel=r_associated | relid=0 | w=10
  6145. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:water, mineral or uric acid metabolism drug
    n1=Okihiro (syndrome de) | n2=en:water, mineral or uric acid metabolism drug | rel=r_associated | relid=0 | w=10
  6146. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wee1 inhibitor azd1775
    n1=Okihiro (syndrome de) | n2=en:wee1 inhibitor azd1775 | rel=r_associated | relid=0 | w=10
  6147. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:weight control agent
    n1=Okihiro (syndrome de) | n2=en:weight control agent | rel=r_associated | relid=0 | w=10
  6148. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wheatgrass juice
    n1=Okihiro (syndrome de) | n2=en:wheatgrass juice | rel=r_associated | relid=0 | w=10
  6149. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:whey protein isolate
    n1=Okihiro (syndrome de) | n2=en:whey protein isolate | rel=r_associated | relid=0 | w=10
  6150. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:white button mushroom extract
    n1=Okihiro (syndrome de) | n2=en:white button mushroom extract | rel=r_associated | relid=0 | w=10
  6151. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:white carrot
    n1=Okihiro (syndrome de) | n2=en:white carrot | rel=r_associated | relid=0 | w=10
  6152. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:white wine
    n1=Okihiro (syndrome de) | n2=en:white wine | rel=r_associated | relid=0 | w=10
  6153. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wild-type reovirus
    n1=Okihiro (syndrome de) | n2=en:wild-type reovirus | rel=r_associated | relid=0 | w=10
  6154. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:witch hazel
    n1=Okihiro (syndrome de) | n2=en:witch hazel | rel=r_associated | relid=0 | w=10
  6155. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wnt signaling inhibitor sm04755
    n1=Okihiro (syndrome de) | n2=en:wnt signaling inhibitor sm04755 | rel=r_associated | relid=0 | w=10
  6156. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wnt-5a mimic hexapeptide foxy-5
    n1=Okihiro (syndrome de) | n2=en:wnt-5a mimic hexapeptide foxy-5 | rel=r_associated | relid=0 | w=10
  6157. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wobe-mugos e
    n1=Okihiro (syndrome de) | n2=en:wobe-mugos e | rel=r_associated | relid=0 | w=10
  6158. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wt1 124-138 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:wt1 124-138 peptide vaccine | rel=r_associated | relid=0 | w=10
  6159. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wt1 126-134 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:wt1 126-134 peptide vaccine | rel=r_associated | relid=0 | w=10
  6160. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wt1 235-243 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:wt1 235-243 peptide vaccine | rel=r_associated | relid=0 | w=10
  6161. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wt1 247-261 peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:wt1 247-261 peptide vaccine | rel=r_associated | relid=0 | w=10
  6162. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wt1 analog peptide vaccine
    n1=Okihiro (syndrome de) | n2=en:wt1 analog peptide vaccine | rel=r_associated | relid=0 | w=10
  6163. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wt1 mrna-electroporated autologous dendritic cell vaccine
    n1=Okihiro (syndrome de) | n2=en:wt1 mrna-electroporated autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=10
  6164. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wt1 peptide vaccine ocv-501
    n1=Okihiro (syndrome de) | n2=en:wt1 peptide vaccine ocv-501 | rel=r_associated | relid=0 | w=10
  6165. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wt1 peptide vaccine wt2725
    n1=Okihiro (syndrome de) | n2=en:wt1 peptide vaccine wt2725 | rel=r_associated | relid=0 | w=10
  6166. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wt1 protein-derived peptide vaccine dsp-7888
    n1=Okihiro (syndrome de) | n2=en:wt1 protein-derived peptide vaccine dsp-7888 | rel=r_associated | relid=0 | w=10
  6167. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wt1-a10/as01b immunotherapeutic gsk2130579a
    n1=Okihiro (syndrome de) | n2=en:wt1-a10/as01b immunotherapeutic gsk2130579a | rel=r_associated | relid=0 | w=10
  6168. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wt1-sensitized t cells
    n1=Okihiro (syndrome de) | n2=en:wt1-sensitized t cells | rel=r_associated | relid=0 | w=10
  6169. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wu-ling-san
    n1=Okihiro (syndrome de) | n2=en:wu-ling-san | rel=r_associated | relid=0 | w=10
  6170. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:wx-uk1
    n1=Okihiro (syndrome de) | n2=en:wx-uk1 | rel=r_associated | relid=0 | w=10
  6171. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xaliproden hydrochloride
    n1=Okihiro (syndrome de) | n2=en:xaliproden hydrochloride | rel=r_associated | relid=0 | w=10
  6172. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xanthine or xanthine derivative
    n1=Okihiro (syndrome de) | n2=en:xanthine or xanthine derivative | rel=r_associated | relid=0 | w=10
  6173. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xanthine oxidase inhibitor
    n1=Okihiro (syndrome de) | n2=en:xanthine oxidase inhibitor | rel=r_associated | relid=0 | w=10
  6174. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xanthohumol
    n1=Okihiro (syndrome de) | n2=en:xanthohumol | rel=r_associated | relid=0 | w=10
  6175. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xbp1-us/xbp1-sp/cd138/cs1 multipeptide vaccine pvx-410
    n1=Okihiro (syndrome de) | n2=en:xbp1-us/xbp1-sp/cd138/cs1 multipeptide vaccine pvx-410 | rel=r_associated | relid=0 | w=10
  6176. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xeliri regimen
    n1=Okihiro (syndrome de) | n2=en:xeliri regimen | rel=r_associated | relid=0 | w=10
  6177. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xelox regimen
    n1=Okihiro (syndrome de) | n2=en:xelox regimen | rel=r_associated | relid=0 | w=10
  6178. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xenobiotics
    n1=Okihiro (syndrome de) | n2=en:xenobiotics | rel=r_associated | relid=0 | w=10
  6179. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xenogeneic tyrosinase dna vaccine
    n1=Okihiro (syndrome de) | n2=en:xenogeneic tyrosinase dna vaccine | rel=r_associated | relid=0 | w=10
  6180. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xenon
    n1=Okihiro (syndrome de) | n2=en:xenon | rel=r_associated | relid=0 | w=10
  6181. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xianling gubao
    n1=Okihiro (syndrome de) | n2=en:xianling gubao | rel=r_associated | relid=0 | w=10
  6182. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xiap/ciap1 antagonist astx660
    n1=Okihiro (syndrome de) | n2=en:xiap/ciap1 antagonist astx660 | rel=r_associated | relid=0 | w=10
  6183. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xiphoid process
    n1=Okihiro (syndrome de) | n2=en:xiphoid process | rel=r_associated | relid=0 | w=10
  6184. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xl820
    n1=Okihiro (syndrome de) | n2=en:xl820 | rel=r_associated | relid=0 | w=10
  6185. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xonrid cream
    n1=Okihiro (syndrome de) | n2=en:xonrid cream | rel=r_associated | relid=0 | w=10
  6186. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xpo1 inhibitor kpt-8602
    n1=Okihiro (syndrome de) | n2=en:xpo1 inhibitor kpt-8602 | rel=r_associated | relid=0 | w=10
  6187. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:xpo1 inhibitor sl-801
    n1=Okihiro (syndrome de) | n2=en:xpo1 inhibitor sl-801 | rel=r_associated | relid=0 | w=10
  6188. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:y 90 monoclonal antibody cc49
    n1=Okihiro (syndrome de) | n2=en:y 90 monoclonal antibody cc49 | rel=r_associated | relid=0 | w=10
  6189. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:y 90 monoclonal antibody hmfg1
    n1=Okihiro (syndrome de) | n2=en:y 90 monoclonal antibody hmfg1 | rel=r_associated | relid=0 | w=10
  6190. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:y 90 monoclonal antibody lym-1
    n1=Okihiro (syndrome de) | n2=en:y 90 monoclonal antibody lym-1 | rel=r_associated | relid=0 | w=10
  6191. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:y 90 monoclonal antibody m170
    n1=Okihiro (syndrome de) | n2=en:y 90 monoclonal antibody m170 | rel=r_associated | relid=0 | w=10
  6192. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:y 90 monoclonal antibody m195
    n1=Okihiro (syndrome de) | n2=en:y 90 monoclonal antibody m195 | rel=r_associated | relid=0 | w=10
  6193. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:y-shape branched pegylated filgrastim
    n1=Okihiro (syndrome de) | n2=en:y-shape branched pegylated filgrastim | rel=r_associated | relid=0 | w=10
  6194. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yangzheng xiaoji supplement
    n1=Okihiro (syndrome de) | n2=en:yangzheng xiaoji supplement | rel=r_associated | relid=0 | w=10
  6195. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yeast
    n1=Okihiro (syndrome de) | n2=en:yeast | rel=r_associated | relid=0 | w=10
  6196. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yellow fever virus antibody
    n1=Okihiro (syndrome de) | n2=en:yellow fever virus antibody | rel=r_associated | relid=0 | w=10
  6197. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yellow phenolphthalein
    n1=Okihiro (syndrome de) | n2=en:yellow phenolphthalein | rel=r_associated | relid=0 | w=10
  6198. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ym598
    n1=Okihiro (syndrome de) | n2=en:ym598 | rel=r_associated | relid=0 | w=10
  6199. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yoshi-864
    n1=Okihiro (syndrome de) | n2=en:yoshi-864 | rel=r_associated | relid=0 | w=10
  6200. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 anti-cd19 monoclonal antibody bu12
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 anti-cd19 monoclonal antibody bu12 | rel=r_associated | relid=0 | w=10
  6201. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 anti-cd45 monoclonal antibody ahn-12
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 anti-cd45 monoclonal antibody ahn-12 | rel=r_associated | relid=0 | w=10
  6202. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 anti-cd45 monoclonal antibody bc8
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 anti-cd45 monoclonal antibody bc8 | rel=r_associated | relid=0 | w=10
  6203. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 anti-cd66 monoclonal antibody bw 250/183
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 anti-cd66 monoclonal antibody bw 250/183 | rel=r_associated | relid=0 | w=10
  6204. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 anti-cdh3 monoclonal antibody ff-21101
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 anti-cdh3 monoclonal antibody ff-21101 | rel=r_associated | relid=0 | w=10
  6205. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 anti-cea monoclonal antibody ct84.66
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 anti-cea monoclonal antibody ct84.66 | rel=r_associated | relid=0 | w=10
  6206. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 basiliximab
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 basiliximab | rel=r_associated | relid=0 | w=10
  6207. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 colloid
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 colloid | rel=r_associated | relid=0 | w=10
  6208. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 daclizumab
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 daclizumab | rel=r_associated | relid=0 | w=10
  6209. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 dota anti-cea monoclonal antibody m5a
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 dota anti-cea monoclonal antibody m5a | rel=r_associated | relid=0 | w=10
  6210. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 glass microspheres
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 glass microspheres | rel=r_associated | relid=0 | w=10
  6211. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 monoclonal antibody b3
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 monoclonal antibody b3 | rel=r_associated | relid=0 | w=10
  6212. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 monoclonal antibody bre-3
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 monoclonal antibody bre-3 | rel=r_associated | relid=0 | w=10
  6213. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 monoclonal antibody hu3s193
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 monoclonal antibody hu3s193 | rel=r_associated | relid=0 | w=10
  6214. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 monoclonal antibody idec-159
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 monoclonal antibody idec-159 | rel=r_associated | relid=0 | w=10
  6215. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 monoclonal antibody mn-14
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 monoclonal antibody mn-14 | rel=r_associated | relid=0 | w=10
  6216. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90 resin microspheres
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90 resin microspheres | rel=r_associated | relid=0 | w=10
  6217. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90-dota-biotin
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90-dota-biotin | rel=r_associated | relid=0 | w=10
  6218. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90-dota-di-hsg peptide imp-288
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90-dota-di-hsg peptide imp-288 | rel=r_associated | relid=0 | w=10
  6219. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90-edotreotide
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90-edotreotide | rel=r_associated | relid=0 | w=10
  6220. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y 90-labeled anti-fzd10 monoclonal antibody otsa101
    n1=Okihiro (syndrome de) | n2=en:yttrium y 90-labeled anti-fzd10 monoclonal antibody otsa101 | rel=r_associated | relid=0 | w=10
  6221. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y-90 clivatuzumab tetraxetan
    n1=Okihiro (syndrome de) | n2=en:yttrium y-90 clivatuzumab tetraxetan | rel=r_associated | relid=0 | w=10
  6222. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y-90 epratuzumab tetraxetan
    n1=Okihiro (syndrome de) | n2=en:yttrium y-90 epratuzumab tetraxetan | rel=r_associated | relid=0 | w=10
  6223. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y-90 ibritumomab tiuxetan
    n1=Okihiro (syndrome de) | n2=en:yttrium y-90 ibritumomab tiuxetan | rel=r_associated | relid=0 | w=10
  6224. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y-90 tacatuzumab tetraxetan
    n1=Okihiro (syndrome de) | n2=en:yttrium y-90 tacatuzumab tetraxetan | rel=r_associated | relid=0 | w=10
  6225. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium y-90-dota-girentuximab
    n1=Okihiro (syndrome de) | n2=en:yttrium y-90-dota-girentuximab | rel=r_associated | relid=0 | w=10
  6226. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:yttrium-90 polycarbonate brachytherapy plaque
    n1=Okihiro (syndrome de) | n2=en:yttrium-90 polycarbonate brachytherapy plaque | rel=r_associated | relid=0 | w=10
  6227. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:z-360
    n1=Okihiro (syndrome de) | n2=en:z-360 | rel=r_associated | relid=0 | w=10
  6228. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:z-endoxifen hydrochloride
    n1=Okihiro (syndrome de) | n2=en:z-endoxifen hydrochloride | rel=r_associated | relid=0 | w=10
  6229. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zalcitabine
    n1=Okihiro (syndrome de) | n2=en:zalcitabine | rel=r_associated | relid=0 | w=10
  6230. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zaleplon
    n1=Okihiro (syndrome de) | n2=en:zaleplon | rel=r_associated | relid=0 | w=10
  6231. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zalutumumab
    n1=Okihiro (syndrome de) | n2=en:zalutumumab | rel=r_associated | relid=0 | w=10
  6232. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zanamivir
    n1=Okihiro (syndrome de) | n2=en:zanamivir | rel=r_associated | relid=0 | w=10
  6233. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zanolimumab
    n1=Okihiro (syndrome de) | n2=en:zanolimumab | rel=r_associated | relid=0 | w=10
  6234. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zen003365
    n1=Okihiro (syndrome de) | n2=en:zen003365 | rel=r_associated | relid=0 | w=10
  6235. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zeniplatin
    n1=Okihiro (syndrome de) | n2=en:zeniplatin | rel=r_associated | relid=0 | w=10
  6236. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zetidoline
    n1=Okihiro (syndrome de) | n2=en:zetidoline | rel=r_associated | relid=0 | w=10
  6237. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zhongyao fufang
    n1=Okihiro (syndrome de) | n2=en:zhongyao fufang | rel=r_associated | relid=0 | w=10
  6238. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zibotentan
    n1=Okihiro (syndrome de) | n2=en:zibotentan | rel=r_associated | relid=0 | w=10
  6239. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ziconotide
    n1=Okihiro (syndrome de) | n2=en:ziconotide | rel=r_associated | relid=0 | w=10
  6240. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zidovudine
    n1=Okihiro (syndrome de) | n2=en:zidovudine | rel=r_associated | relid=0 | w=10
  6241. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zidovudine and derivatives
    n1=Okihiro (syndrome de) | n2=en:zidovudine and derivatives | rel=r_associated | relid=0 | w=10
  6242. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zileuton
    n1=Okihiro (syndrome de) | n2=en:zileuton | rel=r_associated | relid=0 | w=10
  6243. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zinc chloride
    n1=Okihiro (syndrome de) | n2=en:zinc chloride | rel=r_associated | relid=0 | w=10
  6244. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zinc citrate
    n1=Okihiro (syndrome de) | n2=en:zinc citrate | rel=r_associated | relid=0 | w=10
  6245. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zinc gluconate
    n1=Okihiro (syndrome de) | n2=en:zinc gluconate | rel=r_associated | relid=0 | w=10
  6246. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zinc oxide
    n1=Okihiro (syndrome de) | n2=en:zinc oxide | rel=r_associated | relid=0 | w=10
  6247. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zinc oxide/aluminum starch octenylsuccinate/glycyrrhetinic phytosome/vitamin e/botanical extracts-based skin protectant paste
    n1=Okihiro (syndrome de) | n2=en:zinc oxide/aluminum starch octenylsuccinate/glycyrrhetinic phytosome/vitamin e/botanical extracts-based skin protectant paste | rel=r_associated | relid=0 | w=10
  6248. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zinc sulfate
    n1=Okihiro (syndrome de) | n2=en:zinc sulfate | rel=r_associated | relid=0 | w=10
  6249. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zinostatin
    n1=Okihiro (syndrome de) | n2=en:zinostatin | rel=r_associated | relid=0 | w=10
  6250. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ziprasidone
    n1=Okihiro (syndrome de) | n2=en:ziprasidone | rel=r_associated | relid=0 | w=10
  6251. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ziprasidone hydrochloride
    n1=Okihiro (syndrome de) | n2=en:ziprasidone hydrochloride | rel=r_associated | relid=0 | w=10
  6252. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ziprasidone mesylate
    n1=Okihiro (syndrome de) | n2=en:ziprasidone mesylate | rel=r_associated | relid=0 | w=10
  6253. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zirconium zr 89 bevacizumab
    n1=Okihiro (syndrome de) | n2=en:zirconium zr 89 bevacizumab | rel=r_associated | relid=0 | w=10
  6254. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zirconium zr 89 cetuximab
    n1=Okihiro (syndrome de) | n2=en:zirconium zr 89 cetuximab | rel=r_associated | relid=0 | w=10
  6255. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zirconium zr 89 desferrioxamine b monoclonal antibody huj591
    n1=Okihiro (syndrome de) | n2=en:zirconium zr 89 desferrioxamine b monoclonal antibody huj591 | rel=r_associated | relid=0 | w=10
  6256. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zirconium zr 89 df-iab2m
    n1=Okihiro (syndrome de) | n2=en:zirconium zr 89 df-iab2m | rel=r_associated | relid=0 | w=10
  6257. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zirconium zr 89 dfo-mstp2109a
    n1=Okihiro (syndrome de) | n2=en:zirconium zr 89 dfo-mstp2109a | rel=r_associated | relid=0 | w=10
  6258. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zirconium zr 89 girentuximab
    n1=Okihiro (syndrome de) | n2=en:zirconium zr 89 girentuximab | rel=r_associated | relid=0 | w=10
  6259. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zirconium zr 89 trastuzumab
    n1=Okihiro (syndrome de) | n2=en:zirconium zr 89 trastuzumab | rel=r_associated | relid=0 | w=10
  6260. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zirconium zr 89-labeled anti-ca19-9 monoclonal antibody 5b1
    n1=Okihiro (syndrome de) | n2=en:zirconium zr 89-labeled anti-ca19-9 monoclonal antibody 5b1 | rel=r_associated | relid=0 | w=10
  6261. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zirconium zr 89-labeled anti-pd-l1 monoclonal antibody mpdl3280a
    n1=Okihiro (syndrome de) | n2=en:zirconium zr 89-labeled anti-pd-l1 monoclonal antibody mpdl3280a | rel=r_associated | relid=0 | w=10
  6262. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zirconium zr 89-labeled anti-pigf monoclonal antibody ro5323441
    n1=Okihiro (syndrome de) | n2=en:zirconium zr 89-labeled anti-pigf monoclonal antibody ro5323441 | rel=r_associated | relid=0 | w=10
  6263. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zirconium zr 89-labeled monoclonal antibody mmot0530a
    n1=Okihiro (syndrome de) | n2=en:zirconium zr 89-labeled monoclonal antibody mmot0530a | rel=r_associated | relid=0 | w=10
  6264. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zirconium zr 89-labeled ro5479599
    n1=Okihiro (syndrome de) | n2=en:zirconium zr 89-labeled ro5479599 | rel=r_associated | relid=0 | w=10
  6265. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:ziv-aflibercept
    n1=Okihiro (syndrome de) | n2=en:ziv-aflibercept | rel=r_associated | relid=0 | w=10
  6266. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zolazepam
    n1=Okihiro (syndrome de) | n2=en:zolazepam | rel=r_associated | relid=0 | w=10
  6267. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zolazepam hydrochloride
    n1=Okihiro (syndrome de) | n2=en:zolazepam hydrochloride | rel=r_associated | relid=0 | w=10
  6268. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zoledronic acid
    n1=Okihiro (syndrome de) | n2=en:zoledronic acid | rel=r_associated | relid=0 | w=10
  6269. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zolmitriptan
    n1=Okihiro (syndrome de) | n2=en:zolmitriptan | rel=r_associated | relid=0 | w=10
  6270. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zolpidem
    n1=Okihiro (syndrome de) | n2=en:zolpidem | rel=r_associated | relid=0 | w=10
  6271. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zolpidem tartrate
    n1=Okihiro (syndrome de) | n2=en:zolpidem tartrate | rel=r_associated | relid=0 | w=10
  6272. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zoptarelin doxorubicin
    n1=Okihiro (syndrome de) | n2=en:zoptarelin doxorubicin | rel=r_associated | relid=0 | w=10
  6273. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zorubicin hydrochloride
    n1=Okihiro (syndrome de) | n2=en:zorubicin hydrochloride | rel=r_associated | relid=0 | w=10
  6274. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zosuquidar trihydrochloride
    n1=Okihiro (syndrome de) | n2=en:zosuquidar trihydrochloride | rel=r_associated | relid=0 | w=10
  6275. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zotepine
    n1=Okihiro (syndrome de) | n2=en:zotepine | rel=r_associated | relid=0 | w=10
  6276. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zuclopenthixol
    n1=Okihiro (syndrome de) | n2=en:zuclopenthixol | rel=r_associated | relid=0 | w=10
  6277. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zuclopenthixol acetate
    n1=Okihiro (syndrome de) | n2=en:zuclopenthixol acetate | rel=r_associated | relid=0 | w=10
  6278. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zuclopenthixol decanoate
    n1=Okihiro (syndrome de) | n2=en:zuclopenthixol decanoate | rel=r_associated | relid=0 | w=10
  6279. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zuclopenthixol hydrochloride
    n1=Okihiro (syndrome de) | n2=en:zuclopenthixol hydrochloride | rel=r_associated | relid=0 | w=10
  6280. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> en:zyc300
    n1=Okihiro (syndrome de) | n2=en:zyc300 | rel=r_associated | relid=0 | w=10
  6281. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> entorse
    n1=Okihiro (syndrome de) | n2=entorse | rel=r_associated | relid=0 | w=10
  6282. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> épiphyse
    n1=Okihiro (syndrome de) | n2=épiphyse | rel=r_associated | relid=0 | w=10
  6283. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> fémur
    n1=Okihiro (syndrome de) | n2=fémur | rel=r_associated | relid=0 | w=10
  6284. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> fibroxanthogranulome
    n1=Okihiro (syndrome de) | n2=fibroxanthogranulome | rel=r_associated | relid=0 | w=10
  6285. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> fracture
    n1=Okihiro (syndrome de) | n2=fracture | rel=r_associated | relid=0 | w=10
  6286. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> fracture de l'olécrâne
    n1=Okihiro (syndrome de) | n2=fracture de l'olécrâne | rel=r_associated | relid=0 | w=10
  6287. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> fracture
    (lésion)
    n1=Okihiro (syndrome de) | n2=fracture
    (lésion)
    | rel=r_associated | relid=0 | w=10
  6288. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> genou
    n1=Okihiro (syndrome de) | n2=genou | rel=r_associated | relid=0 | w=10
  6289. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> granulome
    n1=Okihiro (syndrome de) | n2=granulome | rel=r_associated | relid=0 | w=10
  6290. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> granulome lipidique
    n1=Okihiro (syndrome de) | n2=granulome lipidique | rel=r_associated | relid=0 | w=10
  6291. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> granulome lipophagique
    n1=Okihiro (syndrome de) | n2=granulome lipophagique | rel=r_associated | relid=0 | w=10
  6292. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> huile
    n1=Okihiro (syndrome de) | n2=huile | rel=r_associated | relid=0 | w=10
  6293. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> huilome
    n1=Okihiro (syndrome de) | n2=huilome | rel=r_associated | relid=0 | w=10
  6294. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> lipogranulome
    n1=Okihiro (syndrome de) | n2=lipogranulome | rel=r_associated | relid=0 | w=10
  6295. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> luxation
    n1=Okihiro (syndrome de) | n2=luxation | rel=r_associated | relid=0 | w=10
  6296. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> médicament
    n1=Okihiro (syndrome de) | n2=médicament | rel=r_associated | relid=0 | w=10
  6297. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> muscle triceps brachial
    n1=Okihiro (syndrome de) | n2=muscle triceps brachial | rel=r_associated | relid=0 | w=10
  6298. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> neuroleptique
    n1=Okihiro (syndrome de) | n2=neuroleptique | rel=r_associated | relid=0 | w=10
  6299. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> olécrane
    n1=Okihiro (syndrome de) | n2=olécrane | rel=r_associated | relid=0 | w=10
  6300. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> olécranien
    n1=Okihiro (syndrome de) | n2=olécranien | rel=r_associated | relid=0 | w=10
  6301. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> os
    n1=Okihiro (syndrome de) | n2=os | rel=r_associated | relid=0 | w=10
  6302. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> os et articulations
    n1=Okihiro (syndrome de) | n2=os et articulations | rel=r_associated | relid=0 | w=10
  6303. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> os
    (squelette)
    n1=Okihiro (syndrome de) | n2=os
    (squelette)
    | rel=r_associated | relid=0 | w=10
  6304. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> ossature
    n1=Okihiro (syndrome de) | n2=ossature | rel=r_associated | relid=0 | w=10
  6305. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> partie du corps
    n1=Okihiro (syndrome de) | n2=partie du corps | rel=r_associated | relid=0 | w=10
  6306. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> pathologie
    n1=Okihiro (syndrome de) | n2=pathologie | rel=r_associated | relid=0 | w=10
  6307. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> péroné
    n1=Okihiro (syndrome de) | n2=péroné | rel=r_associated | relid=0 | w=10
  6308. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> pharmacologie
    n1=Okihiro (syndrome de) | n2=pharmacologie | rel=r_associated | relid=0 | w=10
  6309. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> posologie
    n1=Okihiro (syndrome de) | n2=posologie | rel=r_associated | relid=0 | w=10
  6310. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> processus anconé du cubitus
    n1=Okihiro (syndrome de) | n2=processus anconé du cubitus | rel=r_associated | relid=0 | w=10
  6311. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> processus olécrânien
    n1=Okihiro (syndrome de) | n2=processus olécrânien | rel=r_associated | relid=0 | w=10
  6312. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> pulmonaire
    n1=Okihiro (syndrome de) | n2=pulmonaire | rel=r_associated | relid=0 | w=10
  6313. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> radio
    (rayons X)
    n1=Okihiro (syndrome de) | n2=radio
    (rayons X)
    | rel=r_associated | relid=0 | w=10
  6314. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> radius
    n1=Okihiro (syndrome de) | n2=radius | rel=r_associated | relid=0 | w=10
  6315. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> résection chirurgicale
    n1=Okihiro (syndrome de) | n2=résection chirurgicale | rel=r_associated | relid=0 | w=10
  6316. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> saillie de l'olécrâne
    n1=Okihiro (syndrome de) | n2=saillie de l'olécrâne | rel=r_associated | relid=0 | w=10
  6317. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> saillie de l'olécrane
    n1=Okihiro (syndrome de) | n2=saillie de l'olécrane | rel=r_associated | relid=0 | w=10
  6318. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> saillie olécranienne
    n1=Okihiro (syndrome de) | n2=saillie olécranienne | rel=r_associated | relid=0 | w=10
  6319. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> saillie olécrânienne
    n1=Okihiro (syndrome de) | n2=saillie olécrânienne | rel=r_associated | relid=0 | w=10
  6320. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> squelette
    n1=Okihiro (syndrome de) | n2=squelette | rel=r_associated | relid=0 | w=10
  6321. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> squelette
    (anatomie)
    n1=Okihiro (syndrome de) | n2=squelette
    (anatomie)
    | rel=r_associated | relid=0 | w=10
  6322. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> structure anatomique
    n1=Okihiro (syndrome de) | n2=structure anatomique | rel=r_associated | relid=0 | w=10
  6323. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> syndrome de
    n1=Okihiro (syndrome de) | n2=syndrome de | rel=r_associated | relid=0 | w=10
  6324. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> tendon
    n1=Okihiro (syndrome de) | n2=tendon | rel=r_associated | relid=0 | w=10
  6325. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> tendon du muscle triceps brachial
    n1=Okihiro (syndrome de) | n2=tendon du muscle triceps brachial | rel=r_associated | relid=0 | w=10
  6326. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> tendon du triceps brachial
    n1=Okihiro (syndrome de) | n2=tendon du triceps brachial | rel=r_associated | relid=0 | w=10
  6327. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> tendon tricipital
    n1=Okihiro (syndrome de) | n2=tendon tricipital | rel=r_associated | relid=0 | w=10
  6328. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> thymorégulateur
    n1=Okihiro (syndrome de) | n2=thymorégulateur | rel=r_associated | relid=0 | w=10
  6329. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> tibia
    n1=Okihiro (syndrome de) | n2=tibia | rel=r_associated | relid=0 | w=10
  6330. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> toxicologie
    n1=Okihiro (syndrome de) | n2=toxicologie | rel=r_associated | relid=0 | w=10
  6331. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> trioléine
    n1=Okihiro (syndrome de) | n2=trioléine | rel=r_associated | relid=0 | w=10
  6332. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> trioléines
    n1=Okihiro (syndrome de) | n2=trioléines | rel=r_associated | relid=0 | w=10
  6333. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> tumeur
    n1=Okihiro (syndrome de) | n2=tumeur | rel=r_associated | relid=0 | w=10
  6334. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> ulna
    n1=Okihiro (syndrome de) | n2=ulna | rel=r_associated | relid=0 | w=10
  6335. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> vaselinome
    n1=Okihiro (syndrome de) | n2=vaselinome | rel=r_associated | relid=0 | w=10
  6336. Okihiro (syndrome de) -- r_associated #0: 10 / 0.167 -> xanthogranulome
    n1=Okihiro (syndrome de) | n2=xanthogranulome | rel=r_associated | relid=0 | w=10
  6337. Okihiro (syndrome de) -- r_associated #0: 5 / 0.083 -> en:dosage
    n1=Okihiro (syndrome de) | n2=en:dosage | rel=r_associated | relid=0 | w=5
  6338. Okihiro (syndrome de) -- r_associated #0: 5 / 0.083 -> en:dose range
    n1=Okihiro (syndrome de) | n2=en:dose range | rel=r_associated | relid=0 | w=5
  6339. Okihiro (syndrome de) -- r_associated #0: 5 / 0.083 -> en:dose schedule
    n1=Okihiro (syndrome de) | n2=en:dose schedule | rel=r_associated | relid=0 | w=5
  6340. Okihiro (syndrome de) -- r_associated #0: 5 / 0.083 -> en:liqueur d'expédition
    n1=Okihiro (syndrome de) | n2=en:liqueur d'expédition | rel=r_associated | relid=0 | w=5
  6341. Okihiro (syndrome de) -- r_associated #0: 5 / 0.083 -> en:pharmacology
    n1=Okihiro (syndrome de) | n2=en:pharmacology | rel=r_associated | relid=0 | w=5
  6342. Okihiro (syndrome de) -- r_associated #0: 5 / 0.083 -> en:posology
    n1=Okihiro (syndrome de) | n2=en:posology | rel=r_associated | relid=0 | w=5
  6343. Okihiro (syndrome de) -- r_associated #0: 5 / 0.083 -> en:toxicology
    n1=Okihiro (syndrome de) | n2=en:toxicology | rel=r_associated | relid=0 | w=5
  6344. Okihiro (syndrome de) -- r_associated #0: 5 / 0.083 -> liqueur d'expédition
    n1=Okihiro (syndrome de) | n2=liqueur d'expédition | rel=r_associated | relid=0 | w=5
  6345. Okihiro (syndrome de) -- r_associated #0: 5 / 0.083 -> liqueur de dosage
    n1=Okihiro (syndrome de) | n2=liqueur de dosage | rel=r_associated | relid=0 | w=5
  6346. Okihiro (syndrome de) -- r_associated #0: 5 / 0.083 -> médicaments
    n1=Okihiro (syndrome de) | n2=médicaments | rel=r_associated | relid=0 | w=5
  6347. Okihiro (syndrome de) -- r_associated #0: 5 / 0.083 -> olécrânien
    n1=Okihiro (syndrome de) | n2=olécrânien | rel=r_associated | relid=0 | w=5
  6348. Okihiro (syndrome de) -- r_associated #0: 5 / 0.083 -> oléinées
    n1=Okihiro (syndrome de) | n2=oléinées | rel=r_associated | relid=0 | w=5
  6349. Okihiro (syndrome de) -- r_associated #0: 5 / 0.083 -> oléique
    n1=Okihiro (syndrome de) | n2=oléique | rel=r_associated | relid=0 | w=5
≈ 37 relations entrantes

  1. (syndrome de) --- r_associated #0: 56 --> Okihiro (syndrome de)
    n1=(syndrome de) | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=56
  2. en:duane syndrome --- r_associated #0: 40 --> Okihiro (syndrome de)
    n1=en:duane syndrome | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=40
  3. syndrome de Duane --- r_associated #0: 40 --> Okihiro (syndrome de)
    n1=syndrome de Duane | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=40
  4. syndrome de Türk-Stilling-Duane --- r_associated #0: 40 --> Okihiro (syndrome de)
    n1=syndrome de Türk-Stilling-Duane | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=40
  5. syndrome de duane --- r_associated #0: 40 --> Okihiro (syndrome de)
    n1=syndrome de duane | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=40
  6. olécrane --- r_associated #0: 30 --> Okihiro (syndrome de)
    n1=olécrane | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=30
  7. olécrâne --- r_associated #0: 30 --> Okihiro (syndrome de)
    n1=olécrâne | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=30
  8. oléine --- r_associated #0: 30 --> Okihiro (syndrome de)
    n1=oléine | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=30
  9. élaïne --- r_associated #0: 30 --> Okihiro (syndrome de)
    n1=élaïne | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=30
  10. OKT3 --- r_associated #0: 29 --> Okihiro (syndrome de)
    n1=OKT3 | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=29
  11. en:olanzapine --- r_associated #0: 29 --> Okihiro (syndrome de)
    n1=en:olanzapine | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=29
  12. olanzapine --- r_associated #0: 29 --> Okihiro (syndrome de)
    n1=olanzapine | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=29
  13. olécranectomie --- r_associated #0: 29 --> Okihiro (syndrome de)
    n1=olécranectomie | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=29
  14. syndrome de Okihiro --- r_associated #0: 29 --> Okihiro (syndrome de)
    n1=syndrome de Okihiro | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=29
  15. oléome pulmonaire --- r_associated #0: 28 --> Okihiro (syndrome de)
    n1=oléome pulmonaire | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=28
  16. oléome --- r_associated #0: 26 --> Okihiro (syndrome de)
    n1=oléome | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=26
  17. en:Duane's syndrome --- r_associated #0: 25 --> Okihiro (syndrome de)
    n1=en:Duane's syndrome | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=25
  18. en:Okihiro's syndrome --- r_associated #0: 25 --> Okihiro (syndrome de)
    n1=en:Okihiro's syndrome | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=25
  19. en:oil granuloma --- r_associated #0: 25 --> Okihiro (syndrome de)
    n1=en:oil granuloma | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=25
  20. en:olecranectomy --- r_associated #0: 25 --> Okihiro (syndrome de)
    n1=en:olecranectomy | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=25
  21. en:olecranon --- r_associated #0: 25 --> Okihiro (syndrome de)
    n1=en:olecranon | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=25
  22. en:olein --- r_associated #0: 25 --> Okihiro (syndrome de)
    n1=en:olein | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=25
  23. en:oleoma --- r_associated #0: 25 --> Okihiro (syndrome de)
    n1=en:oleoma | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=25
  24. olézapine --- r_associated #0: 24 --> Okihiro (syndrome de)
    n1=olézapine | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=24
  25. syndrome de türk-stilling-duane --- r_associated #0: 24 --> Okihiro (syndrome de)
    n1=syndrome de türk-stilling-duane | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=24
  26. en:olecranon process of ulna --- r_associated #0: 22 --> Okihiro (syndrome de)
    n1=en:olecranon process of ulna | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=22
  27. en:anconeal process of ulna --- r_associated #0: 21 --> Okihiro (syndrome de)
    n1=en:anconeal process of ulna | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=21
  28. Okihiro --- r_associated #0: 20 --> Okihiro (syndrome de)
    n1=Okihiro | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=20
  29. neuroleptiques --- r_associated #0: 20 --> Okihiro (syndrome de)
    n1=neuroleptiques | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=20
  30. syndrome --- r_associated #0: 20 --> Okihiro (syndrome de)
    n1=syndrome | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=20
  31. Duane (syndrome de) --- r_associated #0: 15 --> Okihiro (syndrome de)
    n1=Duane (syndrome de) | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=15
  32. Olanzapine --- r_associated #0: 15 --> Okihiro (syndrome de)
    n1=Olanzapine | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=15
  33. Olécrane --- r_associated #0: 10 --> Okihiro (syndrome de)
    n1=Olécrane | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=10
  34. en:OKT3 --- r_associated #0: 10 --> Okihiro (syndrome de)
    n1=en:OKT3 | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=10
  35. okt3 --- r_associated #0: 10 --> Okihiro (syndrome de)
    n1=okt3 | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=10
  36. syndrome de Stilling-Türk-Duane --- r_associated #0: 10 --> Okihiro (syndrome de)
    n1=syndrome de Stilling-Türk-Duane | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=10
  37. Türk-Stilling-Duane (syndrome de) --- r_associated #0: 5 --> Okihiro (syndrome de)
    n1=Türk-Stilling-Duane (syndrome de) | n2=Okihiro (syndrome de) | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr